<SEC-DOCUMENT>0000885725-20-000044.txt : 20201105
<SEC-HEADER>0000885725-20-000044.hdr.sgml : 20201105
<ACCEPTANCE-DATETIME>20201105064815
ACCESSION NUMBER:		0000885725-20-000044
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		67
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201105
DATE AS OF CHANGE:		20201105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		201288562

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bsx-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:5aff39ba-e31d-4daa-a93a-6fdd4a47e66b,g:1fac046f-4056-4f94-9a0f-fce45535a3a4,d:8a2e73a0c2ae455a8a5a335cd6209152--><html xmlns:bsx="http://www.bostonscientific.com/20200930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl8zLTEtMS0xLTA_d44b0610-fa65-414f-b16d-36c72a0a4324">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl80LTEtMS0xLTA_bc123495-6de0-4f87-a9c9-82586038fdea">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl81LTEtMS0xLTA_801a0ce1-c51c-4d39-9658-e548ec6cfea3">2020</ix:nonNumeric><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl82LTEtMS0xLTA_cfde9436-62db-42c6-88a5-c9cec714b240">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl83LTEtMS0xLTA_a3619928-60ef-4ac6-aa65-8aa86fc9eab1">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i42920ad2d130414c94e7dd4337df532f_I20201030"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49144bb069c54c75af6cf61abd6b94c0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d357c574ae49f6894555c699e39978_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ba508544a742afb3886d6afa51d329_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed7784314414425be90ef641324a0a0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a952e94562c475881460deca9c1f953_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac50a2fdd97a471d9cf22a475f9b6eb6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9654d2156a734b7bb306daa5f24ac4f6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f2ffdbd3d541cc940fcca69a479645_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc127a01b37a47e08d86d8c2afe2db89_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b17f27c1e6f4baaab1cd43126cfa691_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0256f56d5ebb49ae841f4bd5d04e0506_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic55ae15680004d338d27b266d917e873_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b9bee0e1b914abfbc8ee0729f0f7167_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389d0f154e33475c9cd0ffad7b77ae5c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i395b87fb2a894ca68005db9b471ca8f3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d28bd993914c93a2b6d7bc66d8a2aa_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id32a3651258b4af1be2874b460994080_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5fec6efef8f4034a077c780127b7955_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22b25092af7a42e8b7f7b18357a7e0e5_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id06a3877ad6e4bdeb577199119865754_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95412a9549fb4960bddd35b290d776dc_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id003719d3acb4f2c819a2b870e25e7f3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3783f780c95d415ab119c6cbe0e8e002_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bd0c08e350549ba9bd9e9c0f784b86c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdedf628611e4636be8687e15376e46f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219690bf96274e70abead54b1cdde00a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a512ca465c54054ae1c533835551eb3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5fddd0be6b34cbf9c0c59129d20de59_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d53278bb3374215bfb7111c4e4eb852_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72b10ec5ccaa4c03a9d7d69f78107b06_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d91d7efcbc541c280da9d3c93b4db84_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib24d1e116bfb46d5a09f48c999e73bcd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e6f2b58df5c4e379f9b4bfbd6b43c9d_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc86ac77e4046889ddabb53e93461d1_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c6095e3497547369994d298e3adc925_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6a6c7eff0984f66bf876b54aa555878_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89773722e8443d187d6fe4372399cf2_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6c7a01cd56425e9bfd5e3b6f17711c_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a965a86df74f9e9c8bc0784f3e7c2c_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7ce995bd1640c4aee3f34d47266617_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61d24f1efc934db89e5dbb0533c917ae_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d0a154b29ae451e86bde6739f2a9274_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa6a9f62803f4d98b27fcdd993d68d18_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i332ce0e258df462b836e35e03bde9533_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5e8e513f614ff5a920c76bd85ad3cb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f513f5c52b44fe1a6e0a501a7d892fd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia54f5bbb50bb4be28c6d67abe157ef90_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22eb4f14ab734ae880cbc0fdbf788799_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd13145a5164386acf44a6fb1097a18_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5a732cb9c1647e1807ed514f4dcad3f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e5f52e47224bbd8c81aeddd9c8552c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1033701a5ff945638f415a913d827d89_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45598a0ab9d64a56b01f170bb45bd1ed_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b0ff86adad47a180c0719888cf6a71_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia668be5ffaf547b883b6fdaabe784961_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75abf3104ec34cbdbfe44d606eead82b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fd580f105a4e5381e382e6129b9261_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38127b708b84afab8ea55c25c0b6c18_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8039b774f5c4418c94b57c87727823af_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506512c62581437bbbbefeababd35a7f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i307df6963fea43d7ab493ba4862d9b33_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2caa315022214c4f891424d66b0ab750_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id497f96f1bbd4cfea05234ce48bd7220_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeffcfc2961c4fc3a627a5e430c5fc24_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c67d19c9ea5443387a81c46c1e319db_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i198489441d644b71960becd4df1256c7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if44d8794413a44bd8cb416f5e22758a3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id226c300bfca45e9b55a05b24b6f67b6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa8aa447538c4c9899d80c9a8d7e1f82_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3951d84d8c54e33b4108a6298ded8e6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i432a7e24f8124d53a12c4b06b90f3f3d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eb24a5db4a84f9aac55d92ace8fbb33_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieddb3e5a196249108dd92686400d6e00_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id275aa24a2de46bb97e130263856c8cb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26cdf1b470b441dc8312a69ca2a3a82e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe13d2d881c478c9713420faa1b3a01_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f8de4c7bde4dbfb0824f68791a47e7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456ac438eda6495e82678ce466563701_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icce032be65f744de9ae2f698e732db43_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-19</xbrli:startDate><xbrli:endDate>2019-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbpPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8b95a6dee16943f59d2330f61315da56_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf7c7c10539a427aa016b8f246594fb1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8c1b69039194f6d941fd5b48076ee41_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic20a36eb220b470eba748536a11f26fe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddadff178c5c41a3977cf15d3cf00c99_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ice23b320aba74832b975dd54f9a41b8b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3046b7a84674f07b8b6bc5297d63b3a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77b41059a837448d90bd8dc4312473e1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77e24f9ec65b4419ab13c89e5afacd34_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4948def2b3404998b1a8e76ccc208655_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05dc2bca12f441518b8eae871ad3ce57_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef09943eb2142468d55375ee434dff1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6543e61e1ca452a991a93b48b5860ee_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideeea0ead40f44dd993b303107e7c8c0_D20190611-20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-11</xbrli:startDate><xbrli:endDate>2019-06-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i306877ff66b94d598003e4699fa0e864_I20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8ef1bb81a34679887900294644c59b_D20190129-20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-29</xbrli:startDate><xbrli:endDate>2019-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e985d5f31da4655b4775f3c18736888_I20190129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f8ba5a467c45fe948ec96ca784057a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i085d4caca7b24cb58a868824db62acdc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e7195e106047a191895672017f64b9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i813c67adfd7c4a86afbb6e281c6d478c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec1555f039564481906b06dd35a52e71_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i896dbc3c04fe46f58b32c467a3593953_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fe4e49dc414447fbf120ce2ae4f4623_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf332292a44a478e9ebea4a33fbdd424_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ebccf7ca6b8470782d5496c6de481af_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if244a5996bc34f8ca2bdf001a69336ee_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i14ae891ce6774513aff2cec35b4d31ce_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5c4aa9bf38540239bdd1ab15292743a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4410774845a24a54a144e7dfdfd8ba6e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88663b924d2b458cbccc972e892704cf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b832479fdc344b291fe8b6401da66a0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a217a1106c342bd90cffb6a011624ae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fa93356c3144962a66e1b420a7d3f9d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3790bd2f6293401b8b5a8afd9976f99e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id56d0db5fc654680827529f68c76a516_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bbb535d2f4a44f09dd05caeb7d8477a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f9a34f6262041b292bc78770a80463c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17832c8686724365b57112cd962e98a9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368407ac90bd421f986c8a5c24c675ed_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5853d5a25ac44b929ce01432224f5764_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib57f804f076c49c08bc6003ea608e766_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9542da37d90b419a88f21b32b9c18e21_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1be545420574c14979c7e504aabb492_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26051ae85e46473d81272a66ca863cd2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c3d9625d044893a61231379ae0aa16_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b731401f35464ab0c5a3185d967ae4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cfe5b0fd59340ada20dfb76e33e0309_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i372d2c53d9bd461a84e365951a7e89f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia32c5c68e1584780b49485431c11519d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5994440a5ab43e7824bcb235c5af0d4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5043da4f04a34f68aec48682ecd51130_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaddac085144a42d6aec4edf923f8c7c3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954b543dbcca4f58bb805011cd0e2930_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i3f0f30a839ce400f83708877f49b9875_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2019AggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b7c6355f6f4da2bc3951ba8ac457bc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a6cbe1bcc24e6295df27f547e399d3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i316fcdf591d645a696cb2f1d899e6570_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42fb2c3fa32c4bc597cc49dbf63d74ee_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75faf6b7006a41fa96265cf1f9f67aa0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if002fd16794247e590bb0cd6fee13f1c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if782d561570d49c68f1b0b89799129fc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0eecb377e56463294ebc8b3dffe10dc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee44d3c3f9549e991f73b2fecade56b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7be0d79b1114275af29836966037801_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie83d791495c24438aa2a9934db0f5fbf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4150ff86e91f4b1ea24f3ea91dd6cbfd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc9f66aadb7d47b8b2707a870b298e10_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6833b3853ecf440c91b89098a42c9d15_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf0b89b236347bfb2a0960469c3a865_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="units"><xbrli:measure>bsx:units</xbrli:measure></xbrli:unit><xbrli:context id="ieb220488504c46a48fd04031fccd6f33_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i914745bc3935420f887e082516427691_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3893d347b5444056807f279202372d78_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b6e4b111f24b6c8656058dcbe12e0b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1ea23e5779431d819df7f113a920f6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d13e7a6daeb4e828855c9b09932fb0b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c5fdc3e0c2841679fe97d318ea58261_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee25b48d00f74853992602eb2c53b356_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e066a79d8694e84bb7d59645a985325_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda5c2730294403096ebcb12e679b68b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8dbcfebbf2c45859609734198a2ae94_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9c57ccd0e14aa19b6048d2641cfed5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie07d66f08df541e5a6bd2738ae221eea_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i550b85029b34440588a334f525c0ca30_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fac259a6324f2aa04bf3e997577a63_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i826a2b71a6644d9dbe9440eb86ce853d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if45df496952543af8b99e6950f252bfa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e0da1bd6e74a93b4391d856c9315ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8125d7008104ae1b687a8452733fc60_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i908b44cb3649452a9d48f0aeb4a0b87f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2461e9e08ed24f98af87739812b9cab7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6077953b0caa497d9b5dd8eba2746b7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c292c22eea34b9f93886b4e780ea698_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10d9296653634d229d1784d4e2a5260b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ecd3415137b492d9047dd0721eee7cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64b1627c34744a79852c22f89f4e2bd9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0486c1f5a3dc44bbad592c4face792ce_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i401066db3ff649128198d977bf21c7d9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d8e764d9f154c0ba1fde2f3c18ba6f4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide565556a33042009f2db6eb39c31318_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5585c06b1a414f278e4e8698e3e9ade6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie650a8a143a34390997d58eb8375e627_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1fc603c49e4452b1fe2055d66a5728_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05d67b0c2c82420f89ded5c32461a093_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96fb4dab0df493cb56977ec02e792ab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40844fee5f8f45e0b76f79276d662d4a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fdadf64e0a447b8a6b7edadefcae98_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf8fad34607d4972966fe7b09a5d903a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ce7410ffeb041b585ba5959fc091a98_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2127f61595964047ad8a3dafad593c19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fcdc57567ed49098103241ed9fc2e10_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4c4d99b6f84b108d22a749ed8bcb43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a32bba350f7460f802d9e35490647d0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf53f2e2753142488c3129ebd45bd3f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8b2c94ac6b144dea20cdca5373da9fa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i984aed9feb2742ae9f40f9ab8d399bee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff9eff59418d45d38da26fcd40dba083_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i074cdefffbac46a5aa907b64799c5c18_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide3c2b7d701e44a19150fa05ed088e19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd9e8fd2638a4eb5882534a5a95c4011_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27a0bb0216b14c8eb6488725ad9369e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i883f72b197734176a05916892d1f98aa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dbd5b02a23541cd9066e7e6764eb0be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a969aa844b45eaa688cf2e77a81451_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c7a363bc2a4be7a656ce96470fc32c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3147cace57a14c1e88a7023fa0d1a751_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bcfebb0ff6544389662db268de515a9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0024f7d8ff964efa837a696943046bff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53fefb20cb374b77a6a68660e9ec56df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6cf239eb4aa40688db906dfe60df801_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f7b010ef6d24932aa67070e591431ad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90cc8ab8094b4817b0b7472672466a1e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3ca8274c7c84451adfe5cc6e39d84f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie14af729841249f68bb249aa9328ed14_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i471614cc047e493a97bc532efbc84e9e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f676404a0d4a368a7a8b76358caf94_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0055d17e432d43e6a5716e6ef8c734af_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef58c4a2ac34d8487fda59f2817e413_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbaf3b08ce1a47f0bab1706eec16f414_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8512f90c15ee4bf1a751122703f3e372_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9765c02939444a8b21465369b4d6f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4918679d9a1491c920d33be9eafbb1b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ab56af73414eec9527c4729f49674b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6048faff94fe4e3f8ff35fae909e93f8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96e3727f0c4047e78994b7e46ebbd066_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i188f9ed380a4434fad684f6ec8f9957c_D20200518-20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-18</xbrli:startDate><xbrli:endDate>2020-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a0778d1a32c42a698d0c0d4391be338_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac08e9e5ba84c159c3799c380213ac2_I20200227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a1cc324ff16414fb873ed25161c08e7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36af306e51d44c42bb19eb47b23ae5b4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56c2ccee432470da073b69f5e06f077_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cad1325157949eb8729affa69cd1f9c_I20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea83365e9d284726b2d572cf20af3e78_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3744c29fbf454f11ad39d179e30ed2c8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6793d82e66694285af4326091ac468be_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:AggregateSeniorUnsecuredDelayedDrawTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356171311f5740fda173fd3ecc70f05a_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2daade2444a049a4b2e1cbdd923ce601_I20181219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83915196e3d34a92a3c8eb05366c1b25_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68796c45e93e415abbc18dda7fc8d1fe_I20190819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ad9677f736c4ba4aeef783f34c21d4b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55fcf95b4eb4092b6c279ab4b78debc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec7a450c3d54d0f8b17663bc0bb3763_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4657030099241c583762bbda7fb257e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:Requirementextensionthroughtheremainderof2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic50a96ccf5e5405ea44c3569e511b345_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementthirdquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb1b018038e41b6bcb8d9bc27e45f0f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfourthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0b5203b93642e2a8fdc6e76df7568e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54e4c18dc5a04626b7d5a7ec3770c878_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab04e6a866c54c479502399061c066c8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253c4d1492ec41528006e7fc65ed1f90_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f3cd5bec824c3883ea52033763412c_I20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020SNAggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea047c096481465dbe4a37db91ccd61e_D20200518-20200518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-18</xbrli:startDate><xbrli:endDate>2020-05-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf84351e6d7f46b5b417b3fe7a492801_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if234b468e2014e5f831131ce97f1e3d4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb3528bff5c45a493e93a5e6edaa687_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6773aa82907a4a00b7b3cdf75118628d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e9769b9ff414bd2b8b2073ecdf42894_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba75e1b9e124586932fb7c27ac202af_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da5402f99a740959e8d45ac53a0a17d_I20190225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:February2019AggregateOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia241322b6fe54781a8915e284bf41aa9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25bd1c30873b4a2495db8cd417725ada_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbbf84bbd3c14b8c9b7bd99842df6139_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51badacc45004d658f01556146c4c4d7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i849e8308c4dc4865a29cb7ca737f1d05_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bsx:August2019TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb811284281f4dec9c9d5f3ad78bf9ca_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13011e07a9c4f78b791f39df452c756_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i624957ecbe3e4fbbbd064e40723f0a53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30818acc715047c9ad17d283e629e3a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica793e70ab6c48b08a38c04312340dd1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife92981b4da641aabca9389a91f0a450_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia406644c1ce04cda93abfe713b393765_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i413e4fb8d6234afca3447f3b21048756_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3df7cc192c604254acab7fbfe4adf235_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a0e9005e53465091e8bc2786c7dc97_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id080ca0787b6468a8ad3d631ea2b1130_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7aaf89e580246e2979204c398ade960_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7517236e64694d1f8bc3fc2479c9b98c_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claims"><xbrli:measure>bsx:claims</xbrli:measure></xbrli:unit><xbrli:context id="i71c575ee4ac546e0916bfef92687e6e1_I20201021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53217914a25e498e83f410e223fceb43_I20201021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f1f44e32d174b6f98c5b0276649eb93_I20201021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bsx:AssignedtoonejudgeinMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b934c31d804d8d9a9c89f2fed9a737_I20180912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:UpfrontCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dcbc3c9b20642dd97b2450bb8f713bc_I20180912"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MaximumContingentPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied343c75dd384497a465543451475c7e_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b23f1cf3f54a46ae87e6bafb2588bd_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735ff78c796c4242ade8554aac15b307_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88c3b4165083494aa4c7c21c4f6d3bed_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i927de457f17d4bfc9629007545156993_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i044387e090504fda9610329194e2938f_D20200901-20200901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5544b1d5914e58a5ff9e8a859120c7_D20201027-20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-27</xbrli:startDate><xbrli:endDate>2020-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33acd291741444b7a9ad38bb3a5168fb_I20201027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id033163f06e84414929b16208d102740_D20200527-20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-27</xbrli:startDate><xbrli:endDate>2020-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10084aaaa064d9b9dd7f4c0a7135478_I20200527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e5a839e6644a3ebe0fc87afb8652b7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff49d6c4be2d449b9e042d9f93d88310_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a93e002d5af493191d6045b6aa338c8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if33d9aa5eec440d1be0ea74cd2b49d11_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe224921843489fa50e4d09095407c2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833e41e801144751afbac73b9aa9265c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35462ec189f045ddae63069211960cb6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic884158bc4a143839655392d299dbb94_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefa2ca97a83b42d4bf746ff34f43d60d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf5f2e440b564accbedba954cc39048b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96632a4cb64d4dc6badba032df2ac6a3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedfe6f2561594c8ea46a25a3b46e254b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportablesegments"><xbrli:measure>bsx:reportablesegments</xbrli:measure></xbrli:unit><xbrli:context id="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id99149f63a5749519353038bc1faea89_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0856ffae144147a8a676be77a9661e79_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7af187ab814d74846a21e66345162f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba152e6d345944b6a404d50555024e71_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d58860b34642148a851e295ba585bf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i048389ab0ac64d2c87536a1b5d92aa9c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i208885de1f9f46179e0e8abe705b572e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb4d909a6d644667b4efd3a44da3b9d4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4eb2858779c49a1a5ea2fe50cf134db_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i650712180e0241db9f0773a48064834d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a76ba5fa6be4f6ca2865115cd913496_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a591219122f4c2a8f9ec4a0684b5227_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3ec4a2e86a478a9dabb51fefdcad78_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5295e2ecdd9d4b8ea224afddd4be5043_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cb8cadf62d949b495b63577e0fda131_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d28c3b1694d4c69bd90388ac8bed40a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib92234b181bc4d4f89de8646d2dd9fa3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5664ea4ee0564071be7fd04ebb16c8e4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f90b3ff4704d268311e2eb4815f7cd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74aa340bfd624b43833d9080bc81a794_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b628b4b4bcd4356b45406733cf96466_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeca9d8fa162485891beef8cec914fa9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd362ef82b134b30b14976f7ae67e13b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id836b0b6f49547e69517df5107404e82_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e3ab480d844da48762b90ffff4b1f5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f216b357084f708a38791c0e69fa94_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d6d998c42c481582ee64ca962cc159_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52100b5c46bd49f9a35228954f1c7417_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6fe5ba5da50414d9f4a59566f2373e1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c61c03b46ac4133a1766da24872ad5d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f063ede9a534803a8c2cca679760529_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf4c42c9955e49e7875feec90a8fca77_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da8457277394b6d9cbdbc56a40395dc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38b75c07c0a4e8bb20367199b3a3137_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57f25f59b9aa4aeb9d25e946e240ceec_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie14bf9c81c71484eae0b513f8fc3ee21_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dea49b278804d72b2691e583fa76c5a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie72716294dd24b2483172c0606c195a8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia82abde4de7a4ad291720e38ace07b19_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c50792aabbf4ddb9b06af0078c9cdb3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1997f45a21c8439dbfac180e2b0d74f1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fff6d00823641e094e51bf1fe888c9b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ccbaa46c3c4964a7e1df39c1bc8aed_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95675abed3134712b2d78ee5f0f52204_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0b86161ea44cba9a228eb7c635dd36_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80555f6dd4cb40a48dfd0b2587304fc3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9e41e9d4c44839842870dff12c933c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if81b5cb71db84008b270fc47e76998e6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b15983e106b4e89bda000c883086e9e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a5f3dece36b4d9797ed5acb0b90daf4_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab37d97d08e42a7b67c4e7178669c35_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0acffb658960466eb1fc67e7ca045948_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ce84bb33df4e31990c5963ff81d63d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9793b506e6474cea8ef7b144ff2a1ba9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d4510358244d6fae7ec31c72217294_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05caee353e041109255daf8c865e2ed_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib34d233696a544a1ae2c974370c8315e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e862fbb1c7d413192549928e2464ffa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de65bc069d24d51825bdab4b50bd41c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2099af0836c24bc1b803f81eab14b8a0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb9fb1a2b2f24fa293105915ff8b08e0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id280062840b2435eb308bd4c66b47fcf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10f1a708d4e547908f94f4cbfefc9425_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c352cc7257452c924fa7c4f8f29c39_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9ce64349f174b9898c3ae08f6a8619a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i891b41394ba84479b8e900b71bab7425_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacf8b1e5d2d9412d82011f9725561fe7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0a83ead422742818de6d2d992f45122_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3a2a8cccb44fe89ad6947ec51b189f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88abe695eff4ec79c92c9b51eb144c1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026b1c31e2164480b52d6156bf29ceda_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i083f1c7b584149eda19fe53bf7f9e950_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bca6c5210634d32ba0fb78a24986bfa_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i472c98506bfb45ac973bc5141d646641_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00311d766dd24a468df0201eb3a98a98_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb736062dca24512bad3fa08ad4ac3b8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300d7b781b864c99b873d04c9d8c1861_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b26fb08edb4643836d722d1433826c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5f8b764815543ca89b15a0f65b4286a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60eaf78208af46938794bfa911789a21_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2104c8e67c9c4f7ea81b0f7fd2d47b1b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c6abc5823240358a6851a296ac9701_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bab7eecd6e84feaaa75ed43b6cc6db4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b57559a2bd8439daa00da2ce3307b8c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb32d52b9c8243efbabe0b365289bfbf_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979e2c7f0cad4c01a72c0aa7ef8b510a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41a939d6e964fdb92096b0fe824a09b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied533bdc632d4ce0a14378174c2760eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09381a44114941a4a42b342af6277fcb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24f0a567b61489ea559da0492eb8bd2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i848dace5f06f4632b8e52342192aaa89_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie907d1127d5b4f1891715b552d0f2720_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i332f62f3ea2842fab11b86ca30dc2375_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1119d578b4ea4da9bf0365681fa56dc8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc7104ff33e4c48b5d13452491f1ce5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i717f0d15b6c94e21a894833031631fca_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15ca578eb6044b1296051e9a07918f73_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1973b158c2c7411ca93ed11aa1f7120b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i623c86db3713458ca2b7defbbf8058c7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f9578856994687889ca858501676b9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4f70470d3bd48dcbc4feb2bc35e086d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75f2988c1732418c928a801db05c25b5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i986f91df9ca9493a8d7d15802a1c0570_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f8c7b64fc864c49a306a9b4254fbaa7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i705232db70004ea088c0dc1093c8b9df_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36bcd3ce2ebe47c5bd79a16c0d3b29d9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ba0222e4aa4c59984dae3c8006ad93_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020fd119041d418191cf85bbfc54285c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e13b532f9a64e418eb80c0976c3b6af_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49f9023219ff48cba3a2fc8ae591929a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i105ce581a7544f47ad757216472bcc6d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59107e082d014734a4ee490225fe5ffa_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba53a1d39d394e8280b268a72077bd5a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625dce25ac3c45a38e0390b9592977f2_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3551557143ac42dc88cc80b58e98bdb0_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd4fa8afd39046fc92a81f01071f2a60_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d6e62892f954227b719df17b5bc2c30_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i673c5b0fb6fe4743aa18d48721035a1d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f2be30198a405d8b8ea83a69eaf25f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea70c191ce524d3f869a4a09e65e620f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a3a8a2f83894a3296a3091b4bb232db_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6888bf8540af4896a7727d330b9361f8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b5dcb6fca7c446dacf97994b28f8ad3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8128a4d029a94bb89cb486f5c5f0eb0a_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d9ab6494b964761bf03a135b4b4f64f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i657eb7c32c324e8894346cfcb27b2689_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id843d2538e014a02a8d63e8255b29a90_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id73057f636f442ae8f81a9ac97489ccc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781a010211e840dc81fc687839042bbb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d3e241fffe450cb56f3a263380bccb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f3e53dc9ca94bae9d18d4780150080e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8128e54be7e454695b08432140f99cc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5be373172e034996889706e0c8fad15c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e40dd0d92b4f80be9dc394e4027845_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a16b3866b9041938a6c24f85548a18b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5aec6e059674fe0994035b7a01bb825_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i630933314e5e4cf5bfcc14419acec677_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8511168847a45e096f858b26873d803_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c9704b036b149d689349b41b329038e_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id81bb93af48745e6a559b70678953bfa_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifba26fb5d1414c919d17e80bdc02dd30_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i585a4990b22043b7a34314da74c8dcc7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9b2155f584f430289ab76456eb294f0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia29baba230164973991e71f75d7e2df3_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dc339cf33204e73b732865ff098bcc1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15b282dade649b69746d0ac5cab9434_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEw_d9b67544-8560-4a04-b554-c7c71a067a60">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6M2NmMGE3NmNhNDNmNDI2M2E4NDgwMmYzZjhjZjRmMzMvdGFibGVyYW5nZTozY2YwYTc2Y2E0M2Y0MjYzYTg0ODAyZjNmOGNmNGYzM18wLTAtMS0xLTA_7f2d3bcb-c8bc-42c1-bc94-39c9408d98a8">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8xMjA_1eac534c-975b-447c-9150-d587790ce235">September&#160;30, 2020</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6ZmQ0M2UwYWZjMzg0NDk4ZGI2MzYwOWJlMzUwYmNjM2MvdGFibGVyYW5nZTpmZDQzZTBhZmMzODQ0OThkYjYzNjA5YmUzNTBiY2MzY18wLTAtMS0xLTA_2a68d648-224b-4b22-86a0-c2fb03feff36">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.&#160;<ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEx_86a96ac0-fc26-45b1-ac01-21133e9773a5">1-11083</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEy_aebcd1b5-921b-4cb1-b833-ea42325cb1c4">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6MDBiMDZiYzc1NWNmNDQ2NTlhZDVjYTUwM2RjYWU4YzMvdGFibGVyYW5nZTowMGIwNmJjNzU1Y2Y0NDY1OWFkNWNhNTAzZGNhZThjM18wLTAtMS0xLTA_7ce68bd7-26ac-426f-b0db-f4b4f6be09b6">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6MDBiMDZiYzc1NWNmNDQ2NTlhZDVjYTUwM2RjYWU4YzMvdGFibGVyYW5nZTowMGIwNmJjNzU1Y2Y0NDY1OWFkNWNhNTAzZGNhZThjM18wLTItMS0xLTA_dc8c55da-1a39-4e7f-8363-a3e358f20077">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEz_020562c3-46fe-4c4b-9c16-7c4142e82882">300 Boston Scientific Way</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDE0_bfd9ee95-6a47-4881-9e89-3e0db5ae7e96">Marlborough</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA3_e87ea9a1-1b03-45c0-b62e-90b550f7278a">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA4_3a1337fc-22b4-4727-a21b-366af8c450cc">01752-1234</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA1_d83e7311-8d16-4f2d-82e8-6b58f4c47f66">508</ix:nonNumeric> <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA5_8d4b78d7-c235-481f-bb02-b371bb719bf3">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8xLTAtMS0xLTA_4a0e98d5-39db-4c70-8122-9435bd2e11f5">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8xLTItMS0xLTA_91818f17-e45c-4360-ba52-2fa96b4fb6cc">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8xLTQtMS0xLTA_fc7ec370-432d-4e56-82cf-506e6038e34d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8yLTAtMS0xLTA_b338b6b5-f210-47f6-bb77-c3dd286f5f24">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8yLTItMS0xLTA_1dd2ff7f-df90-4d9b-951e-3b24463bde45">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8yLTQtMS0xLTA_17cfdc7d-6963-4b56-90af-558e1c2461de">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8zLTAtMS0xLTA_875bde9c-9930-4cca-b957-21557dbe27f9">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8zLTItMS0xLTA_9ff79657-6d4e-40b4-9166-50d014b579af">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8zLTQtMS0xLTA_620a332b-8bc8-4d79-8961-51b0d8ee6e73">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDE1_47ff3d86-3207-4384-b9b3-2962ecb4cc56">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA2_b662f966-dc20-4474-b2eb-4070392f7dba">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDg0Y2VhZGU0ZTNiNGY3ZTgwMWExN2UwNTM5MjQ4NjQvdGFibGVyYW5nZTo0ODRjZWFkZTRlM2I0ZjdlODAxYTE3ZTA1MzkyNDg2NF8wLTAtMS0xLTA_5f199c8b-7f1c-4602-ba7e-5e50de566cd0">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDg0Y2VhZGU0ZTNiNGY3ZTgwMWExN2UwNTM5MjQ4NjQvdGFibGVyYW5nZTo0ODRjZWFkZTRlM2I0ZjdlODAxYTE3ZTA1MzkyNDg2NF8xLTMtMS0xLTA_3eda7b78-1f8f-44c2-b82b-b6e3fee57630">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDg0Y2VhZGU0ZTNiNGY3ZTgwMWExN2UwNTM5MjQ4NjQvdGFibGVyYW5nZTo0ODRjZWFkZTRlM2I0ZjdlODAxYTE3ZTA1MzkyNDg2NF8yLTMtMS0xLTA_69d09b0d-fd46-428e-b2d6-c84f6b1e2c75">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDE2_78dee266-d6fb-4177-a2d4-d06d7c9e5a5e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="2" name="dei:EntityListingParValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8xOTY1_ee0f50d0-66c6-4f0f-93c9-650b3adb849a">0.01</ix:nonFraction> par value per share,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;30, 2020 was <ix:nonFraction unitRef="shares" contextRef="i42920ad2d130414c94e7dd4337df532f_I20201030" decimals="0" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDAy_0e140b92-7f0b-4e38-b306-1c5a25050cea">1,431,921,459</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_13">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_16">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_16">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_19">Condensed Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_22">Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_22">4</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_25">Condensed Consolidated Balance Sheets (Unaudited as of September 30, 2020)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_25">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_31">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_34">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_37">Notes to the Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_37">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_136">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_136">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_136">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_163">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_163">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_163">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_166">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_166">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_166">62</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_169">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_169">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_169">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_172">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_172">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_172">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_175">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_175">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_175">63</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_181">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_181">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_181">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_184">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_184">66</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy0xLTEtMS0w_bd0797e1-d9f1-4caf-8914-1c0943ae5af0">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy0zLTEtMS0w_0d296ac5-3b5f-4f98-a393-0da349822833">2,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy01LTEtMS0w_572a1dc7-6d18-47c0-9d09-2cb2c82b3729">7,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy03LTEtMS0w_39369480-ddcd-4e1d-baad-533d226e5cda">7,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC0xLTEtMS0w_08ea91b6-c2c8-484b-a3d0-4378d3d0248a">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC0zLTEtMS0w_56b69682-6610-4d4a-be7a-bbdbbc19f451">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC01LTEtMS0w_68cebac4-83bf-48ba-bf84-693a9aaccb71">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC03LTEtMS0w_0a272e1f-90ad-42a0-be26-6ff8dd63ab29">2,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS0xLTEtMS0w_961540f2-07f3-47b5-9afc-3fb457af7398">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS0zLTEtMS0w_4e9d3f62-29ea-40b9-88ef-69e33ae085cc">1,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS01LTEtMS0w_df53887d-e40b-4ed4-aac4-12f638e8416f">4,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS03LTEtMS0w_260b5eea-5d14-4a96-a5ab-b9f624fab847">5,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC0xLTEtMS0w_2325a6f2-50e9-4d02-89ec-1b1e0c960f15">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC0zLTEtMS0w_9be7b16f-6760-468c-9245-ba287963d28a">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC01LTEtMS0w_3e271645-99cd-4022-bf84-3c1574ab2e0b">2,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC03LTEtMS0w_a94fc253-8874-429a-9cc0-7890dc3fcdf2">2,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS0xLTEtMS0w_8d2770dd-a570-4327-a4f0-81774b8cec61">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS0zLTEtMS0w_dd2d06a6-0638-4432-bde4-3d4e87e0b036">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS01LTEtMS0w_d9163b9b-edf4-4aae-b006-91f0f8fa9fe3">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS03LTEtMS0w_7d54a73b-224d-4466-8154-a5b7656380ee">866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtMS0xLTEtMA_c429d0cd-b781-48f2-b4ba-2913f59f9e75">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtMy0xLTEtMA_90a07168-5f6d-4b6b-a558-34b78dbd1ed0">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtNS0xLTEtMA_3cb8aae2-4b70-4e77-a3f1-d07146f92297">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:RoyaltyExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtNy0xLTEtMA_1440d856-56b3-4703-a6b6-715adab5566f">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtMS0xLTEtMA_0bc44127-b967-485f-af01-1493cc8c9d7f">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtMy0xLTEtMA_6b92aec9-a434-4c39-aa11-b1eec5bafd25">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtNS0xLTEtMA_b42c7e93-a23a-4c3b-9f22-099bc599b41d">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtNy0xLTEtMA_c2dab824-1d08-47c1-a9a1-4883dcb6c443">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtMS0xLTEtMA_db804ac5-e82a-4d57-8553-6ae4ca8fe0f4">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtMy0xLTEtMA_fb2e6f64-1f7f-4469-bae4-9e122e9d9069">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtNS0xLTEtMA_aa7854e8-fa75-410c-9c0a-f6481e3e2402">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtNy0xLTEtMA_7ec8d955-87fb-4aab-b8cb-ebf8aa7da1d7">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtMS0xLTEtMA_c4a48e3c-8572-42b0-b5f3-6210d59821c4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtMy0xLTEtMA_a462f0a0-8d6f-42f1-a8c4-9dad191d7cbd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtNS0xLTEtMA_1a698896-2492-4025-81dc-b12bc0869077">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtNy0xLTEtMA_7a8eded2-55ae-4ecc-81e7-cef042256c26">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtMS0xLTEtMA_d8a00f4b-b5a3-4a6b-9da5-c8b44c68be8e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtMy0xLTEtMA_f94a301d-bdd1-4404-82e9-9aecc0d57e8e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtNS0xLTEtMA_67f92ffe-41b1-453b-b707-a0679c723581">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtNy0xLTEtMA_42e74112-ee61-4807-b3b7-5a6cab7340fb">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtMS0xLTEtMA_1693fa01-b769-4960-85ee-f349de4f2cac">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtMy0xLTEtMA_92a6192a-fae0-4e0b-8cdd-3bb3b30ec25e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtNS0xLTEtMA_aaef14ed-5a9c-46cc-a506-08a2a5b4e635">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtNy0xLTEtMA_3d94a1fc-8b10-4456-a10d-38560f7e386b">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctMS0xLTEtMA_932dfb49-a58e-4cd0-bda3-58db9bdc78ea">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctMy0xLTEtMA_7bc0c71c-b47c-48ec-9a33-37a3b223d0f1">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctNS0xLTEtMA_09cc42c0-94eb-42bc-82a4-c15db2e0403d">4,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctNy0xLTEtMA_e68b68f7-610f-43d2-8c07-936cdf66018d">4,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtMS0xLTEtMA_9b0aaaee-3105-4371-b659-212803176465">205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtMy0xLTEtMA_230f5656-3891-4c19-85f0-98737f81b899">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtNS0xLTEtMA_32be1135-366f-4055-aad7-e1aedd278b88">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtNy0xLTEtMA_7b8a3fdf-1aff-42f0-99b6-5300f8d924e2">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtMS0xLTEtMA_87f62037-69b9-4237-90c7-8eafe41bb4a3">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtMy0xLTEtMA_2e92904b-5e5b-44d7-979e-c139b81595cd">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtNS0xLTEtMA_b5d60ffd-0271-409f-8ce7-4689d33f10a2">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtNy0xLTEtMA_d1918049-2c05-48ed-b049-274ddd62604c">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItMS0xLTEtMA_a31c2bc4-ff58-47e8-989f-a2a1745e32e4">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItMy0xLTEtMA_849a7c9d-fc1d-4063-af9a-25e0cf17abab">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItNS0xLTEtMA_4cabbeba-2213-4b14-a756-c39ef07c060a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItNy0xLTEtMA_f0601ec5-9b4f-46a3-a47f-26c43983e010">322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss)&#160;before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtMS0xLTEtMA_56c32f10-b092-49b3-b023-b837076db91a">227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtMy0xLTEtMA_85da675f-001e-42f0-af18-5a0928681b18">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtNS0xLTEtMA_acb1124d-f2b4-45fc-9d6f-56df386da77e">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtNy0xLTEtMA_f1b6080a-b45e-49fa-8940-35f0ceeca0b8">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtMS0xLTEtMA_e4d2f549-9288-4151-a2e5-9d62db573a60">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtMy0xLTEtMA_60be2669-2306-4dcb-9357-bbad766698f4">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtNS0xLTEtMA_8b095687-458d-4ed6-b955-1d65b5d91306">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtNy0xLTEtMA_82aa1882-8fe6-483c-82bd-26709d3f35e6">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtMS0xLTEtMA_ca8c60a0-c737-46da-9f90-6cbd91b1c437">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtMy0xLTEtMA_dc97edf6-9f66-4b8c-90a1-bbe25e92d21e">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtNS0xLTEtMA_7cff1603-b01c-46a0-a154-daba7c448f01">292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtNy0xLTEtMA_4d1b1f4d-90dc-4380-a323-577fd01b39a0">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtMS0xLTEtMA_1ee2b055-479c-4141-9433-bb76ab4832e6">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtMy0xLTEtMA_a70b647f-490e-4d6d-9e51-c79be63a58cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtNS0xLTEtMA_6cee1074-b8ac-4e32-9a10-18898b7fa304">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:DividendsPreferredStockStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtNy0xLTEtMA_924ceeeb-9b41-4d42-9cd3-4da7e516566b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctMS0xLTEtMA_c42bca24-b98b-4a40-b273-8fe024beae5c">169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctMy0xLTEtMA_4e42219d-8294-470f-af0a-0e537cc68c54">126</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctNS0xLTEtMA_e44af5e7-7296-4f77-b467-38d3bbcfe5fb">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctNy0xLTEtMA_8a404ab8-1359-4f03-ac33-0e53a095421e">704</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktMS0xLTEtMA_ac02930e-25ef-4fbd-bcd4-a94c348b032a">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktMy0xLTEtMA_f6d37c1c-99ae-4f70-8e11-bf46450b2c08">0.09</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktNS0xLTEtMA_5a7cf72a-470b-4597-82b5-eaa92b69f714">0.22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktNy0xLTEtMA_7d43a8b5-c717-4c18-8af5-f9e345d8301e">0.51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)&#160;per common share &#8212; assuming dilution</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtMS0xLTEtMA_5ed1d271-e14b-4fa2-bfa4-d2a92e32aef7">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtMy0xLTEtMA_eac27905-109a-4825-b41d-dbc8e8eebd52">0.09</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtNS0xLTEtMA_f019cdb9-ffe2-4616-8de2-80434cbdec5b">0.22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtNy0xLTEtMA_2a5831f1-e3d2-47a0-a384-98fefc9f7533">0.50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Weighted-average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtMS0xLTEtMA_7c3c44f6-cdd9-4eae-81e2-db343165bf6a">1,430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtMy0xLTEtMA_ec8bdd64-ad4b-4514-9066-5c8f9e40a62c">1,393.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtNS0xLTEtMA_6bc42d5d-8663-4963-956f-e5ec45558cc4">1,413.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtNy0xLTEtMA_32e753d2-429e-4656-83a3-d6193136ec88">1,390.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtMS0xLTEtMA_81496a9f-f35d-4c9b-8a53-3bec2019288c">1,430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtMy0xLTEtMA_c6cb21bb-22ac-42e2-b702-d868bb48d529">1,412.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtNS0xLTEtMA_cf594b3d-1192-44a4-aef4-8959666256bd">1,413.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtNy0xLTEtMA_c2e6d36c-b27b-44d8-8238-b4a1a1041002">1,409.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited condensed consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.674%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi0xLTEtMS0w_ca8c60a0-c737-46da-9f90-6cbd91b1c437">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi0zLTEtMS0w_dc97edf6-9f66-4b8c-90a1-bbe25e92d21e">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi01LTEtMS0w_7cff1603-b01c-46a0-a154-daba7c448f01">292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi03LTEtMS0w_4d1b1f4d-90dc-4380-a323-577fd01b39a0">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC0xLTEtMS0w_c9620e0f-5993-42a8-a4e0-6e2876ded8e3">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC0zLTEtMS0w_8f08946f-85f2-40cb-937a-99a02dcc53e9">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC01LTEtMS0w_c837de19-e140-484e-82b1-b96f56bfc783">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC03LTEtMS0w_dba02ee2-64d2-4805-a23e-065c8f054936">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS0xLTEtMS0w_f9506f87-db58-4de7-bc49-0f63ede05df6">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS0zLTEtMS0w_5c3cf8a6-7d94-4d14-9363-ef0be5adb7e2">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS01LTEtMS0w_520908b5-4fe5-4e34-8ca7-baf1b4125aa2">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS03LTEtMS0w_9a88bf67-7d34-4b52-9c13-2597d85c6185">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in defined benefit pensions and other items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy0xLTEtMS0w_7b9b6164-c0f7-41fa-95b0-96b05001bbf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy0zLTEtMS0w_ebee7daf-c07b-47ca-955a-67530d8a7b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy01LTEtMS0w_2431427d-8f43-4314-a340-d155106dac06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy03LTEtMS0w_40e125d4-01ad-49ed-940d-24b9768f6300">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC0xLTEtMS0w_2cb51971-b595-47d0-bf31-1b0a827f3695">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC0zLTEtMS0w_505779db-65fb-4d8c-87b6-bf646f9a95df">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC01LTEtMS0w_82470711-33a0-4e13-bdf0-4915194cb992">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC03LTEtMS0w_370e5b64-987b-46ff-9e7b-9f2ceb18a789">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS0xLTEtMS0w_e4d863fd-6bec-4aff-8496-61089e33cbe4">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS0zLTEtMS0w_0e72c80b-4406-472b-be2d-6fe2f787460e">186</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS01LTEtMS0w_1382a0e7-e70c-460f-99b3-33f902df782c">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS03LTEtMS0w_bd802d10-7b72-4a29-bb5f-1e1cbc7d8e57">809</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited condensed consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNS0xLTEtMS0w_870f3a58-0dde-487c-88a4-b4506ed74fdf">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNS0zLTEtMS0w_0055a587-5d62-46bd-874a-022bbbb0845c">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNi0xLTEtMS0w_e0baf162-a2e2-47b1-95b3-2d791dcf92f4">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNi0zLTEtMS0w_f6a75a8e-31c3-4a4d-959e-ca1bbf6a39f7">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNy0xLTEtMS0w_d3f3ac47-0e4d-4673-a408-1d3966950684">1,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNy0zLTEtMS0w_729923b4-93eb-4662-a22b-22c638264a76">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOC0xLTEtMS0w_ae59ff94-0116-4639-8db9-6a57dba4ec7b">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOC0zLTEtMS0w_ca54a266-2e68-4db8-9eaa-72ef67211bc6">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOS0xLTEtMS0w_94a92cf5-b3c1-47bd-86b3-6c415b9e417a">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOS0zLTEtMS0w_a64d7780-7838-428b-a3c0-9f02c00888c6">880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTAtMS0xLTEtMA_96ba069d-5151-47f7-b1ec-e3299f36a6cb">6,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTAtMy0xLTEtMA_84b7177a-c87d-45e3-80fe-8441fd3dff74">4,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTEtMS0xLTEtMA_4015c90a-b461-4fdc-bfea-33bbed0eae9e">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTEtMy0xLTEtMA_cd2c6d56-84e2-49cf-8c9f-e3de28c95809">2,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTItMS0xLTEtMA_9ec5f396-e1fc-4f90-8ac2-8b0e7932ea3c">10,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTItMy0xLTEtMA_8f5d1359-1a23-4130-b880-8bfbade446f2">10,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTMtMS0xLTEtMA_4b9acb35-27d4-4e8f-9470-c65675ed9135">6,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTMtMy0xLTEtMA_05a1bf02-95d9-4482-afa0-7a2165b1f97c">7,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTQtMS0xLTEtMA_50290086-fd20-420f-a005-41ffcfd381d6">4,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTQtMy0xLTEtMA_42b45264-8718-4fc0-8b47-9a23704f4177">4,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTUtMS0xLTEtMA_67c4d4a3-1091-411f-b6c7-9298582767d3">1,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTUtMy0xLTEtMA_4ca90ad5-a217-4d3b-bb11-bd528a44016a">1,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTYtMS0xLTEtMA_4b20e95f-ff47-45d9-a9a0-6f3a34588cdc">30,845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTYtMy0xLTEtMA_dcb2b003-b32c-4edc-9953-2f722fbf8257">30,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjAtMS0xLTEtMA_e49301d9-2e2e-4410-8d35-db872978b910">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjAtMy0xLTEtMA_c22f7a09-ca5e-4496-a0c4-61caf87efa43">1,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjEtMS0xLTEtMA_edb385d9-d9a9-4b8c-858e-98de263052b8">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjEtMy0xLTEtMA_ef5cb7a9-343a-4b43-a582-61071c009821">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjItMS0xLTEtMA_05edba08-4142-4291-8476-2631f5825cb6">2,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjItMy0xLTEtMA_90758b51-bbc9-429c-89a9-e9168b32ac95">2,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjMtMS0xLTEtMA_c4872835-d13e-4ac9-867e-32167708d84a">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjMtMy0xLTEtMA_1e4936c7-b8e0-4526-ac91-9fa1c84b25b4">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjQtMS0xLTEtMA_e0d789b8-f13f-4216-9747-449a5c33dce6">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjQtMy0xLTEtMA_75b98579-b413-47ab-a993-421d8a30fbeb">4,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjUtMS0xLTEtMA_fcda3c45-2dfc-4c44-a2e1-f8fd51e47a6d">9,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjUtMy0xLTEtMA_f27e634e-cd63-48f4-9971-689bc50e43e8">8,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="bsx:DeferredTaxLiabilitiesNetNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjYtMS0xLTEtMA_d4a76464-8a2f-48e6-9df9-4e665e12a788">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="bsx:DeferredTaxLiabilitiesNetNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjYtMy0xLTEtMA_e861f068-9602-4595-80b5-02507b0e8f78">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjctMS0xLTEtMA_cdfd5a57-6224-4761-8c29-6c30aa8300a3">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjctMy0xLTEtMA_45942ab3-c7ba-421c-ab5e-c8d3750301a2">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjktMS0xLTEtMA_73b4dc51-45cd-4c35-91a1-9413dc46ca9a"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjktMy0xLTEtMA_60164224-4deb-4094-8b60-222dbecc217e"></ix:nonFraction></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzIx_3aead153-7fb0-485f-b5b6-468256bdb333"><ix:nonFraction unitRef="usdPerShare" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzIx_55617486-c958-4881-bc6e-7f96a2e9bd7b">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzQ3_3714fa9e-aa71-4034-82f2-68e0c88e8a76"><ix:nonFraction unitRef="shares" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzQ3_d712e7de-4dc3-471c-bd9f-477128411e64">50,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzY2_c2da66c0-b9a5-4c16-8984-f4c156edb77b">10,062,500</ix:nonFraction> shares as of September 30, 2020 and none as of December 31, 2019 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMS0xLTEtMA_c99cc6db-57ba-4d47-896b-6ef04edeafe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMy0xLTEtMA_82c6e34c-c9ad-4547-b775-a986ea94da02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzE4_3efe2dc2-ccf3-4a3d-8fbb-539c48a668b3"><ix:nonFraction unitRef="usdPerShare" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzE4_f0b30b52-355a-4293-8576-044c4b86e11c">0.01</ix:nonFraction></ix:nonFraction> par value - authorized <ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzQ0_9536be2c-1037-4ed3-8847-2415b53178c5"><ix:nonFraction unitRef="shares" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzQ0_ecde6757-d7e9-4743-84f6-5070b5b3bbb8">2,000,000,000</ix:nonFraction></ix:nonFraction> shares - issued <ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzYz_69e5d789-f555-4c7e-b705-316e63052ac3">1,679,428,209</ix:nonFraction> shares as of September 30, 2020 and <ix:nonFraction unitRef="shares" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1Xzk3_dceb070c-48fb-4240-b3eb-706f1bb20a12">1,642,488,911</ix:nonFraction> shares as of December 31, 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMS0xLTEtMA_8ca3af28-b0e9-42e0-9e79-9e565a053880">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMy0xLTEtMA_3443c35a-d267-4869-8138-d2264d99533b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost - <ix:nonFraction unitRef="shares" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjM2MzVmYzE2ODcxNzQyMjViZDAzMjZhMjFiZTRmMDgxXzMw_63f22b07-a6a8-46bd-ac35-ce985fd97398"><ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjM2MzVmYzE2ODcxNzQyMjViZDAzMjZhMjFiZTRmMDgxXzMw_fee68b2c-67de-4623-8118-df3f5cac2c7e">247,566,270</ix:nonFraction></ix:nonFraction> shares as of September 30, 2020 and December 31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMS0xLTEtMA_5a15e4ab-1355-49c4-b859-e3e106d1e0c7">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMy0xLTEtMA_d4004542-b72a-4851-808c-b9b19c4f29ac">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzUtMS0xLTEtMA_129b75c9-a545-403c-9e42-2030b498c43b">19,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzUtMy0xLTEtMA_7830cca7-1843-4d56-af74-8e6fbae8e266">17,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzYtMS0xLTEtMA_1f6aec38-8339-4477-8f68-85208586d804">2,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzYtMy0xLTEtMA_25d7b2ff-d893-44f6-8e2f-dbfc841db12a">2,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzctMS0xLTEtMA_d4e154bd-7408-4c08-aaa3-a57f86eda208">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzctMy0xLTEtMA_629f07b6-b229-479e-a20a-7c47b4a1457e">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzgtMS0xLTEtMA_3246d873-fbaf-492a-a1d1-b44a0cb77b22">15,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzgtMy0xLTEtMA_ec18ca4a-4f05-4daf-9e6b-c035a2363156">13,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzktMS0xLTEtMA_455a9158-e06a-4b8d-98b2-94362d27f6dc">30,845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzktMy0xLTEtMA_dff6144d-59bd-482d-9bd2-389b0a2b7f23">30,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited condensed consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.631%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss), Net of Tax</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8ba508544a742afb3886d6afa51d329_I20181231" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMS0xLTEtMA_fe886403-dafd-45ce-8126-7e22c8e59928">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ba508544a742afb3886d6afa51d329_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMy0xLTEtMA_ecbd5fa8-716d-42f4-bf85-f9b42f6b04be">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ed7784314414425be90ef641324a0a0_I20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtNS0xLTEtMA_12798343-f044-48bb-ba0d-8c91e5051532">1,632,148,030</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed7784314414425be90ef641324a0a0_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtNy0xLTEtMA_af75eeb4-7cc7-447c-a584-bd175f0b1de8">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a952e94562c475881460deca9c1f953_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtOS0xLTEtMA_07019acd-2b41-4a5c-b11e-4f8d27480b8b">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac50a2fdd97a471d9cf22a475f9b6eb6_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMTEtMS0xLTA_a778a99d-1761-40a9-ac8e-f6b2283a0a95">17,346</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9654d2156a734b7bb306daa5f24ac4f6_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMTMtMS0xLTA_18c2351d-c797-4be8-91d0-f923e013429a">6,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f2ffdbd3d541cc940fcca69a479645_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMTUtMS0xLTA_db967b7c-9e83-420d-ae09-3a13082feff4">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc127a01b37a47e08d86d8c2afe2db89_D20190101-20190331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjEtMTMtMS0xLTA_f6fa9787-0df3-4250-ad9c-a539dcfc9cfc">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b17f27c1e6f4baaab1cd43126cfa691_D20190101-20190331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjItMTUtMS0xLTA_84f79863-293a-4025-802a-dae7a70d6e88">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0256f56d5ebb49ae841f4bd5d04e0506_D20190101-20190331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjMtNS0xLTEtMA_98244754-5b5a-4818-93d0-64bfb818214d">6,001,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55ae15680004d338d27b266d917e873_D20190101-20190331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjMtMTEtMS0xLTA_3b2fb955-a479-4bb5-85c3-c4b37cd5da62">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b9bee0e1b914abfbc8ee0729f0f7167_I20190331" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMS0xLTEtMA_817ac90a-1505-4fa4-b248-72ae5a9b099c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9bee0e1b914abfbc8ee0729f0f7167_I20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMy0xLTEtMA_6114becc-47f8-4520-9fc7-c032366c5365">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i389d0f154e33475c9cd0ffad7b77ae5c_I20190331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtNS0xLTEtMA_a19add24-525d-45f2-937e-b471f9869044">1,638,149,373</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389d0f154e33475c9cd0ffad7b77ae5c_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtNy0xLTEtMA_5529ae19-2175-4304-86e1-73c8be396a08">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i395b87fb2a894ca68005db9b471ca8f3_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtOS0xLTEtMA_216e8172-17f9-4da3-b935-b3de9626076a">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d28bd993914c93a2b6d7bc66d8a2aa_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMTEtMS0xLTA_defac0e6-13cc-499a-8a66-cf6fef8eab16">17,374</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id32a3651258b4af1be2874b460994080_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMTMtMS0xLTA_74c9938d-bbf1-4e8a-a267-74dc626fc43b">6,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fec6efef8f4034a077c780127b7955_I20190331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMTUtMS0xLTA_80748ce7-67b1-44f9-a0c8-decf80366084">87</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b25092af7a42e8b7f7b18357a7e0e5_D20190401-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjUtMTMtMS0xLTA_cee01d3d-bd98-4672-a3be-9cd59a8cd0d0">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id06a3877ad6e4bdeb577199119865754_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjYtMTUtMS0xLTA_641c3921-6242-4e39-bc5a-9697cfa77031">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95412a9549fb4960bddd35b290d776dc_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjctNS0xLTEtMA_b4642c84-4f88-45f1-811c-2e68e3bf733d">949,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id003719d3acb4f2c819a2b870e25e7f3_D20190401-20190630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjctMTEtMS0xLTA_898a91fc-5bbd-4976-8c2d-fa23e41bf284">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3783f780c95d415ab119c6cbe0e8e002_I20190630" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMS0xLTEtMA_ac9c6bd0-e12f-41ac-812f-8c377760abf3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3783f780c95d415ab119c6cbe0e8e002_I20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMy0xLTEtMA_d41db13b-95b4-4a4d-8773-6f3b3e32fb1a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8bd0c08e350549ba9bd9e9c0f784b86c_I20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtNS0xLTEtMA_15053177-d737-4fec-a487-7bc9c79d3391">1,639,098,930</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd0c08e350549ba9bd9e9c0f784b86c_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtNy0xLTEtMA_2f222776-923e-4570-a981-87286a86701e">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdedf628611e4636be8687e15376e46f_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtOS0xLTEtMA_9d337e41-d252-45ad-8e3f-c6216dc6b5a2">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219690bf96274e70abead54b1cdde00a_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMTEtMS0xLTA_a9e091bd-5086-4134-ae29-43fd8ba509dc">17,422</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a512ca465c54054ae1c533835551eb3_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMTMtMS0xLTA_255abd9b-b3da-45fc-8603-1ed6539bd49c">6,375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fddd0be6b34cbf9c0c59129d20de59_I20190630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMTUtMS0xLTA_a1b34272-8e67-4863-be1a-494bfcc60673">78</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d53278bb3374215bfb7111c4e4eb852_D20190701-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjktMTMtMS0xLTA_d9826264-2297-434a-8627-578dfd96b076">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72b10ec5ccaa4c03a9d7d69f78107b06_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzAtMTUtMS0xLTA_625eeca4-12d3-4b8d-ab11-2fd0d5c7fd96">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d91d7efcbc541c280da9d3c93b4db84_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzEtNS0xLTEtMA_1fd1bb50-d8a0-4b6a-b9f1-fafbfb9e45a1">2,243,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib24d1e116bfb46d5a09f48c999e73bcd_D20190701-20190930" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzEtMTEtMS0xLTA_f3e6dec7-80f9-4092-8868-8741af2d242a">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e6f2b58df5c4e379f9b4bfbd6b43c9d_I20190930" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMS0xLTEtMA_e5de883e-f4bf-49de-9365-3291d368d975">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e6f2b58df5c4e379f9b4bfbd6b43c9d_I20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMy0xLTEtMA_42e45bde-14b9-4849-aa85-71e2868eebf6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dc86ac77e4046889ddabb53e93461d1_I20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItNS0xLTEtMA_163d3a6c-4f04-45bc-a908-fac96f7a735c">1,641,342,509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc86ac77e4046889ddabb53e93461d1_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItNy0xLTEtMA_a2749ccb-f7a1-4ed9-910f-72d66935386d">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c6095e3497547369994d298e3adc925_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItOS0xLTEtMA_14b35496-30ff-4448-96ce-f389b4904f79">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a6c7eff0984f66bf876b54aa555878_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMTEtMS0xLTA_debc8a6b-ab78-49cf-bdec-b58be107d991">17,510</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia89773722e8443d187d6fe4372399cf2_I20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMTMtMS0xLTA_42bc4140-8e37-4614-9ddb-f578ba82025f">6,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6c7a01cd56425e9bfd5e3b6f17711c_I20190930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMTUtMS0xLTA_f12742f1-af7c-4290-8f4b-572b6892626b">138</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a965a86df74f9e9c8bc0784f3e7c2c_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzMtMTMtMS0xLTA_edd68326-a92f-4cb3-a24d-a32503fb6d02">3,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7ce995bd1640c4aee3f34d47266617_D20191001-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzQtMTUtMS0xLTA_c886ab11-da62-43d1-9d10-fd6593b08903">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61d24f1efc934db89e5dbb0533c917ae_D20191001-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzUtNS0xLTEtMA_4fd6a26c-c2b2-4add-98af-13c44ddd27ca">1,146,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d0a154b29ae451e86bde6739f2a9274_D20191001-20191231" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzUtMTEtMS0xLTA_2add9c29-4835-4e1e-8637-92506ef8cef9">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa6a9f62803f4d98b27fcdd993d68d18_I20191231" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMS0xLTEtMA_60a86caa-3569-4eed-88f0-a441de7e3dbc">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a9f62803f4d98b27fcdd993d68d18_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMy0xLTEtMA_78ca224d-5735-4e4d-8666-8b9360b14bf3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i332ce0e258df462b836e35e03bde9533_I20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtNS0xLTEtMA_c754c535-62f6-481c-a059-4f6dc5ffd125">1,642,488,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332ce0e258df462b836e35e03bde9533_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtNy0xLTEtMA_352446a5-af91-4813-ae2e-35ba973ad871">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff5e8e513f614ff5a920c76bd85ad3cb_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtOS0xLTEtMA_deb5405b-ea01-4507-bf5c-0002e78d6b80">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f513f5c52b44fe1a6e0a501a7d892fd_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMTEtMS0xLTA_004ea844-1426-4920-9ee7-c3b1d312454f">17,561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia54f5bbb50bb4be28c6d67abe157ef90_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMTMtMS0xLTA_e5f1c29e-043e-4b45-8785-c4be08b63ac1">2,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eb4f14ab734ae880cbc0fdbf788799_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMTUtMS0xLTA_86b4ef9b-3820-42dc-bb58-2727d9607b78">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd13145a5164386acf44a6fb1097a18_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzctMTMtMS0xLTA_14940670-f5ba-4901-80ce-9946529580e3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacd13145a5164386acf44a6fb1097a18_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzgtMTMtMS0xLTA_ea7eeb8d-953b-47d2-a29a-c1df6451a5f0">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5a732cb9c1647e1807ed514f4dcad3f_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzktMTUtMS0xLTA_3959c2d0-0adf-4582-8dc3-a2f1e2eb8066">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01e5f52e47224bbd8c81aeddd9c8552c_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDAtNS0xLTEtMA_201ab358-c5c2-4eab-b4a4-0b80f502f8a4">4,388,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1033701a5ff945638f415a913d827d89_D20200101-20200331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDAtMTEtMS0xLTA_96b031e8-fa09-4ea4-b7e0-0d5ce2ac72cc">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45598a0ab9d64a56b01f170bb45bd1ed_I20200331" decimals="0" format="ixt:zerodash" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMS0xLTEtMA_11b646e0-8585-49c2-9002-fd69eb31688b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45598a0ab9d64a56b01f170bb45bd1ed_I20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMy0xLTEtMA_bf83b941-7ffd-4dcb-8884-f8ba6cac7919">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80b0ff86adad47a180c0719888cf6a71_I20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtNS0xLTEtMA_c494c2bf-30cf-40b8-8241-2121ba04dc80">1,646,877,242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80b0ff86adad47a180c0719888cf6a71_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtNy0xLTEtMA_73b6868d-1216-43ed-a04e-7c723fa822b5">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia668be5ffaf547b883b6fdaabe784961_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtOS0xLTEtMA_124aa680-e192-404d-b28d-b28adc81fbd7">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75abf3104ec34cbdbfe44d606eead82b_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMTEtMS0xLTA_2a762717-6e58-4aa9-81e6-1bb60edeaed6">17,589</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7fd580f105a4e5381e382e6129b9261_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMTMtMS0xLTA_83c3d997-861c-419a-a8b4-b051dd9394d4">2,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38127b708b84afab8ea55c25c0b6c18_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMTUtMS0xLTA_f0513315-5da8-483d-8ffa-f20cfc8084aa">168</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8039b774f5c4418c94b57c87727823af_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDItMTMtMS0xLTA_eb7c155c-adf4-4d0c-b494-03683b196724">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506512c62581437bbbbefeababd35a7f_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDMtMTUtMS0xLTA_06f09486-c0e3-4005-8f79-7c0551aed927">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i307df6963fea43d7ab493ba4862d9b33_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDQtMS0xLTEtMA_039590e2-e1d8-47b8-9608-3c3e874013c9">10,062,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i307df6963fea43d7ab493ba4862d9b33_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDQtMy0xLTEtMA_60e12a6d-e44d-49cb-90a0-da713621f138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDQtMTEtMS0xLTA_c39d3a4c-764a-4ec0-b31c-f47ff12c0371">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2caa315022214c4f891424d66b0ab750_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDUtNS0xLTEtMA_ceffaef9-ad99-488d-8d69-d96d87954e2a">29,382,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2caa315022214c4f891424d66b0ab750_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDUtNy0xLTEtMA_ea479e5c-791f-4f53-b1d3-7968043e898a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630" decimals="-6" name="bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDUtMTEtMS0xLTA_9ba61cec-69ef-49de-9786-feb64286dbd4">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8039b774f5c4418c94b57c87727823af_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDYtMTMtMS0xLTA_75784ef0-aea7-45d3-8403-2f507c4c5965">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2caa315022214c4f891424d66b0ab750_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDctNS0xLTEtMA_98295c4e-8fc1-4c73-8af6-b66ef371adc1">493,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDctMTEtMS0xLTA_5af40b6c-54e1-4247-8c4d-9d69d95b91d2">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id497f96f1bbd4cfea05234ce48bd7220_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMS0xLTEtMA_3ec08452-2ef0-4a34-b688-51f80074519d">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id497f96f1bbd4cfea05234ce48bd7220_I20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMy0xLTEtMA_7b9d015b-6b73-4e8f-beb7-4614f950b104">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaeffcfc2961c4fc3a627a5e430c5fc24_I20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtNS0xLTEtMA_8329d4bc-a512-4b55-a5bf-d0321c214cad">1,676,753,566</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeffcfc2961c4fc3a627a5e430c5fc24_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtNy0xLTEtMA_c764aec3-4ea4-42ff-8250-540c18cc180b">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c67d19c9ea5443387a81c46c1e319db_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtOS0xLTEtMA_46debc62-50a6-44ea-8a70-6b5a09bb368c">1,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198489441d644b71960becd4df1256c7_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMTEtMS0xLTA_03a81462-6bd0-4962-94d9-0973b894c719">19,590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if44d8794413a44bd8cb416f5e22758a3_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMTMtMS0xLTA_b02f95ac-a7c6-4d86-a09a-09e9a9b74b41">2,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id226c300bfca45e9b55a05b24b6f67b6_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMTUtMS0xLTA_b2ab4da6-45ff-46b0-b9ec-0f958d25be7a">131</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8aa447538c4c9899d80c9a8d7e1f82_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDktMTMtMS0xLTI1MQ_1e5510e0-584e-4d2f-9b4b-4453075b5bf9">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3951d84d8c54e33b4108a6298ded8e6_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTAtMTUtMS0xLTI1OQ_74046442-14eb-42e3-ae8e-e04e3c59981d">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa8aa447538c4c9899d80c9a8d7e1f82_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTEtMTMtMS0xLTI1NQ_2e158cad-b9d7-4c19-966a-1e6654d5ca38">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i432a7e24f8124d53a12c4b06b90f3f3d_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTItNS0xLTEtMjQz_0403db96-f108-45bf-8a56-eb72527f4855">2,674,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb24a5db4a84f9aac55d92ace8fbb33_D20200701-20200930" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTItMTEtMS0xLTI0Nw_f7a9ed2d-4dac-4b44-a818-d3b1d724ba72">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieddb3e5a196249108dd92686400d6e00_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMS0xLTEtMjA4_5a2391e1-13c7-472d-a2ab-c0b9f4180475">10,062,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieddb3e5a196249108dd92686400d6e00_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMy0xLTEtMjEy_df34c213-cebf-450f-85fc-287733a2a8d1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id275aa24a2de46bb97e130263856c8cb_I20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtNS0xLTEtMjE2_d3ea99db-fa76-41dc-85da-355723a28aa1">1,679,428,209</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id275aa24a2de46bb97e130263856c8cb_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtNy0xLTEtMjIw_23b6bf82-bd6e-457a-8726-a5df3e6e4834">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26cdf1b470b441dc8312a69ca2a3a82e_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtOS0xLTEtMjI0_7c8d3eb1-06b8-4809-9b60-f34cddb0d010">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe13d2d881c478c9713420faa1b3a01_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMTEtMS0xLTIyOA_d46438cb-4694-4633-94a5-91f8821e8d33">19,687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10f8de4c7bde4dbfb0824f68791a47e7_I20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMTMtMS0xLTIzMg_beb10834-8688-4cb3-90b9-c923f9365ba9">2,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456ac438eda6495e82678ce466563701_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMTUtMS0xLTIzNg_a03bc23a-6eb7-4293-83d6-d6add9fc0387">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited condensed consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BOSTON SCIENTIFIC CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash provided by (used for) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMy0xLTEtMS0w_ebf8e378-5900-484d-86af-6e2ec061d2ab">835</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMy0zLTEtMS0w_c7f9e3c4-2228-4002-80bc-e1e92304d2f7">1,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNi0xLTEtMS0w_34c445c4-f0e9-4fa4-8728-16bfce868974">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNi0zLTEtMS0w_3d77dfa4-097c-4fe1-909e-8179ea3bb9dd">275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNy0xLTEtMS0w_348bad52-bdf5-459d-8d0d-5f0c7a147089">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNy0zLTEtMS0w_14a21bbb-8564-4f70-bd85-7282fb332a76">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for acquisitions of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOC0xLTEtMS0w_c1f01b5e-67e0-43b4-ac59-ff79d18ca28f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOC0zLTEtMS0w_30baf904-0218-4525-8a0c-7769de085beb">4,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOS0xLTEtMS0w_f5629527-2596-4b77-9222-c273b88e3c77">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOS0zLTEtMS0w_51177db7-3d46-48e0-91e0-d0ee824c546d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for investments and acquisitions of certain technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTAtMS0xLTEtMA_3af583f7-03c6-423f-9310-cb8799092168">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTAtMy0xLTEtMA_ebd40544-0f7c-4dcc-b1bf-6d7c0c75a098">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTEtMS0xLTEtMA_6f153e3c-7721-499b-bb32-e69b7c0382fe">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTEtMy0xLTEtMA_db4aa7fd-6e78-42c7-9aaa-b4928350631e">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for settlements of hedge contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTItMS0xLTEtMA_d5bede94-048c-4fa7-933a-8502a15d61a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTItMy0xLTEtMA_46075416-2daa-44b1-9a05-4f048c212482">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash provided by (used for) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTMtMS0xLTEtMA_3f4da50b-1445-4ddb-8517-f12315a6c7ab">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTMtMy0xLTEtMA_28088748-96e3-43c3-ba90-e66fdbcdced1">4,992</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of contingent consideration and royalty rights established in purchase accounting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="bsx:BusinessAcquisitionContingentConsiderationCashPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTYtMS0xLTEtMA_9933fea8-fd7d-4881-b3ce-03bb8a23b9ce">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="bsx:BusinessAcquisitionContingentConsiderationCashPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTYtMy0xLTEtMA_ce62ff7b-90d8-47f9-ae71-e198e5ea1164">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTctMS0xLTEtMA_ce8fd9e4-d43a-4348-8512-6fab368fcb90">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTctMy0xLTEtMA_cc278ea3-b235-4f2e-a9e1-bded80c327c2">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTgtMS0xLTEtMA_08991bce-f392-4bda-9d7e-15bde69a9b7e">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTgtMy0xLTEtMA_fcc4b5ee-c87b-47f3-b47c-5e3dc557f4cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTktMS0xLTEtMA_a612d8c6-0232-4fe9-9590-2c3c8fec4478">714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTktMy0xLTEtMA_9775386a-08d9-4d7e-a280-2ef85b50c73d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on borrowings from credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjAtMS0xLTEtMA_a5fbabec-3938-4092-a1a6-b717173f1204">1,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjAtMy0xLTEtMA_24b52b13-2c5c-4683-a9d6-20c39639dbf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings on credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjEtMS0xLTEtMA_6a3e92f9-a34d-4d38-afc9-4a4e162a52d5">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjEtMy0xLTEtMA_3e5b175a-0cd9-4e82-a6d1-121274a304cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term borrowings and debt extinguishment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjItMS0xLTEtMA_f4bf5110-94b1-4dab-a3ef-50b6bd9c61fb">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjItMy0xLTEtMA_dd74533b-715c-4860-b0e1-e5a3082fd78c">1,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from long-term borrowings, net of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjMtMS0xLTEtMA_edd2b8c6-0cf3-4fbf-a4ea-27d692395232">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjMtMy0xLTEtMA_c4f55eed-f9a9-40cb-b4f4-c4982450cfef">6,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends paid on preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMS0xLTEtNDkzNA_fb7f93e3-12de-4039-8e63-8ed4d12345db">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMy0xLTEtNDkzNA_d10ddce3-38f3-4f80-be7d-885afad6a4b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of preferred stock in connection with public offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMS0xLTEtMA_65a56cd4-d1bd-4116-8332-9f32ecbd4b8c">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMy0xLTEtMA_a6513430-e31e-4485-9e31-2e70e2919406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock in connection with public offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjUtMS0xLTEtMA_1083ba1f-907a-4898-a958-ff37ae06e188">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjUtMy0xLTEtMA_ce2df813-de7d-41b3-8f94-b6e293c81880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash used to net share settle employee equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjYtMS0xLTEtMA_748624e2-54ef-4ad0-8b02-cf5edc70418a">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="bsx:Paymenttonetsharesettleemployeeequityawards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjYtMy0xLTEtMA_92bf6986-e693-406a-942b-6109afd82b3d">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjctMS0xLTEtMA_1a2ad160-67a1-4744-ad3c-7df4f4b88c4b">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjctMy0xLTEtMA_29f02f84-ffd1-4294-9f36-7f74faaaea4a">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash provided by (used for) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjgtMS0xLTEtMA_bc725fc6-feb4-47df-8745-d573e0459870">1,112</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjgtMy0xLTEtMA_146e53f2-e9f3-4b4a-ad1e-8eb166011a60">3,697</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzAtMS0xLTEtMA_a4c726a4-a745-4978-af71-051d3d0e8721">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzAtMy0xLTEtMA_a14a3976-55c5-43c9-852c-6f661a6c7ba0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzItMS0xLTEtMA_dbd13932-b454-425b-b860-26035f95993a">1,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzItMy0xLTEtMA_8304face-78bc-405e-b4ce-a5ce3dc1eeb1">153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzMtMS0xLTEtMA_037f44a4-b3cb-49cb-baa9-b60fbbdf0ebb">607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzMtMy0xLTEtMA_bbc9781a-185c-423e-bab3-9b5821af1234">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzQtMS0xLTEtMA_20136436-8b68-46ab-93b3-2800b609910a">2,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzQtMy0xLTEtMA_654ccbb9-b6ca-4f7e-a254-456227485998">676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzctMS0xLTEtMA_54c7442d-9e08-4e09-9f35-28309e110123">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzctMy0xLTEtMA_b06b607b-369c-400a-a75d-604f87fa7464">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of contingent consideration recorded in purchase accounting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="bsx:ContingentConsiderationRecognizedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzgtMS0xLTEtMA_a0610f2b-c648-49cb-abea-d230ec813c56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="bsx:ContingentConsiderationRecognizedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzgtMy0xLTEtMA_5b15f44b-72a3-43b5-86ba-00c8bde8faa6">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash impact of transferred royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" sign="-" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzktMS0xLTEtMA_046934f6-65ef-4892-8885-425313e94903">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" format="ixt:zerodash" name="bsx:Noncashimpactoftransferredroyaltyrights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzktMy0xLTEtMA_191db978-a112-4517-bfbd-65aa68d5f5de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Reconciliation to amounts in the unaudited condensed consolidated balance sheets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMi0xLTEtMS0w_870f3a58-0dde-487c-88a4-b4506ed74fdf">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMi0zLTEtMS0w_9ccf66b3-9c3b-4fb5-9ccc-18c87e564424">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMy0xLTEtMS0w_04af877b-5052-4675-87a0-5ced52d9531d">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMy0zLTEtMS0w_260a9569-409e-4959-9fbe-fa8f4c830c9b">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash equivalents included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNC0xLTEtMS0w_e9011d48-bc10-4644-88b4-5933d39b3d7b">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNC0zLTEtMS0w_592be802-a33e-4835-8735-1f8a61396af9">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNS0xLTEtMS0w_fee0119e-2960-4eaa-a7f2-54b7a19562e1">2,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNS0zLTEtMS0w_f72058f3-37bc-4752-ad03-d4d45a3e4a46">676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to the unaudited condensed consolidated financial statements. Amounts may not foot due to rounding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_40"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA1MA_56bcf4ff-d856-44d9-9f2d-2bb782a12947" continuedAt="i437c1c394ac14056a9b5c886927c4684" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and nine months ended September&#160;30, 2020 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2020. For further information, refer to the consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this quarterly report are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2NQ_952b043b-802f-4796-9624-3cbad8c76a00" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our most recent accompanying unaudited condensed consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Implemented Since December 31, 2019</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ASCUpdateNo.201613PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2Nw_a56be7fa-a970-445c-8bdf-a4cb53b8e66a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2016-13</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASC Update No. 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">account. The adoption had an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2Mw_cb131db9-92e2-4301-a1f7-568820e71c51" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i437c1c394ac14056a9b5c886927c4684"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ASCUpdateNo.201818PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2NA_6e48b33c-a168-4365-b5d5-97f98b66b53e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-18</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASC Update No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_46"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjc0ODc3OTA4ODQyNg_00c7b142-d422-4c1f-bd1e-c7782b6ff763" continuedAt="ib53830dd0b9440ca861ee7bfae0870d6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements include the operating results for acquired entities from the respective date of acquisition. We did not complete any material acquisitions or divestitures during the first nine months of 2020. We have not presented supplemental pro forma financial information for prior acquisitions given their results are not material to our unaudited condensed consolidated financial statements. We recorded immaterial purchase price adjustments during the measurement period for the preliminary purchase price allocations of acquisitions in the first nine months of 2020. Transaction costs for these acquisitions were immaterial to our unaudited condensed consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Q3 2019 YTD Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BTG plc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;19, 2019, we announced the closing of our acquisition of BTG, a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we began to integrate BTG's Interventional Medicine business into our Peripheral Interventions division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Interventional Medicine product lines, the BTG portfolio also included a specialty pharmaceutical business (Specialty Pharmaceuticals) comprised of acute care antidotes to treat overexposure to certain medications and toxins and a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price consisted of upfront cash in the aggregate amount of &#163;<ix:nonFraction unitRef="gbp" contextRef="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTI4Nw_8e8d13a2-2af8-4f23-bbba-537d3ef79875">3.312</ix:nonFraction> billion (or $<ix:nonFraction unitRef="usd" contextRef="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTI5NQ_8278cb05-3e69-494c-a29a-aae883796eb0">4.023</ix:nonFraction> billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received <ix:nonFraction unitRef="gbpPerShare" contextRef="i8b95a6dee16943f59d2330f61315da56_I20190819" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTQ0NA_e1152520-9192-4525-a889-7bbaba2b77f3">840</ix:nonFraction> pence (or $<ix:nonFraction unitRef="usdPerShare" contextRef="i8b95a6dee16943f59d2330f61315da56_I20190819" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTQ1Mg_d9cd5ee7-3531-40fd-b406-9c5c35d7a6df">10.20</ix:nonFraction> based on the exchange rate at closing) in cash for each BTG share. The transaction price included $<ix:nonFraction unitRef="usd" contextRef="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTU1NA_a288c082-e92d-4a92-aaf6-e2f4a18e6055">404</ix:nonFraction> million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#160;Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjc0ODc3OTA4NTIzNw_f3f35e45-5103-4939-8915-476ac3cabfa1" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:84.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmQwM2RjY2FkNjRiNTRmODM4MGNlYzI2NjhhNTU2ZGNiL3RhYmxlcmFuZ2U6ZDAzZGNjYWQ2NGI1NGY4MzgwY2VjMjY2OGE1NTZkY2JfMS0xLTEtMS0xNjQw_3961ee25-4491-4975-8729-14510d93ea44">3,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="ib53830dd0b9440ca861ee7bfae0870d6" continuedAt="ic518c270b5af4bb08a4ca1f7119bb706"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjc0ODc3OTA4NTI0MQ_e7f3985c-11b6-4d63-b45d-f9415ddcc0f6" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMS0xLTEtMS0xNjUy_27004fec-b551-46bc-94da-09c08dbb736c">1,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMy0xLTEtMS0xNjUy_e03a898d-9729-4554-957f-f1e0a6bd9892">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNC0xLTEtMS0xNjUy_6413e678-c612-4c25-b0af-767e774dec77">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNS0xLTEtMS0xNjUy_e5a5f2eb-3e48-4183-98f3-b61fe6da43c5">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNi0xLTEtMS0xNjUy_daae8e52-b5e0-4f23-bcd0-76230bd409e8">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNy0xLTEtMS0xNjUy_77c078d1-ac7b-4948-b418-4fd073cb14e2">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfOC0xLTEtMS0xNjUy_1cad64cf-b8d5-4874-9090-9b88f94e50cb">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfOS0xLTEtMS0xNjUy_657914d9-8817-4ac7-a3de-5542de030e01">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMTAtMS0xLTEtMTY1Mg_a30dd2a7-ed13-41ec-9946-a7a237bb0c10">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMTEtMS0xLTEtMTY1Mg_716c6622-8b39-4e5b-89bd-45808a4804ac">3,619</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><ix:nonNumeric contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMzI5ODUzNDg5OTEyNw_c52cc517-7c5e-4795-8774-fa6ca865da7a" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c1b69039194f6d941fd5b48076ee41_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi0xLTEtMS0xNjUy_05cc9fe2-5597-43cf-bebb-a31f1064076e">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic20a36eb220b470eba748536a11f26fe_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi0zLTEtMS0xNjUy_5779301d-f64e-4385-832d-863054e2a620">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iddadff178c5c41a3977cf15d3cf00c99_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi01LTEtMS0xNjUy_fd6929c2-5140-468b-802c-8e4f6d69f03b">18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice23b320aba74832b975dd54f9a41b8b_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi03LTEtMS0xNjUy_b312f7ef-2fe2-4c3a-96ca-0655b159f795">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3046b7a84674f07b8b6bc5297d63b3a_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi05LTEtMS0xNjUy_e47d18ab-4067-4dfb-9273-4c52f3f6357f">12</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b41059a837448d90bd8dc4312473e1_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS0xLTEtMS0xNjUy_d414820f-59f6-40cd-a4ca-c1fc2e925a7d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77e24f9ec65b4419ab13c89e5afacd34_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS0zLTEtMS0xNjUy_4688bb42-ad61-4664-b42b-c701ff7aee36">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4948def2b3404998b1a8e76ccc208655_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS01LTEtMS0xNjUy_76844264-8593-453a-8c49-7b26a926e230">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05dc2bca12f441518b8eae871ad3ce57_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS03LTEtMS0xNjUy_8dd731c2-a1b8-4a4e-8407-0f9426dc1f34">11</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfOC0xLTEtMS0xNjUy_0525bf38-06fb-47c6-89e7-535c04332945">1,785</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of BTG, we recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTY0MjA2Mg_27004fec-b551-46bc-94da-09c08dbb736c">1.644</ix:nonFraction> billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. The goodwill is not deductible for tax purposes. We allocated $<ix:nonFraction unitRef="usd" contextRef="i5ef09943eb2142468d55375ee434dff1_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTY0MjI5OA_c86fbb68-5106-480b-9b9f-cc12bb7d8066">1.406</ix:nonFraction> billion to our Peripheral Interventions reporting unit and $<ix:nonFraction unitRef="usd" contextRef="ib6543e61e1ca452a991a93b48b5860ee_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTY0MjM1Mw_07d6ad20-573d-4209-a279-249add602783">238</ix:nonFraction> million to the Specialty Pharmaceuticals reporting unit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vertiflex, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 11, 2019, we announced the closing of our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="ideeea0ead40f44dd993b303107e7c8c0_D20190611-20190611" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA2OQ_4a96f9fb-7ae7-4f73-87e8-322fa0252e00">465</ix:nonFraction> million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of <ix:nonFraction unitRef="usd" contextRef="i306877ff66b94d598003e4699fa0e864_I20190611" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTMwOA_d42f8a75-0d8d-42e0-b846-71e2c088365d">zero</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i306877ff66b94d598003e4699fa0e864_I20190611" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTMxNA_826f5fcb-d86b-4eab-be8c-3e325683d21e">100</ix:nonFraction> million; however, the payments are uncapped over the three year earn-out period. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Millipede, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we announced the closing of our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="iba8ef1bb81a34679887900294644c59b_D20190129-20190129" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjAzNA_d9110435-ecfb-4161-8c7d-6f0b805cad01">90</ix:nonFraction> million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately <ix:nonFraction unitRef="number" contextRef="i6e985d5f31da4655b4775f3c18736888_I20190129" decimals="2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjI0Mw_f8f1f572-8c11-4a89-978d-810efcccb020">20</ix:nonFraction> percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="iba8ef1bb81a34679887900294644c59b_D20190129-20190129" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjU2Ng_e228cd39-614b-4da7-8249-89238dc97397">325</ix:nonFraction> million and up to an additional $<ix:nonFraction unitRef="usd" contextRef="i6e985d5f31da4655b4775f3c18736888_I20190129" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjU5Mw_a340970f-79cd-4b44-a643-99ce64aaee7d">125</ix:nonFraction> million payment upon achievement of a commercial milestone. Following the closing of the acquisition, we integrated the Millipede business into our Interventional Cardiology division. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="ic518c270b5af4bb08a4ca1f7119bb706" continuedAt="i37e99c9f46ad4ee0b0f6a7ee05dadc40"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjA3Mw_2129e57a-cfbb-4eba-bc38-18c7c316933b" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfMS0xLTEtMS0w_dd4ba253-9d5f-4ec4-bd30-8b92931b7242">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfMi0xLTEtMS0w_887a5bf8-7aaf-4b61-9e05-b80a78588cbd">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" decimals="-6" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfMy0xLTEtMS0w_6fe09c32-0480-428c-a0d0-2e5b0d92b040">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfNC0xLTEtMS0w_b4f743ae-78a0-441a-93b9-1f140e2696ea">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAwMQ_402c6e33-4c7f-4102-aa4d-db7b8e019aec" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfMS0xLTEtMS0w_22554b03-c267-4810-9118-d8e7370921c8">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfMi0xLTEtMS0w_782ecb35-5c80-4607-9582-aadba6b8b98d">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfMy0xLTEtMS0w_20f30275-1956-4572-a682-8fe162d183b0">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNC0xLTEtMS0w_77661ad2-5f64-4162-8ad7-086b916c40b3">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNS0xLTEtMS0w_fb650752-9eb8-43b4-a225-8dff65d6013d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNi0xLTEtMS0w_b0862a9e-e4cc-4143-8e42-d60b3f8d9dae">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNy0xLTEtMS0w_639bbd40-93ee-4b3a-b18e-9659cebeef8a">992</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAyMg_10894b5c-3137-4879-9efb-3ba024115e1f" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f8ba5a467c45fe948ec96ca784057a_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfMi0xLTEtMS0w_fba13bc3-822f-46eb-be60-08e77c66170b">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i085d4caca7b24cb58a868824db62acdc_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfMi0zLTEtMS0w_4068e51f-b094-4052-8ac4-a8a5301891aa">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58e7195e106047a191895672017f64b9_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfMi03LTEtMS0w_ad1bc61e-e5a7-4ef7-8a28-20ff87609975">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i813c67adfd7c4a86afbb6e281c6d478c_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNC0xLTEtMS0w_d6a8c0c3-0616-40d6-b7e2-b2788bf54dc0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iec1555f039564481906b06dd35a52e71_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNC0zLTEtMS0w_d81aea45-ae70-4a0b-8293-ac086b5dfadf">12</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i896dbc3c04fe46f58b32c467a3593953_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNC03LTEtMS0w_76016c0f-a851-46d6-91c5-f6b1fe9db5e4">15</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fe4e49dc414447fbf120ce2ae4f4623_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNi0xLTEtMS0w_d7dbd34e-2a13-4b4b-9495-6e62a6cecf12">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf332292a44a478e9ebea4a33fbdd424_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNi03LTEtMS0w_6aa09b38-23f5-4eec-adb3-8399b66caa14">19</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNy0xLTEtMS0w_f94e0f7e-4ea4-4e1d-96d2-fa269586f0fc">461</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and has been allocated to our reportable segments based on the relative expected benefit. The goodwill recorded relating to our 2019 acquisitions is not deductible for tax purposes.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNTk5OA_8a3a93f0-3008-43ce-85bc-2986cd4114b0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfMS0xLTEtMS0w_b0b53f25-f8eb-468e-b924-2b1e75169bb4">354</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfNC0xLTEtMS0w_92e971d8-ffb7-4430-ab1d-5d15f5e050b6">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="bsx:PaymentOfContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfNS0xLTEtMS0w_b556d0c0-3f76-43e4-821c-58b43b919e6b">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfNi0xLTEtMS0w_63e3fde3-919b-4b8f-9422-cfc2bba1fad9">214</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i37e99c9f46ad4ee0b0f6a7ee05dadc40"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMzk2MA_457e04c7-3fcf-4b08-b93d-fe691d9e1134">627</ix:nonFraction> million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNDE1NQ_92e971d8-ffb7-4430-ab1d-5d15f5e050b6">102</ix:nonFraction> million benefit recorded in the first nine months of 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision Medical Corporation (nVision) for milestones that would not be achieved due to management's discontinuation of the R&amp;D program.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAyMw_fcd8e86b-fc4f-4711-8730-be6055522101" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9ebccf7ca6b8470782d5496c6de481af_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS0xLTEtMS0w_244c7e12-0a49-48c2-b11d-8c270f725fd0">100</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if244a5996bc34f8ca2bdf001a69336ee_I20200930" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS00LTEtMS0w_5e94e803-5125-47b1-bc57-54bc54e0ec94">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i14ae891ce6774513aff2cec35b4d31ce_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS02LTEtMS0w_3e3b808f-1436-4dc4-b9d8-e47bcaedd612">2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5c4aa9bf38540239bdd1ab15292743a_I20200930" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS03LTEtMS0w_8a7a2846-27d8-4a49-9267-64a8053b3fbd">2</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if244a5996bc34f8ca2bdf001a69336ee_I20200930" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMi00LTEtMS0w_dfcf6a7c-885b-43d4-899e-51ab62d46e31">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i14ae891ce6774513aff2cec35b4d31ce_I20200930" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMi02LTEtMS0w_8eff97e8-e305-4ad7-aa3b-e1ebc91a45d3">90</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5c4aa9bf38540239bdd1ab15292743a_I20200930" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMi03LTEtMS0w_688ade03-ad73-4f88-8dc9-059a17df299e">90</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4410774845a24a54a144e7dfdfd8ba6e_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC0xLTEtMS0w_b377a00e-c965-4518-8022-bd095eb33c93">114</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i88663b924d2b458cbccc972e892704cf_I20200930" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC00LTEtMS0w_d8228605-13eb-446f-86d1-de9e3bd18939">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b832479fdc344b291fe8b6401da66a0_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC02LTEtMS0w_b826590d-d607-4b46-99a1-bf02d9803a21">14</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i5a217a1106c342bd90cffb6a011624ae_I20200930" decimals="INF" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC03LTEtMS0w_5fea2dc2-3f48-4959-999f-3a66c68621e7">13</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88663b924d2b458cbccc972e892704cf_I20200930" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNS00LTEtMS0w_6e95e5ec-dfd6-4c67-b710-c25beda97ce4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5b832479fdc344b291fe8b6401da66a0_I20200930" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNS02LTEtMS0w_d41b5abd-2d4a-4c5b-a7ed-7176414a63fc">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a217a1106c342bd90cffb6a011624ae_I20200930" decimals="2" name="bsx:ContingentConsiderationLiabilityProbabilityOfPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNS03LTEtMS0w_9b914bc9-24da-4ace-b13d-1840c2cacdff">87</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to some of our research and development (R&amp;D), commercialization-based and revenue-based milestones are discounted back to the current period using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of September&#160;30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAyNA_1f2bb7ac-3eac-40fe-8e8a-118281960b9d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMi0xLTEtMS0w_482995cb-c7bb-44db-a524-706988cf23f2">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMi0zLTEtMS0w_278889ff-0210-4317-aa72-342732df3c52">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMy0xLTEtMS0w_dca84969-d630-491c-bf5d-7466eccbd445">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMy0zLTEtMS0w_6d6fda41-46e7-480e-8885-cee27eeff371">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNC0xLTEtMS0w_6784e71c-4aee-4115-8000-1e952907e3fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNC0zLTEtMS0w_3043e5f7-ca8e-41e2-abb0-9b7cf96ff6ee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNS0xLTEtMS0w_98d7160e-7abd-4ff3-abb8-1982e3253c8c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNS0zLTEtMS0w_6e0d0868-59ef-4d06-88cf-39d1ff8a07db">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNi0xLTEtMS0w_ad486df7-a3df-4319-a051-30b857f1a332">567</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNi0zLTEtMS0w_ba699ec3-6ccd-477d-927c-e7fe009dc8bd">458</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated statements of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNTg5OA_977c9df4-fd1d-4616-ad6a-ce7445281c99">343</ix:nonFraction> million, which represents amortizable intangible assets, IPR&amp;D, goodwill and deferred tax liabilities. In the third quarter of 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTY0OTI2NzQ1NzQ5MA_e115e29c-0c09-4c79-b779-10e27265d767">65</ix:nonFraction> million non-cash gain presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited condensed consolidated statements of operations to state at fair value one of our portfolio investments treated under the measurement alternative method of accounting.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfNjA4OA_4b421231-dc7b-49a0-9c90-7c61f7a934e0" continuedAt="i1d0743880bb649309b011f58ac88186d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfNjA1OA_6f561e4d-9659-4a86-9630-f27c6ae19067" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fa93356c3144962a66e1b420a7d3f9d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy0xLTEtMS0w_a22bde4f-ecf8-4448-b825-ca2acdd6e4a5">11,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fa93356c3144962a66e1b420a7d3f9d_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy0zLTEtMS0w_9db17cb8-b511-437c-8088-a4c490fcc9e5">6,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3790bd2f6293401b8b5a8afd9976f99e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy01LTEtMS0w_85f3f4f5-4544-4895-abea-3ac7709913cf">12,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3790bd2f6293401b8b5a8afd9976f99e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy03LTEtMS0w_e0f5030d-151d-4463-b27f-0638d69e7517">5,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56d0db5fc654680827529f68c76a516_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC0xLTEtMS0w_332238d6-1b83-4c20-bc8e-c9037cb420e3">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id56d0db5fc654680827529f68c76a516_I20200930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC0zLTEtMS0w_5fd888b2-990e-4568-85e1-63948d63d81f">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bbb535d2f4a44f09dd05caeb7d8477a_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC01LTEtMS0w_f1fe4231-4da8-4440-b06f-f748a465ccdf">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bbb535d2f4a44f09dd05caeb7d8477a_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC03LTEtMS0w_f81ac48e-79ef-40ac-96c1-e5e37f1eeeb2">408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f9a34f6262041b292bc78770a80463c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS0xLTEtMS0w_cabbb011-4e78-4128-907a-1e3443f38270">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f9a34f6262041b292bc78770a80463c_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS0zLTEtMS0w_b85f50f6-cfc4-41c6-aefd-34985d9d5641">1,183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17832c8686724365b57112cd962e98a9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS01LTEtMS0w_ce75f30b-9365-4495-8a58-5e6d25589efb">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17832c8686724365b57112cd962e98a9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS03LTEtMS0w_c89cbbb2-47b8-4c6b-a65a-1633f0d8fecd">1,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi0xLTEtMS0w_401548da-8d59-444e-9301-4d6e0cbda8ae">14,106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi0zLTEtMS0w_260f6d60-e034-4256-a5b6-270d9777638a">7,692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi01LTEtMS0w_4da07433-ab23-4c61-9243-e14caa1615c3">14,299</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi03LTEtMS0w_db350053-5e2f-492a-9b9b-13513cc9e5e0">7,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368407ac90bd421f986c8a5c24c675ed_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC0xLTEtMS0w_eca84286-dd82-490d-911c-fc58cba585df">20,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i368407ac90bd421f986c8a5c24c675ed_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC0zLTEtMS0w_cac7178e-3268-4a5c-b2f2-dfaa9db32447">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5853d5a25ac44b929ce01432224f5764_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC01LTEtMS0w_82ce7da3-3afc-4bfa-9d92-7c46c08e17ec">20,076</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5853d5a25ac44b929ce01432224f5764_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC03LTEtMS0w_2e604728-6c0f-41a3-bb34-11fd69d3f39d">9,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57f804f076c49c08bc6003ea608e766_I20200930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOS0xLTEtMS0w_4b4485e9-41d8-426c-a61c-54b57c5d73ee">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9542da37d90b419a88f21b32b9c18e21_I20191231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOS01LTEtMS0w_f948251b-b095-45e3-8858-566a4a031973">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1be545420574c14979c7e504aabb492_I20200930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTAtMS0xLTEtMA_8792b2ab-9266-4819-aeab-af4bec13c857">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26051ae85e46473d81272a66ca863cd2_I20191231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTAtNS0xLTEtMA_cadadec2-695b-422f-8243-2cb74a2c4b8e">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTEtMS0xLTEtODA2Ng_d101afad-2523-4b3e-8fd2-b42ad68be6ac">383</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTEtNS0xLTEtODA2OQ_9925dad7-af81-4ae6-ad25-3328c0681d3d">782</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. In the first quarter of 2020, following receipt of CE Mark for certain products, we reclassified certain of our IPR&amp;D intangible assets to amortizable technology-related assets and began amortization to reflect their use over their remaining lives.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfNjA3MA_ff19eb83-dba6-418c-92ab-e37a975c2d01" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c3d9625d044893a61231379ae0aa16_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS0xLTEtMS0w_fad436a0-efee-4199-87a9-c70f7b933717">2,061</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b731401f35464ab0c5a3185d967ae4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS0zLTEtMS0w_3a0eb986-ab5c-4882-a8a6-258c3d39a13c">2,192</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfe5b0fd59340ada20dfb76e33e0309_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS01LTEtMS0w_9807db9c-16f9-4f9c-ba16-c8292112edc9">5,676</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i372d2c53d9bd461a84e365951a7e89f2_I20191231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS03LTEtMS0w_1a0cfda3-1a48-4ac1-bb7c-ed06dc97da05">247</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS05LTEtMS0w_cfbeeb91-1b67-49b3-b406-63f2258fb523">10,176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC0xLTEtMS0w_72090d61-5df7-416b-a866-3167456a1b0d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC0zLTEtMS0w_15ab7267-1e3f-44dd-a848-6d53d5e0fb25">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC01LTEtMS0w_07102eee-3f36-47a1-ba9f-04b18ad3912a">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC03LTEtMS0w_e0e9ea98-0195-497c-9800-43c42b452e0d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC05LTEtMS0w_44349e77-c795-4411-bbfd-d6d8116f1d87">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5994440a5ab43e7824bcb235c5af0d4_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy0xLTEtMS0w_41c84625-1cfa-4497-8ffb-f3fbddb1ed33">2,056</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5043da4f04a34f68aec48682ecd51130_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy0zLTEtMS0w_a16f5ae4-0bfd-4b87-91dc-db568c603a09">2,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaddac085144a42d6aec4edf923f8c7c3_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy01LTEtMS0w_7a788c67-fa3d-4d87-ad91-2bb9e2b6ba54">5,646</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954b543dbcca4f58bb805011cd0e2930_I20200930" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy03LTEtMS0w_fe7f13f7-5f7b-44c5-b812-27ed007f4284">241</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy05LTEtMS0w_55f8ee34-16d8-4e11-aee0-8440c6e117fa">10,137</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Indefinite-Lived Intangible Asset Impairment Testing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the third quarter and first nine months of 2020 or 2019. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. In the second quarter of&#160;2020, we performed our annual goodwill impairment test for all of our reporting units and concluded that the fair value of each reporting unit exceeded its carrying value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. We identified the following reporting units in our 2020 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i1d0743880bb649309b011f58ac88186d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, we utilized the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment in the second quarter of 2020. There were no impairment indicators in the third quarter of 2020 that necessitated an interim impairment test.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfMzQyNA_db804ac5-e82a-4d57-8553-6ae4ca8fe0f4">219</ix:nonFraction> million in the third quarter of 2020, none in the third quarter of 2019, $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfMzQ4MA_aa7854e8-fa75-410c-9c0a-f6481e3e2402">452</ix:nonFraction> million in the first nine months of 2020 and $<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfMzUwMA_7ec8d955-87fb-4aab-b8cb-ebf8aa7da1d7">105</ix:nonFraction> million in the first nine months of 2019. The impairment charges recorded in the third quarter of 2020 were primarily associated with IPR&amp;D acquired with Apama Medical Inc. following management&#8217;s decision to cancel the program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first nine months of 2020 also included charges related to nVision and certain other intangible assets initially established following acquisition. In general, these charges were recorded as a result of management&#8217;s decision to change commercial launch plans or discontinue certain R&amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value. In the third quarter of 2020, we performed our annual IPR&amp;D impairment test and evaluated our indefinite-lived core technology assets using the optional qualitative assessment approach and concluded a quantitative test was required for certain IPR&amp;D assets, resulting in the ultimate impairment of the Apama assets discussed above. We also verified that the classification of IPR&amp;D projects and our indefinite-lived core technology assets recognized within our unaudited condensed consolidated balance sheets continues to be appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. In the third quarter of 2020, we determined a recoverability test was required for certain amortizable intangible assets based on our qualitative assessment of impairment indicators, and recorded intangible asset impairment charges as appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within Part II, Item 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contained in our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_61"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzOTA_19080c6d-5993-4c82-b62b-53ea4392b4f8" continuedAt="i50bc91f8b5ea4e30b1206ed120892ed9" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTg0MDc_219cf02b-70fc-4f85-be36-2ec2c81791ff" continuedAt="i28e6092b119842eba96fc629dd499e02" escape="true">Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i28e6092b119842eba96fc629dd499e02">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</ix:continuation></span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i50bc91f8b5ea4e30b1206ed120892ed9" continuedAt="i24ca6855b3174b73bbf7078e9386ab2e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Japanese yen, Euro, Chinese renminbi, Australian dollar and British pound sterling. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast, particularly resulting from the impact of COVID-19 on transaction volumes. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited condensed consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax (AOCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro, Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. We elected to use the spot method to assess effectiveness for our derivatives that are designated as net investment hedges. Under the spot method, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have elected to exclude the spot-forward difference from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. Amortization of the spot-forward difference is then reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;<ix:nonFraction unitRef="eur" contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNDY2OA_212989fc-9536-46b0-b08d-e2b9a637cd1c">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNDY4Ng_90af2a81-8ecb-410e-a471-d71a43bfc787">1.000</ix:nonFraction> billion) in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNDcyMw_fcca8e31-0a2a-460f-b4b2-027c8ababf14">0.625</ix:nonFraction>% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. We dedesignated a portion of the net investment hedge in the second and third quarters of 2020. The notional value of our outstanding net investment hedges was $<ix:nonFraction unitRef="usd" contextRef="ic2b7c6355f6f4da2bc3951ba8ac457bc_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:NotionalValueofOutstandingNetInvestmentHedges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNTA5NA_cd223196-6ac5-4494-aef0-b94730f9b7c6">1.885</ix:nonFraction> billion as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i88a6cbe1bcc24e6295df27f547e399d3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:NotionalValueofOutstandingNetInvestmentHedges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNTExMA_5364c943-d3a3-4d17-8a7d-412e1acdc701">1.950</ix:nonFraction> billion as of December&#160;31, 2019, which includes our derivative and nonderivative instruments designated as net investment hedges. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In the first nine months of 2019, we settled all outstanding contracts for $<ix:nonFraction unitRef="usd" contextRef="i316fcdf591d645a696cb2f1d899e6570_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0Njg3Nw_1ee7a5ce-b1ba-47ba-bdb6-51427f235ce8">294</ix:nonFraction> million, which is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of cash flows. Upon settlement in 2019, we received &#163;<ix:nonFraction unitRef="gbp" contextRef="i42fb2c3fa32c4bc597cc49dbf63d74ee_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeCashReceivedOnHedge" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0NzA1Ng_24e86e2c-0a97-412f-ad8d-7208e481ba0a">3.312</ix:nonFraction> billion of cash to fund our acquisition of BTG, which translated into $<ix:nonFraction unitRef="usd" contextRef="i42fb2c3fa32c4bc597cc49dbf63d74ee_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeCashReceivedOnHedge" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0NzEyMg_0f5901f4-fd46-4ed5-b085-0b45e1d01392">4.303</ix:nonFraction> billion based on hedged currency exchange rates. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i24ca6855b3174b73bbf7078e9386ab2e" continuedAt="ia6360dda6adc46c9a3c310664d6ba85d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized a $<ix:nonFraction unitRef="usd" contextRef="i75faf6b7006a41fa96265cf1f9f67aa0_D20190701-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0ODM5MQ_4d1cdf49-494a-4863-9631-68d1e231554f">207</ix:nonFraction> million loss in the third quarter of 2019 and a $<ix:nonFraction unitRef="usd" contextRef="if002fd16794247e590bb0cd6fee13f1c_D20190101-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0ODQwMw_d20c5dae-bff9-4df0-b5a5-cc4bfb1b7c63">323</ix:nonFraction> million loss in the first nine months of 2019 in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to changes in fair value of the contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of September&#160;30, 2020 and December&#160;31, 2019. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time. In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNzQ2NA_b03b7dff-7af9-46c0-a0c2-21d5be15f592">30</ix:nonFraction> million loss as of September&#160;30, 2020</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a $<ix:nonFraction unitRef="usd" contextRef="if782d561570d49c68f1b0b89799129fc_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNzQ4Nw_57fa2ad4-77b4-458f-9a92-e7466c20e6c9">34</ix:nonFraction> million loss as of December&#160;31, 2019. We recognized immaterial gains and losses in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of our terminated cash flow hedges in the current and prior periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of September&#160;30, 2020 and December&#160;31, 2019. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caption in our unaudited condensed consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. The balance of the deferred gains on our terminated fair value hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was immaterial as of September&#160;30, 2020 and December&#160;31, 2019. We recognized immaterial gains in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of the terminated fair value hedges in the current and prior periods.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNTI_2bb4db9d-8eb0-482c-b8c9-ac1ef03dfa67" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.430%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0eecb377e56463294ebc8b3dffe10dc_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMi00LTEtMS0w_0571bc4a-6f46-415b-a397-d5a2fa44477a">4,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee44d3c3f9549e991f73b2fecade56b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMi02LTEtMS0w_ea330cc1-af20-4f3f-b6de-da1e2db4e399">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7be0d79b1114275af29836966037801_I20200930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMy00LTEtMS0w_60388291-21bb-4dbc-a4a8-7a33279193ac">991</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie83d791495c24438aa2a9934db0f5fbf_I20191231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMy02LTEtMS0w_a45f1171-03b5-479c-bede-b744e46c0bca">953</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4150ff86e91f4b1ea24f3ea91dd6cbfd_I20200930" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNC00LTEtMS0w_327ce380-32d7-4a74-b80d-6df8285c17dd">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc9f66aadb7d47b8b2707a870b298e10_I20191231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNC02LTEtMS0w_b3dc6fc0-aa37-4d37-8bcf-a7cb25efefa0">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6833b3853ecf440c91b89098a42c9d15_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNS00LTEtMS0w_4ab64d79-e7e2-47d8-b2e4-cbb8003da182">4,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf0b89b236347bfb2a0960469c3a865_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNS02LTEtMS0w_cbc0b8d2-95e2-484a-b042-126499b940c1">4,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNy00LTEtMS0w_51eef812-ef4c-492e-b1f9-044b4f86ad70">10,286</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNy02LTEtMS0w_2dbe40d1-82fc-43ea-b803-6da8b0cab7d9">10,218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8364;<ix:nonFraction unitRef="eur" contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfODg0Mg_212989fc-9536-46b0-b08d-e2b9a637cd1c">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfODg2MA_90af2a81-8ecb-410e-a471-d71a43bfc787">1.000</ix:nonFraction> billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in the second and third quarters of 2020.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of September&#160;30, 2020 is within <ix:nonFraction unitRef="units" contextRef="ieb220488504c46a48fd04031fccd6f33_I20200930" decimals="INF" name="bsx:ForwardCurrencyContractsTimetoMaturity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfOTE1NA_c9b405b4-bb5a-47ec-b1e7-bd3083e9c098">60</ix:nonFraction>&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next two years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="ia6360dda6adc46c9a3c310664d6ba85d" continuedAt="i85ba144999d5414aad067420d182f9d8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited condensed consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our unaudited condensed consolidated statements of comprehensive income (loss).</span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNTU_48c92ad0-24a5-4410-862f-a43480826a2c" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.823%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Condensed Consolidated Statements of Operations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0xLTEtMS0w_61a15670-73e3-4310-87d6-84f9308fba5c">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0yLTEtMS0w_46c302b8-aae3-4cd4-8892-05eff5b20361">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0zLTEtMS0w_9da5b496-326a-4f63-b0fb-9a0204f9f689">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS02LTEtMS0w_f9174eca-8d08-4d14-8826-c630374aa812">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS04LTEtMS0w_b75dddd8-c322-4d28-9adf-2d880069f2e0">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS05LTEtMS0w_1779c2ef-f097-4421-923b-59394b789e94">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0xMC0xLTEtMA_94c7d291-45b8-49d9-8398-87ce28c7c473">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0xLTEtMS0w_857161aa-8099-4b95-af82-2f9709b731b4">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0yLTEtMS0w_bdcf1974-eeb6-4196-98fe-b35802305415">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0zLTEtMS0w_bf42c86a-e148-442e-80d1-00902e5feef6">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi02LTEtMS0w_af34f8ad-3765-4365-8a19-484651b3db5c">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi04LTEtMS0w_c883f57f-9d02-45fb-a4f7-282efb9a669c">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi05LTEtMS0w_a16793c6-7e62-4977-9a09-fd380595f5ea">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0xMC0xLTEtMA_51d0e93f-fb09-447b-8dab-8ee72614ba31">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0xLTEtMS0w_21a7e805-42f0-42c9-b89b-f3642380122e">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0yLTEtMS0w_e4553836-935d-479d-a2c8-871a49f0c2bd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0zLTEtMS0w_4c2a093f-08f0-442c-a499-0961241e520c">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC02LTEtMS0w_7b32b0a4-19f5-486b-9192-9ce096f8fd1e">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC04LTEtMS0w_dd6287a4-fa49-4105-95f0-f2688d32f9b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC05LTEtMS0w_93cceca9-9507-4f3e-b9f4-77d276bdea48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0xMC0xLTEtMA_1a3446e5-cf28-4bda-8195-5b4f51032760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914745bc3935420f887e082516427691_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMS0xLTEtMA_3a390b62-5d9e-4949-b816-fd64aabbd4fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914745bc3935420f887e082516427691_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMi0xLTEtMA_42fcc4a0-b0d6-452e-bc8a-142e3a5a0552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914745bc3935420f887e082516427691_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMy0xLTEtMA_62099cff-93d9-4f17-a09e-a73585eaf679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtNi0xLTEtMA_af34f8ad-3765-4365-8a19-484651b3db5c">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914745bc3935420f887e082516427691_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtOC0xLTEtMA_dc185146-64ac-4e9e-a3cf-b0bf10045fd1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914745bc3935420f887e082516427691_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtOS0xLTEtMA_21c10603-1300-4add-8c3d-c7b9a64c1ef3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914745bc3935420f887e082516427691_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMTAtMS0xLTA_839d00d2-c649-4233-a49f-5883373da2b2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMS0xLTEtMA_5ce37ef9-2963-4e9c-9c18-f386a6e9ff9f">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMi0xLTEtMA_67d22b76-fc01-47fb-a336-78d859647054">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMy0xLTEtMA_25a8babb-852e-4323-a993-1d0eadfd9182">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtNi0xLTEtMA_2b7e2980-d77f-4284-89a8-9248749c03e8">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtOC0xLTEtMA_6ce63063-b47d-40d0-9483-75d2ee7ea2b7">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtOS0xLTEtMA_987386b5-276c-488c-aec6-0b4e2630119e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMTAtMS0xLTA_5e6b3dd4-399d-40d5-8566-cbf8d3a65b7b">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMS0xLTEtMA_b6097fd5-0b5b-453f-8e78-dbc78e9b8bbf">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMi0xLTEtMA_d0260824-1cb8-41e4-bdef-e1464dc0fe5f">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMy0xLTEtMA_d932bc2e-0d87-453b-9324-4abaec74baea">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtNi0xLTEtMA_f311ce7d-c1c7-4f48-b947-98497d1c5093">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtOC0xLTEtMA_205a873d-b3eb-485a-a3fb-0d1ebca81f59">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtOS0xLTEtMA_2ea55e9c-2fcb-48f9-a5ed-8e05e748d9b4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMTAtMS0xLTA_b368b2ae-b7f1-406b-a536-205b9c37aa66">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMS0xLTEtMA_c461f4e8-6486-46c6-8b1a-f01a347bea9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMi0xLTEtMA_0fab17ad-74bf-42e5-8462-4016268384bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMy0xLTEtMA_e651d270-9e81-4ec8-89f5-40cf78cc0c85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtNi0xLTEtMA_f311ce7d-c1c7-4f48-b947-98497d1c5093">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtOC0xLTEtMA_908cd261-6fd0-4dae-8ed5-fef23fed0993">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtOS0xLTEtMA_eed0646f-4039-4c59-ac40-9bd5412f2f11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMTAtMS0xLTA_7727b6a1-4d6b-4c38-9ec6-0e7772c3831f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMS0xLTEtMA_631ab5e3-901a-438c-a0a3-85c432a21e5c">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMi0xLTEtMA_21f2f229-5c61-4569-87e1-2d74c62d5745">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMy0xLTEtMA_45bd44dd-b72d-400f-abb3-a9b8b56e6dc9">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktNi0xLTEtMA_848f402a-d704-4789-9f3b-f80a02106480">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktOC0xLTEtMA_d965c63c-a67a-41ed-91cb-b7254e32e166">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktOS0xLTEtMA_d3892c7d-0995-4c73-9fcd-a09de39fa78e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMTAtMS0xLTA_13eee7bc-c86d-4c5a-96fd-de4ead9cb442">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMS0xLTEtMA_bf3d3628-cafb-4101-ab1f-4aa976d65673">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMi0xLTEtMA_9f0a7642-1a57-4b28-b5f6-6d1d2da4194e">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMy0xLTEtMA_42449bd3-0d50-4190-a1f5-707545f1b8e0">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtNi0xLTEtMA_28340566-52c5-44ff-9e8e-3756bcdbfe1c">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtOC0xLTEtMA_3156e3ab-91a0-4ce9-bee1-808958b4081a">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtOS0xLTEtMA_ef0814ea-4f29-446d-ad0e-e3251bad3843">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMTAtMS0xLTA_4364312c-a794-417a-a103-849b47701506">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMS0xLTEtMA_544a45ee-6812-42f6-82c6-3f9fccfe5f05">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMi0xLTEtMA_2c09f75e-9174-47ed-9bc1-4b15c48aa9d0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMy0xLTEtMA_2f6f5be6-93db-4390-b1e4-732c028924ef">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItNi0xLTEtMA_f9a50388-e3d8-48b7-8acc-e2735c5b6249">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItOC0xLTEtMA_d01f9428-9629-4c9d-8878-5829f9a2f018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItOS0xLTEtMA_36f9627c-ff79-452d-bd17-89530a4533fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMTAtMS0xLTA_010d51a4-3fc3-44e8-a10e-d44ac999d23c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMS0xLTEtMA_4bbf6463-1c6c-40c5-baa2-5055ff233302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMi0xLTEtMA_f53e2438-d890-42b3-8960-e7d021b20a2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMy0xLTEtMA_65709914-6af5-4677-8051-e0a118d1c005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtNi0xLTEtMA_28340566-52c5-44ff-9e8e-3756bcdbfe1c">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtOC0xLTEtMA_b62447c9-99bc-4f77-ab50-44833ed40e1e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtOS0xLTEtMA_aa5e948f-3c68-4c20-a5a5-06f1052c78ef">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMTAtMS0xLTA_544c13bd-8c33-4020-8cb2-016b58bffd1f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMS0xLTEtMA_a92a3ed8-c433-446e-bf9b-6a91f63bce98">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMi0xLTEtMA_ce9651f7-b266-4024-82d1-cfc7c26a0d05">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMy0xLTEtMA_6dfd37e4-42f1-4656-acf3-21de96754381">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctNi0xLTEtMA_959cb4d8-0e1c-4cec-ab1b-a8ae8a9b4227">2,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctOC0xLTEtMA_92f4b6ee-a072-4f91-a0d5-bce3754fd2ef">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctOS0xLTEtMA_805692dc-1421-4eca-8125-c2bb249a4395">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMTAtMS0xLTA_898536ea-5338-4b6b-9488-e1a99fe02958">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMS0xLTEtMA_d1fbc86d-c100-450d-8f86-33e4caf2b71b">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMi0xLTEtMA_96a49fee-7fee-41bd-9937-e2b61077c5b2">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMy0xLTEtMA_ad17444c-86b8-4d7c-9f70-960e73492caf">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtNi0xLTEtMA_710527c0-1f16-4971-af1e-f39d09b685bb">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtOC0xLTEtMA_fd337545-674a-4ab8-8ac4-be2b9fa23dec">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930" decimals="-6" name="bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtOS0xLTEtMA_6452223c-fe1a-4bb8-bc6a-3d6842414174">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMTAtMS0xLTA_d0adf6b7-f099-4979-89bb-08e87ca854d1">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMS0xLTEtMA_bb1699e5-c5b2-47f8-8d1f-a97d000f4cb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMi0xLTEtMA_b7613848-b313-4697-a850-a673a6258116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMy0xLTEtMA_95cb99d8-b96b-4c73-b494-fa2288834db0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtNi0xLTEtMA_710527c0-1f16-4971-af1e-f39d09b685bb">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtOC0xLTEtMA_920c02d3-ab4b-4782-a8ba-635cd40adb57">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtOS0xLTEtMA_fc2bcda0-b927-4b52-b9ca-33deb27b8d02">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMTAtMS0xLTA_4a344d88-ff06-407e-9003-9b6424c52a5d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i85ba144999d5414aad067420d182f9d8" continuedAt="ib0b0c6c0eddb4ba380afd750c48145ea"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzOTk_4da879f9-96df-4c06-a49a-2b0e219f4c50" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b6e4b111f24b6c8656058dcbe12e0b_I20200930" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmEwZmIxMGNkYWFhYzQ4MWM4NjAzNWYxMmNhYWFlNDQwL3RhYmxlcmFuZ2U6YTBmYjEwY2RhYWFjNDgxYzg2MDM1ZjEyY2FhYWU0NDBfMS02LTEtMS0w_f60c40e4-e99f-47db-a3cb-cf6e96846287">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d1ea23e5779431d819df7f113a920f6_I20200930" decimals="-6" name="bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmEwZmIxMGNkYWFhYzQ4MWM4NjAzNWYxMmNhYWFlNDQwL3RhYmxlcmFuZ2U6YTBmYjEwY2RhYWFjNDgxYzg2MDM1ZjEyY2FhYWU0NDBfMi02LTEtMS0w_5d78479c-b2e6-46b6-b24b-1102f710ccde">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d13e7a6daeb4e828855c9b09932fb0b_I20200930" decimals="-6" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmEwZmIxMGNkYWFhYzQ4MWM4NjAzNWYxMmNhYWFlNDQwL3RhYmxlcmFuZ2U6YTBmYjEwY2RhYWFjNDgxYzg2MDM1ZjEyY2FhYWU0NDBfMy02LTEtMS0w_26d17cfd-eaf1-4f48-9a12-e5f46d2c0266">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNjE_9835fe32-5ff2-4ed8-9cae-9f87f9ee3add" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.533%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi00LTEtMS0w_f822a9c0-7715-43ed-8199-5428842f56a0">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi02LTEtMS0w_c54003a5-8921-4b06-af22-74a841da1e33">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930" decimals="-6" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi04LTEtMS0w_22bd245c-1001-463d-bcda-84e578d1da52">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi0xMC0xLTEtMA_88e5458a-66e2-43ed-bc97-9df297ba2401">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy00LTEtMS0w_30ad15c2-5eae-4d66-99bc-40429067ac60">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy02LTEtMS0w_0fcff472-955d-4a54-aaf1-91e8f229474a">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy04LTEtMS0w_bb5530ac-a13b-4661-8b5c-8c6081f3fe46">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy0xMC0xLTEtMA_771ea0fd-41d7-4547-b1fc-f40a1e742c9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC00LTEtMS0w_f5565d74-2012-47be-918f-0d2c84308c35">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC02LTEtMS0w_5d7b3ac2-dd54-498a-b95d-8dd9a85d7eaa">207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC04LTEtMS0w_fb3854fe-8bfd-483f-b09e-66516a12d5ee">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930" decimals="-6" sign="-" name="bsx:Netcurrencyexchangegainloss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC0xMC0xLTEtMA_7eaa5972-9698-4e38-9feb-e7dcfa625a25">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="ib0b0c6c0eddb4ba380afd750c48145ea" continuedAt="i46c14f4ca4bb4d0cae590fd48283ee5d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzODY_1f9fa5c9-0a88-4a19-ad68-12e1d4516588" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurements and Disclosures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNjk_9a902d30-f320-4a5e-b5c9-8c387d9a37ec" continuedAt="ifaddd89267b848faa38e582cfa0cc716" escape="true">The following are the balances of our derivative and nonderivative assets and liabilities:</ix:nonNumeric></span></div><ix:continuation id="ifaddd89267b848faa38e582cfa0cc716"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.911%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Balance Sheets (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5fdc3e0c2841679fe97d318ea58261_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNC00LTEtMS0w_44dd3fbd-118e-4231-8474-5c81df7c83c9">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee25b48d00f74853992602eb2c53b356_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNC02LTEtMS0w_85d7aa31-24f7-46d0-b97c-21323b57f80e">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e066a79d8694e84bb7d59645a985325_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNS00LTEtMS0w_cf22c564-6b10-4634-8fd2-0b165183f10e">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda5c2730294403096ebcb12e679b68b_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNS02LTEtMS0w_66d90f08-7aee-4f43-b74e-b39468d9abf3">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8dbcfebbf2c45859609734198a2ae94_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNi00LTEtMS0w_b27376f7-dcea-4995-889c-78549f8e5e3c">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9c57ccd0e14aa19b6048d2641cfed5_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNi02LTEtMS0w_119805cd-15cb-404b-98fe-12dda4580bd2">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie07d66f08df541e5a6bd2738ae221eea_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfOC00LTEtMS0w_1ec1d1dc-710d-4428-ae16-f05f7d1e0c43">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i550b85029b34440588a334f525c0ca30_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfOC02LTEtMS0w_3623cad8-9f98-457c-aefb-8370b340e5cb">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTAtNC0xLTEtMA_f71f503f-1482-4be5-862d-31f255dd1ee7">325</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTAtNi0xLTEtMA_74488ef0-73dc-408a-aad9-e4215c0582af">321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92fac259a6324f2aa04bf3e997577a63_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTQtNC0xLTEtMA_e37d48af-2d88-407e-9a91-4c41d80b2ce2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i826a2b71a6644d9dbe9440eb86ce853d_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTQtNi0xLTEtMA_0e67ab5d-41ef-494f-b978-9b81b154410d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45df496952543af8b99e6950f252bfa_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTUtNC0xLTEtMA_656ed0b7-813d-401f-8ecb-6e0f5d63687e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e0da1bd6e74a93b4391d856c9315ce_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTUtNi0xLTEtMA_8855356a-898d-45a6-aa7d-73d5196978be">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8125d7008104ae1b687a8452733fc60_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTYtNC0xLTEtMA_b3547faf-a689-4a98-abeb-c5e6080fd0b1">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i908b44cb3649452a9d48f0aeb4a0b87f_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTYtNi0xLTEtMA_0ea03d0e-ed86-4a0d-b414-d03f84ed201e">998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8dbcfebbf2c45859609734198a2ae94_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTgtNC0xLTEtMA_5a82d155-fe84-42db-b15e-32e90658a6d5">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9c57ccd0e14aa19b6048d2641cfed5_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTgtNi0xLTEtMA_469c0219-d196-438a-a464-eec71c4d47d9">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2461e9e08ed24f98af87739812b9cab7_I20200930" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjAtNC0xLTEtMA_064e9dd4-0352-448a-90f0-d39b3b8c54d4">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6077953b0caa497d9b5dd8eba2746b7c_I20191231" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjAtNi0xLTEtMA_ada9a20e-9b4a-4ffa-b4d6-20e446010c19">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjEtNC0xLTEtMA_19748004-b08d-402d-a433-fbd2a835e475">1,116</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjEtNi0xLTEtMA_560a4636-9a06-4eee-bbed-8695b97f7b1e">1,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i46c14f4ca4bb4d0cae590fd48283ee5d" continuedAt="i9ad5e3d182a94e55a94a8df260ebe401"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzODk_20243e74-c174-485a-bf7e-3784bd1f2ace" continuedAt="i400602de7dfc461d8df4fcac5a948d82" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xLTEtMS0w_878f4755-3bb5-4e19-8720-d8c437c7a4eb">1,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0zLTEtMS0w_71d5830b-cc10-4221-b0aa-1e9576fa54b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC01LTEtMS0w_aaadbe1f-a963-4896-906b-55690f322be4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC03LTEtMS0w_8c4c39b3-525a-424f-9a27-6f6f73575869">1,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC05LTEtMS0w_2742ece2-d899-4446-bf61-73a96be7754e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xMS0xLTEtMA_1f9a3739-70db-4157-b119-91226e3b6f05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xMy0xLTEtMA_d167550d-09e0-4607-9b98-68e848983852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xNS0xLTEtMA_f6eee9a1-01c9-47a8-8ad3-10e668f29573">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xLTEtMS0w_840f0e25-f6ba-4751-a22e-2773300b56da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0zLTEtMS0w_3cc7af15-660a-4867-99b2-87e2f408bf0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS01LTEtMS0w_69a39677-f386-4852-a9d6-8e4a1cdfcae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS03LTEtMS0w_22f9060d-0450-420d-b783-173d6ddcf1c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS05LTEtMS0w_23d93390-26ab-4f53-b4e7-4f38abed929a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xMS0xLTEtMA_51e013fb-8407-4be5-ac3c-af95baa5401c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xMy0xLTEtMA_206f74a6-2ac5-454e-92ab-f1cc6ac0e54e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xNS0xLTEtMA_a15c3d7f-f37c-4c39-a6c5-4e0a0f45954c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xLTEtMS0w_728a2640-4ef9-4741-804b-7ac259bb9a5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0zLTEtMS0w_2a95ff74-91c7-414a-87bc-10c4b4f50e61">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi01LTEtMS0w_d118b38d-3d32-430f-9842-7235b8a7c451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi03LTEtMS0w_85e282b9-22f4-4f42-b49f-b0ac610e8b70">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi05LTEtMS0w_39c169e8-d1e0-4e73-bb84-6f9050b9dada">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xMS0xLTEtMA_69c86634-4c1c-4e14-9941-e6c044765651">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xMy0xLTEtMA_ab1a28f6-b362-4832-9744-5f95f607118d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xNS0xLTEtMA_e21df99f-ce47-4716-a353-89184d3ac1aa">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xLTEtMS0w_0609f0a3-222c-4df3-890d-2611726e5a05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0zLTEtMS0w_7478bbee-3d85-4b16-aa15-788aa517d4a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy01LTEtMS0w_f8052d3b-148f-4ab7-b7b6-fc193410e259">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy03LTEtMS0w_707fc223-9f9d-45cb-803d-e5ac6b01d0c2">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy05LTEtMS0w_be161798-28c5-49a6-a889-7cbbe7b4e66a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xMS0xLTEtMA_758e8adc-8a11-4d6e-b6ca-3196fc7671b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xMy0xLTEtMA_71699d3f-382a-4469-b8dc-d1b5cab10e94">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xNS0xLTEtMA_18f90606-d989-4e77-a5af-5ef17b500288">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xLTEtMS0w_a32988a4-e5ac-42af-82b2-22da492f4a01">1,717</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0zLTEtMS0w_78882052-72d5-4e28-9922-0df0e111c64b">325</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC01LTEtMS0w_f2dfc249-5b58-4f33-8d92-cbfa5a86844f">396</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC03LTEtMS0w_eabd199c-042b-46e3-ae8f-8eaa2912c52f">2,438</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC05LTEtMS0w_3eb0b106-2598-418a-8942-a9c949851992">51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xMS0xLTEtMA_64014363-0b0e-4285-bfa0-394d5b70c777">321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xMy0xLTEtMA_45b0647c-f313-4f8c-b908-eaa430f50561">518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xNS0xLTEtMA_1434ce28-8ef7-4b77-a395-1292e3a1fdc4">890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMS0xLTEtMA_aee552f7-05af-438d-9ee6-17c0ef69700a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMy0xLTEtMA_4726c3b0-e590-417a-986a-5c29c73b98ac">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtNS0xLTEtMA_4408aacc-a1fa-4159-95c1-5246734c062f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtNy0xLTEtMA_3d207e74-5463-458e-90ed-a5ef1aa667fc">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtOS0xLTEtMA_fcb3c032-8b22-497a-96d8-0a0d714ee330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMTEtMS0xLTA_afa65012-fe9e-44ed-bdde-9ecc1ee4ec83">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMTMtMS0xLTA_de9700ec-7e3b-4a6f-bcb2-1a389567cf06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMTUtMS0xLTA_546c203a-12b7-4181-bffd-7fd1049bb109">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMS0xLTEtMA_3918732a-3df0-4943-a0ac-6e695ac1c1e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMy0xLTEtMA_f263f1d3-64cb-41a1-8291-e35ec58dee49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtNS0xLTEtMA_03fc20fe-7804-4083-88a6-5a389ed5e88f">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtNy0xLTEtMA_2dbb13db-b70d-4db5-a2bc-51e382fce2f5">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtOS0xLTEtMA_2365d0fc-333d-4e05-980e-e293e49c7503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMTEtMS0xLTA_0b9f8179-23ce-4ebf-92bd-a823f270cff1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMTMtMS0xLTA_3b73d857-c444-4605-99aa-20fd97f80b63">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMTUtMS0xLTA_4567c6be-9c1e-41cb-a3a6-03b107224739">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMS0xLTEtMA_8d008ac0-9442-4929-8fd0-4af291ae1280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMy0xLTEtMA_0ecd9601-e81f-4c56-a349-fcb7c3603f13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItNS0xLTEtMA_7afb2f80-26a3-4329-888c-0fbc9504428b">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItNy0xLTEtMA_a3a3acdb-4977-44c9-924a-2f1b975a4c24">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItOS0xLTEtMA_2c99808f-bc52-4188-b6f5-5474eee82620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:zerodash" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMTEtMS0xLTA_a4bb58f6-1161-4729-b3ad-ee4b3675684c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMTMtMS0xLTA_59f17fb6-f3c2-40d0-9edd-3cc1b7b2f010">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMTUtMS0xLTA_44444685-beb0-4924-adbc-cf27c3235a78">571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMS0xLTEtMA_1e2053e2-cf59-4f22-80aa-06cb7eb689a4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMy0xLTEtMA_c97205a1-a905-4056-8b93-1959261eee43">1,116</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtNS0xLTEtMA_a040ab17-e0a7-49c7-8cb8-c6921878c5fa">627</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtNy0xLTEtMA_cefbb472-05c9-4f32-b796-e96af1188f82">1,743</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtOS0xLTEtMA_10ac554f-8921-49f2-abbf-a2f864786e37">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMTEtMS0xLTA_fd18c25b-5d26-496e-9893-dc8e791f411d">1,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMTMtMS0xLTA_4636a9ed-4c52-4d55-bbf1-2ed6968e6519">925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMTUtMS0xLTA_d8ab62ab-5130-4f1b-8746-fcc776da3936">1,963</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $<ix:nonFraction unitRef="usd" contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTQxOTc_878f4755-3bb5-4e19-8720-d8c437c7a4eb">1.716</ix:nonFraction> billion invested in money market funds and time deposits as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0OTQ4OQ_2742ece2-d899-4446-bf61-73a96be7754e">50</ix:nonFraction> million as of December&#160;31, 2019, we held $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTQyNjM_0b5edf48-e4ee-4913-92e5-d1a818053111">305</ix:nonFraction> million in interest-bearing and non-interest-bearing bank accounts as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTQ0MjA_c6c42b6c-0fd6-4027-8652-d86b121009bd">165</ix:nonFraction> million as of December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, principally the contractual right to receive future royalty payments related to Zytiga&#8482;. This contractual right was acquired with BTG on August 19, 2019. Prior to our acquisition of BTG, BTG agreed to pay 50 percent of the Zytiga&#8482; royalty stream, net of certain offsets, to the inventors associated with the intellectual property. In the fourth quarter of 2019, we sold the remaining 50 percent we acquired through our acquisition of BTG of the future Zytiga&#8482; royalty stream for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTUyODM_b19461b3-0c1e-4762-bcda-3014a6759671">256</ix:nonFraction> million to the Ontario Municipal Employees Retirement System (OMERS). In accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we are accounting for the transfer of the royalty stream to OMERS as a secured borrowing, continue to recognize the financial asset and associated liability in our unaudited condensed consolidated balance sheets and do not expect to receive any future cash benefit from Zytiga&#8482; royalties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected the fair value option to account for our licensing arrangements' financial asset and financial liability in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we have recorded the fair values using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i9ad5e3d182a94e55a94a8df260ebe401"><ix:continuation id="i400602de7dfc461d8df4fcac5a948d82" continuedAt="i2858f55ae0ca44508842b4d427a8fc87"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:19.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i64b1627c34744a79852c22f89f4e2bd9_I20200930" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS0xLTEtMS0w_af2fec58-df3c-4c51-ab3b-c3c997beff8c">396</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0486c1f5a3dc44bbad592c4face792ce_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS00LTEtMS0w_b395e431-06f3-4f8d-b2f3-8553499f5719">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i401066db3ff649128198d977bf21c7d9_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS02LTEtMS0w_7f88b906-dc0c-490f-9251-8a7bfd678b40">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d8e764d9f154c0ba1fde2f3c18ba6f4_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS03LTEtMS0w_141048a3-44cf-4c00-964b-168158f18d90">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i64b1627c34744a79852c22f89f4e2bd9_I20200930" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC0xLTEtMS0w_9d1f1c01-cd7f-400a-b241-4f693a3499d6">413</ix:nonFraction> million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide565556a33042009f2db6eb39c31318_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC00LTEtMS0w_18345b37-86ed-4c54-a0b5-3aa97ebc63e8">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5585c06b1a414f278e4e8698e3e9ade6_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC02LTEtMS0w_8daaead9-84bb-4c4f-8297-4d9e54195179">15</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie650a8a143a34390997d58eb8375e627_I20200930" decimals="2" name="bsx:DiscountRateFairValueInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC03LTEtMS0w_37280b30-3771-44ec-9cba-3bad73252bbe">13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of September&#160;30, 2020. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains or losses from the licensing arrangement.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2858f55ae0ca44508842b4d427a8fc87"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfMS0xLTEtMS0w_51dc09d6-6e2e-4d78-8bf2-986077469c80">518</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b1fc603c49e4452b1fe2055d66a5728_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromRoyaltiesReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfMy0xLTEtMS0w_3185e85f-61b6-42e5-8ce4-1b5088276a96">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1fc603c49e4452b1fe2055d66a5728_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfNS0xLTEtMS0w_5a4b1809-6dca-4d83-a2a7-15ff3b4f402a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfNi0xLTEtMS0w_1cd0b171-a0c8-48e1-a3bc-1ce668db6209">396</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfMS0xLTEtMS0w_811d3d70-91ec-4f7b-8dc6-2314f2999b70">571</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05d67b0c2c82420f89ded5c32461a093_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfMy0xLTEtMS0w_c47b3d97-0e71-4106-9aa0-c8c5aef15315">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d67b0c2c82420f89ded5c32461a093_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfNi0xLTEtMS0w_9e2e45cf-ee9b-462d-81d0-5af5e8638d6f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfNy0xLTEtMS0w_0217d1a5-e992-4ad2-a57c-a0faee9f7d8a">413</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTc5MjM_37ffb8a6-b0e4-4ba9-9290-566d6bf92d0a">10.901</ix:nonFraction> billion as of September&#160;30, 2020, including $<ix:nonFraction unitRef="usd" contextRef="if96fb4dab0df493cb56977ec02e792ab_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTc5NDY_3e39ca0d-667e-4ae4-8b16-9a5ff93cf9a5">1.050</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes, and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTc5OTA_36bf01f7-6bea-4ace-b023-fc3f09e8161d">11.020</ix:nonFraction> billion as of December&#160;31, 2019, including $<ix:nonFraction unitRef="usd" contextRef="i40844fee5f8f45e0b76f79276d662d4a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgwMTM_8affe63e-b904-4481-87ff-0f5d6bc61a08">1.004</ix:nonFraction> billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI2Nzc_1e110b98-3f8a-41e2-a913-cb78386372e6" continuedAt="i67112cc92d594b9f9411bd324e2df3c4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjY_a6325e4a-d642-48b0-bcd7-0cfd8835754d">9.336</ix:nonFraction> billion as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfODI_77ab6bcf-81de-4dba-914c-4334e4c86b0d">10.008</ix:nonFraction> billion as of December&#160;31, 2019, presented net of unamortized debt issuance discounts and deferred financing costs. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI3MDI_866cc801-a9b8-42a7-9a4f-41453a73c5e3" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate (1)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fdadf64e0a447b8a6b7edadefcae98_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMy02LTEtMS0w_05b1d198-8f3c-420f-a489-5bc61a64b956">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8fad34607d4972966fe7b09a5d903a_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMy04LTEtMS0w_ca0eda24-0116-4b23-9d36-29d5a345c7a2">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01fdadf64e0a447b8a6b7edadefcae98_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMy0xMC0xLTEtMA_8b49d133-ad16-423f-9bd1-7bd21755cca0">3.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ce7410ffeb041b585ba5959fc091a98_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNS02LTEtMS0w_c4e5e5c3-4a78-4e66-8d14-d8e05a3b6ab8">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2127f61595964047ad8a3dafad593c19_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNS04LTEtMS0w_871914e0-52a7-4535-a2c1-410a5e7641d6">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ce7410ffeb041b585ba5959fc091a98_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNS0xMC0xLTEtMA_0ed25b91-7e36-432a-ae07-1626cbf5d7c8">4.125</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNy02LTEtMS0w_e3204423-92d7-4bc9-9567-2bd79971d956">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4c4d99b6f84b108d22a749ed8bcb43_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNy04LTEtMS0w_e2be6776-f0ec-4c08-86ff-e3914f7c9d46">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNy0xMC0xLTEtMA_e648368b-d43c-4427-ae44-c2b7804e7c69">3.450</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a32bba350f7460f802d9e35490647d0_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOC02LTEtMS0w_9a8aef5e-c3ca-4d6f-b256-ce8bedc1cdae">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf53f2e2753142488c3129ebd45bd3f2_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOC04LTEtMS0w_bb3254d0-5272-48c1-93b6-6d28ba5f198f">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a32bba350f7460f802d9e35490647d0_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOC0xMC0xLTEtMA_eb700419-384f-4f4e-8f4d-9392e0f1504f">3.850</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOS02LTEtMS0w_88d6adcc-180f-42f7-80d1-2bf84ae34b0f">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i984aed9feb2742ae9f40f9ab8d399bee_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOS04LTEtMS0w_981d7fea-574a-46f7-b6c8-454662e81ff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOS0xMC0xLTEtMA_fd9fdf50-2eaf-4722-baae-44f09d903116">1.900</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTAtNi0xLTEtMA_2297c525-c29e-4bdb-a46e-42f900b58c5f">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074cdefffbac46a5aa907b64799c5c18_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTAtOC0xLTEtMA_17d7bd70-dc05-4199-ab7a-f36e01d5d45b">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTAtMTAtMS0xLTA_d9e76364-1899-4641-84b1-442d667c7def">3.750</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTEtNi0xLTEtMA_f38e1748-6f18-47d6-8592-7866cbd7350a">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3c2b7d701e44a19150fa05ed088e19_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTEtOC0xLTEtMA_a991cee6-393d-4bc5-a442-632d32b51cc2">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTEtMTAtMS0xLTA_fcca8e31-0a2a-460f-b4b2-027c8ababf14">0.625</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd9e8fd2638a4eb5882534a5a95c4011_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTItNi0xLTEtMA_146fc519-02fd-48d3-8fc7-dd154e7f14ef">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a0bb0216b14c8eb6488725ad9369e7_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTItOC0xLTEtMA_0b56ea67-076a-4da7-a25f-670d4194379a">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd9e8fd2638a4eb5882534a5a95c4011_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTItMTAtMS0xLTA_09c125a4-c77a-4ee6-b1da-6b957850fed5">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883f72b197734176a05916892d1f98aa_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTMtNi0xLTEtMA_44a7f13e-47c3-4aed-a477-143e346f001a">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbd5b02a23541cd9066e7e6764eb0be_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTMtOC0xLTEtMA_f5efe434-e892-49a8-aa35-87ce571d417b">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i883f72b197734176a05916892d1f98aa_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTMtMTAtMS0xLTA_58acea21-a639-4374-ba71-9dfb576c7dc5">4.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTQtNi0xLTEtMA_49908de5-b4a7-4c08-9e1c-8fab6f59d636">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1c7a363bc2a4be7a656ce96470fc32c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTQtOC0xLTEtMA_316203d1-fd1c-4eb1-94cb-fd4655e2ff65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTQtMTAtMS0xLTA_1d16cb68-3ac2-4deb-906f-7fec581e6746">2.650</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3147cace57a14c1e88a7023fa0d1a751_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTUtNi0xLTEtMA_4a41c9be-1548-4e5a-887c-ff8fa725f363">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bcfebb0ff6544389662db268de515a9_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTUtOC0xLTEtMA_97cd93fc-bd05-4af2-9c74-c6e4b77212dd">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3147cace57a14c1e88a7023fa0d1a751_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTUtMTAtMS0xLTA_132a3ab5-b645-400c-9ab0-2763a841016f">7.000</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0024f7d8ff964efa837a696943046bff_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTYtNi0xLTEtMA_faf5e979-35e1-4d70-99af-c33772978a21">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fefb20cb374b77a6a68660e9ec56df_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTYtOC0xLTEtMA_23b5de90-a2bc-4228-bbae-12a4e68a2cdd">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0024f7d8ff964efa837a696943046bff_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTYtMTAtMS0xLTA_7d3f8e72-99fa-4153-b0cf-1e0c7f48770b">4.550</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6cf239eb4aa40688db906dfe60df801_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTctNi0xLTEtMA_0c60b7e6-432c-4dba-8bd5-db877fb4f7c4">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7b010ef6d24932aa67070e591431ad_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTctOC0xLTEtMA_89d0dea1-77cf-48f0-8bd9-b4fa9cf481ff">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6cf239eb4aa40688db906dfe60df801_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTctMTAtMS0xLTA_c2e9d00c-20cc-4244-9688-4fafc7d662a4">7.375</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTgtNi0xLTEtMA_40a5e124-7930-483e-9834-e1b6c8fa8792">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ca8274c7c84451adfe5cc6e39d84f4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTgtOC0xLTEtMA_c7423f76-ece5-4882-a486-5eceec9a5a02">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTgtMTAtMS0xLTA_d3864568-6e9c-4b05-aa0e-2c8b6069b91c">4.700</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14af729841249f68bb249aa9328ed14_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktNi0xLTEtNTc4NQ_0bc7c5aa-aafe-4780-b83e-bd72262c0227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471614cc047e493a97bc532efbc84e9e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktOC0xLTEtNTc4NQ_be3964a6-c546-44bd-8b43-1fc96b12dd06">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Deferred Financing Costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97f676404a0d4a368a7a8b76358caf94_I20200930" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktNi0xLTEtMA_073e7745-ec57-4c9b-8a2a-33aaf2330cee">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0055d17e432d43e6a5716e6ef8c734af_I20191231" decimals="-6" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktOC0xLTEtMA_b456e17d-088a-4d54-bb67-d77ed624e7d3">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 - 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifef58c4a2ac34d8487fda59f2817e413_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjAtNi0xLTEtMA_ee3e7d43-21b5-4e3e-9057-e6b3f92a3bdc">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbaf3b08ce1a47f0bab1706eec16f414_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjAtOC0xLTEtMA_517d8106-9cba-4609-8c37-9d12a8bf7032">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8512f90c15ee4bf1a751122703f3e372_I20200930" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjEtNi0xLTEtMA_c5875bc0-dea7-416b-b335-e9536b441acf">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9765c02939444a8b21465369b4d6f8_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjEtOC0xLTEtMA_c863d964-5cc3-4d63-b8e9-c7ff1c1aa278">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjItNi0xLTEtMA_de20b90b-729f-4902-b638-ebd554bfe47b">9,325</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjItOC0xLTEtMA_584a0fcf-30c1-4b8e-a32c-a83b222083ea">8,592</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which is a variable-rate instrument based on LIBOR.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a $<ix:nonFraction unitRef="usd" contextRef="if4918679d9a1491c920d33be9eafbb1b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfODc5_fbe23fa3-8716-48e5-920c-252f6f4cb248">2.750</ix:nonFraction> billion revolving credit facility (Revolving Credit Facility) with a global syndicate of commercial banks that matures on December 19, 2023 with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. The credit agreement requires that we comply with certain covenants, including a financial covenant described within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. In the first quarter of 2020, we refinanced $<ix:nonFraction unitRef="usd" contextRef="i75ab56af73414eec9527c4729f49674b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTc5OQ_2cc871fe-dfb7-4235-a42a-fe1956554aa2">1.360</ix:nonFraction> billion of commercial paper using proceeds from the Revolving Credit Facility. In April 2020, we entered into the April 2021 Term Loan, described below, and used the proceeds to repay a portion of the amounts outstanding under the Revolving Credit Facility. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued <ix:nonFraction unitRef="number" contextRef="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTY0OTI2NzQ1NzE0Mg_3d2dd5b3-cb3c-44c1-92fc-f47607c5a3a7">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock, Series A (MCPS) and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. In May 2020, we completed our senior notes offering described below and used a portion of the proceeds to repay $<ix:nonFraction unitRef="usd" contextRef="i6048faff94fe4e3f8ff35fae909e93f8_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjE0Ng_c59ac40f-7423-42c9-ae1a-09c1a984fc87">450</ix:nonFraction> million outstanding under the Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of September&#160;30, 2020 or December&#160;31, 2019. </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i67112cc92d594b9f9411bd324e2df3c4" continuedAt="id4a339b70b0f4c69b7cc9346510ef6e9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i96e3727f0c4047e78994b7e46ebbd066_I20200421" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjQ0MQ_b7f9bb7e-9ddc-4939-aa3d-03072ab942d4">1.250</ix:nonFraction> billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $<ix:nonFraction unitRef="usd" contextRef="i188f9ed380a4434fad684f6ec8f9957c_D20200518-20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjgzNA_86a16439-f8eb-4f09-94b6-e4bbb13f6162">500</ix:nonFraction> million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our MCPS and common stock offerings to repay in full the remaining $<ix:nonFraction unitRef="usd" contextRef="i0a0778d1a32c42a698d0c0d4391be338_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjk4Mw_79a105e2-4a07-43f9-b52b-fb9b81fedec3">750</ix:nonFraction> million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i3ac08e9e5ba84c159c3799c380213ac2_I20200227" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMzEzMQ_d9dda36c-acab-42e9-8c8e-1362a01fb419">1.000</ix:nonFraction> billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding of the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i2a1cc324ff16414fb873ed25161c08e7_I20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA5OTUxMTY0NTI5OQ_dbd35350-6d38-4c0b-865c-0f1ab4964e22">0.85</ix:nonFraction>%. The credit agreement is subject to a financial covenant described below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $<ix:nonFraction unitRef="usd" contextRef="i36af306e51d44c42bb19eb47b23ae5b4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDExOA_70e3c66d-96ca-423c-8f79-04cbc467239d">750</ix:nonFraction> million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $<ix:nonFraction unitRef="usd" contextRef="id56c2ccee432470da073b69f5e06f077_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDE3NQ_f6aa0c11-067b-45c7-afe5-e6e71b5adbee">250</ix:nonFraction> million and terminated the February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i4cad1325157949eb8729affa69cd1f9c_I20191205" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDMwOA_941c62eb-ce43-49f5-87b2-409031e5dddb">700</ix:nonFraction> million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="iea83365e9d284726b2d572cf20af3e78_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDQzMw_53b466e9-40c0-4f84-8902-311bcf4119ba">700</ix:nonFraction> million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $<ix:nonFraction unitRef="usd" contextRef="i3744c29fbf454f11ad39d179e30ed2c8_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDU5MA_b78cc7de-ffc2-47f6-9bf2-780588c48c5b">300</ix:nonFraction> million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i6793d82e66694285af4326091ac468be_I20181219" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDg1NA_9ef40779-c6d5-4687-9642-19f85963f26b">2.000</ix:nonFraction> billion senior unsecured delayed-draw term loan facility consisting of a $<ix:nonFraction unitRef="usd" contextRef="i356171311f5740fda173fd3ecc70f05a_I20181219" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDkyMg_367d2080-d310-4870-a31a-f104ce260ab4">1.000</ix:nonFraction> billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $<ix:nonFraction unitRef="usd" contextRef="i2daade2444a049a4b2e1cbdd923ce601_I20181219" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTA3NA_87f33a99-a9a9-468c-afca-2bfa72f6020e">1.000</ix:nonFraction> billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August&#160;19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $<ix:nonFraction unitRef="usd" contextRef="i83915196e3d34a92a3c8eb05366c1b25_I20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTI4MQ_0613ee93-cfa8-4e12-9793-58640b9d7dae">1.000</ix:nonFraction> billion under the Two-Year Delayed Draw Term Loan and $<ix:nonFraction unitRef="usd" contextRef="i68796c45e93e415abbc18dda7fc8d1fe_I20190819" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTMzMA_aaa0c251-0967-4f83-841e-e7e3cf8c9709">1.000</ix:nonFraction> billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="i7ad9677f736c4ba4aeef783f34c21d4b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTU5OQ_487365ce-ca34-4fdf-b547-3b7dfc53154a">1.000</ix:nonFraction> billion outstanding under the Three-Year Delayed Draw Term Loan (also referred to as the "August 2022 Term Loan" in the debt maturity schedule above). In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of September&#160;30, 2020, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through September&#160;30, 2020, we were in compliance with the financial covenant required by all existing credit facilities described above:</span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI3MTc_1f491378-b5f1-4f80-85ae-43626a5e2761" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:32.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if55fcf95b4eb4092b6c279ab4b78debc_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOmNhMTJkZmNkOTViODRiY2RhNDkxOTRiY2QzMDYwY2EzL3RhYmxlcmFuZ2U6Y2ExMmRmY2Q5NWI4NGJjZGE0OTE5NGJjZDMwNjBjYTNfMi0yLTEtMS0w_b091b7a5-b35b-47f2-a3fc-0f6924660e0f">4.75</ix:nonFraction> times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idec7a450c3d54d0f8b17663bc0bb3763_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOmNhMTJkZmNkOTViODRiY2RhNDkxOTRiY2QzMDYwY2EzL3RhYmxlcmFuZ2U6Y2ExMmRmY2Q5NWI4NGJjZGE0OTE5NGJjZDMwNjBjYTNfMi00LTEtMS0w_b5cedf1a-c082-46aa-8a7d-58e970c75297">3.40</ix:nonFraction> times</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) establish a deemed Consolidated EBITDA of $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:DeemedConsolidatedEBITDA" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjUyMQ_8db52f01-9367-4901-84f1-e73e65386eec">671</ix:nonFraction> million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of <ix:nonFraction unitRef="number" contextRef="ie4657030099241c583762bbda7fb257e_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjczOQ_4812f0b5-9d70-4123-9857-b489e13d3bb4">4.75</ix:nonFraction> times through the remainder of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="id4a339b70b0f4c69b7cc9346510ef6e9" continuedAt="if1720388fc4742cc90c070e7786540c8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2020, with a step-down for each succeeding fiscal quarter end to <ix:nonFraction unitRef="number" contextRef="ic50a96ccf5e5405ea44c3569e511b345_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjgzMg_16834dd9-f6e1-47b4-a880-e8188d0caccf">4.50</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="i0cb1b018038e41b6bcb8d9bc27e45f0f_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjgzNg_6bab6ab6-b0e2-4882-8fa1-643f46ba6a9a">4.25</ix:nonFraction> times, <ix:nonFraction unitRef="number" contextRef="i2a0b5203b93642e2a8fdc6e76df7568e_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjg0MA_840b6c5e-ff1f-407e-a4cf-6abae074647a">4.00</ix:nonFraction> times and ultimately <ix:nonFraction unitRef="number" contextRef="i54e4c18dc5a04626b7d5a7ec3770c878_I20200930" decimals="2" name="bsx:MaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjg1OA_09d27bc4-4c6c-4bef-85c7-5f01e20e11eb">3.75</ix:nonFraction> times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 Revolving Credit Facility and February 2021 Term Loan amendments, the definition of &#8220;Material Adverse Effect&#8221; has been amended to remove the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:ExclusionFromEbitdaForRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzM5NQ_e7a410f4-9321-46d1-8eff-59791f149251">500</ix:nonFraction> million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of September&#160;30, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzUyOQ_1e5f2daf-f746-4b06-841a-5dac3cda2b54">194</ix:nonFraction> million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:LitigationAndDebtExclusionFromEbitda" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzg2MQ_9a3ef5b7-aebf-4229-8a7f-d33a4bcde09d">2.624</ix:nonFraction> billion in the aggregate. As of September&#160;30, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzg5OQ_14a1661b-d201-4b98-aa83-55bfc0773c02">946</ix:nonFraction> million of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this amended covenant could require us to seek to further renegotiate the terms of our Revolving Credit Facility or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="iab04e6a866c54c479502399061c066c8_D20200101-20200930" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI2NzY_5de7f310-8bea-4118-ba3e-70885cf0ac97" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $<ix:nonFraction unitRef="usd" contextRef="i75ab56af73414eec9527c4729f49674b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfODk0MQ_2cc871fe-dfb7-4235-a42a-fe1956554aa2">1.360</ix:nonFraction> billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of September&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMi0xLTEtMS0w_9c6e3e3c-54d8-421d-8644-0bd6cf9fdb58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231" decimals="-6" name="us-gaap:CommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMi0zLTEtMS0w_61281ee9-a910-4e6b-9f8c-e37ad1d27030">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:MaximumCommercialPaperOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMy0xLTEtMS0w_f93cc217-75ae-4d55-bf01-8f617921d039">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:MaximumCommercialPaperOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMy0zLTEtMS0w_79dc8f8c-8a7f-44d3-b873-026d14a79130">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNC0xLTEtMS0w_bae09010-f25a-4724-b7f0-a2ff2b061c98">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNC0zLTEtMS0w_3abd25b8-a999-431c-b638-4d26f39baf83">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab04e6a866c54c479502399061c066c8_D20200101-20200930" name="bsx:WeightedAverageMaturityDays" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNS0xLTEtMS0w_bd774ee7-68d3-4a02-8c82-6935144b9184">0 days</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i253c4d1492ec41528006e7fc65ed1f90_D20190101-20190930" name="bsx:WeightedAverageMaturityDays" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNS0zLTEtMS0w_159ecd17-269a-4e90-85a2-509a9bbd8ce1">55 days</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930" decimals="4" format="ixt:zerodash" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNi0xLTEtMS0w_6028fe78-f305-4b47-a7bf-0a2839d4f8b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNi0zLTEtMS0w_8aff93e9-d3c8-4f05-a69c-36f0ce7e31f3">2.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $<ix:nonFraction unitRef="usd" contextRef="i97f676404a0d4a368a7a8b76358caf94_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTEyOQ_6a130720-0b61-490d-8aa8-fc966e66a583">9.404</ix:nonFraction> billion as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i0055d17e432d43e6a5716e6ef8c734af_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTE0NQ_e76d5e65-a3ea-48fe-b070-f177d556946c">7.661</ix:nonFraction> billion as of December&#160;31, 2019. In May 2020, we completed an offering of $<ix:nonFraction unitRef="usd" contextRef="i43f3cd5bec824c3883ea52033763412c_I20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTE5OQ_49208b57-5f8c-411c-85f2-d2cafb5e58bb">1.700</ix:nonFraction> billion in aggregate principal amount of senior notes comprised of $<ix:nonFraction unitRef="usd" contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTI2MQ_4ee9ac88-d0da-4cbf-85f1-419512c40078">500</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTI2Nw_fd9fdf50-2eaf-4722-baae-44f09d903116">1.900</ix:nonFraction>% senior notes due June 2025 and $<ix:nonFraction unitRef="usd" contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTMwMQ_1af2b6ce-9e31-4f40-ba91-e9f15d53cc1f">1.200</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTMwNw_1d16cb68-3ac2-4deb-906f-7fec581e6746">2.650</ix:nonFraction>% senior notes due June 2030. We used the net proceeds from the offering to refinance $<ix:nonFraction unitRef="usd" contextRef="i6048faff94fe4e3f8ff35fae909e93f8_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTM5NA_b0c46725-28b9-4354-8cf9-45dd82d3b446">450</ix:nonFraction> million of amounts outstanding under the Revolving Credit Facility, prepay $<ix:nonFraction unitRef="usd" contextRef="iea047c096481465dbe4a37db91ccd61e_D20200518-20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTQ2NA_860beeb4-4066-4ef8-a44f-aaa285e9e933">750</ix:nonFraction> million of amounts outstanding under the $<ix:nonFraction unitRef="usd" contextRef="i3ac08e9e5ba84c159c3799c380213ac2_I20200227" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTUwMA_d9dda36c-acab-42e9-8c8e-1362a01fb419">1.000</ix:nonFraction> billion February 2021 Term Loan, prepay $<ix:nonFraction unitRef="usd" contextRef="i188f9ed380a4434fad684f6ec8f9957c_D20200518-20200518" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTUxNA_12d5b3ef-9c47-4735-87e0-f27105f0e98a">500</ix:nonFraction> million of amounts outstanding under the $<ix:nonFraction unitRef="usd" contextRef="i96e3727f0c4047e78994b7e46ebbd066_I20200421" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTU1MA_b7f9bb7e-9ddc-4939-aa3d-03072ab942d4">1.250</ix:nonFraction> billion April 2021 Term Loan and pay related fees, expenses and premiums.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;<ix:nonFraction unitRef="eur" contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTY0OA_212989fc-9536-46b0-b08d-e2b9a637cd1c">900</ix:nonFraction> million (approximately $<ix:nonFraction unitRef="usd" contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTY2Ng_90af2a81-8ecb-410e-a471-d71a43bfc787">1.000</ix:nonFraction> billion) in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTcwMw_fcca8e31-0a2a-460f-b4b2-027c8ababf14">0.625</ix:nonFraction>% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $<ix:nonFraction unitRef="usd" contextRef="icf84351e6d7f46b5b417b3fe7a492801_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxMjQ_1a2aee1e-158d-40b4-90a4-571dda543324">206</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="if234b468e2014e5f831131ce97f1e3d4_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxMzQ_7d9fff64-7051-4a29-b449-140a580b2be1">450</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i3ce7410ffeb041b585ba5959fc091a98_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxMzc_0ed25b91-7e36-432a-ae07-1626cbf5d7c8">4.125</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i8fb3528bff5c45a493e93a5e6edaa687_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxNjM_2a3dc8d9-27a1-4296-af72-8cbdd42189b7">566</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i6773aa82907a4a00b7b3cdf75118628d_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxNzM_f4ec63de-1251-4ba9-a3fb-540bdd00f44c">1.000</ix:nonFraction> billion <ix:nonFraction unitRef="number" contextRef="icd9e8fd2638a4eb5882534a5a95c4011_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxNzY_09c125a4-c77a-4ee6-b1da-6b957850fed5">4.000</ix:nonFraction>% senior notes due 2028 and $<ix:nonFraction unitRef="usd" contextRef="i9e9769b9ff414bd2b8b2073ecdf42894_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAyMDU_40b211af-e6b3-493d-b502-9fcc3cb003a5">227</ix:nonFraction> million of our $<ix:nonFraction unitRef="usd" contextRef="i6ba75e1b9e124586932fb7c27ac202af_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAyMTU_3fda9f9e-868b-44e7-91b0-349a3fa8efbd">750</ix:nonFraction> million <ix:nonFraction unitRef="number" contextRef="i6a32bba350f7460f802d9e35490647d0_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAyMTg_eb700419-384f-4f4e-8f4d-9392e0f1504f">3.850</ix:nonFraction>% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in connection with the transaction. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="if1720388fc4742cc90c070e7786540c8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we completed an offering of&#160;$<ix:nonFraction unitRef="usd" contextRef="i6da5402f99a740959e8d45ac53a0a17d_I20190225" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAzOTI_5f8f3ac1-9a6f-4319-98f3-e4f8806a8802">4.300</ix:nonFraction> billion in&#160;aggregate principal amount of senior notes comprised of $<ix:nonFraction unitRef="usd" contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0NTQ_e3204423-92d7-4bc9-9567-2bd79971d956">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0NjA_e648368b-d43c-4427-ae44-c2b7804e7c69">3.450</ix:nonFraction>% senior notes due&#160;March 2024, $<ix:nonFraction unitRef="usd" contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0ODQ_2297c525-c29e-4bdb-a46e-42f900b58c5f">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0OTA_d9e76364-1899-4641-84b1-442d667c7def">3.750</ix:nonFraction>% senior notes due&#160;March 2026, $<ix:nonFraction unitRef="usd" contextRef="i883f72b197734176a05916892d1f98aa_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1MTQ_44a7f13e-47c3-4aed-a477-143e346f001a">850</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i883f72b197734176a05916892d1f98aa_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1MjA_58acea21-a639-4374-ba71-9dfb576c7dc5">4.000</ix:nonFraction>% senior notes due&#160;March 2029, $<ix:nonFraction unitRef="usd" contextRef="i0024f7d8ff964efa837a696943046bff_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1NDQ_faf5e979-35e1-4d70-99af-c33772978a21">750</ix:nonFraction> million of <ix:nonFraction unitRef="number" contextRef="i0024f7d8ff964efa837a696943046bff_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1NTA_7d3f8e72-99fa-4153-b0cf-1e0c7f48770b">4.550</ix:nonFraction>% senior notes due&#160;March 2039 and $<ix:nonFraction unitRef="usd" contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1Nzc_40a5e124-7930-483e-9834-e1b6c8fa8792">1.000</ix:nonFraction> billion of <ix:nonFraction unitRef="number" contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1ODM_d3864568-6e9c-4b05-aa0e-2c8b6069b91c">4.700</ix:nonFraction>% senior notes due&#160;March 2049. We used a portion of the net proceeds from the offering to repay the $<ix:nonFraction unitRef="usd" contextRef="ia241322b6fe54781a8915e284bf41aa9_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA2NzY_8eeb8091-59b1-4bd5-b7db-eaf8654ab871">850</ix:nonFraction> million plus accrued interest and premium of our <ix:nonFraction unitRef="number" contextRef="i25bd1c30873b4a2495db8cd417725ada_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA3MjA_990a4b7e-8297-4672-bfe4-8e0db9061ff8">6.000</ix:nonFraction>% senior notes due&#160;in January 2020, the $<ix:nonFraction unitRef="usd" contextRef="ibbbf84bbd3c14b8c9b7bd99842df6139_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA3NTE_67e31cce-504a-485c-b612-18e02715d9cf">600</ix:nonFraction> million plus accrued interest and premium of our <ix:nonFraction unitRef="number" contextRef="i51badacc45004d658f01556146c4c4d7_I20200930" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA3OTU_9046011a-a4cf-442c-8e91-40d188a9880c">2.850</ix:nonFraction>% senior notes due&#160;in May 2020 and the $<ix:nonFraction unitRef="usd" contextRef="i849e8308c4dc4865a29cb7ca737f1d05_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA4Mjk_788cc678-6dba-4cd5-9e5c-b78617c9cc05">1.000</ix:nonFraction> billion plus accrued interest of our August 2019 Term Loan. In the third quarter of 2019, the remaining proceeds were used to finance a portion of the acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying unaudited condensed consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI2Njg_19eef041-4954-4e86-813a-d3e060e99f18" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.912%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb811284281f4dec9c9d5f3ad78bf9ca_I20200930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi0xLTEtMS0w_6f085857-2b40-4078-8655-6837019dc565">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if13011e07a9c4f78b791f39df452c756_D20200101-20200930" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi0zLTEtMS0w_bc990c39-f7ec-4e0e-9e82-9df02fa17edc">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i624957ecbe3e4fbbbd064e40723f0a53_I20191231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi01LTEtMS0w_507bf028-3b23-466c-81d9-0a5048cd442f">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i30818acc715047c9ad17d283e629e3a4_D20190101-20191231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi03LTEtMS0w_b06da684-489e-4511-83b6-fa2cef33e719">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica793e70ab6c48b08a38c04312340dd1_I20200930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy0xLTEtMS0w_f8db3d10-cc73-4a20-9438-bf4bf954b0c8">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife92981b4da641aabca9389a91f0a450_D20200101-20200930" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy0zLTEtMS0w_97112398-a63c-468d-b04f-a0a9b886b1e9">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia406644c1ce04cda93abfe713b393765_I20191231" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy01LTEtMS0w_2b81a750-bcb9-4faf-b805-4e144e01139d">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i413e4fb8d6234afca3447f3b21048756_D20190101-20191231" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy03LTEtMS0w_7f441789-dc72-4934-81cf-a3abfb1459aa">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3df7cc192c604254acab7fbfe4adf235_I20200930" decimals="-6" name="us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfNC0xLTEtMS0xMzI0_f4e9743b-b43c-449b-a0af-5b2375b5300c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74a0e9005e53465091e8bc2786c7dc97_D20200101-20200930" decimals="3" name="us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfNC0zLTEtMS0xMzI4_3dc58e0f-7740-4989-8f10-f9966a85d1e5">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTIwNjQ_319ef16e-fa32-4d48-bd9b-b05841eeb390">125</ix:nonFraction> million as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTIwODA_91ddce07-5706-484a-b94f-3909f0f9aa10">105</ix:nonFraction> million as of December&#160;31, 2019, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of September&#160;30, 2020 and December&#160;31, 2019, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 and December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_85"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg2Ng_1e4afea4-bdec-4be9-95dc-c59976350ec2" continuedAt="i899c460725934e4eba57196d5e0c059e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying unaudited condensed consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash, cash equivalents, restricted cash and restricted cash equivalents</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg3NQ_3f84c94c-121e-4cf0-ad40-603fca707cc9" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMi0xLTEtMS0w_870f3a58-0dde-487c-88a4-b4506ed74fdf">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMi0zLTEtMS0w_0055a587-5d62-46bd-874a-022bbbb0845c">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMy0xLTEtMS0w_04af877b-5052-4675-87a0-5ced52d9531d">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMy0zLTEtMS0w_9b894c75-a2cc-42b5-bcb3-4e0b196450ad">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNC0xLTEtMS0w_e9011d48-bc10-4644-88b4-5933d39b3d7b">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNC0zLTEtMS0w_246c9d99-4329-4d0b-808b-1dcbb621bad9">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNS0xLTEtMS0w_643fa283-e38b-4abe-b8a5-9e693c3f834d">2,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNS0zLTEtMS0w_037f44a4-b3cb-49cb-baa9-b60fbbdf0ebb">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i899c460725934e4eba57196d5e0c059e" continuedAt="i9a9c7a84e8514f5cb899de8b7a6c963f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg3Ng_d3b5d7a3-2c94-4648-8524-854754a17d39" continuedAt="i793c7e68f70a4d3385a89673dcb75218" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMi0xLTEtMS0w_b056e292-c4bb-482a-a876-7b410519d05b">1,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMi0zLTEtMS0w_d5e1c1ac-f479-4ed3-9ede-b8674ae1ae87">1,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMy0xLTEtMS0w_4b52e090-631e-42fd-bf44-3c1d486366b0">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMy0zLTEtMS0w_e7da7a52-07be-4a8f-a882-df097f7e12e2">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfNC0xLTEtMS0w_2fbae658-9852-4fc2-b5a5-a169c86b8448">1,598</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsNotesAndLoansReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfNC0zLTEtMS0w_b8a1ab20-5cb6-48c6-9ce6-af8b82fcaa2d">1,828</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><ix:continuation id="i793c7e68f70a4d3385a89673dcb75218"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi0xLTEtMS0w_e24c99ff-bf63-4ac8-8df4-f2635eb382db">94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aaf89e580246e2979204c398ade960_I20190630" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi0zLTEtMS0w_8025a368-a7ef-456e-8181-8785a8f9aecc">73</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi01LTEtMS0w_1717679c-25ba-4c71-bc2f-e68205ff6648">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi03LTEtMS0w_d393e9d7-278f-4e83-847d-fbeeaea9ed9d">68</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMy01LTEtMS0w_eacbbe17-45a2-44d0-8801-f020729dc6f0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC0xLTEtMS0w_41c4654b-ee57-4ba4-b4b3-5215bf9ff376">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC0zLTEtMS0w_1076aa98-988a-4fa5-afbd-36d821ff1529">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC01LTEtMS0w_584c1064-5000-4b01-800c-2505ada12331">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC03LTEtMS0w_0a70cb1c-341e-4777-b82b-cb58bfa3a7f7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS0xLTEtMS0w_1839ea05-1bf8-4185-b68e-35524ffa2af3">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS0zLTEtMS0w_b32a8fc2-2e3b-4cde-9e5f-87d32b7b7579">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS01LTEtMS0w_949463c4-f1f6-4333-b25f-0684b75422e1">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS03LTEtMS0w_b6f90e60-4a21-479c-9a92-5b921f6dbba3">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi0xLTEtMS0w_63fa6625-6676-4af6-8fbd-388500b4e612">103</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi0zLTEtMS0w_e6a3ea03-a805-476e-97be-1fb0d20fd633">75</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi01LTEtMS0w_18d6cd3f-a24b-4bcd-9a57-5daae96c596e">103</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi03LTEtMS0w_da7f3c0d-47cb-4a27-9ab4-89c0bc7db64c">75</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted FASB ASC Topic 326 using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg3Mw_82ec1804-27e1-47f6-bcfe-09d1a8805a26" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMi0xLTEtMS0w_3885de51-bd83-4afe-b8fe-ea123d408212">871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMi0zLTEtMS0w_b9180b52-53a4-4920-a6ca-fe5c511505f3">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMy0xLTEtMS0w_f590730d-d043-4d6f-92dd-87f574f0151f">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMy0zLTEtMS0w_7c6e834b-e531-4221-b4d1-9e903607bcb1">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNC0xLTEtMS0w_166ff7d2-a669-4187-b78d-666e9c024a51">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNC0zLTEtMS0w_2e468218-780a-4e9e-a128-153467fa9e4d">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNS0xLTEtMS0w_846f9194-e6c0-4fbd-8af4-b313a565cadf">1,472</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNS0zLTEtMS0w_eb4f8f94-1c4b-4bb3-a04b-ddb9edf29102">1,579</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg2Mw_d1ce3bdb-c21c-4a60-bfb2-895693dcf64b" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMi0xLTEtMS0w_41a3137a-143a-43b2-8b95-650eda4afbe1">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMi0zLTEtMS0w_bfaa370b-ebd8-4414-9421-69323baf5edf">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMy0xLTEtMS0w_e4a2499f-a15e-4dde-88fd-b852d672bf8c">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:DerivativeAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMy0zLTEtMS0w_bae47518-f56b-41eb-8bf0-326aa718e730">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNC0xLTEtMS0w_69d02af3-eeef-4dc6-a78a-931693304464">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="bsx:Licensingarrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNC0zLTEtMS0w_7b9f16f2-7605-4cab-80fc-8a6d9597e299">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNS0xLTEtMS0w_607b83b7-71af-48d7-ae21-4f91fb7e0df7">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNS0zLTEtMS0w_10c07e17-9718-456e-ab75-68484ac10e80">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNi0xLTEtMS0w_93a615fa-5b29-4c98-b011-e9d9dce13020">894</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNi0zLTEtMS0w_03ac42c4-512b-44e7-b25e-9189e31d7260">880</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i9a9c7a84e8514f5cb899de8b7a6c963f" continuedAt="i2baebb82491b401ba083dc1634c1248c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTgzOA_3c586cdb-f1d5-48ca-8060-e10975ceb12e" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMi0xLTEtMS0w_d0d58d53-c1db-4a5e-963d-df7c5bb03525">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMi0zLTEtMS0w_fc9bd172-4d65-4723-af66-a252bf87e3fc">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMy0xLTEtMS0w_d5f73412-58bd-4159-a56e-1336504621fc">1,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMy0zLTEtMS0w_ac5980d3-e329-436b-93d4-9a73190c2344">1,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="bsx:EquipmentFurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNC0xLTEtMS0w_33a3aee6-356c-469d-b580-a81ab4d016bc">3,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="bsx:EquipmentFurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNC0zLTEtMS0w_ed9b8304-5367-4c9a-9707-80ca9fd8bdf1">3,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNS0xLTEtMS0w_6c8a1e0e-9845-4d05-b354-d3af3a734229">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNS0zLTEtMS0w_87c2f5b1-6b67-4a14-b04f-4b654204b10e">442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNi0xLTEtMS0w_bbf6cb57-59dc-4fde-ade0-f32c17157a3b">5,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNi0zLTEtMS0w_de704666-df19-4ef5-af50-1fb41e3fcf6e">5,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNy0xLTEtMS0w_d7e46b87-7b7a-4e46-a494-99a2cd1f064e">3,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNy0zLTEtMS0w_e483a8fa-52d1-43fe-a024-d7d2b15f27d1">3,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfOC0xLTEtMS0w_a51172cf-030a-4e34-b813-2b9a7c947cbb">2,064</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfOC0zLTEtMS0w_95b76a3f-4aa9-4a2e-a8d4-709e788af9c3">2,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTYyOA_5f0d0b10-ed1f-4aaa-9289-5a897fa99093">84</ix:nonFraction> million&#160;for the third quarter of 2020, $<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTY1Nw_97ae2049-196e-46d4-bf04-888bcaba995b">79</ix:nonFraction> million for the third quarter of 2019, $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTY4Ng_4ffa51d7-6cbf-48fa-991d-3220df0e2b0d">238</ix:nonFraction> million for the first nine months of 2020 and $<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTcwNw_f8fdb22d-65e9-4d4b-9392-b6b293401159">220</ix:nonFraction> million for the first nine months of 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg1OA_a043013e-1c88-4232-9cc2-98fdcc1b1d40" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMi0xLTEtMS0w_0e2a8dde-90f1-4c99-aa65-f703d43ae099">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMi0zLTEtMS0w_109dcad6-e7f4-4ffc-b5ab-591b4d4b18bd">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMy0xLTEtMS0w_8e87268f-b515-4448-bd72-95882110680a">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMy0zLTEtMS0w_e2b679e5-d02e-4ac1-8b9f-ebab2a869db0">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNC0xLTEtMS0w_445227f9-dd80-4342-a811-a457274e0cc8">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNC0zLTEtMS0w_64f2afbc-afea-4108-b450-977fb906a486">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNS0xLTEtMS0w_b73d75b2-bd92-409e-96d5-4ba188d44d45">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNS0zLTEtMS0w_c5822f89-d4ee-4bf2-8a83-55330e49152a">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNi0xLTEtMS0w_0c906544-f914-41e9-8ac2-df88004a1ba2">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="bsx:Licensingarrangementsasset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNi0zLTEtMS0w_d7bb1c06-0494-45c7-9d73-9fb1b5f3b116">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNy0xLTEtMS0w_4e97d515-31b0-4fd8-bb2f-de2dd41b7875">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="bsx:OtherOtherLongtermAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNy0zLTEtMS0w_8262906e-3398-4783-a6ab-e6c712cd780c">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfOC0xLTEtMS0w_062997af-d072-4b67-9b06-4c25dd236f65">1,516</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfOC0zLTEtMS0w_4fa2387d-e90d-4107-9ca1-c7af71f80a13">1,529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg1OQ_bd6996f8-a41b-46d0-8649-d04fb3e3bb02" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMi0xLTEtMS0w_20116ea0-5aa9-4dce-a241-900a8a51174c">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:LitigationReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMi0zLTEtMS0w_f7be57ba-7b15-4880-afe7-5b4f857a8e78">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMy0xLTEtMS0w_b6e89551-c8ec-4a53-a601-ea66c6978453">728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMy0zLTEtMS0w_c8e9c21b-6a25-48c8-98fd-9b73767ad0ec">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNC0xLTEtMS0w_9fb17935-1def-4229-9bbb-4562b40ae17d">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="bsx:AccruedRebatesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNC0zLTEtMS0w_9d666ec5-c2e2-4f03-8402-f53c1ba8c948">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNS0xLTEtMS0w_236714c4-d9a9-4b64-9eb3-171c726304be">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNS0zLTEtMS0w_38f4cc59-54e3-46a2-b1df-282c24379f44">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNi0xLTEtMS0w_6f46ea6b-b0d7-4211-93e6-04e2d420106f">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNi0zLTEtMS0w_c3b9562f-402c-41ba-a580-39e24b0839a0">576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNy0xLTEtMS0w_6f1b815d-7826-4c14-b4ee-b6f28519f894">2,195</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNy0zLTEtMS0w_066ea269-3789-4a20-8c47-6f11d034d363">2,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg2NQ_63b71581-6249-41b1-9d65-a4f0fd708dc5" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMi0xLTEtMS0w_62be734a-0c79-485e-a0d5-fc45e2d6a9a8">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMi0zLTEtMS0w_4de4095f-b828-4905-aaf5-e1c3375103cd">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMy0xLTEtMS0w_b9521f03-5f1e-41c3-a71b-dbcc86aecc1a">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMy0zLTEtMS0w_8c172a45-9753-42e0-a3a7-9be6b37b493d">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNC0xLTEtMS0w_19ac66cd-1bc6-4fb1-a071-71a927a4ee34">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNC0zLTEtMS0w_96cfd521-b749-438a-a091-2043be761936">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNS0xLTEtMS0w_7f6527b4-ad73-4a24-8bbf-a4c8c83ecf98">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNS0zLTEtMS0w_d205c0d1-3f59-457f-b058-28becc30a98c">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNi0xLTEtMS0w_b104e3da-b17c-497c-9685-c65cd3105afe">644</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNi0zLTEtMS0w_b9a7fc6a-e417-4b85-b264-bc0062ed74e2">800</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2baebb82491b401ba083dc1634c1248c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTkwMA_ccdccf54-0b5d-4f8d-94f2-627b83a89620" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMi0xLTEtMS0w_bc56d089-2d0c-4d4c-80bd-106600dec744">571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMi0zLTEtMS0w_de3d6ae3-24bc-448d-89a4-b180b08f6d6a">667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMy0xLTEtMS0w_ca36ac31-a486-4382-b474-473cc5f6c699">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMy0zLTEtMS0w_9e81c35a-0b2f-4403-ad82-53741b035e49">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNC0xLTEtMS0w_c2870e67-4aec-4dc5-a8a7-152d79ca6cfc">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNC0zLTEtMS0w_ccd4c118-48fe-4b00-aefb-1a37578b0791">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNS0xLTEtMS0w_9a96f889-c947-4aae-b86a-2ce5925b576d">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="bsx:Licensingarrangementsliability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNS0zLTEtMS0w_c27f9c74-186c-49d4-b501-1aa240ece497">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNi0xLTEtMS0w_bbb93477-5aff-4c7a-a1d5-9adcc7d9e460">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNi0zLTEtMS0w_90a97d0b-abaa-421f-aa20-4d435e512486">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNy0xLTEtMS0w_8997332c-9aee-4089-b7cb-c25c976ebd8c">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:DeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNy0zLTEtMS0w_2adcdbab-7dd6-42cd-a250-b9d0a5df9338">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOC0xLTEtMS0w_8b6ae1d4-4a13-4482-9f42-81309895e43a">569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOC0zLTEtMS0w_4aff997f-218b-4284-a355-7700c9a075c3">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOS0xLTEtMS0w_e3045eea-a3e3-4867-973d-f08db6c53129">2,132</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOS0zLTEtMS0w_ef34e2e5-f11d-4b83-aaec-e0d3930280d1">2,635</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_94"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMjAzOA_bfceb67a-7fa9-432b-8a4e-3e4fcfe64dd4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMjAzOQ_290ff8a4-8d14-4f03-bbcc-c0e26f8d92b8" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi0xLTEtMS0w_dcde3ffd-5215-4fb7-bfd5-d6a7187f4edc">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi0zLTEtMS0w_5fe2b42c-5d82-447a-a8a3-7d943016a4b1">38.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi01LTEtMS0w_81e4612e-b5fd-4095-a0c4-56653cdc1c11">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi03LTEtMS0w_b017b7df-13a9-4c08-b2b1-2cf31fac8ba6">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rates for the third quarter and first nine months of 2020, as compared to the same periods in 2019, relates primarily to a shift in geographical mix of earnings to higher-tax jurisdictions, partially offset by the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include intangible asset impairment charges, acquisition/divestiture-related net charges, restructuring and restructuring-related net charges, litigation-related net charges as well as certain discrete tax items primarily related to the resolution of an Internal Revenue Service (IRS) audit, as explained below, tax windfall benefits associated with share-based payments, and impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years. The Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTA5OTUxMTYzODgwMQ_73926589-bea3-4231-b9de-aac638663b57">91</ix:nonFraction> million in the third quarter of 2020 to release the reserves related to these years. We anticipate receiving a refund of $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTA5OTUxMTY0MjUzOQ_5c7cfb27-7047-472e-952f-39f8c71a5347">62</ix:nonFraction> million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfODEw_4d9324fe-ad54-4dcd-a510-94cb52953b58">279</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfODY0_29bcd28d-d81f-4bc0-a17a-cfb210acf0b0">185</ix:nonFraction> million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfOTM3_0afa9f9e-2338-4774-8a71-65c51e5103f7">455</ix:nonFraction> million of gross unrecognized tax benefits, of which a net $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfOTkx_4b7aaeb1-1c37-46d2-b0a3-01bed93513e4">355</ix:nonFraction> million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to reaching settlements with tax authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTI2OA_5917b429-97cd-456d-af27-12d3fbff06f0">23</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Economic stimulus legislation has been enacted in many countries in response to COVID-19. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-11" format="ixt:numdotdecimal" name="bsx:TheCARESAct" scale="12" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTQ1NA_5fb1250c-17ea-45e9-a8db-d9345c35cf18">2.2</ix:nonFraction> trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allows us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE4MjM3_065d72cf-9a84-40a6-968c-d84fc7694347" continuedAt="iae707b1fe9a24565a67db5189a16fef4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE4MjM5_413d5a58-7b86-47ef-b8e8-274159fc7860" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our accrual for legal matters that are probable and estimable was $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzM5MTM_cdd0d662-32b0-4906-af63-642ba7f1e283">600</ix:nonFraction> million as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzM5Mjk_ce2b66c7-4619-4dae-a581-08883432aa4a">697</ix:nonFraction> million as of December&#160;31, 2019 and includes certain estimated costs of settlement, damages and defense. The decrease in our legal accrual was mainly due to settlement payments related to litigation with Channel Medsystems, Inc. (Channel) and those associated with product liability cases or claims related to transvaginal surgical mesh products, partially offset by incremental reserves recorded in the third quarter of 2020 described below. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ0NDY_04af877b-5052-4675-87a0-5ced52d9531d">214</ix:nonFraction> million as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ0NjI_9b894c75-a2cc-42b5-bcb3-4e0b196450ad">346</ix:nonFraction> million as of December&#160;31, 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related charges of $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE2NDkyNjc0NjAwNzk_1693fa01-b769-4960-85ee-f349de4f2cac">260</ix:nonFraction> million during the third quarter and first nine months of 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general. In the first nine months of 2019, our litigation-related net credits included a gain of $<ix:nonFraction unitRef="usd" contextRef="i7517236e64694d1f8bc3fc2479c9b98c_D20190101-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ2Njc_ed58f3a8-2f18-4acb-9456-6cc98d744ea5">148</ix:nonFraction> million, which represents a portion of the total $<ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" format="ixt:numdotdecimal" name="bsx:LitigationSettlementReceivedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ3MTE_6ad30cdd-b209-4605-b858-d6adbc878fd1">180</ix:nonFraction> million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;unaudited condensed consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from this settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="iae707b1fe9a24565a67db5189a16fef4" continuedAt="i5ce7bac599274a9bba2a8e08294a3028"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q for the periods ended March 31, 2020 and June 30, 2020 and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 21, 2020, approximately <ix:nonFraction unitRef="claims" contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzk1MzU_442ab09a-2249-4100-a720-322a22f5427a">54,000</ix:nonFraction> product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of October 21, 2020, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately <ix:nonFraction unitRef="claims" contextRef="i53217914a25e498e83f410e223fceb43_I20201021" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzk5MTI_34964df8-5121-46dc-9a64-b05193cca0cb">52,000</ix:nonFraction> cases and claims, adjusted to reflect the Company&#8217;s analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately <ix:nonFraction unitRef="claims" contextRef="i53217914a25e498e83f410e223fceb43_I20201021" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzEwMjgw_34964df8-5121-46dc-9a64-b05193cca0cb">52,000</ix:nonFraction> cases and claims, approximately <ix:nonFraction unitRef="claims" contextRef="i53217914a25e498e83f410e223fceb43_I20201021" decimals="0" format="ixt:numdotdecimal" name="bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzEwMzE1_41f89084-0def-47f9-9176-466fb3b1d24f">47,500</ix:nonFraction> have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over <ix:nonFraction unitRef="claims" contextRef="i1f1f44e32d174b6f98c5b0276649eb93_I20201021" decimals="0" format="ixt:numdotdecimal" name="bsx:Productliabilitycasesorclaimsrelatedtomeshproduct" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzEwODg4_0a47191a-674a-40c5-a29a-f4758c993932">3,100</ix:nonFraction> of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general offices regarding our transvaginal surgical mesh products. We have responded to those requests. On December 12, 2019 the Mississippi Attorney General filed suit against BSC in State Court alleging violations of the Mississippi Consumer Protection Act which the Company plans to vigorously defend. There are fewer than <ix:nonFraction unitRef="claims" contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzExNjg2_874da27b-cab9-4166-813d-9c49003a8b68">25</ix:nonFraction> claims in the United Kingdom. There are also fewer than <ix:nonFraction unitRef="claims" contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021" decimals="0" name="bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzExNzQ1_2c563ed6-5611-4f51-bc4a-e50edc0799f3">15</ix:nonFraction> cases in Canada, inclusive of <ix:nonFraction unitRef="claims" contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021" decimals="0" format="ixt-sec:numwordsen" name="bsx:CertifiedclassactionsinCanadaMesh" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzExNzc4_d2079012-3949-4498-93a5-16d964b1723a">one</ix:nonFraction> certified class action, which has settled and received Court approval. On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. While we believe that our accrual associated with this matter is adequate, changes to this accrual may be required in the future as additional information becomes available. While we continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims and intend to vigorously contest the cases and claims asserted against us that do not settle, the final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Initial trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in 92 filed product liability cases involving our Greenfield Vena Cava Filter, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 624 claims, none of which have been filed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i5ce7bac599274a9bba2a8e08294a3028"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Note G &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> for information regarding our tax litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Matters Concluded Since December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2019, Tissue Anchor Innovations filed a complaint for patent infringement in the United States District Court Central District of California against Fountain Valley Regional Hospital and Medical Center, Los Alamitos Medical Center and us. The complaint alleged that the Solyx&#8482; Sling System infringes US Patent 6,506,190. We reached a confidential settlement in this matter in July 2020, pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, Imran Niazi filed a patent infringement action against us in the U.S. District Court for the Western District of Wisconsin alleging that a U.S. patent owned by him is infringed by our Acuity&#8482; Lead Delivery System. On June 30, 2017, we filed a motion to dismiss for improper venue and on November 7, 2017 the Wisconsin Court granted the motion to dismiss.&#160;On November 13, 2017 Niazi refiled the same action in the U.S. District of Minnesota. We reached a confidential settlement on this matter on February 3, 2020 pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2017, we entered into a definitive agreement with Channel pursuant to which we could have been obligated to pay $<ix:nonFraction unitRef="usd" contextRef="i23b934c31d804d8d9a9c89f2fed9a737_I20180912" decimals="-6" format="ixt:numdotdecimal" name="bsx:AllegedBreachofPurchaseAgreementAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE2NDg5_785a3882-7f66-4080-a7c6-136ac8d44e9e">145</ix:nonFraction> million in cash up-front and a maximum of $<ix:nonFraction unitRef="usd" contextRef="i0dcbc3c9b20642dd97b2450bb8f713bc_I20180912" decimals="-6" format="ixt:numdotdecimal" name="bsx:AllegedBreachofPurchaseAgreementAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE2NTI2_d63268d6-e8ee-42f3-a46a-7d093598a7ab">130</ix:nonFraction> million in contingent payments to acquire Channel. The agreement contained a provision allowing Channel to sell the remaining equity interests of Channel to us upon achievement of a regulatory milestone and an option allowing us to acquire the remaining equity interests. We sent a notice of termination of that agreement to Channel in the second quarter of 2018. On September 12, 2018, Channel filed a complaint in Delaware Chancery Court against us for alleged breach of the agreement. Channel alleged that we breached the agreement by terminating it. We answered the complaint, denied the claims by Channel and counterclaimed to recover part of our investment in Channel, alleging fraud in the inducement. On April 2, 2019, Channel announced its receipt of FDA approval of the Cerene&#8482; Cryotherapy Device. Trial testimony was taken in April 2019, and the post-trial briefing and hearing were completed. During the third quarter of 2019, Channel notified us that they were exercising their option to sell the remaining equity interests in Channel to us. We responded to the notification that we did not intend to purchase Channel since the previous agreement had been terminated. On December 18, 2019, the Chancery Court ruled that Boston Scientific was in breach of the agreement and granted Channel's request for specific performance to require the Company to complete the purchase. On January 10, 2020, we filed a Notice of Appeal of the Chancery Court&#8217;s decision to the Delaware Supreme Court. On February 4, 2020, the Company settled the dispute with Channel resulting in termination of the agreement, payment by the Company of an undisclosed sum and surrender of the Company's equity interest in Channel.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_106"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzUxMTU_f6446aac-ce30-43fa-b85c-2d82a0b3d6f0" continuedAt="i1f99c531091b427c8bf9b10a235934e3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzUy_349c6011-f469-4bcd-91a8-e1e7a614c477">50</ix:nonFraction> million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="ied343c75dd384497a465543451475c7e_I20200527" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ2OA_bdafc251-ff1e-4fe7-849c-e4f8fec8a314">10,062,500</ix:nonFraction> shares of <ix:nonFraction unitRef="number" contextRef="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ4MQ_3d2dd5b3-cb3c-44c1-92fc-f47607c5a3a7">5.50</ix:nonFraction>% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="ied343c75dd384497a465543451475c7e_I20200527" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzU5Mg_8ef78e61-ea53-4c53-b76b-070f45debd91">100</ix:nonFraction> per share. The net proceeds from the MCPS offering were approximately $<ix:nonFraction unitRef="usd" contextRef="if2b23f1cf3f54a46ae87e6bafb2588bd_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzY2Mw_ef4475c8-d65f-42e6-9418-acb2a2aa0df2">975</ix:nonFraction>&#160;million after deducting underwriting discounts and commissions and offering expenses. As of September&#160;30, 2020, our MCPS had an aggregate liquidation preference of $<ix:nonFraction unitRef="usd" contextRef="i735ff78c796c4242ade8554aac15b307_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PreferredStockLiquidationPreferenceValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzgwNA_3d60514c-9975-4658-82cf-34c9e95f8d44">1.006</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of <ix:nonFraction unitRef="number" contextRef="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwMjc_3d2dd5b3-cb3c-44c1-92fc-f47607c5a3a7">5.50</ix:nonFraction>% of the liquidation preference of $<ix:nonFraction unitRef="usdPerShare" contextRef="i735ff78c796c4242ade8554aac15b307_I20200930" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwNjM_abaca7d0-c1d0-41e6-be8a-a044e35651c2">100</ix:nonFraction> per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i1f99c531091b427c8bf9b10a235934e3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="i735ff78c796c4242ade8554aac15b307_I20200930" decimals="2" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzIxNjU_abaca7d0-c1d0-41e6-be8a-a044e35651c2">100</ix:nonFraction> per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between <ix:nonNumeric contextRef="i88c3b4165083494aa4c7c21c4f6d3bed_D20200101-20200930" name="us-gaap:ConvertiblePreferredStockTermsOfConversion" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzIzODA_16265718-9b0a-4089-9880-8daf97f182ef">2.3834</ix:nonNumeric> and <ix:nonNumeric contextRef="i927de457f17d4bfc9629007545156993_D20200101-20200930" name="us-gaap:ConvertiblePreferredStockTermsOfConversion" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzIzODc_c29c8001-416e-4dc4-a764-dd658b3ebca4">2.9197</ix:nonNumeric> shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 1, 2020, we paid to holders of our MCPS as of August 15, 2020 a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i044387e090504fda9610329194e2938f_D20200901-20200901" decimals="4" name="us-gaap:PreferredStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwOTk1MTE2MzMwODg_f5cbeaf6-e906-4b3b-81fc-bb6d2b53e833">1.4361</ix:nonFraction> per MCPS share (or $<ix:nonFraction unitRef="usd" contextRef="i044387e090504fda9610329194e2938f_D20200901-20200901" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwOTk1MTE2MzMxMTA_13f19f6f-1442-4ad6-b9dc-88e7fb3ee486">14</ix:nonFraction> million in aggregate cash dividends), representing a dividend period beginning on the May 27, 2020 issuance date through August 31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 27, 2020, the Audit Committee of our Board of Directors, pursuant to authority delegated to such committee by our Board of Directors, declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="icb5544b1d5914e58a5ff9e8a859120c7_D20201027-20201027" decimals="4" name="us-gaap:PreferredStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzE2NDkyNjc0NDk1OTg_c5fd9a20-db1d-4cd8-8d2e-5544d50ae69b">1.375</ix:nonFraction> per MCPS share (or $<ix:nonFraction unitRef="usd" contextRef="icb5544b1d5914e58a5ff9e8a859120c7_D20201027-20201027" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPreferredStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzE2NDkyNjc0NDk2MDI_e4660aa7-87ae-45af-bc01-7449fb63c712">14</ix:nonFraction> million in aggregate cash dividends) to be paid on December 1, 2020 to holders of our MCPS as of November 15, 2020, representing a dividend period beginning on September 1, 2020 through November 30, 2020. We have presented cumulative, unpaid dividends covering the period from September 1, 2020 through September 30, 2020 totaling $<ix:nonFraction unitRef="usd" contextRef="i33acd291741444b7a9ad38bb3a5168fb_I20201027" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzM2MzY_48917e51-ada4-4f10-8edb-3ea5056cf572">5</ix:nonFraction> million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our unaudited condensed consolidated balance sheet as of September&#160;30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue <ix:nonFraction unitRef="shares" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzM3MjU_68ce7413-374f-4ffc-903d-d143250be5a5">2.000</ix:nonFraction> billion shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzM3NTI_5ed2f5aa-df2c-4728-aee2-edc2060d5824">0.01</ix:nonFraction> par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of <ix:nonFraction unitRef="shares" contextRef="id033163f06e84414929b16208d102740_D20200527-20200527" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ0ODU_60bf0b5b-2e04-4d23-8dbb-56619a08ecc6">29,382,500</ix:nonFraction> shares of common stock at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia10084aaaa064d9b9dd7f4c0a7135478_I20200527" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ1NDE_2056922f-ab4d-416f-a50b-001033898542">34.25</ix:nonFraction> per share. The net proceeds from the common stock offering were approximately $<ix:nonFraction unitRef="usd" contextRef="id033163f06e84414929b16208d102740_D20200527-20200527" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ2MjI_6a158592-0671-4b55-bf8a-58cdf6e72421">975</ix:nonFraction> million after deducting underwriting discounts and commissions and offering expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions and investments.</span></div></ix:continuation><div id="i8a2e73a0c2ae455a8a5a335cd6209152_109"></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzIwNDk_ef51cd3f-633d-4359-8a6f-5c1d952537f8" continuedAt="if9a5834d0ef8429a8da6779602cb3380" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzIwNTY_e5427ecb-2ae5-4695-92bb-99a4b800ff5c" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItMS0xLTEtMA_7c3c44f6-cdd9-4eae-81e2-db343165bf6a">1,430.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItMy0xLTEtMA_ec8bdd64-ad4b-4514-9066-5c8f9e40a62c">1,393.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItNS0xLTEtMA_6bc42d5d-8663-4963-956f-e5ec45558cc4">1,413.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItNy0xLTEtMA_32e753d2-429e-4656-83a3-d6193136ec88">1,390.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtMS0xLTEtMA_143bf555-8954-404f-8be1-234d6a9d88df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtMy0xLTEtMA_700b9275-3e0c-4dc9-b2ba-33b2146da752">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-5" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtNS0xLTEtMA_a8f26ac2-2890-4190-bede-57ba58f12ade">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtNy0xLTEtMA_6dd02ad6-ee5e-4f68-9c8f-261c9601100c">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtMS0xLTEtMA_81496a9f-f35d-4c9b-8a53-3bec2019288c">1,430.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtMy0xLTEtMA_c6cb21bb-22ac-42e2-b702-d868bb48d529">1,412.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtNS0xLTEtMA_cf594b3d-1192-44a4-aef4-8959666256bd">1,413.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtNy0xLTEtMA_c2e6d36c-b27b-44d8-8238-b4a1a1041002">1,409.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="if9a5834d0ef8429a8da6779602cb3380"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzIwNTA_c64e85ee-9918-473f-9a52-9df5f87af6ca" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5e5a839e6644a3ebe0fc87afb8652b7_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItMS0xLTEtMA_2d51adfc-b2c7-4ad2-8b7f-b43f6d1a293c">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff49d6c4be2d449b9e042d9f93d88310_D20190701-20190930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItMy0xLTEtMA_90f03de0-8f78-43c2-9c7b-509a5609f27c">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a93e002d5af493191d6045b6aa338c8_D20200101-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItNS0xLTEtMA_beca971e-5e22-4824-9391-c6c86b0155e5">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if33d9aa5eec440d1be0ea74cd2b49d11_D20190101-20190930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItNy0xLTEtMA_fa4d105e-c6f5-47a4-bfc3-e7bacc3337ac">0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefe224921843489fa50e4d09095407c2_D20200701-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtMS0xLTEtMA_538c4173-d234-4912-bf04-1dcb0da9f7d8">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i833e41e801144751afbac73b9aa9265c_D20190701-20190930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtMy0xLTEtMA_f728ef7d-3be3-4908-bf1e-16d3aaa5ed19">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35462ec189f045ddae63069211960cb6_D20200101-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtNS0xLTEtMA_d7c4f1af-c584-46af-a0d6-b7e6211bde87">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic884158bc4a143839655392d299dbb94_D20190101-20190930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtNy0xLTEtMA_4d6b5765-c6fd-4d6c-a829-731d8ebd0b16">0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefa2ca97a83b42d4bf746ff34f43d60d_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtMS0xLTEtMA_5e0e1803-24d9-48df-bd01-743fb3ae7a39">24</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf5f2e440b564accbedba954cc39048b_D20190701-20190930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtMy0xLTEtMA_3fed3797-cc20-4dcf-b688-c4b03674efdd">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96632a4cb64d4dc6badba032df2ac6a3_D20200101-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtNS0xLTEtMA_96e6c2f6-9481-4d3d-8d36-3d557aae9456">11</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iedfe6f2561594c8ea46a25a3b46e254b_D20190101-20190930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtNy0xLTEtMA_f5b9befe-d9fe-47b6-8cc8-656c58850215">0</ix:nonFraction></span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the third quarter and first nine months of 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> positions in those periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the later of the May 27, 2020 issuance date or the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the third quarter and first nine months of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as presented in our unaudited condensed consolidated statements of operations, for purposes of calculating EPS. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued approximately <ix:nonFraction unitRef="shares" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE1Nzk_681bc10a-ec5d-433f-af46-cbf9892deacf">three</ix:nonFraction> million shares of our common stock in the third quarter of 2020, <ix:nonFraction unitRef="shares" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE2NTY_79b3a86b-ae1a-46e6-990c-d986768d268e">two</ix:nonFraction> million shares in the third quarter of 2019, <ix:nonFraction unitRef="shares" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE3MzM_6e7e4ae0-1368-4e60-9a16-b02a093b242e">eight</ix:nonFraction> million shares in the first nine months of 2020, and <ix:nonFraction unitRef="shares" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE3OTk_e3726bf9-357d-4457-9aaf-44bda2db1cd4">nine</ix:nonFraction> million shares in the first nine months of 2019, following the exercise of stock options, vesting of deferred stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first nine months of 2020 or 2019.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_115"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90ZXh0cmVnaW9uOjQzNTY2NDE1NzQ5MDRlYTk4YTVjNmM0NWVjZGZkMTg3XzE5NDk_1b49f8e8-0973-4c4c-96a6-313ed855dcd9" continuedAt="ieb78939db1254201b199fccc09c2ce90" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our seven core businesses are organized into <ix:nonFraction unitRef="reportablesegments" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90ZXh0cmVnaW9uOjQzNTY2NDE1NzQ5MDRlYTk4YTVjNmM0NWVjZGZkMTg3XzU1_ff2e0053-e09a-489b-8fd1-d17404d278bf">three</ix:nonFraction> reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, intangible asset impairment charges, acquisition/divestitures-related net charges/(credits), restructuring and restructuring-related net charges/(credits), certain EU Medical Device Regulation (MDR) implementation costs and litigation-related charges/(credits). Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our unaudited condensed consolidated statements of operations and are included in the reconciliation below. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our integration of BTG, the acquisition of which closed during the third quarter of 2019, we have included BTG&#8217;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#8217;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. In our Quarterly Report on Form 10-Q for the period ended September 30, 2019, we presented Interventional Medicine and Specialty Pharmaceuticals together as "BTG Acquisition" and outside of our operating and reportable segments for sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. We have revised amounts for the third quarter and first nine months of 2019 to conform to the current year presentation. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="ieb78939db1254201b199fccc09c2ce90"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90ZXh0cmVnaW9uOjQzNTY2NDE1NzQ5MDRlYTk4YTVjNmM0NWVjZGZkMTg3XzE5NjA_8146ce27-2ec9-43e7-8868-ec762c2d478e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages): </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItMS0xLTEtMA_d513ac1d-65cb-44b1-8de8-1c94b1fe7f48">825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItMy0xLTEtMA_f52c67de-3fe4-4737-99ef-1b3a0698430f">845</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItNS0xLTEtMA_6cf04f06-ee5e-4434-abee-afbaa2c77eb0">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99149f63a5749519353038bc1faea89_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItNy0xLTEtMA_149d58ba-a816-4e44-ad59-2a3027e9fe73">2,429</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtMS0xLTEtMA_100135f2-c7a2-44cb-81a0-bccc03e57b7a">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtMy0xLTEtMA_bd7e5ff1-8287-47ff-83a5-d81a5f2877d7">780</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtNS0xLTEtMA_e9bdf861-b181-4748-92e3-c85e0327c625">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0856ffae144147a8a676be77a9661e79_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtNy0xLTEtMA_5ced389a-d3ba-41cd-a896-7c51ebcbbfe5">2,323</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtMS0xLTEtMA_dadcfe72-d029-4cf5-8e9f-26d4b9865001">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7af187ab814d74846a21e66345162f_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtMy0xLTEtMA_5a705c7c-c31b-4556-8f05-9343b8f7eaad">1,058</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtNS0xLTEtMA_2dcba0d4-837f-42e6-b209-2544bbf89ad4">2,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtNy0xLTEtMA_20eb41ad-c14f-42c3-8d6a-c0b2c3d85e88">3,057</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba152e6d345944b6a404d50555024e71_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtMS0xLTEtMA_acc78775-3001-4559-b00b-26c8e03d2dbc">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d58860b34642148a851e295ba585bf_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtMy0xLTEtMA_be47c2e3-2f39-4a43-b88e-88e82f2b3602">2,684</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i048389ab0ac64d2c87536a1b5d92aa9c_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtNS0xLTEtMA_24863300-47cf-4073-87f8-1dc5256000e5">7,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208885de1f9f46179e0e8abe705b572e_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtNy0xLTEtMA_bc028ec0-bd5a-44a7-a776-9fc519088514">7,807</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4d909a6d644667b4efd3a44da3b9d4_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtMS0xLTEtMA_91a6e4d5-eb7e-4e07-a3a6-28f059b29a7e">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4eb2858779c49a1a5ea2fe50cf134db_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtMy0xLTEtMA_e0a4c1e4-9a8d-4a16-9e53-ae94abfca67e">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtNS0xLTEtMA_2384c02b-65c1-49f1-b7f7-f520cf13300e">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650712180e0241db9f0773a48064834d_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtNy0xLTEtMA_fa9e4595-583b-4de7-9549-d91822edbea2">23</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctMS0xLTEtMA_2403f7df-dbd7-48e3-be9a-2ff552c6d607">2,659</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctMy0xLTEtMA_62a11438-61e7-4d04-bc5b-6626363ca40d">2,707</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctNS0xLTEtMA_7f35a72c-45e5-4f4a-b937-547809260201">7,204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctNy0xLTEtMA_9a0fca61-9b9d-4b64-bb7c-15003bf3ab11">7,831</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTEtMS0xLTA_802e2257-0615-49ef-b107-94d1bfddd9f8">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTMtMS0xLTA_e58a53dd-4474-44b8-b074-1165106e88bf">319</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTUtMS0xLTA_5dcf7c46-0390-4de9-b9e0-dbeec2c0f1ca">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id99149f63a5749519353038bc1faea89_D20190101-20190930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTctMS0xLTA_f7427e95-53c4-4474-8403-9797d3ddff29">870</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTEtMS0xLTA_8b7cb4db-d97c-4e11-aee2-083bd6b1f05e">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTMtMS0xLTA_0fd5ac30-4613-4c37-8fcb-30ceb5e53904">166</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTUtMS0xLTA_0532309a-c9f0-4ba7-82aa-515a5de6d710">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0856ffae144147a8a676be77a9661e79_D20190101-20190930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTctMS0xLTA_b02b89c5-a3fe-4a97-8b01-cbd736d0ecc5">488</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTEtMS0xLTA_afde0179-fd92-41ae-80ec-269b2afc843d">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7af187ab814d74846a21e66345162f_D20190701-20190930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTMtMS0xLTA_bc8796db-8259-4eeb-a20f-86ae93c1ffb1">283</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTUtMS0xLTA_e88dc4d8-6070-4247-8106-a795ada42f15">593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930" decimals="-6" name="bsx:OperatingIncomeAllocatedToReportableSegments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTctMS0xLTA_c7c6bf41-efed-487c-a3f7-362ab5f371c6">860</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a76ba5fa6be4f6ca2865115cd913496_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTEtMS0xLTA_231dc0b3-f2dd-49b7-bf3d-60f11830b6bc">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a591219122f4c2a8f9ec4a0684b5227_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTMtMS0xLTA_34a05465-c667-4621-b062-08459c0806b6">768</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3ec4a2e86a478a9dabb51fefdcad78_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTUtMS0xLTA_a8076491-1bc5-4246-88f3-62891aa44de7">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5295e2ecdd9d4b8ea224afddd4be5043_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTctMS0xLTA_5e11f459-4a8d-49d6-9670-2e83721ccf06">2,218</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4d909a6d644667b4efd3a44da3b9d4_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTEtMS0xLTA_02a88f3c-21c4-4b32-9315-adde5a3d61fc">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4eb2858779c49a1a5ea2fe50cf134db_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTMtMS0xLTA_a958d285-6835-4df6-b924-3f3271aba2ed">13</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTUtMS0xLTA_4c194add-b19c-4038-89d7-4c21bfc1b09e">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650712180e0241db9f0773a48064834d_D20190101-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTctMS0xLTA_9dae1174-7646-4b2c-a751-f701bb5713e5">13</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cb8cadf62d949b495b63577e0fda131_D20200701-20200930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTEtMS0xLTA_84de4a91-2857-4865-9ade-f2da2ff3c9f6">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d28c3b1694d4c69bd90388ac8bed40a_D20190701-20190930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTMtMS0xLTA_1cbc812c-7ecb-43d6-a506-7aa335e042a8">75</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92234b181bc4d4f89de8646d2dd9fa3_D20200101-20200930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTUtMS0xLTA_21d307aa-5982-441b-b613-9054546ffd97">330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5664ea4ee0564071be7fd04ebb16c8e4_D20190101-20190930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTctMS0xLTA_d7c9b95e-16f9-4a15-b5d2-d4eecfe3e942">215</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5f90b3ff4704d268311e2eb4815f7cd_D20200701-20200930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTEtMS0xLTA_9671c494-61de-4181-98fc-f4a70ebe9370">629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74aa340bfd624b43833d9080bc81a794_D20190701-20190930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTMtMS0xLTA_eedd754b-341c-43e3-b185-256fcf33602f">146</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b628b4b4bcd4356b45406733cf96466_D20200101-20200930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTUtMS0xLTA_a8d64df5-df1d-4529-bf42-70cc1f8c49d7">957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieeca9d8fa162485891beef8cec914fa9_D20190101-20190930" decimals="-6" name="bsx:OperatingIncomeUnallocatedToSegment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTctMS0xLTA_62461233-0db6-4f0f-a493-45cd65b5fe0d">210</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTEtMS0xLTA_55da2737-f649-45b4-b71a-3a7e33fd6533">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTMtMS0xLTA_11f7771a-55aa-43fc-8d09-6e8cfcd9dd3e">178</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTUtMS0xLTA_5fb8bdfb-602c-4a85-8df0-21bedd7daffa">595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTctMS0xLTA_0f401640-a526-474b-b8d8-15a7fbb53e55">498</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTEtMS0xLTA_34462ddb-b2bb-4548-ba34-746f56dc6b1c">205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTMtMS0xLTA_9b260bb7-ba8f-40b7-aaac-1ed96274746f">383</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTUtMS0xLTA_b1289db5-3373-454e-8f91-4e85526a4209">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTctMS0xLTA_532710d3-8970-48bd-83a1-b46c6c1474cd">1,308</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTEtMS0xLTA_eea1ddd7-2107-4ed9-a8e0-eda2fb4efc1e">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTMtMS0xLTA_dda37faa-9759-4fe2-a508-023446416819">292</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTUtMS0xLTA_db4c0af4-5ab6-4056-bda7-997be5561120">256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTctMS0xLTA_86eecda4-d2e6-4626-a0b8-3703114cf61d">615</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTEtMS0xLTA_499fb652-88f2-48bb-ba67-93554d3a0ca7">227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTMtMS0xLTA_0c3915f2-27f8-4347-b0e0-6389d874ba21">91</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTUtMS0xLTA_a03211b8-41b1-4ad7-b43c-ce082438982b">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTctMS0xLTA_47850e24-502b-47e4-922c-7b378bdcf030">693</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTEtMS0xLTA_4225b29d-2e88-437c-bfd1-fcc7f5299f21">37.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTMtMS0xLTA_d0d5ebde-16af-4449-9c1f-52b1fbf37930">37.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTUtMS0xLTA_76734d04-03ae-471f-ba1f-b70cc0f71029">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id99149f63a5749519353038bc1faea89_D20190101-20190930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTctMS0xLTA_38ae9fae-12f4-4d77-aee4-c7707d124e36">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTEtMS0xLTA_4963e948-c933-42c0-b526-dac61f87a9d0">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTMtMS0xLTA_84f39d3a-132e-4aff-a75a-acb7fa8dabaa">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTUtMS0xLTA_ed5eb530-69ed-42ba-ba15-ce701076326e">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0856ffae144147a8a676be77a9661e79_D20190101-20190930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTctMS0xLTA_d63e2bd2-f033-4cb9-add6-6575667d47fc">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTEtMS0xLTA_a47f1f87-77ce-493e-981d-c4af4ca864a1">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a7af187ab814d74846a21e66345162f_D20190701-20190930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTMtMS0xLTA_96caf9fa-fe73-4924-b014-b6f1206a67ee">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTUtMS0xLTA_a1047d76-f321-4426-a4fb-b579726514a6">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930" decimals="3" name="bsx:SegmentOperatingIncomeasaPercentageofNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTctMS0xLTA_d5f2cb85-7adb-4111-bb23-b49771f6adb6">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzI3NzU_156133ee-8359-46a6-954c-337595e3ff0f" continuedAt="i3365c6391f1447d28c6924f01a32793f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our unaudited condensed consolidated statements of operations. <ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzI3NzI_8bc767d7-164b-4c26-86a2-23aa545648e3" continuedAt="i961212ac391e4f8589093eec5b965c82" escape="true">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):</ix:nonNumeric></span></div><ix:continuation id="i961212ac391e4f8589093eec5b965c82"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd362ef82b134b30b14976f7ae67e13b_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtMS0xLTEtMA_2de45f9b-fb03-4e7e-9a28-45322521f086">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id836b0b6f49547e69517df5107404e82_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtMy0xLTEtMA_0f05fdc5-f919-4849-aa9b-88228a95163e">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32e3ab480d844da48762b90ffff4b1f5_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtNS0xLTEtMA_475fc703-de78-426f-8c21-a762809e6d01">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f216b357084f708a38791c0e69fa94_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtNy0xLTEtMA_2c6db90d-5671-40ef-b727-c0fdbd9e0266">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d6d998c42c481582ee64ca962cc159_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtOS0xLTEtMA_284fd85d-4b42-4567-8964-63c899b25d18">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52100b5c46bd49f9a35228954f1c7417_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtMTEtMS0xLTA_b9dd5688-3f72-48c0-acf9-bf3c9f3e896d">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fe5ba5da50414d9f4a59566f2373e1_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtMS0xLTEtMA_d8b8c739-a696-4075-9102-231d951bc32d">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c61c03b46ac4133a1766da24872ad5d_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtMy0xLTEtMA_737f49d6-928c-4fca-a6d1-3decccdddb20">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f063ede9a534803a8c2cca679760529_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtNS0xLTEtMA_e3f7743f-870d-4e09-ac47-5cbf90ece933">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4c42c9955e49e7875feec90a8fca77_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtNy0xLTEtMA_d12ff206-4426-49a7-b878-df6ed3a2c37f">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5da8457277394b6d9cbdbc56a40395dc_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtOS0xLTEtMA_47c71d30-4a36-4f61-8f31-a2f8c7de9a4d">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38b75c07c0a4e8bb20367199b3a3137_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtMTEtMS0xLTA_7e988b82-abc9-498a-8f36-0df4e15672f4">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f25f59b9aa4aeb9d25e946e240ceec_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtMS0xLTEtMA_b3325aab-8ef8-4cd6-9e66-583e787fde09">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie14bf9c81c71484eae0b513f8fc3ee21_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtMy0xLTEtMA_89370cd1-b681-4432-b74a-76e9710661a0">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dea49b278804d72b2691e583fa76c5a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtNS0xLTEtMA_258070de-14cc-449e-995e-362989017473">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72716294dd24b2483172c0606c195a8_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtNy0xLTEtMA_b24bdbaf-bed9-4490-bd38-96953096200b">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82abde4de7a4ad291720e38ace07b19_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtOS0xLTEtMA_323b928d-0134-49a6-a76b-8f55184e3390">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c50792aabbf4ddb9b06af0078c9cdb3_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtMTEtMS0xLTA_4b89af29-707c-4544-aec1-29ce849a7eee">478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1997f45a21c8439dbfac180e2b0d74f1_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtMS0xLTEtMA_2879a4bd-3305-4d61-b238-f24a92ad352c">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fff6d00823641e094e51bf1fe888c9b_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtMy0xLTEtMA_fa0ebd8e-575f-42c3-8df3-660f828be67d">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ccbaa46c3c4964a7e1df39c1bc8aed_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtNS0xLTEtMA_bc75579a-a526-4a0e-b43f-e5b9dcad3977">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95675abed3134712b2d78ee5f0f52204_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtNy0xLTEtMA_f261ae73-4e2b-4c08-89b1-909620140407">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0b86161ea44cba9a228eb7c635dd36_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtOS0xLTEtMA_9f9cca47-5750-432f-93fc-b64641ea0f8b">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80555f6dd4cb40a48dfd0b2587304fc3_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtMTEtMS0xLTA_fa4aa9b1-1409-4388-959a-a5551b0c6125">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e9e41e9d4c44839842870dff12c933c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctMS0xLTEtMA_a2dc17ca-2984-40d2-b544-daa6a90eadaa">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81b5cb71db84008b270fc47e76998e6_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctMy0xLTEtMA_2a17ce4c-a976-4e90-9658-d4d9ce68d587">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b15983e106b4e89bda000c883086e9e_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctNS0xLTEtMA_7d9347ce-cafc-47ce-bc3b-4caf7cb72d8f">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5f3dece36b4d9797ed5acb0b90daf4_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctNy0xLTEtMA_d9ca4e15-1cf0-403e-80ba-18259416c410">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ab37d97d08e42a7b67c4e7178669c35_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctOS0xLTEtMA_68c1100f-2a1f-4c6b-98ca-d35493f18a54">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acffb658960466eb1fc67e7ca045948_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctMTEtMS0xLTA_2ba91230-3260-49bc-ad38-414121c346df">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ce84bb33df4e31990c5963ff81d63d_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtMS0xLTEtMA_b9a111bc-4f1c-4fed-b504-e046fb3cfd61">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9793b506e6474cea8ef7b144ff2a1ba9_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtMy0xLTEtMA_e1fe51a7-923b-4032-a88e-5f836541934d">331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d4510358244d6fae7ec31c72217294_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtNS0xLTEtMA_9bf3f668-e67d-4100-8573-e8c44c08d59a">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib05caee353e041109255daf8c865e2ed_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtNy0xLTEtMA_eaf5f5e5-1013-4427-b35f-5f0f56389c80">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib34d233696a544a1ae2c974370c8315e_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtOS0xLTEtMA_f5a45752-5d7c-47fb-8d72-c26f708e54b5">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e862fbb1c7d413192549928e2464ffa_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtMTEtMS0xLTA_09671cbb-d765-4d93-b4c7-41fa337e1e5c">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de65bc069d24d51825bdab4b50bd41c_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktMS0xLTEtMA_2865dd68-bffb-44a9-82db-099f485390e5">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2099af0836c24bc1b803f81eab14b8a0_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktMy0xLTEtMA_c866c25e-608f-40e1-8fbc-782adb5a3edf">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9fb1a2b2f24fa293105915ff8b08e0_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktNS0xLTEtMA_d0455936-75a2-413f-8e87-7ef30dd34ea9">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id280062840b2435eb308bd4c66b47fcf_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktNy0xLTEtMA_eedf5614-0390-465c-bddc-513590fba556">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f1a708d4e547908f94f4cbfefc9425_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktOS0xLTEtMA_a5ef4a87-7f20-47cb-9eb2-42a2f3880eae">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95c352cc7257452c924fa7c4f8f29c39_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktMTEtMS0xLTA_e63ab700-fb26-461e-a0ab-686ac934d4c0">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ce64349f174b9898c3ae08f6a8619a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTEtMS0xLTA_32aa4e15-6c5d-4413-87e8-e0c6beaa8fb4">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891b41394ba84479b8e900b71bab7425_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTMtMS0xLTA_6b37a241-10cd-44ce-9940-e80e881452ad">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf8b1e5d2d9412d82011f9725561fe7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTUtMS0xLTA_e15cc870-ed88-4020-9e92-ed5bb93e2c72">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a83ead422742818de6d2d992f45122_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTctMS0xLTA_a4c84c88-7bba-40a1-b105-1750d011637c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3a2a8cccb44fe89ad6947ec51b189f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTktMS0xLTA_7bf095e6-6444-4433-a877-6ffa3b89dad8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88abe695eff4ec79c92c9b51eb144c1_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTExLTEtMS0w_32b2701a-dd30-4a75-a883-f577d73dd749">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i026b1c31e2164480b52d6156bf29ceda_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTEtMS0xLTA_69e78b41-d9f3-4e24-9832-4f0777accd04">1,560</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i083f1c7b584149eda19fe53bf7f9e950_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTMtMS0xLTA_cdf28620-2c76-49ab-a4e1-ed0b95d5dc9f">1,098</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTUtMS0xLTA_2403f7df-dbd7-48e3-be9a-2ff552c6d607">2,659</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bca6c5210634d32ba0fb78a24986bfa_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTctMS0xLTA_e93e22c6-4f6f-44a9-a775-2087f4bd0c3f">1,580</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472c98506bfb45ac973bc5141d646641_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTktMS0xLTA_3306ad01-06db-49cb-8545-6fa9a55afbd4">1,126</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTExLTEtMS0w_62a11438-61e7-4d04-bc5b-6626363ca40d">2,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00311d766dd24a468df0201eb3a98a98_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtMS0xLTEtMA_4fbc2454-2b51-45e4-9ebd-8d946ee4b1ad">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb736062dca24512bad3fa08ad4ac3b8_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtMy0xLTEtMA_197e7e01-6115-43b1-8088-4f17644c1955">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300d7b781b864c99b873d04c9d8c1861_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtNS0xLTEtMA_eb31511a-b6c7-419e-9965-877365a5c7cc">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b26fb08edb4643836d722d1433826c_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtNy0xLTEtMA_6680b28b-de70-4620-b7ad-e1f3ca1897b8">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5f8b764815543ca89b15a0f65b4286a_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtOS0xLTEtMA_0fcf7215-1863-4bea-8f91-104f9c61736b">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60eaf78208af46938794bfa911789a21_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtMTEtMS0xLTA_5b46a1a8-dbe9-4552-a911-5fb643cd361e">1,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2104c8e67c9c4f7ea81b0f7fd2d47b1b_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtMS0xLTEtMA_bef14f5d-84bc-445b-8489-54ae36d71796">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c6abc5823240358a6851a296ac9701_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtMy0xLTEtMA_5f1a1118-6583-4de5-827e-7c7a09cca759">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bab7eecd6e84feaaa75ed43b6cc6db4_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtNS0xLTEtMA_b723a6c2-cc22-430b-bfc0-77b29b5b755e">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b57559a2bd8439daa00da2ce3307b8c_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtNy0xLTEtMA_4e6d14bc-2787-4679-8624-8f6450888853">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb32d52b9c8243efbabe0b365289bfbf_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtOS0xLTEtMA_639b687f-25ef-43fb-a2b5-9f20cf95eb59">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979e2c7f0cad4c01a72c0aa7ef8b510a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtMTEtMS0xLTA_8207bc49-e616-4ea2-9b5b-2178dec41011">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41a939d6e964fdb92096b0fe824a09b_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtMS0xLTEtMA_5559bec6-02d4-4e56-ac5f-c7bf5b92d4a5">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied533bdc632d4ce0a14378174c2760eb_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtMy0xLTEtMA_ab8f1e5d-7a0f-41f1-9128-bdcb05c02d42">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09381a44114941a4a42b342af6277fcb_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtNS0xLTEtMA_9a4bf778-23f3-4a61-ab6e-f28b910eaa82">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24f0a567b61489ea559da0492eb8bd2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtNy0xLTEtMA_ece85057-8568-4010-b22c-60403ec63092">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i848dace5f06f4632b8e52342192aaa89_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtOS0xLTEtMA_fb181b92-2cc1-47db-a90e-55506cc9ce3c">607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie907d1127d5b4f1891715b552d0f2720_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtMTEtMS0xLTA_5eaea30d-5bf8-4999-9751-08bf740cd98f">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i332f62f3ea2842fab11b86ca30dc2375_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtMS0xLTEtMA_13d59c2b-0937-484a-b9a1-7f33df90bbe7">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1119d578b4ea4da9bf0365681fa56dc8_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtMy0xLTEtMA_99127d7e-f448-4edd-98d8-496c938041b8">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc7104ff33e4c48b5d13452491f1ce5_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtNS0xLTEtMA_535b8a14-1784-4c7b-a6d1-368408445afa">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717f0d15b6c94e21a894833031631fca_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtNy0xLTEtMA_38e2b09f-86fe-4589-bd79-9f46b1f25952">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ca578eb6044b1296051e9a07918f73_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtOS0xLTEtMA_1e32e898-c436-4756-bc57-bd3625d14dfd">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1973b158c2c7411ca93ed11aa1f7120b_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtMTEtMS0xLTA_f02e7285-eb84-43eb-82b5-db9d90aa43a6">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i623c86db3713458ca2b7defbbf8058c7_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctMS0xLTEtMA_95c6976b-1f05-4302-a33f-aa3cee2ef4c8">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f9578856994687889ca858501676b9_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctMy0xLTEtMA_dab1de41-e39b-405d-acc8-3a5b8f55636c">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f70470d3bd48dcbc4feb2bc35e086d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctNS0xLTEtMA_a4f3f94e-e346-4f62-83a3-59cf5e927787">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f2988c1732418c928a801db05c25b5_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctNy0xLTEtMA_7166182d-c0a2-4dba-9b48-51a6c4564d8b">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i986f91df9ca9493a8d7d15802a1c0570_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctOS0xLTEtMA_68e8ee6a-330b-4960-8ec1-fe07497bea18">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f8c7b64fc864c49a306a9b4254fbaa7_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctMTEtMS0xLTA_c159faad-6f1b-4de4-b761-011c501b5bcf">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705232db70004ea088c0dc1093c8b9df_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtMS0xLTEtMA_3b166427-e604-419e-ac02-c2d4ac836bc2">741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36bcd3ce2ebe47c5bd79a16c0d3b29d9_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtMy0xLTEtMA_2a5e499a-993f-4ca4-b1d9-126631246a32">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ba0222e4aa4c59984dae3c8006ad93_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtNS0xLTEtMA_3d38128d-0098-42f5-86fa-880c2ecb18af">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020fd119041d418191cf85bbfc54285c_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtNy0xLTEtMA_92eb2931-a0a1-4924-a4c3-a4c4b6aeffda">942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e13b532f9a64e418eb80c0976c3b6af_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtOS0xLTEtMA_307137d6-8cbc-4446-b087-5fc2ee8215b9">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f9023219ff48cba3a2fc8ae591929a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtMTEtMS0xLTA_8711b5d0-df1c-464a-b1e9-e2b7f7c01dae">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i105ce581a7544f47ad757216472bcc6d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktMS0xLTEtMA_128a8c16-c47b-4913-8c6b-ac0725732a40">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59107e082d014734a4ee490225fe5ffa_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktMy0xLTEtMA_0e7ceb52-9d3b-4d50-904a-cfee8db83ffe">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba53a1d39d394e8280b268a72077bd5a_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktNS0xLTEtMA_56f72b4c-372a-4192-ad42-5d1f21df84e8">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625dce25ac3c45a38e0390b9592977f2_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktNy0xLTEtMA_a3b587a6-9018-443a-8a36-94b63f6cb3f4">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3551557143ac42dc88cc80b58e98bdb0_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktOS0xLTEtMA_ed1e1328-61f3-4109-aedc-4d4523f93ac3">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4fa8afd39046fc92a81f01071f2a60_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktMTEtMS0xLTA_7785ed67-3027-4247-ad66-5604fdb71db6">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6e62892f954227b719df17b5bc2c30_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTEtMS0xLTA_4ba2cdca-c8cb-412a-953c-4e346388c396">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673c5b0fb6fe4743aa18d48721035a1d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTMtMS0xLTA_ef8fb4e2-a562-4bd1-8190-e1f676a4908f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTUtMS0xLTA_2384c02b-65c1-49f1-b7f7-f520cf13300e">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3f2be30198a405d8b8ea83a69eaf25f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTctMS0xLTA_80f9926c-d81e-4d06-bc0a-3cab376177ad">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea70c191ce524d3f869a4a09e65e620f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTktMS0xLTA_a008f848-7899-4126-86b9-1fc8552e4be4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3a8a2f83894a3296a3091b4bb232db_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTExLTEtMS0w_e63641d8-6368-4e35-8fa4-fc155f53cb5e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6888bf8540af4896a7727d330b9361f8_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTEtMS0xLTA_506bcc21-ba66-4373-879f-d9e95a162f26">4,167</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5dcb6fca7c446dacf97994b28f8ad3_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTMtMS0xLTA_3e9b0ac3-026f-4f56-9f3b-9e1a5ce31743">3,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTUtMS0xLTA_7f35a72c-45e5-4f4a-b937-547809260201">7,204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8128a4d029a94bb89cb486f5c5f0eb0a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTctMS0xLTA_a504bddf-95d3-45f5-935b-44934232452a">4,462</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d9ab6494b964761bf03a135b4b4f64f_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTktMS0xLTA_d6c338b0-7be3-4c43-88fc-403ddfad32f8">3,369</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTExLTEtMS0w_9a0fca61-9b9d-4b64-bb7c-15003bf3ab11">7,831</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657eb7c32c324e8894346cfcb27b2689_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItMS0xLTEtMA_1839ede9-79d2-4bf4-85d1-49ebaa395f96">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id843d2538e014a02a8d63e8255b29a90_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItMy0xLTEtMA_b981401a-5968-4a63-b598-2669550c4b86">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73057f636f442ae8f81a9ac97489ccc_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItNS0xLTEtMA_90fa21f8-7909-4d7f-bc19-0182748eef19">4,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781a010211e840dc81fc687839042bbb_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItNy0xLTEtMA_e9f0bd1a-2df4-43e4-b73c-7234b3a02048">4,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d3e241fffe450cb56f3a263380bccb_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtMS0xLTEtMA_c6a4a440-4c2e-4349-bc47-8f1037eb67ee">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3e53dc9ca94bae9d18d4780150080e_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtMy0xLTEtMA_e56ccaa5-0fae-4117-8755-bf601ace50a5">535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8128e54be7e454695b08432140f99cc_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtNS0xLTEtMA_804d5152-c0b7-4cb5-8f5d-59a7718129c0">1,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5be373172e034996889706e0c8fad15c_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtNy0xLTEtMA_7f78709b-da47-4783-a663-e1fef1005d76">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e40dd0d92b4f80be9dc394e4027845_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtMS0xLTEtMA_bfd894c1-586a-48d9-98da-1ddf278805d4">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a16b3866b9041938a6c24f85548a18b_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtMy0xLTEtMA_654fcbd6-d4c8-43ee-baa3-8dce0258bec6">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5aec6e059674fe0994035b7a01bb825_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtNS0xLTEtMA_8f5e9f4b-8653-4133-b547-6a93852a5e67">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630933314e5e4cf5bfcc14419acec677_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtNy0xLTEtMA_e6d1aef0-69b2-45b6-839b-e6f45c3be3f5">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8511168847a45e096f858b26873d803_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtMS0xLTEtMA_eda6671f-5935-4164-b589-635c21b4bc03">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9704b036b149d689349b41b329038e_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtMy0xLTEtMA_f0465717-5a61-493e-8357-a2cc929c6073">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id81bb93af48745e6a559b70678953bfa_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtNS0xLTEtMA_1dcbaa3c-8df7-4083-9bb8-5fba9101f398">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba26fb5d1414c919d17e80bdc02dd30_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtNy0xLTEtMA_8a72b870-76b2-48fb-b0cd-d5496416b2af">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba152e6d345944b6a404d50555024e71_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtMS0xLTEtMA_0069db0c-d2be-4a85-a71b-31b3e1e8cb9b">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d58860b34642148a851e295ba585bf_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtMy0xLTEtMA_b1161e30-58a9-42af-96fa-fa54868d35ec">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i048389ab0ac64d2c87536a1b5d92aa9c_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtNS0xLTEtMA_e12f0054-6350-4d0e-9532-ac50590d8297">7,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i208885de1f9f46179e0e8abe705b572e_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtNy0xLTEtMA_01e60194-e145-4ea9-9f10-c3107b001e01">7,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ce64349f174b9898c3ae08f6a8619a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctMS0xLTEtMA_32aa4e15-6c5d-4413-87e8-e0c6beaa8fb4">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a83ead422742818de6d2d992f45122_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctMy0xLTEtMzE4_a4c84c88-7bba-40a1-b105-1750d011637c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6e62892f954227b719df17b5bc2c30_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctNS0xLTEtMA_4ba2cdca-c8cb-412a-953c-4e346388c396">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3f2be30198a405d8b8ea83a69eaf25f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctNy0xLTEtMzM2_80f9926c-d81e-4d06-bc0a-3cab376177ad">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891b41394ba84479b8e900b71bab7425_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtMS0xLTEtMA_6b37a241-10cd-44ce-9940-e80e881452ad">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3a2a8cccb44fe89ad6947ec51b189f_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtMy0xLTEtMzE4_7bf095e6-6444-4433-a877-6ffa3b89dad8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673c5b0fb6fe4743aa18d48721035a1d_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtNS0xLTEtMA_ef8fb4e2-a562-4bd1-8190-e1f676a4908f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea70c191ce524d3f869a4a09e65e620f_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtNy0xLTEtMzM5_a008f848-7899-4126-86b9-1fc8552e4be4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf8b1e5d2d9412d82011f9725561fe7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktMS0xLTEtMA_e15cc870-ed88-4020-9e92-ed5bb93e2c72">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88abe695eff4ec79c92c9b51eb144c1_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktMy0xLTEtMA_32b2701a-dd30-4a75-a883-f577d73dd749">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i585a4990b22043b7a34314da74c8dcc7_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktNS0xLTEtMA_8df36c75-de87-46c0-ae82-d21917dbfcb0">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3a8a2f83894a3296a3091b4bb232db_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktNy0xLTEtMA_e63641d8-6368-4e35-8fa4-fc155f53cb5e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTEtMS0xLTA_2403f7df-dbd7-48e3-be9a-2ff552c6d607">2,659</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTMtMS0xLTA_c9104a88-7ca6-431d-b673-bb42e37438a2">2,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTUtMS0xLTA_ed67460e-2abe-4035-bb39-9dfa51e3fbae">7,204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTctMS0xLTA_83fd2947-03b7-4abd-ad17-f59e823c3e1e"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTctMS0xLTA_b51fe2ab-1eeb-4072-bcf1-b659e154cb28">7,831</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b2155f584f430289ab76456eb294f0_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTEtMS0xLTA_eea6375a-2c99-425e-9624-5a5c8d2ba80f">278</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia29baba230164973991e71f75d7e2df3_D20190701-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTMtMS0xLTA_30f5de8d-c3d7-44a8-837e-691e493d0938">310</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc339cf33204e73b732865ff098bcc1_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTUtMS0xLTA_178908b7-2c0b-4009-8ad7-ab700df00df6">800</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15b282dade649b69746d0ac5cab9434_D20190101-20190930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTctMS0xLTA_7e1ba743-06fd-488f-9de7-1baf03004d71">925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the <ix:nonFraction unitRef="units" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="0" name="bsx:EmergingMarketstotalnumberofcountries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzMxMg_98ce6fd6-e78a-4bee-8a2f-0447477a0312">20</ix:nonFraction> countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets, which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.</span></div></ix:continuation></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i3365c6391f1447d28c6924f01a32793f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited condensed consolidated balance sheets. Our deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4Xzk0Nw_800f7ed8-8cd2-4f85-a395-6f326ef219b4">405</ix:nonFraction> million as of September&#160;30, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4Xzk2Mw_02772638-e6a1-4c36-a43b-f81074b13895">400</ix:nonFraction> million as of December&#160;31, 2019. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. We recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzEyMjY_8e0dec98-97c3-454e-ba2f-10ed5eb8b889">28</ix:nonFraction> million in the third quarter and $<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzEyNTE_f0d08c46-45d4-4c1b-87f3-1a7c2870456f">84</ix:nonFraction> million in the first nine months of 2020 that was included in the above contract liability balance as of December&#160;31, 2019. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit and record the amount for estimated sales returns as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. We recently received FDA approval and began the U.S. launch of our next generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#8482; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In the third quarter of 2020, we incurred $<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzI3NDg3NzkwODUyNjk_f7f3cb34-0b2d-4f44-91b5-8e38b9612ad6">63</ix:nonFraction> million in revenue charges primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div></ix:continuation><div><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_124"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90ZXh0cmVnaW9uOjg2MTFkNzA1NDViMzRmNjNhN2MyMDllZDdkMjQ3NDgyXzY0Mg_0722dd14-c59f-42ab-b9e5-9715091ef061" continuedAt="i1e8a3359ef7644f28a87ee7e56cc40f1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90ZXh0cmVnaW9uOjg2MTFkNzA1NDViMzRmNjNhN2MyMDllZDdkMjQ3NDgyXzY0NA_98714fad-e714-4deb-ae26-47e2a0573d90" continuedAt="i6a31e62661094299bf46a3fff1fd116c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtMS0xLTEtMA_049777f0-1bb3-4616-8116-06227de93319">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtMy0xLTEtMA_00f406ca-acaf-412e-a812-a76fb2170ae0">222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtNy0xLTEtMA_bf3cdd23-88e1-4b69-b224-166b31c742a5">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtOS0xLTEtMA_5588a774-da52-4c0b-b0b3-747469898031">131</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItMS0xLTEtMA_4c84822b-0e6a-484d-89a0-ebda97f369ea">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItMy0xLTEtMA_d621b7d3-c3b6-4fd4-b48e-f3b773471188">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItNy0xLTEtMA_7d2656fe-d5ae-4eb1-bf5c-d4c06d52ae7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItOS0xLTEtMA_88fb17ef-3a7c-4338-ac27-5e55cfc0bd66">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtMS0xLTEtMA_1e4b96a1-7d9a-40a2-aaa4-f81fb227f352">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtMy0xLTEtMA_74893298-ad6f-4a6c-9bcf-0c117cd1074b">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtNy0xLTEtMA_2ef8f6eb-8960-42ba-b8f0-6b409b461c28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtOS0xLTEtMA_65f3bee6-721a-48c7-89a6-d0b8c73f84ac">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtMS0xLTEtMA_536dede2-b2f6-4563-b58e-7702aea9f5db">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtMy0xLTEtMA_4a2bea45-d7f3-41ec-957a-a195228b65b8">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtNy0xLTEtMA_1b359bd5-cbf3-4f95-8125-71f05b439861">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtOS0xLTEtMA_de758055-084b-411b-8eb5-e719752de8dd">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtMS0xLTEtMA_e39ec550-4ab6-4892-9c2f-05205a471ca1">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtMy0xLTEtMA_d701aecd-755e-49ef-a80c-55e1c1b3125d">158</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtNy0xLTEtMA_d5223829-a26c-477c-8622-3f082b6b39c7">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtOS0xLTEtMA_e0c3dab9-8ffb-4201-afea-b035b187b998">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="i1e8a3359ef7644f28a87ee7e56cc40f1" continuedAt="i73dd92b9ddf3486ab166bd2355eb439d"><ix:continuation id="i6a31e62661094299bf46a3fff1fd116c"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7aaf89e580246e2979204c398ade960_I20190630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtMS0xLTEtMA_c9163386-7e9d-4e52-98c5-8cfad830696e">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aaf89e580246e2979204c398ade960_I20190630" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtMy0xLTEtMA_242508c5-2821-431c-8f28-c43aefeb10c8">150</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7aaf89e580246e2979204c398ade960_I20190630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtNy0xLTEtMA_eb16e90e-f32c-4a17-b7d6-fbafd2960aa9">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aaf89e580246e2979204c398ade960_I20190630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtOS0xLTEtMA_f69b10d5-47a9-4cd5-b406-63cb37abf842">78</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItMS0xLTEtMA_fbf08b8e-f50b-472b-ba7f-2b9e350d88ce">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItMy0xLTEtMA_4206c911-e165-4448-83be-d265e12ec562">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItNy0xLTEtMA_f4eb8bee-1d22-4512-90d1-69e7febbe411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItOS0xLTEtMA_e22a4090-4cad-49e4-b0de-9cbe94584a42">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtMS0xLTEtMA_c78b64fb-705f-4016-9842-61a0f0528a68">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtMy0xLTEtMA_c6b6c83c-d9fa-4353-973e-c61b69f6b931">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtNy0xLTEtMA_54f983cb-edab-4ff6-bb59-1fa0541fea7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtOS0xLTEtMA_aef8cfbd-a874-41a9-829d-442c9e0d560d">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtMS0xLTEtMA_2106a5d5-b0b3-4b0f-92b0-584b1302952b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtMy0xLTEtMA_e07a859d-90c8-47c8-b0c3-601e30df6dbd">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtNy0xLTEtMA_9d995a06-ce16-46a5-8e6b-45c43e222fca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtOS0xLTEtMA_4a26f0ec-6ccf-4710-8d44-2f3e1b85cec2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtMS0xLTEtMA_7643ef06-a3ca-47c3-94cb-11d17630166b">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtMy0xLTEtMA_142e64f9-4678-4a30-981b-76b4ab093504">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtNy0xLTEtMA_418574ea-4d4b-4c49-8cb6-ab50fbd9d567">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtOS0xLTEtMA_bdb44053-afc3-4fae-ab9b-db5d15dcbaf3">138</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtMS0xLTEtMA_46ffa41b-0308-42c0-98ea-cd6f83c957e6">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtMy0xLTEtMA_5ee14335-452d-487e-ad30-fe6ab3f9f706">173</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtNy0xLTEtMA_60556b55-ed12-4336-889d-b278b0a7611f">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d357c574ae49f6894555c699e39978_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtOS0xLTEtMA_484fb3b5-2f18-466d-b951-39649e112204">270</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItMS0xLTEtMA_d5ca2f76-34bf-40be-93eb-9ae4d3f99ad5">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItMy0xLTEtMA_64bbcfbe-f613-4909-8d1c-9120d89d2469">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItNy0xLTEtMA_f493ca5c-a843-4372-856e-04eee718555d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItOS0xLTEtMA_dc4f2cf9-1ad8-4525-981d-8e9717798876">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtMS0xLTEtMA_b75eafdd-ee41-4b01-aaca-66bf2041d08d">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtMy0xLTEtMA_5560b9e1-e2b9-45e4-93e0-82cd31f9c74c">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtNy0xLTEtMA_7980e13b-6441-4c30-88cc-1654d7c7afcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtOS0xLTEtMA_acfdfb23-e8dc-46b2-b883-fccfd922345d">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtMS0xLTEtMA_b0282837-d7fb-400e-8cc9-54b456b47894">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtMy0xLTEtMA_5bc52919-dd07-4a32-99be-a2b56f1b6b98">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtNy0xLTEtMA_375f3a7d-5e3d-4b8e-93f3-af2d09c1cc85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtOS0xLTEtMA_330e0719-3c30-4e91-9148-e8a565c40b62">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtMS0xLTEtMA_aca6dc01-408f-403f-811d-30070f2ad398">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtMy0xLTEtMA_53f743aa-0c79-453e-bc19-31853f578b83">158</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtNy0xLTEtMA_50cf60d4-c2fb-49ba-be80-21e9471eff54">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtOS0xLTEtMA_f0925ef6-19a2-409f-8a01-e9e05701c900">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtMS0xLTEtMA_cc7bc786-4c00-40e5-8f54-a452c1fbb6d7">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtMy0xLTEtMA_4f42e666-bdea-4f53-a67e-952a124bc9fa">111</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtNy0xLTEtMA_95dc2c1e-4c70-4ed3-bff3-cac4e9ce9a9d">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtOS0xLTEtMA_b16a18a0-9291-440c-b77b-d1da66349af7">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItMS0xLTEtMA_2952d7fd-66dd-40a0-ad08-4cb700c2d257">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItMy0xLTEtMA_ea0a11ae-651d-4400-b590-16d170e30ee5">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItNy0xLTEtMA_2d91efdf-eb7c-4dbf-9e9a-8e608689baa9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItOS0xLTEtMA_74ccf4ff-843f-4590-b297-11e393d62de8">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtMS0xLTEtMA_f029102b-321a-4c7a-af5a-81cc05971e12">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtMy0xLTEtMA_ae4fb066-be76-4525-aa2a-08552c4b8f80">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtNy0xLTEtMA_ffbbb9a2-3372-4867-a982-875d554e18c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtOS0xLTEtMA_e450b1b4-6330-4d9d-833a-add84929b623">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtMS0xLTEtMA_efd39e73-ceab-4db9-9a69-ea6f4ee326d0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtMy0xLTEtMA_edc75164-b1c0-4869-90ce-0103ce2f7adf">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtNy0xLTEtMA_901efa94-4ee4-4ff6-a378-88aea63ee5dd">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtOS0xLTEtMA_34a5831a-edd5-4967-9240-1977ace72121">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtMS0xLTEtMA_f90af057-c6e3-4602-970f-a04ae7edb4a2">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtMy0xLTEtMA_982f392a-8a1b-4b6a-9d72-42550c860fc8">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtNy0xLTEtMA_7fd433b3-32af-4810-8b4e-71cb1ff9a881">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce032be65f744de9ae2f698e732db43_I20190930" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtOS0xLTEtMA_5f7d4019-d696-4408-add0-b832234761ab">138</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i73dd92b9ddf3486ab166bd2355eb439d" continuedAt="i0ccbeaa675124591ba1753742eca6405"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0ccbeaa675124591ba1753742eca6405"> were reduced by immaterial income tax impacts in the third quarter and first nine months of 2020 and 2019.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_130"></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3Njc_f8a289f1-37ee-4282-8f5f-09b76544b181" continuedAt="ic95c4205dd734d12a8569673b9eed8fb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our unaudited condensed consolidated financial statements.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><ix:continuation id="ic95c4205dd734d12a8569673b9eed8fb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3NDg3NzkwNzQ4NDE_830cfc52-4aa5-4478-a08e-a687b5ddd7d2" continuedAt="ia0556bebda6e4d46ad9d2a0491cd4b5a" escape="true">ASC Update No. 2020-10</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ia0556bebda6e4d46ad9d2a0491cd4b5a" continuedAt="i256c1c7478bc41c3815bdf3244c46040"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i256c1c7478bc41c3815bdf3244c46040">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning after December 15, 2020, for public business entities. Early application of the amendments is permitted for any annual or interim period for which financial statements have not been issued. We are currently in the process of determining the effect that the amendments will have on our financial position and results of operations.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3ODc_5ceaa7c2-8795-4e98-b691-2a5d0db4ba70" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930" name="bsx:ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3NzA_1884cc7e-a4da-4449-a57a-b27a1c384e28" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods.&#160;Early adoption is permitted, including adoption in an interim period.&#160;We are currently in the process of assessing in which quarter to adopt, as well as determining the effect that the adoption will have on our financial position and results of operations.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our unaudited condensed consolidated financial statements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="padding-left:49.5pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.36pt">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. Our products and technologies are used to diagnose or treat a wide range of medical conditions, including cardiovascular, digestive, respiratory, urological, pelvic health and neurological conditions. We continue to innovate in these areas and are committed to the goal of extending our innovations into new geographies and high-growth, adjacent markets. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the novel strain of coronavirus (SARS-Cov-2), and its disease commonly known as COVID-19 (COVID-19), was reported in China and has since widely impacted the global public health and economic environment. In March 2020, the World Health Organization (WHO) declared COVID-19, including all additional variations and strains thereof, a global pandemic (COVID-19 pandemic). Our business trends through the first two months of the year were in line with internal expectations; however, as COVID-19 reached a global pandemic level, procedural volumes significantly declined, negatively impacting revenue and operating income. While the majority of procedures using our products are deferrable, most of the conditions that we treat are generally fairly acute and cannot be deferred for extended periods. As the pandemic spread worldwide and with COVID-19 cases confirmed in all major geographies, many elective and semi-emergent procedures were postponed, enabling hospital staff to focus critical resources on caring for COVID-19 patients. Some jurisdictions mandated elective procedure bans that included financial penalties for non-compliance in the second quarter. Certain of these bans continued to be in effect in the third quarter or evolved to reduce capacity available for elective procedures. In other jurisdictions, the timing of the pandemic and public health measures have resulted in lower levels of COVID-19 cases, while hospitals have also developed protocols such that elective procedures may be conducted safely and are approaching pre-COVID-19 pandemic levels. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While much of the global economy reopened in the third quarter, the COVID-19 pandemic is ongoing, and renewed restrictions are being contemplated or implemented in areas that had previously reopened, including in parts of Europe and the U.S where COVID-19 cases are rising. The ongoing pandemic and accompanying restrictions continue to negatively impact our net sales, gross profit margin, operating income and net income. Our net sales declined 1.8 percent in the third quarter and 8.0 percent in the first nine months of 2020, with the most significant decline occurring in the second quarter, particularly in April 2020, and relatively smaller declines during the third quarter. Global sales trends consistently improved as physicians resumed performing elective and semi-emergent procedures previously deferred and referral rates of new patients improved. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Entering the second quarter of 2020, we implemented cost reduction initiatives, including decreases in travel, meetings and customer events, hiring, clinical programs and certain research and development projects which largely remained in effect during the third quarter of 2020. We also implemented a temporary four-day work week for many employees globally and reduced employee compensation, including temporary significant cuts in the salaries of our executive officers and the cash retainer paid to our Board of Directors. In addition, we temporarily closed and/or reduced production levels at certain of our manufacturing sites in an effort to align our build plans to the current and expected demand environment. During the second quarter of 2020, as COVID-19 cases began to decrease in certain geographies, we implemented a careful and tiered approach for employees to return to our sites following state and local ordinances. Employees with the greatest need to access onsite resources to perform their roles have returned first, while those who can effectively work remotely will continue to do so in order to facilitate maximum social distancing in our sites and within our communities. All of our plants have now resumed manufacturing and are increasing their utilization levels, but many remained below full capacity in the third quarter of 2020. For non-executive officer employees, in those jurisdictions where temporary four-day work weeks and reductions in employee compensation were in effect, those measures concluded at the beginning of the third quarter. We also announced during the third quarter the end of the aforementioned reductions in executive officer pay, except for the salary reduction for our Chief Executive Officer, which continued through October 2020. We further announced that a portion of the annual cash retainer for our Board of Directors would be restored, beginning with a payment made during the fourth quarter of 2020. While we have implemented measures to reduce costs, our operating expenses as a percentage of net sales increased during the third quarter of 2020, as compared to the prior year, as approximately 70 percent of our operating expenses are fixed in nature. Our gross profit margin was also unfavorably impacted particularly in the second quarter of 2020, as compared to prior year, due primarily to manufacturing costs associated with abnormally low production levels in our plants, and improved sequentially in the third quarter as production levels increased. Because the severity, magnitude, and duration of the COVID-19 pandemic and its </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">economic consequences are uncertain and rapidly changing, the pandemic&#8217;s impact on our operations and financial performance, as well as its impact on our ability to execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Procedural delays from the further resurgence of COVID-19 infections may negatively impact demand for our products, net sales, gross profit margin and operating expenses as a percentage of net sales in the fourth quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to focus our efforts on the health and safety of patients, healthcare providers and employees, while executing our mission of transforming lives through innovative medical solutions to improve the health of patients around the world. Since the onset of COVID-19, our global crisis management team has focused on protecting our employees and customers, optimizing our operations and securing our supply chain. We have successfully implemented business continuity plans including establishing a medical advisory group for employees, leveraging work from home infrastructure to facilitate social distancing, limiting sales visits to critical cases and accelerating capabilities to provide remote physician support. While we expect the COVID-19 pandemic will continue to negatively impact our 2020 performance, we continue to believe our long-term fundamentals remain strong and we will manage through these challenges with strategic focus and the winning spirit of our global team. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the recoverability of the assets in our unaudited condensed consolidated balance sheet as of September&#160;30, 2020 in accordance with relevant authoritative accounting literature. We considered the disruptions caused by COVID-19, including revised forecasted sales and customer demand, a decline in the price of our common stock and macroeconomic factors potentially impacting accounts receivable, inventory, investments, intangible assets, goodwill and other assets and liabilities. Where forward-looking estimates are required, we made a good-faith estimate based on information available as of the balance sheet date. We have continued to monitor for indicators of impairment through the date of this Quarterly Report filed on Form 10-Q, and reflected accordingly in the accompanying condensed consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Social Responsibility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enabling a culture of diversity, equity and inclusion is essential to enhance employee engagement and our performance. Within our workplace, our Employee Resource Groups are at the heart of this culture. They provide forums for us to learn from one another, celebrate our diversity and develop inclusive leadership skills. Within many of the communities in which we operate, we have launched and funded a multi-year program to combat racism, inequity and injustice focused on five pillars: community, economic empowerment, education, healthcare disparities and government/legislative change. We also continue our long-term sponsorship of our Close the Gap initiative, which focuses on raising awareness and empowering healthcare providers to reach more patients of color, fight longstanding inequities, and address barriers to care. Through Close the Gap, hospitals and health systems are provided with zip code level data that highlight the disparities in treatment between white and non-white patients in their communities. The information allows health care administrators and providers to focus on improving care to underserved populations within their communities. As evidence of our progress, in the third quarter of 2020, we were named among the Top 50 of America&#8217;s Most Just Companies by Forbes/Just Capital, ranking #38 overall and also tied for #1 for diversity, equity and inclusion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recognize the need to minimize the impact of the manufacturing of our products on the environment and have committed to carbon neutrality in our manufacturing and key distribution sites by 2030.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September 30, 2020 </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the third quarter of 2020 were $2.659 billion, as compared to $2.707 billion for the third quarter of 2019. This decrease of $48 million, or 1.8 percent, included operational net sales declines of 2.5 percent and the positive impact of 70 basis points from foreign currency fluctuations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Operational net sales included $99 million in the third quarter of 2020 associated with our acquisition of BTG plc (BTG) for the period prior to mid-August 2020, for which there were no prior period net sales. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our net sales by global business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net loss available to common stockholders for the third quarter of 2020 was $169 million, or $(0.12) per diluted share. Our reported results for the third quarter of 2020 included certain charges and/or credits totaling $698 million (after-tax), or $0.48 per diluted share. Excluding these items, adjusted net income available to common stockholders for the third quarter of 2020 was $530 million, or $0.37 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1,2 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income for the third quarter of 2019 was $126 million, or $0.09 per diluted share. Our reported results for the third quarter of 2019 included certain charges and/or credits totaling $424 million (after-tax), or $0.30 per diluted share. Excluding these items, adjusted net income for the third quarter of 2019 was $550 million, or $0.39 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational net sales growth rates, which exclude the impact of foreign currency fluctuations, and adjusted measures, which exclude certain items required by generally accepted accounting principles in the United States (U.S. GAAP), are not prepared in accordance with U.S. GAAP and should not be considered in isolation from, or as a replacement for, the most directly comparable GAAP measure. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for a discussion of management&#8217;s use of these non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In May 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. Refer to the reconciliations below for the impact of the MCPS cumulative preferred stock dividends on our calculations of earnings per share (EPS).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(169)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestiture-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment impairment charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU Medical device regulation (MDR) implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(3) For the third quarter of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited condensed consolidated statements of operations, for purposes of calculating EPS. We have assumed dilution of 13.6 million common stock equivalents related to employee stock options for all or a portion of the non-GAAP adjustments, which were anti-dilutive for GAAP purposes due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> position.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment impairment charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU MDR implementation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.00)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">550</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.39</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2020 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net sales for the first nine months of 2020 were $7.204 billion, as compared to $7.831 billion for the first nine months of 2019. This decrease of $626 million, or 8.0 percent, included operational net sales declines of 7.6 percent and the negative impact of 40 basis points from foreign currency fluctuations. Operational net sales included $413 million in the first nine months of 2020 associated with our acquisition of Vertiflex, Inc. (Vertiflex) for the period prior to June 2020 and our acquisition of BTG plc (BTG) for the period prior to mid-August 2020, for both of which there were no prior period net sales. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our net sales by global business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net loss available to common stockholders for the first nine months of 2020 was $311 million, or $(0.22) per diluted share. Our reported results for the first nine months of 2020 included certain charges and/or credits totaling $1.351 billion (after-tax), or $0.95 per diluted share. Excluding these items, adjusted net income available to common stockholders for the first nine months of 2020 was $1.040 billion, or $0.73 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net income for the first nine months of 2019 was $704 million, or $0.50 per diluted share. Our reported results for the first nine months of 2019 included certain charges and/or credits totaling $887 million (after-tax), or $0.63 per diluted share. Excluding these items, adjusted net income for the first nine months of 2019 was $1.590 billion, or $1.13 per diluted share.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Results and Business Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of these reconciling items:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Preferred stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss) available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.22)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition/divestitures-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment impairment charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expenses (benefits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss) available to common stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,040</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(4) For the first nine months of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of EPS. Accordingly, GAAP </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> and Adjusted net income were reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">, as presented in our unaudited condensed consolidated statements of operations, for purposes of calculating EPS. We have assumed dilution of 14.1 million common stock equivalents related to employee stock options for all or a portion of the non-GAAP adjustments, which were anti-dilutive for GAAP purposes due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> position.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Impact per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">704</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and restructuring-related net charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment impairment charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU MDR implementation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discrete tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted net income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $835 million for the first nine months of 2020. As of September&#160;30, 2020, we had total debt outstanding of $9.336 billion net of unamortized debt issuance discounts and deferred financing costs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $2.022 billion and working capital of $2.858 billion. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Results and Business Overview </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section describes an overview of our product offerings and results of operations by business unit. For additional information on our businesses and their product offerings, see Item&#160;1. Business of our most recent Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Following our integration of BTG, the acquisition of which closed during the third quarter of 2019, we have included BTG&#8217;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#8217;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. In our Quarterly Report on Form 10-Q for the period ended September 30, 2019, we presented Interventional Medicine and Specialty Pharmaceuticals together as "BTG Acquisition" and outside of our operating and reportable segments for net sales. We have revised amounts for the third quarter and first nine months of 2019 to conform to the current year presentation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Sales</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides our net sales by business and the relative change in growth on a reported basis. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:37.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2.3)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">757</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.0)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,002</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5.3)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,684</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3.7)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">n/a</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.8)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10.5)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,985</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14.6)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,862</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,057</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6.4)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,807</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10.1)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">n/a</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8.0)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MedSurg </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endoscopy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with innovative, less-invasive technologies. Our net sales of Endoscopy products for the third quarter of 2020 were $475 million or 18 percent of our consolidated net sales and for the first nine months of 2020 were $1.265 billion or 18 percent of our consolidated net sales. Our Endoscopy net sales decreased $10 million, or 2.1 percent, in the third quarter of 2020 and decreased $131 million, or 9.4 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this decrease included operational net sales declines of 3.0 percent and a positive impact of 90 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this decrease included operational net sales declines of 9.1 percent and a negative impact of 30 basis points from foreign currency fluctuations, compared to the prior year period. These year-over-year changes were primarily driven by declines in elective or semi-emergent upper endoscopy and colonoscopy procedures due to the COVID-19 pandemic environment, partially offset by growth of our pancreaticobiliary and infection prevention products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Urology and Pelvic Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions for both male and female anatomies. Our net sales of Urology and Pelvic Health products for the third quarter of 2020 were $350 million or 13 percent of our consolidated net sales and for the first nine months of 2020 were $910 million or 13 percent of our consolidated net sales. Our Urology and Pelvic Health net sales decreased $9 million, or 2.6 percent, in the third quarter of 2020 and decreased $123 million, or 11.9 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this decrease included operational net sales declines of 3.0 percent and a positive impact of 40 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this decrease included operational net sales declines of 11.6 percent and a negative impact of 30 basis points from foreign currency fluctuations, compared to the prior year period. The decline in sales for the first nine months of 2020 compared to the prior year was due primarily to a reduction in sales of our prosthetic urology and pelvic floor franchises, which were negatively impacted by COVID -19 given their elective or semi-emergent nature. During the third quarter of 2020, our stone and prostate health franchises returned to growth, which was offset by the reduction in sales due to the divestiture of our Intrauterine Health business in the second quarter of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rhythm and Neuro </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cardiac Rhythm Management </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cardiac Rhythm Management (CRM) business develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. Our net sales of CRM products for the third quarter of 2020 were </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$465 million or 17 percent of our consolidated net sales and for the first nine months of 2020 were $1.253 billion or 17 percent of our consolidated net sales. Our CRM net sales decreased $13 million, or 2.7 percent, in the third quarter of 2020 and decreased $213 million, or 14.5 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this decrease included operational net sales declines of 3.7 percent and a positive impact of 100 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this decrease included operational net sales declines of 14.3 percent and a negative impact of 20 basis points from foreign currency fluctuations, compared to the prior year period. These year-over-year changes were primarily due to a decline in both defibrillator and pacemaker procedures due to the deferral of semi-emergent and emergent procedures in the COVID-19 pandemic environment. In June 2020, we announced U.S. 510(k) clearance for the LUX-Dx&#8482; Insertable Cardiac Monitor (ICM) system, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope. We started U.S. commercialization of this device in the third quarter of 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrophysiology </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Electrophysiology business develops and manufactures less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Our net sales of Electrophysiology products for the third quarter of 2020 were $76 million or 3 percent of our consolidated net sales and for the first nine months of 2020 were $202 million or 3 percent of our consolidated net sales. Our Electrophysiology net sales decreased $5 million, or 6.0 percent, in the third quarter of 2020 and decreased $43 million, or 17.5 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this decrease included operational net sales declines of 7.5 percent and a positive impact of 150 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this decrease included operational net sales declines of 17.6 percent and a positive impact of 10 basis points from foreign currency fluctuations, compared to the prior year period. Sales of our mapping and navigation products and our core diagnostic and therapeutic devices declined year over year due to the impact of COVID-19 and deferral of elective Electrophysiology procedures. In June 2020, we announced the U.S. launch of the DIRECTSENSE&#8482; Technology, a tool for monitoring radiofrequency (RF) energy delivery during cardiac ablation procedures available on the Rhythmia&#8482; Mapping System. Additionally, in the second quarter of 2020 we received CE mark approval for the INTELLANAV STABLEPOINT&#8482; Ablation Catheter enabled with DIRECTSENSE Technology and contact force assessment. This technology, along with our early 2020 CE mark approval for the POLARx&#8482; Cryoablation System, began European commercialization in the third quarter of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuromodulation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Our net sales of Neuromodulation products for the third quarter of 2020 were $216 million or 8 percent of our consolidated net sales and for the first nine months of 2020 were $529 million or 7 percent of our consolidated net sales. Our Neuromodulation net sales decreased $5 million, or 2.5 percent, in the third quarter of 2020 and decreased $83 million, or 13.5 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this decrease included operational net sales declines of 3.0 percent and a positive impact of 50 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this decrease included operational net sales declines of 13.4 percent and a negative impact of 10 basis points from foreign currency fluctuations, compared to the prior year period. These year-over-year changes were primarily due to sales declines in our spinal cord stimulation (SCS) systems due to deferral of elective procedures in the COVID-19 pandemic environment. The unfavorable impact was partially offset by higher Superion&#8482; Indirect Decompression System sales, which was purchased as part of our Vertiflex acquisition in the second quarter of 2019, and deep brain stimulation (DBS) system sales. In the third quarter of 2020, we received CE Mark and initiated a limited market release of the fourth generation Vercise Genus&#8482; DBS System in Europe and we announced the European launch of the WaveWriter Alpha&#8482; Spinal Cord Stimulator (SCS) Systems.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interventional Cardiology </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Interventional Cardiology business develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Our net sales of Interventional Cardiology products for the third quarter of 2020 were $586 million or 22 percent of our consolidated net sales and for the first nine months of 2020 were $1.714 billion or 24 percent of our consolidated net sales. Our Interventional Cardiology net sales decreased $114 million, or 16.3 percent, in the third quarter of 2020 and decreased $353 million, or 17.1 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this decrease included operational net sales declines of 16.8 percent and a positive impact of 50 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this decrease included operational net sales declines of 16.4 percent and a negative impact of 70 basis points from foreign currency </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fluctuations, compared to the prior year period. These year-over-year changes were primarily driven by our coronary stent and other complex percutaneous coronary intervention (PCI) franchises, with a significant slowdown in procedural volumes in the COVID-19 pandemic environment. Within our structural heart business, in the first half of 2020, sales of our WATCHMAN&#8482; Left Atrial Appendage Closure (LAAC) Device were also negatively impacted by COVID-19. In the third quarter of 2020, they were further negatively impacted by $63 million in revenue charges primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. Based on the progress of our U.S. limited market release, we have moved into full launch ahead of schedule and are targeting a complete conversion to WATCHMAN FLX&#8482; Device by mid-2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peripheral Interventions </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Peripheral Interventions business develops and manufactures products to diagnose and treat peripheral arterial and venous diseases, as well as products to diagnose, treat and ease various forms of cancer. In the third quarter of 2019, we completed the acquisition of BTG. We are integrating BTG's Interventional Medicine (IM) portfolio into the Peripheral Interventions division, adding complementary technologies in the areas of venous disease and interventional oncology. Our net sales of Peripheral Interventions products for the third quarter of 2020 were $416 million or 16 percent of our consolidated net sales and for the first nine months of 2020 were $1.148 billion or 16 percent of our consolidated net sales. Our Peripheral Interventions net sales increased $58 million, or 16.1 percent, in the third quarter of 2020 and increased $159 million, or 16.0 percent, in the first nine months of 2020, compared to the prior year periods. In the third quarter of 2020, this increase included operational net sales growth of 15.4 percent and a positive impact of 70 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, this increase included operational net sales growth of 16.5 percent and a negative impact of 50 basis points from foreign currency fluctuations, compared to the prior year period. These year-over-year changes were primarily driven by the Interventional Oncology franchise, including our TheraSphere&#8482; Y-90 radioactive glass microspheres acquired with BTG, as well as growth in our drug-eluting portfolio, including the Eluvia&#8482; drug-eluting stent and Ranger &#8482; drug-coated balloon. Excluding BTG for the period prior to mid-August 2020 for which there were no prior year net sales and the related divestiture of our drug-eluting and bland embolic microsphere portfolio, our Peripheral Interventions net sales increased $7 million, or 2.0 percent, in the third quarter of 2020 and decreased $54 million, or 5.5 percent, in the first nine months of 2020, compared to the prior year periods, primarily due to the deferral of semi-emergent and elective procedures in the COVID-19 pandemic environment, notably impacting core peripheral technologies and stents. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Specialty Pharmaceuticals </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the BTG acquisition in the third quarter of 2019, we present BTG&#8217;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. Our Specialty Pharmaceuticals business develops and manufactures acute care antidotes to treat overexposure to certain medications and toxins. These products are sold primarily in the U.S. through small, specialist sales teams and through commercial partners elsewhere, where approved or permitted. Our net sales of Specialty Pharmaceuticals products for the third quarter of 2020 were $74 million or 3 percent of our consolidated net sales and for the first nine months of 2020 were $183 million or 3 percent of our consolidated net sales, and have not been significantly impacted by the COVID-19 pandemic. Our net sales prior to the mid-August 2019 closing date of the BTG acquisition do not include Specialty Pharmaceuticals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategic imperative to drive global expansion, we are seeking to grow net sales and market share by expanding our global presence, including in Emerging Markets. We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets, which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam. Our Emerging Markets net sales represented 10 percent of our consolidated net sales in the third quarter of 2020 and 11 percent in the third quarter of 2019. Our Emerging Markets net sales represented 11 percent of our consolidated net sales in the first nine months of 2020 and 12 percent in the first nine months of 2019. In the third quarter of 2020, our Emerging Markets net sales declined 10.3 percent on a reported basis including operational net sales declines of 7.1 percent and a negative impact of 320 basis points from foreign currency fluctuations, compared to the prior year period. In the first nine months of 2020, our Emerging Markets net sales declined 13.5 percent on a reported basis including operational net sales declines of 9.1 percent and a negative impact of 440 basis points from foreign currency fluctuations, compared to the prior year period. The decline in the third quarter and first nine months of 2020 was largely driven by the impact of COVID-19 on our sales in Brazil in the second and third quarters of 2020, as the situation </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deteriorated in Latin America, and our sales in China in the first quarter of 2020, where COVID-19 first emerged and was the most prevalent for the duration of the quarter. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was $1.790 billion for the third quarter of 2020, $1.930 billion for the third quarter of 2019, $4.740 billion for the first nine months of 2020 and $5.566 billion for the first nine months of 2019. As a percentage of net sales, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased to 67.3 percent in the third quarter of 2020, as compared to 71.3 percent in the third quarter of 2019. As a percentage of net sales, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased to 65.8 percent in the first nine months of 2020, as compared to 71.1 percent in the first nine months of 2019. The following is a reconciliation of our gross profit margins and a description of the drivers of the changes from period to period:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended September 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abnormal production variances</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory charges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales pricing and mix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing cost reductions</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net impact of foreign currency fluctuations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WATCHMAN FLX&#8482; transition</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other, including other period expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit margin - period ended September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.8%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The primary factors contributing to the decrease in our gross profit margin in the first nine months of 2020, as compared to the same periods in 2019, were manufacturing costs of $19 million in the third quarter and $145 million in the first nine months of 2020 associated with abnormally low production levels resulting from plant shutdowns and reduced operations. During the third quarter of 2020, our gross margin was further negatively impacted by $63 million in revenue charges primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device. In addition, the decrease in gross margin in each period was attributable to unfavorable product mix due to the deferral of procedures using higher-margin products, price declines related primarily to sales of our coronary drug-eluting stent products, excess and obsolete inventory charges due to lower forecasted demand for certain of our products as well as the amortization of the inventory fair value step up recorded in connection with our acquisition of BTG. These decreases were partially offset by manufacturing cost reductions driven by our process improvement programs in each period as well as favorable foreign currency fluctuations in the first nine months of 2020. In the fourth quarter of 2020, we anticipate a negative impact to total gross profit margin associated with the ongoing conversion of LAAC customers to a consignment inventory model. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> above for additional information on the fourth quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our operating expenses:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative (SG&amp;A) expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development (R&amp;D) expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $28 million, or 3 percent, as compared to the third quarter of 2019 and were 40 basis points lower as a percentage of net sales. In the first nine months of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $89 million, or 3 percent, as compared to the first nine months of 2019 and were 190 basis points higher as a percentage of net sales. The decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the third quarter and first nine months of 2020, as compared to the same periods in the prior year, was due primarily to our efforts to reduce expenditures to minimize the impact of the COVID-19 pandemic. We implemented several cost reduction initiatives, including decreases in travel, meetings and customer events, hiring and other variable spending. During the second quarter, we also implemented a temporary four-day work week for many employees globally and reduced employee compensation, including temporary significant cuts in the salaries of our executive officers and the cash retainer paid to our Board of Directors. For non-executive officer employees, in those jurisdictions where temporary four-day work weeks and reductions in employee compensation were in effect, those measures concluded at the beginning of the third quarter. We also announced during the third quarter the end of the aforementioned reductions in executive officer pay, except for the salary reduction for our Chief Executive Officer, which continued through October 2020. We further announced that a portion of the annual cash retainer for our Board of Directors would be restored, beginning with a payment made during the fourth quarter of 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D Expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to advancing medical technologies and investing in meaningful R&amp;D projects across our businesses. In the third quarter of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $9 million, or 3 percent, as compared to the third quarter of 2019 and were 60 basis points higher as a percentage of net sales. In the first nine months of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&amp;D expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $9 million, or 1 percent, as compared to the first nine months of 2019, and were 80 basis points higher as a percentage of net sales. As we seek to recover from the COVID-19 pandemic, we expect to continue to make investments across our businesses in order to maintain a pipeline of new products that we believe will contribute to profitable sales growth. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $4 million, or 25 percent, as compared to the third quarter of 2019, and was 20 basis points lower as a percentage of net sales. In the first nine months of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decreased $16 million, or 34 percent, as compared to the first nine months of 2019, and was 20 basis points lower as a percentage of net sales. The decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the third quarter and first nine months of 2020, as compared to the same periods in the prior year, relates primarily to the expiration of certain royalty agreements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of certain of our other operating expenses, which are excluded by management for purposes of evaluating operating performance, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further description of certain operating expenses:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:35.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.318%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges (credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related net charges (credits)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $19 million, or 11 percent, as compared to third quarter of 2019. In the first nine months of 2020, our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased $97 million, or 19 percent, as compared to first nine months of 2019. The increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the third quarter and first nine months of 2020, as compared to the same periods in the prior year, was driven by an increase in the balance of amortizable intangible assets due to recent acquisitions, including BTG. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Asset Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $219 million in the third quarter of 2020, none in the third quarter of 2019, $452 million in the first nine months of 2020 and $105 million in the first nine months of 2019. The impairment charges recorded in the third quarter of 2020 were primarily associated with IPR&amp;D acquired with Apama Medical Inc. following management&#8217;s decision to cancel the program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first nine months of 2020 also included charges related to nVision Medical Corporation (nVision) and certain other intangible assets initially established following acquisition. In general, these charges were recorded as a result of management&#8217;s decision to change commercial launch plans or discontinue certain R&amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item&#160;7 of our most recent Annual Report on Form 10-K for additional details for a discussion of key assumptions used in our goodwill and intangible asset impairment testing and future events that could have a negative impact on the recoverability of our goodwill and intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Expense (Benefit)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To recognize changes in the fair value of our contingent consideration liability, we recorded net expenses in the third quarter of 2020 and third quarter of 2019. We recorded net benefits in the first nine months of 2020 and first nine months of 2019. The $102 million benefit recorded in the first nine months of 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision for milestones that would not be achieved due to management's discontinuation of the R&amp;D program. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for additional details related to our contingent consideration arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges (Credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, our Board of Directors approved, and we committed to, a restructuring initiative (the 2016 Restructuring Plan), which was initiated in the second quarter of 2016 and substantially completed in 2019. The 2016 Restructuring Plan resulted in total pre-tax charges of $271 million and approximately $255 million in cash outlays. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2018, our Board of Directors approved, and we committed to, a new global restructuring program (the 2019 Restructuring Plan). The 2019 Restructuring Plan is expected to result in total pre-tax charges of approximately $200 million to $300 million and approximately $180 million to $280 million of these charges are expected to result in cash outlays. A substantial portion of the savings are being reinvested in strategic growth initiatives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring charges, net of credits, pursuant to these programs were $3 million in the third quarter of 2020, $3 million in the third quarter of 2019, $16 million in the first nine months of 2020 and $10 million in first nine months of 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note G &#8211; Restructuring-related Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional details related to our restructuring plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related charges of $260 million during the third quarter and first nine months of 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In first nine months of 2019, our litigation-related net credits included a gain of $148 million, which represents a portion of the total $180 million one-time settlement payment received from Edwards in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;unaudited condensed consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from the Edwards settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation, and therefore, additional losses may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with the financial covenant required by our credit arrangements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for discussion of our material legal proceedings.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and average borrowing rate:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.299%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average borrowing rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and our average borrowing rate decreased in the third quarter of 2020 and first nine months of 2020, both as compared to the same periods in the prior year, primarily due to our euro-denominated senior notes offering in November 2019, which carries lower interest rates than the senior notes we partially repaid with proceeds from the offering.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for information regarding our debt obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other, net </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign currency gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains (losses) on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(197)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(322)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2019, we settled all outstanding non-designated forward currency contracts that we entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. We recognized a $207 million loss in the third quarter of 2019 and a $323 million loss in the first nine months of 2019 in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to changes in fair value of the contracts. These amounts are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition/divestiture-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the reconciliation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of management's use of non-GAAP financial measures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, we recorded a $65 million non-cash gain presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited condensed consolidated statements of operations to state at fair value one of our portfolio investments treated under the measurement alternative method of accounting. This gain is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment impairment charges (credits) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presented in the reconciliation of our results of operations prepared in accordance with U.S. GAAP to those adjusted results considered by management. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the reconciliation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of management's use of non-GAAP financial measures.</span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_151"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Rates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rates for the third quarter and first nine months of 2020, as compared to the same periods in 2019, relates primarily to a shift in geographical mix of earnings to higher-tax jurisdictions, partially offset by the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include intangible asset impairment charges, acquisition/divestiture-related net charges, restructuring and restructuring-related net </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charges, litigation-related net charges as well as certain discrete tax items primarily related to the resolution of an Internal Revenue Service (IRS) audit, as explained below, tax windfall benefits associated with share-based payments, and impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years. The Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91 million in the third quarter of 2020 to release the reserves related to these years. We anticipate receiving a refund of $62 million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic stimulus legislation has been enacted in many countries in response to COVID-19. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allows us to preserve cash generated from operations to service our debt obligations and other near-term commitments. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_154"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results are affected by the selection and application of accounting policies and methods. In the nine months ended September&#160;30, 2020, there were no changes to the application of critical accounting policies previously disclosed in our most recent Annual Report on Form 10-K. We have included below information relating to our annual goodwill impairment test performed in the second quarter of 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Goodwill Valuation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the third quarter and first nine months of 2020 or 2019. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. In the second quarter of&#160;2020, we performed our annual goodwill impairment test for all of our reporting units and concluded that the fair value of each reporting unit exceeded its carrying value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. We identified the following reporting units in our 2020 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we utilized the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment in the second quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_157"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently in a strong financial position with solid liquidity, a prudent debt maturity profile, and have credit arrangements with a broad, global, and robust commercial banking syndicate. We believe our long-term fundamentals remain strong given our innovative product portfolio and pipeline, our category leadership strategy and talented global team. As a result of the impact of the COVID-19 pandemic on our business, we took proactive steps in the second quarter of 2020 to reduce costs and ensure we are in a strong position to support customers and patients as healthcare systems recover and elective and semi-emergent procedures resume. These actions included increasing available liquidity and preemptively amending our financial covenant requirement for our outstanding credit arrangements, implementing significant cost reductions as described above in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and slowing planned capital expenditures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a cross-functional strategic cash management team to take appropriate actions to ensure we continue to optimize funds in the near and long-term to execute our core mission. To address the temporary adverse impacts of COVID-19 on our business, we have taken steps to manage outstanding borrowings and increase available liquidity. In May 2020, we completed an offering </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $1.700 billion in aggregate principal amount of senior notes and used the net proceeds to prepay $1.250 billion of amounts outstanding under our February 2021 and April 2021 Term Loan and pay related fees, expenses and premiums, as well as to refinance $450 million of amounts outstanding under our Revolving Credit Facility. We now have full access to the $2.750 billion of available liquidity under our Revolving Credit Facility. In May 2020, we also completed public equity offerings of preferred stock and common stock, as discussed below, and used a portion of the combined net proceeds to repay in full the remaining amounts outstanding under the April 2021 Term Loan. During the third quarter of 2020, we made a further prepayment of the remaining $250 million outstanding under our February 2021 Term Loan and terminated the facility. For additional details related to our debt obligations, including our financial covenant requirement, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current business plan, we believe our existing balance of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, future cash generated from operations, access to capital markets and existing credit facilities will be sufficient to fund our operations, invest in our infrastructure, pay our legal-related liabilities, pay taxes due and service and repay our existing debt for the next 12 months.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Covenant</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through September&#160;30, 2020, we were in compliance with the financial covenant required by all existing credit facilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) establish a deemed Consolidated EBITDA of $671 million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of 4.75 times through the remainder of 2020, with a step-down for each succeeding fiscal quarter end to 4.50 times, 4.25 times, 4.00 times and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 Revolving Credit Facility and February 2021 Term Loan amendments, the definition of &#8220;Material Adverse Effect&#8221; has been amended to remove the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020. We believe that we have the ability to comply with the amended covenant requirement for the next 12 months. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our acquisitions involve the payment of contingent consideration. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for further details regarding the estimated potential amount of future contingent consideration we could be required to pay associated with our acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we are optimizing operational output and continuing to work with suppliers to renegotiate open purchase obligations. As we execute these plans, there may be reductions to our future minimum purchase obligations and commitments as reported in our most recent Annual Report filed on Form 10-K. These purchase obligations relate primarily to non-cancellable raw material supply commitments and capital expenditures entered in the normal course of business. In addition, recent transactions within our debt portfolio may result in changes to our interest payment schedule and amounts within.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other material changes to our contractual obligations and commitments as reported in our most recent Annual Report filed on Form 10-K, with the exception of our debt obligations discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item 1 of this Quarterly Report on Form 10-Q. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. On May 27, 2020, we also completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses. We used a portion of the net proceeds to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements contained in Item 1 of this Quarterly Report on Form 10-Q. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions and investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received $107 million in the first nine months of 2020 and $113 million in the first nine months of 2019 in proceeds from stock issuances related to our stock option and employee stock purchase plans. Proceeds from the exercise of employee stock options and employee stock purchases vary from period to period based upon, among other factors, fluctuations in the trading price of our common stock and in the exercise and stock purchase patterns of our employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock in the first nine months of 2020 or 2019. As of September&#160;30, 2020, the remaining authorization to repurchase shares under our 2013 share repurchase program was $535 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our material legal proceedings see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note J &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements implemented since December&#160;31, 2019 is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and information regarding new accounting pronouncements to be implemented is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note N &#8211; New Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established controls and procedures to escalate enterprise level issues, including cybersecurity matters, to the appropriate management levels within our organization and our Board of Directors, or members or committees thereof, as appropriate. Under our framework, cybersecurity issues are analyzed by subject matter experts and a crisis committee for potential financial, operational, and reputational risks, based on, among other factors, the nature of the matter and breadth of impact. Matters determined to present potential material impacts to the Company&#8217;s financial results, operations, and/or reputation are immediately reported by management to the Board of Directors, or individual members or committees thereof, as appropriate, in accordance with our escalation framework. In addition, we have established procedures to ensure that management responsible for overseeing the effectiveness of disclosure controls is informed in a timely manner of known cybersecurity risks and incidents that may materially impact our operations and that timely public disclosure is made as appropriate.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Trading Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors and executive officers are subject to our Stock Trading Policy, which is designed to facilitate compliance with insider trading laws and governs transactions in our common stock and related derivative securities. Our policy designates certain regular periods, dictated by release of financial results, in which trading is restricted for individuals in information-sensitive positions, including directors and executive officers. In addition, additional periods of trading restriction may be imposed as determined by the President, General Counsel, or Chief Financial Officer in light of material pending developments. Further, during permitted windows, individuals in information-sensitive positions are required to seek pre-clearance for trades from the General Counsel, who assesses whether there are any important pending developments, including cybersecurity matters, which need to be made public before the individual may participate in the market.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Periodically, certain of our executive officers adopt written stock trading plans in accordance with Rule 10b5-1 under the Exchange Act and our own Stock Trading Policy. A Rule 10b5-1 Trading Plan is a written document that pre-establishes the amount, prices and dates (or formulas for determining the amounts, prices and dates) of future purchases or sales of our stock, including shares issued upon exercise of stock options or vesting of deferred stock units. These plans are entered into at a time when the person is not in possession of material non-public information about our Company. We disclose details regarding individual Rule 10b5-1 Trading Plans by our executive officers on the Investor Relations section of our website, under the Governance Overview section.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our unaudited condensed consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share (EPS) that exclude certain amounts and operational net sales growth that exclude the impact of foreign currency fluctuations. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To calculate adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share we exclude certain charges (credits) from GAAP net income and GAAP net income available to common stockholders. Amounts are presented after-tax using our effective tax rate, unless the amount is a significant unusual or infrequently occurring item in accordance with FASB ASC section 740-270-30, "General Methodology and Use of Estimated Annual Effective Tax Rate." Please refer to Part II, Item 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our most recent Annual Report filed on Form 10-K filed with the Securities and Exchange Commission (SEC) for an explanation of each of these adjustments and the reasons for excluding each item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GAAP financial measures most directly comparable to adjusted net income (loss), adjusted net income (loss) available to common stockholders and adjusted net income (loss) per share are GAAP net income (loss), GAAP net income (loss) available to common stockholders and GAAP net income (loss) per common share - assuming dilution, respectively. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior period. The GAAP financial measure most directly comparable to operational growth rate percentages is growth rate percentages using net sales on a GAAP basis. </span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the relevant sections of this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales and profit or loss. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that presenting adjusted net income (loss), adjusted net income (loss) available to common stockholders, adjusted net income (loss) per share that exclude certain amounts and operational net sales growth that exclude the impact of changes in foreign currency exchange rates, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision-making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safe Harbor for Forward-Looking Statements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we may make from time to time, including statements contained in this Quarterly Report on Form 10-Q and information incorporated by reference herein, constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by words like &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;aiming&#8221; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The forward-looking statements in this Quarterly Report on Form 10-Q are based on certain risks and uncertainties, including the risk factors described in Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our most recent Annual Report on Form 10-K and the specific risk factors discussed herein and in connection with forward-looking statements throughout this Quarterly Report on Form 10-Q, which could cause actual results to vary materially from the expectations and projections expressed or implied by our forward-looking statements. These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this Quarterly Report.&#160;As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. Risks and uncertainties that may cause such differences include, among other things: the impact of the COVID-19 pandemic on our operations and financial results, future U.S. and global economic, political, competitive, reimbursement and regulatory conditions, new product introductions and the market acceptance of those products, markets for our products, expected pricing environment, expected procedural volumes, the closing and integration of acquisitions, clinical trial results, demographic trends, intellectual property rights, litigation, financial market conditions, the execution and effect of our restructuring program, the execution and effect of our business strategy, including our cost-savings and growth initiatives and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict, including those that have emerged or have increased in significance or likelihood as a result of COVID-19.&#160;All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our most recent Annual Report on Form 10-K filed with the SEC, which we may update in Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;in subsequent Quarterly Reports on Form 10-Q that we will file hereafter, and Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;in this Quarterly Report on Form 10-Q.&#160;We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.&#160;This cautionary statement is applicable to all forward-looking statements contained in this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the important risk factors that could cause our actual results to differ materially from our expectations in any forward-looking statements. For further discussion of these and other risk factors, see Part I, Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K and Part II, Item 1A.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in this Quarterly Report on Form 10-Q. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Businesses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic on the U.S. and global economies and financial markets,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic upon the scheduling of elective and semi-emergent procedures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of natural disasters, public health crises, including the COVID-19 pandemic, and other catastrophic events,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of COVID-19 on our global manufacturing and distribution system including the quality of our products,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to recover and increase net sales, expand the market, capture market share and adapt to market volatility,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competitive offerings and related declines in average selling prices for our products,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing impact on our business of physician alignment to hospitals, governmental investigations and audits of hospitals and other market and economic conditions on the overall number of procedures performed,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The performance of, and physician and patient confidence in, our products and technologies or those of our competitors,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact and outcome of ongoing and future clinical trials and market studies undertaken by us, our competitors or other third parties or perceived product performance of our or our competitors' products,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Variations in clinical results, reliability or product performance of our and our competitors' products, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to acquire or develop, launch and supply new or next-generation products and technologies worldwide and in line with our commercialization strategies in a timely and successful manner and with respect to our recent acquisitions,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of consolidation and competition in the markets in which we do business or plan to do business,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption in the manufacture or supply of certain components, materials or products, or the failure to secure in a timely manner alternative manufacturing or additional or replacement components, materials or products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">Our ability to achieve our projected level or mix of product sales, as some of our products are more profitable than others,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to retain and attract key personnel, including those associated with recent acquisitions,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The inability of certain of our employees to return to work full time following reduced work schedules, or our inability to recruit personnel into direct labor roles,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain regulatory approval in the U.S. and around the world, including EU MDR and the associated timing and cost of product approval, and</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased pressure on the availability and rate of third-party reimbursement for our products and procedures in the U.S. and around the world, including with respect to the timing and costs of creating and expanding markets for new products and technologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Compliance, Litigation and Data Protection</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of healthcare policy changes and legislative or regulatory efforts in the U.S., the EU and around the world to modify product approval or reimbursement processes, including a trend toward demonstrating clinical outcomes, comparative effectiveness and cost efficiency, as well as the impact of other healthcare reform legislation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with our regulatory compliance and quality systems and activities in the U.S., the EU and around the world, including meeting regulatory standards applicable to manufacturing and quality processes,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to minimize or avoid future field actions or FDA warning letters relating to our products and processes and the ongoing inherent risk of potential physician advisories related to our or our competitors' products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of increased scrutiny of and heightened global regulatory enforcement facing the medical device industry arising from political and regulatory changes, economic pressures or otherwise, including under U.S. Anti-Kickback Statute, U.S. False Claims Act and similar laws in other jurisdictions, U.S. Foreign Corrupt Practices Act (FCPA) and similar laws in other jurisdictions, and U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with current and future asserted litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of our litigation and risk management practices, including self-insurance and compliance activities on our loss contingencies, legal provision and cash flows,</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of, diversion of management attention as a result of, and costs to cooperate with, litigate and/or resolve governmental investigations and our class action, product liability, contract and other legal proceedings,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of failure to protect our intellectual property rights and the outcome of patent litigation,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to operate properly our information systems that support our business operations and protect our data integrity and products from a cyber-attack or other breach that has a material adverse effect on our business, reputation or results of operations, and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovation and Certain Growth Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing, size and nature of our strategic growth initiatives and market opportunities, including with respect to our internal research and development platforms and externally available research and development platforms and technologies and the ultimate cost and success of those initiatives and opportunities,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to complete planned clinical trials successfully, obtain regulatory approvals and launch new and next generation products in a timely manner consistent with cost estimates, including the successful completion of projects from in-process research and development,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to identify and prioritize our internal research and development project portfolio and our external investment portfolio on profitable net sales growth opportunities as well as to maintain the estimated timing and costs of such projects and expected revenue levels for the resulting products and technologies,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop, manufacture and market new products and technologies successfully and in a timely manner and the ability of our competitors and other third parties to develop products or technologies that render our products or technologies noncompetitive or obsolete, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute appropriate decisions to discontinue, write-down or reduce the funding of any of our research and development projects, including projects from in-process research and development from our acquisitions, in our growth adjacencies or otherwise,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on acquisitions, alliances or investments to introduce new products or technologies and to enter new or adjacent growth markets and our ability to fund them or to fund contingent payments with respect to those acquisitions, alliances and investments, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential failure to successfully integrate and realize the expected benefits, including cost synergies, from the strategic acquisitions, alliances and investments we have consummated or may consummate in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Markets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependency on international net sales to achieve growth, including in emerging markets,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The timing and collectability of customer payments, as well as our ability to continue factoring customer receivables where we have factoring arrangements, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact on pricing due to national tenders,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geopolitical and economic conditions, including civil unrest, terrorist activity, governmental changes, restrictions on the ability to transfer capital across borders, tariffs and other protectionist measures,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">The United Kingdom&#8217;s departure from the European Union,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Protection of our intellectual property, </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including FCPA, MDR, and similar laws in other jurisdictions,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with U.S. and foreign export control, trade embargo and customs laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in reimbursement practices and policies,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of significant developments or uncertainties stemming from the U.S. administration and the November 3, 2020 presidential and congressional elections, including changes in U.S. trade policies, tariffs and the reaction of other countries thereto, particularly China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to maintain or expand our worldwide market positions in the various markets in which we compete or seek to compete, including through investments in product diversification and emerging markets such as Brazil, Russia, India and China,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging markets, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses and resulting margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to generate sufficient cash flow to fund operations, capital expenditures, global expansion initiatives, any litigation settlements and judgments, share repurchases and strategic investments and acquisitions as well as maintaining our investment grade ratings and managing our debt levels and financial covenant compliance, particularly in light of the COVID-19 pandemic and lower demand for our products,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to access the public and private capital markets when desired and to issue debt or equity securities on terms reasonably acceptable to us,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The unfavorable resolution of open tax matters, exposure to additional tax liabilities and the impact of changes in U.S. and international tax laws,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of examinations and assessments by domestic and international taxing authorities on our tax provision, financial condition or results of operations,</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:14.5pt">The issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The possibility of counterparty default on our derivative financial instruments,</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of potential intangible asset impairment charges, including on our results of operations, and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to collect outstanding and future receivables and/or sell receivables under our factoring programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost Reduction and Optimization Initiatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risks associated with changes made or expected to be made to our organizational and operational structure, pursuant to our restructuring plans as well as any further restructuring or optimization plans we may undertake in the future and our ability to recognize benefits and cost reductions from such programs and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business disruption and employee distraction as we execute our global compliance program, restructuring and optimization plans and divestitures of assets or businesses and implement our other strategic and cost reduction initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture and sell medical devices globally and our earnings and cash flows are exposed to market risk from changes in currency exchange rates and interest rates. We address these risks through a risk management program that includes the use of derivative financial instruments. We operate the program pursuant to documented corporate risk management policies. We do not enter derivative transactions for speculative purposes. Gains and losses on derivative financial instruments substantially offset losses and gains on underlying hedged exposures. Furthermore, we manage our exposure to counterparty risk on derivative instruments by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our currency risk consists primarily of foreign currency denominated firm commitments, forecasted foreign currency denominated intercompany and third-party transactions and net investments in certain subsidiaries. We use both nonderivative (primarily European manufacturing operations) and derivative instruments to manage our earnings and cash flow exposure to changes in currency exchange rates. We had currency derivative instruments outstanding in the contract amount of $9.392 billion as of September&#160;30, 2020 and $9.221 billion as of December&#160;31, 2019. A ten percent appreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would increase the derivative instruments&#8217; fair value by $338 million as of September&#160;30, 2020 as compared to $337 million as of December&#160;31, 2019. A ten percent depreciation in the U.S. dollar&#8217;s value relative to the hedged currencies would decrease the derivative instruments&#8217; fair value by $414 million as of September&#160;30, 2020 as compared to $412 million as of December&#160;31, 2019. Any increase or decrease in the fair value of our currency exchange rate sensitive derivative instruments would be substantially offset by a corresponding decrease or increase in the fair value of the hedged underlying asset, liability or forecasted transaction, resulting in minimal impacts on our unaudited condensed consolidated statements of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We have historically used interest rate derivative instruments to manage our earnings and cash flow exposure to changes in interest rates. We had no interest rate derivative instruments outstanding as of September&#160;30, 2020 and December&#160;31, 2019. As of September&#160;30, 2020, $9.404 billion in aggregate principal amount of our outstanding debt obligations were at fixed interest rates, representing approximately 100 percent of our total debt, on an amortized cost basis. As of September&#160;30, 2020, our outstanding debt obligations at fixed interest rates were comprised of senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q for further information regarding our derivative financial instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:35.36pt">CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (CEO) and our Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of September&#160;30, 2020 pursuant to Rule&#160;13a-15(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Disclosure controls and procedures are designed to ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, our CEO and CFO concluded that, as of September&#160;30, 2020, our disclosure controls and procedures were effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no changes in our internal control over financial reporting in the three-month period ended September&#160;30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. While there are a number of business risks that have emerged associated with COVID-19 (Refer to Risk Factors contained in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Part I. Item 1A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of this Quarterly Report), we are continuing to monitor these risks and have implemented business continuity measures as described within Management&#8217;s Discussion and Analysis. Additionally, the Company has provided regular updates to the Board of Directors on risk mitigation strategies to ensure transparent decision making and appropriate Board oversight.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Further, while many of our employees worked remotely to adhere to COVID-19 social distancing requirements, this did not affect our ability to maintain financial reporting systems, internal controls over financial reporting or disclosure controls and procedures. Prior to the COVID-19 pandemic, we were leveraging electronic tools to facilitate our global close process and to connect our physically dispersed team of finance professionals in offices around the world. While the quarterly close cycles were performed remotely, fundamentally, the work performed, and the processes and controls executed did not change. As we approach year-end, we are evaluating the potential impact, if any, to internal control over financial reporting relating to potential restrictions to access to consigned inventory at customer locations for our inventory count procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_172"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note G &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements contained in Item&#160;1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_175"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the information set forth below and other information contained elsewhere in this report, you should carefully consider the factors discussed in Part&#160;I, Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report filed on Form 10-K, which could materially affect our business, financial condition or future results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing global COVID-19 pandemic and related impacts are having a material adverse effect on our operations, financial performance and cash flows. We are unable to predict the extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position and the achievement of our strategic objectives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our operations, financial performance and cash flows have been negatively impacted by the ongoing COVID-19 pandemic that has caused, and is expected to continue to cause, the global slowdown of economic activity (including the decrease in demand for a broad variety of goods and services), disruptions in global supply chains and significant volatility, disruption of financial markets, a U.S. economic recession and, potentially, a global economic recession. Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing, and difficult to predict, the pandemic&#8217;s impact on our operations and financial performance, as well as its impact on our ability to execute our business strategies and initiatives successfully, remains uncertain and difficult to predict. Further, the ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business and individuals&#8217; actions that have been and continue to be taken in response to the pandemic (including restrictions on travel, transport and workforce pressures, and voluntary or mandated deferrals or postponements of elective procedures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; and the timing and pace of recovery when the COVID-19 pandemic subsides, which could be impacted by a number of factors, including limited provider capacity to perform procedures using our products that were deferred as a result of the pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has subjected, and is expected to continue to subject, our operations, financial performance and financial condition to a number of risks, including, but not limited to those discussed below:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Operations-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: Across all of our businesses, we are facing increased operational challenges from the need to protect employee health and safety. Some of these challenges include site shutdowns, workplace disruptions and restrictions on the movement of people, raw materials and goods, both at our own facilities and at customers and suppliers. We are also experiencing, and expect to continue experiencing, lower demand and volume for certain products and services, customer requests for potential payment deferrals or other contract modifications, delays of deliveries and other factors related directly and indirectly to the COVID-19 pandemic that adversely impact our businesses. We expect that the longer the period of economic and global supply chain and disruption continues, the more material the cumulative adverse impact will be on our business operations, financial performance and results of operations. Our ability to manufacture our products is highly dependent on our ability to maintain the safety and health of our employees. The ability of our employees to work may be significantly impacted by one or more employee contracting or being exposed to COVID-19. Additionally, when the economic recovery following the COVID-19 pandemic occurs, we may experience unpredictable increases in demand for certain of our products, which could exceed our capacity to meet such demand on a timely basis or at all, which could have a material adverse impact on our business operations, financial performance and results of operations.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Customer-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: In particular, as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments are taking to quell the spread of COVID-19 and protect our customers, employees, and the patients receiving our products, we have experienced significant and unpredictable reductions in demand for certain of our products as health care customers re-prioritize the treatment of patients. For example, in the United States in mid-March, governmental authorities began recommending, and in certain cases required, that elective procedures be suspended or canceled to avoid non-essential patient exposure to medical environments and potential </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">infection with COVID-19 and to focus limited resources and personnel capacity toward the treatment of COVID-19. These measures and challenges significantly reduced our net sales in the second and third quarters and the situation remains challenging. In certain jurisdictions, however, the timing of the pandemic and public health measures have resulted in lower levels of COVID-19 cases and some hospitals have developed protocols such that elective procedures may be conducted safely and are approaching pre-COVID-19 pandemic levels. Further, once the pandemic subsides, we anticipate there may be some continued reluctance upon the part of some patients to seek medical attention in a hospital setting.&#160;In addition, for the majority of patients who do seek appointments with physicians and surgeries to be performed at hospitals and ambulatory surgery centers relating to a variety of medical conditions, we anticipate there may be a substantial backlog. As a result, patients seeking to schedule or reschedule elective or deferrable procedures utilizing our products may have to navigate potentially limited healthcare provider capacity. We believe this likely patient reluctance and potential healthcare provider capacity could have an adverse effect on our sales following the end of the pandemic. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Employee-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In an attempt to proactively address the changed business environment caused by COVID-19, in order to preserve employees&#8217; jobs and ensure we are able to quickly respond to increased customer demand, when deferrable procedures resume as permitted by development or conclusion of the pandemic, we made temporary work hour reductions, and corresponding salary reductions, where appropriate, for many of our employees. However, because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing, and difficult to predict, we may, in the future, have to consider taking additional actions including further reductions to salary and work hours, furloughs, restructuring, layoffs or extensions of remote work arrangements, which may negatively impact our workforce and our business. These negative impacts could include inhibiting our ability to quickly respond to increased customer demand and to take advantage of more favorable economic and market conditions after the pandemic subsides as well as lower productivity and higher employee attrition.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting-related risks: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally accepted accounting principles and the related authoritative guidance are complex and involve subjective judgments.&#160;In particular, the accounting for revenue, inventory, goodwill, intangible assets, income taxes and other assets and liabilities requires reliance on forward looking estimates of sales and/or earnings.&#160;Due to the uncertainty surrounding the COVID-19 pandemic, estimating the future performance of our business is extremely challenging and the range of deviation from internal estimates could be more significant in this environment. Changes in the underlying estimates, assumptions or judgments could have a material adverse impact on our future results of operations, financial position and cash flows.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Leverage- and market-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The current financial market dynamics and volatility pose heightened risks to our previously announced timelines for decreasing our leverage, which we expect to be delayed as we seek to maintain appropriate liquidity to compensate for lower cash flows from operations or as variables impacting our leverage ratios fluctuate with extreme market volatility. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.5pt">Liquidity- and funding-related risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">: While we have significant sources of cash and liquidity and access to committed credit lines, a prolonged period of generating lower cash from operations could adversely affect our financial condition and the achievement of our strategic objectives. Additionally, there can also be no assurance that we will not face credit rating downgrades as a result of weaker than anticipated performance of our businesses, slower progress in decreasing our leverage or other factors. Future downgrades could further adversely affect our cost of funds and related margins, liquidity, competitive position and access to capital markets, and a significant downgrade could have an adverse commercial impact on our business. Conditions in the financial and credit markets may also limit the availability of funding or increase the cost of funding (including for receivables monetization or supply chain finance programs, as well as increased borrowing costs and higher interest rates), which could adversely affect our business, financial position and results of operations. Although the U.S. federal and other governments have instituted and/or announced a number of funding programs to support businesses, our ability or willingness to access funding under such programs may be limited by regulations or other guidance, or by further change or uncertainty related to the terms of these programs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic continues to adversely affect our operating and financial results, it may also have the effect of heightening many of the other risks described in the risk factors in our Annual Report on Form 10-K for the year ended December 31, 2019. Further, the COVID-19 pandemic may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our operations or financial results, particularly if the COVID-19 pandemic and its associated impacts reoccur in successive waves in the coming months.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_181"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (* documents filed or furnished with this report, # compensatory plans or arrangements) </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302q32020.htm">Certification of the Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302q32020.htm">Certification of the Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906q32020.htm">Certification of the Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906q32020.htm">Certification of the Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i8a2e73a0c2ae455a8a5a335cd6209152_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8a2e73a0c2ae455a8a5a335cd6209152_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on November&#160;5, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and<br/>Chief Financial Officer&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-ceo302q32020.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i3488a9590c8547cfbc980ed430858e5c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael F. Mahoney, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 5, 2020</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-cfo302q32020.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ie06955b138ec4f5e831a415f7c8a5394_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel J. Brennan, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:2.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 5, 2020</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-ceo906q32020.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia60895cbab624a67bec0bdc5e05df3ce_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended September&#160;30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael F. Mahoney</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael F. Mahoney</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 5, 2020</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-cfo906q32020.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i4599f3612ea34f3791a55186507cd667_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Boston Scientific Corporation (the &#8220;Company&#8221;) for the period ended September&#160;30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:6.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification shall not be deemed &#34;filed&#34; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934 regardless of any general incorporation language in such filing.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:4.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel J. Brennan</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Brennan</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 5, 2020</font></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bsx-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:5aff39ba-e31d-4daa-a93a-6fdd4a47e66b,g:1fac046f-4056-4f94-9a0f-fce45535a3a4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0001001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statement of Cash Flows (Supplemental Disclosure)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.bostonscientific.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationBasisofPresentationPolicies" roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationASUsImplementedDetails" roleURI="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails">
        <link:definition>2403401 - Disclosure - Basis of Presentation ASUs Implemented (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationMaterialSubsequentEventDetails" roleURI="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails">
        <link:definition>2404402 - Disclosure - Basis of Presentation Material Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestments" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments">
        <link:definition>2105102 - Disclosure - Acquisitions and Strategic Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandStrategicInvestmentsTables" roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables">
        <link:definition>2306301 - Disclosure - Acquisitions and Strategic Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsDetails" roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails">
        <link:definition>2407403 - Disclosure - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationDetails" roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails">
        <link:definition>2408404 - Disclosure - Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicInvestmentsDetails" roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails">
        <link:definition>2409405 - Disclosure - Strategic Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2110103 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillPolicies" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies">
        <link:definition>2211202 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillTables" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables">
        <link:definition>2312302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsDetails" roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails">
        <link:definition>2413406 - Disclosure - Goodwill and Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurements" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements">
        <link:definition>2114104 - Disclosure - Hedging Activities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies">
        <link:definition>2215203 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsTables" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables">
        <link:definition>2316303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesandFairValueMeasurementsDetails" roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails">
        <link:definition>2417407 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitments" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments">
        <link:definition>2118105 - Disclosure - Contractual Obligations and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsTables" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables">
        <link:definition>2319304 - Disclosure - Contractual Obligations and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualObligationsandCommitmentsDetails" roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails">
        <link:definition>2420408 - Disclosure - Contractual Obligations and Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformation" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation">
        <link:definition>2121106 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationTables" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables">
        <link:definition>2322305 - Disclosure - Supplemental Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalBalanceSheetInformationDetails" roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails">
        <link:definition>2423409 - Disclosure - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.bostonscientific.com/role/IncomeTaxes">
        <link:definition>2124107 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables">
        <link:definition>2325306 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails">
        <link:definition>2426410 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies">
        <link:definition>2127108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesCommitmentsandContingenciesPolicies" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies">
        <link:definition>2228204 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2429411 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.bostonscientific.com/role/StockholdersEquity">
        <link:definition>2130109 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails">
        <link:definition>2431412 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstanding" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding">
        <link:definition>2132110 - Disclosure - Weighted Average Shares Outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingTables" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables">
        <link:definition>2333307 - Disclosure - Weighted Average Shares Outstanding (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WeightedAverageSharesOutstandingDetails" roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails">
        <link:definition>2434413 - Disclosure - Weighted Average Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.bostonscientific.com/role/SegmentReporting">
        <link:definition>2135111 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.bostonscientific.com/role/SegmentReportingTables">
        <link:definition>2336308 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails">
        <link:definition>2437414 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.bostonscientific.com/role/Revenue">
        <link:definition>2138112 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.bostonscientific.com/role/RevenueTables">
        <link:definition>2339309 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.bostonscientific.com/role/RevenueDetails">
        <link:definition>2440415 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncome" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome">
        <link:definition>2141113 - Disclosure - Changes in Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies">
        <link:definition>2242205 - Disclosure - Changes in Other Comprehensive Income Changes in Other Comprehensive Income (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeTables" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables">
        <link:definition>2343310 - Disclosure - Changes in Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ChangesinOtherComprehensiveIncomeDetails" roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails">
        <link:definition>2444416 - Disclosure - Changes in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements">
        <link:definition>2145114 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2246206 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductCanada" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_OperatingleaseLiabilityDomain" abstract="true" name="OperatingleaseLiabilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" abstract="false" name="ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfourthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_PaymentOfContingentConsideration" abstract="false" name="PaymentOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Noncashimpactoftransferredroyaltyrights" abstract="false" name="Noncashimpactoftransferredroyaltyrights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" abstract="false" name="ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EquipmentFurnitureAndFixturesGross" abstract="false" name="EquipmentFurnitureAndFixturesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_March2039NotesMember" abstract="true" name="March2039NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2026NotesMember" abstract="true" name="March2026NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Requirementextensionthroughtheremainderof2020Member" abstract="true" name="Requirementextensionthroughtheremainderof2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_June2030NotesMember" abstract="true" name="June2030NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalNeuromodulationNmReportingUnitMember" abstract="true" name="GlobalNeuromodulationNmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EmergingMarketstotalnumberofcountries" abstract="false" name="EmergingMarketstotalnumberofcountries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_May2020NotesMember" abstract="true" name="May2020NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" abstract="false" name="Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_AllegedBreachofPurchaseAgreementAmount" abstract="false" name="AllegedBreachofPurchaseAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Licensingarrangementsliability" abstract="false" name="Licensingarrangementsliability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CertifiedclassactionsinCanadaMesh" abstract="false" name="CertifiedclassactionsinCanadaMesh" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_CurrentRequirementMember" abstract="true" name="CurrentRequirementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ActualCovenantMember" abstract="true" name="ActualCovenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CorporateExpensesincludinghedgingactivitiesMember" abstract="true" name="CorporateExpensesincludinghedgingactivitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_February2019AggregateOfferingMember" abstract="true" name="February2019AggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_WeightedAverageMaturityDays" abstract="false" name="WeightedAverageMaturityDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="us-types:durationStringItemType"/>
  <xs:element id="bsx_NotionalValueofOutstandingNetInvestmentHedges" abstract="false" name="NotionalValueofOutstandingNetInvestmentHedges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" abstract="true" name="CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationAbstract" abstract="true" name="SupplementalBalanceSheetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" abstract="true" name="CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_GlobalCrmReportingUnitMember" abstract="true" name="GlobalCrmReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_January2040NotesMember" abstract="true" name="January2040NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationLiabilityProbabilityOfPayment" abstract="false" name="ContingentConsiderationLiabilityProbabilityOfPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_ForeigncurrencydenominatedindebtMember" abstract="true" name="ForeigncurrencydenominatedindebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalPeripheralInterventionsPiReportingUnitMember" abstract="true" name="GlobalPeripheralInterventionsPiReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_August2022TermLoanMember" abstract="true" name="August2022TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LitigationAndDebtExclusionFromEbitda" abstract="false" name="LitigationAndDebtExclusionFromEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_GlobalEndoscopyEndoReportingUnitMember" abstract="true" name="GlobalEndoscopyEndoReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Paymenttonetsharesettleemployeeequityawards" abstract="false" name="Paymenttonetsharesettleemployeeequityawards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" abstract="false" name="LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_August2019TermLoanMember" abstract="true" name="August2019TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" abstract="false" name="SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_DeferredTaxLiabilitiesNetNoncurrent" abstract="false" name="DeferredTaxLiabilitiesNetNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_May2022NotesMember" abstract="true" name="May2022NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_RhythmandNeuroMember" abstract="true" name="RhythmandNeuroMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_MaximumContingentPaymentMember" abstract="true" name="MaximumContingentPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201613PolicyTextBlock" abstract="false" name="ASCUpdateNo.201613PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_GlobalUrologyandPelvicHealthReportingUnitMember" abstract="true" name="GlobalUrologyandPelvicHealthReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Netcurrencyexchangegainloss" abstract="false" name="Netcurrencyexchangegainloss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_IntangibleAssetsDomain" abstract="true" name="IntangibleAssetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_December2027NotesMember" abstract="true" name="December2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_UpfrontCashMember" abstract="true" name="UpfrontCashMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ExclusionFromEbitdaForRestructuringCharges" abstract="false" name="ExclusionFromEbitdaForRestructuringCharges" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LicensingarrangementassetsMember" abstract="true" name="LicensingarrangementassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" abstract="false" name="CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_EuroDenominatedFactoringArrangementsMember" abstract="true" name="EuroDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_November2019AggregateOfferingMember" abstract="true" name="November2019AggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" abstract="false" name="ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_BTGAcquisitionMember" abstract="true" name="BTGAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_EurodenominatedoutstandingdebtMember" abstract="true" name="EurodenominatedoutstandingdebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_BusinessAcquisitionContingentConsiderationCashPayment" abstract="false" name="BusinessAcquisitionContingentConsiderationCashPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Licensingarrangements" abstract="false" name="Licensingarrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_SupplementalBalanceSheetInformationTextualsAbstract" abstract="true" name="SupplementalBalanceSheetInformationTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_February2021TermLoanMember" abstract="true" name="February2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OperatingleaserightofuseassetAxis" abstract="true" name="OperatingleaserightofuseassetAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_MillipedeInc.Member" abstract="true" name="MillipedeInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AccruedRebatesCurrent" abstract="false" name="AccruedRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_The2018FacilityDomain" abstract="true" name="The2018FacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_MaximumCommercialPaperOutstanding" abstract="false" name="MaximumCommercialPaperOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_DeemedConsolidatedEBITDA" abstract="false" name="DeemedConsolidatedEBITDA" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationTable" abstract="true" name="ScheduleofIncomeTaxRateReconciliationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_May2020SNAggregateOfferingMember" abstract="true" name="May2020SNAggregateOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_November2035NotesMember" abstract="true" name="November2035NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ThreeYearDelayedDrawTermLoanMember" abstract="true" name="ThreeYearDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AssignedtoonejudgeinMAMember" abstract="true" name="AssignedtoonejudgeinMAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_StatementDomain" abstract="true" name="StatementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_October2023NotesMember" abstract="true" name="October2023NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ContingentConsiderationRecognizedInPeriod" abstract="false" name="ContingentConsiderationRecognizedInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_LitigationSettlementReceivedGain" abstract="false" name="LitigationSettlementReceivedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ForwardCurrencyContractsTimetoMaturity" abstract="false" name="ForwardCurrencyContractsTimetoMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_VertiflexIncMember" abstract="true" name="VertiflexIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" abstract="false" name="ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_ScheduleofIncomeTaxRateReconciliationLineItems" abstract="true" name="ScheduleofIncomeTaxRateReconciliationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CovenantAxis" abstract="true" name="CovenantAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementthirdquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" abstract="false" name="ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_Licensingarrangementsasset" abstract="false" name="Licensingarrangementsasset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StatementAxis" abstract="true" name="StatementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_MaximumLeverageRatio" abstract="false" name="MaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bsx_EntityAbstract" abstract="true" name="EntityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_IntangibleAssetsAxis" abstract="true" name="IntangibleAssetsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_April2021TermLoanMember" abstract="true" name="April2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2024NotesMember" abstract="true" name="March2024NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DiscountRateFairValueInput" abstract="false" name="DiscountRateFairValueInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_SpecialChargesMember" abstract="true" name="SpecialChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_GlobalInterventionalCardiologyIcReportingUnitMember" abstract="true" name="GlobalInterventionalCardiologyIcReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RDRegulatoryandCommercializationbasedMilestoneMember" abstract="true" name="RDRegulatoryandCommercializationbasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_BSXReportableSegmentsMember" abstract="true" name="BSXReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_May2025NotesMember" abstract="true" name="May2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" abstract="true" name="CondensedConsolidatedBalanceSheetParentheticalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" abstract="false" name="DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_SegmentOperatingIncomeasaPercentageofNetSales" abstract="false" name="SegmentOperatingIncomeasaPercentageofNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="bsx_OperatingleaseLiabilityAxis" abstract="true" name="OperatingleaseLiabilityAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ScheduleofIntangibleAssetsandGoodwillTable" abstract="true" name="ScheduleofIntangibleAssetsandGoodwillTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bsx_January2020NotesMember" abstract="true" name="January2020NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RenminbiDenominatedFactoringArrangementsMember" abstract="true" name="RenminbiDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementfifthquarterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" abstract="false" name="TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_A2020TermLoanMember" abstract="true" name="A2020TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" abstract="true" name="RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_SpecialtyPharmaceuticalsMember" abstract="true" name="SpecialtyPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_MedsurgMember" abstract="true" name="MedsurgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2028NotesMember" abstract="true" name="March2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TwoYearDelayedDrawTermLoanMember" abstract="true" name="TwoYearDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" abstract="false" name="ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_IntangibleAssetsandGoodwillLineItems" abstract="true" name="IntangibleAssetsandGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bsx_GlobalElectrophysiologyEpReportingUnitMember" abstract="true" name="GlobalElectrophysiologyEpReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OtherOtherLongtermAssets" abstract="false" name="OtherOtherLongtermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_OperatingIncomeAllocatedToReportableSegments" abstract="false" name="OperatingIncomeAllocatedToReportableSegments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_ASCUpdateNo.201818PolicyTextBlock" abstract="false" name="ASCUpdateNo.201818PolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="bsx_OperatingleaserightofuseassetDomain" abstract="true" name="OperatingleaserightofuseassetDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2029NotesMember" abstract="true" name="March2029NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_March2049NotesMember" abstract="true" name="March2049NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" abstract="true" name="AggregateSeniorUnsecuredDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_LicensingarrangementliabilitiesMember" abstract="true" name="LicensingarrangementliabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_TotalAllocatedToReportableSegmentsMember" abstract="true" name="TotalAllocatedToReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_OperatingIncomeUnallocatedToSegment" abstract="false" name="OperatingIncomeUnallocatedToSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_TheCARESAct" abstract="false" name="TheCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_A2019AcquisitionsVertiflexAndMillipedeMember" abstract="true" name="A2019AcquisitionsVertiflexAndMillipedeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" abstract="false" name="Productliabilitycasesorclaimsrelatedtomeshproduct" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bsx_LatinAmericaandCanadaMember" abstract="true" name="LatinAmericaandCanadaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" abstract="false" name="DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bsx_YenDenominatedFactoringArrangementsMember" abstract="true" name="YenDenominatedFactoringArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_CovenantDomain" abstract="true" name="CovenantDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bsx-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:5aff39ba-e31d-4daa-a93a-6fdd4a47e66b,g:1fac046f-4056-4f94-9a0f-fce45535a3a4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20200930.xsd#CoverDocument"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c1e89934-2155-4a6b-819a-d4764ff9b575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f5adafbc-6476-45a8-b2e3-c6a42a8f9b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c1e89934-2155-4a6b-819a-d4764ff9b575" xlink:to="loc_us-gaap_GrossProfit_f5adafbc-6476-45a8-b2e3-c6a42a8f9b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1c3bd536-75be-4a4a-8488-bdf6ced69e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c1e89934-2155-4a6b-819a-d4764ff9b575" xlink:to="loc_us-gaap_OperatingExpenses_1c3bd536-75be-4a4a-8488-bdf6ced69e86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_28b5f857-5c75-49fc-964d-c094af2d52e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_40e0135d-11f5-4c4c-9ca3-06486e63ff93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_28b5f857-5c75-49fc-964d-c094af2d52e2" xlink:to="loc_us-gaap_DividendsPreferredStockStock_40e0135d-11f5-4c4c-9ca3-06486e63ff93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3404ce4b-5110-43a6-aa0b-57b3dae1b589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_28b5f857-5c75-49fc-964d-c094af2d52e2" xlink:to="loc_us-gaap_ProfitLoss_3404ce4b-5110-43a6-aa0b-57b3dae1b589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fc47780-392f-4955-91e3-cc7db5dabd85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0926fe5f-d90e-4e07-953e-72db0b61b53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fc47780-392f-4955-91e3-cc7db5dabd85" xlink:to="loc_us-gaap_OperatingIncomeLoss_0926fe5f-d90e-4e07-953e-72db0b61b53b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3591adfb-f858-4bc5-bcc5-67cd8d398518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fc47780-392f-4955-91e3-cc7db5dabd85" xlink:to="loc_us-gaap_InterestExpense_3591adfb-f858-4bc5-bcc5-67cd8d398518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4ca21b48-3e99-44ca-804d-666b650e3319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5fc47780-392f-4955-91e3-cc7db5dabd85" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4ca21b48-3e99-44ca-804d-666b650e3319" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5ff3fcf7-6dad-419b-ba88-a7abcdbb0643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5ff3fcf7-6dad-419b-ba88-a7abcdbb0643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_c0ad99c7-2eb8-4c64-8e1e-b4d45e2828e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_c0ad99c7-2eb8-4c64-8e1e-b4d45e2828e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_d9d8da85-3a0c-4108-b0b5-ca05af8952c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_RoyaltyExpense_d9d8da85-3a0c-4108-b0b5-ca05af8952c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1afea43d-4605-4a79-9475-8ce4d7d4ac99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1afea43d-4605-4a79-9475-8ce4d7d4ac99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d4c5dbdd-ac26-458e-ae08-b52cffae5c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d4c5dbdd-ac26-458e-ae08-b52cffae5c27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5544c043-fb9f-4c99-b8ed-1069e358c5bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_RestructuringCharges_5544c043-fb9f-4c99-b8ed-1069e358c5bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_da1922d4-bb64-46f4-a746-e2c7991abb5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_da1922d4-bb64-46f4-a746-e2c7991abb5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_db2bd668-abdc-4ce9-a3f0-432c2aa51f10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c2681e59-7766-4e57-9cfd-4fb930e02a44" xlink:to="loc_us-gaap_LitigationSettlementExpense_db2bd668-abdc-4ce9-a3f0-432c2aa51f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bfa40e33-3a5c-48b7-baee-b07b6231d7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2d2db60-22cf-4764-b39b-0b6c1662deb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bfa40e33-3a5c-48b7-baee-b07b6231d7c4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2d2db60-22cf-4764-b39b-0b6c1662deb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_beb52c37-faca-42d5-8fb0-19e7a13da41c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_bfa40e33-3a5c-48b7-baee-b07b6231d7c4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_beb52c37-faca-42d5-8fb0-19e7a13da41c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cae46497-40c6-4f77-8729-6f5fc0ac1edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a717c7fd-134c-4180-b393-5e89c1a540c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_cae46497-40c6-4f77-8729-6f5fc0ac1edd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a717c7fd-134c-4180-b393-5e89c1a540c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d382bc0-3397-4856-981e-fbc25c4667c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_cae46497-40c6-4f77-8729-6f5fc0ac1edd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5d382bc0-3397-4856-981e-fbc25c4667c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b5145652-9144-46a2-9f46-46c900779c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f686d3f7-8298-4dab-a0b5-b97dde67ef9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b5145652-9144-46a2-9f46-46c900779c95" xlink:to="loc_us-gaap_ProfitLoss_f686d3f7-8298-4dab-a0b5-b97dde67ef9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0ed2b005-59ce-4605-9e1d-f38c3285fcb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b5145652-9144-46a2-9f46-46c900779c95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0ed2b005-59ce-4605-9e1d-f38c3285fcb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b9ff16f1-394f-4f8b-a100-94b2fa60e056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_747799cc-f411-49b8-ad81-e96abe5bd35e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b9ff16f1-394f-4f8b-a100-94b2fa60e056" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_747799cc-f411-49b8-ad81-e96abe5bd35e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1a451ac8-d1fa-4ad0-9f34-867dcd2fc049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b9ff16f1-394f-4f8b-a100-94b2fa60e056" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1a451ac8-d1fa-4ad0-9f34-867dcd2fc049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e60c56a8-e26d-48dc-9d07-de6d1a247689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b9ff16f1-394f-4f8b-a100-94b2fa60e056" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e60c56a8-e26d-48dc-9d07-de6d1a247689" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_32344a66-7f08-4166-88be-76f221b13a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:to="loc_us-gaap_LiabilitiesCurrent_32344a66-7f08-4166-88be-76f221b13a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_bfe5f61a-56a4-40ff-a8e9-7870f94fdba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_bfe5f61a-56a4-40ff-a8e9-7870f94fdba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent_0523e685-cbbf-4387-88d2-95d6e53b7114" xlink:href="bsx-20200930.xsd#bsx_DeferredTaxLiabilitiesNetNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:to="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent_0523e685-cbbf-4387-88d2-95d6e53b7114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cce415d5-54e3-4340-8a4b-125452c9f15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cce415d5-54e3-4340-8a4b-125452c9f15a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1ce6d499-fdca-40fa-bd13-15834f3ab8a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1ce6d499-fdca-40fa-bd13-15834f3ab8a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_00906c1a-9c26-485d-840b-a653ab4457f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f759e8e7-0867-4c2d-a3f0-2995abb7539d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_00906c1a-9c26-485d-840b-a653ab4457f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5ae42672-af63-4e07-83d5-b2479cfaa398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_39fff6b0-c684-4fd0-9194-f5ddf69bc778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5ae42672-af63-4e07-83d5-b2479cfaa398" xlink:to="loc_us-gaap_DebtCurrent_39fff6b0-c684-4fd0-9194-f5ddf69bc778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3bfcb338-810c-4868-af89-28948314e92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5ae42672-af63-4e07-83d5-b2479cfaa398" xlink:to="loc_us-gaap_AccountsPayableCurrent_3bfcb338-810c-4868-af89-28948314e92f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6cb6f4fb-a293-41cb-98a8-ad03e679fbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5ae42672-af63-4e07-83d5-b2479cfaa398" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6cb6f4fb-a293-41cb-98a8-ad03e679fbfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1bc2caeb-f80e-4a17-bcad-b9d9dde9f5c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5ae42672-af63-4e07-83d5-b2479cfaa398" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1bc2caeb-f80e-4a17-bcad-b9d9dde9f5c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5a7f6b8c-63dc-4499-811e-afeb0e450bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:to="loc_us-gaap_PreferredStockValue_5a7f6b8c-63dc-4499-811e-afeb0e450bdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f9e08c16-84ea-4395-86a3-a7a1b136acd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:to="loc_us-gaap_CommonStockValue_f9e08c16-84ea-4395-86a3-a7a1b136acd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_82305aae-539b-4ea7-92f5-b8426e716db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:to="loc_us-gaap_TreasuryStockValue_82305aae-539b-4ea7-92f5-b8426e716db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_15e41c51-05e2-4622-840b-217ab6c12818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_15e41c51-05e2-4622-840b-217ab6c12818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9c2c39de-2ac7-42f8-a715-87cbb9c1ebc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9c2c39de-2ac7-42f8-a715-87cbb9c1ebc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ae81e411-5c2b-43f4-b890-28ca5a69f901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd4b0ccc-c9dc-40c0-87fd-0c6ed3f5433e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ae81e411-5c2b-43f4-b890-28ca5a69f901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_82a7e5dc-b99a-4734-97c7-02a2a2f0ff64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ccf778dc-1a75-4d2f-b063-474f48662d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82a7e5dc-b99a-4734-97c7-02a2a2f0ff64" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ccf778dc-1a75-4d2f-b063-474f48662d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3ead6e0a-89a0-4659-a986-e843917171aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82a7e5dc-b99a-4734-97c7-02a2a2f0ff64" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3ead6e0a-89a0-4659-a986-e843917171aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_38414b8b-15d1-4901-aa76-112f87b2c454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82a7e5dc-b99a-4734-97c7-02a2a2f0ff64" xlink:to="loc_us-gaap_InventoryNet_38414b8b-15d1-4901-aa76-112f87b2c454" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_cef547e5-ac24-40cb-b311-dd147b881df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82a7e5dc-b99a-4734-97c7-02a2a2f0ff64" xlink:to="loc_us-gaap_PrepaidTaxes_cef547e5-ac24-40cb-b311-dd147b881df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1346e0d-cbcb-4a97-8c06-bbec809db882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82a7e5dc-b99a-4734-97c7-02a2a2f0ff64" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f1346e0d-cbcb-4a97-8c06-bbec809db882" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d133989e-b602-4d26-bbb1-09735b30f287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:to="loc_us-gaap_AssetsCurrent_d133989e-b602-4d26-bbb1-09735b30f287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_844f50d5-74fc-40ce-bdc9-e216fc1e8314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_844f50d5-74fc-40ce-bdc9-e216fc1e8314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8dcaad7f-1d08-47f0-a3c9-9fd2600e4fac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:to="loc_us-gaap_Goodwill_8dcaad7f-1d08-47f0-a3c9-9fd2600e4fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0e73b8e-6a18-482e-8c1a-3ff4b60b3b76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0e73b8e-6a18-482e-8c1a-3ff4b60b3b76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_21cbaf8f-fcb1-408b-99d5-68f8729d07fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_21cbaf8f-fcb1-408b-99d5-68f8729d07fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1da10ec5-773a-4680-90d7-f933eca8d835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_194fb547-f816-4d1b-a639-ed75a5220f1c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1da10ec5-773a-4680-90d7-f933eca8d835" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_069ea442-8175-4b17-8923-260351e0b2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_069ea442-8175-4b17-8923-260351e0b2f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b2574df2-bb26-4860-97e1-a644f9dda76f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_b2574df2-bb26-4860-97e1-a644f9dda76f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7ebe817a-5f94-4305-81e3-bec6b1a921ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7ebe817a-5f94-4305-81e3-bec6b1a921ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c31a6180-4249-43a4-a688-9c2d9d0ca5c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c31a6180-4249-43a4-a688-9c2d9d0ca5c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_a5b34b5c-b261-4feb-9c7c-c5b8fd45ce7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_a5b34b5c-b261-4feb-9c7c-c5b8fd45ce7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ea2c9d51-ff26-42eb-a8f8-2537569c1345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_ea2c9d51-ff26-42eb-a8f8-2537569c1345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_cfe5171e-1499-4d66-8098-6b75ce799971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca274f03-e4eb-4ba8-afea-a52c68a26b5d" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_cfe5171e-1499-4d66-8098-6b75ce799971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment_c1365c3c-cc66-49ef-88a2-887c11c4aec7" xlink:href="bsx-20200930.xsd#bsx_BusinessAcquisitionContingentConsiderationCashPayment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment_c1365c3c-cc66-49ef-88a2-887c11c4aec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_b6311b22-164d-4db5-a27f-0cb2740b23e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_b6311b22-164d-4db5-a27f-0cb2740b23e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_32c71854-a85b-4a0c-9b69-46b0c60f5a15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_32c71854-a85b-4a0c-9b69-46b0c60f5a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_0cf5a464-322b-41a0-9010-b961c7791e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_0cf5a464-322b-41a0-9010-b961c7791e65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_438410e0-09e4-4e4d-ad6a-ace043b0c224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_438410e0-09e4-4e4d-ad6a-ace043b0c224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_3550c25c-68b8-4720-bda5-ade6634c07b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_3550c25c-68b8-4720-bda5-ade6634c07b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_441b7d33-e858-4729-90b1-9c07b65156d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_441b7d33-e858-4729-90b1-9c07b65156d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_05ffba96-55bd-4609-a8c9-cca99560d1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_05ffba96-55bd-4609-a8c9-cca99560d1be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_d24587b3-136e-4603-a621-05a4059349b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_PaymentsOfDividends_d24587b3-136e-4603-a621-05a4059349b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_623c0c6f-1e5f-46d1-8fe5-ff20efadaa03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_623c0c6f-1e5f-46d1-8fe5-ff20efadaa03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1a436ba8-4c2d-4787-9f2c-79edc1963cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_1a436ba8-4c2d-4787-9f2c-79edc1963cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_d272966e-ebf2-4326-9d25-d783cf2068c8" xlink:href="bsx-20200930.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_d272966e-ebf2-4326-9d25-d783cf2068c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_12a978f8-7d18-4a55-b41b-b49bd1d6e66a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16c4bfc-c47b-47c7-894c-1465cdc13ee1" xlink:to="loc_us-gaap_ProceedsFromStockPlans_12a978f8-7d18-4a55-b41b-b49bd1d6e66a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a17d8461-f209-4690-a36a-2927636999df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a98b296a-dcab-445b-bc8d-fcf07828dc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a17d8461-f209-4690-a36a-2927636999df" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a98b296a-dcab-445b-bc8d-fcf07828dc72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_976d0f90-87f0-455f-b10a-b3accb4edbb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a17d8461-f209-4690-a36a-2927636999df" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_976d0f90-87f0-455f-b10a-b3accb4edbb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22194356-707c-4580-a38f-0d8c2620857e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a17d8461-f209-4690-a36a-2927636999df" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22194356-707c-4580-a38f-0d8c2620857e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a30ff6d8-f879-4adc-ae63-5c8639da6473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a17d8461-f209-4690-a36a-2927636999df" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a30ff6d8-f879-4adc-ae63-5c8639da6473" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationBasisofPresentationPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationASUsImplementedDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationMaterialSubsequentEventDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsandStrategicInvestments"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContingentConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#StrategicInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsGoodwillPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitments"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformation"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_b2f3a524-ba89-4ccd-b2a5-b62aa2bd5293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_b2f3a524-ba89-4ccd-b2a5-b62aa2bd5293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4498e75c-4d42-4594-ac69-50c911408258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4498e75c-4d42-4594-ac69-50c911408258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_bc7e848a-1060-41bf-8791-c91ced39d7ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:to="loc_us-gaap_DerivativeAssets_bc7e848a-1060-41bf-8791-c91ced39d7ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4cef47e2-0c52-497e-a556-99ab4ca7714d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:to="loc_us-gaap_Investments_4cef47e2-0c52-497e-a556-99ab4ca7714d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_0976d08b-cbe4-4c9f-9473-acd536d24e51" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsasset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:to="loc_bsx_Licensingarrangementsasset_0976d08b-cbe4-4c9f-9473-acd536d24e51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_f8e6e6cc-e82c-4792-9450-419656c94225" xlink:href="bsx-20200930.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_bacbcd58-7e56-418b-8242-cb0be98f658f" xlink:to="loc_bsx_OtherOtherLongtermAssets_f8e6e6cc-e82c-4792-9450-419656c94225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d02fd885-710e-4103-a3bb-6ae2735ba532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_d207a4b8-5e10-4f42-953c-320555d4c3eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d02fd885-710e-4103-a3bb-6ae2735ba532" xlink:to="loc_us-gaap_DeferredRevenueCurrent_d207a4b8-5e10-4f42-953c-320555d4c3eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_f46ef518-6815-495d-a807-5c5043160c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d02fd885-710e-4103-a3bb-6ae2735ba532" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_f46ef518-6815-495d-a807-5c5043160c59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_7ea5e18a-e857-4bf7-ba7f-a2fcb0c3c5f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d02fd885-710e-4103-a3bb-6ae2735ba532" xlink:to="loc_us-gaap_TaxesPayableCurrent_7ea5e18a-e857-4bf7-ba7f-a2fcb0c3c5f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_2cd8acec-55b9-44be-87fd-7a0acfd969e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d02fd885-710e-4103-a3bb-6ae2735ba532" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_2cd8acec-55b9-44be-87fd-7a0acfd969e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_80d8fa9e-154b-4bbe-94ef-78cbb223091e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_93b1b5b2-b2f8-4d1d-88f3-4c3cfe3476af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_80d8fa9e-154b-4bbe-94ef-78cbb223091e" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_93b1b5b2-b2f8-4d1d-88f3-4c3cfe3476af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_d66bc094-746b-4900-99ab-032f13267359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_80d8fa9e-154b-4bbe-94ef-78cbb223091e" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_d66bc094-746b-4900-99ab-032f13267359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_9f9c47eb-b7cb-46f0-bcc2-58a63edac337" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_80d8fa9e-154b-4bbe-94ef-78cbb223091e" xlink:to="loc_bsx_Licensingarrangements_9f9c47eb-b7cb-46f0-bcc2-58a63edac337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_25bd3a30-7490-4220-a002-c2d9a1d4f9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_80d8fa9e-154b-4bbe-94ef-78cbb223091e" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_25bd3a30-7490-4220-a002-c2d9a1d4f9c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d8149afd-b7c8-4f69-8d87-94ab6b8dbf41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_73f51447-7261-46d2-badf-1f6f0c3f978b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d8149afd-b7c8-4f69-8d87-94ab6b8dbf41" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_73f51447-7261-46d2-badf-1f6f0c3f978b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a9fc1f00-065e-4f15-bc1f-a2a6baf1b7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d8149afd-b7c8-4f69-8d87-94ab6b8dbf41" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a9fc1f00-065e-4f15-bc1f-a2a6baf1b7c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_2efff7b8-5d3e-406c-a298-d58eff2a3d6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_4b0cdb22-ba60-470b-a3b0-1414a9666293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_2efff7b8-5d3e-406c-a298-d58eff2a3d6b" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_4b0cdb22-ba60-470b-a3b0-1414a9666293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_42554904-aca0-4b85-a9fe-29062acecdef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_2efff7b8-5d3e-406c-a298-d58eff2a3d6b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_42554904-aca0-4b85-a9fe-29062acecdef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_343fb557-0c15-4036-ba8e-327141e956ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_e6b7b3a0-1a75-4ea2-b0d3-95fa36c6afb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_343fb557-0c15-4036-ba8e-327141e956ad" xlink:to="loc_us-gaap_LitigationReserveCurrent_e6b7b3a0-1a75-4ea2-b0d3-95fa36c6afb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_aba18ede-d8f1-4cb3-9ad6-1deacca5f381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_343fb557-0c15-4036-ba8e-327141e956ad" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_aba18ede-d8f1-4cb3-9ad6-1deacca5f381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_2b17b596-243f-4850-aa85-aa8f60d5f2e7" xlink:href="bsx-20200930.xsd#bsx_AccruedRebatesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_343fb557-0c15-4036-ba8e-327141e956ad" xlink:to="loc_bsx_AccruedRebatesCurrent_2b17b596-243f-4850-aa85-aa8f60d5f2e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_feedff47-a0b6-40a0-865a-317bfcb6778d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_343fb557-0c15-4036-ba8e-327141e956ad" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_feedff47-a0b6-40a0-865a-317bfcb6778d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f81c1cce-d70c-4adf-941e-45cfe4813779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_343fb557-0c15-4036-ba8e-327141e956ad" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f81c1cce-d70c-4adf-941e-45cfe4813779" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b7b4a358-19e9-42f6-a3f9-b4ade5d1f2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2d24b87b-f2a8-449f-ae44-b96b678e0901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b7b4a358-19e9-42f6-a3f9-b4ade5d1f2fe" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2d24b87b-f2a8-449f-ae44-b96b678e0901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1b8d6601-a4d7-4ab7-8a1a-cd2099db02f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b7b4a358-19e9-42f6-a3f9-b4ade5d1f2fe" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1b8d6601-a4d7-4ab7-8a1a-cd2099db02f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6d38375d-525e-4893-919d-bba0e3490931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b7b4a358-19e9-42f6-a3f9-b4ade5d1f2fe" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6d38375d-525e-4893-919d-bba0e3490931" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_e50bfdf0-0742-41f8-89ea-190669baa092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_e50bfdf0-0742-41f8-89ea-190669baa092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_ecc7552a-f950-4ca0-be65-8d3e817fd9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_ecc7552a-f950-4ca0-be65-8d3e817fd9ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c94446e4-d648-455e-948b-e48dd15cde74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c94446e4-d648-455e-948b-e48dd15cde74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_8e22dc9b-7e26-40d9-ab7f-b7176888f7f8" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsliability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_bsx_Licensingarrangementsliability_8e22dc9b-7e26-40d9-ab7f-b7176888f7f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b76074ab-d499-4d06-b926-752aa6548922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b76074ab-d499-4d06-b926-752aa6548922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_b640652d-943a-42ec-93b0-2c8cd13b6ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_us-gaap_DeferredRevenue_b640652d-943a-42ec-93b0-2c8cd13b6ea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_da4c2e3d-693b-4f93-b98c-6163daa626f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cf03ebb4-4760-4da5-b0cf-8e8a5831e227" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_da4c2e3d-693b-4f93-b98c-6163daa626f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#StockholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstanding"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85961a40-9bf3-4edd-a46c-9ead16521d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dee97ec-b0b4-4961-8760-cfa1cfdd9ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85961a40-9bf3-4edd-a46c-9ead16521d8d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dee97ec-b0b4-4961-8760-cfa1cfdd9ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a2b02e4c-bacf-4348-b81d-7de9364dbe0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85961a40-9bf3-4edd-a46c-9ead16521d8d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a2b02e4c-bacf-4348-b81d-7de9364dbe0a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReporting"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReportingTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c695bd0c-cc68-4a1e-ada8-3518a9e1042e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_45591500-76e8-4af7-bcdf-cbee46388866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c695bd0c-cc68-4a1e-ada8-3518a9e1042e" xlink:to="loc_us-gaap_OperatingIncomeLoss_45591500-76e8-4af7-bcdf-cbee46388866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3335f4ad-23cc-4b8c-8739-8f47f85f5d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c695bd0c-cc68-4a1e-ada8-3518a9e1042e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3335f4ad-23cc-4b8c-8739-8f47f85f5d5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20200930.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#RevenueDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a016ecd4-594d-4430-aade-a679dcd1f93e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6808af75-c6a4-43c6-b79e-5bd666486001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a016ecd4-594d-4430-aade-a679dcd1f93e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6808af75-c6a4-43c6-b79e-5bd666486001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_8e23a2ba-2a09-437b-bb1c-cb21cfc4aa7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a016ecd4-594d-4430-aade-a679dcd1f93e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_8e23a2ba-2a09-437b-bb1c-cb21cfc4aa7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1f163061-5c10-4bed-a756-00c6cba8ed42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c755b34b-a9fc-4a7d-94ba-663f2a867525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1f163061-5c10-4bed-a756-00c6cba8ed42" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c755b34b-a9fc-4a7d-94ba-663f2a867525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5beb704c-17b6-4a15-8bc0-66ea2acad686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1f163061-5c10-4bed-a756-00c6cba8ed42" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5beb704c-17b6-4a15-8bc0-66ea2acad686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_36eb5eed-ea17-4828-98a3-1d107cfe1efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_e6627b6f-27c7-4945-9c41-b0ff8b476076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_36eb5eed-ea17-4828-98a3-1d107cfe1efd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_e6627b6f-27c7-4945-9c41-b0ff8b476076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_d4b653bf-b64d-4c92-aa10-f280dd916660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_36eb5eed-ea17-4828-98a3-1d107cfe1efd" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_d4b653bf-b64d-4c92-aa10-f280dd916660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_289d879c-84e3-4b16-a3c3-896a05bdbeca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a5704ba1-5b7a-456a-bdcd-5f19c5b8d366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_289d879c-84e3-4b16-a3c3-896a05bdbeca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a5704ba1-5b7a-456a-bdcd-5f19c5b8d366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_40788b6a-584c-4313-b154-90ee71533e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_289d879c-84e3-4b16-a3c3-896a05bdbeca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_40788b6a-584c-4313-b154-90ee71533e01" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20200930.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#NewAccountingPronouncementsPolicies"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bsx-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:5aff39ba-e31d-4daa-a93a-6fdd4a47e66b,g:1fac046f-4056-4f94-9a0f-fce45535a3a4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20200930.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i4aee3f11c3414f968b1ca8bc6d848069_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_70048862-fa6c-4256-b5b1-6af13153abfc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentType_70048862-fa6c-4256-b5b1-6af13153abfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_60b09d71-a6b0-4334-b8ff-9b9bc4d7cd51" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentQuarterlyReport_60b09d71-a6b0-4334-b8ff-9b9bc4d7cd51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c92f75c8-9f35-4fd2-b50f-9bbd877e2fed" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentPeriodEndDate_c92f75c8-9f35-4fd2-b50f-9bbd877e2fed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2934de8a-edfb-446e-af28-919c6ee9b09b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentTransitionReport_2934de8a-edfb-446e-af28-919c6ee9b09b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_194767fe-726f-42d8-8358-a4bb34f4a9ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityFileNumber_194767fe-726f-42d8-8358-a4bb34f4a9ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e8e286bd-458a-48ec-a472-b6affd98ca1c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityRegistrantName_e8e286bd-458a-48ec-a472-b6affd98ca1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7d6cec00-24a5-4fba-a2ec-9141ac3d9c3a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7d6cec00-24a5-4fba-a2ec-9141ac3d9c3a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cc6b88e2-33ac-42d5-ad65-3cc45fc1e37f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityTaxIdentificationNumber_cc6b88e2-33ac-42d5-ad65-3cc45fc1e37f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_325abe16-8d49-4fd5-bfee-f763eead8d89" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressAddressLine1_325abe16-8d49-4fd5-bfee-f763eead8d89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bee56e56-bc00-40d4-98c6-9e424160dd40" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressCityOrTown_bee56e56-bc00-40d4-98c6-9e424160dd40" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6bcce44e-b5a1-4de9-86b7-197d627a8aa4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressStateOrProvince_6bcce44e-b5a1-4de9-86b7-197d627a8aa4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_013e4f3d-b0a3-4459-a70a-df27ea417cc1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressPostalZipCode_013e4f3d-b0a3-4459-a70a-df27ea417cc1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_74cf9c41-ec36-414c-81b9-6500ad351c6e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_CityAreaCode_74cf9c41-ec36-414c-81b9-6500ad351c6e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_57bb061c-28e6-419f-8786-7ce45c6edaf1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_LocalPhoneNumber_57bb061c-28e6-419f-8786-7ce45c6edaf1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7a784154-d7ca-4753-bf35-5cedcc346b25" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_Security12bTitle_7a784154-d7ca-4753-bf35-5cedcc346b25" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_261b3cdf-9077-48c7-be50-8a0b3ad31ca3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_TradingSymbol_261b3cdf-9077-48c7-be50-8a0b3ad31ca3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4b9e59a1-00c5-4436-a99f-1a2064aa7971" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_SecurityExchangeName_4b9e59a1-00c5-4436-a99f-1a2064aa7971" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_235e6d1a-2235-4108-80be-1646850d5dd8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityCurrentReportingStatus_235e6d1a-2235-4108-80be-1646850d5dd8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_60dab55a-4d28-4326-b0c0-a032eb18854f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityInteractiveDataCurrent_60dab55a-4d28-4326-b0c0-a032eb18854f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a874c8a3-8dfa-490a-a9e4-818a4f3cbbf5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityFilerCategory_a874c8a3-8dfa-490a-a9e4-818a4f3cbbf5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9ca320e1-54b4-4fe6-b505-e82a4d9e6f93" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntitySmallBusiness_9ca320e1-54b4-4fe6-b505-e82a4d9e6f93" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d4befe5a-4186-4cdb-9dfe-6f5d364f9865" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityEmergingGrowthCompany_d4befe5a-4186-4cdb-9dfe-6f5d364f9865" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6cedbbe2-6b1b-452a-9fd4-3bd2b20ff955" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityShellCompany_6cedbbe2-6b1b-452a-9fd4-3bd2b20ff955" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_328f3166-b91d-4c11-89ad-be50c9c498e8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityListingParValuePerShare_328f3166-b91d-4c11-89ad-be50c9c498e8" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3f28a406-f4d2-4938-ad8a-c10180bc1e7b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3f28a406-f4d2-4938-ad8a-c10180bc1e7b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_70e63056-a40c-42af-92a9-04daf88d1cb4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityCentralIndexKey_70e63056-a40c-42af-92a9-04daf88d1cb4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c2ca65ae-8808-4be0-9772-362125290f78" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_CurrentFiscalYearEndDate_c2ca65ae-8808-4be0-9772-362125290f78" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4217e734-9c7e-47b4-a856-53b20a54f8ad" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentFiscalYearFocus_4217e734-9c7e-47b4-a856-53b20a54f8ad" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7a71c558-1813-4366-b1a7-59ad321ed73b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7a71c558-1813-4366-b1a7-59ad321ed73b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eb820698-0a53-46ba-ae53-de88485bd816" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_AmendmentFlag_eb820698-0a53-46ba-ae53-de88485bd816" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4509248c-02fa-4fd0-ba9d-6db1fc351a48_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:to="loc_us-gaap_ClassOfStockDomain_4509248c-02fa-4fd0-ba9d-6db1fc351a48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:to="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d3356cd2-c3ed-47b2-9b6e-fb4dea7475b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:to="loc_us-gaap_CommonStockMember_d3356cd2-c3ed-47b2-9b6e-fb4dea7475b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_8a2e0883-9640-4ce9-897f-28111f991a08" xlink:href="bsx-20200930.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:to="loc_bsx_SeniorNotedue2027Member_8a2e0883-9640-4ce9-897f-28111f991a08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_f26a766b-1f59-4fb8-8a45-a073cb0a21fc" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:to="loc_bsx_A550MCPSSeriesAMember_f26a766b-1f59-4fb8-8a45-a073cb0a21fc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="iff295be3d7ae4f89b1eb7b5ce44ce921_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34dbd289-2d95-49b3-a9bf-f1945bbe3671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34dbd289-2d95-49b3-a9bf-f1945bbe3671" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0f060b96-e893-4f5e-aa1d-8d941fa7cdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0f060b96-e893-4f5e-aa1d-8d941fa7cdca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_61ed6ea2-2a9f-4b36-aa8b-c057aea0e217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_GrossProfit_61ed6ea2-2a9f-4b36-aa8b-c057aea0e217" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c21c63cb-5152-4574-a901-03d7fe9bfa17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c21c63cb-5152-4574-a901-03d7fe9bfa17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_957d64ea-8be5-4eb1-bc6b-b69a6b8c0349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_957d64ea-8be5-4eb1-bc6b-b69a6b8c0349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_ce86ed67-85da-4108-a081-d5f218e2313d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_RoyaltyExpense_ce86ed67-85da-4108-a081-d5f218e2313d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8d1ae27d-8989-4173-99ce-814dcc8326fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8d1ae27d-8989-4173-99ce-814dcc8326fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3939a9e9-719b-4dc6-b5bc-9f214cc90bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3939a9e9-719b-4dc6-b5bc-9f214cc90bd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_040b327f-3ab0-4d37-b82d-422452885ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_040b327f-3ab0-4d37-b82d-422452885ac6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1c93a21d-8298-4466-9bdb-6021352d8133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_RestructuringCharges_1c93a21d-8298-4466-9bdb-6021352d8133" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_4afe3480-7b58-44a3-b61b-31b45febaa2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_LitigationSettlementExpense_4afe3480-7b58-44a3-b61b-31b45febaa2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3b4d700a-2820-4623-b864-06e18c89368e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_OperatingExpenses_3b4d700a-2820-4623-b864-06e18c89368e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_496b8697-58f0-46d3-bf46-7089d79a9aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_OperatingIncomeLoss_496b8697-58f0-46d3-bf46-7089d79a9aba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c636efad-d1bd-4241-b979-da80c3cfde2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:to="loc_us-gaap_InterestExpense_c636efad-d1bd-4241-b979-da80c3cfde2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7fe71971-472f-4087-88ec-3e4531b8dd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7fe71971-472f-4087-88ec-3e4531b8dd30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd82d575-ccbb-41f3-b497-4105d751bcad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd82d575-ccbb-41f3-b497-4105d751bcad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c3f3db2a-79fb-412b-b6ec-0bcc883a0922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c3f3db2a-79fb-412b-b6ec-0bcc883a0922" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_760f0a2d-49a7-4f1f-9f0d-40ffbc79bae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_ProfitLoss_760f0a2d-49a7-4f1f-9f0d-40ffbc79bae8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_24a8b0a8-8bc3-4f65-acf4-524472f6ea74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_DividendsPreferredStockStock_24a8b0a8-8bc3-4f65-acf4-524472f6ea74" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f524b585-bcfa-4d21-a303-8e5d8994b08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f524b585-bcfa-4d21-a303-8e5d8994b08f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_661314ad-e464-4589-8c5e-d6be922506fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_EarningsPerShareBasic_661314ad-e464-4589-8c5e-d6be922506fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a847e06b-c1fe-45ea-a7fb-540502151de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a847e06b-c1fe-45ea-a7fb-540502151de1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_10fd962e-f9e7-4b27-84f8-9e4dc31e3392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_10fd962e-f9e7-4b27-84f8-9e4dc31e3392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_92053b8b-8722-4eea-8b64-81d242857d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_92053b8b-8722-4eea-8b64-81d242857d66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:to="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1db7a665-74df-402b-bce1-191ed9350cde_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1db7a665-74df-402b-bce1-191ed9350cde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_69f7f1e2-968b-4fb9-a6a2-607c1e782656" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:to="loc_srt_ScenarioUnspecifiedDomain_69f7f1e2-968b-4fb9-a6a2-607c1e782656" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i173f2f79490a445da8c6e2aada633fe2_CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ca153d5-a406-4cb0-850a-1860d99775e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_ProfitLoss_6ca153d5-a406-4cb0-850a-1860d99775e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_de6deb49-9429-4fe3-9088-9c63a9274baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_de6deb49-9429-4fe3-9088-9c63a9274baa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_41075385-c361-47eb-8fb8-297129d9bb6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_41075385-c361-47eb-8fb8-297129d9bb6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b1229c33-d630-42d1-91c6-6834e40f46e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b1229c33-d630-42d1-91c6-6834e40f46e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52cbe5c7-9e30-4285-98d6-53cf4be33a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52cbe5c7-9e30-4285-98d6-53cf4be33a0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb4108d5-df61-43fd-8c8e-e4e858295ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb4108d5-df61-43fd-8c8e-e4e858295ae8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:to="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6e3868e8-6dbf-448c-a220-6803b59f891d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6e3868e8-6dbf-448c-a220-6803b59f891d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_280e8a03-f666-4145-917c-9873d7818d31" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_280e8a03-f666-4145-917c-9873d7818d31" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i189e4e4a962c43d6a21f9214458396d4_CondensedConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:to="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7baa94d-44b3-4a43-906b-34ecf7f5ed98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7baa94d-44b3-4a43-906b-34ecf7f5ed98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_7dcbb28c-2749-41ba-ba57-111d0472272c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_7dcbb28c-2749-41ba-ba57-111d0472272c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e6bb4aff-ef40-4fec-a13c-0e3379528c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_InventoryNet_e6bb4aff-ef40-4fec-a13c-0e3379528c41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_8dc57c29-dd47-434d-8b6a-329bd450cb4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_PrepaidTaxes_8dc57c29-dd47-434d-8b6a-329bd450cb4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34090aa4-681b-4965-a93c-a141c6cbc601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34090aa4-681b-4965-a93c-a141c6cbc601" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b0d68b93-2cf4-428e-9630-f1e929f3debd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_AssetsCurrent_b0d68b93-2cf4-428e-9630-f1e929f3debd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f5ace6dd-cc1e-4b24-8504-20f546e7077e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f5ace6dd-cc1e-4b24-8504-20f546e7077e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98d3a209-69dd-4c07-9d32-edcbbf5159b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_Goodwill_98d3a209-69dd-4c07-9d32-edcbbf5159b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0e365d44-e336-4b15-bb54-aa60150a6817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0e365d44-e336-4b15-bb54-aa60150a6817" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb8a025a-053a-4a0d-b4bd-4efe0ab78e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb8a025a-053a-4a0d-b4bd-4efe0ab78e1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f5b80522-6674-4ff7-9f41-160a16513c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f5b80522-6674-4ff7-9f41-160a16513c29" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f1efee41-542a-4a34-98a7-f18273321f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_Assets_f1efee41-542a-4a34-98a7-f18273321f92" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2325e20b-e806-4555-9301-113423a2157b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_DebtCurrent_2325e20b-e806-4555-9301-113423a2157b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_50d36e13-ba01-49d0-a4ed-74a29f9b156a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_AccountsPayableCurrent_50d36e13-ba01-49d0-a4ed-74a29f9b156a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5aaa085d-3cf4-448c-a7fb-11659b3fbbbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5aaa085d-3cf4-448c-a7fb-11659b3fbbbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2bd5b331-fd73-4f95-9d48-f4de7c431039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2bd5b331-fd73-4f95-9d48-f4de7c431039" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_93b5a9cd-cd72-46c9-94d6-dc276e4a4007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_LiabilitiesCurrent_93b5a9cd-cd72-46c9-94d6-dc276e4a4007" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_487fa4b9-9baf-4a8d-a976-7a32054896b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_487fa4b9-9baf-4a8d-a976-7a32054896b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent_8f4f80f0-9d1f-49c3-9ee6-8c18e55c0c50" xlink:href="bsx-20200930.xsd#bsx_DeferredTaxLiabilitiesNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent_8f4f80f0-9d1f-49c3-9ee6-8c18e55c0c50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3d088ac9-fefb-46b7-b267-8f99e9d621ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3d088ac9-fefb-46b7-b267-8f99e9d621ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6174e54c-1b00-4b21-b63f-eb8f7ed76108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6174e54c-1b00-4b21-b63f-eb8f7ed76108" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c762c1a0-91cf-4e43-9040-1f03c42abc14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_PreferredStockValue_c762c1a0-91cf-4e43-9040-1f03c42abc14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7ecb0c85-47d2-4a2f-9e4a-83e2334d126e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_CommonStockValue_7ecb0c85-47d2-4a2f-9e4a-83e2334d126e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_db4a1841-9eb4-4b1e-b66e-3eadc3b0e72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_TreasuryStockValue_db4a1841-9eb4-4b1e-b66e-3eadc3b0e72e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2e031f49-daaa-496d-8aff-f5a06e6cc094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2e031f49-daaa-496d-8aff-f5a06e6cc094" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d60a513e-f168-4ad1-acea-c345808fd6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d60a513e-f168-4ad1-acea-c345808fd6c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3d9a87d2-da63-43a4-8a05-15cc401020b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3d9a87d2-da63-43a4-8a05-15cc401020b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4376c43a-8026-482d-86fa-00b1fe742fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4376c43a-8026-482d-86fa-00b1fe742fb2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d983b35e-a875-4acc-822b-efe09da0f174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d983b35e-a875-4acc-822b-efe09da0f174" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:to="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:to="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_54882288-e8a6-4b1f-b763-8286a0f59989_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:to="loc_srt_ScenarioUnspecifiedDomain_54882288-e8a6-4b1f-b763-8286a0f59989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ad7410cf-4d5e-413d-8a8b-e128de7afb37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ad7410cf-4d5e-413d-8a8b-e128de7afb37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4339fe1d-23a0-4b62-9143-a751ffe1738a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:to="loc_us-gaap_ClassOfStockDomain_4339fe1d-23a0-4b62-9143-a751ffe1738a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ea827d55-7e3f-48e8-a4b9-183f9f1a4d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:to="loc_us-gaap_ClassOfStockDomain_ea827d55-7e3f-48e8-a4b9-183f9f1a4d94" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ia2b67d73b6a6419dba1df539ec64fc84_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended" id="i6a3501eb7e6849fc8154e971e3374568_CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f390843f-4635-455a-b4e2-a2a95ac75e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f390843f-4635-455a-b4e2-a2a95ac75e2d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_547fa8d0-bffd-4e55-bc84-92af867e9833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_547fa8d0-bffd-4e55-bc84-92af867e9833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e6bb582f-6d0a-4cf8-80cb-027d34cf8325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_SharesIssued_e6bb582f-6d0a-4cf8-80cb-027d34cf8325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_06e65416-a179-456f-b3f3-e6310f042b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_ProfitLoss_06e65416-a179-456f-b3f3-e6310f042b7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c837c0c6-29bc-4e81-8576-38b2c6ba7e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c837c0c6-29bc-4e81-8576-38b2c6ba7e53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1838e23c-e04c-420b-845c-eeff7058c50b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1838e23c-e04c-420b-845c-eeff7058c50b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d6a6a761-bd65-4124-b742-a2accdd26dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d6a6a761-bd65-4124-b742-a2accdd26dd1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_569ce8a0-c280-4b86-8dc9-0a8b164a4f05" xlink:href="bsx-20200930.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_569ce8a0-c280-4b86-8dc9-0a8b164a4f05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_c1246be4-17fe-4a83-ad4c-81c86c91320a" xlink:href="bsx-20200930.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_c1246be4-17fe-4a83-ad4c-81c86c91320a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27f7ee60-2754-4f09-8a98-db2b50fcfa1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27f7ee60-2754-4f09-8a98-db2b50fcfa1d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_d16ea8c2-6954-4994-9165-d58d155d5718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_DividendsPreferredStockCash_d16ea8c2-6954-4994-9165-d58d155d5718" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_6aede5ae-380e-4d2b-94e3-d94c355db553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_6aede5ae-380e-4d2b-94e3-d94c355db553" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_2d9321ce-b89b-4b68-a1ed-c51469f7df62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_2d9321ce-b89b-4b68-a1ed-c51469f7df62" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_387b0bd4-7e75-42d0-a62b-f6e9bd160bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ca26726b-75d3-4150-b130-d409395e2f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f390843f-4635-455a-b4e2-a2a95ac75e2d" xlink:to="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_83742ed4-63df-45de-b750-b2018844d040_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:to="loc_us-gaap_EquityComponentDomain_83742ed4-63df-45de-b750-b2018844d040_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:to="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_6731f05a-6503-493c-8af8-f31973a51b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_PreferredStockMember_6731f05a-6503-493c-8af8-f31973a51b8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c46f66ec-156d-412b-923a-4a338f7a7187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_CommonStockMember_c46f66ec-156d-412b-923a-4a338f7a7187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_36f1cbe3-815e-4822-ad73-7e71823f147d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_TreasuryStockMember_36f1cbe3-815e-4822-ad73-7e71823f147d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0e5bb205-057f-4e39-a766-646d67effc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0e5bb205-057f-4e39-a766-646d67effc5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_91447a96-e87a-4e0a-8438-cca9af7a9a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_RetainedEarningsMember_91447a96-e87a-4e0a-8438-cca9af7a9a9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_31106e46-9f01-452f-93ca-0df8b537f48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_31106e46-9f01-452f-93ca-0df8b537f48d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c84a88ab-2ec9-4ca5-9230-451476dad769_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:to="loc_us-gaap_ClassOfStockDomain_c84a88ab-2ec9-4ca5-9230-451476dad769_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f98eba2a-402d-453b-b91e-c6e82f260fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:to="loc_us-gaap_ClassOfStockDomain_f98eba2a-402d-453b-b91e-c6e82f260fd9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i3995eed0557b4d36868757eb5f5e79e7_CondensedConsolidatedStatementsofCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_07519391-e1a1-493d-957c-76408935d536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_07519391-e1a1-493d-957c-76408935d536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b9fef538-5ebf-4e1e-b3e4-75535b5b8d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_07519391-e1a1-493d-957c-76408935d536" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b9fef538-5ebf-4e1e-b3e4-75535b5b8d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77fdff6f-4661-4303-a80d-1d110a25cfff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77fdff6f-4661-4303-a80d-1d110a25cfff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_236ab812-6e4e-42b4-861d-f026820ca465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_236ab812-6e4e-42b4-861d-f026820ca465" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b924bf7a-6b38-48ed-92f2-2bce54d5cc54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b924bf7a-6b38-48ed-92f2-2bce54d5cc54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3650d8b0-080b-4e17-9f3b-a53474ee49fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3650d8b0-080b-4e17-9f3b-a53474ee49fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_2fbf864f-1f61-46be-8260-2d96d6cc8207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_2fbf864f-1f61-46be-8260-2d96d6cc8207" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_17ae8457-f174-4db2-9a46-ddc5ebe66981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_17ae8457-f174-4db2-9a46-ddc5ebe66981" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_73ffcb25-395d-4313-ba81-bbca35446f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_73ffcb25-395d-4313-ba81-bbca35446f80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48b937a9-5581-448a-ace5-1645e3bac16a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48b937a9-5581-448a-ace5-1645e3bac16a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment_4d76c04b-8111-400f-986f-0fd914ad75d2" xlink:href="bsx-20200930.xsd#bsx_BusinessAcquisitionContingentConsiderationCashPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment_4d76c04b-8111-400f-986f-0fd914ad75d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c65ddb09-b872-4535-86bf-00066ad50641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c65ddb09-b872-4535-86bf-00066ad50641" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_65f8f2f8-92e2-4390-8674-1fb2193014b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_65f8f2f8-92e2-4390-8674-1fb2193014b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_99fafb7c-5ad5-4779-bcd2-2f7cfb172691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_99fafb7c-5ad5-4779-bcd2-2f7cfb172691" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f87c7d25-c750-4187-a558-bee2f822de2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f87c7d25-c750-4187-a558-bee2f822de2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_874542df-cfe7-4848-a5f7-fb2458e219a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_874542df-cfe7-4848-a5f7-fb2458e219a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_c7328951-ed86-4456-b7ee-7cca4a0b531d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_c7328951-ed86-4456-b7ee-7cca4a0b531d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_b07a8119-2d7e-4e61-8499-5aa66601b75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_b07a8119-2d7e-4e61-8499-5aa66601b75c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_9d65f10e-a707-4979-99c4-a2c3b8ac9762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_PaymentsOfDividends_9d65f10e-a707-4979-99c4-a2c3b8ac9762" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0e62f762-a5b0-42c8-96fb-c632c1d5483f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0e62f762-a5b0-42c8-96fb-c632c1d5483f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fa5dfc44-1f71-4f13-bf04-864972d55b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fa5dfc44-1f71-4f13-bf04-864972d55b3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_7b686517-2753-496c-a2bc-4eaec97f4ae3" xlink:href="bsx-20200930.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_7b686517-2753-496c-a2bc-4eaec97f4ae3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_901688c7-77a5-49c7-aeeb-b07a6ceaa152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromStockPlans_901688c7-77a5-49c7-aeeb-b07a6ceaa152" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40cb8c5f-3168-45cd-9dab-36dc08883fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40cb8c5f-3168-45cd-9dab-36dc08883fe4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1b68a95-2b63-4ada-8d71-2b2fc69ac518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1b68a95-2b63-4ada-8d71-2b2fc69ac518" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92822231-2487-4905-86fb-02e2e43a5972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92822231-2487-4905-86fb-02e2e43a5972" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b398754-90ca-4ffb-95fc-c8fef33c0aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b398754-90ca-4ffb-95fc-c8fef33c0aac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_778f53e6-9fcc-4df2-88ef-8e085146a250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_600fcd23-795a-4002-b310-01b908f8131d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:to="loc_us-gaap_ShareBasedCompensation_600fcd23-795a-4002-b310-01b908f8131d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationRecognizedInPeriod_1ff44b9e-53d5-4c9e-b9fa-b2cb21071fdf" xlink:href="bsx-20200930.xsd#bsx_ContingentConsiderationRecognizedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:to="loc_bsx_ContingentConsiderationRecognizedInPeriod_1ff44b9e-53d5-4c9e-b9fa-b2cb21071fdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_a913cbd3-88d5-4503-a21f-77fe24e9ef6b" xlink:href="bsx-20200930.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_a913cbd3-88d5-4503-a21f-77fe24e9ef6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:to="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e60a96ca-8b9b-4035-9eb3-7f6d07d42113_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e60a96ca-8b9b-4035-9eb3-7f6d07d42113_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_779161eb-5610-4ae7-b95b-eb35d6f518a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:to="loc_srt_ScenarioUnspecifiedDomain_779161eb-5610-4ae7-b95b-eb35d6f518a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended" id="i833459f95c7e4645a6a073482373eef6_CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4b24927-913b-4785-9e22-a2f48f52870f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4b24927-913b-4785-9e22-a2f48f52870f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9bd4863f-d64a-4ae7-8217-519717624dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9bd4863f-d64a-4ae7-8217-519717624dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ded84693-3a32-4e6b-941d-e063f2cdfa07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ded84693-3a32-4e6b-941d-e063f2cdfa07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40da9530-e86c-4367-ae16-adb46ba6b167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40da9530-e86c-4367-ae16-adb46ba6b167" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:href="bsx-20200930.xsd#bsx_StatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:to="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_de06db50-4e28-44f7-bc0b-89e8c906a8a1_default" xlink:href="bsx-20200930.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:to="loc_bsx_StatementDomain_de06db50-4e28-44f7-bc0b-89e8c906a8a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_7becd5d4-7f89-4257-b5b3-56ea7b522761" xlink:href="bsx-20200930.xsd#bsx_StatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:to="loc_bsx_StatementDomain_7becd5d4-7f89-4257-b5b3-56ea7b522761" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="extended" id="i059fb78ff972474cb866301b44035c84_BasisofPresentation"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationBasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="extended" id="i946eb8c8ee174cbb9027a38d593d7300_BasisofPresentationBasisofPresentationPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationASUsImplementedDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails" xlink:type="extended" id="if2594e7104b1430db0bb914d29e474d8_BasisofPresentationASUsImplementedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b23da22-36d0-456e-8056-9094b63c16c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b23da22-36d0-456e-8056-9094b63c16c9" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityDomain_cf515ad1-2343-4ca1-afe6-1b83b44e273e_default" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:to="loc_bsx_OperatingleaseLiabilityDomain_cf515ad1-2343-4ca1-afe6-1b83b44e273e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityDomain_b112bbfe-5b92-461e-af93-b72214938d69" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:to="loc_bsx_OperatingleaseLiabilityDomain_b112bbfe-5b92-461e-af93-b72214938d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetDomain_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6_default" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:to="loc_bsx_OperatingleaserightofuseassetDomain_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetDomain_e66ab79b-c569-4910-8364-40284d42781d" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:to="loc_bsx_OperatingleaserightofuseassetDomain_e66ab79b-c569-4910-8364-40284d42781d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fd5e6ec2-7086-48ce-b50a-e661b10133eb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fd5e6ec2-7086-48ce-b50a-e661b10133eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_df40e571-8400-4219-8399-5535e14dce49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:to="loc_us-gaap_TypeOfAdoptionMember_df40e571-8400-4219-8399-5535e14dce49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationMaterialSubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails" xlink:type="extended" id="i37db7aaaa2e64d36af8614838798242b_BasisofPresentationMaterialSubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_133a8aad-a1ce-497a-b0d5-8ec3c333b920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_133a8aad-a1ce-497a-b0d5-8ec3c333b920" xlink:to="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f9c426ee-ea3d-495e-9966-056fb2702eb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f9c426ee-ea3d-495e-9966-056fb2702eb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1ed44f10-0bca-47b9-b8b1-7d4892943386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1ed44f10-0bca-47b9-b8b1-7d4892943386" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsandStrategicInvestments"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended" id="ic8a0f3c651ec4d6daf1341d5fd904b0b_AcquisitionsandStrategicInvestments"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended" id="i02944e0d858b4f768fd174c6b63b3056_AcquisitionsandStrategicInvestmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_80ec982a-9557-40d3-815b-0c7ff3c24286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_80ec982a-9557-40d3-815b-0c7ff3c24286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_458ddb09-822d-404f-8667-3cf5dc30fa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_458ddb09-822d-404f-8667-3cf5dc30fa78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2b860f65-1970-4431-9942-aa87a08084a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2b860f65-1970-4431-9942-aa87a08084a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d12a2abf-4991-460d-a22e-664bbee4a1a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d12a2abf-4991-460d-a22e-664bbee4a1a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_544dd2bf-918a-4ca8-9034-ab695a77f27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_544dd2bf-918a-4ca8-9034-ab695a77f27a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_168d7687-2f69-4c52-84aa-d57e844d7080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_168d7687-2f69-4c52-84aa-d57e844d7080" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a38270f-8a2b-4b47-a5b9-742bc8794c9e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a38270f-8a2b-4b47-a5b9-742bc8794c9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_dfcfb24b-e403-42a0-8c9f-b328d7ca8805" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:to="loc_bsx_BTGAcquisitionMember_dfcfb24b-e403-42a0-8c9f-b328d7ca8805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a99e48a3-c441-4609-b807-0f61138a9b21" xlink:href="bsx-20200930.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a99e48a3-c441-4609-b807-0f61138a9b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b14fda39-d264-4c15-a9fa-adfb76325cbb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b14fda39-d264-4c15-a9fa-adfb76325cbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_31a25e48-495f-4a1a-b596-f15e429be902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_31a25e48-495f-4a1a-b596-f15e429be902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_dc092305-6c40-4661-80e3-0f059dad0e3b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:to="loc_srt_OwnershipDomain_dc092305-6c40-4661-80e3-0f059dad0e3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_848dcf08-e15e-486f-8823-227a7e5b0f3d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:to="loc_srt_OwnershipDomain_848dcf08-e15e-486f-8823-227a7e5b0f3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2262011f-3940-4bd3-a292-96047b769c85_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:to="loc_us-gaap_ClassOfStockDomain_2262011f-3940-4bd3-a292-96047b769c85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d32db7c-7189-4c96-882a-6b152f172bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:to="loc_us-gaap_ClassOfStockDomain_6d32db7c-7189-4c96-882a-6b152f172bea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="extended" id="idac24a9544804f06a47bff27ac78a201_AcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_fc4e8462-5dba-4199-a64e-434a5368f420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_fc4e8462-5dba-4199-a64e-434a5368f420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_7b50af89-96ad-4e19-9aaf-721b25420ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_7b50af89-96ad-4e19-9aaf-721b25420ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1209b6e4-a57e-4212-95df-376d1640885a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1209b6e4-a57e-4212-95df-376d1640885a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4ef4e2f2-129c-49a9-a2c6-fcb5a13c1390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4ef4e2f2-129c-49a9-a2c6-fcb5a13c1390" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_35c31f0b-6e14-42ab-b4f4-924b545939e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_35c31f0b-6e14-42ab-b4f4-924b545939e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d5108184-341f-42ca-bf17-1aed21127642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_Goodwill_d5108184-341f-42ca-bf17-1aed21127642" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8cf332b4-27f4-4229-8cc1-5b4107c5e616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8cf332b4-27f4-4229-8cc1-5b4107c5e616" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_deae6cdc-9f80-4848-a18b-689e965d2327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_deae6cdc-9f80-4848-a18b-689e965d2327" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_52efc46b-4205-43d4-b1ab-f4db19c82a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_52efc46b-4205-43d4-b1ab-f4db19c82a00" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0fa8f28d-8040-4e9d-a37a-768ac114d96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0fa8f28d-8040-4e9d-a37a-768ac114d96e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_b087a09f-2eb2-4a51-827c-ef140d74a874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_b087a09f-2eb2-4a51-827c-ef140d74a874" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ff75a10e-cda6-462a-b0ce-ada840992a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ff75a10e-cda6-462a-b0ce-ada840992a07" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ad1bd305-8cff-41ad-a551-28ae68bc70c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ad1bd305-8cff-41ad-a551-28ae68bc70c8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ac93013a-557c-4886-8c18-6d646fd6ab80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ac93013a-557c-4886-8c18-6d646fd6ab80" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_572bcd3f-03ad-49ce-b8c8-cd169e749d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_572bcd3f-03ad-49ce-b8c8-cd169e749d90" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2268b05f-b77e-4efb-8f4c-acd4db5ff9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2268b05f-b77e-4efb-8f4c-acd4db5ff9a3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2630a39c-f527-45d0-92ab-407363bcea3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2630a39c-f527-45d0-92ab-407363bcea3c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_32903401-d11c-4513-9f5a-83bb304b1cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_32903401-d11c-4513-9f5a-83bb304b1cf3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_3354ab46-ecc8-4c56-9efa-0947bb06404f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_3354ab46-ecc8-4c56-9efa-0947bb06404f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e304f526-69b7-4d1c-ab4a-6175bac4fb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e304f526-69b7-4d1c-ab4a-6175bac4fb27" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_27b34189-ef96-4ac4-8eba-6a6cf1070117" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_bsx_DiscountRateFairValueInput_27b34189-ef96-4ac4-8eba-6a6cf1070117" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_218a3033-685c-4b03-940b-03c0b7a561bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_218a3033-685c-4b03-940b-03c0b7a561bd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_23e808f3-7660-4a81-b4c2-6aceb41b77a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_23e808f3-7660-4a81-b4c2-6aceb41b77a6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_30ff17ec-9af4-459e-91dc-52a642c6efcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_30ff17ec-9af4-459e-91dc-52a642c6efcf" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50d69463-4b05-4cc7-a6b6-696a68c3c0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50d69463-4b05-4cc7-a6b6-696a68c3c0b3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96294e5e-22f0-49e4-865a-134764f8be9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96294e5e-22f0-49e4-865a-134764f8be9b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40862d12-f256-4b83-9820-21997088f332_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40862d12-f256-4b83-9820-21997088f332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_9d8fb3f3-aa96-4253-847e-2e0a11e6831d" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_BTGAcquisitionMember_9d8fb3f3-aa96-4253-847e-2e0a11e6831d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_fe39f986-b768-485a-a037-8096dd7d04f7" xlink:href="bsx-20200930.xsd#bsx_VertiflexIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_VertiflexIncMember_fe39f986-b768-485a-a037-8096dd7d04f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeInc.Member_8d18b57f-bda4-439f-a8e2-9e9800cb3b82" xlink:href="bsx-20200930.xsd#bsx_MillipedeInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_MillipedeInc.Member_8d18b57f-bda4-439f-a8e2-9e9800cb3b82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a1fa1abb-8408-416a-b3fd-1c0669d6abf3" xlink:href="bsx-20200930.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a1fa1abb-8408-416a-b3fd-1c0669d6abf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60d753f5-f1dd-4cda-99fc-d225b9599e5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_60d753f5-f1dd-4cda-99fc-d225b9599e5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cdf53231-47ff-407c-b581-47de601b5968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cdf53231-47ff-407c-b581-47de601b5968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_7b4818c0-b12d-4b36-a1fd-5e81ba04e06d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_7b4818c0-b12d-4b36-a1fd-5e81ba04e06d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_49481224-abe0-4fac-9f76-5b1e8a2d5d2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_49481224-abe0-4fac-9f76-5b1e8a2d5d2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_03f55173-869e-4f5b-a1ec-ad234dafe8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_03f55173-869e-4f5b-a1ec-ad234dafe8cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_e5d7caa0-e52b-4e11-9ca3-29a729165d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_e5d7caa0-e52b-4e11-9ca3-29a729165d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_25d49f22-7a7d-41f2-958b-e5b7b0f68895_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:to="loc_srt_RangeMember_25d49f22-7a7d-41f2-958b-e5b7b0f68895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:to="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2a4163a2-346b-4709-b7bd-ec0aeeee8a7d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:to="loc_srt_MinimumMember_2a4163a2-346b-4709-b7bd-ec0aeeee8a7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e209f316-d617-4aa2-b2df-e23927b60bb3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:to="loc_srt_MaximumMember_e209f316-d617-4aa2-b2df-e23927b60bb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_42aef818-caca-4412-9ecc-995de8be6792" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:to="loc_srt_WeightedAverageMember_42aef818-caca-4412-9ecc-995de8be6792" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_75197565-aac8-4675-8933-e0b8df0ab251_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:to="loc_us-gaap_SegmentDomain_75197565-aac8-4675-8933-e0b8df0ab251_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:to="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_e20d1fcd-bc0d-42a8-88c0-0bac734276ce" xlink:href="bsx-20200930.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_e20d1fcd-bc0d-42a8-88c0-0bac734276ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_edb40954-4ca5-4d17-9294-896ebc18c154" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_edb40954-4ca5-4d17-9294-896ebc18c154" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContingentConsiderationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended" id="i2a310c4ce013448d8781713c4f2c82fd_ContingentConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c554baca-2bee-45f8-82cf-6c2d0cb5a7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c554baca-2bee-45f8-82cf-6c2d0cb5a7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbd99c1f-cffc-4363-84d5-a24ff4f9be77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbd99c1f-cffc-4363-84d5-a24ff4f9be77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_b378a028-ca7c-4c3f-a919-586f235a80b6" xlink:href="bsx-20200930.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_bsx_PaymentOfContingentConsideration_b378a028-ca7c-4c3f-a919-586f235a80b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c52d685-f9a7-47d6-834f-d9c0f0d3528c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4373ad43-5bcd-441a-a976-a3eb79ca348f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4373ad43-5bcd-441a-a976-a3eb79ca348f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8909a6d3-7b51-4b91-bd96-769b6612b13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_fc1bd9d1-3046-4b78-ab96-deee34772b02" xlink:href="bsx-20200930.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_fc1bd9d1-3046-4b78-ab96-deee34772b02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_b303bbce-9e8d-4d88-ab55-d45b604267c0" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:to="loc_bsx_DiscountRateFairValueInput_b303bbce-9e8d-4d88-ab55-d45b604267c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:to="loc_srt_RangeMember_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:to="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb7caa6e-f9c0-4903-a417-d6a70dd437cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:to="loc_srt_MinimumMember_cb7caa6e-f9c0-4903-a417-d6a70dd437cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2d8dd2c-2198-4329-95a2-551bf1a27f99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:to="loc_srt_MaximumMember_a2d8dd2c-2198-4329-95a2-551bf1a27f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_56eddab8-6f49-4ebe-953f-4428d5a06b50" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:to="loc_srt_WeightedAverageMember_56eddab8-6f49-4ebe-953f-4428d5a06b50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_8afbac0b-bce0-46ec-8030-f50a0fd539cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:to="loc_us-gaap_ValuationTechniqueDomain_8afbac0b-bce0-46ec-8030-f50a0fd539cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1af067ac-ce4e-47db-bf5f-3ce51d3ccec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1af067ac-ce4e-47db-bf5f-3ce51d3ccec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b7552de2-a962-4e4c-ac4c-ba040ea8b764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_1af067ac-ce4e-47db-bf5f-3ce51d3ccec3" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b7552de2-a962-4e4c-ac4c-ba040ea8b764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d46382-6f17-4fa4-b562-639cf0aff617_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d46382-6f17-4fa4-b562-639cf0aff617_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a4b7e0-77a8-4296-a95e-0222608414ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a4b7e0-77a8-4296-a95e-0222608414ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_9a0c6619-3ed5-4724-bd5c-f4dfdad46d07" xlink:href="bsx-20200930.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_9a0c6619-3ed5-4724-bd5c-f4dfdad46d07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_27d50d2d-f95e-401d-94e8-ae4f1a00703b" xlink:href="bsx-20200930.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:to="loc_bsx_RevenueBasedPaymentsMember_27d50d2d-f95e-401d-94e8-ae4f1a00703b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#StrategicInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended" id="i7affb336cfe34fb9b3c76ee31face137_StrategicInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_2464be7f-0215-48e0-a897-a7347155910e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_2464be7f-0215-48e0-a897-a7347155910e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_516f6e7d-a5a1-4a88-ab24-d00db7518dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquityMethodInvestments_516f6e7d-a5a1-4a88-ab24-d00db7518dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e558234d-963a-4703-8926-c0cb3c6ec465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e558234d-963a-4703-8926-c0cb3c6ec465" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cd6dbb2d-a34d-4731-810b-20a29ddd0487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cd6dbb2d-a34d-4731-810b-20a29ddd0487" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7573141-3150-4420-aea9-e3559fa5beeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7573141-3150-4420-aea9-e3559fa5beeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4f617b91-47b2-4f5b-9467-25c6166d424c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_Investments_4f617b91-47b2-4f5b-9467-25c6166d424c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_399b683f-6826-4667-b67f-6782638936e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_399b683f-6826-4667-b67f-6782638936e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_128a5098-178d-4965-8b88-180bc18f35ce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_128a5098-178d-4965-8b88-180bc18f35ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08101584-101d-4a74-a84c-5012146e6686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_08101584-101d-4a74-a84c-5012146e6686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f15af9a0-35e0-4b64-9d78-c7acbe4d6717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_08101584-101d-4a74-a84c-5012146e6686" xlink:to="loc_us-gaap_SubsequentEventMember_f15af9a0-35e0-4b64-9d78-c7acbe4d6717" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="i150d19eba01a4ac99dd3c4e2e9732c11_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsGoodwillPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies" xlink:type="extended" id="i8f69f09b39624e97b3db9dab6522c82d_GoodwillandOtherIntangibleAssetsGoodwillPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="extended" id="i5d1a2069902147528eafa6cc291b2423_GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended" id="i6da458630c1f47a08b545c5eada39783_GoodwillandOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51ca52ec-67cf-47d8-8d46-39ba69b92371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51ca52ec-67cf-47d8-8d46-39ba69b92371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c21c2259-c050-4e6a-9ec2-9446d0648a78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c21c2259-c050-4e6a-9ec2-9446d0648a78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_5eb4fecd-1284-4d8d-8a58-4e98e00622b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_GoodwillGross_5eb4fecd-1284-4d8d-8a58-4e98e00622b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_9a76cacc-8617-433b-ba44-d100fc4bbc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_9a76cacc-8617-433b-ba44-d100fc4bbc69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26f98a74-6d6a-49c0-b216-e62903a73f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26f98a74-6d6a-49c0-b216-e62903a73f02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_524f9197-6aef-4872-a310-3b39887df324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_524f9197-6aef-4872-a310-3b39887df324" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27a848b7-38cf-4d20-8b09-a777790139fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:to="loc_us-gaap_Goodwill_27a848b7-38cf-4d20-8b09-a777790139fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7820eb20-d4fc-4a25-85bd-2ebd572d7a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7820eb20-d4fc-4a25-85bd-2ebd572d7a2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aed2f901-a8f1-4c15-a7dd-b65c46294652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIntangibleAssetsandGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain_469a1501-e3af-4e69-bf3b-f6b305d830c2_default" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:to="loc_bsx_IntangibleAssetsDomain_469a1501-e3af-4e69-bf3b-f6b305d830c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain_d0a8b110-ab4c-4438-a1ab-4e7035c44597" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:to="loc_bsx_IntangibleAssetsDomain_d0a8b110-ab4c-4438-a1ab-4e7035c44597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_56d05bcc-dcea-463c-8371-66c1957d7d2f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:to="loc_srt_RangeMember_56d05bcc-dcea-463c-8371-66c1957d7d2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:to="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_96fda023-3d6b-4a8c-940e-a914bb1c2524" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:to="loc_srt_MinimumMember_96fda023-3d6b-4a8c-940e-a914bb1c2524" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_690de0b7-a267-4a58-a728-e8544789fb87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:to="loc_srt_MaximumMember_690de0b7-a267-4a58-a728-e8544789fb87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9d2d8279-c292-4c7b-883f-884aacb7051c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9d2d8279-c292-4c7b-883f-884aacb7051c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f840e2f8-fab7-4053-898e-4ed02c85617a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f840e2f8-fab7-4053-898e-4ed02c85617a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_718814c6-e739-4521-8f00-96f580dd1906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:to="loc_us-gaap_PatentsMember_718814c6-e739-4521-8f00-96f580dd1906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_91b37f38-20ce-443b-bf4b-ca3b6943247f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_91b37f38-20ce-443b-bf4b-ca3b6943247f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_a1e0fb0c-8b58-4f85-9155-fc510dba7e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:to="loc_us-gaap_GoodwillMember_a1e0fb0c-8b58-4f85-9155-fc510dba7e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ca4f4d3f-5c73-46ec-bbb9-0031509fb7d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ca4f4d3f-5c73-46ec-bbb9-0031509fb7d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0558f7ed-0cd1-40a6-8941-e7f1b5d8bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0558f7ed-0cd1-40a6-8941-e7f1b5d8bfeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_884a1bc8-3009-453f-9b0f-37f2eba6bde2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:to="loc_us-gaap_SegmentDomain_884a1bc8-3009-453f-9b0f-37f2eba6bde2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:to="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_d476ab86-0fa8-42b8-8340-3ab11625f6b0" xlink:href="bsx-20200930.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_MedsurgMember_d476ab86-0fa8-42b8-8340-3ab11625f6b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_c6adfe47-1503-4ea2-a9a1-ebb020719a2e" xlink:href="bsx-20200930.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_RhythmandNeuroMember_c6adfe47-1503-4ea2-a9a1-ebb020719a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_1dc440f8-6b36-4a78-8a9e-a3cd6c73aace" xlink:href="bsx-20200930.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_CardiovascularMember_1dc440f8-6b36-4a78-8a9e-a3cd6c73aace" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_e3b05393-b829-4403-a4d5-97a1e2e30b36" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_e3b05393-b829-4403-a4d5-97a1e2e30b36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_b64dbb33-3163-4dc6-98b7-206bee004353" xlink:href="bsx-20200930.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_b64dbb33-3163-4dc6-98b7-206bee004353" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_6539a9a4-e432-411c-949e-0c1d87a20614" xlink:href="bsx-20200930.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_6539a9a4-e432-411c-949e-0c1d87a20614" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_edf4c1c6-af27-4ada-b91e-a9fc67df95c0" xlink:href="bsx-20200930.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_edf4c1c6-af27-4ada-b91e-a9fc67df95c0" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended" id="i4f053cabf24844409ea9b4a46265814d_HedgingActivitiesandFairValueMeasurements"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="extended" id="ie9cdd5c34bd0457daaef56b8fe9db4f9_FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended" id="i61ea1b16b75447ed985f90106d3fc98f_HedgingActivitiesandFairValueMeasurementsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_19c1d433-1655-49f3-b047-461b6e5763b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_19c1d433-1655-49f3-b047-461b6e5763b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e8a8e401-7d35-495b-a3e4-4a907b74597c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e8a8e401-7d35-495b-a3e4-4a907b74597c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_869f3ab9-329d-4a50-9d48-e3520b201675" xlink:href="bsx-20200930.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_869f3ab9-329d-4a50-9d48-e3520b201675" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b0526f0d-e8cf-4238-8b47-179e80599a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b0526f0d-e8cf-4238-8b47-179e80599a50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_9aeb8cf4-356c-4e11-84bb-4ed7bcf36d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_9aeb8cf4-356c-4e11-84bb-4ed7bcf36d26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_10e2583e-f67c-49ac-a17d-d6f16e38e810_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_10e2583e-f67c-49ac-a17d-d6f16e38e810_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_47e69825-09e2-4c0a-a167-70aff31ad2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_47e69825-09e2-4c0a-a167-70aff31ad2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c01ffbc-6777-41b1-9704-3a46619d6b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e198d901-8e15-4d6d-bf01-c0da253c34b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c01ffbc-6777-41b1-9704-3a46619d6b68" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e198d901-8e15-4d6d-bf01-c0da253c34b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c01ffbc-6777-41b1-9704-3a46619d6b68" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_28b40ec9-23a5-4848-b52c-f2d8c2e853f2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_28b40ec9-23a5-4848-b52c-f2d8c2e853f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e118f000-e4a6-4fd4-87c9-700b93a05533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e118f000-e4a6-4fd4-87c9-700b93a05533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b7d91915-7407-4437-b919-9f2688f4fa5b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b7d91915-7407-4437-b919-9f2688f4fa5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81c05b60-2d90-46e8-bdab-3489d10e05a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81c05b60-2d90-46e8-bdab-3489d10e05a2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended" id="id0a51966d64748e1b2fead6c1f5e7dd3_HedgingActivitiesandFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5e216b29-6ac6-462b-91db-dfe25012436e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_LongTermDebt_5e216b29-6ac6-462b-91db-dfe25012436e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93d53d41-f40e-45d6-ae46-0f12ad440cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93d53d41-f40e-45d6-ae46-0f12ad440cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NotionalValueofOutstandingNetInvestmentHedges_e61171cf-ee50-4147-8c32-b541223290c2" xlink:href="bsx-20200930.xsd#bsx_NotionalValueofOutstandingNetInvestmentHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_NotionalValueofOutstandingNetInvestmentHedges_e61171cf-ee50-4147-8c32-b541223290c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_aef18e6d-a4ed-4855-968f-44ce2e81704a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_aef18e6d-a4ed-4855-968f-44ce2e81704a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_6ce1484b-ba6d-4369-a224-571a3b718749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_6ce1484b-ba6d-4369-a224-571a3b718749" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_3147b188-2700-4037-93ff-d7c507023e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_3147b188-2700-4037-93ff-d7c507023e3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_04e7dd3b-dc79-4080-9df4-56ab6a75e92c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_04e7dd3b-dc79-4080-9df4-56ab6a75e92c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_84796a94-215d-4922-9cfa-8d316e730af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeNotionalAmount_84796a94-215d-4922-9cfa-8d316e730af9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_9f0be40f-b26e-4110-a32e-57b908c6da25" xlink:href="bsx-20200930.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_9f0be40f-b26e-4110-a32e-57b908c6da25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76e27273-042c-4d6c-b269-dc8b11177328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76e27273-042c-4d6c-b269-dc8b11177328" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cd47887c-6bd2-4fa6-9f51-84b9a847dcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cd47887c-6bd2-4fa6-9f51-84b9a847dcfc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_bbc972ef-6738-4745-9748-829c950e2546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_bbc972ef-6738-4745-9748-829c950e2546" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6f361ba7-0c4a-4608-9908-2a4062e259bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6f361ba7-0c4a-4608-9908-2a4062e259bf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6105452d-049c-4b35-9067-6fc97f7f811b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6105452d-049c-4b35-9067-6fc97f7f811b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_426fdae7-308e-45e4-98da-5421320bbcca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_426fdae7-308e-45e4-98da-5421320bbcca" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e55c1621-ce3f-486f-a2df-243be0abb8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e55c1621-ce3f-486f-a2df-243be0abb8d1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d378a8f7-1663-4698-ba93-42bfa6b74a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d378a8f7-1663-4698-ba93-42bfa6b74a41" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_4ddf8e5f-2a0b-47b7-8df2-f591da499379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_4ddf8e5f-2a0b-47b7-8df2-f591da499379" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_ed8b76f1-907d-44ba-b2e0-b8d43c787077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_ed8b76f1-907d-44ba-b2e0-b8d43c787077" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8560f9dd-12bb-452d-9fcc-5ecbb3dd6c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_InterestExpense_8560f9dd-12bb-452d-9fcc-5ecbb3dd6c1d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_f88d378a-ac89-4551-86dd-09805b92c671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_f88d378a-ac89-4551-86dd-09805b92c671" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_1ae015b3-eb96-4ade-835c-ec839baf5e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_1ae015b3-eb96-4ade-835c-ec839baf5e15" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_8fce3d3f-01ba-4818-be72-67453720dee4" xlink:href="bsx-20200930.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_8fce3d3f-01ba-4818-be72-67453720dee4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_3e1074cd-e54d-4346-ad48-90a628d3a272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_3e1074cd-e54d-4346-ad48-90a628d3a272" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_cf0d5cf0-540c-409c-91a3-0583b7d60bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_cf0d5cf0-540c-409c-91a3-0583b7d60bbe" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_ec1ab356-28e4-4078-bc1b-e36f19140d07" xlink:href="bsx-20200930.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_ec1ab356-28e4-4078-bc1b-e36f19140d07" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1fbc7e8c-54d0-4c07-b49a-979777ea7719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1fbc7e8c-54d0-4c07-b49a-979777ea7719" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9c3cfecf-714c-4123-adeb-aafdb7d0441d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9c3cfecf-714c-4123-adeb-aafdb7d0441d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_f1fb591f-c64f-46a9-bb4a-4cc84ac62130" xlink:href="bsx-20200930.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_Netcurrencyexchangegainloss_f1fb591f-c64f-46a9-bb4a-4cc84ac62130" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c15e7750-9bec-47ba-9083-aeaaa7e0ed64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c15e7750-9bec-47ba-9083-aeaaa7e0ed64" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ae4fdc51-5a86-4a3d-ad68-a1309e04eb03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ae4fdc51-5a86-4a3d-ad68-a1309e04eb03" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bc3ca97d-578e-4db9-986d-07a80eb64c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bc3ca97d-578e-4db9-986d-07a80eb64c92" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b28e98ee-8d31-43be-b5c7-19ed388eff55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b28e98ee-8d31-43be-b5c7-19ed388eff55" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_b386e7d8-692e-4cb0-854d-0e68de214ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_b386e7d8-692e-4cb0-854d-0e68de214ee0" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c250399b-07c5-4096-8c29-bdcfd7e1b447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c250399b-07c5-4096-8c29-bdcfd7e1b447" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6dbec774-4766-492c-91c3-4d9c4058519c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6dbec774-4766-492c-91c3-4d9c4058519c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_40bb033f-c862-45a4-8f75-775cf76ab15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:to="loc_us-gaap_CashFlowHedgingMember_40bb033f-c862-45a4-8f75-775cf76ab15d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_04a7d756-78fe-4f96-ae2a-ed2e4978eba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_04a7d756-78fe-4f96-ae2a-ed2e4978eba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_93e9b4d7-1132-44a2-9238-77bc0c1a26b8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_93e9b4d7-1132-44a2-9238-77bc0c1a26b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdc98e18-2a82-4963-9de4-47df8f56b4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdc98e18-2a82-4963-9de4-47df8f56b4af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ea050cb4-5170-4a9e-b9ac-cd60e280d1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:to="loc_us-gaap_NondesignatedMember_ea050cb4-5170-4a9e-b9ac-cd60e280d1ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_83a02cf7-d835-47d5-94e5-44f0d2b39310_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_83a02cf7-d835-47d5-94e5-44f0d2b39310_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_b67b726c-0efd-4cde-b6ab-54d7fa3cfe09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_b67b726c-0efd-4cde-b6ab-54d7fa3cfe09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a22322a6-2af0-448c-916b-8681531e50f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a22322a6-2af0-448c-916b-8681531e50f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_7eee15e7-e9fa-4739-9f48-b0933fdc4488" xlink:href="bsx-20200930.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_7eee15e7-e9fa-4739-9f48-b0933fdc4488" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_3860136f-9190-4da8-b361-d69fcdb49255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_us-gaap_InterestRateContractMember_3860136f-9190-4da8-b361-d69fcdb49255" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768f40c9-3ec2-41da-a66f-7f41c0f1417c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_768f40c9-3ec2-41da-a66f-7f41c0f1417c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1bd25c5e-2462-48c4-a577-94097f5e2ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1bd25c5e-2462-48c4-a577-94097f5e2ee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_fc91cc16-bf7b-47e9-ae69-3e4285796dc4" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1bd25c5e-2462-48c4-a577-94097f5e2ee6" xlink:to="loc_bsx_BTGAcquisitionMember_fc91cc16-bf7b-47e9-ae69-3e4285796dc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1be6b871-2233-4e19-919a-2f2b75f5032f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1be6b871-2233-4e19-919a-2f2b75f5032f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_dc434edb-c432-4815-b09b-95c57783f673" xlink:href="bsx-20200930.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:to="loc_bsx_November2019AggregateOfferingMember_dc434edb-c432-4815-b09b-95c57783f673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_c2c1ee25-3165-4dbd-b3a9-a58853ffaa3f" xlink:href="bsx-20200930.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:to="loc_bsx_December2027NotesMember_c2c1ee25-3165-4dbd-b3a9-a58853ffaa3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1f99710a-b07f-447b-bb24-3d3c0b214316_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1f99710a-b07f-447b-bb24-3d3c0b214316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_3d91157f-996a-474b-9236-be9f2bda4cd3" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_bsx_LicensingarrangementassetsMember_3d91157f-996a-474b-9236-be9f2bda4cd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f1bd144-8452-4ba5-8c81-f81e83fac631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f1bd144-8452-4ba5-8c81-f81e83fac631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_439821bb-619b-4b23-a111-86853aa76da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_439821bb-619b-4b23-a111-86853aa76da1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8367d76a-fe34-4f89-b4e8-63d6d33713f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8367d76a-fe34-4f89-b4e8-63d6d33713f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3c93368d-7178-47e7-97fd-d62447d74690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3c93368d-7178-47e7-97fd-d62447d74690" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_aa01891b-89dc-471d-a8c3-b85552947597_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_aa01891b-89dc-471d-a8c3-b85552947597_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4d6d17ae-76af-47cc-96a0-253f73815289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:to="loc_us-gaap_CostOfSalesMember_4d6d17ae-76af-47cc-96a0-253f73815289" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_e9bc5eb1-f415-4b71-81b0-a85541e40763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:to="loc_us-gaap_InterestExpenseMember_e9bc5eb1-f415-4b71-81b0-a85541e40763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b763a48-7ff0-4f28-996a-4ba5e104df94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b763a48-7ff0-4f28-996a-4ba5e104df94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_fcf35e4f-8c5a-4881-9eb8-748b935ede7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_fcf35e4f-8c5a-4881-9eb8-748b935ede7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4992865d-2c97-4599-9e2b-9de7ba95dd37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4992865d-2c97-4599-9e2b-9de7ba95dd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8cc16945-5517-4ff3-a5d8-f0f254a5bc6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_DerivativeAssets_8cc16945-5517-4ff3-a5d8-f0f254a5bc6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_ea9f62e0-f376-47cf-91c1-3751829f93d2" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsasset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_Licensingarrangementsasset_ea9f62e0-f376-47cf-91c1-3751829f93d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e1b38d40-6c9f-4079-bd67-bb97ab65efaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e1b38d40-6c9f-4079-bd67-bb97ab65efaf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_16786dc5-0838-45ea-97fc-2ce8915ca328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_DerivativeLiabilities_16786dc5-0838-45ea-97fc-2ce8915ca328" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_466e9c19-4321-44aa-88bc-1f73b66c32a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_466e9c19-4321-44aa-88bc-1f73b66c32a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_89043bdc-5748-4147-bee8-e98d23c4a0ff" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsliability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_Licensingarrangementsliability_89043bdc-5748-4147-bee8-e98d23c4a0ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ae189e26-c4a9-40cd-aadf-07ef7b8ed20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ae189e26-c4a9-40cd-aadf-07ef7b8ed20b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_2264bae5-a2fb-4ccd-b37c-62b28b5fda1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_Cash_2264bae5-a2fb-4ccd-b37c-62b28b5fda1c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_6cd59127-4e15-487d-9882-4e5e4dd1dfa9" xlink:href="bsx-20200930.xsd#bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_6cd59127-4e15-487d-9882-4e5e4dd1dfa9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_bad95965-a2c7-467b-b4b3-ce42b0db1183" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_DiscountRateFairValueInput_bad95965-a2c7-467b-b4b3-ce42b0db1183" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_0987fca6-b1fd-407a-8a74-444e1b48e998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_0987fca6-b1fd-407a-8a74-444e1b48e998" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_be84a4c7-7783-4b5b-a4b0-7f026ccc7c68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_PaymentsForRoyalties_be84a4c7-7783-4b5b-a4b0-7f026ccc7c68" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_ba493a4d-7645-4caf-abb9-40b25cd4323a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_ba493a4d-7645-4caf-abb9-40b25cd4323a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_31e4c4f1-cd4a-419e-bc58-d909689fb550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_DebtInstrumentFairValue_31e4c4f1-cd4a-419e-bc58-d909689fb550" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ff923217-2a7a-43dd-9f2d-eab8bf072b16_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:to="loc_srt_RangeMember_ff923217-2a7a-43dd-9f2d-eab8bf072b16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:to="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_ca85dc59-0e6d-458b-bc32-0932c170896e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:to="loc_srt_WeightedAverageMember_ca85dc59-0e6d-458b-bc32-0932c170896e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8ca553f-dc29-46af-b23b-50853b64b2ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:to="loc_srt_MinimumMember_b8ca553f-dc29-46af-b23b-50853b64b2ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_67cabe5a-94ac-47a2-92fa-777f7f296bf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:to="loc_srt_MaximumMember_67cabe5a-94ac-47a2-92fa-777f7f296bf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3e21c6d5-e766-4af1-afb2-cd13ae26809b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3e21c6d5-e766-4af1-afb2-cd13ae26809b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_45f13832-856b-4071-a1fa-ea2bbeb6e3e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_45f13832-856b-4071-a1fa-ea2bbeb6e3e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_132ad723-bd84-45ad-b94e-9ce96997102c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_45f13832-856b-4071-a1fa-ea2bbeb6e3e3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_132ad723-bd84-45ad-b94e-9ce96997102c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0bcdfe7c-6de4-407f-9c5b-f05082e8d870_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0bcdfe7c-6de4-407f-9c5b-f05082e8d870_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c16a0f33-1585-450a-9606-c9a567671db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c16a0f33-1585-450a-9606-c9a567671db7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_59af9f24-6fa5-4975-bb25-cfdc821ff323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_59af9f24-6fa5-4975-bb25-cfdc821ff323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_94c5d6f8-9fd9-4a86-9d43-43684df81afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_94c5d6f8-9fd9-4a86-9d43-43684df81afa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_7fb5b8bc-f41d-4dc9-820e-a1756e48174b" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:to="loc_bsx_LicensingarrangementassetsMember_7fb5b8bc-f41d-4dc9-820e-a1756e48174b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_db52ca21-5ef7-49b3-ae28-5aaa363dd43e" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_db52ca21-5ef7-49b3-ae28-5aaa363dd43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EurodenominatedoutstandingdebtMember_649c13b6-f15b-4721-837c-b41708c8cbe6" xlink:href="bsx-20200930.xsd#bsx_EurodenominatedoutstandingdebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:to="loc_bsx_EurodenominatedoutstandingdebtMember_649c13b6-f15b-4721-837c-b41708c8cbe6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitments"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended" id="i9cb88fd7c9a94b7f97ec28f8885d20a4_ContractualObligationsandCommitments"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended" id="ifb1d118b81de49a89b9cbef2570a394f_ContractualObligationsandCommitmentsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_b92e3821-d40d-42b2-8fd8-20b1e332dc41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_84c84c73-be3b-4226-8274-e1c2468acc44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_b92e3821-d40d-42b2-8fd8-20b1e332dc41" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_84c84c73-be3b-4226-8274-e1c2468acc44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_b92e3821-d40d-42b2-8fd8-20b1e332dc41" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_47b8408b-5c9c-45c2-8c57-311e68034ed4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_47b8408b-5c9c-45c2-8c57-311e68034ed4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9d6c0fcf-3463-4b26-b2f8-fbacb00b5231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9d6c0fcf-3463-4b26-b2f8-fbacb00b5231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0d4805ed-70be-4ca2-97f1-51d5e0fa77f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_9d6c0fcf-3463-4b26-b2f8-fbacb00b5231" xlink:to="loc_us-gaap_CommercialPaperMember_0d4805ed-70be-4ca2-97f1-51d5e0fa77f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:to="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_534f6bcb-b6a3-4491-b5af-887d28e47b6e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_534f6bcb-b6a3-4491-b5af-887d28e47b6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e17e4327-a7d1-4e25-8d33-837ecdac4619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e17e4327-a7d1-4e25-8d33-837ecdac4619" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended" id="ia43c51b95f654471b1aaac02ac8467f9_ContractualObligationsandCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ca9f336a-f63d-4fe7-b570-987b852a7e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ca9f336a-f63d-4fe7-b570-987b852a7e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ea5af19c-802a-4589-bf95-63b28474631a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LongTermDebt_ea5af19c-802a-4589-bf95-63b28474631a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6d2ab3b8-98e7-471b-bd34-c0cff346d561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6d2ab3b8-98e7-471b-bd34-c0cff346d561" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0b5d8b21-7594-485a-915c-b325e7d832fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0b5d8b21-7594-485a-915c-b325e7d832fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c4a3b696-baec-49f9-8470-122cfa538fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c4a3b696-baec-49f9-8470-122cfa538fdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a96ac06-89de-459c-9818-e4bcda7f3803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a96ac06-89de-459c-9818-e4bcda7f3803" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_1eb8774f-a5bf-4bac-af01-c442bf277add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_1eb8774f-a5bf-4bac-af01-c442bf277add" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c1eac2d0-314b-43bb-bcb9-fce594b9a29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c1eac2d0-314b-43bb-bcb9-fce594b9a29c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_95c3be08-9522-48e1-a653-7d87d6b0e195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_95c3be08-9522-48e1-a653-7d87d6b0e195" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6bd807a7-1be4-4c99-933d-13bfb2d74a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ShortTermBorrowings_6bd807a7-1be4-4c99-933d-13bfb2d74a90" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e1cec499-082e-4343-9cc9-085a872b02f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_RepaymentsOfDebt_e1cec499-082e-4343-9cc9-085a872b02f8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ab87c5a7-41ae-4127-980d-3c66f49d2967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LineOfCredit_ab87c5a7-41ae-4127-980d-3c66f49d2967" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_657ca2b0-9077-4941-b66a-1ae7c1470b49" xlink:href="bsx-20200930.xsd#bsx_MaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_MaximumLeverageRatio_657ca2b0-9077-4941-b66a-1ae7c1470b49" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA_15a34f37-ddb1-467f-a420-0bc93d6c0a91" xlink:href="bsx-20200930.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_DeemedConsolidatedEBITDA_15a34f37-ddb1-467f-a420-0bc93d6c0a91" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_7bcc0baf-2e7b-411f-bcdf-b698eb71b10f" xlink:href="bsx-20200930.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_7bcc0baf-2e7b-411f-bcdf-b698eb71b10f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_42e48611-fe71-4045-8481-2b4a2c163ec4" xlink:href="bsx-20200930.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_42e48611-fe71-4045-8481-2b4a2c163ec4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_a183de3b-ec0e-4f23-9d7d-c7138df1e451" xlink:href="bsx-20200930.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_a183de3b-ec0e-4f23-9d7d-c7138df1e451" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2f66be43-152c-4a68-a96d-858e44bee641" xlink:href="bsx-20200930.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2f66be43-152c-4a68-a96d-858e44bee641" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_b85784e4-77f3-42c8-b7b2-b36877bafe17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_CommercialPaper_b85784e4-77f3-42c8-b7b2-b36877bafe17" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding_ca4d3264-e0e5-4c99-bcee-a4a4e4bf0922" xlink:href="bsx-20200930.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_MaximumCommercialPaperOutstanding_ca4d3264-e0e5-4c99-bcee-a4a4e4bf0922" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_dc4f98a4-f91f-4364-9ad4-fc9ccd342650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_dc4f98a4-f91f-4364-9ad4-fc9ccd342650" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageMaturityDays_9588b5c9-d944-46cc-bfb6-fc5d5376ef67" xlink:href="bsx-20200930.xsd#bsx_WeightedAverageMaturityDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_WeightedAverageMaturityDays_9588b5c9-d944-46cc-bfb6-fc5d5376ef67" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_1aa3cbac-3d0f-488e-b864-a32cdee93817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_1aa3cbac-3d0f-488e-b864-a32cdee93817" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_e460861f-1621-44e7-91c1-3f13894afc5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_e460861f-1621-44e7-91c1-3f13894afc5d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_f1f37dd5-cfab-440f-83a5-c78041370a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_f1f37dd5-cfab-440f-83a5-c78041370a84" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d678f4e7-7976-46bb-88e0-6c56a34d66ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d678f4e7-7976-46bb-88e0-6c56a34d66ec" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_7099675c-100a-4277-9c3d-7265fe389b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_7099675c-100a-4277-9c3d-7265fe389b04" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4315c651-8d4c-46c6-b8d6-da49ae150c2c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:to="loc_us-gaap_ClassOfStockDomain_4315c651-8d4c-46c6-b8d6-da49ae150c2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_55569921-d54b-46c4-af13-b927aa451687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:to="loc_us-gaap_ClassOfStockDomain_55569921-d54b-46c4-af13-b927aa451687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_46576518-8ba9-4658-9a7e-fae6b3b27581" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_55569921-d54b-46c4-af13-b927aa451687" xlink:to="loc_bsx_A550MCPSSeriesAMember_46576518-8ba9-4658-9a7e-fae6b3b27581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0cb3ac42-09c1-4969-a1f1-6a992f94046c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0cb3ac42-09c1-4969-a1f1-6a992f94046c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember_e81441d2-7102-47e5-965c-07fa48d46a46" xlink:href="bsx-20200930.xsd#bsx_April2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_April2021TermLoanMember_e81441d2-7102-47e5-965c-07fa48d46a46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember_2ff1c986-b6d6-4eb4-b6a9-72624c638398" xlink:href="bsx-20200930.xsd#bsx_A2020TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_A2020TermLoanMember_2ff1c986-b6d6-4eb4-b6a9-72624c638398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember_5e90882b-9308-42cb-ac83-56352678ed72" xlink:href="bsx-20200930.xsd#bsx_February2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_February2021TermLoanMember_5e90882b-9308-42cb-ac83-56352678ed72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember_7395b9b6-10d0-4460-8125-bda131ed3631" xlink:href="bsx-20200930.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_ThreeYearDelayedDrawTermLoanMember_7395b9b6-10d0-4460-8125-bda131ed3631" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember_2fe73c39-fb08-4a1a-83e1-d60c1a9ab194" xlink:href="bsx-20200930.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_TwoYearDelayedDrawTermLoanMember_2fe73c39-fb08-4a1a-83e1-d60c1a9ab194" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_cfefbe4a-14cb-4b9f-9891-5fe467a4a6bd" xlink:href="bsx-20200930.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_cfefbe4a-14cb-4b9f-9891-5fe467a4a6bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_c3852c11-6c5b-4fb2-9994-e50fdfab79a4" xlink:href="bsx-20200930.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_c3852c11-6c5b-4fb2-9994-e50fdfab79a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_32407f56-6ba6-4586-88ad-d538ef618873" xlink:href="bsx-20200930.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_32407f56-6ba6-4586-88ad-d538ef618873" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_4722b8ee-fca3-4c5c-b7bc-e1ba7b886053" xlink:href="bsx-20200930.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_4722b8ee-fca3-4c5c-b7bc-e1ba7b886053" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9bebdc93-6027-45b9-80f3-9f541969f245_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9bebdc93-6027-45b9-80f3-9f541969f245_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember_0df4d404-91da-4837-a85e-88509f91bf2a" xlink:href="bsx-20200930.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_February2019AggregateOfferingMember_0df4d404-91da-4837-a85e-88509f91bf2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember_c1f7049f-a177-444e-b867-65f970d911b9" xlink:href="bsx-20200930.xsd#bsx_January2020NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_January2020NotesMember_c1f7049f-a177-444e-b867-65f970d911b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember_1f97016e-c6c5-46cc-ad4b-150844706ca6" xlink:href="bsx-20200930.xsd#bsx_May2020NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2020NotesMember_1f97016e-c6c5-46cc-ad4b-150844706ca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_be35978d-c190-4c84-b95d-82e80b1505f1" xlink:href="bsx-20200930.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_November2019AggregateOfferingMember_be35978d-c190-4c84-b95d-82e80b1505f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_ebe93a1e-213c-4b7b-b19c-675f736a123e" xlink:href="bsx-20200930.xsd#bsx_May2022NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2022NotesMember_ebe93a1e-213c-4b7b-b19c-675f736a123e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_d380dc83-217f-4278-be64-dda3bc8ec63a" xlink:href="bsx-20200930.xsd#bsx_October2023NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_October2023NotesMember_d380dc83-217f-4278-be64-dda3bc8ec63a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b7b4b2a1-279f-4a47-be3d-e1dcea4a7e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b7b4b2a1-279f-4a47-be3d-e1dcea4a7e76" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_0f812751-71dd-4077-a800-727bf01b9f96" xlink:href="bsx-20200930.xsd#bsx_March2024NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2024NotesMember_0f812751-71dd-4077-a800-727bf01b9f96" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_d5193e03-feab-4ec1-b6f9-c3be0b16a8dd" xlink:href="bsx-20200930.xsd#bsx_May2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2025NotesMember_d5193e03-feab-4ec1-b6f9-c3be0b16a8dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_fceaa81e-5240-468b-8c07-78dc8bc3dfa9" xlink:href="bsx-20200930.xsd#bsx_March2026NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2026NotesMember_fceaa81e-5240-468b-8c07-78dc8bc3dfa9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_4de98e45-f9f9-4429-b240-06a282afa961" xlink:href="bsx-20200930.xsd#bsx_December2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_December2027NotesMember_4de98e45-f9f9-4429-b240-06a282afa961" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_928d9cae-44ad-49b8-b778-b7c1ee21b55e" xlink:href="bsx-20200930.xsd#bsx_March2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2028NotesMember_928d9cae-44ad-49b8-b778-b7c1ee21b55e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_ca1f1783-dc63-42da-afa8-93405c1ea69e" xlink:href="bsx-20200930.xsd#bsx_March2029NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2029NotesMember_ca1f1783-dc63-42da-afa8-93405c1ea69e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_4a92d527-a882-4e83-9c6f-c4b60853507a" xlink:href="bsx-20200930.xsd#bsx_November2035NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_November2035NotesMember_4a92d527-a882-4e83-9c6f-c4b60853507a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_65789187-51b6-47ed-a9c9-9f95313bbdc4" xlink:href="bsx-20200930.xsd#bsx_March2039NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2039NotesMember_65789187-51b6-47ed-a9c9-9f95313bbdc4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_a572d661-6a13-4eb3-9e35-c5166621de05" xlink:href="bsx-20200930.xsd#bsx_January2040NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_January2040NotesMember_a572d661-6a13-4eb3-9e35-c5166621de05" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_ca7b9414-952c-4bb7-bb82-8eebdee95de6" xlink:href="bsx-20200930.xsd#bsx_March2049NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2049NotesMember_ca7b9414-952c-4bb7-bb82-8eebdee95de6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4945b543-73dc-4057-9547-8473f29449fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_InterestRateSwapMember_4945b543-73dc-4057-9547-8473f29449fe" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_62a1e554-e9c4-43fe-8835-bcb38387b802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_62a1e554-e9c4-43fe-8835-bcb38387b802" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_05d84a7f-2770-4fe4-8c18-6b9cdad45403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_SeniorNotesMember_05d84a7f-2770-4fe4-8c18-6b9cdad45403" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_7b8d8326-03d2-4ecc-95f6-8c86ba6095f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_UnsecuredDebtMember_7b8d8326-03d2-4ecc-95f6-8c86ba6095f9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_75b5d93e-3622-41ca-b480-81179535c7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_75b5d93e-3622-41ca-b480-81179535c7cf" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_ffc8151b-0cb7-4bc8-96f2-22652332a12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_ffc8151b-0cb7-4bc8-96f2-22652332a12a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2022TermLoanMember_d5c74f09-f90e-4f81-a154-84ab5fd5baa0" xlink:href="bsx-20200930.xsd#bsx_August2022TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_August2022TermLoanMember_d5c74f09-f90e-4f81-a154-84ab5fd5baa0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember_d422dba0-2805-4a12-9038-833276b79328" xlink:href="bsx-20200930.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2020SNAggregateOfferingMember_d422dba0-2805-4a12-9038-833276b79328" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_46e6d94d-4323-44c8-a07d-a894ee6a532a" xlink:href="bsx-20200930.xsd#bsx_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_June2025NotesMember_46e6d94d-4323-44c8-a07d-a894ee6a532a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_b22a9edc-20ec-4987-9c53-9ddd6d316494" xlink:href="bsx-20200930.xsd#bsx_June2030NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_June2030NotesMember_b22a9edc-20ec-4987-9c53-9ddd6d316494" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_086d6056-5d25-4a8d-b7dd-94f4b7332b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_086d6056-5d25-4a8d-b7dd-94f4b7332b4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_3d235eb6-dbea-4cef-bfbc-4dd78f842d13" xlink:href="bsx-20200930.xsd#bsx_The2018FacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_086d6056-5d25-4a8d-b7dd-94f4b7332b4e" xlink:to="loc_bsx_The2018FacilityDomain_3d235eb6-dbea-4cef-bfbc-4dd78f842d13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_06618f91-3099-429d-bbcf-f232d13ed9a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:to="loc_us-gaap_CreditFacilityDomain_06618f91-3099-429d-bbcf-f232d13ed9a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eac41ce8-f014-4e5a-b853-4f2e3a2cc760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:to="loc_us-gaap_CreditFacilityDomain_eac41ce8-f014-4e5a-b853-4f2e3a2cc760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4a00833d-d2f3-4a95-b408-f9969fbbbad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_eac41ce8-f014-4e5a-b853-4f2e3a2cc760" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4a00833d-d2f3-4a95-b408-f9969fbbbad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:href="bsx-20200930.xsd#bsx_CovenantAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_c2a25549-7e44-4e5a-93ac-697a2a2cb985_default" xlink:href="bsx-20200930.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:to="loc_bsx_CovenantDomain_c2a25549-7e44-4e5a-93ac-697a2a2cb985_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:href="bsx-20200930.xsd#bsx_CovenantDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:to="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_8adba552-4c9e-4af6-ac01-bca3052addc0" xlink:href="bsx-20200930.xsd#bsx_CurrentRequirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_CurrentRequirementMember_8adba552-4c9e-4af6-ac01-bca3052addc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_636e6e5c-1c43-49bb-9fb2-9321409a686a" xlink:href="bsx-20200930.xsd#bsx_ActualCovenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_ActualCovenantMember_636e6e5c-1c43-49bb-9fb2-9321409a686a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_dd768cfb-4f1b-4ba1-babc-dff36a4a2638" xlink:href="bsx-20200930.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_dd768cfb-4f1b-4ba1-babc-dff36a4a2638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_6b25b7c7-f4bf-42fd-935a-a834f9d7b293" xlink:href="bsx-20200930.xsd#bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_6b25b7c7-f4bf-42fd-935a-a834f9d7b293" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_b9709854-a4e6-485b-9411-2afb5bce07f4" xlink:href="bsx-20200930.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_b9709854-a4e6-485b-9411-2afb5bce07f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_c9805401-884b-426a-b2b1-55f119638b33" xlink:href="bsx-20200930.xsd#bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_c9805401-884b-426a-b2b1-55f119638b33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Requirementextensionthroughtheremainderof2020Member_c2972047-0a42-49da-8c16-9afb7a6dda6c" xlink:href="bsx-20200930.xsd#bsx_Requirementextensionthroughtheremainderof2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_Requirementextensionthroughtheremainderof2020Member_c2972047-0a42-49da-8c16-9afb7a6dda6c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_8a89636e-a49a-4e80-b23b-305f5d17557d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_8a89636e-a49a-4e80-b23b-305f5d17557d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_389c7f5d-b378-46bd-b169-01de8ae9f3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:to="loc_us-gaap_CommercialPaperMember_389c7f5d-b378-46bd-b169-01de8ae9f3ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_a9b34315-9e8a-4750-a6f0-3aeec0c49c67" xlink:href="bsx-20200930.xsd#bsx_August2019TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:to="loc_bsx_August2019TermLoanMember_a9b34315-9e8a-4750-a6f0-3aeec0c49c67" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformation"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended" id="id42029b732ed458f8dfe68ecb79caebf_SupplementalBalanceSheetInformation"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended" id="i12546bdbdf0a430b86a34349b1ef0297_SupplementalBalanceSheetInformationTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i89c2e938b19f415488787e6810705097_SupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:href="bsx-20200930.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7fd56b4-9636-405b-94b0-2ba7826c9d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7fd56b4-9636-405b-94b0-2ba7826c9d0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b537d631-d799-43c9-a0fd-d8412f25bef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b537d631-d799-43c9-a0fd-d8412f25bef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_47f096d2-3638-4125-8b08-9f2422fb9512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_47f096d2-3638-4125-8b08-9f2422fb9512" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba54d83d-6c63-491a-b839-6c460ec4a012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba54d83d-6c63-491a-b839-6c460ec4a012" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_663af04d-8a3e-43ce-8052-7cfde8e3f7fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_663af04d-8a3e-43ce-8052-7cfde8e3f7fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c1cca6b5-e66a-4bb1-89ec-062a1cddae85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c1cca6b5-e66a-4bb1-89ec-062a1cddae85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_87693064-bdf8-4454-8e48-eca6fad7aecd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_87693064-bdf8-4454-8e48-eca6fad7aecd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8a4a2056-3283-48e5-8790-3667eb616668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8a4a2056-3283-48e5-8790-3667eb616668" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended" id="i9d75fc0c12c048c5be781b27d9d15e0f_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended" id="ifa50dbfa07c1468dadbced87bc59a96a_IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e9ff20c1-687e-4e6d-b4f1-295568b85460" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e9ff20c1-687e-4e6d-b4f1-295568b85460" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:to="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cd573a03-3267-45e5-8afe-01f61c9d6db8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:to="loc_us-gaap_VariableRateDomain_cd573a03-3267-45e5-8afe-01f61c9d6db8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b533626-ecaa-42e2-b3dc-0d3043ec41b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:to="loc_us-gaap_VariableRateDomain_1b533626-ecaa-42e2-b3dc-0d3043ec41b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="extended" id="ia3f2ee331e2f49bda8505755d4a84859_IncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended" id="i4266b2eb8ae64fc49d0bd65421351c14_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="extended" id="i8ec55e41ee644234a076447170adda77_CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i544eb397572d446798a7f6573ca809e7_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7aea2f1-18e3-41b6-ae07-67ecefb47fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7aea2f1-18e3-41b6-ae07-67ecefb47fe6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_13a995e3-caeb-49d3-a337-6a1560f0f1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_13a995e3-caeb-49d3-a337-6a1560f0f1e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f233386f-d2f6-48c7-92ae-319351ed7918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_LitigationSettlementExpense_f233386f-d2f6-48c7-92ae-319351ed7918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain_d09976ae-92f7-4fa7-8dba-4d1aa9e367ee" xlink:href="bsx-20200930.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_LitigationSettlementReceivedGain_d09976ae-92f7-4fa7-8dba-4d1aa9e367ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_3db9158c-c0a5-45b8-a86a-038aec2aa7e6" xlink:href="bsx-20200930.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_3db9158c-c0a5-45b8-a86a-038aec2aa7e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_d7c7680b-f7c8-4fe3-8a17-12917fc102b3" xlink:href="bsx-20200930.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_d7c7680b-f7c8-4fe3-8a17-12917fc102b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh_8619080b-961e-429a-a78c-5e75567ad32a" xlink:href="bsx-20200930.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_CertifiedclassactionsinCanadaMesh_8619080b-961e-429a-a78c-5e75567ad32a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_f73bdd8d-fe87-4e11-8ceb-f4963cb3892c" xlink:href="bsx-20200930.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_f73bdd8d-fe87-4e11-8ceb-f4963cb3892c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_b4e76f50-9966-4bfd-8c34-0aab991d4c45" xlink:href="bsx-20200930.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_b4e76f50-9966-4bfd-8c34-0aab991d4c45" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllegedBreachofPurchaseAgreementAmount_4c2adc55-b4ce-49a8-9ad8-15fe9604e939" xlink:href="bsx-20200930.xsd#bsx_AllegedBreachofPurchaseAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_AllegedBreachofPurchaseAgreementAmount_4c2adc55-b4ce-49a8-9ad8-15fe9604e939" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cfcd92aa-b64b-477f-8e54-4681039ff5ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cfcd92aa-b64b-477f-8e54-4681039ff5ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UpfrontCashMember_d09a228d-aa86-45d7-989b-68ab0092c445" xlink:href="bsx-20200930.xsd#bsx_UpfrontCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:to="loc_bsx_UpfrontCashMember_d09a228d-aa86-45d7-989b-68ab0092c445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumContingentPaymentMember_d53f1f8b-16e2-49d2-a6a7-91ee7309622f" xlink:href="bsx-20200930.xsd#bsx_MaximumContingentPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:to="loc_bsx_MaximumContingentPaymentMember_d53f1f8b-16e2-49d2-a6a7-91ee7309622f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1b0c6641-0fd3-4410-8be5-304ac136b3dd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:to="loc_us-gaap_LitigationStatusDomain_1b0c6641-0fd3-4410-8be5-304ac136b3dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7cd43848-7841-4b9b-ae03-0898bd6ca901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:to="loc_us-gaap_LitigationStatusDomain_7cd43848-7841-4b9b-ae03-0898bd6ca901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_e60b49bb-b45b-4c5f-aedc-87095501d690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7cd43848-7841-4b9b-ae03-0898bd6ca901" xlink:to="loc_us-gaap_SettledLitigationMember_e60b49bb-b45b-4c5f-aedc-87095501d690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d05f3679-e7e2-47b4-a93f-b1b11ffc5854_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:to="loc_srt_LitigationCaseTypeDomain_d05f3679-e7e2-47b4-a93f-b1b11ffc5854_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7dd0094c-3154-47e0-8904-1a6f28c3ad73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:to="loc_srt_LitigationCaseTypeDomain_7dd0094c-3154-47e0-8904-1a6f28c3ad73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedtoonejudgeinMAMember_20719726-fd47-4da8-b4d8-2c967a8a9fc8" xlink:href="bsx-20200930.xsd#bsx_AssignedtoonejudgeinMAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7dd0094c-3154-47e0-8904-1a6f28c3ad73" xlink:to="loc_bsx_AssignedtoonejudgeinMAMember_20719726-fd47-4da8-b4d8-2c967a8a9fc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_96b27426-b742-4397-8051-743002f28821_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_96b27426-b742-4397-8051-743002f28821_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0db68c21-ee2d-47cf-9ba2-ed8cc1c914a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0db68c21-ee2d-47cf-9ba2-ed8cc1c914a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0f03ca32-dbb5-4828-95b8-858990a8dabb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0db68c21-ee2d-47cf-9ba2-ed8cc1c914a3" xlink:to="loc_us-gaap_SubsequentEventMember_0f03ca32-dbb5-4828-95b8-858990a8dabb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20200930.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended" id="ib86970b245904ba78afda8cf07cb9dd4_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended" id="ie5eaacb15b72458091c2f7900016cee4_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_18d3f4e6-cf12-4494-8610-b289ef68c3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_18d3f4e6-cf12-4494-8610-b289ef68c3a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_45717b03-1d18-4bb2-b70c-1f19f79e413c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_45717b03-1d18-4bb2-b70c-1f19f79e413c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_4df32a9f-fee0-4593-8be6-609681f24edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_4df32a9f-fee0-4593-8be6-609681f24edd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b9587f34-faed-41a3-a61d-196995ff26f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b9587f34-faed-41a3-a61d-196995ff26f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_839284e9-18db-416a-a135-d9cf30b9449f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_839284e9-18db-416a-a135-d9cf30b9449f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2b4cb07f-38cc-4874-a422-007e6db1d3aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2b4cb07f-38cc-4874-a422-007e6db1d3aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_becef193-2044-4849-a73c-c3e39cd3f8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_becef193-2044-4849-a73c-c3e39cd3f8cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_20527c8d-22a9-43d7-8626-29cf0c2b3ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_20527c8d-22a9-43d7-8626-29cf0c2b3ba4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_d8097e20-6bfc-4e07-a134-0c091227542d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PaymentsOfDividends_d8097e20-6bfc-4e07-a134-0c091227542d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_1b700cde-599f-49e7-b2d4-2de48c0534b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_1b700cde-599f-49e7-b2d4-2de48c0534b8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_e1839808-55d5-4b1e-b587-8fcc50f92d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_DividendsPreferredStockCash_e1839808-55d5-4b1e-b587-8fcc50f92d1f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_41363269-2526-4b89-97bf-f07e6ab13049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_41363269-2526-4b89-97bf-f07e6ab13049" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5902ca6d-f07a-4984-85b4-9d560459e536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5902ca6d-f07a-4984-85b4-9d560459e536" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5403b562-5ccf-40ce-ad1d-7f51b6252177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5403b562-5ccf-40ce-ad1d-7f51b6252177" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29725dc4-c1bf-40a8-bc73-cbadb7e573a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29725dc4-c1bf-40a8-bc73-cbadb7e573a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a9175616-97a1-46a0-b207-2d9e3b8d49d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a9175616-97a1-46a0-b207-2d9e3b8d49d9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_160dbf74-502b-4979-9aac-3a69b76a868f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_160dbf74-502b-4979-9aac-3a69b76a868f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:to="loc_us-gaap_ClassOfStockDomain_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:to="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_cf9eee01-fae4-42af-9529-848547b6bc86" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:to="loc_bsx_A550MCPSSeriesAMember_cf9eee01-fae4-42af-9529-848547b6bc86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_063eff5f-9f57-4389-a76b-b2d453ddad59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:to="loc_us-gaap_CommonStockMember_063eff5f-9f57-4389-a76b-b2d453ddad59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_29c05706-1bf4-49b3-bb68-2ad3df4bfed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:to="loc_us-gaap_PreferredStockMember_29c05706-1bf4-49b3-bb68-2ad3df4bfed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d4811b32-9186-4a9d-accc-9b4246f3a9ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d4811b32-9186-4a9d-accc-9b4246f3a9ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_562482fd-a59d-4095-9963-9f23e93ad53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_562482fd-a59d-4095-9963-9f23e93ad53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1afc203a-86eb-455e-91e8-785e76ecec28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_562482fd-a59d-4095-9963-9f23e93ad53c" xlink:to="loc_us-gaap_SubsequentEventMember_1afc203a-86eb-455e-91e8-785e76ecec28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c1d66a21-89a6-4e8c-852d-95d17d7dd23e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:to="loc_srt_RangeMember_c1d66a21-89a6-4e8c-852d-95d17d7dd23e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:to="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_953dd3bc-d6dc-4be1-9247-797cf2be4400" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:to="loc_srt_MinimumMember_953dd3bc-d6dc-4be1-9247-797cf2be4400" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b9a111e-259f-423b-bb82-8244ba12f635" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:to="loc_srt_MaximumMember_2b9a111e-259f-423b-bb82-8244ba12f635" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstanding"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended" id="ibcfab64a1b6d4398a35c0e9c37c48ce9_WeightedAverageSharesOutstanding"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended" id="ie2490f9c5d03492d90a73165f2bf9f36_WeightedAverageSharesOutstandingTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended" id="ifd50a7c6df2a40d491e6c1688cd0d0db_WeightedAverageSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5faf45ac-59ba-42f2-aeaf-54c0f8ded86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5faf45ac-59ba-42f2-aeaf-54c0f8ded86d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_899b65bb-ab6a-40f0-91ad-a2028d1eb173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_899b65bb-ab6a-40f0-91ad-a2028d1eb173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2d84867-27d6-4c43-9d83-4d5c3ad48b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2d84867-27d6-4c43-9d83-4d5c3ad48b6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e59c7596-4219-46af-b721-f1b6d45348ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e59c7596-4219-46af-b721-f1b6d45348ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7fc22b8b-8833-48a5-8147-581e011ca33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7fc22b8b-8833-48a5-8147-581e011ca33b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7f7d1f77-0e62-46d8-9571-297793d7c77a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7f7d1f77-0e62-46d8-9571-297793d7c77a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_377b9830-2825-4dbd-9b9a-c43bca322d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:to="loc_us-gaap_StockCompensationPlanMember_377b9830-2825-4dbd-9b9a-c43bca322d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_eb9f8db6-a6c3-46fd-8bfa-6e120bf73986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:to="loc_us-gaap_EmployeeStockOptionMember_eb9f8db6-a6c3-46fd-8bfa-6e120bf73986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_c303b578-56e8-43d3-8243-5daa0852fbab" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:to="loc_bsx_A550MCPSSeriesAMember_c303b578-56e8-43d3-8243-5daa0852fbab" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReporting"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended" id="i646e5a1fda604b919c1ffadc6f507a15_SegmentReporting"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReportingTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended" id="i0b03ca6bca164e0e85213fbe912a2a0a_SegmentReportingTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended" id="ifea72b0c69334da9b0cffba2ac5a0f98_SegmentReportingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_281161a1-0881-480f-9c29-3a6e5f9f2bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_281161a1-0881-480f-9c29-3a6e5f9f2bb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_ba3b738a-ed08-4e18-951d-de2816202466" xlink:href="bsx-20200930.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_ba3b738a-ed08-4e18-951d-de2816202466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_8f33817a-efe1-4bfd-bf7e-d9bd80b77550" xlink:href="bsx-20200930.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_8f33817a-efe1-4bfd-bf7e-d9bd80b77550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_082b0229-a780-4708-81a2-96cf0323f483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_082b0229-a780-4708-81a2-96cf0323f483" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c41ab3a7-6a7d-49ad-a842-b49046822758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_OperatingIncomeLoss_c41ab3a7-6a7d-49ad-a842-b49046822758" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d4e4fa7d-d033-4b49-907a-09715099f27e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d4e4fa7d-d033-4b49-907a-09715099f27e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de3361f5-32e0-4d88-8874-d459d08e47b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de3361f5-32e0-4d88-8874-d459d08e47b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_6196cd7d-e638-4429-91a7-594dbdce4069" xlink:href="bsx-20200930.xsd#bsx_SegmentOperatingIncomeasaPercentageofNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_6196cd7d-e638-4429-91a7-594dbdce4069" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a8201d62-7881-4c30-ad57-4a214e50cd9a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:to="loc_us-gaap_SegmentDomain_a8201d62-7881-4c30-ad57-4a214e50cd9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:to="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_cefc02a1-9ff0-4bd2-9546-1d41dfefe049" xlink:href="bsx-20200930.xsd#bsx_MedsurgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_MedsurgMember_cefc02a1-9ff0-4bd2-9546-1d41dfefe049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_71e175a9-9ef8-4b22-b7e5-0f5a9770d32e" xlink:href="bsx-20200930.xsd#bsx_RhythmandNeuroMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_RhythmandNeuroMember_71e175a9-9ef8-4b22-b7e5-0f5a9770d32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_8db29de2-dad8-4387-be91-2835f8f29f5c" xlink:href="bsx-20200930.xsd#bsx_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_CardiovascularMember_8db29de2-dad8-4387-be91-2835f8f29f5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_9b914d4f-d823-4d9d-a80f-f3359a191b29" xlink:href="bsx-20200930.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_BSXReportableSegmentsMember_9b914d4f-d823-4d9d-a80f-f3359a191b29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_aaccc618-ed73-4028-8862-bc95ab982db1" xlink:href="bsx-20200930.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_aaccc618-ed73-4028-8862-bc95ab982db1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_cf1eb8c3-e01d-4ddb-af9a-f59a1a6cbe5e" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_cf1eb8c3-e01d-4ddb-af9a-f59a1a6cbe5e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_b8f4cfb7-143a-4455-a1db-73a666a2e65d" xlink:href="bsx-20200930.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_b8f4cfb7-143a-4455-a1db-73a666a2e65d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_29edf6c7-3670-4729-8e1b-18b6c4db8cba" xlink:href="bsx-20200930.xsd#bsx_SpecialChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_SpecialChargesMember_29edf6c7-3670-4729-8e1b-18b6c4db8cba" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20200930.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended" id="i00a7638e343144ed887c3c6f414b552e_Revenue"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended" id="i3e54d753bdaf43dabfb9b014ebff8aeb_RevenueTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended" id="ied84d3670e3f444e882854b8a71642b8_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries_1822ff8c-bcaf-4d0e-9a75-75aa617ee63d" xlink:href="bsx-20200930.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:to="loc_bsx_EmergingMarketstotalnumberofcountries_1822ff8c-bcaf-4d0e-9a75-75aa617ee63d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_abae130f-76d0-46ea-8843-167eb05e230f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_abae130f-76d0-46ea-8843-167eb05e230f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_18d9601b-490b-44fa-b42d-a3f93ba73280_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:to="loc_us-gaap_SegmentDomain_18d9601b-490b-44fa-b42d-a3f93ba73280_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c9bf3541-81cf-4780-b190-19f61260e4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:to="loc_us-gaap_SegmentDomain_c9bf3541-81cf-4780-b190-19f61260e4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_6b1cde10-f4bd-41fc-bb7d-28e6c4c8fe91" xlink:href="bsx-20200930.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9bf3541-81cf-4780-b190-19f61260e4db" xlink:to="loc_bsx_BSXReportableSegmentsMember_6b1cde10-f4bd-41fc-bb7d-28e6c4c8fe91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_082cda7c-a705-46ee-bd17-5735beb4dbf5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:to="loc_srt_ProductsAndServicesDomain_082cda7c-a705-46ee-bd17-5735beb4dbf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:to="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_7413fa64-0bc4-4b86-ba3d-ee9546f47059" xlink:href="bsx-20200930.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_7413fa64-0bc4-4b86-ba3d-ee9546f47059" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_c69e7549-830e-49f1-9c04-a2a57835bfd5" xlink:href="bsx-20200930.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_c69e7549-830e-49f1-9c04-a2a57835bfd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_21948cf7-06c0-48bf-94c3-6bec37ab9baa" xlink:href="bsx-20200930.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_21948cf7-06c0-48bf-94c3-6bec37ab9baa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_6ce03e73-8930-4960-a257-b8802b13fa8d" xlink:href="bsx-20200930.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_6ce03e73-8930-4960-a257-b8802b13fa8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_58cb1791-e4a5-4775-be47-36e5d4cd4271" xlink:href="bsx-20200930.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_58cb1791-e4a5-4775-be47-36e5d4cd4271" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_1a10d4d2-47ff-4f7f-bf5a-4bb71d8b4afa" xlink:href="bsx-20200930.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_1a10d4d2-47ff-4f7f-bf5a-4bb71d8b4afa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_190ccffa-47c3-49ec-8dec-c0792c0a5552" xlink:href="bsx-20200930.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_190ccffa-47c3-49ec-8dec-c0792c0a5552" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_b5916387-209e-4210-8577-4aad4be58335" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_b5916387-209e-4210-8577-4aad4be58335" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_32daa403-3f8b-4f5a-9a29-901817882a0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:to="loc_srt_SegmentGeographicalDomain_32daa403-3f8b-4f5a-9a29-901817882a0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:to="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e5d957f1-136d-49f6-a6ac-2ab1d516a617" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_country_US_e5d957f1-136d-49f6-a6ac-2ab1d516a617" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_9a6c89f9-124b-4452-a6c6-e73544c38359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_us-gaap_NonUsMember_9a6c89f9-124b-4452-a6c6-e73544c38359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_a5c504ae-30e9-4e4c-83b5-2f769e54f2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_us-gaap_EMEAMember_a5c504ae-30e9-4e4c-83b5-2f769e54f2e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_b8e1770d-fad2-49a3-bddf-f8732fba29ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_srt_AsiaPacificMember_b8e1770d-fad2-49a3-bddf-f8732fba29ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_d9bdafa3-fa65-4a5e-9fbb-732197d1dc3e" xlink:href="bsx-20200930.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_bsx_LatinAmericaandCanadaMember_d9bdafa3-fa65-4a5e-9fbb-732197d1dc3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_12154f0c-b3b4-4ec9-953b-16c1a1fb1612" xlink:href="bsx-20200930.xsd#bsx_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_bsx_EmergingMarketsMember_12154f0c-b3b4-4ec9-953b-16c1a1fb1612" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended" id="i683c4bfd58f64ad5bce2c1466664a5d4_ChangesinOtherComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="extended" id="i0209c136cefa4f979d284ebf151a7e8e_ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended" id="i1f13af5d328947d18e67a8b1ca090eeb_ChangesinOtherComprehensiveIncomeTables"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended" id="i47dd5754c69146c7a11f9be5359a1b44_ChangesinOtherComprehensiveIncomeDetails"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20200930.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended" id="idcea168951c44098968f631eb8060d31_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#NewAccountingPronouncementsPolicies"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended" id="i9aaf7c0076f145e2b72563d505aa8514_NewAccountingPronouncementsPolicies"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bsx-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:5aff39ba-e31d-4daa-a93a-6fdd4a47e66b,g:1fac046f-4056-4f94-9a0f-fce45535a3a4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_f5c47225-3985-4b5e-a8e5-4118afbcb192_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2e62ef1c-4b61-424e-9581-5a50b65fda89_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_59439164-974b-4cb7-ac50-ab86a54cfc5d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_db9e5d00-9382-4d44-8e74-f3bd66ff4522_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0b360e45-58de-42eb-b74e-7d7dfdf02cae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_a04dd21f-3740-4295-a7f4-9b739f411347_terseLabel_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal payments remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20200930.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_662f0d62-e53a-4c40-af01-12c1d1e1d504_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_674ea005-a381-41f7-9adc-69f2dfd2ac4c_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_8584a1ea-94cf-41c9-9d30-222832881ffe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingleaseLiabilityAxis_658e16d8-0244-4265-9b24-14f9c91e57ef_terseLabel_en-US" xlink:label="lab_bsx_OperatingleaseLiabilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Liability [Axis]</link:label>
    <link:label id="lab_bsx_OperatingleaseLiabilityAxis_label_en-US" xlink:label="lab_bsx_OperatingleaseLiabilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Liability [Axis]</link:label>
    <link:label id="lab_bsx_OperatingleaseLiabilityAxis_documentation_en-US" xlink:label="lab_bsx_OperatingleaseLiabilityAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Liability [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityAxis" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingleaseLiabilityAxis" xlink:to="lab_bsx_OperatingleaseLiabilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c37b7422-5edc-4466-89de-915c665a61b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Other Comprehensive Income [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_a2bc5c75-30ff-4952-9b12-43bb62310663_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_6f9150fa-2cc7-48f1-9461-9cfc6aec3449_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_bf297f53-5cd0-4f29-af2e-2a1d82042b3b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_dcb8c3ba-fe06-419a-83af-aa1e39b139e6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_3d65330a-572f-4bd7-a87f-0692369532e2_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_a10c46f4-c700-47e0-8a64-96d972360f0e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d26900a5-a270-40f7-ad6c-f1b5440b8969_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_52863a49-f865-47fb-81b8-edd99b1839ee_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_cb5b88c1-f8d3-4abc-aaf3-b854bb5e7be9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9bf9641f-c359-4a0e-9c3e-4decc1f60f5c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_70a2b9fc-46c8-4b3f-88c3-afbd6ef9009d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings on credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_377fa3ff-5ccd-4d18-8f25-fb53707affc1_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_26940534-76c8-4d91-8930-1e94de791cbf_verboseLabel_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_label_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_documentation_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:href="bsx-20200930.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:to="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_b3721fad-5930-462d-b124-11cabc079f7c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_The2018FacilityDomain_18115280-d96c-4aab-845a-12f390bf286b_terseLabel_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Member]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_label_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility [Domain]</link:label>
    <link:label id="lab_bsx_The2018FacilityDomain_documentation_en-US" xlink:label="lab_bsx_The2018FacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">the 2018 Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain" xlink:href="bsx-20200930.xsd#bsx_The2018FacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_The2018FacilityDomain" xlink:to="lab_bsx_The2018FacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f36a4ea3-2b79-4ca3-ba95-568cc1c1d729_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_55b34553-7ead-4a7d-bcd2-7d610cc455d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c266910c-c6a4-4f33-a56c-c142babd077b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1ad2924e-d9c5-447a-820b-50b90fbbe7cb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9e67aa12-2fb9-4112-9bbf-66ba6a0c7a87_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_2fb99392-8b78-4b57-abc7-7dfa9421c627_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_fd150983-ddda-4e95-9b84-0c0f0a162348_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d95d65f3-0856-473e-9b82-06e1f052101e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1429c456-60b3-436f-aa3e-650fad556094_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9f254b57-b79b-4f60-9193-42193638882a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_b4e90bcf-1e0f-4054-9b52-99858b5702fe_terseLabel_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bsx_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bsx_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract" xlink:href="bsx-20200930.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherCurrentAssetsAbstract" xlink:to="lab_bsx_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2371609c-b21f-419b-9c5a-a7eb61cd6a5c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_bf6334b2-b65a-4340-89dd-df3645052684_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5b0605e6-8229-423c-a3f3-e0be9c56d032_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_99c2d624-4f8d-408c-ad7e-1fa2eecaad12_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_6e8e02f9-aa0e-494b-9bcb-6148d85b16b6_negatedLabel_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_label_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_bsx_PaymentOfContingentConsideration_documentation_en-US" xlink:label="lab_bsx_PaymentOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration" xlink:href="bsx-20200930.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_PaymentOfContingentConsideration" xlink:to="lab_bsx_PaymentOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_475f1df4-b9f0-4f4a-a4a6-ab6c83abd05e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_800d37ec-afdb-4fa2-bb14-26ade0686b00_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_1cdea5ef-542c-4078-abd5-81bfd2d27a58_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_78c36cbe-a07c-4f84-80fc-f8262e8665ea_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ActualCovenantMember_c81ef3be-ad85-4dd6-a8b0-94c293949912_terseLabel_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_label_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual, Covenant [Member]</link:label>
    <link:label id="lab_bsx_ActualCovenantMember_documentation_en-US" xlink:label="lab_bsx_ActualCovenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember" xlink:href="bsx-20200930.xsd#bsx_ActualCovenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ActualCovenantMember" xlink:to="lab_bsx_ActualCovenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_ebd53f90-696f-429a-bc23-490790d38e8e_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:href="bsx-20200930.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:to="lab_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_58c9cf42-25e3-4eb2-b5e3-5c8fb023b3d8_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MedsurgMember_d4d86c3f-adeb-48c9-914e-741f51e31d1f_terseLabel_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_label_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:label id="lab_bsx_MedsurgMember_documentation_en-US" xlink:label="lab_bsx_MedsurgMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember" xlink:href="bsx-20200930.xsd#bsx_MedsurgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MedsurgMember" xlink:to="lab_bsx_MedsurgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_3435d989-8774-48f4-ba03-f4dbbeb8968d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_c4aa3668-8dcf-4b08-b638-7008945bcc5c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_673d08aa-345f-49b7-91c1-2e52a608dd22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_fd9896f0-523e-4959-a1e9-dc20e7a96d80_terseLabel_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_label_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_documentation_en-US" xlink:label="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:href="bsx-20200930.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:to="lab_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8030f255-2c8c-4675-9b2d-df1d13ad2985_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_65278103-e569-42ce-a52c-918226020fdb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_6c24f122-070c-4f8d-8fd3-61770ff1900d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_0f2e2669-e97b-47ba-a039-8c4337dcca0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f773ac8a-97fc-4580-9882-840e2694d144_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_912b5b6c-0f1f-46b0-bfaa-751faa8240e1_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20200930.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_ef512a80-7bcc-41fd-9f2d-98432d9facb1_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_d6f180f8-0b32-4748-8ee4-6ca624c56f74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3afa68cb-e018-4919-9054-efff53f88b47_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_7c03f1fa-31ef-4918-8814-c46ca4713285_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6411c285-656b-4bfa-aac4-9a983f4e9ac6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c4b13fd1-6e07-41a0-a9ac-124113c69288_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_e4f26868-7836-4a9b-a24e-b9bc0dfaf820_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_122b10a5-0e0d-48de-9a3c-f794fa37f76d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of September 30, 2020 and none as of December 31, 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangements_9b8dcb8e-178c-40e5-9824-e6c3d82b69b1_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_label_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:label id="lab_bsx_Licensingarrangements_documentation_en-US" xlink:label="lab_bsx_Licensingarrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangements" xlink:to="lab_bsx_Licensingarrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201613PolicyTextBlock_843c1326-81f1-418a-8b98-dfd8179de20c_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201613PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2016-13 [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201613PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201613PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2016-13 [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201613PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201613PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201613PolicyTextBlock" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201613PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201613PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201613PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_88245701-1c4b-44a0-8c98-271f03f34e8d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_68bc3a53-defb-4b6a-ad9b-3ab17212fa3d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingleaseLiabilityDomain_18d23b26-a354-4081-970b-784bc2270fd0_terseLabel_en-US" xlink:label="lab_bsx_OperatingleaseLiabilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Liability [Domain]</link:label>
    <link:label id="lab_bsx_OperatingleaseLiabilityDomain_label_en-US" xlink:label="lab_bsx_OperatingleaseLiabilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Liability [Domain]</link:label>
    <link:label id="lab_bsx_OperatingleaseLiabilityDomain_documentation_en-US" xlink:label="lab_bsx_OperatingleaseLiabilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Operating lease, Liability [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityDomain" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingleaseLiabilityDomain" xlink:to="lab_bsx_OperatingleaseLiabilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_59b33302-910c-4238-81d7-0a6c5a470b25_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_a065a48f-ff0b-4f2e-8893-d2babad1af44_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e7dd43ed-2904-4f00-b55f-efde1af4a0a8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_7d460518-86c9-4cec-9ced-a2d9e84d926a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CardiovascularMember_33f3964e-4f80-4212-8f91-2afa29d0d673_terseLabel_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_label_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_bsx_CardiovascularMember_documentation_en-US" xlink:label="lab_bsx_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember" xlink:href="bsx-20200930.xsd#bsx_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CardiovascularMember" xlink:to="lab_bsx_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_dc84c07a-fbe7-4614-945f-2d0bb4c74478_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c3bdf2f2-9e00-4658-af57-a49f788e6c65_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d205d0a5-d493-4de7-93ff-524a439d4e5e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_786f5ce0-f8e3-4051-8fbf-6f4b37d0a4b3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6a7da753-cab5-4fdb-bbe5-7f4ecf9c2297_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalty rights</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_6708835c-a479-42ef-aebe-1ef6ed28e5c9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_61f9d3ee-e7de-4e6b-8d94-0dbe669eae51_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</link:label>
    <link:label id="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:to="lab_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_543dbe6a-bb34-45f1-9504-8985d8330692_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_cfdba460-e222-4c5c-9b1b-f63bd387ca41_terseLabel_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_label_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:label id="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_documentation_en-US" xlink:label="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D, Regulatory and Commercialization-based Milestone [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:href="bsx-20200930.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:to="lab_bsx_RDRegulatoryandCommercializationbasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54e83891-893e-4f65-bd77-a4eb17af7fce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rates on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_9e589f81-d837-42c5-87c3-9b22d5e91f77_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_81cfe787-1450-4ebe-b893-9a3a2483ada2_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_6436eaa1-96ba-4064-81bf-779042e52264_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_65597022-4152-4612-94bd-b17b936b32e7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c6d098bf-a99d-4f16-b67d-fcc75da8aa51_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_7f78e964-3a74-40e6-9c4c-1c27357143d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_7ee2446c-2244-4b8d-9443-a25a00e2e522_terseLabel_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_EuroDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Factoring Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:href="bsx-20200930.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EuroDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_EuroDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_1dc6983c-90fb-4ea1-8bee-f9f1527d2360_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_4ca8f47e-cb94-483a-a796-f49edf620601_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_0f67322a-d449-4694-a1eb-41e6caaf4eb9_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-10 Codification Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_4cec0e55-1fed-4f1e-ad92-f8e623b82a9a_terseLabel_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology (Uro) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Urology and Pelvic Health Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:to="lab_bsx_GlobalUrologyandPelvicHealthReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_37614c19-eacf-467d-9d14-5c3ac590478f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_VertiflexIncMember_d1661623-fd3b-41c5-9b20-e110ac9fb27b_terseLabel_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc. [Member]</link:label>
    <link:label id="lab_bsx_VertiflexIncMember_label_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc. [Member]</link:label>
    <link:label id="lab_bsx_VertiflexIncMember_documentation_en-US" xlink:label="lab_bsx_VertiflexIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertiflex, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember" xlink:href="bsx-20200930.xsd#bsx_VertiflexIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_VertiflexIncMember" xlink:to="lab_bsx_VertiflexIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_0297877a-7484-46d1-94d7-14add5185fa6_terseLabel_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Peripheral Interventions (PI) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:to="lab_bsx_GlobalPeripheralInterventionsPiReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e40edc13-44a8-4415-a540-5165a4786177_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_e5cfec53-e308-4739-a947-d6964f8612c0_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment_f2933197-6c01-4feb-9f29-f1e81e070029_negatedTerseLabel_en-US" xlink:label="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration and royalty rights established in purchase accounting</link:label>
    <link:label id="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment_label_en-US" xlink:label="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Cash Payment</link:label>
    <link:label id="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment_documentation_en-US" xlink:label="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Cash Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment" xlink:href="bsx-20200930.xsd#bsx_BusinessAcquisitionContingentConsiderationCashPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment" xlink:to="lab_bsx_BusinessAcquisitionContingentConsiderationCashPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_be7d1ea7-d420-4c94-8a41-a5fa0f8c3459_terseLabel_en-US" xlink:label="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fourth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fourth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fourth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20200930.xsd#bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201818PolicyTextBlock_12090015-0bad-4bdb-ae86-5d405245a32f_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201818PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-18 [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201818PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201818PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-18 [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201818PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201818PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying The Interaction Between Topic 808 and Topic 606 [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201818PolicyTextBlock" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201818PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201818PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201818PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_88fb3cfd-deba-4829-88be-3766ef3e3490_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_69c27b0b-8783-4aa0-afc5-70c64e04eddb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_59787a4b-00e5-4af5-92bb-2984e7babb24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_February2021TermLoanMember_080630ac-6d0e-470c-945e-670b40aea979_terseLabel_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_February2021TermLoanMember_label_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_February2021TermLoanMember_documentation_en-US" xlink:label="lab_bsx_February2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember" xlink:href="bsx-20200930.xsd#bsx_February2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_February2021TermLoanMember" xlink:to="lab_bsx_February2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_0f9c1442-9dfc-4812-94e5-2546b742318e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_2e7ced26-460b-4ee6-b3db-d7c5985f1bf5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Par value)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_7b700d33-4ba0-4818-b60b-7e1904b8f187_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_e2bdd473-6356-40e5-a9de-3f0217365954_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5b6b3817-d9fd-4b8e-aa7b-4815bb1e2080_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_1aefe691-2181-425a-92ef-bfa817ee24d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_db6cfa6b-9295-4b14-9250-ccf2ef484b2d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_107ddd91-47bb-41b2-8092-32e881f5e25a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_844ee8fc-22ff-46e6-a5d1-5f32397667ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantAxis_be95f31b-7af6-4573-ae2c-634f872df1b9_terseLabel_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_label_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Axis]</link:label>
    <link:label id="lab_bsx_CovenantAxis_documentation_en-US" xlink:label="lab_bsx_CovenantAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis" xlink:href="bsx-20200930.xsd#bsx_CovenantAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantAxis" xlink:to="lab_bsx_CovenantAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_47611dbc-2612-4fc3-ab89-5147d038fcc6_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_69cf822b-a4b5-4aaa-bd4d-5c01f8fb2537_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_ec9ad92b-8fe3-461b-84d5-70fbeaa14087_verboseLabel_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses and currency exchange [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_label_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:label id="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember_documentation_en-US" xlink:label="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses including hedging activities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:href="bsx-20200930.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:to="lab_bsx_CorporateExpensesincludinghedgingactivitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_2ec6458d-4aea-4260-a4f0-811510a42c79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_58435f98-6318-4649-b9d0-7f3c70a6adbb_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_b187f4ac-1db5-44c0-a33d-84ac90178486_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on borrowings from credit facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales_83cebe82-7941-44f2-9804-4511c4dd8f9b_terseLabel_en-US" xlink:label="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income as a Percentage of Net Sales</link:label>
    <link:label id="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales_label_en-US" xlink:label="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income as a Percentage of Net Sales</link:label>
    <link:label id="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales_documentation_en-US" xlink:label="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income as a Percentage of Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:href="bsx-20200930.xsd#bsx_SegmentOperatingIncomeasaPercentageofNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:to="lab_bsx_SegmentOperatingIncomeasaPercentageofNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_ffbf5203-b01a-4e97-8ae2-b91d2b8f3eba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_10de9877-f4c0-413f-a4ac-8f33b4a74ab9_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2028NotesMember_3852dff4-e2a9-426e-a9f6-659ed26f198c_verboseLabel_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_label_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2028NotesMember_documentation_en-US" xlink:label="lab_bsx_March2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2028 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember" xlink:href="bsx-20200930.xsd#bsx_March2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2028NotesMember" xlink:to="lab_bsx_March2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_0588ff3b-682e-4805-b129-a7dca5f08220_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_e6f66328-5dec-491c-8513-7706cd81712b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_b8ec0e8c-438e-4196-ac13-a36816768690_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_1caed240-b1df-4c4c-a71e-0f69ad7f5fc4_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Common stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:href="bsx-20200930.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_663f5eb6-f280-44c7-a5ff-db70d87aa88a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock_97c06b3f-f73d-4ca7-82b8-dc06c0190cab_terseLabel_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]</link:label>
    <link:label id="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" xlink:href="bsx-20200930.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" xlink:to="lab_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_da5f8cfe-c2b6-4291-9870-cb3f96df3375_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_868d1bf4-95b0-4118-86a1-d04dd949c5ad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8f606dcc-cbf2-40cf-918c-4265a555ea85_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_88b19d69-fcae-49d3-b343-5647f66a8fe4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_39db5ff9-a4a1-4f20-a4e3-66227eedc810_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion_a1d48b83-ae42-4977-98e6-5b676acf961d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Terms of Conversion</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Terms of Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_cdc7a64a-cfc5-4ed9-a4e9-7dd22e4604e8_terseLabel_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_label_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:label id="lab_bsx_ExclusionFromEbitdaForRestructuringCharges_documentation_en-US" xlink:label="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion from EBITDA for Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:href="bsx-20200930.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:to="lab_bsx_ExclusionFromEbitdaForRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_2ffba292-7d04-4192-b78d-cbc560d9751d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_92e3764b-01f2-40ef-90c6-08a109c83e57_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_de686c39-60e5-4f77-90c3-badfb4c5ac82_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementliabilitiesMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementliabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementliabilitiesMember" xlink:to="lab_bsx_LicensingarrangementliabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b163ce5-b2fa-4a42-90b7-9a4464d08dd6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_August2019TermLoanMember_57261224-e943-42c5-a63a-13bbc0a464f4_terseLabel_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2019TermLoanMember_label_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2019TermLoanMember_documentation_en-US" xlink:label="lab_bsx_August2019TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2019 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember" xlink:href="bsx-20200930.xsd#bsx_August2019TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_August2019TermLoanMember" xlink:to="lab_bsx_August2019TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_2e330a26-41f7-4582-a6ea-94d90bb68606_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_e8ce3845-b54e-47a2-a390-9c3fa321fb39_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect adjustment for adoption of ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_b002fbe6-4e8b-4066-8dfa-9ea6acc16752_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:to="lab_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_42e0d5dc-b3e9-4c6f-a99d-d1aa8cb54ecb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_66b92685-2dfa-4ff2-b747-36ab6e65c103_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_4d3ac9c1-4885-444a-9d2e-9a1cf261418d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for settlements of hedge contracts</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_7bfaa2f7-6238-4bfb-a1ab-6b00dfe96ce5_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeInvestingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3b04920c-2a9b-432c-9721-b6f9a49e5eb7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_aab51739-2ad9-40b4-849b-407a1cad892d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_c3ca5c94-a858-447d-a500-115c8e6cbed9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_fc8ec98b-97e3-46e9-858d-69529dfa2cd1_terseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_341741ab-45c3-44d2-adf1-57ed7c68b6f5_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_660fd096-b23e-438f-a56e-95ed5330f84d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9df267e7-1db5-4587-aa6a-3d5ddb511e06_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_79e78ed8-c2a0-4f0b-b2f1-41d34c8aefbd_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL BALANCE SHEET INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_956839e1-b023-473f-9ace-fd7c9718a397_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligation</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsMember_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsMember" xlink:to="lab_us-gaap_CapitalLeaseObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_53f427fb-5023-423d-8e1e-e26e9f23abe9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b52955de-4fef-4fb3-8b69-1388fa9e524e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumContingentPaymentMember_acd9c93d-be2e-4713-b5a2-972dbd5f0d5f_terseLabel_en-US" xlink:label="lab_bsx_MaximumContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Payment [Member]</link:label>
    <link:label id="lab_bsx_MaximumContingentPaymentMember_label_en-US" xlink:label="lab_bsx_MaximumContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Payment [Member]</link:label>
    <link:label id="lab_bsx_MaximumContingentPaymentMember_documentation_en-US" xlink:label="lab_bsx_MaximumContingentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Contingent Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumContingentPaymentMember" xlink:href="bsx-20200930.xsd#bsx_MaximumContingentPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumContingentPaymentMember" xlink:to="lab_bsx_MaximumContingentPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c7ad5547-d19d-43f0-9370-8039ae9b7733_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_b73cd804-fbde-495e-9cd0-7e6ad65cb1de_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_5c357930-506f-4327-ab1f-1426b30af263_negatedTerseLabel_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_label_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:label id="lab_bsx_Paymenttonetsharesettleemployeeequityawards_documentation_en-US" xlink:label="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to net share settle employee equity awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:href="bsx-20200930.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:to="lab_bsx_Paymenttonetsharesettleemployeeequityawards" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_UpfrontCashMember_3271b306-054a-4ac5-b923-93b47f2ebb33_terseLabel_en-US" xlink:label="lab_bsx_UpfrontCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Cash [Member]</link:label>
    <link:label id="lab_bsx_UpfrontCashMember_label_en-US" xlink:label="lab_bsx_UpfrontCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Cash [Member]</link:label>
    <link:label id="lab_bsx_UpfrontCashMember_documentation_en-US" xlink:label="lab_bsx_UpfrontCashMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UpfrontCashMember" xlink:href="bsx-20200930.xsd#bsx_UpfrontCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_UpfrontCashMember" xlink:to="lab_bsx_UpfrontCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_05069544-8843-4067-b446-5bb040ecd151_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_9531deef-55ae-40c8-ad70-277a3a951f9d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_356c40b2-86ce-4579-a930-d045decc84a3_negatedLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation-related net charges (credits)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_439563aa-fbbe-4283-921c-e5d587e842f9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash equivalents included in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_209158c9-bf6d-4958-aeba-3ddd0fd1ced7_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents in Other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_020ecc8b-c5fe-4bda-8485-3a36673605ca_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_label_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:label id="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration liability, probability of payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:href="bsx-20200930.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:to="lab_bsx_ContingentConsiderationLiabilityProbabilityOfPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_13f4d16b-dd59-4830-b0d3-8bf26f70d474_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_9e6f3ea3-c7a0-49de-93fb-7d3cb67bef66_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8ee110e9-d40e-4239-931d-8886eaf4f73e_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50c3f094-a3e2-4e4f-81ff-71a5287b936f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ef24cbb6-5780-4a51-833b-40a379ac5c5d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_d87bee61-5933-448c-8ca1-a0153f6bc25c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_59c634c8-ce49-453a-96f7-8df173726d2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_3102515c-0d84-43ee-a9d5-6244b1e6f9c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_0a1b0ab2-8d2d-4f8d-b000-8cbabcd15f16_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_72a98b14-a671-4003-8541-af158318172b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_f249a9ef-4bfb-417d-88fc-15b300c43f2a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_895c2880-d0de-4110-b28a-54ecf8d98129_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_79d4de4d-29de-49c9-bda1-736bcedb99fb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_c03817c3-ec57-44b9-87b0-8febcfeac495_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CovenantDomain_29518366-43ab-4402-ba13-86f32fae284e_terseLabel_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_label_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant [Domain]</link:label>
    <link:label id="lab_bsx_CovenantDomain_documentation_en-US" xlink:label="lab_bsx_CovenantDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain" xlink:href="bsx-20200930.xsd#bsx_CovenantDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CovenantDomain" xlink:to="lab_bsx_CovenantDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillMember_984d0e8a-eac3-4f58-a3ad-4a8e6dffe91e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:label id="lab_us-gaap_GoodwillMember_label_en-US" xlink:label="lab_us-gaap_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillMember" xlink:to="lab_us-gaap_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RhythmandNeuroMember_8206e5c9-bd1f-4d04-bcf9-d8e970c80577_terseLabel_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_label_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:label id="lab_bsx_RhythmandNeuroMember_documentation_en-US" xlink:label="lab_bsx_RhythmandNeuroMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhythm and Neuro [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember" xlink:href="bsx-20200930.xsd#bsx_RhythmandNeuroMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RhythmandNeuroMember" xlink:to="lab_bsx_RhythmandNeuroMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_220961f9-5941-4861-9d2a-4e6b45078c0a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7750f51c-926d-40ed-8cf3-435239baf2b0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d28e1fa9-ce70-423b-8a98-1c5d94834902_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_2fb061e9-2356-4d23-8d5a-bedd95e0215b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_6b3eabbf-4671-4261-ae77-f446cceaa63a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c9e4ac7a-c8ec-4efa-8740-9fb3886d33ec_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b70a06d7-c27e-4a1a-ae1d-acab15638706_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2020NotesMember_fc39dd8e-3475-4150-a15f-9be55132c82e_terseLabel_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2020NotesMember_label_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2020NotesMember_documentation_en-US" xlink:label="lab_bsx_May2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember" xlink:href="bsx-20200930.xsd#bsx_May2020NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2020NotesMember" xlink:to="lab_bsx_May2020NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_6ee1aa45-81dd-43c3-91d4-45ba968661ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_24cfa332-f592-4fdb-9cec-226836c4652e_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_935c863b-b394-43da-8c0f-e09d0e800cdf_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_ace659dd-df8a-4949-9bc0-d8c6aa74a61a_terseLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_48babda9-8e21-498b-b608-f6a6b6d93fbd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_d7261f33-4886-4d10-9ee7-f5e4d85e7af5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_d60e7ffb-6c42-469b-98d7-778d308876a0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_f26f4c09-45cd-43e6-8df3-2ab6df6980a9_terseLabel_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_label_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bsx_SpecialtyPharmaceuticalsMember_documentation_en-US" xlink:label="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialtyPharmaceuticalsMember" xlink:to="lab_bsx_SpecialtyPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_6e3083d9-81cb-4f7d-a94f-42a90fc9b22c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_24b16b4a-dedf-4ff2-a1b9-3dd0f088a503_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_cdef4bf6-205d-4d57-b85b-fe46372604c9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_d188494e-82c6-4231-90d1-ac8b3f7d2a15_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ba76d0cb-9929-4fa6-a926-0771d31424f0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_34c9e33a-982e-46f7-ab74-c18150959773_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_48807802-2340-4560-bd28-d0492b7ebe42_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_341961ce-a9ed-4074-a4bb-9d65079efb76_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_bc63fb37-97ea-421b-9a55-1ef83d7563d1_terseLabel_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_label_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:label id="lab_bsx_ForeigncurrencydenominatedindebtMember_documentation_en-US" xlink:label="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">foreign currency denominated in debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:href="bsx-20200930.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForeigncurrencydenominatedindebtMember" xlink:to="lab_bsx_ForeigncurrencydenominatedindebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_1b9f82d0-3e7b-46d7-8465-136eb6a52825_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c1b8d616-4f65-479b-a006-14121cd6d5a5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_ee02525c-d8a7-4e8e-9762-7d32f1905a32_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_0c506c5a-bb88-4791-9d71-f1f1395c1f4f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3e2d55f4-b57f-489f-98d7-512f161681ba_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_fed99d3e-4f06-41b8-a0c9-8dabc3fddc6f_terseLabel_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_documentation_en-US" xlink:label="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:href="bsx-20200930.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:to="lab_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_fbc0587d-0311-4e53-bb09-c9118f94c59d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings, Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_fcacb27c-8d96-42e7-8414-6e3e29eed729_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3b1510d1-6efd-4e99-8920-7f8fd3cf56d7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2030NotesMember_360076f8-78bc-488f-9fab-5dae15a5d0d9_terseLabel_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_label_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2030NotesMember_documentation_en-US" xlink:label="lab_bsx_June2030NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2030 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember" xlink:href="bsx-20200930.xsd#bsx_June2030NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2030NotesMember" xlink:to="lab_bsx_June2030NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_6738fdef-0835-484b-b9d6-99f4fa940e39_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fe35169c-790d-422a-a21b-39ce68cb9d7a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_81e7c985-e0c0-4203-9b2c-cec8f0607651_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_2826a191-d15f-4fd1-91d7-9aec040ac6ed_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_8c1a89ac-2238-4639-ba5c-f37826774404_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_4ce9fa00-2a49-4254-982d-a0734a7ec231_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_59821080-b3d6-4175-b252-7f820e516a28_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_4fa06614-5b43-4845-874b-34ce8a9fc708_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3c63ff6e-97da-4f5a-bd81-0f2b5310275a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_61294fc3-7854-4f1f-9cb7-b0bc769f8c59_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_label_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill [Line Items]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsandGoodwillLineItems_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems" xlink:to="lab_bsx_IntangibleAssetsandGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_55560000-5b40-483a-80a1-1ada12ed4874_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_b5241ac9-c713-4a40-9fe1-07daffa5087a_terseLabel_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_label_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</link:label>
    <link:label id="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_documentation_en-US" xlink:label="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:href="bsx-20200930.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:to="lab_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6fd508eb-7ce4-480a-9ff7-7ec302bb2cc2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_92be8642-fd2f-4077-b8e1-9221330bcb40_terseLabel_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_label_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:label id="lab_bsx_OtherOtherLongtermAssets_documentation_en-US" xlink:label="lab_bsx_OtherOtherLongtermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets" xlink:href="bsx-20200930.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OtherOtherLongtermAssets" xlink:to="lab_bsx_OtherOtherLongtermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_496b2acd-d87e-4644-a855-a0ccc6a9ac69_verboseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_909ebe8c-c80e-4e98-9f07-f9e3c2a556bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_dc9ca985-689e-4942-90c0-ce542c4ecfbb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_60450c79-e2e2-4e5b-8941-558f89761a04_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingleaserightofuseassetAxis_cabe4651-6844-40e5-afaa-aa88eef4e2bc_terseLabel_en-US" xlink:label="lab_bsx_OperatingleaserightofuseassetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset [Axis]</link:label>
    <link:label id="lab_bsx_OperatingleaserightofuseassetAxis_label_en-US" xlink:label="lab_bsx_OperatingleaserightofuseassetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset [Axis]</link:label>
    <link:label id="lab_bsx_OperatingleaserightofuseassetAxis_documentation_en-US" xlink:label="lab_bsx_OperatingleaserightofuseassetAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetAxis" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingleaserightofuseassetAxis" xlink:to="lab_bsx_OperatingleaserightofuseassetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_31ba0fac-d85f-4701-a1ac-aa722c5cbc4a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="lab_us-gaap_ClassOfStockDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_384415e3-741d-4471-899a-7da12286d25c_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average interest rate of de-recognized receivables</link:label>
    <link:label id="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_label_en-US" xlink:label="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable with Imputed Interest, Effective Yield (Interest Rate)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:to="lab_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_0efb2202-8760-4850-9077-e8217edb6c65_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_772ed7fa-b08f-48ea-8d25-b4e4987c359c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6288183c-1c3b-4ef2-bc98-e66055f3c441_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f17ae3bd-ea1b-4b36-a03f-717fe7129b89_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b2458392-56c3-4e0c-bda9-df33e4a9f17b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_40b1454b-5d65-4edd-b7a1-b086abb16385_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_October2023NotesMember_aa095ac4-e954-461b-8289-a8f11781dfdf_terseLabel_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_label_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:label id="lab_bsx_October2023NotesMember_documentation_en-US" xlink:label="lab_bsx_October2023NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember" xlink:href="bsx-20200930.xsd#bsx_October2023NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_October2023NotesMember" xlink:to="lab_bsx_October2023NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3631004e-4f78-4aa8-b880-4b1600637577_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3e662d33-7451-4f51-9f9b-e06bd22ba728_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_658db073-f480-420b-9a21-a6a7812e2e40_terseLabel_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_label_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:label id="lab_bsx_CertifiedclassactionsinCanadaMesh_documentation_en-US" xlink:label="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certified class actions in Canada, Mesh</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh" xlink:href="bsx-20200930.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CertifiedclassactionsinCanadaMesh" xlink:to="lab_bsx_CertifiedclassactionsinCanadaMesh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_614f2146-edfb-420b-b635-fbc49d4cb0da_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_5296bf72-f301-43d4-af7d-b394b6df0716_verboseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_62e81928-a0be-4e99-b475-0ff895023e79_terseLabel_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalNeuromodulationNmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Neuromodulation (NM) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:to="lab_bsx_GlobalNeuromodulationNmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a416aaaf-5a0d-482a-9def-1605f5ac7f35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d8f4c954-1ba9-4ec9-9fc4-266dac5c9c9e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_8cc4a3e3-8d10-4572-bf37-6f8cdafaef58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_c0e93403-5c21-4068-8db7-e6373101f37f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_3a4ef59e-2144-427b-9324-7b2850c11959_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - Canada</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:href="bsx-20200930.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_1ab14de9-5956-46cd-b71a-28c45a86c9d1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_b6a32a43-12d2-46e8-a2cc-bf105cc4c034_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_377dbd33-c3d9-48fb-bd8e-b99d2b1ef832_terseLabel_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_label_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:label id="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_documentation_en-US" xlink:label="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:href="bsx-20200930.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:to="lab_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_30a21cae-5af5-4acc-b25c-c86de445f97f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_fa82a655-25d9-407f-bdb0-2b7d8b625a59_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_29f7f3a6-8b85-46bc-9e48-07b65e00b441_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_2ded2086-6c02-4650-8d91-bfed1b115ca4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (Shares Issued)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_9d025ad5-bf4d-4855-b6e2-1c84ff3904fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_e9c5c2d1-bae3-4b99-95c8-ded3480b53bf_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_898a36ff-c324-4da0-ad96-faab0c7dd5c6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_6637a7ee-443e-47f4-a2fb-30bf35288bf6_terseLabel_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_TwoYearDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two-Year Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember" xlink:href="bsx-20200930.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TwoYearDelayedDrawTermLoanMember" xlink:to="lab_bsx_TwoYearDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_63b7735c-52d5-4651-9ad6-18f5dd8afc38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e2e0f0c2-9f17-4bb5-8531-ed7d58582518_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_6c23da24-b06a-46db-b7bf-0497a52d9363_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_62e35fc5-b874-4e95-a2e7-af8ec68e8191_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_a950631e-900e-45dd-8503-87c8a0949e09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_cd157a15-d9a9-447d-b9b2-f8ec33b51272_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_caeda9c8-c08b-4fa1-b22a-358dd6215522_terseLabel_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_RenminbiDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renminbi Denominated Factoring Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:href="bsx-20200930.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_RenminbiDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_ba8307e9-32b5-4267-b2f8-d950051e3bda_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d62c2bbc-4bfb-423d-b12c-b75ddd5cafa6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss)&#160;before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_a365b9fa-a1f7-4210-aacf-804731395e6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_32edfe31-914c-4ff8-afa5-1e268de01c38_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_6976f6ff-8786-4f7f-a1da-072e4a84632a_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a69c97c0-2a4a-4620-a5d7-5698c556de55_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d5fa139d-6989-43ef-ae75-4e00d5a7cb57_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7a9dcdd3-7076-44c7-93f5-27bd08775ed6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_983e10d6-e0b9-4e7a-aae5-b017986150f0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MillipedeInc.Member_167bfbcc-8dc3-47ba-aa3c-92a346829a88_terseLabel_en-US" xlink:label="lab_bsx_MillipedeInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede, Inc. [Member]</link:label>
    <link:label id="lab_bsx_MillipedeInc.Member_label_en-US" xlink:label="lab_bsx_MillipedeInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede, Inc. [Member]</link:label>
    <link:label id="lab_bsx_MillipedeInc.Member_documentation_en-US" xlink:label="lab_bsx_MillipedeInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Millipede, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeInc.Member" xlink:href="bsx-20200930.xsd#bsx_MillipedeInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MillipedeInc.Member" xlink:to="lab_bsx_MillipedeInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_44e1b5db-74e3-44b6-9473-ff1c09898895_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_89aeba1a-8cb0-402f-a10c-ebe8a3a9f620_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of preferred stock in connection with public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Requirementextensionthroughtheremainderof2020Member_b964c491-41a8-48d5-9c4d-3ff88b009d50_terseLabel_en-US" xlink:label="lab_bsx_Requirementextensionthroughtheremainderof2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020 [Member]</link:label>
    <link:label id="lab_bsx_Requirementextensionthroughtheremainderof2020Member_label_en-US" xlink:label="lab_bsx_Requirementextensionthroughtheremainderof2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020 [Member]</link:label>
    <link:label id="lab_bsx_Requirementextensionthroughtheremainderof2020Member_documentation_en-US" xlink:label="lab_bsx_Requirementextensionthroughtheremainderof2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, extension through the remainder of 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Requirementextensionthroughtheremainderof2020Member" xlink:href="bsx-20200930.xsd#bsx_Requirementextensionthroughtheremainderof2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Requirementextensionthroughtheremainderof2020Member" xlink:to="lab_bsx_Requirementextensionthroughtheremainderof2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f277bfea-75cf-4e39-8618-052ae773d104_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DiscountRateFairValueInput_531f979a-29fb-4847-8153-e4f9ca573ee8_terseLabel_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_label_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:label id="lab_bsx_DiscountRateFairValueInput_documentation_en-US" xlink:label="lab_bsx_DiscountRateFairValueInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Rate, Fair Value Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DiscountRateFairValueInput" xlink:to="lab_bsx_DiscountRateFairValueInput" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d620c59d-d560-463b-9dc5-92bb549afa71_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4e3f8772-6f09-42bc-a158-b8b2ca4597cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3dedd9d-ffec-4208-8d85-1a282befb2c0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_e3f34947-e22f-43e8-a86a-0886a54cb2a7_terseLabel_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_label_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:label id="lab_bsx_LitigationSettlementReceivedGain_documentation_en-US" xlink:label="lab_bsx_LitigationSettlementReceivedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Received, Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain" xlink:href="bsx-20200930.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationSettlementReceivedGain" xlink:to="lab_bsx_LitigationSettlementReceivedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0cafcb94-ceb6-41f9-835e-d655cd2ff07b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5348dcae-d5f3-4207-80ff-c71bd1751623_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_64ef7d21-e6bc-490a-a2ff-9959610c01df_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in defined benefit pensions and other items</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ec147633-43b2-4fe7-aba9-9cc72c51ee84_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_2e3902b6-141f-4aa8-834c-30868da0a629_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_2d3bfbb1-cb7b-43a7-b04d-4c11b61997cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EntityAbstract_b83874b7-524c-4822-9ca1-fe73e62fa7fe_terseLabel_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_label_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:label id="lab_bsx_EntityAbstract_documentation_en-US" xlink:label="lab_bsx_EntityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract" xlink:href="bsx-20200930.xsd#bsx_EntityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EntityAbstract" xlink:to="lab_bsx_EntityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_41e6de43-5c3c-4420-88c3-c08bf84232c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9dc46e6c-bf55-438f-b9d3-5e5c344f6f9a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_e0b9e2ac-9c26-4196-8fa8-f40dea0c60a0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_59a80bd6-090e-4fdd-9fa3-38ca9ca06ad8_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_9aafa8b4-1c23-49fe-ac94-f37e4a156b8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_498e4be2-35e9-46cf-9c31-dd1726030599_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4cc6d524-3059-4597-a6dc-28a2aac27aac_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Utilization of allowances</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_5de9a682-8a19-4b1f-a394-16f109af0de1_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_d9265434-a060-457a-96d0-a2289ee41109_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC [Member]</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d6e2673a-88ba-43a5-96c9-b6f36049b5ec_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_d6fd94a0-e814-47bd-8adf-5b7e22181900_terseLabel_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_label_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:label id="lab_bsx_Noncashimpactoftransferredroyaltyrights_documentation_en-US" xlink:label="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash impact of transferred royalty rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:href="bsx-20200930.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Noncashimpactoftransferredroyaltyrights" xlink:to="lab_bsx_Noncashimpactoftransferredroyaltyrights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ba2b1a5a-40a6-454c-9381-63cc057e93fc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_949637f2-eb54-49e0-b029-b7c0bf252e9d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5949dc27-297b-408b-8549-f23888c03e5b_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Beginning Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b5134c9c-caa4-4c43-bbd2-53dd9ef16a94_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Ending Balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_40d5096f-4c00-4cd9-801d-05a267351d1d_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cd327fbc-808c-4282-8367-9a2f83bcfdcb_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_867df341-90df-4d72-9b5e-57fed98296b3_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for legal matters that are probable and estimable</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_66b003f1-9ee5-46e7-87b1-76585a9b594d_terseLabel_en-US" xlink:label="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:href="bsx-20200930.xsd#bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_b3890e2a-8afa-4248-a9a8-f46acd848a6a_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_bd9b7f5e-84ec-4d56-b4cb-ed0da8a9c535_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d476c9f2-3132-41ec-8dd1-f55fe57dd77f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_113e394b-89fd-4e7c-ab09-75ef8027ac87_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ee62bf46-dbd9-44da-a1a2-799d39e6c078_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_33fb953d-0997-4454-b351-e521d63e49e3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7a61c76a-d28b-4fb7-b1aa-473bbf3361dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_1ed77052-9fcc-4cd3-8133-5daa45c09469_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_b869db90-7b5d-49c8-998e-8484a9494908_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_6c409f92-52bb-423b-a543-dcbe2c47a5c2_terseLabel_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, third quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20200930.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_28e9389d-9fc8-42fe-a025-3194294e8da3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_6ab463ed-068f-47e3-b9e7-5c86e6613d75_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_8413fef9-47b7-484d-b80a-d563d1416926_terseLabel_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_label_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:label id="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_documentation_en-US" xlink:label="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requirement, fifth quarter following qualified acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:href="bsx-20200930.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:to="lab_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2020NotesMember_ed15f409-cf17-46b3-b942-66fea8439625_terseLabel_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2020NotesMember_label_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2020NotesMember_documentation_en-US" xlink:label="lab_bsx_January2020NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember" xlink:href="bsx-20200930.xsd#bsx_January2020NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2020NotesMember" xlink:to="lab_bsx_January2020NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_7940c586-3c79-4e59-9461-5c603ed4a2b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a6b247fd-8c9a-42c4-88c4-daddcc7c0dd5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_43a71695-f22b-4e7b-bb51-92de16eb2ab5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_94e71e53-606f-4366-a523-745ace7c80b8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_97f639aa-73c1-438e-9987-b6440cf7ef78_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_fd57ff9e-a06c-4cbe-b53f-30498584f3aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_f14ca39e-91a7-4fb1-be6e-93a5bc76f0ba_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_d25f4f4b-9bd6-48f3-bcee-233f332a914a_terseLabel_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:label id="lab_bsx_BSXReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_BSXReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BSX Reportable Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember" xlink:href="bsx-20200930.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BSXReportableSegmentsMember" xlink:to="lab_bsx_BSXReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_34879226-1815-4372-89ee-b004dd470b88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2035NotesMember_9b879a60-516f-497e-a5df-e29abe5a029b_terseLabel_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_label_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:label id="lab_bsx_November2035NotesMember_documentation_en-US" xlink:label="lab_bsx_November2035NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2035 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember" xlink:href="bsx-20200930.xsd#bsx_November2035NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2035NotesMember" xlink:to="lab_bsx_November2035NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_260ace79-98aa-41bd-94ac-73a5c304506e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_774bc661-57a5-4bd9-912a-5dd601272f4e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_5d213a30-662b-4bfb-94c9-48c3c50b4e21_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3f758444-87ac-424f-bfba-1ce7a8199b9c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1b934434-dee8-44d1-a1b1-dd52b0f88375_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_5412708d-99fc-479a-a928-a840b54d351e_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_5516f7e7-435d-42f0-af3c-765e339a5b69_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_60d253b1-a29e-4475-92ce-fc5a29e220ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8df79829-b40b-4165-9f30-2ad21d47bc1f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c2913ebd-e0a1-4e60-8d5e-3698bf0cea7f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6ae2f89a-047c-4808-85f8-9344a0c747cf_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_3857dfcb-27e7-4a6a-98f9-25b4b4bbbe40_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_e0546547-3658-40e2-b8e2-8dd0185098b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:to="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bda0a463-96a7-413d-9449-6a28c1dddecc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_38cbd97a-6c73-46ee-9c95-0ae793331da8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_23334394-baa7-4833-b520-478cc90b1b34_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_899d5a61-48b9-499c-add5-ed0ac6f8c9d8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1dac9ce1-8e40-4bad-aa86-84ef5c4fe564_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_80d4c2ef-8f19-4a60-ae1a-2fbb483bbebd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_900785e4-7f28-49bb-9f87-c60b0cb53b6e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_954b7fec-e264-4f91-94b6-6ae1891692c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0757e98a-77c9-48fc-a51d-d9ea17a81cb6_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_c3bbde4c-d3fd-42ef-8b93-380b4b970e35_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_b049d68f-b93b-4982-a892-7e317aaa6627_terseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:href="bsx-20200930.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_92dc4ba5-00dc-4086-888a-f572aa64760f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_213564a4-b398-498b-85d7-aa4f3512dae9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_ce2ae9db-1b35-4873-bd82-f00181d0fd6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4fd5d540-eb1f-4721-83f4-3e5050f6fbf9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_2c1b71f0-14eb-43ab-81b3-123c9f37ef51_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_a490b067-9fd6-457e-92ee-d97277e4bfac_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_6f68ded5-e098-4fcd-b0a1-fd2f55ebbfda_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_feffefb5-56f9-4b14-a4a9-e88c66cade66_verboseLabel_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_label_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information (Textuals) [Abstract]</link:label>
    <link:label id="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract_documentation_en-US" xlink:label="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Information.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:href="bsx-20200930.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:to="lab_bsx_SupplementalBalanceSheetInformationTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_b75c2697-b136-4781-a07f-9bb027cfea73_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementAxis_0a6b2e8e-9443-445d-bdf2-642427476c86_terseLabel_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_label_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:label id="lab_bsx_StatementAxis_documentation_en-US" xlink:label="lab_bsx_StatementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis" xlink:href="bsx-20200930.xsd#bsx_StatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementAxis" xlink:to="lab_bsx_StatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_15ea08be-7287-45d9-99b6-eb8db5f3b3d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_4a4360dc-1282-40c9-a425-ed409dcc0347_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5c6d0714-b1d0-4269-8e0b-988db49b7601_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_88b81bc7-c0b6-4c35-9a04-ce89e011df9c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_7e6d0c21-a66f-4033-94f4-26ea0a2df1b7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Gain on Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_4ac60e82-8983-45c4-b639-f81925c368a1_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_d041c2b1-b5d3-4aae-b1af-72013e4aca9a_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_c6e0bbf2-6e56-4c5b-912b-d8cd440fe631_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_c151d0e7-8f00-4a65-8836-1abd51877a20_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreferenceValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsasset_e8f48ff8-c1f0-4be1-bf24-2d1bedc72203_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_label_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:label id="lab_bsx_Licensingarrangementsasset_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsasset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsasset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsasset" xlink:to="lab_bsx_Licensingarrangementsasset" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_54193137-16e1-4d9c-874b-b1baf7b1bc26_terseLabel_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_label_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:label id="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_documentation_en-US" xlink:label="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Product liability cases and claims settled related to Mesh product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:href="bsx-20200930.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:to="lab_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_f131cfb6-1e84-48ef-a3f9-7d7a00717112_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_69dd65f6-7c3b-4146-8c15-f51aff99dad9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_450e8782-e55b-4d25-b6da-06589ff3ae60_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_2228662c-0d75-455f-a153-d65a857f1f5b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b489354a-4da4-4125-afe2-defcca8610fd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_4f892f57-8dad-4085-b28e-43c194db5c9b_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_30f97e26-fbf5-4e93-aecf-b6fd640edc15_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_c8744863-ee66-4e45-9966-45a6f8f8abf3_terseLabel_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February2019AggregateOffering [Member]</link:label>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_label_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February2019AggregateOffering [Member]</link:label>
    <link:label id="lab_bsx_February2019AggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_February2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February2019AggregateOffering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember" xlink:href="bsx-20200930.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_February2019AggregateOfferingMember" xlink:to="lab_bsx_February2019AggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7a936359-ea04-4504-9922-44ded215d480_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_2806931e-f640-497e-852b-7459ea11409b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_53e318d4-b65a-4b09-a551-b999be73c2ca_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d9c9cd61-ce2c-4a79-bf6c-9a41b260b678_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration expense (benefit)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_33ddbaba-5308-4286-9dae-b4e668258696_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_43d96355-8500-4803-8a20-4d468fc7a3a8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_afb47ba8-e00a-48b9-85e9-67e3df018891_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_f7a173a6-076a-48c6-9fca-f4cb389cb667_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Line Items]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_00c6d47e-43e6-49db-b6d4-707b578bfa89_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_f0360fca-f486-4489-b5a8-1a281302152c_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_f7301610-255d-4ab8-a1ba-a533a0b63ad4_terseLabel_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_label_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity</link:label>
    <link:label id="lab_bsx_ForwardCurrencyContractsTimetoMaturity_documentation_en-US" xlink:label="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Currency Contracts, Time to Maturity in Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:href="bsx-20200930.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:to="lab_bsx_ForwardCurrencyContractsTimetoMaturity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_c47d7823-cf3e-4063-a4af-f0296955a92a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2aad935c-d4b8-49b9-b87b-75b343661f8e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_a84665ff-c8c1-4ea5-9123-6d13cf96c9b7_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_205224e7-5892-4175-8d4c-0c176d15ae27_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockCash" xlink:to="lab_us-gaap_DividendsPreferredStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2049NotesMember_32d894b0-fb5f-46cf-9a52-6d0b4265079d_terseLabel_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_label_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2049NotesMember_documentation_en-US" xlink:label="lab_bsx_March2049NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2049 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember" xlink:href="bsx-20200930.xsd#bsx_March2049NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2049NotesMember" xlink:to="lab_bsx_March2049NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2039NotesMember_e6682e15-a88c-4eab-9520-da08402c18c8_terseLabel_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_label_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2039NotesMember_documentation_en-US" xlink:label="lab_bsx_March2039NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2039 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember" xlink:href="bsx-20200930.xsd#bsx_March2039NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2039NotesMember" xlink:to="lab_bsx_March2039NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_8d8eff3d-b2a6-4c67-a3ff-5bb1e0ae5255_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_2cce0d99-3ced-44ce-aebd-091b235b10f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e989ef5c-f083-49ac-b08f-7f7598f3b8b1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_a1dd84c5-0c6c-4492-b331-1acd2409c833_negatedTerseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_label_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:label id="lab_bsx_OperatingIncomeUnallocatedToSegment_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Unallocated to Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:href="bsx-20200930.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeUnallocatedToSegment" xlink:to="lab_bsx_OperatingIncomeUnallocatedToSegment" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketsMember_a05bd1ee-3484-47e4-bd3d-5c070caa27d6_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_label_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_bsx_EmergingMarketsMember_documentation_en-US" xlink:label="lab_bsx_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember" xlink:href="bsx-20200930.xsd#bsx_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketsMember" xlink:to="lab_bsx_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_27468e00-be6c-47bf-a1d2-89d3e41f142d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent_dcb98354-dd8e-49ca-9fd1-eb12b1012133_terseLabel_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent_label_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net Noncurrent</link:label>
    <link:label id="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent_documentation_en-US" xlink:label="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent" xlink:href="bsx-20200930.xsd#bsx_DeferredTaxLiabilitiesNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent" xlink:to="lab_bsx_DeferredTaxLiabilitiesNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_c0584515-8c74-426f-ae4d-bba489e9ced3_terseLabel_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:to="lab_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_aa989a64-239f-417f-ad19-061f946dc934_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e8857131-8176-48ea-8d50-aa10d1bf858c_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_4b8c600e-368c-4722-b256-3a134a9dc023_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_899326f6-e96d-4f37-9549-a31ef48dd2e5_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3fe21c6c-36a6-4c88-94d4-947e19ae7d3e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_95b6baba-9abd-41a5-85a2-13a7f133af22_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_a2f2f6d6-8ea9-4757-88f3-1f99518260a5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_5d2cf649-2011-4905-a411-d68c7d5d6b7c_terseLabel_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_label_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:label id="lab_bsx_OperatingIncomeAllocatedToReportableSegments_documentation_en-US" xlink:label="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Allocated to Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:href="bsx-20200930.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:to="lab_bsx_OperatingIncomeAllocatedToReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_2b4da01c-0104-490c-a855-8484a0626f05_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_21fd6a21-f6c4-46f3-b9d6-51297a86e7f4_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_label_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Rate Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:to="lab_bsx_ScheduleofIncomeTaxRateReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_5d6d82b8-efc4-4645-8be6-f918bb6292d4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_08e8a50e-5ab2-4044-a339-16f42df18898_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and restricted cash equivalents included in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_8dd792ab-a191-400c-b9be-c30ee9f9e4e1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents in Other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TheCARESAct_64aa48a7-fd9b-4b94-ae57-1d4ed1010611_terseLabel_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_label_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:label id="lab_bsx_TheCARESAct_documentation_en-US" xlink:label="lab_bsx_TheCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct" xlink:href="bsx-20200930.xsd#bsx_TheCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TheCARESAct" xlink:to="lab_bsx_TheCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9f2a4db5-59e6-4013-a379-a4fe2236d03b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_308c76ce-5282-40ba-aecc-2f66f1df3671_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_2ab131dc-538a-49dc-8eea-7c77868971d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_d8040f46-7354-4312-b76a-98481fe46c74_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_bed544d0-b078-41ca-938a-262e98d1e6d6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_bf8f210f-bbde-45ae-901a-f048dfce060d_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_877d8269-6435-45b1-9f00-02e4b21f15a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_5176d304-2e60-42f3-b91a-e26a9fab4cf9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves, current</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_602b5ef2-2249-46c7-bf4b-a7e202f404e0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_7c04cd8b-5c0c-4201-859a-9a40f9ce62ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_438fd069-f108-412f-b976-74a3c2a003b5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_0c541ff1-552b-4503-b125-95ec24c1f7a7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_7656d33f-867e-4806-bf85-f8e0e6b58c78_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_d5a06722-6545-4588-b08b-9e754dc084ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_af146556-8175-4dd7-9a8b-a422e70b67db_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_11cbc588-8bed-4fd6-909c-101b3709a4cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_81e6b55b-42b9-4a4c-8120-a2ae1fa49b0d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assuming dilution</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4a7a75d6-c0e1-43a9-a8d7-560aca1c14eb_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_06e15610-f481-4045-ba8c-9bdb82c8c6ad_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cf79f48a-efb1-4f7f-8a5b-b5cd31b30e3f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_99d3bbb6-3802-4ae1-8b7d-bc8f5bcda7a1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_a41d972b-d700-4afd-9b85-524a757a62ff_terseLabel_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_label_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:label id="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_documentation_en-US" xlink:label="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product - United Kingdom</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:href="bsx-20200930.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:to="lab_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_9b8c443d-c1c2-4117-ae02-d3879632674a_terseLabel_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Interventional Cardiology (IC) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:to="lab_bsx_GlobalInterventionalCardiologyIcReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_03ed19a5-390a-4afd-9d96-978fed6a5dbc_terseLabel_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issuance (Value in excess of par)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_label_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:label id="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_documentation_en-US" xlink:label="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues (Preferred stock)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:href="bsx-20200930.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:to="lab_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_ee4aa4bb-db29-49a4-8b43-6ff0a7d5a215_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_97c28574-6c40-486d-b10a-48730fd39fd9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_e39a79c8-3d32-4dde-a685-60d885700001_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2022NotesMember_5925c49f-9f69-4000-ada9-de2133588500_terseLabel_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_label_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2022NotesMember_documentation_en-US" xlink:label="lab_bsx_May2022NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2022 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember" xlink:href="bsx-20200930.xsd#bsx_May2022NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2022NotesMember" xlink:to="lab_bsx_May2022NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_51ca9a94-acae-468d-a574-79d228357afa_terseLabel_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_label_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:label id="lab_bsx_LicensingarrangementassetsMember_documentation_en-US" xlink:label="lab_bsx_LicensingarrangementassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangement assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LicensingarrangementassetsMember" xlink:to="lab_bsx_LicensingarrangementassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_78e3cbe6-b9fa-4f0c-97ca-7f1f8770bed2_terseLabel_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_label_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:label id="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:href="bsx-20200930.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:to="lab_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_42f74e72-0dc8-47e6-bdcf-4349001f8c55_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c5c8534d-ff58-4672-a455-24f6dcae4b96_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_a43919a0-9d0b-4e86-88e9-e3082819a61e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_3ead65cb-4083-4184-af73-abbe7df57fdb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsAxis_35f3debb-423b-4bbd-b5f5-193c0b8b14da_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsAxis_label_en-US" xlink:label="lab_bsx_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsAxis_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsAxis" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsAxis" xlink:to="lab_bsx_IntangibleAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_b6474397-3f34-47ab-bec4-3bc0826c9879_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_224beb7d-f07c-4438-a1d0-2c49cc4e01b5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f127fc5b-7174-4c54-a0d2-5c49ffbf8661_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,679,428,209 shares as of September 30, 2020 and 1,642,488,911 shares as of December 31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_64f311f6-18cc-4c19-9302-e97191b8c3c2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_13ae1b3e-d393-457f-ac8a-fb5e703d53d8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term borrowings, net of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt and Capital Securities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_aa9f97e9-f717-4bbc-b816-288aaf45ab4a_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_a6f98903-b527-4aec-9f97-e453b3bfca8a_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_803a3a58-4437-4602-a1a3-7ad93e602a3e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts receivable, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_December2027NotesMember_9237f50f-d1da-47a0-86d6-039bc169d5d6_terseLabel_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_label_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:label id="lab_bsx_December2027NotesMember_documentation_en-US" xlink:label="lab_bsx_December2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2027 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember" xlink:href="bsx-20200930.xsd#bsx_December2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_December2027NotesMember" xlink:to="lab_bsx_December2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_288e4517-2f91-4b19-a00b-90224120c75a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_ce0e3af9-d304-46e6-9676-bc8920ddfe26_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_IntangibleAssetsDomain_c54585f2-62ce-451d-84cf-8b4dbe7696f2_terseLabel_en-US" xlink:label="lab_bsx_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Domain]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsDomain_label_en-US" xlink:label="lab_bsx_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Domain]</link:label>
    <link:label id="lab_bsx_IntangibleAssetsDomain_documentation_en-US" xlink:label="lab_bsx_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_IntangibleAssetsDomain" xlink:to="lab_bsx_IntangibleAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_05a134f0-f262-49e5-81a3-67d116fbf15e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_9ed8ddcd-7224-4a80-b764-6382b6f29139_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_21deb66c-f7d8-4de5-8be0-356ca034f9a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_be9a35e1-a63d-440a-a545-8835d66e785a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6e2baab7-a366-48b7-97d1-866d6d239c98_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_bd5137d6-d0a6-45bc-a50a-06ca91efad6b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_592dfa57-b757-437f-92fe-d751c66b81a3_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_90ad031d-5c48-49cc-a900-bbaa372f58f9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AssignedtoonejudgeinMAMember_03b95710-57da-44ac-adb9-6d112ef58cb4_terseLabel_en-US" xlink:label="lab_bsx_AssignedtoonejudgeinMAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:label id="lab_bsx_AssignedtoonejudgeinMAMember_label_en-US" xlink:label="lab_bsx_AssignedtoonejudgeinMAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:label id="lab_bsx_AssignedtoonejudgeinMAMember_documentation_en-US" xlink:label="lab_bsx_AssignedtoonejudgeinMAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned to one judge in MA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedtoonejudgeinMAMember" xlink:href="bsx-20200930.xsd#bsx_AssignedtoonejudgeinMAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AssignedtoonejudgeinMAMember" xlink:to="lab_bsx_AssignedtoonejudgeinMAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_fb3a43c2-3960-4a1d-926a-fc7732c3b636_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_5e422c3d-be51-4562-817f-1964a3caf9cf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_94551dd7-ffaf-4bed-b84b-a6e7ac9e65cc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c72a3ddb-8d4d-416c-ab27-ace556db68c2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8e5b83ee-7fbb-47b7-bfdb-f5dab93e4766_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e27454e8-5d3a-4f60-bfa2-f676bbcccad0_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2026NotesMember_3431f0a8-b552-4f1e-b271-f0635c98139e_terseLabel_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_label_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2026NotesMember_documentation_en-US" xlink:label="lab_bsx_March2026NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2026 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember" xlink:href="bsx-20200930.xsd#bsx_March2026NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2026NotesMember" xlink:to="lab_bsx_March2026NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EurodenominatedoutstandingdebtMember_6040859c-7076-4f2a-902e-d0521b5acce2_terseLabel_en-US" xlink:label="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EurodenominatedoutstandingdebtMember_label_en-US" xlink:label="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:label id="lab_bsx_EurodenominatedoutstandingdebtMember_documentation_en-US" xlink:label="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated outstanding debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EurodenominatedoutstandingdebtMember" xlink:href="bsx-20200930.xsd#bsx_EurodenominatedoutstandingdebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EurodenominatedoutstandingdebtMember" xlink:to="lab_bsx_EurodenominatedoutstandingdebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_1bf8b871-e934-4f52-bedf-3f7e47dbea28_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2020TermLoanMember_5ea0ba77-e947-44db-a45d-98d1a064cb13_terseLabel_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_A2020TermLoanMember_label_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_A2020TermLoanMember_documentation_en-US" xlink:label="lab_bsx_A2020TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember" xlink:href="bsx-20200930.xsd#bsx_A2020TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2020TermLoanMember" xlink:to="lab_bsx_A2020TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_2aff0e50-fd92-49d8-bf43-701c123e364a_terseLabel_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_label_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen Denominated Factoring Arrangements [Member]</link:label>
    <link:label id="lab_bsx_YenDenominatedFactoringArrangementsMember_documentation_en-US" xlink:label="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yen denominated factoring arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:href="bsx-20200930.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_YenDenominatedFactoringArrangementsMember" xlink:to="lab_bsx_YenDenominatedFactoringArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_OperatingleaserightofuseassetDomain_293b13fe-57f0-4e1a-bad5-64bd6ba1b3f6_terseLabel_en-US" xlink:label="lab_bsx_OperatingleaserightofuseassetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset [Domain]</link:label>
    <link:label id="lab_bsx_OperatingleaserightofuseassetDomain_label_en-US" xlink:label="lab_bsx_OperatingleaserightofuseassetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset [Domain]</link:label>
    <link:label id="lab_bsx_OperatingleaserightofuseassetDomain_documentation_en-US" xlink:label="lab_bsx_OperatingleaserightofuseassetDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Operating lease, right-of-use asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetDomain" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_OperatingleaserightofuseassetDomain" xlink:to="lab_bsx_OperatingleaserightofuseassetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SpecialChargesMember_ceed9278-fa71-4dd9-8583-03263fb14a09_terseLabel_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_label_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special Charges [Member]</link:label>
    <link:label id="lab_bsx_SpecialChargesMember_documentation_en-US" xlink:label="lab_bsx_SpecialChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember" xlink:href="bsx-20200930.xsd#bsx_SpecialChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SpecialChargesMember" xlink:to="lab_bsx_SpecialChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_06a81472-201b-418f-ba01-f6bb18fe0d62_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_2447aee4-43ab-4b14-b03d-37e77e2eeeb6_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_d91a8c05-c5d3-4b5a-a8d9-1f8c6e01aa0b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_6e3c0891-18bd-49cb-9bf6-46716c897d3c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_1d881857-bf92-4c47-88c7-eee6f83fa89c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_960e8b61-14a3-47c1-8d09-145edf04b019_terseLabel_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_label_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) [Policy Text Block]</link:label>
    <link:label id="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_documentation_en-US" xlink:label="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:to="lab_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_7696814d-1d7c-4f5f-a030-1bfc8299becf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7986fe8d-d3c3-4b66-87fd-c7e88844f3ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_be1b8d76-0c03-4c78-9105-df5b47daac82_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7c04ac16-9e3f-4287-938e-21311bd6224b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_d18bd9f0-bfc7-4430-aea5-da302c7866ef_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0e09444f-cbee-46d9-afad-c726630248a5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_3c16d409-d794-49b7-97e4-075117dc6d72_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_June2025NotesMember_47beed4f-2c30-48d9-a408-d18068040877_terseLabel_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_label_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_June2025NotesMember_documentation_en-US" xlink:label="lab_bsx_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember" xlink:href="bsx-20200930.xsd#bsx_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_June2025NotesMember" xlink:to="lab_bsx_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_5f65a7c7-feda-41b3-a675-8e6ff7c5a4ce_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_2f763b2f-1e3c-4ca6-b5d5-b901f162b513_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings and debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b9282af-3da6-4dd9-9bbb-d894305bd122_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4a34f153-eede-4408-ab25-8acfac2e9cc9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_67bfa139-75ed-42e0-a1b7-61fab74931b0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_5497736a-7db3-43a2-82cd-e21124b852ec_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_45dbb4a7-4499-4ca4-a99f-46655e41d9bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_8f84ec11-933f-4572-bb6b-b754a822bd8f_terseLabel_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total countries</link:label>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_label_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:label id="lab_bsx_EmergingMarketstotalnumberofcountries_documentation_en-US" xlink:label="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets total number of countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries" xlink:href="bsx-20200930.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EmergingMarketstotalnumberofcountries" xlink:to="lab_bsx_EmergingMarketstotalnumberofcountries" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_a6d98e2e-73d5-4f90-b470-dddcd1d8b70b_terseLabel_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_label_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims related to mesh product</link:label>
    <link:label id="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_documentation_en-US" xlink:label="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability cases or claims asserted related to mesh products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:href="bsx-20200930.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:to="lab_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_cc3b0a19-a985-4179-8396-af030d072d0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0b8c8130-bb95-4ace-9355-8920dfea9905_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_40548870-99fb-4a27-8a81-9f2da40aadce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_974d6af1-f0cc-4cf8-bd72-cb60c07153e0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2024NotesMember_f35e2528-debd-4b50-98da-6c9b3e6d6528_terseLabel_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_label_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2024NotesMember_documentation_en-US" xlink:label="lab_bsx_March2024NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2024 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember" xlink:href="bsx-20200930.xsd#bsx_March2024NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2024NotesMember" xlink:to="lab_bsx_March2024NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_cc5ab796-a74c-4bef-8fd3-8894f46777e0_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_6d700c08-49bb-4217-9004-fd5f210a2bb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_01f86be5-1088-4781-b0fc-c7882f0de36c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_7cc57397-04d2-4834-9e83-de7c876b895f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_f2cf9638-1790-4c0e-9c70-57ddb9315057_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e17e6a90-d9b4-4d8f-a022-70796cdb809e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fae87ce2-5d57-4ad2-9090-9c2f78ce5d9c_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ac4c50a0-bdb6-42bb-bb09-2525eccd497d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_e799dcd0-20fb-4ef9-b74e-1ba2a582b5f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid on preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_2fb3bb5a-b561-40a1-b107-1a53bc7cd860_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_510cb2fa-5e84-45d6-a7b5-cd7475980955_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_00a156a0-17e4-426d-ae96-d02272ecc571_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7b0b27df-b887-4940-8eaf-75659b47a0e1_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_bf0eeb47-b5e1-49d8-b58d-3b16bf08c888_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_20ed8220-ab5c-42d7-bd86-21b2950e3dd1_terseLabel_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_label_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:label id="lab_bsx_MaximumCommercialPaperOutstanding_documentation_en-US" xlink:label="lab_bsx_MaximumCommercialPaperOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Commercial Paper Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding" xlink:href="bsx-20200930.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumCommercialPaperOutstanding" xlink:to="lab_bsx_MaximumCommercialPaperOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_d425b2ed-b784-4c08-82f4-58bd5e7d4561_terseLabel_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_label_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Debt Exclusion from EBITDA</link:label>
    <link:label id="lab_bsx_LitigationAndDebtExclusionFromEbitda_documentation_en-US" xlink:label="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:href="bsx-20200930.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LitigationAndDebtExclusionFromEbitda" xlink:to="lab_bsx_LitigationAndDebtExclusionFromEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_37a80f9e-b4a0-4575-86df-89dffeb19406_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_58fde5ec-905d-48ba-8ea1-cc35665e2f0d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fe41ac19-9f9f-4dc1-8280-60257db5f602_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_d61ea2fb-7f7b-4f4a-a7cd-deaa797b9895_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_7970ec9c-81cd-4ef3-80d3-e3fe498134a5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f62d78c5-a197-4ab7-baa9-913d475aaa3f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0d9010ce-0e79-480f-9a80-14f169b35f78_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_3b2cda4c-2fb0-42ab-9d82-eb60ca95830a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_50842bef-e6ca-4dc5-9e8b-c34754708cab_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_12f458f6-01e2-419f-b984-60fb1bf883fa_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c66418b7-54ee-4359-916a-6f5e330d0160_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_20c31ba9-d364-4745-91f8-cd353e745d41_terseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_label_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_021b14ca-7004-4db9-80e4-7d7a9e6db231_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_e0bc8bb2-76f9-442e-8f35-6c025243fac8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_c2a22e47-724e-483b-881d-ce42642fbec9_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges (credits)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c40ecff0-2e2f-4bbd-9fa3-689ebe1d3a00_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_69c7a279-2814-435a-aaf3-a3844769a2aa_terseLabel_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_label_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_May2020SNAggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_May2020SNAggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 SN Aggregate Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember" xlink:href="bsx-20200930.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2020SNAggregateOfferingMember" xlink:to="lab_bsx_May2020SNAggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ContingentConsiderationRecognizedInPeriod_271b8ddd-ac17-479d-a55a-d1c6540f313a_terseLabel_en-US" xlink:label="lab_bsx_ContingentConsiderationRecognizedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent consideration recorded in purchase accounting</link:label>
    <link:label id="lab_bsx_ContingentConsiderationRecognizedInPeriod_label_en-US" xlink:label="lab_bsx_ContingentConsiderationRecognizedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recognized in the period</link:label>
    <link:label id="lab_bsx_ContingentConsiderationRecognizedInPeriod_documentation_en-US" xlink:label="lab_bsx_ContingentConsiderationRecognizedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recognized in the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationRecognizedInPeriod" xlink:href="bsx-20200930.xsd#bsx_ContingentConsiderationRecognizedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ContingentConsiderationRecognizedInPeriod" xlink:to="lab_bsx_ContingentConsiderationRecognizedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_cb514e3d-8f20-4cfd-9d56-9ca92b6d4bfb_terseLabel_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_label_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:label id="lab_bsx_LatinAmericaandCanadaMember_documentation_en-US" xlink:label="lab_bsx_LatinAmericaandCanadaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Canada [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember" xlink:href="bsx-20200930.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_LatinAmericaandCanadaMember" xlink:to="lab_bsx_LatinAmericaandCanadaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b3c0b7d3-e82f-43c1-8fb9-214a74168467_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_StatementDomain_16084a8b-7f98-4934-9d3f-29725e125b61_terseLabel_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_label_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">statement [Domain]</link:label>
    <link:label id="lab_bsx_StatementDomain_documentation_en-US" xlink:label="lab_bsx_StatementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for statement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain" xlink:href="bsx-20200930.xsd#bsx_StatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_StatementDomain" xlink:to="lab_bsx_StatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_652c00a1-40a4-43d5-ac04-a7cdc046b512_terseLabel_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_label_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:label id="lab_bsx_Netcurrencyexchangegainloss_documentation_en-US" xlink:label="lab_bsx_Netcurrencyexchangegainloss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net currency exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss" xlink:href="bsx-20200930.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Netcurrencyexchangegainloss" xlink:to="lab_bsx_Netcurrencyexchangegainloss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5586d86a-a444-47c6-8c29-4efe55a1f16a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c1ef11b2-e687-46d7-aca1-1911b91ac00f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4dadaad3-7813-46d5-82be-1a8f8f373d60_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8013e42e-a082-4fe0-958d-cd887dc0f2a7_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_e174fdee-e0f1-4d40-9144-292362889da5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_d6c44c6f-2daf-4b01-afd8-9dce6a958b26_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1ef17b25-cb3f-4197-a5df-62ae595c3da5_verboseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_4cea2a34-66dd-40a4-9574-43fdb9072f9b_terseLabel_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Electrophysiology (EP) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:to="lab_bsx_GlobalElectrophysiologyEpReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_August2022TermLoanMember_73a8e69f-35ad-45b7-8778-ea021d3f3d73_terseLabel_en-US" xlink:label="lab_bsx_August2022TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2022 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2022TermLoanMember_label_en-US" xlink:label="lab_bsx_August2022TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2022 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_August2022TermLoanMember_documentation_en-US" xlink:label="lab_bsx_August2022TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">August 2022 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2022TermLoanMember" xlink:href="bsx-20200930.xsd#bsx_August2022TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_August2022TermLoanMember" xlink:to="lab_bsx_August2022TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_553d363c-2b26-4141-b8df-05c5ddc08e00_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_b62bbc73-4133-4991-a158-04a3e9227e33_terseLabel_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_label_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</link:label>
    <link:label id="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of term loan and revolving credit facility agreement compliance with debt covenants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:href="bsx-20200930.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:to="lab_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_8c330484-cf1f-4ed1-9cc2-e155d94ef7c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_8d91b994-a15c-4029-880f-8968fdd3665d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_590cb1a6-8cff-4fb3-9c52-201ada500f94_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_eda4a168-12ea-4e84-bd89-060ba2aa022e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_3ec1a4a3-a7ee-4d28-a139-35578e5b27ba_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_MaximumLeverageRatio_2e0167ea-773b-4c7f-93f1-7a8e4c526f9f_terseLabel_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_label_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Leverage Ratio</link:label>
    <link:label id="lab_bsx_MaximumLeverageRatio_documentation_en-US" xlink:label="lab_bsx_MaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio permitted by revolving credit facility agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio" xlink:href="bsx-20200930.xsd#bsx_MaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_MaximumLeverageRatio" xlink:to="lab_bsx_MaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_0d33c914-2221-448c-a0e6-86b13493eddb_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_100d65c6-c581-4860-870c-9fa910da66b5_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_WeightedAverageMaturityDays_e58a6861-d4df-41c3-8062-824a7b0fde5a_terseLabel_en-US" xlink:label="lab_bsx_WeightedAverageMaturityDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity, Days</link:label>
    <link:label id="lab_bsx_WeightedAverageMaturityDays_label_en-US" xlink:label="lab_bsx_WeightedAverageMaturityDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity, Days</link:label>
    <link:label id="lab_bsx_WeightedAverageMaturityDays_documentation_en-US" xlink:label="lab_bsx_WeightedAverageMaturityDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Maturity, Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageMaturityDays" xlink:href="bsx-20200930.xsd#bsx_WeightedAverageMaturityDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_WeightedAverageMaturityDays" xlink:to="lab_bsx_WeightedAverageMaturityDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_b3a04806-3f3d-4ea9-a60d-754334e0abe6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_a957a879-e79c-4c55-b738-2b15ca69e913_terseLabel_en-US" xlink:label="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:label id="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_label_en-US" xlink:label="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:label id="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_documentation_en-US" xlink:label="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from secured borrowings relating to royalty arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" xlink:href="bsx-20200930.xsd#bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" xlink:to="lab_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_4c027408-6d9f-4770-8a44-a311be2a052e_terseLabel_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalEndoscopyEndoReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Endoscopy (Endo) Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:to="lab_bsx_GlobalEndoscopyEndoReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_da62c976-a9fe-4db2-bc2c-451fa65a5a1d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_20ba36cb-9c03-4d14-91ea-daab3f58180e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a94b3a30-90ab-45c9-8d25-3d148321667e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_2839308a-917d-4b3e-ace9-4a9d8f327fb9_terseLabel_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:label id="lab_bsx_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_bsx_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">revenue-based payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember" xlink:href="bsx-20200930.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_RevenueBasedPaymentsMember" xlink:to="lab_bsx_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_3d7894f7-d444-44b2-b73c-3d22b2c54846_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AllegedBreachofPurchaseAgreementAmount_638e7950-3632-4636-a2ab-5161a6917859_terseLabel_en-US" xlink:label="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alleged Breach of Purchase Agreement, Amount</link:label>
    <link:label id="lab_bsx_AllegedBreachofPurchaseAgreementAmount_label_en-US" xlink:label="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alleged Breach of Purchase Agreement, Amount</link:label>
    <link:label id="lab_bsx_AllegedBreachofPurchaseAgreementAmount_documentation_en-US" xlink:label="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alleged Breach of Purchase Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:href="bsx-20200930.xsd#bsx_AllegedBreachofPurchaseAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:to="lab_bsx_AllegedBreachofPurchaseAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_99152642-eb8d-4bc7-901f-dc447d0fa668_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_ab8e2bc7-67af-4adb-a379-4a99c959b0ed_terseLabel_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_label_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:label id="lab_bsx_DeemedConsolidatedEBITDA_documentation_en-US" xlink:label="lab_bsx_DeemedConsolidatedEBITDA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Consolidated EBITDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA" xlink:href="bsx-20200930.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_DeemedConsolidatedEBITDA" xlink:to="lab_bsx_DeemedConsolidatedEBITDA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_24bf3d16-dce9-4bf6-a068-d71ffa00822d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_bc280c3a-99f4-4af1-9b6e-37681320dd46_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_April2021TermLoanMember_c99b7888-dfb2-49ea-bd67-c87badf75fc0_terseLabel_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_April2021TermLoanMember_label_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:label id="lab_bsx_April2021TermLoanMember_documentation_en-US" xlink:label="lab_bsx_April2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2021 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember" xlink:href="bsx-20200930.xsd#bsx_April2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_April2021TermLoanMember" xlink:to="lab_bsx_April2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b0867e1f-f10f-4ced-8d70-1137a657172b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_6976bd6e-735f-450a-b890-9059a7753bea_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_50635630-9d93-42e3-b579-9f6045566c7b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d6095b43-4c17-47bc-a10c-eb7762e5c123_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc02ec6e-47fa-4225-86a1-af26ddfe880f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_37e99972-438b-4057-87f0-de3ab2b3c493_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4db40423-ac16-43bf-a1e8-adc2098a3ae6_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND STRATEGIC INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_25d5769b-6610-4c48-88f0-0317fd33942d_terseLabel_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_label_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:label id="lab_bsx_GlobalCrmReportingUnitMember_documentation_en-US" xlink:label="lab_bsx_GlobalCrmReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global CRM Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember" xlink:href="bsx-20200930.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_GlobalCrmReportingUnitMember" xlink:to="lab_bsx_GlobalCrmReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3d592e68-80b2-4f3d-b673-d69e19e957ac_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5d187c31-0d8f-4690-9e28-6322e1a60f4c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f651ce4e-866e-4146-96f0-b25fd28f883b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fd0e22a9-bd1b-489d-b935-b50294d6d52e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_c4d487d9-258f-4753-a906-070f0596f3aa_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_90819160-0570-4e55-9968-95df8a2d6da4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_e7c7b91d-bbfd-40ca-85f3-2c127720ccb4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ce9b6edc-3b5a-450c-b357-0d575fdfc8bf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_814580f8-3eb0-4877-a95e-819416a709e5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_af0bb6ca-b948-454c-abde-93b2a531a23f_terseLabel_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_label_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross</link:label>
    <link:label id="lab_bsx_EquipmentFurnitureAndFixturesGross_documentation_en-US" xlink:label="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture and fixtures Gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:href="bsx-20200930.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_EquipmentFurnitureAndFixturesGross" xlink:to="lab_bsx_EquipmentFurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_260b3fdf-6775-489f-b56f-4a01b5841c81_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_d070c82d-6b8e-44c8-b588-42ada03964fa_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_6433f8ec-f595-40da-be18-467382b1a20f_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4f9cd37b-c119-48c4-8e2d-38167ccd9f3e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_4629b7b2-4888-4c0a-91af-a29061f23e5f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_92f9ee56-6e3b-495f-8c49-c252f94a5e74_terseLabel_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Senior Unsecured Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:href="bsx-20200930.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:to="lab_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_90cf7940-e3b7-4f64-8688-f4fbd02c97a5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement alternative investments (1)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6d882e3-74dd-4bb1-a417-d17d5fc2e9d1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3826f08c-c643-4796-809b-daa8c00ca246_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33c8b82e-5bc9-4683-97d3-9193c3a46c2c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_d861a575-d409-4ad3-a20d-9de206e53b14_terseLabel_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_label_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:label id="lab_bsx_TotalAllocatedToReportableSegmentsMember_documentation_en-US" xlink:label="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total allocated to reportable segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:href="bsx-20200930.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_TotalAllocatedToReportableSegmentsMember" xlink:to="lab_bsx_TotalAllocatedToReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_b253872e-9c1b-400b-bae1-82ff2b91d010_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_PreferredStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_25222d2c-5c31-4c18-9071-216528bc4f44_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_CurrentRequirementMember_34c669e8-7c74-4da3-9a00-483f3bcf8a0c_terseLabel_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_label_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement [Member]</link:label>
    <link:label id="lab_bsx_CurrentRequirementMember_documentation_en-US" xlink:label="lab_bsx_CurrentRequirementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Requirement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember" xlink:href="bsx-20200930.xsd#bsx_CurrentRequirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_CurrentRequirementMember" xlink:to="lab_bsx_CurrentRequirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_b6529134-2d57-4442-9934-384e20c1c65b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_abf29adf-6f6a-4c29-bf15-2c6b91747f16_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_22d623f5-7ad3-447e-8fd1-7ab818675ea6_terseLabel_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_bsx_ThreeYearDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three-Year Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:href="bsx-20200930.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:to="lab_bsx_ThreeYearDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_90d082a0-d7e6-448e-8efb-1d839648086a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_Licensingarrangementsliability_e760dde6-e356-4c96-8995-1ddaa6abcc43_terseLabel_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_label_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:label id="lab_bsx_Licensingarrangementsliability_documentation_en-US" xlink:label="lab_bsx_Licensingarrangementsliability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing arrangements, liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsliability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_Licensingarrangementsliability" xlink:to="lab_bsx_Licensingarrangementsliability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_74b85b72-1812-47a2-8a88-1bcc3727615d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:label id="lab_us-gaap_DerivativeCashReceivedOnHedge_label_en-US" xlink:label="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cash Received on Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCashReceivedOnHedge" xlink:to="lab_us-gaap_DerivativeCashReceivedOnHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d36b359c-c53b-4e42-9b33-12f396b94697_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_b17bb12f-b3f6-4739-8ad1-5d9a58634b85_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_AccruedRebatesCurrent_322eab7a-2cf7-4d7a-9654-1b0c6db9cc36_terseLabel_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_label_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:label id="lab_bsx_AccruedRebatesCurrent_documentation_en-US" xlink:label="lab_bsx_AccruedRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent" xlink:href="bsx-20200930.xsd#bsx_AccruedRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_AccruedRebatesCurrent" xlink:to="lab_bsx_AccruedRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0ea065d-43b3-41bd-bd8d-f89c1c958c4f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c4f51de-1de8-4f04-92eb-1cd84e7e5c63_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3adab1d0-5ef4-4ffc-8743-026e5bbfd8e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dcd63875-d257-4303-9357-1e7bf9dd3149_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_740c0980-64ea-4ffd-8e0d-22dc79fa0f02_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_21825275-d6d9-42e6-86b0-3ccc7f8f0939_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_9b971435-6216-4ae0-bead-fa4a83bf2126_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_1eae0100-03a4-491e-903d-99b9325d9ea6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_97519c4d-39e3-4712-908b-ce03aceba2ae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8decc413-bf1a-4e6f-91b9-8724462d57dd_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_24db9ae7-e610-4c9c-a6be-5d25a178236d_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e3e8868b-ac65-4e4b-bdd1-51d77911455a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_878d5cf9-1058-48fa-9a56-a6e8185038a4_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_06f94735-a534-4af0-814d-f66bb4496cea_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)&#160;per common share &#8212; assuming dilution</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_March2029NotesMember_f1e7489e-7636-4834-9283-e38378ccee97_terseLabel_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_label_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:label id="lab_bsx_March2029NotesMember_documentation_en-US" xlink:label="lab_bsx_March2029NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2029 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember" xlink:href="bsx-20200930.xsd#bsx_March2029NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_March2029NotesMember" xlink:to="lab_bsx_March2029NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_bdfe574b-c32f-4a6b-96fd-c9062af24eee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_01cf464c-8efa-45c3-9e40-ddb96b10a9cc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4b0de565-6c97-4166-8495-51bf7a9792bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_6fbb101b-c37d-4472-9ae0-3ee6c3fdaf3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_94e5561f-bb6c-4b09-acf7-8df12dbb48cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_efbdaed3-e63a-4735-a576-cc44e7e54e31_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_8ee8c721-a85f-4673-ac23-c302d48ef07d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f7f5ffdb-81ff-4380-82f8-0f3910a7f619_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bf469f1e-0ee3-4be8-b04c-dc8c5c6ea2c2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_bed8f138-ddff-4c14-9aa6-1852d5e9c8bc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_BTGAcquisitionMember_8c8f9372-d5ea-4b52-ab59-7c2d3be30a72_terseLabel_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_BTGAcquisitionMember_label_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:label id="lab_bsx_BTGAcquisitionMember_documentation_en-US" xlink:label="lab_bsx_BTGAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BTG Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_BTGAcquisitionMember" xlink:to="lab_bsx_BTGAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_be2f1b96-ce00-49c1-a7dd-82b56a1e1e93_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_71ab1e1c-7c80-4633-b52f-8638fe52ca72_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_61a325fd-0c1f-4f84-b9fa-6fe9ac663740_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_678ecc70-7c2d-427b-acc2-282eb722690c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_419bd118-5c18-47ed-9d39-f35e3b3ad33d_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_94e7874e-fe45-454c-86d7-5b1a2677ac5d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c6c99931-046e-4d25-a57c-979f42a5b09c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_dfa0b5de-4b57-465f-b8c4-41c690af0e8c_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a6b79e15-5744-429f-b890-130691365c40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c506a2b6-a90d-4e4a-bfec-51588f46dfeb_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_d4dc8469-4a4d-4ae4-a2f8-b46172640770_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_13a4c0dd-f41b-487b-9ac2-6eb6095242fc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1c97a5c4-8f4f-4c31-be31-77f269dcadde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4a38ad08-4ad6-44ff-9821-e437fad426bb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingParValuePerShare_028ba626-102c-476a-b628-4a7f3e00b4a5_terseLabel_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:label id="lab_dei_EntityListingParValuePerShare_label_en-US" xlink:label="lab_dei_EntityListingParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listing, Par Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingParValuePerShare" xlink:to="lab_dei_EntityListingParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_8ab57f64-8a71-42d0-ae16-daaceb0e37fb_terseLabel_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede) [Member]</link:label>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_label_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede) [Member]</link:label>
    <link:label id="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_documentation_en-US" xlink:label="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions (Vertiflex and Millipede) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:href="bsx-20200930.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:to="lab_bsx_A2019AcquisitionsVertiflexAndMillipedeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f1fa3843-a68a-4e86-b20c-4cf9476324b1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_8bc74b72-21d4-4698-9394-5875bc9910a6_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_e326f605-0e51-4c58-8e2d-3eb8a7399d1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_74f4797d-8486-4536-b919-dad3dea58405_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate from continuing operations</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e55bb6a4-1b83-4f20-820a-3f5249f09535_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a233b1c0-b80f-4da0-b173-1351c725b027_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash provided by (used for) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_ce69a174-060f-4107-97cf-7c0f2f841445_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for investments and acquisitions of certain technologies</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges_5a72d01d-5c6c-4cb0-a426-246e29441f82_terseLabel_en-US" xlink:label="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Value of Outstanding Net Investment Hedges</link:label>
    <link:label id="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges_label_en-US" xlink:label="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Value of Outstanding Net Investment Hedges</link:label>
    <link:label id="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges_documentation_en-US" xlink:label="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Value of Outstanding Net Investment Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NotionalValueofOutstandingNetInvestmentHedges" xlink:href="bsx-20200930.xsd#bsx_NotionalValueofOutstandingNetInvestmentHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_NotionalValueofOutstandingNetInvestmentHedges" xlink:to="lab_bsx_NotionalValueofOutstandingNetInvestmentHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b93a71c0-86a7-475d-9133-6c52f9f2aaf9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_January2040NotesMember_71b91f80-386c-4bf8-b21c-e82fc2bb7ea9_terseLabel_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_label_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:label id="lab_bsx_January2040NotesMember_documentation_en-US" xlink:label="lab_bsx_January2040NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2040 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember" xlink:href="bsx-20200930.xsd#bsx_January2040NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_January2040NotesMember" xlink:to="lab_bsx_January2040NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable_5a65117c-d62f-4e0a-b6c5-1a5a05e21b49_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable_label_en-US" xlink:label="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:label id="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable_documentation_en-US" xlink:label="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIntangibleAssetsandGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:to="lab_bsx_ScheduleofIntangibleAssetsandGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_40f9e7f6-dcfa-49d9-8d2b-5db0db9a1681_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_f6828440-f45b-4cbe-bf89-04fb7650cc9d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_5ef3f3b2-5f9b-4e1c-8dbf-695e19e46ffa_terseLabel_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_ee2e2d56-b57e-4185-9c5c-92f66f9c3c8c_verboseLabel_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_label_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:label id="lab_bsx_November2019AggregateOfferingMember_documentation_en-US" xlink:label="lab_bsx_November2019AggregateOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2019 Aggregate Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember" xlink:href="bsx-20200930.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_November2019AggregateOfferingMember" xlink:to="lab_bsx_November2019AggregateOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_82a89ca3-e9ae-4f77-ba39-f929f993196a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_May2025NotesMember_51d02188-6232-4e64-831b-9400c483e856_terseLabel_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_label_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:label id="lab_bsx_May2025NotesMember_documentation_en-US" xlink:label="lab_bsx_May2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2025 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember" xlink:href="bsx-20200930.xsd#bsx_May2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_May2025NotesMember" xlink:to="lab_bsx_May2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_ad0c17d0-07a3-440c-a864-30760bb993ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost - 247,566,270 shares as of September 30, 2020 and December 31, 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c3089e5a-b736-400b-9fad-7ff592afa772_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Outstanding [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_355d81bc-fe0b-4819-a77f-081d5a574343_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9bc81334-6343-45db-b9fb-36b06a3d510b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_31130a70-a998-4ffc-bed4-e78ab7ff02ca_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_413a89c5-e11f-4b88-bb80-be9d160b5dea_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_1c7678b7-f00c-40df-933b-81ffd1badbaf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (Shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_057115e9-f304-4448-9dd0-97b12196f1cc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_3f704525-7f4a-4fd2-a7d1-7351c17debbd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPreferredStockStock_label_en-US" xlink:label="lab_us-gaap_DividendsPreferredStockStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPreferredStockStock" xlink:to="lab_us-gaap_DividendsPreferredStockStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_4e1a365a-9b6e-44ec-95ab-a56f9f445fd6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_bb65724d-b0f8-4fe1-b279-81c2b521fd11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_e1847a28-cb55-4b70-b765-b702bec2d5da_terseLabel_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_label_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:label id="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_documentation_en-US" xlink:label="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:href="bsx-20200930.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:to="lab_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bsx-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:5aff39ba-e31d-4daa-a93a-6fdd4a47e66b,g:1fac046f-4056-4f94-9a0f-fce45535a3a4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20200930.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EntityAbstract_537cd4c6-afbb-44bd-8306-202fb61ccd5f" xlink:href="bsx-20200930.xsd#bsx_EntityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_EntityAbstract_537cd4c6-afbb-44bd-8306-202fb61ccd5f" xlink:to="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4509248c-02fa-4fd0-ba9d-6db1fc351a48" xlink:to="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d3356cd2-c3ed-47b2-9b6e-fb4dea7475b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:to="loc_us-gaap_CommonStockMember_d3356cd2-c3ed-47b2-9b6e-fb4dea7475b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_8a2e0883-9640-4ce9-897f-28111f991a08" xlink:href="bsx-20200930.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:to="loc_bsx_SeniorNotedue2027Member_8a2e0883-9640-4ce9-897f-28111f991a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_f26a766b-1f59-4fb8-8a45-a073cb0a21fc" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_464cb04f-a37c-4c11-b29d-d77bc4ed9cbc" xlink:to="loc_bsx_A550MCPSSeriesAMember_f26a766b-1f59-4fb8-8a45-a073cb0a21fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_95dcf0ed-5845-4a5c-81c6-8a0e2fea56e4" xlink:to="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_70048862-fa6c-4256-b5b1-6af13153abfc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentType_70048862-fa6c-4256-b5b1-6af13153abfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_60b09d71-a6b0-4334-b8ff-9b9bc4d7cd51" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentQuarterlyReport_60b09d71-a6b0-4334-b8ff-9b9bc4d7cd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c92f75c8-9f35-4fd2-b50f-9bbd877e2fed" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentPeriodEndDate_c92f75c8-9f35-4fd2-b50f-9bbd877e2fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2934de8a-edfb-446e-af28-919c6ee9b09b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentTransitionReport_2934de8a-edfb-446e-af28-919c6ee9b09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_194767fe-726f-42d8-8358-a4bb34f4a9ce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityFileNumber_194767fe-726f-42d8-8358-a4bb34f4a9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e8e286bd-458a-48ec-a472-b6affd98ca1c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityRegistrantName_e8e286bd-458a-48ec-a472-b6affd98ca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7d6cec00-24a5-4fba-a2ec-9141ac3d9c3a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7d6cec00-24a5-4fba-a2ec-9141ac3d9c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cc6b88e2-33ac-42d5-ad65-3cc45fc1e37f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityTaxIdentificationNumber_cc6b88e2-33ac-42d5-ad65-3cc45fc1e37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_325abe16-8d49-4fd5-bfee-f763eead8d89" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressAddressLine1_325abe16-8d49-4fd5-bfee-f763eead8d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bee56e56-bc00-40d4-98c6-9e424160dd40" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressCityOrTown_bee56e56-bc00-40d4-98c6-9e424160dd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6bcce44e-b5a1-4de9-86b7-197d627a8aa4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressStateOrProvince_6bcce44e-b5a1-4de9-86b7-197d627a8aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_013e4f3d-b0a3-4459-a70a-df27ea417cc1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityAddressPostalZipCode_013e4f3d-b0a3-4459-a70a-df27ea417cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_74cf9c41-ec36-414c-81b9-6500ad351c6e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_CityAreaCode_74cf9c41-ec36-414c-81b9-6500ad351c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_57bb061c-28e6-419f-8786-7ce45c6edaf1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_LocalPhoneNumber_57bb061c-28e6-419f-8786-7ce45c6edaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7a784154-d7ca-4753-bf35-5cedcc346b25" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_Security12bTitle_7a784154-d7ca-4753-bf35-5cedcc346b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_261b3cdf-9077-48c7-be50-8a0b3ad31ca3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_TradingSymbol_261b3cdf-9077-48c7-be50-8a0b3ad31ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4b9e59a1-00c5-4436-a99f-1a2064aa7971" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_SecurityExchangeName_4b9e59a1-00c5-4436-a99f-1a2064aa7971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_235e6d1a-2235-4108-80be-1646850d5dd8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityCurrentReportingStatus_235e6d1a-2235-4108-80be-1646850d5dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_60dab55a-4d28-4326-b0c0-a032eb18854f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityInteractiveDataCurrent_60dab55a-4d28-4326-b0c0-a032eb18854f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a874c8a3-8dfa-490a-a9e4-818a4f3cbbf5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityFilerCategory_a874c8a3-8dfa-490a-a9e4-818a4f3cbbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9ca320e1-54b4-4fe6-b505-e82a4d9e6f93" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntitySmallBusiness_9ca320e1-54b4-4fe6-b505-e82a4d9e6f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d4befe5a-4186-4cdb-9dfe-6f5d364f9865" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityEmergingGrowthCompany_d4befe5a-4186-4cdb-9dfe-6f5d364f9865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6cedbbe2-6b1b-452a-9fd4-3bd2b20ff955" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityShellCompany_6cedbbe2-6b1b-452a-9fd4-3bd2b20ff955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingParValuePerShare_328f3166-b91d-4c11-89ad-be50c9c498e8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityListingParValuePerShare"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityListingParValuePerShare_328f3166-b91d-4c11-89ad-be50c9c498e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3f28a406-f4d2-4938-ad8a-c10180bc1e7b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3f28a406-f4d2-4938-ad8a-c10180bc1e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_70e63056-a40c-42af-92a9-04daf88d1cb4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_EntityCentralIndexKey_70e63056-a40c-42af-92a9-04daf88d1cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c2ca65ae-8808-4be0-9772-362125290f78" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_CurrentFiscalYearEndDate_c2ca65ae-8808-4be0-9772-362125290f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_4217e734-9c7e-47b4-a856-53b20a54f8ad" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentFiscalYearFocus_4217e734-9c7e-47b4-a856-53b20a54f8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7a71c558-1813-4366-b1a7-59ad321ed73b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7a71c558-1813-4366-b1a7-59ad321ed73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eb820698-0a53-46ba-ae53-de88485bd816" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_13b7d764-cc64-42a1-b50d-bc523d01895a" xlink:to="loc_dei_AmendmentFlag_eb820698-0a53-46ba-ae53-de88485bd816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e3737c3a-f157-4e4d-9a40-6e8d5ebf29ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e3737c3a-f157-4e4d-9a40-6e8d5ebf29ab" xlink:to="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:to="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_69f7f1e2-968b-4fb9-a6a2-607c1e782656" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1db7a665-74df-402b-bce1-191ed9350cde" xlink:to="loc_srt_ScenarioUnspecifiedDomain_69f7f1e2-968b-4fb9-a6a2-607c1e782656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1b3f3582-bd74-4bcb-b1a9-21676365c3d6" xlink:to="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34dbd289-2d95-49b3-a9bf-f1945bbe3671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34dbd289-2d95-49b3-a9bf-f1945bbe3671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0f060b96-e893-4f5e-aa1d-8d941fa7cdca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0f060b96-e893-4f5e-aa1d-8d941fa7cdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_61ed6ea2-2a9f-4b36-aa8b-c057aea0e217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_GrossProfit_61ed6ea2-2a9f-4b36-aa8b-c057aea0e217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c21c63cb-5152-4574-a901-03d7fe9bfa17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c21c63cb-5152-4574-a901-03d7fe9bfa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_957d64ea-8be5-4eb1-bc6b-b69a6b8c0349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_957d64ea-8be5-4eb1-bc6b-b69a6b8c0349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_ce86ed67-85da-4108-a081-d5f218e2313d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_RoyaltyExpense_ce86ed67-85da-4108-a081-d5f218e2313d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8d1ae27d-8989-4173-99ce-814dcc8326fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8d1ae27d-8989-4173-99ce-814dcc8326fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3939a9e9-719b-4dc6-b5bc-9f214cc90bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_3939a9e9-719b-4dc6-b5bc-9f214cc90bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_040b327f-3ab0-4d37-b82d-422452885ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_040b327f-3ab0-4d37-b82d-422452885ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1c93a21d-8298-4466-9bdb-6021352d8133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_RestructuringCharges_1c93a21d-8298-4466-9bdb-6021352d8133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_4afe3480-7b58-44a3-b61b-31b45febaa2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_LitigationSettlementExpense_4afe3480-7b58-44a3-b61b-31b45febaa2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3b4d700a-2820-4623-b864-06e18c89368e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b09f6d2a-b8fc-4875-a573-782d7255e814" xlink:to="loc_us-gaap_OperatingExpenses_3b4d700a-2820-4623-b864-06e18c89368e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_496b8697-58f0-46d3-bf46-7089d79a9aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_OperatingIncomeLoss_496b8697-58f0-46d3-bf46-7089d79a9aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c636efad-d1bd-4241-b979-da80c3cfde2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:to="loc_us-gaap_InterestExpense_c636efad-d1bd-4241-b979-da80c3cfde2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7fe71971-472f-4087-88ec-3e4531b8dd30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_903ae3d5-c9b7-47ba-95af-980534f77be7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7fe71971-472f-4087-88ec-3e4531b8dd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd82d575-ccbb-41f3-b497-4105d751bcad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dd82d575-ccbb-41f3-b497-4105d751bcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c3f3db2a-79fb-412b-b6ec-0bcc883a0922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c3f3db2a-79fb-412b-b6ec-0bcc883a0922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_760f0a2d-49a7-4f1f-9f0d-40ffbc79bae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_ProfitLoss_760f0a2d-49a7-4f1f-9f0d-40ffbc79bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockStock_24a8b0a8-8bc3-4f65-acf4-524472f6ea74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_DividendsPreferredStockStock_24a8b0a8-8bc3-4f65-acf4-524472f6ea74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f524b585-bcfa-4d21-a303-8e5d8994b08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f524b585-bcfa-4d21-a303-8e5d8994b08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_661314ad-e464-4589-8c5e-d6be922506fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_EarningsPerShareBasic_661314ad-e464-4589-8c5e-d6be922506fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a847e06b-c1fe-45ea-a7fb-540502151de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a847e06b-c1fe-45ea-a7fb-540502151de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a9bec07a-2027-4034-8760-f106a2e97696" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_10fd962e-f9e7-4b27-84f8-9e4dc31e3392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_10fd962e-f9e7-4b27-84f8-9e4dc31e3392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_92053b8b-8722-4eea-8b64-81d242857d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_62fbf8af-425f-4066-8aa2-15e0d292c095" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_92053b8b-8722-4eea-8b64-81d242857d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f3bdbe31-c00a-49f4-a9ee-bb8c21176aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f3bdbe31-c00a-49f4-a9ee-bb8c21176aaf" xlink:to="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:to="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_280e8a03-f666-4145-917c-9873d7818d31" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6e3868e8-6dbf-448c-a220-6803b59f891d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_280e8a03-f666-4145-917c-9873d7818d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3a2f7baf-5b22-480a-a56e-5dd9e361c2fa" xlink:to="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ca153d5-a406-4cb0-850a-1860d99775e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_ProfitLoss_6ca153d5-a406-4cb0-850a-1860d99775e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_de6deb49-9429-4fe3-9088-9c63a9274baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_de6deb49-9429-4fe3-9088-9c63a9274baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_41075385-c361-47eb-8fb8-297129d9bb6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_41075385-c361-47eb-8fb8-297129d9bb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b1229c33-d630-42d1-91c6-6834e40f46e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b1229c33-d630-42d1-91c6-6834e40f46e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52cbe5c7-9e30-4285-98d6-53cf4be33a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e94c5ee4-18ff-40c9-b7df-2db4d8070dd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_52cbe5c7-9e30-4285-98d6-53cf4be33a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb4108d5-df61-43fd-8c8e-e4e858295ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_030ba801-718e-4740-ba6c-4dcc98c4c497" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb4108d5-df61-43fd-8c8e-e4e858295ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1aec7a4e-b7f5-4eca-a7b7-7dbd326e3eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1aec7a4e-b7f5-4eca-a7b7-7dbd326e3eef" xlink:to="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:to="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ad7410cf-4d5e-413d-8a8b-e128de7afb37" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_54882288-e8a6-4b1f-b763-8286a0f59989" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ad7410cf-4d5e-413d-8a8b-e128de7afb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ea827d55-7e3f-48e8-a4b9-183f9f1a4d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4339fe1d-23a0-4b62-9143-a751ffe1738a" xlink:to="loc_us-gaap_ClassOfStockDomain_ea827d55-7e3f-48e8-a4b9-183f9f1a4d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00a7d6e5-c17d-475f-8a7c-6d9b37939c83" xlink:to="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:to="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7baa94d-44b3-4a43-906b-34ecf7f5ed98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f7baa94d-44b3-4a43-906b-34ecf7f5ed98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_7dcbb28c-2749-41ba-ba57-111d0472272c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_7dcbb28c-2749-41ba-ba57-111d0472272c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e6bb4aff-ef40-4fec-a13c-0e3379528c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_InventoryNet_e6bb4aff-ef40-4fec-a13c-0e3379528c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_8dc57c29-dd47-434d-8b6a-329bd450cb4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_PrepaidTaxes_8dc57c29-dd47-434d-8b6a-329bd450cb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34090aa4-681b-4965-a93c-a141c6cbc601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34090aa4-681b-4965-a93c-a141c6cbc601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b0d68b93-2cf4-428e-9630-f1e929f3debd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_69a76a91-5c26-473f-95ae-269d3bd51c77" xlink:to="loc_us-gaap_AssetsCurrent_b0d68b93-2cf4-428e-9630-f1e929f3debd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f5ace6dd-cc1e-4b24-8504-20f546e7077e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f5ace6dd-cc1e-4b24-8504-20f546e7077e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98d3a209-69dd-4c07-9d32-edcbbf5159b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_Goodwill_98d3a209-69dd-4c07-9d32-edcbbf5159b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0e365d44-e336-4b15-bb54-aa60150a6817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0e365d44-e336-4b15-bb54-aa60150a6817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb8a025a-053a-4a0d-b4bd-4efe0ab78e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fb8a025a-053a-4a0d-b4bd-4efe0ab78e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f5b80522-6674-4ff7-9f41-160a16513c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f5b80522-6674-4ff7-9f41-160a16513c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f1efee41-542a-4a34-98a7-f18273321f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68469ed1-fad8-4647-8d2a-012db219cc4d" xlink:to="loc_us-gaap_Assets_f1efee41-542a-4a34-98a7-f18273321f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c35fab97-2e8f-41bf-9660-e4c18b2a4542" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2325e20b-e806-4555-9301-113423a2157b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_DebtCurrent_2325e20b-e806-4555-9301-113423a2157b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_50d36e13-ba01-49d0-a4ed-74a29f9b156a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_AccountsPayableCurrent_50d36e13-ba01-49d0-a4ed-74a29f9b156a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5aaa085d-3cf4-448c-a7fb-11659b3fbbbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5aaa085d-3cf4-448c-a7fb-11659b3fbbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2bd5b331-fd73-4f95-9d48-f4de7c431039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2bd5b331-fd73-4f95-9d48-f4de7c431039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_93b5a9cd-cd72-46c9-94d6-dc276e4a4007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d7c04a8f-1fa6-4de8-9d78-7985dc452d20" xlink:to="loc_us-gaap_LiabilitiesCurrent_93b5a9cd-cd72-46c9-94d6-dc276e4a4007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_487fa4b9-9baf-4a8d-a976-7a32054896b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_487fa4b9-9baf-4a8d-a976-7a32054896b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent_8f4f80f0-9d1f-49c3-9ee6-8c18e55c0c50" xlink:href="bsx-20200930.xsd#bsx_DeferredTaxLiabilitiesNetNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_bsx_DeferredTaxLiabilitiesNetNoncurrent_8f4f80f0-9d1f-49c3-9ee6-8c18e55c0c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3d088ac9-fefb-46b7-b267-8f99e9d621ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3d088ac9-fefb-46b7-b267-8f99e9d621ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6174e54c-1b00-4b21-b63f-eb8f7ed76108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6174e54c-1b00-4b21-b63f-eb8f7ed76108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c762c1a0-91cf-4e43-9040-1f03c42abc14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_PreferredStockValue_c762c1a0-91cf-4e43-9040-1f03c42abc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7ecb0c85-47d2-4a2f-9e4a-83e2334d126e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_CommonStockValue_7ecb0c85-47d2-4a2f-9e4a-83e2334d126e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_db4a1841-9eb4-4b1e-b66e-3eadc3b0e72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_TreasuryStockValue_db4a1841-9eb4-4b1e-b66e-3eadc3b0e72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2e031f49-daaa-496d-8aff-f5a06e6cc094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2e031f49-daaa-496d-8aff-f5a06e6cc094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d60a513e-f168-4ad1-acea-c345808fd6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d60a513e-f168-4ad1-acea-c345808fd6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3d9a87d2-da63-43a4-8a05-15cc401020b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3d9a87d2-da63-43a4-8a05-15cc401020b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4376c43a-8026-482d-86fa-00b1fe742fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_478259b6-aebd-4eca-8cf0-457b006d55e9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4376c43a-8026-482d-86fa-00b1fe742fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d983b35e-a875-4acc-822b-efe09da0f174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55842cb3-53a9-41dd-9d5c-d422c6df503c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d983b35e-a875-4acc-822b-efe09da0f174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:href="bsx-20200930.xsd#bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_36908322-4801-4a8a-b11d-facd38d68297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_36908322-4801-4a8a-b11d-facd38d68297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_34f905dc-8e5c-41c9-b086-f31da9a60419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_34f905dc-8e5c-41c9-b086-f31da9a60419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_91bff13c-0828-403b-b4bc-67111b8a8c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_CommonStockSharesIssued_91bff13c-0828-403b-b4bc-67111b8a8c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fc56d9d8-58fc-427e-97b9-70cd8ca6980a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fc56d9d8-58fc-427e-97b9-70cd8ca6980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5cf9bfdf-e5b6-4665-abdd-1055a14b20fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5cf9bfdf-e5b6-4665-abdd-1055a14b20fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1b57e86c-8808-4c16-96ac-b8b98f62053f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1b57e86c-8808-4c16-96ac-b8b98f62053f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_4e532746-126a-496e-927c-29077b98d6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract_47e84be0-6449-41ba-87da-4f80937ee8ff" xlink:to="loc_us-gaap_TreasuryStockShares_4e532746-126a-496e-927c-29077b98d6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9b33926b-a824-41f2-b4cf-7b9366b9dd95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9b33926b-a824-41f2-b4cf-7b9366b9dd95" xlink:to="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83742ed4-63df-45de-b750-b2018844d040" xlink:to="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_6731f05a-6503-493c-8af8-f31973a51b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_PreferredStockMember_6731f05a-6503-493c-8af8-f31973a51b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c46f66ec-156d-412b-923a-4a338f7a7187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_CommonStockMember_c46f66ec-156d-412b-923a-4a338f7a7187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_36f1cbe3-815e-4822-ad73-7e71823f147d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_TreasuryStockMember_36f1cbe3-815e-4822-ad73-7e71823f147d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0e5bb205-057f-4e39-a766-646d67effc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0e5bb205-057f-4e39-a766-646d67effc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_91447a96-e87a-4e0a-8438-cca9af7a9a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_RetainedEarningsMember_91447a96-e87a-4e0a-8438-cca9af7a9a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_31106e46-9f01-452f-93ca-0df8b537f48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1c8c43ac-fabc-4405-9ac0-6aad9908a154" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_31106e46-9f01-452f-93ca-0df8b537f48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f98eba2a-402d-453b-b91e-c6e82f260fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c84a88ab-2ec9-4ca5-9230-451476dad769" xlink:to="loc_us-gaap_ClassOfStockDomain_f98eba2a-402d-453b-b91e-c6e82f260fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f390843f-4635-455a-b4e2-a2a95ac75e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b42f30c6-dcdc-44aa-8072-97f16cdfa665" xlink:to="loc_us-gaap_StatementLineItems_f390843f-4635-455a-b4e2-a2a95ac75e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f390843f-4635-455a-b4e2-a2a95ac75e2d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_547fa8d0-bffd-4e55-bc84-92af867e9833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_547fa8d0-bffd-4e55-bc84-92af867e9833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_e6bb582f-6d0a-4cf8-80cb-027d34cf8325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_SharesIssued_e6bb582f-6d0a-4cf8-80cb-027d34cf8325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_06e65416-a179-456f-b3f3-e6310f042b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_ProfitLoss_06e65416-a179-456f-b3f3-e6310f042b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c837c0c6-29bc-4e81-8576-38b2c6ba7e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_c837c0c6-29bc-4e81-8576-38b2c6ba7e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1838e23c-e04c-420b-845c-eeff7058c50b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1838e23c-e04c-420b-845c-eeff7058c50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d6a6a761-bd65-4124-b742-a2accdd26dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_d6a6a761-bd65-4124-b742-a2accdd26dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_569ce8a0-c280-4b86-8dc9-0a8b164a4f05" xlink:href="bsx-20200930.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock_569ce8a0-c280-4b86-8dc9-0a8b164a4f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_c1246be4-17fe-4a83-ad4c-81c86c91320a" xlink:href="bsx-20200930.xsd#bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock_c1246be4-17fe-4a83-ad4c-81c86c91320a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27f7ee60-2754-4f09-8a98-db2b50fcfa1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27f7ee60-2754-4f09-8a98-db2b50fcfa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_d16ea8c2-6954-4994-9165-d58d155d5718" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_DividendsPreferredStockCash_d16ea8c2-6954-4994-9165-d58d155d5718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_6aede5ae-380e-4d2b-94e3-d94c355db553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_6aede5ae-380e-4d2b-94e3-d94c355db553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_2d9321ce-b89b-4b68-a1ed-c51469f7df62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease_2d9321ce-b89b-4b68-a1ed-c51469f7df62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_387b0bd4-7e75-42d0-a62b-f6e9bd160bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_387b0bd4-7e75-42d0-a62b-f6e9bd160bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ca26726b-75d3-4150-b130-d409395e2f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7601db55-28bc-49bb-b1b3-e9d4836c5d4b" xlink:to="loc_us-gaap_SharesIssued_ca26726b-75d3-4150-b130-d409395e2f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_afcd875a-c18c-4e8b-a5de-f385a472a24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_afcd875a-c18c-4e8b-a5de-f385a472a24a" xlink:to="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:to="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_779161eb-5610-4ae7-b95b-eb35d6f518a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_e60a96ca-8b9b-4035-9eb3-7f6d07d42113" xlink:to="loc_srt_ScenarioUnspecifiedDomain_779161eb-5610-4ae7-b95b-eb35d6f518a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f189cd70-c2f7-4c50-8ea5-d110e9f168d4" xlink:to="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_07519391-e1a1-493d-957c-76408935d536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_07519391-e1a1-493d-957c-76408935d536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b9fef538-5ebf-4e1e-b3e4-75535b5b8d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_07519391-e1a1-493d-957c-76408935d536" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b9fef538-5ebf-4e1e-b3e4-75535b5b8d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77fdff6f-4661-4303-a80d-1d110a25cfff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77fdff6f-4661-4303-a80d-1d110a25cfff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_236ab812-6e4e-42b4-861d-f026820ca465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_236ab812-6e4e-42b4-861d-f026820ca465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b924bf7a-6b38-48ed-92f2-2bce54d5cc54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b924bf7a-6b38-48ed-92f2-2bce54d5cc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3650d8b0-080b-4e17-9f3b-a53474ee49fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_3650d8b0-080b-4e17-9f3b-a53474ee49fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_2fbf864f-1f61-46be-8260-2d96d6cc8207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_2fbf864f-1f61-46be-8260-2d96d6cc8207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_17ae8457-f174-4db2-9a46-ddc5ebe66981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_17ae8457-f174-4db2-9a46-ddc5ebe66981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_73ffcb25-395d-4313-ba81-bbca35446f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_73ffcb25-395d-4313-ba81-bbca35446f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48b937a9-5581-448a-ace5-1645e3bac16a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b8c8ba8f-d6d0-4aa3-aa05-0df789761acf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_48b937a9-5581-448a-ace5-1645e3bac16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment_4d76c04b-8111-400f-986f-0fd914ad75d2" xlink:href="bsx-20200930.xsd#bsx_BusinessAcquisitionContingentConsiderationCashPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_bsx_BusinessAcquisitionContingentConsiderationCashPayment_4d76c04b-8111-400f-986f-0fd914ad75d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_c65ddb09-b872-4535-86bf-00066ad50641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_c65ddb09-b872-4535-86bf-00066ad50641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_65f8f2f8-92e2-4390-8674-1fb2193014b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_65f8f2f8-92e2-4390-8674-1fb2193014b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_99fafb7c-5ad5-4779-bcd2-2f7cfb172691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_99fafb7c-5ad5-4779-bcd2-2f7cfb172691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f87c7d25-c750-4187-a558-bee2f822de2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_f87c7d25-c750-4187-a558-bee2f822de2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_874542df-cfe7-4848-a5f7-fb2458e219a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_874542df-cfe7-4848-a5f7-fb2458e219a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_c7328951-ed86-4456-b7ee-7cca4a0b531d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_c7328951-ed86-4456-b7ee-7cca4a0b531d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_b07a8119-2d7e-4e61-8499-5aa66601b75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_b07a8119-2d7e-4e61-8499-5aa66601b75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_9d65f10e-a707-4979-99c4-a2c3b8ac9762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_PaymentsOfDividends_9d65f10e-a707-4979-99c4-a2c3b8ac9762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0e62f762-a5b0-42c8-96fb-c632c1d5483f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0e62f762-a5b0-42c8-96fb-c632c1d5483f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fa5dfc44-1f71-4f13-bf04-864972d55b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fa5dfc44-1f71-4f13-bf04-864972d55b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Paymenttonetsharesettleemployeeequityawards_7b686517-2753-496c-a2bc-4eaec97f4ae3" xlink:href="bsx-20200930.xsd#bsx_Paymenttonetsharesettleemployeeequityawards"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_bsx_Paymenttonetsharesettleemployeeequityawards_7b686517-2753-496c-a2bc-4eaec97f4ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_901688c7-77a5-49c7-aeeb-b07a6ceaa152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_ProceedsFromStockPlans_901688c7-77a5-49c7-aeeb-b07a6ceaa152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40cb8c5f-3168-45cd-9dab-36dc08883fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44355921-cd48-4585-97df-1e11800e83d0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40cb8c5f-3168-45cd-9dab-36dc08883fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1b68a95-2b63-4ada-8d71-2b2fc69ac518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1b68a95-2b63-4ada-8d71-2b2fc69ac518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92822231-2487-4905-86fb-02e2e43a5972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92822231-2487-4905-86fb-02e2e43a5972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b398754-90ca-4ffb-95fc-c8fef33c0aac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b398754-90ca-4ffb-95fc-c8fef33c0aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_778f53e6-9fcc-4df2-88ef-8e085146a250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_778f53e6-9fcc-4df2-88ef-8e085146a250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8c843a9-0296-471c-b207-d77081e66bfe" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_600fcd23-795a-4002-b310-01b908f8131d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:to="loc_us-gaap_ShareBasedCompensation_600fcd23-795a-4002-b310-01b908f8131d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationRecognizedInPeriod_1ff44b9e-53d5-4c9e-b9fa-b2cb21071fdf" xlink:href="bsx-20200930.xsd#bsx_ContingentConsiderationRecognizedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:to="loc_bsx_ContingentConsiderationRecognizedInPeriod_1ff44b9e-53d5-4c9e-b9fa-b2cb21071fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Noncashimpactoftransferredroyaltyrights_a913cbd3-88d5-4503-a21f-77fe24e9ef6b" xlink:href="bsx-20200930.xsd#bsx_Noncashimpactoftransferredroyaltyrights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2d78f065-0c6e-4ae0-8bd4-f92e1c28864d" xlink:to="loc_bsx_Noncashimpactoftransferredroyaltyrights_a913cbd3-88d5-4503-a21f-77fe24e9ef6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="bsx-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_e83227f0-f7e6-4f4d-ad86-35192468c846" xlink:href="bsx-20200930.xsd#bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract_e83227f0-f7e6-4f4d-ad86-35192468c846" xlink:to="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:href="bsx-20200930.xsd#bsx_StatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:to="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_StatementDomain_7becd5d4-7f89-4257-b5b3-56ea7b522761" xlink:href="bsx-20200930.xsd#bsx_StatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_StatementAxis_de06db50-4e28-44f7-bc0b-89e8c906a8a1" xlink:to="loc_bsx_StatementDomain_7becd5d4-7f89-4257-b5b3-56ea7b522761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_75f0d1eb-f8c7-4fec-b4cb-68cea16e5d7c" xlink:to="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4b24927-913b-4785-9e22-a2f48f52870f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4b24927-913b-4785-9e22-a2f48f52870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9bd4863f-d64a-4ae7-8217-519717624dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9bd4863f-d64a-4ae7-8217-519717624dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ded84693-3a32-4e6b-941d-e063f2cdfa07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ded84693-3a32-4e6b-941d-e063f2cdfa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40da9530-e86c-4367-ae16-adb46ba6b167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd13eb88-0074-43dc-8286-a1aa4c7b9745" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40da9530-e86c-4367-ae16-adb46ba6b167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e6c055b-b5a6-49d5-828c-18af32fdf114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8a0388c0-c6f0-4704-b1c6-ae61e57b79b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e6c055b-b5a6-49d5-828c-18af32fdf114" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8a0388c0-c6f0-4704-b1c6-ae61e57b79b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a91080a6-7024-4e0e-9ae7-b5bbec6ad27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_dc0acd01-a3da-4cba-9da3-a586d8cde8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a91080a6-7024-4e0e-9ae7-b5bbec6ad27c" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_dc0acd01-a3da-4cba-9da3-a586d8cde8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201613PolicyTextBlock_fb89fabf-99b7-4f7f-bd3e-016a2c1d3fb0" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201613PolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a91080a6-7024-4e0e-9ae7-b5bbec6ad27c" xlink:to="loc_bsx_ASCUpdateNo.201613PolicyTextBlock_fb89fabf-99b7-4f7f-bd3e-016a2c1d3fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_b4adf986-b155-46cb-bb2a-c59ddb34f849" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a91080a6-7024-4e0e-9ae7-b5bbec6ad27c" xlink:to="loc_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock_b4adf986-b155-46cb-bb2a-c59ddb34f849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201818PolicyTextBlock_f254350b-388d-4827-8c88-7cf6e1379a3f" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201818PolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a91080a6-7024-4e0e-9ae7-b5bbec6ad27c" xlink:to="loc_bsx_ASCUpdateNo.201818PolicyTextBlock_f254350b-388d-4827-8c88-7cf6e1379a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationASUsImplementedDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_88416b49-1d93-4aec-ae03-ec6a3e43feb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_88416b49-1d93-4aec-ae03-ec6a3e43feb1" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaseLiabilityDomain_b112bbfe-5b92-461e-af93-b72214938d69" xlink:href="bsx-20200930.xsd#bsx_OperatingleaseLiabilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OperatingleaseLiabilityAxis_cf515ad1-2343-4ca1-afe6-1b83b44e273e" xlink:to="loc_bsx_OperatingleaseLiabilityDomain_b112bbfe-5b92-461e-af93-b72214938d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingleaserightofuseassetDomain_e66ab79b-c569-4910-8364-40284d42781d" xlink:href="bsx-20200930.xsd#bsx_OperatingleaserightofuseassetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OperatingleaserightofuseassetAxis_a964af8b-5e83-4645-ae5a-ed2fedcbb1c6" xlink:to="loc_bsx_OperatingleaserightofuseassetDomain_e66ab79b-c569-4910-8364-40284d42781d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_df40e571-8400-4219-8399-5535e14dce49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_fd5e6ec2-7086-48ce-b50a-e661b10133eb" xlink:to="loc_us-gaap_TypeOfAdoptionMember_df40e571-8400-4219-8399-5535e14dce49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b23da22-36d0-456e-8056-9094b63c16c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8142e5c-e4fb-4758-87b0-82f191e1ab1e" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b23da22-36d0-456e-8056-9094b63c16c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#BasisofPresentationMaterialSubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d87961df-b9d3-4c0c-be73-083608b8461d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d87961df-b9d3-4c0c-be73-083608b8461d" xlink:to="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1ed44f10-0bca-47b9-b8b1-7d4892943386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f9c426ee-ea3d-495e-9966-056fb2702eb8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1ed44f10-0bca-47b9-b8b1-7d4892943386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_133a8aad-a1ce-497a-b0d5-8ec3c333b920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3fe6f092-d611-4339-805a-10b95c6a9dbd" xlink:to="loc_us-gaap_SubsequentEventLineItems_133a8aad-a1ce-497a-b0d5-8ec3c333b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsandStrategicInvestments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1ef37751-7e73-42bf-8ade-b8ba3764f78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_bc60cfcb-466e-44d0-830e-dcd98f58a707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1ef37751-7e73-42bf-8ade-b8ba3764f78a" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_bc60cfcb-466e-44d0-830e-dcd98f58a707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsandStrategicInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_caca9801-fd0d-4d03-8380-8e202e3fb3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_caca9801-fd0d-4d03-8380-8e202e3fb3ae" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2a38270f-8a2b-4b47-a5b9-742bc8794c9e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_dfcfb24b-e403-42a0-8c9f-b328d7ca8805" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:to="loc_bsx_BTGAcquisitionMember_dfcfb24b-e403-42a0-8c9f-b328d7ca8805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a99e48a3-c441-4609-b807-0f61138a9b21" xlink:href="bsx-20200930.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e440259-0bfb-4557-88f2-8254d9092cb7" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a99e48a3-c441-4609-b807-0f61138a9b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_31a25e48-495f-4a1a-b596-f15e429be902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b14fda39-d264-4c15-a9fa-adfb76325cbb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_31a25e48-495f-4a1a-b596-f15e429be902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_848dcf08-e15e-486f-8823-227a7e5b0f3d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_dc092305-6c40-4661-80e3-0f059dad0e3b" xlink:to="loc_srt_OwnershipDomain_848dcf08-e15e-486f-8823-227a7e5b0f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d32db7c-7189-4c96-882a-6b152f172bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2262011f-3940-4bd3-a292-96047b769c85" xlink:to="loc_us-gaap_ClassOfStockDomain_6d32db7c-7189-4c96-882a-6b152f172bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8d5de230-f103-4238-9c7b-d6248f37cb20" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_80ec982a-9557-40d3-815b-0c7ff3c24286" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_80ec982a-9557-40d3-815b-0c7ff3c24286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_458ddb09-822d-404f-8667-3cf5dc30fa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_458ddb09-822d-404f-8667-3cf5dc30fa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2b860f65-1970-4431-9942-aa87a08084a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_2b860f65-1970-4431-9942-aa87a08084a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d12a2abf-4991-460d-a22e-664bbee4a1a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d12a2abf-4991-460d-a22e-664bbee4a1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_544dd2bf-918a-4ca8-9034-ab695a77f27a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_544dd2bf-918a-4ca8-9034-ab695a77f27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_168d7687-2f69-4c52-84aa-d57e844d7080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_82200c0d-40d6-4b92-bf94-1d850076b3a1" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock_168d7687-2f69-4c52-84aa-d57e844d7080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#AcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/AcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e8caa935-8f63-439e-954c-9db686417840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e8caa935-8f63-439e-954c-9db686417840" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40862d12-f256-4b83-9820-21997088f332" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_9d8fb3f3-aa96-4253-847e-2e0a11e6831d" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_BTGAcquisitionMember_9d8fb3f3-aa96-4253-847e-2e0a11e6831d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_VertiflexIncMember_fe39f986-b768-485a-a037-8096dd7d04f7" xlink:href="bsx-20200930.xsd#bsx_VertiflexIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_VertiflexIncMember_fe39f986-b768-485a-a037-8096dd7d04f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MillipedeInc.Member_8d18b57f-bda4-439f-a8e2-9e9800cb3b82" xlink:href="bsx-20200930.xsd#bsx_MillipedeInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_MillipedeInc.Member_8d18b57f-bda4-439f-a8e2-9e9800cb3b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a1fa1abb-8408-416a-b3fd-1c0669d6abf3" xlink:href="bsx-20200930.xsd#bsx_A2019AcquisitionsVertiflexAndMillipedeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91c32f1e-1a24-4530-8ab3-5613aa8ce6ba" xlink:to="loc_bsx_A2019AcquisitionsVertiflexAndMillipedeMember_a1fa1abb-8408-416a-b3fd-1c0669d6abf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_60d753f5-f1dd-4cda-99fc-d225b9599e5c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cdf53231-47ff-407c-b581-47de601b5968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cdf53231-47ff-407c-b581-47de601b5968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_7b4818c0-b12d-4b36-a1fd-5e81ba04e06d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8d6d6423-08cb-415a-a55c-6064ffec7261" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_7b4818c0-b12d-4b36-a1fd-5e81ba04e06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_49481224-abe0-4fac-9f76-5b1e8a2d5d2e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_03f55173-869e-4f5b-a1ec-ad234dafe8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_03f55173-869e-4f5b-a1ec-ad234dafe8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_e5d7caa0-e52b-4e11-9ca3-29a729165d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a323c2e9-582f-4d6e-bf78-0dc57decd05d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_e5d7caa0-e52b-4e11-9ca3-29a729165d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_25d49f22-7a7d-41f2-958b-e5b7b0f68895" xlink:to="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2a4163a2-346b-4709-b7bd-ec0aeeee8a7d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:to="loc_srt_MinimumMember_2a4163a2-346b-4709-b7bd-ec0aeeee8a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e209f316-d617-4aa2-b2df-e23927b60bb3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:to="loc_srt_MaximumMember_e209f316-d617-4aa2-b2df-e23927b60bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_42aef818-caca-4412-9ecc-995de8be6792" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a0ee5f4-e886-491f-b546-086df8458370" xlink:to="loc_srt_WeightedAverageMember_42aef818-caca-4412-9ecc-995de8be6792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_75197565-aac8-4675-8933-e0b8df0ab251" xlink:to="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_e20d1fcd-bc0d-42a8-88c0-0bac734276ce" xlink:href="bsx-20200930.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_e20d1fcd-bc0d-42a8-88c0-0bac734276ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_edb40954-4ca5-4d17-9294-896ebc18c154" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3db8d64c-0b97-4fe9-8466-c83f08b73cc1" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_edb40954-4ca5-4d17-9294-896ebc18c154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bd0b7620-4fd5-4213-8fa5-e505a2d280a6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_fc4e8462-5dba-4199-a64e-434a5368f420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_fc4e8462-5dba-4199-a64e-434a5368f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_7b50af89-96ad-4e19-9aaf-721b25420ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_7b50af89-96ad-4e19-9aaf-721b25420ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1209b6e4-a57e-4212-95df-376d1640885a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1209b6e4-a57e-4212-95df-376d1640885a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4ef4e2f2-129c-49a9-a2c6-fcb5a13c1390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4ef4e2f2-129c-49a9-a2c6-fcb5a13c1390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_35c31f0b-6e14-42ab-b4f4-924b545939e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_35c31f0b-6e14-42ab-b4f4-924b545939e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d5108184-341f-42ca-bf17-1aed21127642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_Goodwill_d5108184-341f-42ca-bf17-1aed21127642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8cf332b4-27f4-4229-8cc1-5b4107c5e616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8cf332b4-27f4-4229-8cc1-5b4107c5e616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_deae6cdc-9f80-4848-a18b-689e965d2327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_deae6cdc-9f80-4848-a18b-689e965d2327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_52efc46b-4205-43d4-b1ab-f4db19c82a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_52efc46b-4205-43d4-b1ab-f4db19c82a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0fa8f28d-8040-4e9d-a37a-768ac114d96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0fa8f28d-8040-4e9d-a37a-768ac114d96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_b087a09f-2eb2-4a51-827c-ef140d74a874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_b087a09f-2eb2-4a51-827c-ef140d74a874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ff75a10e-cda6-462a-b0ce-ada840992a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_ff75a10e-cda6-462a-b0ce-ada840992a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ad1bd305-8cff-41ad-a551-28ae68bc70c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_ad1bd305-8cff-41ad-a551-28ae68bc70c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ac93013a-557c-4886-8c18-6d646fd6ab80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_ac93013a-557c-4886-8c18-6d646fd6ab80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_572bcd3f-03ad-49ce-b8c8-cd169e749d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_572bcd3f-03ad-49ce-b8c8-cd169e749d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2268b05f-b77e-4efb-8f4c-acd4db5ff9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2268b05f-b77e-4efb-8f4c-acd4db5ff9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2630a39c-f527-45d0-92ab-407363bcea3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2630a39c-f527-45d0-92ab-407363bcea3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_32903401-d11c-4513-9f5a-83bb304b1cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_32903401-d11c-4513-9f5a-83bb304b1cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_3354ab46-ecc8-4c56-9efa-0947bb06404f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_3354ab46-ecc8-4c56-9efa-0947bb06404f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e304f526-69b7-4d1c-ab4a-6175bac4fb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e304f526-69b7-4d1c-ab4a-6175bac4fb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_27b34189-ef96-4ac4-8eba-6a6cf1070117" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_bsx_DiscountRateFairValueInput_27b34189-ef96-4ac4-8eba-6a6cf1070117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_218a3033-685c-4b03-940b-03c0b7a561bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_218a3033-685c-4b03-940b-03c0b7a561bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_23e808f3-7660-4a81-b4c2-6aceb41b77a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow_23e808f3-7660-4a81-b4c2-6aceb41b77a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_30ff17ec-9af4-459e-91dc-52a642c6efcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_30ff17ec-9af4-459e-91dc-52a642c6efcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50d69463-4b05-4cc7-a6b6-696a68c3c0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_50d69463-4b05-4cc7-a6b6-696a68c3c0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96294e5e-22f0-49e4-865a-134764f8be9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3436e42a-74ad-4e4f-95f0-03e390f554e4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_96294e5e-22f0-49e4-865a-134764f8be9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3218c913-3a3a-4a9c-9fee-3ae6e7037b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3218c913-3a3a-4a9c-9fee-3ae6e7037b99" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4a38b9b0-eb91-4af7-9586-f59d6d8bf4bd" xlink:to="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cb7caa6e-f9c0-4903-a417-d6a70dd437cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:to="loc_srt_MinimumMember_cb7caa6e-f9c0-4903-a417-d6a70dd437cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2d8dd2c-2198-4329-95a2-551bf1a27f99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:to="loc_srt_MaximumMember_a2d8dd2c-2198-4329-95a2-551bf1a27f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_56eddab8-6f49-4ebe-953f-4428d5a06b50" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0299b39-98b5-4a07-a543-d9f70a9fc734" xlink:to="loc_srt_WeightedAverageMember_56eddab8-6f49-4ebe-953f-4428d5a06b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1af067ac-ce4e-47db-bf5f-3ce51d3ccec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_8afbac0b-bce0-46ec-8030-f50a0fd539cd" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1af067ac-ce4e-47db-bf5f-3ce51d3ccec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b7552de2-a962-4e4c-ac4c-ba040ea8b764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_1af067ac-ce4e-47db-bf5f-3ce51d3ccec3" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_b7552de2-a962-4e4c-ac4c-ba040ea8b764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a4b7e0-77a8-4296-a95e-0222608414ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_66d46382-6f17-4fa4-b562-639cf0aff617" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22a4b7e0-77a8-4296-a95e-0222608414ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_fdfbc0b1-b5f0-42ec-927f-a61bbfb0ce4b" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_9a0c6619-3ed5-4724-bd5c-f4dfdad46d07" xlink:href="bsx-20200930.xsd#bsx_RDRegulatoryandCommercializationbasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:to="loc_bsx_RDRegulatoryandCommercializationbasedMilestoneMember_9a0c6619-3ed5-4724-bd5c-f4dfdad46d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RevenueBasedPaymentsMember_27d50d2d-f95e-401d-94e8-ae4f1a00703b" xlink:href="bsx-20200930.xsd#bsx_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_18e5859f-5d20-4aa5-b1cb-0332ceea2b38" xlink:to="loc_bsx_RevenueBasedPaymentsMember_27d50d2d-f95e-401d-94e8-ae4f1a00703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_3208f5a6-26d4-4444-8afc-92608bb9d578" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c554baca-2bee-45f8-82cf-6c2d0cb5a7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c554baca-2bee-45f8-82cf-6c2d0cb5a7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbd99c1f-cffc-4363-84d5-a24ff4f9be77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bbd99c1f-cffc-4363-84d5-a24ff4f9be77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_PaymentOfContingentConsideration_b378a028-ca7c-4c3f-a919-586f235a80b6" xlink:href="bsx-20200930.xsd#bsx_PaymentOfContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_bsx_PaymentOfContingentConsideration_b378a028-ca7c-4c3f-a919-586f235a80b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c52d685-f9a7-47d6-834f-d9c0f0d3528c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b6fa8e0c-9980-4c58-af58-48acd0e1c419" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_5c52d685-f9a7-47d6-834f-d9c0f0d3528c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_af30454c-d97f-4513-b64e-030ea811a55f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4373ad43-5bcd-441a-a976-a3eb79ca348f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_4373ad43-5bcd-441a-a976-a3eb79ca348f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_9a5f274c-f72d-4747-b3e6-db4a4924598a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8909a6d3-7b51-4b91-bd96-769b6612b13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8909a6d3-7b51-4b91-bd96-769b6612b13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_fc1bd9d1-3046-4b78-ab96-deee34772b02" xlink:href="bsx-20200930.xsd#bsx_ContingentConsiderationLiabilityProbabilityOfPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:to="loc_bsx_ContingentConsiderationLiabilityProbabilityOfPayment_fc1bd9d1-3046-4b78-ab96-deee34772b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_b303bbce-9e8d-4d88-ab55-d45b604267c0" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_9476efbb-b3ea-4e51-aacc-0729e5b07753" xlink:to="loc_bsx_DiscountRateFairValueInput_b303bbce-9e8d-4d88-ab55-d45b604267c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#StrategicInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StrategicInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ded5f671-d892-46b4-9ceb-d124bce4f9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ded5f671-d892-46b4-9ceb-d124bce4f9ab" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_08101584-101d-4a74-a84c-5012146e6686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_128a5098-178d-4965-8b88-180bc18f35ce" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_08101584-101d-4a74-a84c-5012146e6686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f15af9a0-35e0-4b64-9d78-c7acbe4d6717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_08101584-101d-4a74-a84c-5012146e6686" xlink:to="loc_us-gaap_SubsequentEventMember_f15af9a0-35e0-4b64-9d78-c7acbe4d6717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_5055c414-8231-4b00-b348-73672e85c482" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_2464be7f-0215-48e0-a897-a7347155910e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_2464be7f-0215-48e0-a897-a7347155910e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_516f6e7d-a5a1-4a88-ab24-d00db7518dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquityMethodInvestments_516f6e7d-a5a1-4a88-ab24-d00db7518dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e558234d-963a-4703-8926-c0cb3c6ec465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e558234d-963a-4703-8926-c0cb3c6ec465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cd6dbb2d-a34d-4731-810b-20a29ddd0487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cd6dbb2d-a34d-4731-810b-20a29ddd0487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7573141-3150-4420-aea9-e3559fa5beeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7573141-3150-4420-aea9-e3559fa5beeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4f617b91-47b2-4f5b-9467-25c6166d424c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_Investments_4f617b91-47b2-4f5b-9467-25c6166d424c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_399b683f-6826-4667-b67f-6782638936e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_f56582ba-4a8f-43d7-85ec-628f22c48bbc" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_399b683f-6826-4667-b67f-6782638936e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c96623c-ed22-47c0-a688-7a2ca2c9ac28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_18a74a66-52ef-4c7e-a079-e9c4bb577d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c96623c-ed22-47c0-a688-7a2ca2c9ac28" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_18a74a66-52ef-4c7e-a079-e9c4bb577d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsGoodwillPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3d4c0aa4-2cc8-443b-a3b6-55a4cd39d683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_c8315fba-22ab-4e5a-b0bc-68509872b054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3d4c0aa4-2cc8-443b-a3b6-55a4cd39d683" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_c8315fba-22ab-4e5a-b0bc-68509872b054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_51dfdbb5-3f46-4a14-b5a3-b70c809a04ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3d4c0aa4-2cc8-443b-a3b6-55a4cd39d683" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_51dfdbb5-3f46-4a14-b5a3-b70c809a04ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#GoodwillandOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f30e955-76a8-43cb-8e6d-dd6be8fe5bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIntangibleAssetsandGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f30e955-76a8-43cb-8e6d-dd6be8fe5bc4" xlink:to="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsDomain_d0a8b110-ab4c-4438-a1ab-4e7035c44597" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsAxis_469a1501-e3af-4e69-bf3b-f6b305d830c2" xlink:to="loc_bsx_IntangibleAssetsDomain_d0a8b110-ab4c-4438-a1ab-4e7035c44597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_56d05bcc-dcea-463c-8371-66c1957d7d2f" xlink:to="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_96fda023-3d6b-4a8c-940e-a914bb1c2524" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:to="loc_srt_MinimumMember_96fda023-3d6b-4a8c-940e-a914bb1c2524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_690de0b7-a267-4a58-a728-e8544789fb87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_462d694e-5ff0-4439-b5bc-efa01296c729" xlink:to="loc_srt_MaximumMember_690de0b7-a267-4a58-a728-e8544789fb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9d2d8279-c292-4c7b-883f-884aacb7051c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f840e2f8-fab7-4053-898e-4ed02c85617a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_f840e2f8-fab7-4053-898e-4ed02c85617a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_718814c6-e739-4521-8f00-96f580dd1906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:to="loc_us-gaap_PatentsMember_718814c6-e739-4521-8f00-96f580dd1906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_91b37f38-20ce-443b-bf4b-ca3b6943247f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0675799a-470e-48c3-a304-335d9cbdab2d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_91b37f38-20ce-443b-bf4b-ca3b6943247f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_93ef91a3-ab7c-4f5c-bbc2-61e1dab2ee89" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillMember_a1e0fb0c-8b58-4f85-9155-fc510dba7e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:to="loc_us-gaap_GoodwillMember_a1e0fb0c-8b58-4f85-9155-fc510dba7e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ca4f4d3f-5c73-46ec-bbb9-0031509fb7d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ca4f4d3f-5c73-46ec-bbb9-0031509fb7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0558f7ed-0cd1-40a6-8941-e7f1b5d8bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ededd188-bdd5-4ab1-8835-5a15b3018b7d" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_0558f7ed-0cd1-40a6-8941-e7f1b5d8bfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_884a1bc8-3009-453f-9b0f-37f2eba6bde2" xlink:to="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_d476ab86-0fa8-42b8-8340-3ab11625f6b0" xlink:href="bsx-20200930.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_MedsurgMember_d476ab86-0fa8-42b8-8340-3ab11625f6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_c6adfe47-1503-4ea2-a9a1-ebb020719a2e" xlink:href="bsx-20200930.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_RhythmandNeuroMember_c6adfe47-1503-4ea2-a9a1-ebb020719a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_1dc440f8-6b36-4a78-8a9e-a3cd6c73aace" xlink:href="bsx-20200930.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_CardiovascularMember_1dc440f8-6b36-4a78-8a9e-a3cd6c73aace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_e3b05393-b829-4403-a4d5-97a1e2e30b36" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_e3b05393-b829-4403-a4d5-97a1e2e30b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_b64dbb33-3163-4dc6-98b7-206bee004353" xlink:href="bsx-20200930.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_b64dbb33-3163-4dc6-98b7-206bee004353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_6539a9a4-e432-411c-949e-0c1d87a20614" xlink:href="bsx-20200930.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_6539a9a4-e432-411c-949e-0c1d87a20614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_edf4c1c6-af27-4ada-b91e-a9fc67df95c0" xlink:href="bsx-20200930.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7677ab9f-4d64-4137-ad6b-53628e98da86" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_edf4c1c6-af27-4ada-b91e-a9fc67df95c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:href="bsx-20200930.xsd#bsx_IntangibleAssetsandGoodwillLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIntangibleAssetsandGoodwillTable_e00fa128-3363-4009-896b-110c8ba24bb2" xlink:to="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51ca52ec-67cf-47d8-8d46-39ba69b92371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51ca52ec-67cf-47d8-8d46-39ba69b92371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c21c2259-c050-4e6a-9ec2-9446d0648a78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c21c2259-c050-4e6a-9ec2-9446d0648a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_5eb4fecd-1284-4d8d-8a58-4e98e00622b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_GoodwillGross_5eb4fecd-1284-4d8d-8a58-4e98e00622b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_9a76cacc-8617-433b-ba44-d100fc4bbc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_9a76cacc-8617-433b-ba44-d100fc4bbc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26f98a74-6d6a-49c0-b216-e62903a73f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26f98a74-6d6a-49c0-b216-e62903a73f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_524f9197-6aef-4872-a310-3b39887df324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_524f9197-6aef-4872-a310-3b39887df324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_IntangibleAssetsandGoodwillLineItems_d8841031-66c6-43e2-a90f-fd710f7d3fc3" xlink:to="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27a848b7-38cf-4d20-8b09-a777790139fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:to="loc_us-gaap_Goodwill_27a848b7-38cf-4d20-8b09-a777790139fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7820eb20-d4fc-4a25-85bd-2ebd572d7a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_7820eb20-d4fc-4a25-85bd-2ebd572d7a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_aed2f901-a8f1-4c15-a7dd-b65c46294652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5452a845-7633-402d-a9ef-f5c5ba14ae1c" xlink:to="loc_us-gaap_Goodwill_aed2f901-a8f1-4c15-a7dd-b65c46294652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_30bc9c09-e210-443e-aae8-367c03f71396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5fe0554d-5bcd-417d-ad91-58e0e2b47551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_30bc9c09-e210-443e-aae8-367c03f71396" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_5fe0554d-5bcd-417d-ad91-58e0e2b47551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9570aa9c-f414-40ed-9255-77381dd7ce1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5fe0554d-5bcd-417d-ad91-58e0e2b47551" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9570aa9c-f414-40ed-9255-77381dd7ce1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9ff705ae-b452-4ab6-b038-56f36cbc88da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_e4267ff7-e30a-4064-a54f-d3f2db67e432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ff705ae-b452-4ab6-b038-56f36cbc88da" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_e4267ff7-e30a-4064-a54f-d3f2db67e432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b53f83ba-6e84-496c-92f6-215227a3a0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ff705ae-b452-4ab6-b038-56f36cbc88da" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b53f83ba-6e84-496c-92f6-215227a3a0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dce72ca9-a808-44cd-8894-0811f2984d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dce72ca9-a808-44cd-8894-0811f2984d1a" xlink:to="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_47e69825-09e2-4c0a-a167-70aff31ad2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_10e2583e-f67c-49ac-a17d-d6f16e38e810" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_47e69825-09e2-4c0a-a167-70aff31ad2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_acba0596-4178-4e06-816f-7bb5a7ac5a51" xlink:to="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_19c1d433-1655-49f3-b047-461b6e5763b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_19c1d433-1655-49f3-b047-461b6e5763b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e8a8e401-7d35-495b-a3e4-4a907b74597c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e8a8e401-7d35-495b-a3e4-4a907b74597c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_869f3ab9-329d-4a50-9d48-e3520b201675" xlink:href="bsx-20200930.xsd#bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock_869f3ab9-329d-4a50-9d48-e3520b201675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b0526f0d-e8cf-4238-8b47-179e80599a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_b0526f0d-e8cf-4238-8b47-179e80599a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_9aeb8cf4-356c-4e11-84bb-4ed7bcf36d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e5deec1b-8569-4c1d-b346-2dfe0a8aa81e" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_9aeb8cf4-356c-4e11-84bb-4ed7bcf36d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8f1bbe11-ad87-4c9f-b957-aaa8221ba459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dce72ca9-a808-44cd-8894-0811f2984d1a" xlink:to="loc_us-gaap_FairValueDisclosuresAbstract_8f1bbe11-ad87-4c9f-b957-aaa8221ba459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8f1bbe11-ad87-4c9f-b957-aaa8221ba459" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e118f000-e4a6-4fd4-87c9-700b93a05533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_28b40ec9-23a5-4848-b52c-f2d8c2e853f2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e118f000-e4a6-4fd4-87c9-700b93a05533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81c05b60-2d90-46e8-bdab-3489d10e05a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b7d91915-7407-4437-b919-9f2688f4fa5b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81c05b60-2d90-46e8-bdab-3489d10e05a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c01ffbc-6777-41b1-9704-3a46619d6b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_06f01597-61bf-480f-ae00-23d095132544" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c01ffbc-6777-41b1-9704-3a46619d6b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e198d901-8e15-4d6d-bf01-c0da253c34b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1c01ffbc-6777-41b1-9704-3a46619d6b68" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e198d901-8e15-4d6d-bf01-c0da253c34b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#HedgingActivitiesandFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0054fa1a-c550-449c-aa3e-4273118584f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0054fa1a-c550-449c-aa3e-4273118584f7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6dbec774-4766-492c-91c3-4d9c4058519c" xlink:to="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_40bb033f-c862-45a4-8f75-775cf76ab15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:to="loc_us-gaap_CashFlowHedgingMember_40bb033f-c862-45a4-8f75-775cf76ab15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_04a7d756-78fe-4f96-ae2a-ed2e4978eba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_798c48e2-716d-4aaa-b1a7-eab1595a3679" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_04a7d756-78fe-4f96-ae2a-ed2e4978eba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_93e9b4d7-1132-44a2-9238-77bc0c1a26b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdc98e18-2a82-4963-9de4-47df8f56b4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cdc98e18-2a82-4963-9de4-47df8f56b4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ea050cb4-5170-4a9e-b9ac-cd60e280d1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_20499e7c-cf18-4140-9739-566ff1ac5375" xlink:to="loc_us-gaap_NondesignatedMember_ea050cb4-5170-4a9e-b9ac-cd60e280d1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_83a02cf7-d835-47d5-94e5-44f0d2b39310" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_b67b726c-0efd-4cde-b6ab-54d7fa3cfe09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_b67b726c-0efd-4cde-b6ab-54d7fa3cfe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_a22322a6-2af0-448c-916b-8681531e50f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_us-gaap_ForeignExchangeContractMember_a22322a6-2af0-448c-916b-8681531e50f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForeigncurrencydenominatedindebtMember_7eee15e7-e9fa-4739-9f48-b0933fdc4488" xlink:href="bsx-20200930.xsd#bsx_ForeigncurrencydenominatedindebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_bsx_ForeigncurrencydenominatedindebtMember_7eee15e7-e9fa-4739-9f48-b0933fdc4488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_3860136f-9190-4da8-b361-d69fcdb49255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c55210d-6739-4f72-a4c5-f2bc43a8c442" xlink:to="loc_us-gaap_InterestRateContractMember_3860136f-9190-4da8-b361-d69fcdb49255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1bd25c5e-2462-48c4-a577-94097f5e2ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_768f40c9-3ec2-41da-a66f-7f41c0f1417c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1bd25c5e-2462-48c4-a577-94097f5e2ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BTGAcquisitionMember_fc91cc16-bf7b-47e9-ae69-3e4285796dc4" xlink:href="bsx-20200930.xsd#bsx_BTGAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1bd25c5e-2462-48c4-a577-94097f5e2ee6" xlink:to="loc_bsx_BTGAcquisitionMember_fc91cc16-bf7b-47e9-ae69-3e4285796dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1be6b871-2233-4e19-919a-2f2b75f5032f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_dc434edb-c432-4815-b09b-95c57783f673" xlink:href="bsx-20200930.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:to="loc_bsx_November2019AggregateOfferingMember_dc434edb-c432-4815-b09b-95c57783f673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_c2c1ee25-3165-4dbd-b3a9-a58853ffaa3f" xlink:href="bsx-20200930.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_239cbaa6-e544-4ef3-81a9-0dec1c764313" xlink:to="loc_bsx_December2027NotesMember_c2c1ee25-3165-4dbd-b3a9-a58853ffaa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1f99710a-b07f-447b-bb24-3d3c0b214316" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_3d91157f-996a-474b-9236-be9f2bda4cd3" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_bsx_LicensingarrangementassetsMember_3d91157f-996a-474b-9236-be9f2bda4cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f1bd144-8452-4ba5-8c81-f81e83fac631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f1bd144-8452-4ba5-8c81-f81e83fac631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_439821bb-619b-4b23-a111-86853aa76da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_439821bb-619b-4b23-a111-86853aa76da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_8367d76a-fe34-4f89-b4e8-63d6d33713f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_8367d76a-fe34-4f89-b4e8-63d6d33713f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3c93368d-7178-47e7-97fd-d62447d74690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_23525667-d836-4429-86a7-25537328eb50" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3c93368d-7178-47e7-97fd-d62447d74690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_aa01891b-89dc-471d-a8c3-b85552947597" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4d6d17ae-76af-47cc-96a0-253f73815289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:to="loc_us-gaap_CostOfSalesMember_4d6d17ae-76af-47cc-96a0-253f73815289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_e9bc5eb1-f415-4b71-81b0-a85541e40763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:to="loc_us-gaap_InterestExpenseMember_e9bc5eb1-f415-4b71-81b0-a85541e40763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b763a48-7ff0-4f28-996a-4ba5e104df94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2390c679-f471-4e4c-9b29-f6020525cfe7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9b763a48-7ff0-4f28-996a-4ba5e104df94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_078bd149-10ce-4c2e-be9f-d8f29fda1e43" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5e216b29-6ac6-462b-91db-dfe25012436e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_LongTermDebt_5e216b29-6ac6-462b-91db-dfe25012436e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93d53d41-f40e-45d6-ae46-0f12ad440cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93d53d41-f40e-45d6-ae46-0f12ad440cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_NotionalValueofOutstandingNetInvestmentHedges_e61171cf-ee50-4147-8c32-b541223290c2" xlink:href="bsx-20200930.xsd#bsx_NotionalValueofOutstandingNetInvestmentHedges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_NotionalValueofOutstandingNetInvestmentHedges_e61171cf-ee50-4147-8c32-b541223290c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeInvestingActivities_aef18e6d-a4ed-4855-968f-44ce2e81704a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_PaymentsForHedgeInvestingActivities_aef18e6d-a4ed-4855-968f-44ce2e81704a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCashReceivedOnHedge_6ce1484b-ba6d-4369-a224-571a3b718749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCashReceivedOnHedge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeCashReceivedOnHedge_6ce1484b-ba6d-4369-a224-571a3b718749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_3147b188-2700-4037-93ff-d7c507023e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_3147b188-2700-4037-93ff-d7c507023e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_04e7dd3b-dc79-4080-9df4-56ab6a75e92c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet_04e7dd3b-dc79-4080-9df4-56ab6a75e92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_84796a94-215d-4922-9cfa-8d316e730af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeNotionalAmount_84796a94-215d-4922-9cfa-8d316e730af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ForwardCurrencyContractsTimetoMaturity_9f0be40f-b26e-4110-a32e-57b908c6da25" xlink:href="bsx-20200930.xsd#bsx_ForwardCurrencyContractsTimetoMaturity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_ForwardCurrencyContractsTimetoMaturity_9f0be40f-b26e-4110-a32e-57b908c6da25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76e27273-042c-4d6c-b269-dc8b11177328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_76e27273-042c-4d6c-b269-dc8b11177328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cd47887c-6bd2-4fa6-9f51-84b9a847dcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_cd47887c-6bd2-4fa6-9f51-84b9a847dcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_bbc972ef-6738-4745-9748-829c950e2546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_bbc972ef-6738-4745-9748-829c950e2546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6f361ba7-0c4a-4608-9908-2a4062e259bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6f361ba7-0c4a-4608-9908-2a4062e259bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6105452d-049c-4b35-9067-6fc97f7f811b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6105452d-049c-4b35-9067-6fc97f7f811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_426fdae7-308e-45e4-98da-5421320bbcca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_426fdae7-308e-45e4-98da-5421320bbcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e55c1621-ce3f-486f-a2df-243be0abb8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e55c1621-ce3f-486f-a2df-243be0abb8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d378a8f7-1663-4698-ba93-42bfa6b74a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d378a8f7-1663-4698-ba93-42bfa6b74a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_4ddf8e5f-2a0b-47b7-8df2-f591da499379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax_4ddf8e5f-2a0b-47b7-8df2-f591da499379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_ed8b76f1-907d-44ba-b2e0-b8d43c787077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_ed8b76f1-907d-44ba-b2e0-b8d43c787077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8560f9dd-12bb-452d-9fcc-5ecbb3dd6c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_InterestExpense_8560f9dd-12bb-452d-9fcc-5ecbb3dd6c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_f88d378a-ac89-4551-86dd-09805b92c671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_f88d378a-ac89-4551-86dd-09805b92c671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_1ae015b3-eb96-4ade-835c-ec839baf5e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_1ae015b3-eb96-4ade-835c-ec839baf5e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_8fce3d3f-01ba-4818-be72-67453720dee4" xlink:href="bsx-20200930.xsd#bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax_8fce3d3f-01ba-4818-be72-67453720dee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_3e1074cd-e54d-4346-ad48-90a628d3a272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_3e1074cd-e54d-4346-ad48-90a628d3a272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_cf0d5cf0-540c-409c-91a3-0583b7d60bbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_cf0d5cf0-540c-409c-91a3-0583b7d60bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_ec1ab356-28e4-4078-bc1b-e36f19140d07" xlink:href="bsx-20200930.xsd#bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet_ec1ab356-28e4-4078-bc1b-e36f19140d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1fbc7e8c-54d0-4c07-b49a-979777ea7719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_1fbc7e8c-54d0-4c07-b49a-979777ea7719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9c3cfecf-714c-4123-adeb-aafdb7d0441d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_9c3cfecf-714c-4123-adeb-aafdb7d0441d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Netcurrencyexchangegainloss_f1fb591f-c64f-46a9-bb4a-4cc84ac62130" xlink:href="bsx-20200930.xsd#bsx_Netcurrencyexchangegainloss"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_bsx_Netcurrencyexchangegainloss_f1fb591f-c64f-46a9-bb4a-4cc84ac62130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c15e7750-9bec-47ba-9083-aeaaa7e0ed64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_c15e7750-9bec-47ba-9083-aeaaa7e0ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ae4fdc51-5a86-4a3d-ad68-a1309e04eb03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ae4fdc51-5a86-4a3d-ad68-a1309e04eb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bc3ca97d-578e-4db9-986d-07a80eb64c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_bc3ca97d-578e-4db9-986d-07a80eb64c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b28e98ee-8d31-43be-b5c7-19ed388eff55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_b28e98ee-8d31-43be-b5c7-19ed388eff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_b386e7d8-692e-4cb0-854d-0e68de214ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_b386e7d8-692e-4cb0-854d-0e68de214ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c250399b-07c5-4096-8c29-bdcfd7e1b447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a690ab50-5765-4830-885a-3434e294db2d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c250399b-07c5-4096-8c29-bdcfd7e1b447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0054fa1a-c550-449c-aa3e-4273118584f7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ff923217-2a7a-43dd-9f2d-eab8bf072b16" xlink:to="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_ca85dc59-0e6d-458b-bc32-0932c170896e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:to="loc_srt_WeightedAverageMember_ca85dc59-0e6d-458b-bc32-0932c170896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8ca553f-dc29-46af-b23b-50853b64b2ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:to="loc_srt_MinimumMember_b8ca553f-dc29-46af-b23b-50853b64b2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_67cabe5a-94ac-47a2-92fa-777f7f296bf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c74427af-cb45-4503-9d17-cd5ef1230744" xlink:to="loc_srt_MaximumMember_67cabe5a-94ac-47a2-92fa-777f7f296bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_45f13832-856b-4071-a1fa-ea2bbeb6e3e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3e21c6d5-e766-4af1-afb2-cd13ae26809b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_45f13832-856b-4071-a1fa-ea2bbeb6e3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_132ad723-bd84-45ad-b94e-9ce96997102c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_45f13832-856b-4071-a1fa-ea2bbeb6e3e3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_132ad723-bd84-45ad-b94e-9ce96997102c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0bcdfe7c-6de4-407f-9c5b-f05082e8d870" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c16a0f33-1585-450a-9606-c9a567671db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c16a0f33-1585-450a-9606-c9a567671db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_59af9f24-6fa5-4975-bb25-cfdc821ff323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_59af9f24-6fa5-4975-bb25-cfdc821ff323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_94c5d6f8-9fd9-4a86-9d43-43684df81afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_52500104-889e-4fad-9582-0a71f6453fcd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_94c5d6f8-9fd9-4a86-9d43-43684df81afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8dfb2377-ecd1-4e79-b9a9-ee3740d38ccd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementassetsMember_7fb5b8bc-f41d-4dc9-820e-a1756e48174b" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:to="loc_bsx_LicensingarrangementassetsMember_7fb5b8bc-f41d-4dc9-820e-a1756e48174b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LicensingarrangementliabilitiesMember_db52ca21-5ef7-49b3-ae28-5aaa363dd43e" xlink:href="bsx-20200930.xsd#bsx_LicensingarrangementliabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:to="loc_bsx_LicensingarrangementliabilitiesMember_db52ca21-5ef7-49b3-ae28-5aaa363dd43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EurodenominatedoutstandingdebtMember_649c13b6-f15b-4721-837c-b41708c8cbe6" xlink:href="bsx-20200930.xsd#bsx_EurodenominatedoutstandingdebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_149d1fbf-595b-4d01-a0cb-12c966f733a3" xlink:to="loc_bsx_EurodenominatedoutstandingdebtMember_649c13b6-f15b-4721-837c-b41708c8cbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b8afceba-9f59-4954-9a02-3359e6eaee68" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_fcf35e4f-8c5a-4881-9eb8-748b935ede7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_fcf35e4f-8c5a-4881-9eb8-748b935ede7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_4992865d-2c97-4599-9e2b-9de7ba95dd37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_4992865d-2c97-4599-9e2b-9de7ba95dd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8cc16945-5517-4ff3-a5d8-f0f254a5bc6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_DerivativeAssets_8cc16945-5517-4ff3-a5d8-f0f254a5bc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_ea9f62e0-f376-47cf-91c1-3751829f93d2" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_Licensingarrangementsasset_ea9f62e0-f376-47cf-91c1-3751829f93d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e1b38d40-6c9f-4079-bd67-bb97ab65efaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e1b38d40-6c9f-4079-bd67-bb97ab65efaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_16786dc5-0838-45ea-97fc-2ce8915ca328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_DerivativeLiabilities_16786dc5-0838-45ea-97fc-2ce8915ca328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_466e9c19-4321-44aa-88bc-1f73b66c32a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_466e9c19-4321-44aa-88bc-1f73b66c32a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_89043bdc-5748-4147-bee8-e98d23c4a0ff" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_Licensingarrangementsliability_89043bdc-5748-4147-bee8-e98d23c4a0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ae189e26-c4a9-40cd-aadf-07ef7b8ed20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ae189e26-c4a9-40cd-aadf-07ef7b8ed20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_2264bae5-a2fb-4ccd-b37c-62b28b5fda1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_Cash_2264bae5-a2fb-4ccd-b37c-62b28b5fda1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_6cd59127-4e15-487d-9882-4e5e4dd1dfa9" xlink:href="bsx-20200930.xsd#bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements_6cd59127-4e15-487d-9882-4e5e4dd1dfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DiscountRateFairValueInput_bad95965-a2c7-467b-b4b3-ce42b0db1183" xlink:href="bsx-20200930.xsd#bsx_DiscountRateFairValueInput"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_bsx_DiscountRateFairValueInput_bad95965-a2c7-467b-b4b3-ce42b0db1183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_0987fca6-b1fd-407a-8a74-444e1b48e998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_0987fca6-b1fd-407a-8a74-444e1b48e998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_be84a4c7-7783-4b5b-a4b0-7f026ccc7c68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_PaymentsForRoyalties_be84a4c7-7783-4b5b-a4b0-7f026ccc7c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_ba493a4d-7645-4caf-abb9-40b25cd4323a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption_ba493a4d-7645-4caf-abb9-40b25cd4323a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_31e4c4f1-cd4a-419e-bc58-d909689fb550" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1659b968-4e45-419e-be21-f3ea53580534" xlink:to="loc_us-gaap_DebtInstrumentFairValue_31e4c4f1-cd4a-419e-bc58-d909689fb550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitments"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3304468e-2e92-4fd0-847c-099d0d8ceb10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5b940930-15d9-43b6-a4b3-65f53da9d3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3304468e-2e92-4fd0-847c-099d0d8ceb10" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5b940930-15d9-43b6-a4b3-65f53da9d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b63f4e7b-fc5b-4e6f-b152-35297879ee7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b63f4e7b-fc5b-4e6f-b152-35297879ee7e" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9d6c0fcf-3463-4b26-b2f8-fbacb00b5231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_47b8408b-5c9c-45c2-8c57-311e68034ed4" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9d6c0fcf-3463-4b26-b2f8-fbacb00b5231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_0d4805ed-70be-4ca2-97f1-51d5e0fa77f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_9d6c0fcf-3463-4b26-b2f8-fbacb00b5231" xlink:to="loc_us-gaap_CommercialPaperMember_0d4805ed-70be-4ca2-97f1-51d5e0fa77f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:to="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e17e4327-a7d1-4e25-8d33-837ecdac4619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_534f6bcb-b6a3-4491-b5af-887d28e47b6e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e17e4327-a7d1-4e25-8d33-837ecdac4619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_b92e3821-d40d-42b2-8fd8-20b1e332dc41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_91eb2355-dd6a-4bb4-ba9b-31da6cafcb67" xlink:to="loc_us-gaap_ShortTermDebtLineItems_b92e3821-d40d-42b2-8fd8-20b1e332dc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_84c84c73-be3b-4226-8274-e1c2468acc44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_b92e3821-d40d-42b2-8fd8-20b1e332dc41" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_84c84c73-be3b-4226-8274-e1c2468acc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bd6bb13a-c9b8-4949-ad44-d571ea7b6f61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b63f4e7b-fc5b-4e6f-b152-35297879ee7e" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bd6bb13a-c9b8-4949-ad44-d571ea7b6f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_3ea7730d-4962-4d32-9a36-b4de28621009" xlink:href="bsx-20200930.xsd#bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b63f4e7b-fc5b-4e6f-b152-35297879ee7e" xlink:to="loc_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock_3ea7730d-4962-4d32-9a36-b4de28621009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_8b161215-6d3a-4a8b-90b1-df7f75f44e7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b63f4e7b-fc5b-4e6f-b152-35297879ee7e" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock_8b161215-6d3a-4a8b-90b1-df7f75f44e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ContractualObligationsandCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2c7f7b0f-c55f-4b2b-b7ec-aa0158dcf46f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2c7f7b0f-c55f-4b2b-b7ec-aa0158dcf46f" xlink:to="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_55569921-d54b-46c4-af13-b927aa451687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4315c651-8d4c-46c6-b8d6-da49ae150c2c" xlink:to="loc_us-gaap_ClassOfStockDomain_55569921-d54b-46c4-af13-b927aa451687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_46576518-8ba9-4658-9a7e-fae6b3b27581" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_55569921-d54b-46c4-af13-b927aa451687" xlink:to="loc_bsx_A550MCPSSeriesAMember_46576518-8ba9-4658-9a7e-fae6b3b27581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cb3ac42-09c1-4969-a1f1-6a992f94046c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_April2021TermLoanMember_e81441d2-7102-47e5-965c-07fa48d46a46" xlink:href="bsx-20200930.xsd#bsx_April2021TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_April2021TermLoanMember_e81441d2-7102-47e5-965c-07fa48d46a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A2020TermLoanMember_2ff1c986-b6d6-4eb4-b6a9-72624c638398" xlink:href="bsx-20200930.xsd#bsx_A2020TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_A2020TermLoanMember_2ff1c986-b6d6-4eb4-b6a9-72624c638398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2021TermLoanMember_5e90882b-9308-42cb-ac83-56352678ed72" xlink:href="bsx-20200930.xsd#bsx_February2021TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_February2021TermLoanMember_5e90882b-9308-42cb-ac83-56352678ed72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ThreeYearDelayedDrawTermLoanMember_7395b9b6-10d0-4460-8125-bda131ed3631" xlink:href="bsx-20200930.xsd#bsx_ThreeYearDelayedDrawTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_ThreeYearDelayedDrawTermLoanMember_7395b9b6-10d0-4460-8125-bda131ed3631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TwoYearDelayedDrawTermLoanMember_2fe73c39-fb08-4a1a-83e1-d60c1a9ab194" xlink:href="bsx-20200930.xsd#bsx_TwoYearDelayedDrawTermLoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_TwoYearDelayedDrawTermLoanMember_2fe73c39-fb08-4a1a-83e1-d60c1a9ab194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_cfefbe4a-14cb-4b9f-9891-5fe467a4a6bd" xlink:href="bsx-20200930.xsd#bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember_cfefbe4a-14cb-4b9f-9891-5fe467a4a6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EuroDenominatedFactoringArrangementsMember_c3852c11-6c5b-4fb2-9994-e50fdfab79a4" xlink:href="bsx-20200930.xsd#bsx_EuroDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_EuroDenominatedFactoringArrangementsMember_c3852c11-6c5b-4fb2-9994-e50fdfab79a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_YenDenominatedFactoringArrangementsMember_32407f56-6ba6-4586-88ad-d538ef618873" xlink:href="bsx-20200930.xsd#bsx_YenDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_YenDenominatedFactoringArrangementsMember_32407f56-6ba6-4586-88ad-d538ef618873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_4722b8ee-fca3-4c5c-b7bc-e1ba7b886053" xlink:href="bsx-20200930.xsd#bsx_RenminbiDenominatedFactoringArrangementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9bd18bde-f959-4d15-9a81-bbd61538e715" xlink:to="loc_bsx_RenminbiDenominatedFactoringArrangementsMember_4722b8ee-fca3-4c5c-b7bc-e1ba7b886053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9bebdc93-6027-45b9-80f3-9f541969f245" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_February2019AggregateOfferingMember_0df4d404-91da-4837-a85e-88509f91bf2a" xlink:href="bsx-20200930.xsd#bsx_February2019AggregateOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_February2019AggregateOfferingMember_0df4d404-91da-4837-a85e-88509f91bf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2020NotesMember_c1f7049f-a177-444e-b867-65f970d911b9" xlink:href="bsx-20200930.xsd#bsx_January2020NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_January2020NotesMember_c1f7049f-a177-444e-b867-65f970d911b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020NotesMember_1f97016e-c6c5-46cc-ad4b-150844706ca6" xlink:href="bsx-20200930.xsd#bsx_May2020NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2020NotesMember_1f97016e-c6c5-46cc-ad4b-150844706ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2019AggregateOfferingMember_be35978d-c190-4c84-b95d-82e80b1505f1" xlink:href="bsx-20200930.xsd#bsx_November2019AggregateOfferingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_November2019AggregateOfferingMember_be35978d-c190-4c84-b95d-82e80b1505f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2022NotesMember_ebe93a1e-213c-4b7b-b19c-675f736a123e" xlink:href="bsx-20200930.xsd#bsx_May2022NotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2022NotesMember_ebe93a1e-213c-4b7b-b19c-675f736a123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_October2023NotesMember_d380dc83-217f-4278-be64-dda3bc8ec63a" xlink:href="bsx-20200930.xsd#bsx_October2023NotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_October2023NotesMember_d380dc83-217f-4278-be64-dda3bc8ec63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b7b4b2a1-279f-4a47-be3d-e1dcea4a7e76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b7b4b2a1-279f-4a47-be3d-e1dcea4a7e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2024NotesMember_0f812751-71dd-4077-a800-727bf01b9f96" xlink:href="bsx-20200930.xsd#bsx_March2024NotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2024NotesMember_0f812751-71dd-4077-a800-727bf01b9f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2025NotesMember_d5193e03-feab-4ec1-b6f9-c3be0b16a8dd" xlink:href="bsx-20200930.xsd#bsx_May2025NotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2025NotesMember_d5193e03-feab-4ec1-b6f9-c3be0b16a8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2026NotesMember_fceaa81e-5240-468b-8c07-78dc8bc3dfa9" xlink:href="bsx-20200930.xsd#bsx_March2026NotesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2026NotesMember_fceaa81e-5240-468b-8c07-78dc8bc3dfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_December2027NotesMember_4de98e45-f9f9-4429-b240-06a282afa961" xlink:href="bsx-20200930.xsd#bsx_December2027NotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_December2027NotesMember_4de98e45-f9f9-4429-b240-06a282afa961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2028NotesMember_928d9cae-44ad-49b8-b778-b7c1ee21b55e" xlink:href="bsx-20200930.xsd#bsx_March2028NotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2028NotesMember_928d9cae-44ad-49b8-b778-b7c1ee21b55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2029NotesMember_ca1f1783-dc63-42da-afa8-93405c1ea69e" xlink:href="bsx-20200930.xsd#bsx_March2029NotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2029NotesMember_ca1f1783-dc63-42da-afa8-93405c1ea69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_November2035NotesMember_4a92d527-a882-4e83-9c6f-c4b60853507a" xlink:href="bsx-20200930.xsd#bsx_November2035NotesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_November2035NotesMember_4a92d527-a882-4e83-9c6f-c4b60853507a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2039NotesMember_65789187-51b6-47ed-a9c9-9f95313bbdc4" xlink:href="bsx-20200930.xsd#bsx_March2039NotesMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2039NotesMember_65789187-51b6-47ed-a9c9-9f95313bbdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_January2040NotesMember_a572d661-6a13-4eb3-9e35-c5166621de05" xlink:href="bsx-20200930.xsd#bsx_January2040NotesMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_January2040NotesMember_a572d661-6a13-4eb3-9e35-c5166621de05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_March2049NotesMember_ca7b9414-952c-4bb7-bb82-8eebdee95de6" xlink:href="bsx-20200930.xsd#bsx_March2049NotesMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_March2049NotesMember_ca7b9414-952c-4bb7-bb82-8eebdee95de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4945b543-73dc-4057-9547-8473f29449fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_InterestRateSwapMember_4945b543-73dc-4057-9547-8473f29449fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsMember_62a1e554-e9c4-43fe-8835-bcb38387b802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_CapitalLeaseObligationsMember_62a1e554-e9c4-43fe-8835-bcb38387b802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_05d84a7f-2770-4fe4-8c18-6b9cdad45403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_SeniorNotesMember_05d84a7f-2770-4fe4-8c18-6b9cdad45403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_7b8d8326-03d2-4ecc-95f6-8c86ba6095f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_UnsecuredDebtMember_7b8d8326-03d2-4ecc-95f6-8c86ba6095f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_75b5d93e-3622-41ca-b480-81179535c7cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_75b5d93e-3622-41ca-b480-81179535c7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_ffc8151b-0cb7-4bc8-96f2-22652332a12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_ffc8151b-0cb7-4bc8-96f2-22652332a12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2022TermLoanMember_d5c74f09-f90e-4f81-a154-84ab5fd5baa0" xlink:href="bsx-20200930.xsd#bsx_August2022TermLoanMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_August2022TermLoanMember_d5c74f09-f90e-4f81-a154-84ab5fd5baa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_May2020SNAggregateOfferingMember_d422dba0-2805-4a12-9038-833276b79328" xlink:href="bsx-20200930.xsd#bsx_May2020SNAggregateOfferingMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_May2020SNAggregateOfferingMember_d422dba0-2805-4a12-9038-833276b79328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2025NotesMember_46e6d94d-4323-44c8-a07d-a894ee6a532a" xlink:href="bsx-20200930.xsd#bsx_June2025NotesMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_June2025NotesMember_46e6d94d-4323-44c8-a07d-a894ee6a532a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_June2030NotesMember_b22a9edc-20ec-4987-9c53-9ddd6d316494" xlink:href="bsx-20200930.xsd#bsx_June2030NotesMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2e72d30-463f-4551-a89b-0c955c89f189" xlink:to="loc_bsx_June2030NotesMember_b22a9edc-20ec-4987-9c53-9ddd6d316494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_086d6056-5d25-4a8d-b7dd-94f4b7332b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d0d5aba1-6da0-4dc7-9176-7c6d84a2e219" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_086d6056-5d25-4a8d-b7dd-94f4b7332b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_The2018FacilityDomain_3d235eb6-dbea-4cef-bfbc-4dd78f842d13" xlink:href="bsx-20200930.xsd#bsx_The2018FacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_086d6056-5d25-4a8d-b7dd-94f4b7332b4e" xlink:to="loc_bsx_The2018FacilityDomain_3d235eb6-dbea-4cef-bfbc-4dd78f842d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eac41ce8-f014-4e5a-b853-4f2e3a2cc760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_06618f91-3099-429d-bbcf-f232d13ed9a3" xlink:to="loc_us-gaap_CreditFacilityDomain_eac41ce8-f014-4e5a-b853-4f2e3a2cc760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4a00833d-d2f3-4a95-b408-f9969fbbbad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_eac41ce8-f014-4e5a-b853-4f2e3a2cc760" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4a00833d-d2f3-4a95-b408-f9969fbbbad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:href="bsx-20200930.xsd#bsx_CovenantAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:href="bsx-20200930.xsd#bsx_CovenantDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantAxis_c2a25549-7e44-4e5a-93ac-697a2a2cb985" xlink:to="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CurrentRequirementMember_8adba552-4c9e-4af6-ac01-bca3052addc0" xlink:href="bsx-20200930.xsd#bsx_CurrentRequirementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_CurrentRequirementMember_8adba552-4c9e-4af6-ac01-bca3052addc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ActualCovenantMember_636e6e5c-1c43-49bb-9fb2-9321409a686a" xlink:href="bsx-20200930.xsd#bsx_ActualCovenantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_ActualCovenantMember_636e6e5c-1c43-49bb-9fb2-9321409a686a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_dd768cfb-4f1b-4ba1-babc-dff36a4a2638" xlink:href="bsx-20200930.xsd#bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember_dd768cfb-4f1b-4ba1-babc-dff36a4a2638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_6b25b7c7-f4bf-42fd-935a-a834f9d7b293" xlink:href="bsx-20200930.xsd#bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember_6b25b7c7-f4bf-42fd-935a-a834f9d7b293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_b9709854-a4e6-485b-9411-2afb5bce07f4" xlink:href="bsx-20200930.xsd#bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember_b9709854-a4e6-485b-9411-2afb5bce07f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_c9805401-884b-426a-b2b1-55f119638b33" xlink:href="bsx-20200930.xsd#bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember_c9805401-884b-426a-b2b1-55f119638b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Requirementextensionthroughtheremainderof2020Member_c2972047-0a42-49da-8c16-9afb7a6dda6c" xlink:href="bsx-20200930.xsd#bsx_Requirementextensionthroughtheremainderof2020Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CovenantDomain_d2dbf609-f058-4f7a-9bf7-122e383c0454" xlink:to="loc_bsx_Requirementextensionthroughtheremainderof2020Member_c2972047-0a42-49da-8c16-9afb7a6dda6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_8a89636e-a49a-4e80-b23b-305f5d17557d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_389c7f5d-b378-46bd-b169-01de8ae9f3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:to="loc_us-gaap_CommercialPaperMember_389c7f5d-b378-46bd-b169-01de8ae9f3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_August2019TermLoanMember_a9b34315-9e8a-4750-a6f0-3aeec0c49c67" xlink:href="bsx-20200930.xsd#bsx_August2019TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_9aa617f9-0ac7-42cc-8a06-a9f45bff4ba1" xlink:to="loc_bsx_August2019TermLoanMember_a9b34315-9e8a-4750-a6f0-3aeec0c49c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6d31e121-1be7-4420-b177-af8d92693fbf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ca9f336a-f63d-4fe7-b570-987b852a7e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ca9f336a-f63d-4fe7-b570-987b852a7e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ea5af19c-802a-4589-bf95-63b28474631a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LongTermDebt_ea5af19c-802a-4589-bf95-63b28474631a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6d2ab3b8-98e7-471b-bd34-c0cff346d561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6d2ab3b8-98e7-471b-bd34-c0cff346d561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0b5d8b21-7594-485a-915c-b325e7d832fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0b5d8b21-7594-485a-915c-b325e7d832fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c4a3b696-baec-49f9-8470-122cfa538fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c4a3b696-baec-49f9-8470-122cfa538fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a96ac06-89de-459c-9818-e4bcda7f3803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0a96ac06-89de-459c-9818-e4bcda7f3803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_1eb8774f-a5bf-4bac-af01-c442bf277add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_1eb8774f-a5bf-4bac-af01-c442bf277add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_c1eac2d0-314b-43bb-bcb9-fce594b9a29c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_c1eac2d0-314b-43bb-bcb9-fce594b9a29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_95c3be08-9522-48e1-a653-7d87d6b0e195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_95c3be08-9522-48e1-a653-7d87d6b0e195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6bd807a7-1be4-4c99-933d-13bfb2d74a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ShortTermBorrowings_6bd807a7-1be4-4c99-933d-13bfb2d74a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e1cec499-082e-4343-9cc9-085a872b02f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_RepaymentsOfDebt_e1cec499-082e-4343-9cc9-085a872b02f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ab87c5a7-41ae-4127-980d-3c66f49d2967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LineOfCredit_ab87c5a7-41ae-4127-980d-3c66f49d2967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumLeverageRatio_657ca2b0-9077-4941-b66a-1ae7c1470b49" xlink:href="bsx-20200930.xsd#bsx_MaximumLeverageRatio"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_MaximumLeverageRatio_657ca2b0-9077-4941-b66a-1ae7c1470b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_DeemedConsolidatedEBITDA_15a34f37-ddb1-467f-a420-0bc93d6c0a91" xlink:href="bsx-20200930.xsd#bsx_DeemedConsolidatedEBITDA"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_DeemedConsolidatedEBITDA_15a34f37-ddb1-467f-a420-0bc93d6c0a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_7bcc0baf-2e7b-411f-bcdf-b698eb71b10f" xlink:href="bsx-20200930.xsd#bsx_ExclusionFromEbitdaForRestructuringCharges"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_ExclusionFromEbitdaForRestructuringCharges_7bcc0baf-2e7b-411f-bcdf-b698eb71b10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_42e48611-fe71-4045-8481-2b4a2c163ec4" xlink:href="bsx-20200930.xsd#bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_42e48611-fe71-4045-8481-2b4a2c163ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationAndDebtExclusionFromEbitda_a183de3b-ec0e-4f23-9d7d-c7138df1e451" xlink:href="bsx-20200930.xsd#bsx_LitigationAndDebtExclusionFromEbitda"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_LitigationAndDebtExclusionFromEbitda_a183de3b-ec0e-4f23-9d7d-c7138df1e451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2f66be43-152c-4a68-a96d-858e44bee641" xlink:href="bsx-20200930.xsd#bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda_2f66be43-152c-4a68-a96d-858e44bee641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_b85784e4-77f3-42c8-b7b2-b36877bafe17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_CommercialPaper_b85784e4-77f3-42c8-b7b2-b36877bafe17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumCommercialPaperOutstanding_ca4d3264-e0e5-4c99-bcee-a4a4e4bf0922" xlink:href="bsx-20200930.xsd#bsx_MaximumCommercialPaperOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_MaximumCommercialPaperOutstanding_ca4d3264-e0e5-4c99-bcee-a4a4e4bf0922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_dc4f98a4-f91f-4364-9ad4-fc9ccd342650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_dc4f98a4-f91f-4364-9ad4-fc9ccd342650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_WeightedAverageMaturityDays_9588b5c9-d944-46cc-bfb6-fc5d5376ef67" xlink:href="bsx-20200930.xsd#bsx_WeightedAverageMaturityDays"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_bsx_WeightedAverageMaturityDays_9588b5c9-d944-46cc-bfb6-fc5d5376ef67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_1aa3cbac-3d0f-488e-b864-a32cdee93817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_1aa3cbac-3d0f-488e-b864-a32cdee93817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_e460861f-1621-44e7-91c1-3f13894afc5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_e460861f-1621-44e7-91c1-3f13894afc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_f1f37dd5-cfab-440f-83a5-c78041370a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized_f1f37dd5-cfab-440f-83a5-c78041370a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d678f4e7-7976-46bb-88e0-6c56a34d66ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate_d678f4e7-7976-46bb-88e0-6c56a34d66ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_7099675c-100a-4277-9c3d-7265fe389b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f32763bb-ece4-468d-93fa-ec65b8a53608" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_7099675c-100a-4277-9c3d-7265fe389b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_51441070-5a2d-4d9d-a3cd-130732725ac6" xlink:href="bsx-20200930.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2b2e9075-a870-4657-972b-a854efcb24df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_51441070-5a2d-4d9d-a3cd-130732725ac6" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_2b2e9075-a870-4657-972b-a854efcb24df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:href="bsx-20200930.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock_0223b6a7-ec88-4dae-ab95-1d979ff95679" xlink:href="bsx-20200930.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock_0223b6a7-ec88-4dae-ab95-1d979ff95679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e6083c14-3a17-4c85-a023-d46f48888f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e6083c14-3a17-4c85-a023-d46f48888f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_52217d73-ed56-4552-8793-c7dac7efae15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_52217d73-ed56-4552-8793-c7dac7efae15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_f5d611e7-fbd3-426e-9ad7-3b9736be6ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_f5d611e7-fbd3-426e-9ad7-3b9736be6ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fb913104-453f-4ef0-a7eb-02eb179dd840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_fb913104-453f-4ef0-a7eb-02eb179dd840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_d9375c78-79a2-4f89-93e1-1a5db0c5cb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_d9375c78-79a2-4f89-93e1-1a5db0c5cb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fe5f2bcc-f662-43fd-8d4f-1793498cd8e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fe5f2bcc-f662-43fd-8d4f-1793498cd8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_cf4657fc-63b8-4653-bd7e-3c4714b14790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_cf4657fc-63b8-4653-bd7e-3c4714b14790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_57a692c8-43d5-44bf-bd28-bdb3cbef3953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_7fd3ad9a-00e3-4e8b-816a-cd4f19d7d930" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_57a692c8-43d5-44bf-bd28-bdb3cbef3953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#SupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:href="bsx-20200930.xsd#bsx_SupplementalBalanceSheetInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c1cca6b5-e66a-4bb1-89ec-062a1cddae85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_663af04d-8a3e-43ce-8052-7cfde8e3f7fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c1cca6b5-e66a-4bb1-89ec-062a1cddae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8a4a2056-3283-48e5-8790-3667eb616668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_87693064-bdf8-4454-8e48-eca6fad7aecd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8a4a2056-3283-48e5-8790-3667eb616668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:href="bsx-20200930.xsd#bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ac800ad-23ea-4d4c-9274-13992db247c4" xlink:to="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7fd56b4-9636-405b-94b0-2ba7826c9d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a7fd56b4-9636-405b-94b0-2ba7826c9d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b537d631-d799-43c9-a0fd-d8412f25bef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b537d631-d799-43c9-a0fd-d8412f25bef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_47f096d2-3638-4125-8b08-9f2422fb9512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_47f096d2-3638-4125-8b08-9f2422fb9512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba54d83d-6c63-491a-b839-6c460ec4a012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems_0061b9f5-0e56-4b09-930f-c4ecb9686255" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba54d83d-6c63-491a-b839-6c460ec4a012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:href="bsx-20200930.xsd#bsx_OtherCurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_7c32b42e-032b-454a-98bb-b548abccff59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_7c32b42e-032b-454a-98bb-b548abccff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_03dad2c0-8968-4f83-8c3c-cfe28092d516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_03dad2c0-8968-4f83-8c3c-cfe28092d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangements_0a9df79d-d676-4574-8351-a4127da60a3c" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:to="loc_bsx_Licensingarrangements_0a9df79d-d676-4574-8351-a4127da60a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_4131b5e4-7955-4b31-8591-98ef84497ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_4131b5e4-7955-4b31-8591-98ef84497ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_24264447-e6ea-4f68-96c9-8be5829fe73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_OtherCurrentAssetsAbstract_51082085-5438-437d-942d-6c915f50d718" xlink:to="loc_us-gaap_OtherAssetsCurrent_24264447-e6ea-4f68-96c9-8be5829fe73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_e9668141-f102-4ddf-966b-abc8f54c1180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_e9668141-f102-4ddf-966b-abc8f54c1180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_ee48b8cb-9550-4803-8ecc-92d6c31757b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_e9668141-f102-4ddf-966b-abc8f54c1180" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_ee48b8cb-9550-4803-8ecc-92d6c31757b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_116c778e-dc93-43ef-b9bc-b720164771bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_e9668141-f102-4ddf-966b-abc8f54c1180" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_116c778e-dc93-43ef-b9bc-b720164771bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_57c645a8-8f11-4743-8c65-f6a227a06b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract_e9668141-f102-4ddf-966b-abc8f54c1180" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrent_57c645a8-8f11-4743-8c65-f6a227a06b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_2dfefb0a-6a3e-43ac-a97e-95497a38038e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_2dfefb0a-6a3e-43ac-a97e-95497a38038e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_44ed109d-03f0-4226-9a4e-503c5092fb30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:to="loc_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal_44ed109d-03f0-4226-9a4e-503c5092fb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_3afdc94e-2445-47c6-a288-33d811d827f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_3afdc94e-2445-47c6-a288-33d811d827f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_b4269a10-8896-48e3-8f89-ee837faeb0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_b4269a10-8896-48e3-8f89-ee837faeb0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7abb6483-3e75-4ad5-b319-228bf80118fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_bae04ca0-98c3-48b0-bf03-453f7dd88999" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7abb6483-3e75-4ad5-b319-228bf80118fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_cca09fde-4d4b-4ee0-9133-ac04b58003d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_InventoryNetAbstract_cca09fde-4d4b-4ee0-9133-ac04b58003d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b9204132-e4be-4380-913d-969883d2ca7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cca09fde-4d4b-4ee0-9133-ac04b58003d4" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b9204132-e4be-4380-913d-969883d2ca7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e8305502-cb6f-4651-946e-e08bf28287ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cca09fde-4d4b-4ee0-9133-ac04b58003d4" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e8305502-cb6f-4651-946e-e08bf28287ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3169f472-2891-4f44-a5c4-be390946105e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cca09fde-4d4b-4ee0-9133-ac04b58003d4" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_3169f472-2891-4f44-a5c4-be390946105e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a3e7f603-7965-46e0-a946-1c80aa846cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cca09fde-4d4b-4ee0-9133-ac04b58003d4" xlink:to="loc_us-gaap_InventoryNet_a3e7f603-7965-46e0-a946-1c80aa846cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_ffb8f9b6-c7f6-4cb9-b782-886c89ac3378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_us-gaap_Land_ffb8f9b6-c7f6-4cb9-b782-886c89ac3378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_db87ba1e-5a16-4f39-a7b3-cc879d14d38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_db87ba1e-5a16-4f39-a7b3-cc879d14d38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EquipmentFurnitureAndFixturesGross_297c5b1b-a3d9-4a10-b821-ac10a2e540cc" xlink:href="bsx-20200930.xsd#bsx_EquipmentFurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_bsx_EquipmentFurnitureAndFixturesGross_297c5b1b-a3d9-4a10-b821-ac10a2e540cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_17ca5aee-2c07-4cd4-9a38-1ed99dcf03dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_us-gaap_ConstructionInProgressGross_17ca5aee-2c07-4cd4-9a38-1ed99dcf03dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f09bbcaa-df6d-44d0-a723-57c79710d305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f09bbcaa-df6d-44d0-a723-57c79710d305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e4da66e3-6171-4a47-911c-ef445de3363b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e4da66e3-6171-4a47-911c-ef445de3363b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f0b4cf54-f73c-48e7-b3d5-364da61d3265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_7efd9faa-57bc-4559-8d2d-bfe286372277" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f0b4cf54-f73c-48e7-b3d5-364da61d3265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_04161b2a-1428-4a61-a838-5a68698f16ee" xlink:href="bsx-20200930.xsd#bsx_SupplementalBalanceSheetInformationTextualsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_04161b2a-1428-4a61-a838-5a68698f16ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_22518c93-f106-4d59-bc0a-e8ad86547783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationTextualsAbstract_04161b2a-1428-4a61-a838-5a68698f16ee" xlink:to="loc_us-gaap_Depreciation_22518c93-f106-4d59-bc0a-e8ad86547783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ca8c701a-1468-4a49-84a6-6c808fa141fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_ca8c701a-1468-4a49-84a6-6c808fa141fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9eb5b20c-1b5c-4dba-b699-b71f871e3b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9eb5b20c-1b5c-4dba-b699-b71f871e3b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_56b88a74-2d7f-4178-b075-23883f4339e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_us-gaap_DerivativeAssets_56b88a74-2d7f-4178-b075-23883f4339e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_fdf80049-d438-4976-9dfa-07b21d823f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_us-gaap_Investments_fdf80049-d438-4976-9dfa-07b21d823f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsasset_2855887a-7a57-4171-ada1-7f785faa80b2" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsasset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_bsx_Licensingarrangementsasset_2855887a-7a57-4171-ada1-7f785faa80b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OtherOtherLongtermAssets_54da9863-f299-4af7-8a56-086c5a39e1fb" xlink:href="bsx-20200930.xsd#bsx_OtherOtherLongtermAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_bsx_OtherOtherLongtermAssets_54da9863-f299-4af7-8a56-086c5a39e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b360deb9-952e-4dfb-be99-bd582762076c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_59fed11e-b418-4372-be2d-e487eb1567a5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b360deb9-952e-4dfb-be99-bd582762076c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_65a464a0-b673-4fd7-8ae6-7d88a067ab37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:to="loc_us-gaap_LitigationReserveCurrent_65a464a0-b673-4fd7-8ae6-7d88a067ab37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3e913a4e-93f8-4d41-91af-10ad1d383aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3e913a4e-93f8-4d41-91af-10ad1d383aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AccruedRebatesCurrent_f2ce6157-637b-4119-8026-9c4749f76835" xlink:href="bsx-20200930.xsd#bsx_AccruedRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:to="loc_bsx_AccruedRebatesCurrent_f2ce6157-637b-4119-8026-9c4749f76835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7e55d1fe-7d91-4466-8f61-5e26e9f25063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7e55d1fe-7d91-4466-8f61-5e26e9f25063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_605dcadb-ad12-454f-be16-0585fccc4784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_605dcadb-ad12-454f-be16-0585fccc4784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f772eb16-f908-4e96-8146-547cf2df339e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_e25d7eef-e48a-4728-a524-2c3605786b61" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f772eb16-f908-4e96-8146-547cf2df339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_2f361d73-def0-4c4f-b1f4-42c5af9de96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:to="loc_us-gaap_DeferredRevenueCurrent_2f361d73-def0-4c4f-b1f4-42c5af9de96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_02c36808-80c1-49c6-b095-bc0743a4498d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_02c36808-80c1-49c6-b095-bc0743a4498d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_267a2962-ef25-47f8-9211-86d55d60f443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:to="loc_us-gaap_TaxesPayableCurrent_267a2962-ef25-47f8-9211-86d55d60f443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_9fed5ce0-bb4e-41b3-a70a-493a04146661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_9fed5ce0-bb4e-41b3-a70a-493a04146661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_360d2014-8d41-417e-8a91-b61b65ffc27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_61a1d7d4-00d0-4498-a1e3-d36b848437a2" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_360d2014-8d41-417e-8a91-b61b65ffc27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_SupplementalBalanceSheetInformationAbstract_668b10ac-0a03-4457-9e29-c7baaef5bad3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_2f945baa-7d68-498f-bf82-1efcbbf1c90a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_2f945baa-7d68-498f-bf82-1efcbbf1c90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_0b2f7682-5677-4768-aeff-990e5abccdac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_0b2f7682-5677-4768-aeff-990e5abccdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0bfff9dc-f197-4615-a70f-9c8473470738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0bfff9dc-f197-4615-a70f-9c8473470738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Licensingarrangementsliability_5dc9932c-2be0-4e71-a272-2c21b72c83b5" xlink:href="bsx-20200930.xsd#bsx_Licensingarrangementsliability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_bsx_Licensingarrangementsliability_5dc9932c-2be0-4e71-a272-2c21b72c83b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dba6b547-5de4-4c64-93e8-23e27046f8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dba6b547-5de4-4c64-93e8-23e27046f8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_e343d8b7-c4cc-4857-8880-bd6d9452b910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_DeferredRevenue_e343d8b7-c4cc-4857-8880-bd6d9452b910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_68a7f032-22e1-45ce-bd92-41b466dcd199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_68a7f032-22e1-45ce-bd92-41b466dcd199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_26dd9a66-7b24-45b2-85a5-a8f4402ea561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_8e9a8c15-d701-4fc0-a676-c6714be1b416" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_26dd9a66-7b24-45b2-85a5-a8f4402ea561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9325b698-46c0-445b-b0ba-e0ec5d951418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8fc822d1-30ac-461d-bb5b-29c8c0cf3a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9325b698-46c0-445b-b0ba-e0ec5d951418" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8fc822d1-30ac-461d-bb5b-29c8c0cf3a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9f60dd09-9f0f-4497-8d86-002cfd4e6395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIncomeTaxRateReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f60dd09-9f0f-4497-8d86-002cfd4e6395" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:to="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b533626-ecaa-42e2-b3dc-0d3043ec41b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_cd573a03-3267-45e5-8afe-01f61c9d6db8" xlink:to="loc_us-gaap_VariableRateDomain_1b533626-ecaa-42e2-b3dc-0d3043ec41b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e9ff20c1-687e-4e6d-b4f1-295568b85460" xlink:href="bsx-20200930.xsd#bsx_ScheduleofIncomeTaxRateReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bsx_ScheduleofIncomeTaxRateReconciliationTable_2186ba0e-7350-430b-9725-3eb6c357729e" xlink:to="loc_bsx_ScheduleofIncomeTaxRateReconciliationLineItems_e9ff20c1-687e-4e6d-b4f1-295568b85460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_fa4c40b6-b505-4d47-aa6a-84709ed89443" xlink:href="bsx-20200930.xsd#bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f60dd09-9f0f-4497-8d86-002cfd4e6395" xlink:to="loc_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock_fa4c40b6-b505-4d47-aa6a-84709ed89443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_022de872-97d6-4bb9-9ec7-78eb87d89439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_310c1991-3fae-457e-8415-2f743bbfdb42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_022de872-97d6-4bb9-9ec7-78eb87d89439" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_310c1991-3fae-457e-8415-2f743bbfdb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2c080f77-5613-4365-a0db-51892566e368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_310c1991-3fae-457e-8415-2f743bbfdb42" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2c080f77-5613-4365-a0db-51892566e368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a6a58b67-a56e-41d5-b456-75e941d5c8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_310c1991-3fae-457e-8415-2f743bbfdb42" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a6a58b67-a56e-41d5-b456-75e941d5c8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4e278f65-e9e9-4ec7-a9e9-65dc80cb3d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_310c1991-3fae-457e-8415-2f743bbfdb42" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4e278f65-e9e9-4ec7-a9e9-65dc80cb3d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a3bf5603-fe96-4d59-9dcd-add05542977e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_022de872-97d6-4bb9-9ec7-78eb87d89439" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a3bf5603-fe96-4d59-9dcd-add05542977e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TheCARESAct_d5932859-cf22-4252-8446-45249fd4f9cd" xlink:href="bsx-20200930.xsd#bsx_TheCARESAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_022de872-97d6-4bb9-9ec7-78eb87d89439" xlink:to="loc_bsx_TheCARESAct_d5932859-cf22-4252-8446-45249fd4f9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_7dd941da-9f4b-4d00-8b43-8157fade7fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_022de872-97d6-4bb9-9ec7-78eb87d89439" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_7dd941da-9f4b-4d00-8b43-8157fade7fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_982e6a71-2359-422a-8a6c-dfe4ed3f0b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_022de872-97d6-4bb9-9ec7-78eb87d89439" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_982e6a71-2359-422a-8a6c-dfe4ed3f0b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9b1873bf-d844-4621-8323-7e319d2c9fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_995c2a6f-1c52-4e62-bbd6-3eeee4edd1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9b1873bf-d844-4621-8323-7e319d2c9fb0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_995c2a6f-1c52-4e62-bbd6-3eeee4edd1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingenciesCommitmentsandContingenciesPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6802ca50-d5e7-4bfd-8bd2-026b41ef05f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_c880591b-e7b6-4549-aaa9-d9ab58c5c9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6802ca50-d5e7-4bfd-8bd2-026b41ef05f8" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_c880591b-e7b6-4549-aaa9-d9ab58c5c9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3d90ce7f-1dfb-48ba-a2cb-44f78c120661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3d90ce7f-1dfb-48ba-a2cb-44f78c120661" xlink:to="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cfcd92aa-b64b-477f-8e54-4681039ff5ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_UpfrontCashMember_d09a228d-aa86-45d7-989b-68ab0092c445" xlink:href="bsx-20200930.xsd#bsx_UpfrontCashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:to="loc_bsx_UpfrontCashMember_d09a228d-aa86-45d7-989b-68ab0092c445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MaximumContingentPaymentMember_d53f1f8b-16e2-49d2-a6a7-91ee7309622f" xlink:href="bsx-20200930.xsd#bsx_MaximumContingentPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f67d6e08-5151-4c0a-ac87-b26ac4613e52" xlink:to="loc_bsx_MaximumContingentPaymentMember_d53f1f8b-16e2-49d2-a6a7-91ee7309622f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7cd43848-7841-4b9b-ae03-0898bd6ca901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_1b0c6641-0fd3-4410-8be5-304ac136b3dd" xlink:to="loc_us-gaap_LitigationStatusDomain_7cd43848-7841-4b9b-ae03-0898bd6ca901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_e60b49bb-b45b-4c5f-aedc-87095501d690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7cd43848-7841-4b9b-ae03-0898bd6ca901" xlink:to="loc_us-gaap_SettledLitigationMember_e60b49bb-b45b-4c5f-aedc-87095501d690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7dd0094c-3154-47e0-8904-1a6f28c3ad73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d05f3679-e7e2-47b4-a93f-b1b11ffc5854" xlink:to="loc_srt_LitigationCaseTypeDomain_7dd0094c-3154-47e0-8904-1a6f28c3ad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AssignedtoonejudgeinMAMember_20719726-fd47-4da8-b4d8-2c967a8a9fc8" xlink:href="bsx-20200930.xsd#bsx_AssignedtoonejudgeinMAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7dd0094c-3154-47e0-8904-1a6f28c3ad73" xlink:to="loc_bsx_AssignedtoonejudgeinMAMember_20719726-fd47-4da8-b4d8-2c967a8a9fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0db68c21-ee2d-47cf-9ba2-ed8cc1c914a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96b27426-b742-4397-8051-743002f28821" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0db68c21-ee2d-47cf-9ba2-ed8cc1c914a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0f03ca32-dbb5-4828-95b8-858990a8dabb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0db68c21-ee2d-47cf-9ba2-ed8cc1c914a3" xlink:to="loc_us-gaap_SubsequentEventMember_0f03ca32-dbb5-4828-95b8-858990a8dabb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_25d397f7-1717-4da1-a271-ba6c05474f1f" xlink:to="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7aea2f1-18e3-41b6-ae07-67ecefb47fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_e7aea2f1-18e3-41b6-ae07-67ecefb47fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_13a995e3-caeb-49d3-a337-6a1560f0f1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_13a995e3-caeb-49d3-a337-6a1560f0f1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f233386f-d2f6-48c7-92ae-319351ed7918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_us-gaap_LitigationSettlementExpense_f233386f-d2f6-48c7-92ae-319351ed7918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LitigationSettlementReceivedGain_d09976ae-92f7-4fa7-8dba-4d1aa9e367ee" xlink:href="bsx-20200930.xsd#bsx_LitigationSettlementReceivedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_LitigationSettlementReceivedGain_d09976ae-92f7-4fa7-8dba-4d1aa9e367ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_3db9158c-c0a5-45b8-a86a-038aec2aa7e6" xlink:href="bsx-20200930.xsd#bsx_Productliabilitycasesorclaimsrelatedtomeshproduct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct_3db9158c-c0a5-45b8-a86a-038aec2aa7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_d7c7680b-f7c8-4fe3-8a17-12917fc102b3" xlink:href="bsx-20200930.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada_d7c7680b-f7c8-4fe3-8a17-12917fc102b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CertifiedclassactionsinCanadaMesh_8619080b-961e-429a-a78c-5e75567ad32a" xlink:href="bsx-20200930.xsd#bsx_CertifiedclassactionsinCanadaMesh"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_CertifiedclassactionsinCanadaMesh_8619080b-961e-429a-a78c-5e75567ad32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_f73bdd8d-fe87-4e11-8ceb-f4963cb3892c" xlink:href="bsx-20200930.xsd#bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom_f73bdd8d-fe87-4e11-8ceb-f4963cb3892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_b4e76f50-9966-4bfd-8c34-0aab991d4c45" xlink:href="bsx-20200930.xsd#bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct_b4e76f50-9966-4bfd-8c34-0aab991d4c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_AllegedBreachofPurchaseAgreementAmount_4c2adc55-b4ce-49a8-9ad8-15fe9604e939" xlink:href="bsx-20200930.xsd#bsx_AllegedBreachofPurchaseAgreementAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7942e4c0-6980-4c03-9cee-937158d3a6e1" xlink:to="loc_bsx_AllegedBreachofPurchaseAgreementAmount_4c2adc55-b4ce-49a8-9ad8-15fe9604e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="simple" xlink:href="bsx-20200930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6c207ee0-7448-4e6b-8b2b-2a700ceaff7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_de695fae-c6b6-415a-abab-b35833db1e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6c207ee0-7448-4e6b-8b2b-2a700ceaff7d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_de695fae-c6b6-415a-abab-b35833db1e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_cfa48175-4e6e-413e-a839-9cd1b125ed67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDisclosuresAbstract_72e9343f-8070-483a-a407-8d0690c8db50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_cfa48175-4e6e-413e-a839-9cd1b125ed67" xlink:to="loc_us-gaap_ClassOfStockDisclosuresAbstract_72e9343f-8070-483a-a407-8d0690c8db50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDisclosuresAbstract_72e9343f-8070-483a-a407-8d0690c8db50" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9ef932c8-0ac2-4e9b-93f6-d70b3bb395aa" xlink:to="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_cf9eee01-fae4-42af-9529-848547b6bc86" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:to="loc_bsx_A550MCPSSeriesAMember_cf9eee01-fae4-42af-9529-848547b6bc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_063eff5f-9f57-4389-a76b-b2d453ddad59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:to="loc_us-gaap_CommonStockMember_063eff5f-9f57-4389-a76b-b2d453ddad59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_29c05706-1bf4-49b3-bb68-2ad3df4bfed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a3d4ce7c-e7bf-4744-b12f-b5bf454d89ac" xlink:to="loc_us-gaap_PreferredStockMember_29c05706-1bf4-49b3-bb68-2ad3df4bfed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_562482fd-a59d-4095-9963-9f23e93ad53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d4811b32-9186-4a9d-accc-9b4246f3a9ac" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_562482fd-a59d-4095-9963-9f23e93ad53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1afc203a-86eb-455e-91e8-785e76ecec28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_562482fd-a59d-4095-9963-9f23e93ad53c" xlink:to="loc_us-gaap_SubsequentEventMember_1afc203a-86eb-455e-91e8-785e76ecec28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c1d66a21-89a6-4e8c-852d-95d17d7dd23e" xlink:to="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_953dd3bc-d6dc-4be1-9247-797cf2be4400" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:to="loc_srt_MinimumMember_953dd3bc-d6dc-4be1-9247-797cf2be4400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2b9a111e-259f-423b-bb82-8244ba12f635" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0ffeb811-560c-4b2c-8f5d-1e3c4fe37660" xlink:to="loc_srt_MaximumMember_2b9a111e-259f-423b-bb82-8244ba12f635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0032a7e1-5eb5-4921-8cb8-d241c7021eb2" xlink:to="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_18d3f4e6-cf12-4494-8610-b289ef68c3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_18d3f4e6-cf12-4494-8610-b289ef68c3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_45717b03-1d18-4bb2-b70c-1f19f79e413c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_45717b03-1d18-4bb2-b70c-1f19f79e413c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_4df32a9f-fee0-4593-8be6-609681f24edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_4df32a9f-fee0-4593-8be6-609681f24edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_b9587f34-faed-41a3-a61d-196995ff26f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_b9587f34-faed-41a3-a61d-196995ff26f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_839284e9-18db-416a-a135-d9cf30b9449f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_839284e9-18db-416a-a135-d9cf30b9449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2b4cb07f-38cc-4874-a422-007e6db1d3aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_2b4cb07f-38cc-4874-a422-007e6db1d3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_becef193-2044-4849-a73c-c3e39cd3f8cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ConvertiblePreferredStockTermsOfConversion_becef193-2044-4849-a73c-c3e39cd3f8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_20527c8d-22a9-43d7-8626-29cf0c2b3ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareCashPaid_20527c8d-22a9-43d7-8626-29cf0c2b3ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_d8097e20-6bfc-4e07-a134-0c091227542d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PaymentsOfDividends_d8097e20-6bfc-4e07-a134-0c091227542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsPerShareDeclared_1b700cde-599f-49e7-b2d4-2de48c0534b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_PreferredStockDividendsPerShareDeclared_1b700cde-599f-49e7-b2d4-2de48c0534b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_e1839808-55d5-4b1e-b587-8fcc50f92d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_DividendsPreferredStockCash_e1839808-55d5-4b1e-b587-8fcc50f92d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_41363269-2526-4b89-97bf-f07e6ab13049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_41363269-2526-4b89-97bf-f07e6ab13049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5902ca6d-f07a-4984-85b4-9d560459e536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5902ca6d-f07a-4984-85b4-9d560459e536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5403b562-5ccf-40ce-ad1d-7f51b6252177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5403b562-5ccf-40ce-ad1d-7f51b6252177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29725dc4-c1bf-40a8-bc73-cbadb7e573a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_29725dc4-c1bf-40a8-bc73-cbadb7e573a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_a9175616-97a1-46a0-b207-2d9e3b8d49d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_a9175616-97a1-46a0-b207-2d9e3b8d49d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_160dbf74-502b-4979-9aac-3a69b76a868f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f688d52b-0f6f-4ec1-9bbb-ae8ca7f1e2c4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_160dbf74-502b-4979-9aac-3a69b76a868f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstanding"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_050eac13-3244-4ff9-ab46-355e4cbbf97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_2422e387-0950-49fe-8849-acd1dca39922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_050eac13-3244-4ff9-ab46-355e4cbbf97b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_2422e387-0950-49fe-8849-acd1dca39922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstandingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_76299920-5cca-4c72-8bb0-0f68d7086d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_5df679fb-550a-4c65-9a02-641dfabed28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_76299920-5cca-4c72-8bb0-0f68d7086d46" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_5df679fb-550a-4c65-9a02-641dfabed28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9f858311-a6cd-47ee-bb5c-95ed1096e71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_76299920-5cca-4c72-8bb0-0f68d7086d46" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_9f858311-a6cd-47ee-bb5c-95ed1096e71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#WeightedAverageSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_802d4c05-fe1b-4af3-803d-7be462aa3e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_802d4c05-fe1b-4af3-803d-7be462aa3e19" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7f7d1f77-0e62-46d8-9571-297793d7c77a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_377b9830-2825-4dbd-9b9a-c43bca322d59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:to="loc_us-gaap_StockCompensationPlanMember_377b9830-2825-4dbd-9b9a-c43bca322d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_eb9f8db6-a6c3-46fd-8bfa-6e120bf73986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:to="loc_us-gaap_EmployeeStockOptionMember_eb9f8db6-a6c3-46fd-8bfa-6e120bf73986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_c303b578-56e8-43d3-8243-5daa0852fbab" xlink:href="bsx-20200930.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2f3136fe-9c04-46ea-b499-b2cabe041639" xlink:to="loc_bsx_A550MCPSSeriesAMember_c303b578-56e8-43d3-8243-5daa0852fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ac1c8737-3a7d-4297-bf70-c2715553d517" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5faf45ac-59ba-42f2-aeaf-54c0f8ded86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5faf45ac-59ba-42f2-aeaf-54c0f8ded86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_899b65bb-ab6a-40f0-91ad-a2028d1eb173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_899b65bb-ab6a-40f0-91ad-a2028d1eb173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2d84867-27d6-4c43-9d83-4d5c3ad48b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a2d84867-27d6-4c43-9d83-4d5c3ad48b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e59c7596-4219-46af-b721-f1b6d45348ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e59c7596-4219-46af-b721-f1b6d45348ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7fc22b8b-8833-48a5-8147-581e011ca33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1da399cf-22d5-47b2-be15-c8eadd10ef15" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_7fc22b8b-8833-48a5-8147-581e011ca33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8838a361-5bd5-4b67-8d4f-41e949b6647d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_026cff25-767b-4c05-ae13-e56f55028349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8838a361-5bd5-4b67-8d4f-41e949b6647d" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_026cff25-767b-4c05-ae13-e56f55028349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2602a69f-979b-4715-af8c-e99ba2acb0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4ac67aff-f3ef-4caa-92c0-be2c1d422de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2602a69f-979b-4715-af8c-e99ba2acb0a7" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4ac67aff-f3ef-4caa-92c0-be2c1d422de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_19d5d4f0-16f3-4279-b60b-48522ef44a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b016faea-b523-42a5-82a6-808307b0bab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_19d5d4f0-16f3-4279-b60b-48522ef44a5d" xlink:to="loc_us-gaap_NumberOfReportableSegments_b016faea-b523-42a5-82a6-808307b0bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_19d5d4f0-16f3-4279-b60b-48522ef44a5d" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a8201d62-7881-4c30-ad57-4a214e50cd9a" xlink:to="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_MedsurgMember_cefc02a1-9ff0-4bd2-9546-1d41dfefe049" xlink:href="bsx-20200930.xsd#bsx_MedsurgMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_MedsurgMember_cefc02a1-9ff0-4bd2-9546-1d41dfefe049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_RhythmandNeuroMember_71e175a9-9ef8-4b22-b7e5-0f5a9770d32e" xlink:href="bsx-20200930.xsd#bsx_RhythmandNeuroMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_RhythmandNeuroMember_71e175a9-9ef8-4b22-b7e5-0f5a9770d32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CardiovascularMember_8db29de2-dad8-4387-be91-2835f8f29f5c" xlink:href="bsx-20200930.xsd#bsx_CardiovascularMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_CardiovascularMember_8db29de2-dad8-4387-be91-2835f8f29f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_9b914d4f-d823-4d9d-a80f-f3359a191b29" xlink:href="bsx-20200930.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_BSXReportableSegmentsMember_9b914d4f-d823-4d9d-a80f-f3359a191b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_TotalAllocatedToReportableSegmentsMember_aaccc618-ed73-4028-8862-bc95ab982db1" xlink:href="bsx-20200930.xsd#bsx_TotalAllocatedToReportableSegmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_TotalAllocatedToReportableSegmentsMember_aaccc618-ed73-4028-8862-bc95ab982db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_cf1eb8c3-e01d-4ddb-af9a-f59a1a6cbe5e" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_cf1eb8c3-e01d-4ddb-af9a-f59a1a6cbe5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_b8f4cfb7-143a-4455-a1db-73a666a2e65d" xlink:href="bsx-20200930.xsd#bsx_CorporateExpensesincludinghedgingactivitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_CorporateExpensesincludinghedgingactivitiesMember_b8f4cfb7-143a-4455-a1db-73a666a2e65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialChargesMember_29edf6c7-3670-4729-8e1b-18b6c4db8cba" xlink:href="bsx-20200930.xsd#bsx_SpecialChargesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df51969b-a4b0-42da-894a-752ad95a9de1" xlink:to="loc_bsx_SpecialChargesMember_29edf6c7-3670-4729-8e1b-18b6c4db8cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_211013eb-0b21-4914-8a5b-9c99ede32c8e" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_281161a1-0881-480f-9c29-3a6e5f9f2bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_281161a1-0881-480f-9c29-3a6e5f9f2bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_261850d7-6565-42c8-a245-776c610b1731" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeAllocatedToReportableSegments_ba3b738a-ed08-4e18-951d-de2816202466" xlink:href="bsx-20200930.xsd#bsx_OperatingIncomeAllocatedToReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_bsx_OperatingIncomeAllocatedToReportableSegments_ba3b738a-ed08-4e18-951d-de2816202466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_OperatingIncomeUnallocatedToSegment_8f33817a-efe1-4bfd-bf7e-d9bd80b77550" xlink:href="bsx-20200930.xsd#bsx_OperatingIncomeUnallocatedToSegment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_bsx_OperatingIncomeUnallocatedToSegment_8f33817a-efe1-4bfd-bf7e-d9bd80b77550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_082b0229-a780-4708-81a2-96cf0323f483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_082b0229-a780-4708-81a2-96cf0323f483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c41ab3a7-6a7d-49ad-a842-b49046822758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_OperatingIncomeLoss_c41ab3a7-6a7d-49ad-a842-b49046822758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d4e4fa7d-d033-4b49-907a-09715099f27e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d4e4fa7d-d033-4b49-907a-09715099f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de3361f5-32e0-4d88-8874-d459d08e47b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_de3361f5-32e0-4d88-8874-d459d08e47b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_6196cd7d-e638-4429-91a7-594dbdce4069" xlink:href="bsx-20200930.xsd#bsx_SegmentOperatingIncomeasaPercentageofNetSales"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract_ea797409-5365-4ce4-b108-34733c24650c" xlink:to="loc_bsx_SegmentOperatingIncomeasaPercentageofNetSales_6196cd7d-e638-4429-91a7-594dbdce4069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/Revenue" xlink:type="simple" xlink:href="bsx-20200930.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7c9b2a7d-8319-4f80-b65b-8a558219fa3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9d072c39-dc73-447c-98f5-e7ac8461fcf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7c9b2a7d-8319-4f80-b65b-8a558219fa3e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9d072c39-dc73-447c-98f5-e7ac8461fcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_695721c2-34fa-43d4-9f3e-35b494491128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_6b80a135-ebf0-4685-9401-70f68fb53f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_695721c2-34fa-43d4-9f3e-35b494491128" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_6b80a135-ebf0-4685-9401-70f68fb53f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_977e723c-eab2-4c46-8bc1-48af1c29b986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_6b80a135-ebf0-4685-9401-70f68fb53f31" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_977e723c-eab2-4c46-8bc1-48af1c29b986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c72963fe-5625-4046-a975-f6ebd24b9636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_d483406e-b126-4bd9-a6a9-f1901d816197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c72963fe-5625-4046-a975-f6ebd24b9636" xlink:to="loc_us-gaap_DisaggregationOfRevenueAbstract_d483406e-b126-4bd9-a6a9-f1901d816197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_d483406e-b126-4bd9-a6a9-f1901d816197" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c9bf3541-81cf-4780-b190-19f61260e4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_18d9601b-490b-44fa-b42d-a3f93ba73280" xlink:to="loc_us-gaap_SegmentDomain_c9bf3541-81cf-4780-b190-19f61260e4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_BSXReportableSegmentsMember_6b1cde10-f4bd-41fc-bb7d-28e6c4c8fe91" xlink:href="bsx-20200930.xsd#bsx_BSXReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9bf3541-81cf-4780-b190-19f61260e4db" xlink:to="loc_bsx_BSXReportableSegmentsMember_6b1cde10-f4bd-41fc-bb7d-28e6c4c8fe91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_082cda7c-a705-46ee-bd17-5735beb4dbf5" xlink:to="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_7413fa64-0bc4-4b86-ba3d-ee9546f47059" xlink:href="bsx-20200930.xsd#bsx_GlobalEndoscopyEndoReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalEndoscopyEndoReportingUnitMember_7413fa64-0bc4-4b86-ba3d-ee9546f47059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_c69e7549-830e-49f1-9c04-a2a57835bfd5" xlink:href="bsx-20200930.xsd#bsx_GlobalUrologyandPelvicHealthReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalUrologyandPelvicHealthReportingUnitMember_c69e7549-830e-49f1-9c04-a2a57835bfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalCrmReportingUnitMember_21948cf7-06c0-48bf-94c3-6bec37ab9baa" xlink:href="bsx-20200930.xsd#bsx_GlobalCrmReportingUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalCrmReportingUnitMember_21948cf7-06c0-48bf-94c3-6bec37ab9baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_6ce03e73-8930-4960-a257-b8802b13fa8d" xlink:href="bsx-20200930.xsd#bsx_GlobalElectrophysiologyEpReportingUnitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalElectrophysiologyEpReportingUnitMember_6ce03e73-8930-4960-a257-b8802b13fa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_58cb1791-e4a5-4775-be47-36e5d4cd4271" xlink:href="bsx-20200930.xsd#bsx_GlobalNeuromodulationNmReportingUnitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalNeuromodulationNmReportingUnitMember_58cb1791-e4a5-4775-be47-36e5d4cd4271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_1a10d4d2-47ff-4f7f-bf5a-4bb71d8b4afa" xlink:href="bsx-20200930.xsd#bsx_GlobalInterventionalCardiologyIcReportingUnitMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalInterventionalCardiologyIcReportingUnitMember_1a10d4d2-47ff-4f7f-bf5a-4bb71d8b4afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_190ccffa-47c3-49ec-8dec-c0792c0a5552" xlink:href="bsx-20200930.xsd#bsx_GlobalPeripheralInterventionsPiReportingUnitMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_GlobalPeripheralInterventionsPiReportingUnitMember_190ccffa-47c3-49ec-8dec-c0792c0a5552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SpecialtyPharmaceuticalsMember_b5916387-209e-4210-8577-4aad4be58335" xlink:href="bsx-20200930.xsd#bsx_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7476936f-0ee8-46ca-8373-9984e4b5db6c" xlink:to="loc_bsx_SpecialtyPharmaceuticalsMember_b5916387-209e-4210-8577-4aad4be58335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_32daa403-3f8b-4f5a-9a29-901817882a0c" xlink:to="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e5d957f1-136d-49f6-a6ac-2ab1d516a617" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_country_US_e5d957f1-136d-49f6-a6ac-2ab1d516a617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_9a6c89f9-124b-4452-a6c6-e73544c38359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_us-gaap_NonUsMember_9a6c89f9-124b-4452-a6c6-e73544c38359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_a5c504ae-30e9-4e4c-83b5-2f769e54f2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_us-gaap_EMEAMember_a5c504ae-30e9-4e4c-83b5-2f769e54f2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_b8e1770d-fad2-49a3-bddf-f8732fba29ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_srt_AsiaPacificMember_b8e1770d-fad2-49a3-bddf-f8732fba29ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_LatinAmericaandCanadaMember_d9bdafa3-fa65-4a5e-9fbb-732197d1dc3e" xlink:href="bsx-20200930.xsd#bsx_LatinAmericaandCanadaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_bsx_LatinAmericaandCanadaMember_d9bdafa3-fa65-4a5e-9fbb-732197d1dc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketsMember_12154f0c-b3b4-4ec9-953b-16c1a1fb1612" xlink:href="bsx-20200930.xsd#bsx_EmergingMarketsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2eb9d699-c215-40b4-9e3e-a148909e98c5" xlink:to="loc_bsx_EmergingMarketsMember_12154f0c-b3b4-4ec9-953b-16c1a1fb1612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e3f6a41b-3f0f-4609-9420-2213fffe207a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_EmergingMarketstotalnumberofcountries_1822ff8c-bcaf-4d0e-9a75-75aa617ee63d" xlink:href="bsx-20200930.xsd#bsx_EmergingMarketstotalnumberofcountries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:to="loc_bsx_EmergingMarketstotalnumberofcountries_1822ff8c-bcaf-4d0e-9a75-75aa617ee63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_abae130f-76d0-46ea-8843-167eb05e230f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2ea5af0e-1c43-4715-b8a6-b25743ea750f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_abae130f-76d0-46ea-8843-167eb05e230f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityAbstract_6df9d312-3961-458f-bfa1-db225b4b23ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_d483406e-b126-4bd9-a6a9-f1901d816197" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityAbstract_6df9d312-3961-458f-bfa1-db225b4b23ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2f8a0060-ef48-46f7-bd1e-99eaf849fe19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityAbstract_6df9d312-3961-458f-bfa1-db225b4b23ba" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2f8a0060-ef48-46f7-bd1e-99eaf849fe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5b693085-01f7-46f3-a85c-5f71ef9c2f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_d483406e-b126-4bd9-a6a9-f1901d816197" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5b693085-01f7-46f3-a85c-5f71ef9c2f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_c5ac1741-7aa4-4f9b-9f36-df2366901fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5b693085-01f7-46f3-a85c-5f71ef9c2f18" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_c5ac1741-7aa4-4f9b-9f36-df2366901fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_94e1a495-778f-4ff7-b96a-fe8a9df8c0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_5b693085-01f7-46f3-a85c-5f71ef9c2f18" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_94e1a495-778f-4ff7-b96a-fe8a9df8c0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_4758df5b-251d-435a-a7ae-061e21bd5eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8410c681-eb4b-43a3-88d4-b11deed86915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_4758df5b-251d-435a-a7ae-061e21bd5eb1" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_8410c681-eb4b-43a3-88d4-b11deed86915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeChangesinOtherComprehensiveIncomePolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_1dbebe0f-ac4b-4f85-b8fe-44744e4626af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_255d9e9b-8ba5-404f-97d5-f8a580d6ec79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_1dbebe0f-ac4b-4f85-b8fe-44744e4626af" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_255d9e9b-8ba5-404f-97d5-f8a580d6ec79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="bsx-20200930.xsd#ChangesinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_89465530-3006-48bc-b211-9827834048ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_89465530-3006-48bc-b211-9827834048ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59a3cb1c-c369-4c8d-b4f8-0c46dbc0e40b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_59a3cb1c-c369-4c8d-b4f8-0c46dbc0e40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64c54e49-37e0-4580-a653-e2d1a0866894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_64c54e49-37e0-4580-a653-e2d1a0866894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f412607a-9f84-465a-bdbd-feaac4a32323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f412607a-9f84-465a-bdbd-feaac4a32323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_efb1c4c2-f72d-4d93-96f0-a36397d2c4b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_efb1c4c2-f72d-4d93-96f0-a36397d2c4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_49cb8a36-92dc-4f85-b952-0e87a8f42922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_49cb8a36-92dc-4f85-b952-0e87a8f42922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ee73d093-b335-44c6-99b9-6ff8b8d005b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ee73d093-b335-44c6-99b9-6ff8b8d005b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_25478797-8ea1-4a20-b76f-69d6eac0b658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_25478797-8ea1-4a20-b76f-69d6eac0b658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6acb9489-a2b6-412d-8c32-beaae2df89b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6acb9489-a2b6-412d-8c32-beaae2df89b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c69b1db7-bf52-4856-a333-58893e3b475d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c69b1db7-bf52-4856-a333-58893e3b475d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3f0c1f1a-ad4f-4aca-840d-3749f821c409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3f0c1f1a-ad4f-4aca-840d-3749f821c409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_664bad0b-06e0-4cc7-8a09-1f478f55aa35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_664bad0b-06e0-4cc7-8a09-1f478f55aa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_7d44dc62-fbd2-4f93-a658-809333ddcb49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_7d44dc62-fbd2-4f93-a658-809333ddcb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_0ae1c4c7-959f-4018-a6d5-e28e8be5090b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_0ae1c4c7-959f-4018-a6d5-e28e8be5090b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0d195933-54c8-4e81-ae2a-db72dc18892d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0d195933-54c8-4e81-ae2a-db72dc18892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5617ceb-1d0c-4518-9d89-bddb7cbabf14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract_5c46635c-7ae7-4490-9966-24e5e4526250" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c5617ceb-1d0c-4518-9d89-bddb7cbabf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="bsx-20200930.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ca04162d-1341-4f5c-bb1d-96680c77950a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_09c33f3a-6a65-4cb8-a7a9-326226bf333d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ca04162d-1341-4f5c-bb1d-96680c77950a" xlink:to="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_09c33f3a-6a65-4cb8-a7a9-326226bf333d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="bsx-20200930.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_61cb635a-1a42-4122-9ef6-c0cd2d1f505b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_9fe28eea-20f2-4b2c-a24c-a422b8259a17" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_61cb635a-1a42-4122-9ef6-c0cd2d1f505b" xlink:to="loc_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock_9fe28eea-20f2-4b2c-a24c-a422b8259a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_8da756f6-9d64-4f27-9810-ecf96af77989" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_61cb635a-1a42-4122-9ef6-c0cd2d1f505b" xlink:to="loc_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock_8da756f6-9d64-4f27-9810-ecf96af77989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_d68eba9f-8621-4a43-bfae-e4d55ad5e2a4" xlink:href="bsx-20200930.xsd#bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_61cb635a-1a42-4122-9ef6-c0cd2d1f505b" xlink:to="loc_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock_d68eba9f-8621-4a43-bfae-e4d55ad5e2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>bsx-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20200930"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bsx-20200930.xsd" xlink:type="simple"/>
    <context id="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42920ad2d130414c94e7dd4337df532f_I20201030">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i49144bb069c54c75af6cf61abd6b94c0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i96d357c574ae49f6894555c699e39978_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8ba508544a742afb3886d6afa51d329_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6ed7784314414425be90ef641324a0a0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1a952e94562c475881460deca9c1f953_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iac50a2fdd97a471d9cf22a475f9b6eb6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9654d2156a734b7bb306daa5f24ac4f6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i20f2ffdbd3d541cc940fcca69a479645_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibc127a01b37a47e08d86d8c2afe2db89_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1b17f27c1e6f4baaab1cd43126cfa691_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i0256f56d5ebb49ae841f4bd5d04e0506_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic55ae15680004d338d27b266d917e873_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i1b9bee0e1b914abfbc8ee0729f0f7167_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i389d0f154e33475c9cd0ffad7b77ae5c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i395b87fb2a894ca68005db9b471ca8f3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i00d28bd993914c93a2b6d7bc66d8a2aa_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id32a3651258b4af1be2874b460994080_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if5fec6efef8f4034a077c780127b7955_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i22b25092af7a42e8b7f7b18357a7e0e5_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id06a3877ad6e4bdeb577199119865754_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i95412a9549fb4960bddd35b290d776dc_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id003719d3acb4f2c819a2b870e25e7f3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3783f780c95d415ab119c6cbe0e8e002_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8bd0c08e350549ba9bd9e9c0f784b86c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifdedf628611e4636be8687e15376e46f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i219690bf96274e70abead54b1cdde00a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4a512ca465c54054ae1c533835551eb3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id5fddd0be6b34cbf9c0c59129d20de59_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i1d53278bb3374215bfb7111c4e4eb852_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i72b10ec5ccaa4c03a9d7d69f78107b06_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2d91d7efcbc541c280da9d3c93b4db84_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib24d1e116bfb46d5a09f48c999e73bcd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4e6f2b58df5c4e379f9b4bfbd6b43c9d_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5dc86ac77e4046889ddabb53e93461d1_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i7c6095e3497547369994d298e3adc925_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib6a6c7eff0984f66bf876b54aa555878_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ia89773722e8443d187d6fe4372399cf2_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ibc6c7a01cd56425e9bfd5e3b6f17711c_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id9a965a86df74f9e9c8bc0784f3e7c2c_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieb7ce995bd1640c4aee3f34d47266617_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i61d24f1efc934db89e5dbb0533c917ae_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d0a154b29ae451e86bde6739f2a9274_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa6a9f62803f4d98b27fcdd993d68d18_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i332ce0e258df462b836e35e03bde9533_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff5e8e513f614ff5a920c76bd85ad3cb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5f513f5c52b44fe1a6e0a501a7d892fd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia54f5bbb50bb4be28c6d67abe157ef90_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i22eb4f14ab734ae880cbc0fdbf788799_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacd13145a5164386acf44a6fb1097a18_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia5a732cb9c1647e1807ed514f4dcad3f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i01e5f52e47224bbd8c81aeddd9c8552c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1033701a5ff945638f415a913d827d89_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i45598a0ab9d64a56b01f170bb45bd1ed_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i80b0ff86adad47a180c0719888cf6a71_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia668be5ffaf547b883b6fdaabe784961_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i75abf3104ec34cbdbfe44d606eead82b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie7fd580f105a4e5381e382e6129b9261_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie38127b708b84afab8ea55c25c0b6c18_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8039b774f5c4418c94b57c87727823af_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i506512c62581437bbbbefeababd35a7f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i307df6963fea43d7ab493ba4862d9b33_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2caa315022214c4f891424d66b0ab750_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id497f96f1bbd4cfea05234ce48bd7220_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaeffcfc2961c4fc3a627a5e430c5fc24_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8c67d19c9ea5443387a81c46c1e319db_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i198489441d644b71960becd4df1256c7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if44d8794413a44bd8cb416f5e22758a3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id226c300bfca45e9b55a05b24b6f67b6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaa8aa447538c4c9899d80c9a8d7e1f82_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic3951d84d8c54e33b4108a6298ded8e6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i432a7e24f8124d53a12c4b06b90f3f3d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6eb24a5db4a84f9aac55d92ace8fbb33_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieddb3e5a196249108dd92686400d6e00_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id275aa24a2de46bb97e130263856c8cb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i26cdf1b470b441dc8312a69ca2a3a82e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icbe13d2d881c478c9713420faa1b3a01_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i10f8de4c7bde4dbfb0824f68791a47e7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i456ac438eda6495e82678ce466563701_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icce032be65f744de9ae2f698e732db43_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-19</startDate>
            <endDate>2019-08-19</endDate>
        </period>
    </context>
    <context id="i8b95a6dee16943f59d2330f61315da56_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibf7c7c10539a427aa016b8f246594fb1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id8c1b69039194f6d941fd5b48076ee41_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic20a36eb220b470eba748536a11f26fe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iddadff178c5c41a3977cf15d3cf00c99_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ice23b320aba74832b975dd54f9a41b8b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id3046b7a84674f07b8b6bc5297d63b3a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i77b41059a837448d90bd8dc4312473e1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i77e24f9ec65b4419ab13c89e5afacd34_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4948def2b3404998b1a8e76ccc208655_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05dc2bca12f441518b8eae871ad3ce57_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5ef09943eb2142468d55375ee434dff1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib6543e61e1ca452a991a93b48b5860ee_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ideeea0ead40f44dd993b303107e7c8c0_D20190611-20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-11</startDate>
            <endDate>2019-06-11</endDate>
        </period>
    </context>
    <context id="i306877ff66b94d598003e4699fa0e864_I20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:VertiflexIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-11</instant>
        </period>
    </context>
    <context id="iba8ef1bb81a34679887900294644c59b_D20190129-20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-29</startDate>
            <endDate>2019-01-29</endDate>
        </period>
    </context>
    <context id="i6e985d5f31da4655b4775f3c18736888_I20190129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MillipedeInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-29</instant>
        </period>
    </context>
    <context id="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic0f8ba5a467c45fe948ec96ca784057a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i085d4caca7b24cb58a868824db62acdc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i58e7195e106047a191895672017f64b9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i813c67adfd7c4a86afbb6e281c6d478c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iec1555f039564481906b06dd35a52e71_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i896dbc3c04fe46f58b32c467a3593953_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0fe4e49dc414447fbf120ce2ae4f4623_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibf332292a44a478e9ebea4a33fbdd424_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:A2019AcquisitionsVertiflexAndMillipedeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9ebccf7ca6b8470782d5496c6de481af_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if244a5996bc34f8ca2bdf001a69336ee_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i14ae891ce6774513aff2cec35b4d31ce_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic5c4aa9bf38540239bdd1ab15292743a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RDRegulatoryandCommercializationbasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4410774845a24a54a144e7dfdfd8ba6e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i88663b924d2b458cbccc972e892704cf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5b832479fdc344b291fe8b6401da66a0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5a217a1106c342bd90cffb6a011624ae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bsx:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6fa93356c3144962a66e1b420a7d3f9d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3790bd2f6293401b8b5a8afd9976f99e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id56d0db5fc654680827529f68c76a516_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5bbb535d2f4a44f09dd05caeb7d8477a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f9a34f6262041b292bc78770a80463c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i17832c8686724365b57112cd962e98a9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i368407ac90bd421f986c8a5c24c675ed_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5853d5a25ac44b929ce01432224f5764_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib57f804f076c49c08bc6003ea608e766_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9542da37d90b419a88f21b32b9c18e21_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1be545420574c14979c7e504aabb492_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i26051ae85e46473d81272a66ca863cd2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i15c3d9625d044893a61231379ae0aa16_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i88b731401f35464ab0c5a3185d967ae4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cfe5b0fd59340ada20dfb76e33e0309_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i372d2c53d9bd461a84e365951a7e89f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia32c5c68e1584780b49485431c11519d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if5994440a5ab43e7824bcb235c5af0d4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5043da4f04a34f68aec48682ecd51130_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaddac085144a42d6aec4edf923f8c7c3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i954b543dbcca4f58bb805011cd0e2930_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3f0f30a839ce400f83708877f49b9875_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2019AggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic2b7c6355f6f4da2bc3951ba8ac457bc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i88a6cbe1bcc24e6295df27f547e399d3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i316fcdf591d645a696cb2f1d899e6570_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i42fb2c3fa32c4bc597cc49dbf63d74ee_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i75faf6b7006a41fa96265cf1f9f67aa0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if002fd16794247e590bb0cd6fee13f1c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:BTGAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if782d561570d49c68f1b0b89799129fc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if0eecb377e56463294ebc8b3dffe10dc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5ee44d3c3f9549e991f73b2fecade56b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7be0d79b1114275af29836966037801_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie83d791495c24438aa2a9934db0f5fbf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4150ff86e91f4b1ea24f3ea91dd6cbfd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idc9f66aadb7d47b8b2707a870b298e10_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6833b3853ecf440c91b89098a42c9d15_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6bf0b89b236347bfb2a0960469c3a865_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb220488504c46a48fd04031fccd6f33_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8fe0316282a44a288aef134dc528a100_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i914745bc3935420f887e082516427691_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6967897db2ca432fa42b803e744defe7_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic015da7b060944ef821764347c50c2bb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bsx:ForeigncurrencydenominatedindebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3893d347b5444056807f279202372d78_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i55b6e4b111f24b6c8656058dcbe12e0b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5d1ea23e5779431d819df7f113a920f6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3d13e7a6daeb4e828855c9b09932fb0b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1c5fdc3e0c2841679fe97d318ea58261_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iee25b48d00f74853992602eb2c53b356_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e066a79d8694e84bb7d59645a985325_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibda5c2730294403096ebcb12e679b68b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8dbcfebbf2c45859609734198a2ae94_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idd9c57ccd0e14aa19b6048d2641cfed5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie07d66f08df541e5a6bd2738ae221eea_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i550b85029b34440588a334f525c0ca30_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i92fac259a6324f2aa04bf3e997577a63_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i826a2b71a6644d9dbe9440eb86ce853d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if45df496952543af8b99e6950f252bfa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie9e0da1bd6e74a93b4391d856c9315ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8125d7008104ae1b687a8452733fc60_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i908b44cb3649452a9d48f0aeb4a0b87f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2461e9e08ed24f98af87739812b9cab7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6077953b0caa497d9b5dd8eba2746b7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1c292c22eea34b9f93886b4e780ea698_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i10d9296653634d229d1784d4e2a5260b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ecd3415137b492d9047dd0721eee7cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64b1627c34744a79852c22f89f4e2bd9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0486c1f5a3dc44bbad592c4face792ce_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i401066db3ff649128198d977bf21c7d9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2d8e764d9f154c0ba1fde2f3c18ba6f4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ide565556a33042009f2db6eb39c31318_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5585c06b1a414f278e4e8698e3e9ade6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie650a8a143a34390997d58eb8375e627_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2b1fc603c49e4452b1fe2055d66a5728_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i05d67b0c2c82420f89ded5c32461a093_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:LicensingarrangementliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if96fb4dab0df493cb56977ec02e792ab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i40844fee5f8f45e0b76f79276d662d4a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">bsx:EurodenominatedoutstandingdebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01fdadf64e0a447b8a6b7edadefcae98_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idf8fad34607d4972966fe7b09a5d903a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2022NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ce7410ffeb041b585ba5959fc091a98_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2127f61595964047ad8a3dafad593c19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fcdc57567ed49098103241ed9fc2e10_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iec4c4d99b6f84b108d22a749ed8bcb43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2024NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6a32bba350f7460f802d9e35490647d0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf53f2e2753142488c3129ebd45bd3f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8b2c94ac6b144dea20cdca5373da9fa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i984aed9feb2742ae9f40f9ab8d399bee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff9eff59418d45d38da26fcd40dba083_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i074cdefffbac46a5aa907b64799c5c18_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2026NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide3c2b7d701e44a19150fa05ed088e19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:December2027NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icd9e8fd2638a4eb5882534a5a95c4011_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i27a0bb0216b14c8eb6488725ad9369e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i883f72b197734176a05916892d1f98aa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8dbd5b02a23541cd9066e7e6764eb0be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2029NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i32a969aa844b45eaa688cf2e77a81451_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie1c7a363bc2a4be7a656ce96470fc32c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:June2030NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3147cace57a14c1e88a7023fa0d1a751_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2bcfebb0ff6544389662db268de515a9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:November2035NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0024f7d8ff964efa837a696943046bff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i53fefb20cb374b77a6a68660e9ec56df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2039NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6cf239eb4aa40688db906dfe60df801_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0f7b010ef6d24932aa67070e591431ad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2040NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90cc8ab8094b4817b0b7472672466a1e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib3ca8274c7c84451adfe5cc6e39d84f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2049NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie14af729841249f68bb249aa9328ed14_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i471614cc047e493a97bc532efbc84e9e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:August2022TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i97f676404a0d4a368a7a8b76358caf94_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0055d17e432d43e6a5716e6ef8c734af_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifef58c4a2ac34d8487fda59f2817e413_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idbaf3b08ce1a47f0bab1706eec16f414_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8512f90c15ee4bf1a751122703f3e372_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iec9765c02939444a8b21465369b4d6f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if4918679d9a1491c920d33be9eafbb1b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i75ab56af73414eec9527c4729f49674b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6048faff94fe4e3f8ff35fae909e93f8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">bsx:The2018FacilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i96e3727f0c4047e78994b7e46ebbd066_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="i188f9ed380a4434fad684f6ec8f9957c_D20200518-20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="i0a0778d1a32c42a698d0c0d4391be338_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:April2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i3ac08e9e5ba84c159c3799c380213ac2_I20200227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="i2a1cc324ff16414fb873ed25161c08e7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i36af306e51d44c42bb19eb47b23ae5b4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id56c2ccee432470da073b69f5e06f077_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4cad1325157949eb8729affa69cd1f9c_I20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <context id="iea83365e9d284726b2d572cf20af3e78_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3744c29fbf454f11ad39d179e30ed2c8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:A2020TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6793d82e66694285af4326091ac468be_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:AggregateSeniorUnsecuredDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i356171311f5740fda173fd3ecc70f05a_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i2daade2444a049a4b2e1cbdd923ce601_I20181219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-19</instant>
        </period>
    </context>
    <context id="i83915196e3d34a92a3c8eb05366c1b25_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:TwoYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i68796c45e93e415abbc18dda7fc8d1fe_I20190819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-19</instant>
        </period>
    </context>
    <context id="i7ad9677f736c4ba4aeef783f34c21d4b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:ThreeYearDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if55fcf95b4eb4092b6c279ab4b78debc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:CurrentRequirementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idec7a450c3d54d0f8b17663bc0bb3763_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:ActualCovenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie4657030099241c583762bbda7fb257e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:Requirementextensionthroughtheremainderof2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic50a96ccf5e5405ea44c3569e511b345_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementthirdquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0cb1b018038e41b6bcb8d9bc27e45f0f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfourthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2a0b5203b93642e2a8fdc6e76df7568e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementfifthquarterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i54e4c18dc5a04626b7d5a7ec3770c878_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bsx:CovenantAxis">bsx:RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iab04e6a866c54c479502399061c066c8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i253c4d1492ec41528006e7fc65ed1f90_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i43f3cd5bec824c3883ea52033763412c_I20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020SNAggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="iea047c096481465dbe4a37db91ccd61e_D20200518-20200518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:February2021TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <context id="icf84351e6d7f46b5b417b3fe7a492801_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if234b468e2014e5f831131ce97f1e3d4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:October2023NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8fb3528bff5c45a493e93a5e6edaa687_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6773aa82907a4a00b7b3cdf75118628d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:March2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9e9769b9ff414bd2b8b2073ecdf42894_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ba75e1b9e124586932fb7c27ac202af_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6da5402f99a740959e8d45ac53a0a17d_I20190225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:February2019AggregateOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-25</instant>
        </period>
    </context>
    <context id="ia241322b6fe54781a8915e284bf41aa9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25bd1c30873b4a2495db8cd417725ada_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:January2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibbbf84bbd3c14b8c9b7bd99842df6139_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i51badacc45004d658f01556146c4c4d7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">bsx:May2020NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i849e8308c4dc4865a29cb7ca737f1d05_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">bsx:August2019TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieb811284281f4dec9c9d5f3ad78bf9ca_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if13011e07a9c4f78b791f39df452c756_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i624957ecbe3e4fbbbd064e40723f0a53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i30818acc715047c9ad17d283e629e3a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:EuroDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ica793e70ab6c48b08a38c04312340dd1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ife92981b4da641aabca9389a91f0a450_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia406644c1ce04cda93abfe713b393765_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i413e4fb8d6234afca3447f3b21048756_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:YenDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3df7cc192c604254acab7fbfe4adf235_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i74a0e9005e53465091e8bc2786c7dc97_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bsx:RenminbiDenominatedFactoringArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id080ca0787b6468a8ad3d631ea2b1130_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id7aaf89e580246e2979204c398ade960_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i7517236e64694d1f8bc3fc2479c9b98c_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i71c575ee4ac546e0916bfef92687e6e1_I20201021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-21</instant>
        </period>
    </context>
    <context id="i53217914a25e498e83f410e223fceb43_I20201021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-21</instant>
        </period>
    </context>
    <context id="i1f1f44e32d174b6f98c5b0276649eb93_I20201021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bsx:AssignedtoonejudgeinMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-21</instant>
        </period>
    </context>
    <context id="i23b934c31d804d8d9a9c89f2fed9a737_I20180912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:UpfrontCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-12</instant>
        </period>
    </context>
    <context id="i0dcbc3c9b20642dd97b2450bb8f713bc_I20180912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bsx:MaximumContingentPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-12</instant>
        </period>
    </context>
    <context id="ied343c75dd384497a465543451475c7e_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="if2b23f1cf3f54a46ae87e6bafb2588bd_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="i735ff78c796c4242ade8554aac15b307_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i88c3b4165083494aa4c7c21c4f6d3bed_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i927de457f17d4bfc9629007545156993_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i044387e090504fda9610329194e2938f_D20200901-20200901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-01</endDate>
        </period>
    </context>
    <context id="icb5544b1d5914e58a5ff9e8a859120c7_D20201027-20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-27</startDate>
            <endDate>2020-10-27</endDate>
        </period>
    </context>
    <context id="i33acd291741444b7a9ad38bb3a5168fb_I20201027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-27</instant>
        </period>
    </context>
    <context id="id033163f06e84414929b16208d102740_D20200527-20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-27</startDate>
            <endDate>2020-05-27</endDate>
        </period>
    </context>
    <context id="ia10084aaaa064d9b9dd7f4c0a7135478_I20200527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="ic5e5a839e6644a3ebe0fc87afb8652b7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff49d6c4be2d449b9e042d9f93d88310_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1a93e002d5af493191d6045b6aa338c8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if33d9aa5eec440d1be0ea74cd2b49d11_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iefe224921843489fa50e4d09095407c2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i833e41e801144751afbac73b9aa9265c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i35462ec189f045ddae63069211960cb6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic884158bc4a143839655392d299dbb94_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iefa2ca97a83b42d4bf746ff34f43d60d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf5f2e440b564accbedba954cc39048b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i96632a4cb64d4dc6badba032df2ac6a3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iedfe6f2561594c8ea46a25a3b46e254b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id99149f63a5749519353038bc1faea89_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:MedsurgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0856ffae144147a8a676be77a9661e79_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:RhythmandNeuroMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3a7af187ab814d74846a21e66345162f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iba152e6d345944b6a404d50555024e71_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57d58860b34642148a851e295ba585bf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i048389ab0ac64d2c87536a1b5d92aa9c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i208885de1f9f46179e0e8abe705b572e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ibb4d909a6d644667b4efd3a44da3b9d4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4eb2858779c49a1a5ea2fe50cf134db_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i650712180e0241db9f0773a48064834d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8a76ba5fa6be4f6ca2865115cd913496_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0a591219122f4c2a8f9ec4a0684b5227_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iaa3ec4a2e86a478a9dabb51fefdcad78_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5295e2ecdd9d4b8ea224afddd4be5043_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:TotalAllocatedToReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1cb8cadf62d949b495b63577e0fda131_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4d28c3b1694d4c69bd90388ac8bed40a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib92234b181bc4d4f89de8646d2dd9fa3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5664ea4ee0564071be7fd04ebb16c8e4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:CorporateExpensesincludinghedgingactivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id5f90b3ff4704d268311e2eb4815f7cd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i74aa340bfd624b43833d9080bc81a794_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7b628b4b4bcd4356b45406733cf96466_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieeca9d8fa162485891beef8cec914fa9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:SpecialChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idd362ef82b134b30b14976f7ae67e13b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id836b0b6f49547e69517df5107404e82_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i32e3ab480d844da48762b90ffff4b1f5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie1f216b357084f708a38791c0e69fa94_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i18d6d998c42c481582ee64ca962cc159_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i52100b5c46bd49f9a35228954f1c7417_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie6fe5ba5da50414d9f4a59566f2373e1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c61c03b46ac4133a1766da24872ad5d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f063ede9a534803a8c2cca679760529_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf4c42c9955e49e7875feec90a8fca77_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5da8457277394b6d9cbdbc56a40395dc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia38b75c07c0a4e8bb20367199b3a3137_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i57f25f59b9aa4aeb9d25e946e240ceec_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie14bf9c81c71484eae0b513f8fc3ee21_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7dea49b278804d72b2691e583fa76c5a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie72716294dd24b2483172c0606c195a8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia82abde4de7a4ad291720e38ace07b19_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i8c50792aabbf4ddb9b06af0078c9cdb3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1997f45a21c8439dbfac180e2b0d74f1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7fff6d00823641e094e51bf1fe888c9b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28ccbaa46c3c4964a7e1df39c1bc8aed_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i95675abed3134712b2d78ee5f0f52204_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifd0b86161ea44cba9a228eb7c635dd36_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i80555f6dd4cb40a48dfd0b2587304fc3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0e9e41e9d4c44839842870dff12c933c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if81b5cb71db84008b270fc47e76998e6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0b15983e106b4e89bda000c883086e9e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9a5f3dece36b4d9797ed5acb0b90daf4_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6ab37d97d08e42a7b67c4e7178669c35_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0acffb658960466eb1fc67e7ca045948_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib1ce84bb33df4e31990c5963ff81d63d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9793b506e6474cea8ef7b144ff2a1ba9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1d4510358244d6fae7ec31c72217294_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib05caee353e041109255daf8c865e2ed_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib34d233696a544a1ae2c974370c8315e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1e862fbb1c7d413192549928e2464ffa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4de65bc069d24d51825bdab4b50bd41c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2099af0836c24bc1b803f81eab14b8a0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icb9fb1a2b2f24fa293105915ff8b08e0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id280062840b2435eb308bd4c66b47fcf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i10f1a708d4e547908f94f4cbfefc9425_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i95c352cc7257452c924fa7c4f8f29c39_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id9ce64349f174b9898c3ae08f6a8619a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i891b41394ba84479b8e900b71bab7425_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacf8b1e5d2d9412d82011f9725561fe7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie0a83ead422742818de6d2d992f45122_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ida3a2a8cccb44fe89ad6947ec51b189f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if88abe695eff4ec79c92c9b51eb144c1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i026b1c31e2164480b52d6156bf29ceda_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i083f1c7b584149eda19fe53bf7f9e950_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9bca6c5210634d32ba0fb78a24986bfa_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i472c98506bfb45ac973bc5141d646641_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i00311d766dd24a468df0201eb3a98a98_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb736062dca24512bad3fa08ad4ac3b8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i300d7b781b864c99b873d04c9d8c1861_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i52b26fb08edb4643836d722d1433826c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib5f8b764815543ca89b15a0f65b4286a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i60eaf78208af46938794bfa911789a21_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalEndoscopyEndoReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2104c8e67c9c4f7ea81b0f7fd2d47b1b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib4c6abc5823240358a6851a296ac9701_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2bab7eecd6e84feaaa75ed43b6cc6db4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b57559a2bd8439daa00da2ce3307b8c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifb32d52b9c8243efbabe0b365289bfbf_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i979e2c7f0cad4c01a72c0aa7ef8b510a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalUrologyandPelvicHealthReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia41a939d6e964fdb92096b0fe824a09b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied533bdc632d4ce0a14378174c2760eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i09381a44114941a4a42b342af6277fcb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic24f0a567b61489ea559da0492eb8bd2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i848dace5f06f4632b8e52342192aaa89_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie907d1127d5b4f1891715b552d0f2720_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalCrmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i332f62f3ea2842fab11b86ca30dc2375_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1119d578b4ea4da9bf0365681fa56dc8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3cc7104ff33e4c48b5d13452491f1ce5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i717f0d15b6c94e21a894833031631fca_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i15ca578eb6044b1296051e9a07918f73_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1973b158c2c7411ca93ed11aa1f7120b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalElectrophysiologyEpReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i623c86db3713458ca2b7defbbf8058c7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i89f9578856994687889ca858501676b9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic4f70470d3bd48dcbc4feb2bc35e086d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i75f2988c1732418c928a801db05c25b5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i986f91df9ca9493a8d7d15802a1c0570_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3f8c7b64fc864c49a306a9b4254fbaa7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalNeuromodulationNmReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i705232db70004ea088c0dc1093c8b9df_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36bcd3ce2ebe47c5bd79a16c0d3b29d9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i81ba0222e4aa4c59984dae3c8006ad93_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i020fd119041d418191cf85bbfc54285c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5e13b532f9a64e418eb80c0976c3b6af_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i49f9023219ff48cba3a2fc8ae591929a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalInterventionalCardiologyIcReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i105ce581a7544f47ad757216472bcc6d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i59107e082d014734a4ee490225fe5ffa_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iba53a1d39d394e8280b268a72077bd5a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i625dce25ac3c45a38e0390b9592977f2_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3551557143ac42dc88cc80b58e98bdb0_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifd4fa8afd39046fc92a81f01071f2a60_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:GlobalPeripheralInterventionsPiReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7d6e62892f954227b719df17b5bc2c30_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i673c5b0fb6fe4743aa18d48721035a1d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3f2be30198a405d8b8ea83a69eaf25f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iea70c191ce524d3f869a4a09e65e620f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3a3a8a2f83894a3296a3091b4bb232db_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6888bf8540af4896a7727d330b9361f8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3b5dcb6fca7c446dacf97994b28f8ad3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8128a4d029a94bb89cb486f5c5f0eb0a_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6d9ab6494b964761bf03a135b4b4f64f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i657eb7c32c324e8894346cfcb27b2689_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id843d2538e014a02a8d63e8255b29a90_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id73057f636f442ae8f81a9ac97489ccc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i781a010211e840dc81fc687839042bbb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i54d3e241fffe450cb56f3a263380bccb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f3e53dc9ca94bae9d18d4780150080e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic8128e54be7e454695b08432140f99cc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5be373172e034996889706e0c8fad15c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia4e40dd0d92b4f80be9dc394e4027845_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5a16b3866b9041938a6c24f85548a18b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic5aec6e059674fe0994035b7a01bb825_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i630933314e5e4cf5bfcc14419acec677_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib8511168847a45e096f858b26873d803_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c9704b036b149d689349b41b329038e_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id81bb93af48745e6a559b70678953bfa_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifba26fb5d1414c919d17e80bdc02dd30_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:LatinAmericaandCanadaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bsx:BSXReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i585a4990b22043b7a34314da74c8dcc7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bsx:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie9b2155f584f430289ab76456eb294f0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia29baba230164973991e71f75d7e2df3_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6dc339cf33204e73b732865ff098bcc1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie15b282dade649b69746d0ac5cab9434_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bsx:EmergingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="gbpPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:GBP</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="units">
        <measure>bsx:units</measure>
    </unit>
    <unit id="claims">
        <measure>bsx:claims</measure>
    </unit>
    <unit id="reportablesegments">
        <measure>bsx:reportablesegments</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl8zLTEtMS0xLTA_d44b0610-fa65-414f-b16d-36c72a0a4324">0000885725</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl80LTEtMS0xLTA_bc123495-6de0-4f87-a9c9-82586038fdea">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl81LTEtMS0xLTA_801a0ce1-c51c-4d39-9658-e548ec6cfea3">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl82LTEtMS0xLTA_cfde9436-62db-42c6-88a5-c9cec714b240">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80L2ZyYWc6NGJjMWE0YmFmNjkyNDNhZGFkNmUxZmYxZTQxNjNmOGIvdGFibGU6NzVmYmI2MmNjMDdmNDMzNDhmZjM0ZGNlNWYwZTBkMDIvdGFibGVyYW5nZTo3NWZiYjYyY2MwN2Y0MzM0OGZmMzRkY2U1ZjBlMGQwMl83LTEtMS0xLTA_a3619928-60ef-4ac6-aa65-8aa86fc9eab1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEw_d9b67544-8560-4a04-b554-c7c71a067a60">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6M2NmMGE3NmNhNDNmNDI2M2E4NDgwMmYzZjhjZjRmMzMvdGFibGVyYW5nZTozY2YwYTc2Y2E0M2Y0MjYzYTg0ODAyZjNmOGNmNGYzM18wLTAtMS0xLTA_7f2d3bcb-c8bc-42c1-bc94-39c9408d98a8">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8xMjA_1eac534c-975b-447c-9150-d587790ce235">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6ZmQ0M2UwYWZjMzg0NDk4ZGI2MzYwOWJlMzUwYmNjM2MvdGFibGVyYW5nZTpmZDQzZTBhZmMzODQ0OThkYjYzNjA5YmUzNTBiY2MzY18wLTAtMS0xLTA_2a68d648-224b-4b22-86a0-c2fb03feff36">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEx_86a96ac0-fc26-45b1-ac01-21133e9773a5">1-11083</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEy_aebcd1b5-921b-4cb1-b833-ea42325cb1c4">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6MDBiMDZiYzc1NWNmNDQ2NTlhZDVjYTUwM2RjYWU4YzMvdGFibGVyYW5nZTowMGIwNmJjNzU1Y2Y0NDY1OWFkNWNhNTAzZGNhZThjM18wLTAtMS0xLTA_7ce68bd7-26ac-426f-b0db-f4b4f6be09b6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6MDBiMDZiYzc1NWNmNDQ2NTlhZDVjYTUwM2RjYWU4YzMvdGFibGVyYW5nZTowMGIwNmJjNzU1Y2Y0NDY1OWFkNWNhNTAzZGNhZThjM18wLTItMS0xLTA_dc8c55da-1a39-4e7f-8363-a3e358f20077">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDEz_020562c3-46fe-4c4b-9c16-7c4142e82882">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDE0_bfd9ee95-6a47-4881-9e89-3e0db5ae7e96">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA3_e87ea9a1-1b03-45c0-b62e-90b550f7278a">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA4_3a1337fc-22b4-4727-a21b-366af8c450cc">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA1_d83e7311-8d16-4f2d-82e8-6b58f4c47f66">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA5_8d4b78d7-c235-481f-bb02-b371bb719bf3">683-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8xLTAtMS0xLTA_4a0e98d5-39db-4c70-8122-9435bd2e11f5">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8xLTItMS0xLTA_91818f17-e45c-4360-ba52-2fa96b4fb6cc">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibf6860fc56ec4a86b0c0962809c68667_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8xLTQtMS0xLTA_fc7ec370-432d-4e56-82cf-506e6038e34d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8yLTAtMS0xLTA_b338b6b5-f210-47f6-bb77-c3dd286f5f24">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8yLTItMS0xLTA_1dd2ff7f-df90-4d9b-951e-3b24463bde45">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic29862a820de4732bcaf096adeff0fe6_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8yLTQtMS0xLTA_17cfdc7d-6963-4b56-90af-558e1c2461de">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8zLTAtMS0xLTA_875bde9c-9930-4cca-b957-21557dbe27f9">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8zLTItMS0xLTA_9ff79657-6d4e-40b4-9166-50d014b579af">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icf1a9bf818be4808a72d5760167e44e9_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDgxMTFiNDg5M2I1NDZlYTgzNGY0Y2QyOWZlYzJkNmIvdGFibGVyYW5nZTo0ODExMWI0ODkzYjU0NmVhODM0ZjRjZDI5ZmVjMmQ2Yl8zLTQtMS0xLTA_620a332b-8bc8-4d79-8961-51b0d8ee6e73">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDE1_47ff3d86-3207-4384-b9b3-2962ecb4cc56">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDA2_b662f966-dc20-4474-b2eb-4070392f7dba">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDg0Y2VhZGU0ZTNiNGY3ZTgwMWExN2UwNTM5MjQ4NjQvdGFibGVyYW5nZTo0ODRjZWFkZTRlM2I0ZjdlODAxYTE3ZTA1MzkyNDg2NF8wLTAtMS0xLTA_5f199c8b-7f1c-4602-ba7e-5e50de566cd0">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDg0Y2VhZGU0ZTNiNGY3ZTgwMWExN2UwNTM5MjQ4NjQvdGFibGVyYW5nZTo0ODRjZWFkZTRlM2I0ZjdlODAxYTE3ZTA1MzkyNDg2NF8xLTMtMS0xLTA_3eda7b78-1f8f-44c2-b82b-b6e3fee57630">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGFibGU6NDg0Y2VhZGU0ZTNiNGY3ZTgwMWExN2UwNTM5MjQ4NjQvdGFibGVyYW5nZTo0ODRjZWFkZTRlM2I0ZjdlODAxYTE3ZTA1MzkyNDg2NF8yLTMtMS0xLTA_69d09b0d-fd46-428e-b2d6-c84f6b1e2c75">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDE2_78dee266-d6fb-4177-a2d4-d06d7c9e5a5e">false</dei:EntityShellCompany>
    <dei:EntityListingParValuePerShare
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8xOTY1_ee0f50d0-66c6-4f0f-93c9-650b3adb849a"
      unitRef="usdPerShare">0.01</dei:EntityListingParValuePerShare>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i42920ad2d130414c94e7dd4337df532f_I20201030"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xL2ZyYWc6MGE2NDUxNjA0NGI2NDE0NThmZjQ2YzEwZjI0NzU4MmYvdGV4dHJlZ2lvbjowYTY0NTE2MDQ0YjY0MTQ1OGZmNDZjMTBmMjQ3NTgyZl8yMDAy_0e140b92-7f0b-4e38-b306-1c5a25050cea"
      unitRef="shares">1431921459</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy0xLTEtMS0w_bd0797e1-d9f1-4caf-8914-1c0943ae5af0"
      unitRef="usd">2659000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy0zLTEtMS0w_0d296ac5-3b5f-4f98-a393-0da349822833"
      unitRef="usd">2707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy01LTEtMS0w_572a1dc7-6d18-47c0-9d09-2cb2c82b3729"
      unitRef="usd">7204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMy03LTEtMS0w_39369480-ddcd-4e1d-baad-533d226e5cda"
      unitRef="usd">7831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC0xLTEtMS0w_08ea91b6-c2c8-484b-a3d0-4378d3d0248a"
      unitRef="usd">869000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC0zLTEtMS0w_56b69682-6610-4d4a-be7a-bbdbbc19f451"
      unitRef="usd">777000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC01LTEtMS0w_68cebac4-83bf-48ba-bf84-693a9aaccb71"
      unitRef="usd">2465000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNC03LTEtMS0w_0a272e1f-90ad-42a0-be26-6ff8dd63ab29"
      unitRef="usd">2265000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS0xLTEtMS0w_961540f2-07f3-47b5-9afc-3fb457af7398"
      unitRef="usd">1790000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS0zLTEtMS0w_4e9d3f62-29ea-40b9-88ef-69e33ae085cc"
      unitRef="usd">1930000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS01LTEtMS0w_df53887d-e40b-4ed4-aac4-12f638e8416f"
      unitRef="usd">4740000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfNS03LTEtMS0w_260b5eea-5d14-4a96-a5ab-b9f624fab847"
      unitRef="usd">5566000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC0xLTEtMS0w_2325a6f2-50e9-4d02-89ec-1b1e0c960f15"
      unitRef="usd">984000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC0zLTEtMS0w_9be7b16f-6760-468c-9245-ba287963d28a"
      unitRef="usd">1012000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC01LTEtMS0w_3e271645-99cd-4022-bf84-3c1574ab2e0b"
      unitRef="usd">2760000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOC03LTEtMS0w_a94fc253-8874-429a-9cc0-7890dc3fcdf2"
      unitRef="usd">2849000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS0xLTEtMS0w_8d2770dd-a570-4327-a4f0-81774b8cec61"
      unitRef="usd">315000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS0zLTEtMS0w_dd2d06a6-0638-4432-bde4-3d4e87e0b036"
      unitRef="usd">306000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS01LTEtMS0w_d9163b9b-edf4-4aae-b006-91f0f8fa9fe3"
      unitRef="usd">857000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfOS03LTEtMS0w_7d54a73b-224d-4466-8154-a5b7656380ee"
      unitRef="usd">866000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:RoyaltyExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtMS0xLTEtMA_c429d0cd-b781-48f2-b4ba-2913f59f9e75"
      unitRef="usd">12000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtMy0xLTEtMA_90a07168-5f6d-4b6b-a558-34b78dbd1ed0"
      unitRef="usd">15000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtNS0xLTEtMA_3cb8aae2-4b70-4e77-a3f1-d07146f92297"
      unitRef="usd">32000000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTAtNy0xLTEtMA_1440d856-56b3-4703-a6b6-715adab5566f"
      unitRef="usd">48000000</us-gaap:RoyaltyExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtMS0xLTEtMA_0bc44127-b967-485f-af01-1493cc8c9d7f"
      unitRef="usd">197000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtMy0xLTEtMA_6b92aec9-a434-4c39-aa11-b1eec5bafd25"
      unitRef="usd">178000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtNS0xLTEtMA_b42c7e93-a23a-4c3b-9f22-099bc599b41d"
      unitRef="usd">595000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTEtNy0xLTEtMA_c2dab824-1d08-47c1-a9a1-4883dcb6c443"
      unitRef="usd">498000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtMS0xLTEtMA_db804ac5-e82a-4d57-8553-6ae4ca8fe0f4"
      unitRef="usd">219000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtMy0xLTEtMA_fb2e6f64-1f7f-4469-bae4-9e122e9d9069"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtNS0xLTEtMA_aa7854e8-fa75-410c-9c0a-f6481e3e2402"
      unitRef="usd">452000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTMtNy0xLTEtMA_7ec8d955-87fb-4aab-b8cb-ebf8aa7da1d7"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtMS0xLTEtMA_c4a48e3c-8572-42b0-b5f3-6210d59821c4"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtMy0xLTEtMA_a462f0a0-8d6f-42f1-a8c4-9dad191d7cbd"
      unitRef="usd">8000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtNS0xLTEtMA_1a698896-2492-4025-81dc-b12bc0869077"
      unitRef="usd">-102000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTQtNy0xLTEtMA_7a8eded2-55ae-4ecc-81e7-cef042256c26"
      unitRef="usd">-9000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:RestructuringCharges
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtMS0xLTEtMA_d8a00f4b-b5a3-4a6b-9da5-c8b44c68be8e"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtMy0xLTEtMA_f94a301d-bdd1-4404-82e9-9aecc0d57e8e"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtNS0xLTEtMA_67f92ffe-41b1-453b-b707-a0679c723581"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTUtNy0xLTEtMA_42e74112-ee61-4807-b3b7-5a6cab7340fb"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:LitigationSettlementExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtMS0xLTEtMA_1693fa01-b769-4960-85ee-f349de4f2cac"
      unitRef="usd">260000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtMy0xLTEtMA_92a6192a-fae0-4e0b-8cdd-3bb3b30ec25e"
      unitRef="usd">25000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtNS0xLTEtMA_aaef14ed-5a9c-46cc-a506-08a2a5b4e635"
      unitRef="usd">260000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTYtNy0xLTEtMA_3d94a1fc-8b10-4456-a10d-38560f7e386b"
      unitRef="usd">-108000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:OperatingExpenses
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctMS0xLTEtMA_932dfb49-a58e-4cd0-bda3-58db9bdc78ea"
      unitRef="usd">1995000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctMy0xLTEtMA_7bc0c71c-b47c-48ec-9a33-37a3b223d0f1"
      unitRef="usd">1547000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctNS0xLTEtMA_09cc42c0-94eb-42bc-82a4-c15db2e0403d"
      unitRef="usd">4870000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTctNy0xLTEtMA_e68b68f7-610f-43d2-8c07-936cdf66018d"
      unitRef="usd">4258000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtMS0xLTEtMA_9b0aaaee-3105-4371-b659-212803176465"
      unitRef="usd">-205000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtMy0xLTEtMA_230f5656-3891-4c19-85f0-98737f81b899"
      unitRef="usd">383000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtNS0xLTEtMA_32be1135-366f-4055-aad7-e1aedd278b88"
      unitRef="usd">-130000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMTgtNy0xLTEtMA_7b8a3fdf-1aff-42f0-99b6-5300f8d924e2"
      unitRef="usd">1308000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtMS0xLTEtMA_87f62037-69b9-4237-90c7-8eafe41bb4a3"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtMy0xLTEtMA_2e92904b-5e5b-44d7-979e-c139b81595cd"
      unitRef="usd">95000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtNS0xLTEtMA_b5d60ffd-0271-409f-8ce7-4689d33f10a2"
      unitRef="usd">265000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjEtNy0xLTEtMA_d1918049-2c05-48ed-b049-274ddd62604c"
      unitRef="usd">294000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItMS0xLTEtMA_a31c2bc4-ff58-47e8-989f-a2a1745e32e4"
      unitRef="usd">64000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItMy0xLTEtMA_849a7c9d-fc1d-4063-af9a-25e0cf17abab"
      unitRef="usd">-197000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItNS0xLTEtMA_4cabbeba-2213-4b14-a756-c39ef07c060a"
      unitRef="usd">9000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjItNy0xLTEtMA_f0601ec5-9b4f-46a3-a47f-26c43983e010"
      unitRef="usd">-322000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtMS0xLTEtMA_56c32f10-b092-49b3-b023-b837076db91a"
      unitRef="usd">-227000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtMy0xLTEtMA_85da675f-001e-42f0-af18-5a0928681b18"
      unitRef="usd">91000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtNS0xLTEtMA_acb1124d-f2b4-45fc-9d6f-56df386da77e"
      unitRef="usd">-386000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjMtNy0xLTEtMA_f1b6080a-b45e-49fa-8940-35f0ceeca0b8"
      unitRef="usd">693000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtMS0xLTEtMA_e4d2f549-9288-4151-a2e5-9d62db573a60"
      unitRef="usd">-72000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtMy0xLTEtMA_60be2669-2306-4dcb-9357-bbad766698f4"
      unitRef="usd">-35000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtNS0xLTEtMA_8b095687-458d-4ed6-b955-1d65b5d91306"
      unitRef="usd">-94000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjQtNy0xLTEtMA_82aa1882-8fe6-483c-82bd-26709d3f35e6"
      unitRef="usd">-11000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtMS0xLTEtMA_ca8c60a0-c737-46da-9f90-6cbd91b1c437"
      unitRef="usd">-155000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtMy0xLTEtMA_dc97edf6-9f66-4b8c-90a1-bbe25e92d21e"
      unitRef="usd">126000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtNS0xLTEtMA_7cff1603-b01c-46a0-a154-daba7c448f01"
      unitRef="usd">-292000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjUtNy0xLTEtMA_4d1b1f4d-90dc-4380-a323-577fd01b39a0"
      unitRef="usd">704000000</us-gaap:ProfitLoss>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtMS0xLTEtMA_1ee2b055-479c-4141-9433-bb76ab4832e6"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtMy0xLTEtMA_a70b647f-490e-4d6d-9e51-c79be63a58cb"
      unitRef="usd">0</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtNS0xLTEtMA_6cee1074-b8ac-4e32-9a10-18898b7fa304"
      unitRef="usd">19000000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjYtNy0xLTEtMA_924ceeeb-9b41-4d42-9cd3-4da7e516566b"
      unitRef="usd">0</us-gaap:DividendsPreferredStockStock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctMS0xLTEtMA_c42bca24-b98b-4a40-b273-8fe024beae5c"
      unitRef="usd">-169000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctMy0xLTEtMA_4e42219d-8294-470f-af0a-0e537cc68c54"
      unitRef="usd">126000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctNS0xLTEtMA_e44af5e7-7296-4f77-b467-38d3bbcfe5fb"
      unitRef="usd">-311000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjctNy0xLTEtMA_8a404ab8-1359-4f03-ac33-0e53a095421e"
      unitRef="usd">704000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktMS0xLTEtMA_ac02930e-25ef-4fbd-bcd4-a94c348b032a"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktMy0xLTEtMA_f6d37c1c-99ae-4f70-8e11-bf46450b2c08"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktNS0xLTEtMA_5a7cf72a-470b-4597-82b5-eaa92b69f714"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMjktNy0xLTEtMA_7d43a8b5-c717-4c18-8af5-f9e345d8301e"
      unitRef="usdPerShare">0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtMS0xLTEtMA_5ed1d271-e14b-4fa2-bfa4-d2a92e32aef7"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtMy0xLTEtMA_eac27905-109a-4825-b41d-dbc8e8eebd52"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtNS0xLTEtMA_f019cdb9-ffe2-4616-8de2-80434cbdec5b"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzAtNy0xLTEtMA_2a5831f1-e3d2-47a0-a384-98fefc9f7533"
      unitRef="usdPerShare">0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtMS0xLTEtMA_7c3c44f6-cdd9-4eae-81e2-db343165bf6a"
      unitRef="shares">1430900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtMy0xLTEtMA_ec8bdd64-ad4b-4514-9066-5c8f9e40a62c"
      unitRef="shares">1393100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtNS0xLTEtMA_6bc42d5d-8663-4963-956f-e5ec45558cc4"
      unitRef="shares">1413000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzMtNy0xLTEtMA_32e753d2-429e-4656-83a3-d6193136ec88"
      unitRef="shares">1390600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtMS0xLTEtMA_81496a9f-f35d-4c9b-8a53-3bec2019288c"
      unitRef="shares">1430900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtMy0xLTEtMA_c6cb21bb-22ac-42e2-b702-d868bb48d529"
      unitRef="shares">1412200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtNS0xLTEtMA_cf594b3d-1192-44a4-aef4-8959666256bd"
      unitRef="shares">1413000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xOS9mcmFnOjA0OWIwZDRkNDliNjQ1ODc5MjlkZjRlMzgyZjIwYjUyL3RhYmxlOjU4NzAxZWMwMGQ0YzQ4NjFiMjMwNWFlNWEzMGVlOTZlL3RhYmxlcmFuZ2U6NTg3MDFlYzAwZDRjNDg2MWIyMzA1YWU1YTMwZWU5NmVfMzQtNy0xLTEtMA_c2e6d36c-b27b-44d8-8238-b4a1a1041002"
      unitRef="shares">1409700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi0xLTEtMS0w_ca8c60a0-c737-46da-9f90-6cbd91b1c437"
      unitRef="usd">-155000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi0zLTEtMS0w_dc97edf6-9f66-4b8c-90a1-bbe25e92d21e"
      unitRef="usd">126000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi01LTEtMS0w_7cff1603-b01c-46a0-a154-daba7c448f01"
      unitRef="usd">-292000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfMi03LTEtMS0w_4d1b1f4d-90dc-4380-a323-577fd01b39a0"
      unitRef="usd">704000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC0xLTEtMS0w_c9620e0f-5993-42a8-a4e0-6e2876ded8e3"
      unitRef="usd">84000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC0zLTEtMS0w_8f08946f-85f2-40cb-937a-99a02dcc53e9"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC01LTEtMS0w_c837de19-e140-484e-82b1-b96f56bfc783"
      unitRef="usd">-104000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNC03LTEtMS0w_dba02ee2-64d2-4805-a23e-065c8f054936"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS0xLTEtMS0w_f9506f87-db58-4de7-bc49-0f63ede05df6"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS0zLTEtMS0w_5c3cf8a6-7d94-4d14-9363-ef0be5adb7e2"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS01LTEtMS0w_520908b5-4fe5-4e34-8ca7-baf1b4125aa2"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNS03LTEtMS0w_9a88bf67-7d34-4b52-9c13-2597d85c6185"
      unitRef="usd">102000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy0xLTEtMS0w_7b9b6164-c0f7-41fa-95b0-96b05001bbf2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy0zLTEtMS0w_ebee7daf-c07b-47ca-955a-67530d8a7b79"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy01LTEtMS0w_2431427d-8f43-4314-a340-d155106dac06"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfNy03LTEtMS0w_40e125d4-01ad-49ed-940d-24b9768f6300"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC0xLTEtMS0w_2cb51971-b595-47d0-bf31-1b0a827f3695"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC0zLTEtMS0w_505779db-65fb-4d8c-87b6-bf646f9a95df"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC01LTEtMS0w_82470711-33a0-4e13-bdf0-4915194cb992"
      unitRef="usd">-119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOC03LTEtMS0w_370e5b64-987b-46ff-9e7b-9f2ceb18a789"
      unitRef="usd">105000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS0xLTEtMS0w_e4d863fd-6bec-4aff-8496-61089e33cbe4"
      unitRef="usd">-135000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS0zLTEtMS0w_0e72c80b-4406-472b-be2d-6fe2f787460e"
      unitRef="usd">186000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS01LTEtMS0w_1382a0e7-e70c-460f-99b3-33f902df782c"
      unitRef="usd">-411000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yMi9mcmFnOmU5MjcxY2JiZDE0ZjRiMWU5MjhiNzE1NTg4MzcwYzkxL3RhYmxlOjA2ZDU5ZjU1MDY4ODRiZjg4YzVhMDFmYjQ0OGQxMmFjL3RhYmxlcmFuZ2U6MDZkNTlmNTUwNjg4NGJmODhjNWEwMWZiNDQ4ZDEyYWNfOS03LTEtMS0w_bd802d10-7b72-4a29-bb5f-1e1cbc7d8e57"
      unitRef="usd">809000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNS0xLTEtMS0w_870f3a58-0dde-487c-88a4-b4506ed74fdf"
      unitRef="usd">2022000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNS0zLTEtMS0w_0055a587-5d62-46bd-874a-022bbbb0845c"
      unitRef="usd">217000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNi0xLTEtMS0w_e0baf162-a2e2-47b1-95b3-2d791dcf92f4"
      unitRef="usd">1598000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNi0zLTEtMS0w_f6a75a8e-31c3-4a4d-959e-ca1bbf6a39f7"
      unitRef="usd">1828000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNy0xLTEtMS0w_d3f3ac47-0e4d-4673-a408-1d3966950684"
      unitRef="usd">1472000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfNy0zLTEtMS0w_729923b4-93eb-4662-a22b-22c638264a76"
      unitRef="usd">1579000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOC0xLTEtMS0w_ae59ff94-0116-4639-8db9-6a57dba4ec7b"
      unitRef="usd">174000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOC0zLTEtMS0w_ca54a266-2e68-4db8-9eaa-72ef67211bc6"
      unitRef="usd">195000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOS0xLTEtMS0w_94a92cf5-b3c1-47bd-86b3-6c415b9e417a"
      unitRef="usd">894000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfOS0zLTEtMS0w_a64d7780-7838-428b-a3c0-9f02c00888c6"
      unitRef="usd">880000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTAtMS0xLTEtMA_96ba069d-5151-47f7-b1ec-e3299f36a6cb"
      unitRef="usd">6160000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTAtMy0xLTEtMA_84b7177a-c87d-45e3-80fe-8441fd3dff74"
      unitRef="usd">4699000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTEtMS0xLTEtMA_4015c90a-b461-4fdc-bfea-33bbed0eae9e"
      unitRef="usd">2064000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTEtMy0xLTEtMA_cd2c6d56-84e2-49cf-8c9f-e3de28c95809"
      unitRef="usd">2079000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTItMS0xLTEtMA_9ec5f396-e1fc-4f90-8ac2-8b0e7932ea3c"
      unitRef="usd">10137000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTItMy0xLTEtMA_8f5d1359-1a23-4130-b880-8bfbade446f2"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTMtMS0xLTEtMA_4b9acb35-27d4-4e8f-9470-c65675ed9135"
      unitRef="usd">6797000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTMtMy0xLTEtMA_05a1bf02-95d9-4482-afa0-7a2165b1f97c"
      unitRef="usd">7886000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTQtMS0xLTEtMA_50290086-fd20-420f-a005-41ffcfd381d6"
      unitRef="usd">4172000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTQtMy0xLTEtMA_42b45264-8718-4fc0-8b47-9a23704f4177"
      unitRef="usd">4196000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTUtMS0xLTEtMA_67c4d4a3-1091-411f-b6c7-9298582767d3"
      unitRef="usd">1516000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTUtMy0xLTEtMA_4ca90ad5-a217-4d3b-bb11-bd528a44016a"
      unitRef="usd">1529000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTYtMS0xLTEtMA_4b20e95f-ff47-45d9-a9a0-6f3a34588cdc"
      unitRef="usd">30845000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMTYtMy0xLTEtMA_dcb2b003-b32c-4edc-9953-2f722fbf8257"
      unitRef="usd">30565000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjAtMS0xLTEtMA_e49301d9-2e2e-4410-8d35-db872978b910"
      unitRef="usd">11000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjAtMy0xLTEtMA_c22f7a09-ca5e-4496-a0c4-61caf87efa43"
      unitRef="usd">1416000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjEtMS0xLTEtMA_edb385d9-d9a9-4b8c-858e-98de263052b8"
      unitRef="usd">452000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjEtMy0xLTEtMA_ef5cb7a9-343a-4b43-a582-61071c009821"
      unitRef="usd">542000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjItMS0xLTEtMA_05edba08-4142-4291-8476-2631f5825cb6"
      unitRef="usd">2195000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjItMy0xLTEtMA_90758b51-bbc9-429c-89a9-e9168b32ac95"
      unitRef="usd">2109000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjMtMS0xLTEtMA_c4872835-d13e-4ac9-867e-32167708d84a"
      unitRef="usd">644000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjMtMy0xLTEtMA_1e4936c7-b8e0-4526-ac91-9fa1c84b25b4"
      unitRef="usd">800000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjQtMS0xLTEtMA_e0d789b8-f13f-4216-9747-449a5c33dce6"
      unitRef="usd">3302000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjQtMy0xLTEtMA_75b98579-b413-47ab-a993-421d8a30fbeb"
      unitRef="usd">4866000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjUtMS0xLTEtMA_fcda3c45-2dfc-4c44-a2e1-f8fd51e47a6d"
      unitRef="usd">9325000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjUtMy0xLTEtMA_f27e634e-cd63-48f4-9971-689bc50e43e8"
      unitRef="usd">8592000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <bsx:DeferredTaxLiabilitiesNetNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjYtMS0xLTEtMA_d4a76464-8a2f-48e6-9df9-4e665e12a788"
      unitRef="usd">522000000</bsx:DeferredTaxLiabilitiesNetNoncurrent>
    <bsx:DeferredTaxLiabilitiesNetNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjYtMy0xLTEtMA_e861f068-9602-4595-80b5-02507b0e8f78"
      unitRef="usd">595000000</bsx:DeferredTaxLiabilitiesNetNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjctMS0xLTEtMA_cdfd5a57-6224-4761-8c29-6c30aa8300a3"
      unitRef="usd">2132000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjctMy0xLTEtMA_45942ab3-c7ba-421c-ab5e-c8d3750301a2"
      unitRef="usd">2635000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjktMS0xLTEtMA_73b4dc51-45cd-4c35-91a1-9413dc46ca9a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMjktMy0xLTEtMA_60164224-4deb-4094-8b60-222dbecc217e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzIx_3aead153-7fb0-485f-b5b6-468256bdb333"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzIx_55617486-c958-4881-bc6e-7f96a2e9bd7b"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzQ3_3714fa9e-aa71-4034-82f2-68e0c88e8a76"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzQ3_d712e7de-4dc3-471c-bd9f-477128411e64"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjJmMjQ0OGQ2N2NkZjQ2NTliOTA4YjBmY2M5OTBjMDAwXzY2_c2da66c0-b9a5-4c16-8984-f4c156edb77b"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMS0xLTEtMA_c99cc6db-57ba-4d47-896b-6ef04edeafe4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzItMy0xLTEtMA_82c6e34c-c9ad-4547-b775-a986ea94da02"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzE4_3efe2dc2-ccf3-4a3d-8fbb-539c48a668b3"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzE4_f0b30b52-355a-4293-8576-044c4b86e11c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzQ0_9536be2c-1037-4ed3-8847-2415b53178c5"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzQ0_ecde6757-d7e9-4743-84f6-5070b5b3bbb8"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1XzYz_69e5d789-f555-4c7e-b705-316e63052ac3"
      unitRef="shares">1679428209</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjg4NmQyZTcyMzk1ZTRhNGZhOGI3NzcxYzIzZWNmOTU1Xzk3_dceb070c-48fb-4240-b3eb-706f1bb20a12"
      unitRef="shares">1642488911</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMS0xLTEtMA_8ca3af28-b0e9-42e0-9e79-9e565a053880"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzMtMy0xLTEtMA_3443c35a-d267-4869-8138-d2264d99533b"
      unitRef="usd">16000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjM2MzVmYzE2ODcxNzQyMjViZDAzMjZhMjFiZTRmMDgxXzMw_63f22b07-a6a8-46bd-ac35-ce985fd97398"
      unitRef="shares">247566270</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjM2MzVmYzE2ODcxNzQyMjViZDAzMjZhMjFiZTRmMDgxXzMw_fee68b2c-67de-4623-8118-df3f5cac2c7e"
      unitRef="shares">247566270</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMS0xLTEtMA_5a15e4ab-1355-49c4-b859-e3e106d1e0c7"
      unitRef="usd">1717000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzQtMy0xLTEtMA_d4004542-b72a-4851-808c-b9b19c4f29ac"
      unitRef="usd">1717000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzUtMS0xLTEtMA_129b75c9-a545-403c-9e42-2030b498c43b"
      unitRef="usd">19687000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzUtMy0xLTEtMA_7830cca7-1843-4d56-af74-8e6fbae8e266"
      unitRef="usd">17561000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzYtMS0xLTEtMA_1f6aec38-8339-4477-8f68-85208586d804"
      unitRef="usd">-2574000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzYtMy0xLTEtMA_25d7b2ff-d893-44f6-8e2f-dbfc841db12a"
      unitRef="usd">-2253000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzctMS0xLTEtMA_d4e154bd-7408-4c08-aaa3-a57f86eda208"
      unitRef="usd">151000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzctMy0xLTEtMA_629f07b6-b229-479e-a20a-7c47b4a1457e"
      unitRef="usd">270000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzgtMS0xLTEtMA_3246d873-fbaf-492a-a1d1-b44a0cb77b22"
      unitRef="usd">15564000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzgtMy0xLTEtMA_ec18ca4a-4f05-4daf-9e6b-c035a2363156"
      unitRef="usd">13877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzktMS0xLTEtMA_455a9158-e06a-4b8d-98b2-94362d27f6dc"
      unitRef="usd">30845000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8yNS9mcmFnOjYwNDlkNDY0ZjM3YTQ4NTRiOTUyMTdmOWMwMjdkN2Y2L3RhYmxlOjI3NTM0NzJmZmJhZTQ0ZmZhYTY5ZDNlZDQ1NDIwNmIxL3RhYmxlcmFuZ2U6Mjc1MzQ3MmZmYmFlNDRmZmFhNjlkM2VkNDU0MjA2YjFfMzktMy0xLTEtMA_dff6144d-59bd-482d-9bd2-389b0a2b7f23"
      unitRef="usd">30565000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="if8ba508544a742afb3886d6afa51d329_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMS0xLTEtMA_fe886403-dafd-45ce-8126-7e22c8e59928"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8ba508544a742afb3886d6afa51d329_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMy0xLTEtMA_ecbd5fa8-716d-42f4-bf85-f9b42f6b04be"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i6ed7784314414425be90ef641324a0a0_I20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtNS0xLTEtMA_12798343-f044-48bb-ba0d-8c91e5051532"
      unitRef="shares">1632148030</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ed7784314414425be90ef641324a0a0_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtNy0xLTEtMA_af75eeb4-7cc7-447c-a584-bd175f0b1de8"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a952e94562c475881460deca9c1f953_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtOS0xLTEtMA_07019acd-2b41-4a5c-b11e-4f8d27480b8b"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac50a2fdd97a471d9cf22a475f9b6eb6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMTEtMS0xLTA_a778a99d-1761-40a9-ac8e-f6b2283a0a95"
      unitRef="usd">17346000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9654d2156a734b7bb306daa5f24ac4f6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMTMtMS0xLTA_18c2351d-c797-4be8-91d0-f923e013429a"
      unitRef="usd">-6953000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20f2ffdbd3d541cc940fcca69a479645_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjAtMTUtMS0xLTA_db967b7c-9e83-420d-ae09-3a13082feff4"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ibc127a01b37a47e08d86d8c2afe2db89_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjEtMTMtMS0xLTA_f6fa9787-0df3-4250-ad9c-a539dcfc9cfc"
      unitRef="usd">424000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1b17f27c1e6f4baaab1cd43126cfa691_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjItMTUtMS0xLTA_84f79863-293a-4025-802a-dae7a70d6e88"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i0256f56d5ebb49ae841f4bd5d04e0506_D20190101-20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjMtNS0xLTEtMA_98244754-5b5a-4818-93d0-64bfb818214d"
      unitRef="shares">6001343</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ic55ae15680004d338d27b266d917e873_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjMtMTEtMS0xLTA_3b2fb955-a479-4bb5-85c3-c4b37cd5da62"
      unitRef="usd">28000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i1b9bee0e1b914abfbc8ee0729f0f7167_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMS0xLTEtMA_817ac90a-1505-4fa4-b248-72ae5a9b099c"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b9bee0e1b914abfbc8ee0729f0f7167_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMy0xLTEtMA_6114becc-47f8-4520-9fc7-c032366c5365"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i389d0f154e33475c9cd0ffad7b77ae5c_I20190331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtNS0xLTEtMA_a19add24-525d-45f2-937e-b471f9869044"
      unitRef="shares">1638149373</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i389d0f154e33475c9cd0ffad7b77ae5c_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtNy0xLTEtMA_5529ae19-2175-4304-86e1-73c8be396a08"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i395b87fb2a894ca68005db9b471ca8f3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtOS0xLTEtMA_216e8172-17f9-4da3-b935-b3de9626076a"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00d28bd993914c93a2b6d7bc66d8a2aa_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMTEtMS0xLTA_defac0e6-13cc-499a-8a66-cf6fef8eab16"
      unitRef="usd">17374000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id32a3651258b4af1be2874b460994080_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMTMtMS0xLTA_74c9938d-bbf1-4e8a-a267-74dc626fc43b"
      unitRef="usd">-6528000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5fec6efef8f4034a077c780127b7955_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjQtMTUtMS0xLTA_80748ce7-67b1-44f9-a0c8-decf80366084"
      unitRef="usd">87000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i22b25092af7a42e8b7f7b18357a7e0e5_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjUtMTMtMS0xLTA_cee01d3d-bd98-4672-a3be-9cd59a8cd0d0"
      unitRef="usd">154000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id06a3877ad6e4bdeb577199119865754_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjYtMTUtMS0xLTA_641c3921-6242-4e39-bc5a-9697cfa77031"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i95412a9549fb4960bddd35b290d776dc_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjctNS0xLTEtMA_b4642c84-4f88-45f1-811c-2e68e3bf733d"
      unitRef="shares">949557</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="id003719d3acb4f2c819a2b870e25e7f3_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjctMTEtMS0xLTA_898a91fc-5bbd-4976-8c2d-fa23e41bf284"
      unitRef="usd">48000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i3783f780c95d415ab119c6cbe0e8e002_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMS0xLTEtMA_ac9c6bd0-e12f-41ac-812f-8c377760abf3"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3783f780c95d415ab119c6cbe0e8e002_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMy0xLTEtMA_d41db13b-95b4-4a4d-8773-6f3b3e32fb1a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i8bd0c08e350549ba9bd9e9c0f784b86c_I20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtNS0xLTEtMA_15053177-d737-4fec-a487-7bc9c79d3391"
      unitRef="shares">1639098930</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8bd0c08e350549ba9bd9e9c0f784b86c_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtNy0xLTEtMA_2f222776-923e-4570-a981-87286a86701e"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifdedf628611e4636be8687e15376e46f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtOS0xLTEtMA_9d337e41-d252-45ad-8e3f-c6216dc6b5a2"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i219690bf96274e70abead54b1cdde00a_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMTEtMS0xLTA_a9e091bd-5086-4134-ae29-43fd8ba509dc"
      unitRef="usd">17422000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a512ca465c54054ae1c533835551eb3_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMTMtMS0xLTA_255abd9b-b3da-45fc-8603-1ed6539bd49c"
      unitRef="usd">-6375000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5fddd0be6b34cbf9c0c59129d20de59_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjgtMTUtMS0xLTA_a1b34272-8e67-4863-be1a-494bfcc60673"
      unitRef="usd">78000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1d53278bb3374215bfb7111c4e4eb852_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMjktMTMtMS0xLTA_d9826264-2297-434a-8627-578dfd96b076"
      unitRef="usd">126000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i72b10ec5ccaa4c03a9d7d69f78107b06_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzAtMTUtMS0xLTA_625eeca4-12d3-4b8d-ab11-2fd0d5c7fd96"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i2d91d7efcbc541c280da9d3c93b4db84_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzEtNS0xLTEtMA_1fd1bb50-d8a0-4b6a-b9f1-fafbfb9e45a1"
      unitRef="shares">2243579</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="ib24d1e116bfb46d5a09f48c999e73bcd_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzEtMTEtMS0xLTA_f3e6dec7-80f9-4092-8868-8741af2d242a"
      unitRef="usd">89000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i4e6f2b58df5c4e379f9b4bfbd6b43c9d_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMS0xLTEtMA_e5de883e-f4bf-49de-9365-3291d368d975"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4e6f2b58df5c4e379f9b4bfbd6b43c9d_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMy0xLTEtMA_42e45bde-14b9-4849-aa85-71e2868eebf6"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i5dc86ac77e4046889ddabb53e93461d1_I20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItNS0xLTEtMA_163d3a6c-4f04-45bc-a908-fac96f7a735c"
      unitRef="shares">1641342509</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dc86ac77e4046889ddabb53e93461d1_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItNy0xLTEtMA_a2749ccb-f7a1-4ed9-910f-72d66935386d"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c6095e3497547369994d298e3adc925_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItOS0xLTEtMA_14b35496-30ff-4448-96ce-f389b4904f79"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6a6c7eff0984f66bf876b54aa555878_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMTEtMS0xLTA_debc8a6b-ab78-49cf-bdec-b58be107d991"
      unitRef="usd">17510000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia89773722e8443d187d6fe4372399cf2_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMTMtMS0xLTA_42bc4140-8e37-4614-9ddb-f578ba82025f"
      unitRef="usd">-6249000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc6c7a01cd56425e9bfd5e3b6f17711c_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzItMTUtMS0xLTA_f12742f1-af7c-4290-8f4b-572b6892626b"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="id9a965a86df74f9e9c8bc0784f3e7c2c_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzMtMTMtMS0xLTA_edd68326-a92f-4cb3-a24d-a32503fb6d02"
      unitRef="usd">3996000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb7ce995bd1640c4aee3f34d47266617_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzQtMTUtMS0xLTA_c886ab11-da62-43d1-9d10-fd6593b08903"
      unitRef="usd">132000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i61d24f1efc934db89e5dbb0533c917ae_D20191001-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzUtNS0xLTEtMA_4fd6a26c-c2b2-4add-98af-13c44ddd27ca"
      unitRef="shares">1146402</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i5d0a154b29ae451e86bde6739f2a9274_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzUtMTEtMS0xLTA_2add9c29-4835-4e1e-8637-92506ef8cef9"
      unitRef="usd">50000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="iaa6a9f62803f4d98b27fcdd993d68d18_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMS0xLTEtMA_60a86caa-3569-4eed-88f0-a441de7e3dbc"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa6a9f62803f4d98b27fcdd993d68d18_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMy0xLTEtMA_78ca224d-5735-4e4d-8666-8b9360b14bf3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i332ce0e258df462b836e35e03bde9533_I20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtNS0xLTEtMA_c754c535-62f6-481c-a059-4f6dc5ffd125"
      unitRef="shares">1642488911</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i332ce0e258df462b836e35e03bde9533_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtNy0xLTEtMA_352446a5-af91-4813-ae2e-35ba973ad871"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff5e8e513f614ff5a920c76bd85ad3cb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtOS0xLTEtMA_deb5405b-ea01-4507-bf5c-0002e78d6b80"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f513f5c52b44fe1a6e0a501a7d892fd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMTEtMS0xLTA_004ea844-1426-4920-9ee7-c3b1d312454f"
      unitRef="usd">17561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia54f5bbb50bb4be28c6d67abe157ef90_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMTMtMS0xLTA_e5f1c29e-043e-4b45-8785-c4be08b63ac1"
      unitRef="usd">-2253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22eb4f14ab734ae880cbc0fdbf788799_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzYtMTUtMS0xLTA_86b4ef9b-3820-42dc-bb58-2727d9607b78"
      unitRef="usd">270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iacd13145a5164386acf44a6fb1097a18_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzctMTMtMS0xLTA_14940670-f5ba-4901-80ce-9946529580e3"
      unitRef="usd">11000000</us-gaap:ProfitLoss>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="iacd13145a5164386acf44a6fb1097a18_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzgtMTMtMS0xLTA_ea7eeb8d-953b-47d2-a29a-c1df6451a5f0"
      unitRef="usd">-10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5a732cb9c1647e1807ed514f4dcad3f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfMzktMTUtMS0xLTA_3959c2d0-0adf-4582-8dc3-a2f1e2eb8066"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i01e5f52e47224bbd8c81aeddd9c8552c_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDAtNS0xLTEtMA_201ab358-c5c2-4eab-b4a4-0b80f502f8a4"
      unitRef="shares">4388331</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i1033701a5ff945638f415a913d827d89_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDAtMTEtMS0xLTA_96b031e8-fa09-4ea4-b7e0-0d5ce2ac72cc"
      unitRef="usd">28000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="i45598a0ab9d64a56b01f170bb45bd1ed_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMS0xLTEtMA_11b646e0-8585-49c2-9002-fd69eb31688b"
      unitRef="shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45598a0ab9d64a56b01f170bb45bd1ed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMy0xLTEtMA_bf83b941-7ffd-4dcb-8884-f8ba6cac7919"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i80b0ff86adad47a180c0719888cf6a71_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtNS0xLTEtMA_c494c2bf-30cf-40b8-8241-2121ba04dc80"
      unitRef="shares">1646877242</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80b0ff86adad47a180c0719888cf6a71_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtNy0xLTEtMA_73b6868d-1216-43ed-a04e-7c723fa822b5"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia668be5ffaf547b883b6fdaabe784961_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtOS0xLTEtMA_124aa680-e192-404d-b28d-b28adc81fbd7"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75abf3104ec34cbdbfe44d606eead82b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMTEtMS0xLTA_2a762717-6e58-4aa9-81e6-1bb60edeaed6"
      unitRef="usd">17589000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7fd580f105a4e5381e382e6129b9261_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMTMtMS0xLTA_83c3d997-861c-419a-a8b4-b051dd9394d4"
      unitRef="usd">-2252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie38127b708b84afab8ea55c25c0b6c18_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDEtMTUtMS0xLTA_f0513315-5da8-483d-8ffa-f20cfc8084aa"
      unitRef="usd">168000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8039b774f5c4418c94b57c87727823af_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDItMTMtMS0xLTA_eb7c155c-adf4-4d0c-b494-03683b196724"
      unitRef="usd">-147000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i506512c62581437bbbbefeababd35a7f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDMtMTUtMS0xLTA_06f09486-c0e3-4005-8f79-7c0551aed927"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i307df6963fea43d7ab493ba4862d9b33_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDQtMS0xLTEtMA_039590e2-e1d8-47b8-9608-3c3e874013c9"
      unitRef="shares">10062500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i307df6963fea43d7ab493ba4862d9b33_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDQtMy0xLTEtMA_60e12a6d-e44d-49cb-90a0-da713621f138"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock
      contextRef="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDQtMTEtMS0xLTA_c39d3a4c-764a-4ec0-b31c-f47ff12c0371"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesPreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i2caa315022214c4f891424d66b0ab750_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDUtNS0xLTEtMA_ceffaef9-ad99-488d-8d69-d96d87954e2a"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i2caa315022214c4f891424d66b0ab750_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDUtNy0xLTEtMA_ea479e5c-791f-4f53-b1d3-7968043e898a"
      unitRef="usd">0</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock
      contextRef="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDUtMTEtMS0xLTA_9ba61cec-69ef-49de-9786-feb64286dbd4"
      unitRef="usd">975000000</bsx:StockIssuedDuringPeriodValueNewIssuesCommonStock>
    <us-gaap:DividendsPreferredStockCash
      contextRef="i8039b774f5c4418c94b57c87727823af_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDYtMTMtMS0xLTA_75784ef0-aea7-45d3-8403-2f507c4c5965"
      unitRef="usd">-5000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i2caa315022214c4f891424d66b0ab750_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDctNS0xLTEtMA_98295c4e-8fc1-4c73-8af6-b66ef371adc1"
      unitRef="shares">493824</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="idc14b3dac90341a0bd2982e51f6daeef_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDctMTEtMS0xLTA_5af40b6c-54e1-4247-8c4d-9d69d95b91d2"
      unitRef="usd">50000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="id497f96f1bbd4cfea05234ce48bd7220_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMS0xLTEtMA_3ec08452-2ef0-4a34-b688-51f80074519d"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id497f96f1bbd4cfea05234ce48bd7220_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMy0xLTEtMA_7b9d015b-6b73-4e8f-beb7-4614f950b104"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="iaeffcfc2961c4fc3a627a5e430c5fc24_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtNS0xLTEtMA_8329d4bc-a512-4b55-a5bf-d0321c214cad"
      unitRef="shares">1676753566</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaeffcfc2961c4fc3a627a5e430c5fc24_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtNy0xLTEtMA_c764aec3-4ea4-42ff-8250-540c18cc180b"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c67d19c9ea5443387a81c46c1e319db_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtOS0xLTEtMA_46debc62-50a6-44ea-8a70-6b5a09bb368c"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i198489441d644b71960becd4df1256c7_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMTEtMS0xLTA_03a81462-6bd0-4962-94d9-0973b894c719"
      unitRef="usd">19590000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if44d8794413a44bd8cb416f5e22758a3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMTMtMS0xLTA_b02f95ac-a7c6-4d86-a09a-09e9a9b74b41"
      unitRef="usd">-2405000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id226c300bfca45e9b55a05b24b6f67b6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDgtMTUtMS0xLTA_b2ab4da6-45ff-46b0-b9ec-0f958d25be7a"
      unitRef="usd">131000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iaa8aa447538c4c9899d80c9a8d7e1f82_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNDktMTMtMS0xLTI1MQ_1e5510e0-584e-4d2f-9b4b-4453075b5bf9"
      unitRef="usd">-155000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3951d84d8c54e33b4108a6298ded8e6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTAtMTUtMS0xLTI1OQ_74046442-14eb-42e3-ae8e-e04e3c59981d"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsPreferredStockCash
      contextRef="iaa8aa447538c4c9899d80c9a8d7e1f82_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTEtMTMtMS0xLTI1NQ_2e158cad-b9d7-4c19-966a-1e6654d5ca38"
      unitRef="usd">-14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="i432a7e24f8124d53a12c4b06b90f3f3d_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTItNS0xLTEtMjQz_0403db96-f108-45bf-8a56-eb72527f4855"
      unitRef="shares">2674643</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="i6eb24a5db4a84f9aac55d92ace8fbb33_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTItMTEtMS0xLTI0Nw_f7a9ed2d-4dac-4b44-a818-d3b1d724ba72"
      unitRef="usd">97000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ieddb3e5a196249108dd92686400d6e00_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMS0xLTEtMjA4_5a2391e1-13c7-472d-a2ab-c0b9f4180475"
      unitRef="shares">10062500</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieddb3e5a196249108dd92686400d6e00_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMy0xLTEtMjEy_df34c213-cebf-450f-85fc-287733a2a8d1"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="id275aa24a2de46bb97e130263856c8cb_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtNS0xLTEtMjE2_d3ea99db-fa76-41dc-85da-355723a28aa1"
      unitRef="shares">1679428209</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id275aa24a2de46bb97e130263856c8cb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtNy0xLTEtMjIw_23b6bf82-bd6e-457a-8726-a5df3e6e4834"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26cdf1b470b441dc8312a69ca2a3a82e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtOS0xLTEtMjI0_7c8d3eb1-06b8-4809-9b60-f34cddb0d010"
      unitRef="usd">-1717000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icbe13d2d881c478c9713420faa1b3a01_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMTEtMS0xLTIyOA_d46438cb-4694-4633-94a5-91f8821e8d33"
      unitRef="usd">19687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10f8de4c7bde4dbfb0824f68791a47e7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMTMtMS0xLTIzMg_beb10834-8688-4cb3-90b9-c923f9365ba9"
      unitRef="usd">-2574000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i456ac438eda6495e82678ce466563701_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zMS9mcmFnOmVjNWZiY2YzYjlhYjQ1ZTJiOWFhMzBiZDU1ZmExMGE1L3RhYmxlOjBkZTViNzQyOGFhNjQ1NWViOTlkMjkzZDFiMTIzNGZhL3RhYmxlcmFuZ2U6MGRlNWI3NDI4YWE2NDU1ZWI5OWQyOTNkMWIxMjM0ZmFfNTMtMTUtMS0xLTIzNg_a03bc23a-6eb7-4293-83d6-d6add9fc0387"
      unitRef="usd">151000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMy0xLTEtMS0w_ebf8e378-5900-484d-86af-6e2ec061d2ab"
      unitRef="usd">835000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMy0zLTEtMS0w_c7f9e3c4-2228-4002-80bc-e1e92304d2f7"
      unitRef="usd">1144000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNi0xLTEtMS0w_34c445c4-f0e9-4fa4-8728-16bfce868974"
      unitRef="usd">217000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNi0zLTEtMS0w_3d77dfa4-097c-4fe1-909e-8179ea3bb9dd"
      unitRef="usd">275000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNy0xLTEtMS0w_348bad52-bdf5-459d-8d0d-5f0c7a147089"
      unitRef="usd">6000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfNy0zLTEtMS0w_14a21bbb-8564-4f70-bd85-7282fb332a76"
      unitRef="usd">5000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOC0xLTEtMS0w_c1f01b5e-67e0-43b4-ac59-ff79d18ca28f"
      unitRef="usd">3000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOC0zLTEtMS0w_30baf904-0218-4525-8a0c-7769de085beb"
      unitRef="usd">4382000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOS0xLTEtMS0w_f5629527-2596-4b77-9222-c273b88e3c77"
      unitRef="usd">-66000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfOS0zLTEtMS0w_51177db7-3d46-48e0-91e0-d0ee824c546d"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTAtMS0xLTEtMA_3af583f7-03c6-423f-9310-cb8799092168"
      unitRef="usd">130000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTAtMy0xLTEtMA_ebd40544-0f7c-4dcc-b1bf-6d7c0c75a098"
      unitRef="usd">137000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTEtMS0xLTEtMA_6f153e3c-7721-499b-bb32-e69b7c0382fe"
      unitRef="usd">15000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTEtMy0xLTEtMA_db4aa7fd-6e78-42c7-9aaa-b4928350631e"
      unitRef="usd">90000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTItMS0xLTEtMA_d5bede94-048c-4fa7-933a-8502a15d61a3"
      unitRef="usd">0</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTItMy0xLTEtMA_46075416-2daa-44b1-9a05-4f048c212482"
      unitRef="usd">294000000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTMtMS0xLTEtMA_3f4da50b-1445-4ddb-8517-f12315a6c7ab"
      unitRef="usd">-264000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTMtMy0xLTEtMA_28088748-96e3-43c3-ba90-e66fdbcdced1"
      unitRef="usd">-4992000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <bsx:BusinessAcquisitionContingentConsiderationCashPayment
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTYtMS0xLTEtMA_9933fea8-fd7d-4881-b3ce-03bb8a23b9ce"
      unitRef="usd">132000000</bsx:BusinessAcquisitionContingentConsiderationCashPayment>
    <bsx:BusinessAcquisitionContingentConsiderationCashPayment
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTYtMy0xLTEtMA_ce62ff7b-90d8-47f9-ae71-e198e5ea1164"
      unitRef="usd">135000000</bsx:BusinessAcquisitionContingentConsiderationCashPayment>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTctMS0xLTEtMA_ce8fd9e4-d43a-4348-8512-6fab368fcb90"
      unitRef="usd">2950000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTctMy0xLTEtMA_cc278ea3-b235-4f2e-a9e1-bded80c327c2"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTgtMS0xLTEtMA_08991bce-f392-4bda-9d7e-15bde69a9b7e"
      unitRef="usd">2245000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTgtMy0xLTEtMA_fcc4b5ee-c87b-47f3-b47c-5e3dc557f4cd"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTktMS0xLTEtMA_a612d8c6-0232-4fe9-9590-2c3c8fec4478"
      unitRef="usd">-714000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMTktMy0xLTEtMA_9775386a-08d9-4d7e-a280-2ef85b50c73d"
      unitRef="usd">13000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjAtMS0xLTEtMA_a5fbabec-3938-4092-a1a6-b717173f1204"
      unitRef="usd">1919000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjAtMy0xLTEtMA_24b52b13-2c5c-4683-a9d6-20c39639dbf7"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjEtMS0xLTEtMA_6a3e92f9-a34d-4d38-afc9-4a4e162a52d5"
      unitRef="usd">1916000000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjEtMy0xLTEtMA_3e5b175a-0cd9-4e82-a6d1-121274a304cd"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjItMS0xLTEtMA_f4bf5110-94b1-4dab-a3ef-50b6bd9c61fb"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjItMy0xLTEtMA_dd74533b-715c-4860-b0e1-e5a3082fd78c"
      unitRef="usd">1472000000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjMtMS0xLTEtMA_edd2b8c6-0cf3-4fbf-a4ea-27d692395232"
      unitRef="usd">1683000000</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjMtMy0xLTEtMA_c4f55eed-f9a9-40cb-b4f4-c4982450cfef"
      unitRef="usd">6243000000</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
    <us-gaap:PaymentsOfDividends
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMS0xLTEtNDkzNA_fb7f93e3-12de-4039-8e63-8ed4d12345db"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMy0xLTEtNDkzNA_d10ddce3-38f3-4f80-be7d-885afad6a4b9"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMS0xLTEtMA_65a56cd4-d1bd-4116-8332-9f32ecbd4b8c"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjQtMy0xLTEtMA_a6513430-e31e-4485-9e31-2e70e2919406"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjUtMS0xLTEtMA_1083ba1f-907a-4898-a958-ff37ae06e188"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjUtMy0xLTEtMA_ce2df813-de7d-41b3-8f94-b6e293c81880"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjYtMS0xLTEtMA_748624e2-54ef-4ad0-8b02-cf5edc70418a"
      unitRef="usd">59000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <bsx:Paymenttonetsharesettleemployeeequityawards
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjYtMy0xLTEtMA_92bf6986-e693-406a-942b-6109afd82b3d"
      unitRef="usd">64000000</bsx:Paymenttonetsharesettleemployeeequityawards>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjctMS0xLTEtMA_1a2ad160-67a1-4744-ad3c-7df4f4b88c4b"
      unitRef="usd">107000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjctMy0xLTEtMA_29f02f84-ffd1-4294-9f36-7f74faaaea4a"
      unitRef="usd">113000000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjgtMS0xLTEtMA_bc725fc6-feb4-47df-8745-d573e0459870"
      unitRef="usd">1112000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMjgtMy0xLTEtMA_146e53f2-e9f3-4b4a-ad1e-8eb166011a60"
      unitRef="usd">3697000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzAtMS0xLTEtMA_a4c726a4-a745-4978-af71-051d3d0e8721"
      unitRef="usd">-8000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzAtMy0xLTEtMA_a14a3976-55c5-43c9-852c-6f661a6c7ba0"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzItMS0xLTEtMA_dbd13932-b454-425b-b860-26035f95993a"
      unitRef="usd">1675000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzItMy0xLTEtMA_8304face-78bc-405e-b4ce-a5ce3dc1eeb1"
      unitRef="usd">-153000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzMtMS0xLTEtMA_037f44a4-b3cb-49cb-baa9-b60fbbdf0ebb"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzMtMy0xLTEtMA_bbc9781a-185c-423e-bab3-9b5821af1234"
      unitRef="usd">829000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzQtMS0xLTEtMA_20136436-8b68-46ab-93b3-2800b609910a"
      unitRef="usd">2282000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzQtMy0xLTEtMA_654ccbb9-b6ca-4f7e-a254-456227485998"
      unitRef="usd">676000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ShareBasedCompensation
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzctMS0xLTEtMA_54c7442d-9e08-4e09-9f35-28309e110123"
      unitRef="usd">128000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzctMy0xLTEtMA_b06b607b-369c-400a-a75d-604f87fa7464"
      unitRef="usd">116000000</us-gaap:ShareBasedCompensation>
    <bsx:ContingentConsiderationRecognizedInPeriod
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzgtMS0xLTEtMA_a0610f2b-c648-49cb-abea-d230ec813c56"
      unitRef="usd">0</bsx:ContingentConsiderationRecognizedInPeriod>
    <bsx:ContingentConsiderationRecognizedInPeriod
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzgtMy0xLTEtMA_5b15f44b-72a3-43b5-86ba-00c8bde8faa6"
      unitRef="usd">127000000</bsx:ContingentConsiderationRecognizedInPeriod>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzktMS0xLTEtMA_046934f6-65ef-4892-8885-425313e94903"
      unitRef="usd">-66000000</bsx:Noncashimpactoftransferredroyaltyrights>
    <bsx:Noncashimpactoftransferredroyaltyrights
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjRmNjM0YTE5YjI3NDRhYzA4ZGQ3ZmNkOGRiMjNjMTJmL3RhYmxlcmFuZ2U6NGY2MzRhMTliMjc0NGFjMDhkZDdmY2Q4ZGIyM2MxMmZfMzktMy0xLTEtMA_191db978-a112-4517-bfbd-65aa68d5f5de"
      unitRef="usd">0</bsx:Noncashimpactoftransferredroyaltyrights>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMi0xLTEtMS0w_870f3a58-0dde-487c-88a4-b4506ed74fdf"
      unitRef="usd">2022000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMi0zLTEtMS0w_9ccf66b3-9c3b-4fb5-9ccc-18c87e564424"
      unitRef="usd">277000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMy0xLTEtMS0w_04af877b-5052-4675-87a0-5ced52d9531d"
      unitRef="usd">214000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfMy0zLTEtMS0w_260a9569-409e-4959-9fbe-fa8f4c830c9b"
      unitRef="usd">357000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNC0xLTEtMS0w_e9011d48-bc10-4644-88b4-5933d39b3d7b"
      unitRef="usd">46000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNC0zLTEtMS0w_592be802-a33e-4835-8735-1f8a61396af9"
      unitRef="usd">43000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNS0xLTEtMS0w_fee0119e-2960-4eaa-a7f2-54b7a19562e1"
      unitRef="usd">2282000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8zNC9mcmFnOjYxMDhhNWM0MTE2YjRjNDk5YTdlZmQ4NGI2OWJmNjZiL3RhYmxlOjc4NDg0MDI1ZDllYzRjYjRhM2Y5NGIwYTY2NGU4NzczL3RhYmxlcmFuZ2U6Nzg0ODQwMjVkOWVjNGNiNGEzZjk0YjBhNjY0ZTg3NzNfNS0zLTEtMS0w_f72058f3-37bc-4752-ad03-d4d45a3e4a46"
      unitRef="usd">676000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA1MA_56bcf4ff-d856-44d9-9f2d-2bb782a12947">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE A &#x2013; BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and nine months ended September&#160;30, 2020 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2020. For further information, refer to the consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reported in millions within this quarterly report are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our most recent accompanying unaudited condensed consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Implemented Since December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2016-13&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASC Update No. 2016-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Instruments - Credit Losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and recorded a corresponding increase in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a contra &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;account. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-15&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-18&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the FASB issued ASC Update No. 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2NQ_952b043b-802f-4796-9624-3cbad8c76a00">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate events occurring after the date of our most recent accompanying unaudited condensed consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note H &#x2013; Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <bsx:ASCUpdateNo.201613PolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2Nw_a56be7fa-a970-445c-8bdf-a4cb53b8e66a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2016-13&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASC Update No. 2016-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Instruments - Credit Losses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(FASB ASC Topic 326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and recorded a corresponding increase in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a contra &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;account. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo.201613PolicyTextBlock>
    <bsx:ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2Mw_cb131db9-92e2-4301-a1f7-568820e71c51">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-15&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software (Subtopic 350-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock>
    <bsx:ASCUpdateNo.201818PolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80MC9mcmFnOmJjZDNiNjQ3YTgwNTQzOGZhYmFkYTMxZjNhNGQ2MzQ0L3RleHRyZWdpb246YmNkM2I2NDdhODA1NDM4ZmFiYWRhMzFmM2E0ZDYzNDRfNTA2NA_6e48b33c-a168-4365-b5d5-97f98b66b53e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2018-18&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, the FASB issued ASC Update No. 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo.201818PolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjc0ODc3OTA4ODQyNg_00c7b142-d422-4c1f-bd1e-c7782b6ff763">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE B &#x2013; ACQUISITIONS AND STRATEGIC INVESTMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our unaudited condensed consolidated financial statements include the operating results for acquired entities from the respective date of acquisition. We did not complete any material acquisitions or divestitures during the first nine months of 2020. We have not presented supplemental pro forma financial information for prior acquisitions given their results are not material to our unaudited condensed consolidated financial statements. We recorded immaterial purchase price adjustments during the measurement period for the preliminary purchase price allocations of acquisitions in the first nine months of 2020. Transaction costs for these acquisitions were immaterial to our unaudited condensed consolidated financial statements and were expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Q3 2019 YTD Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;BTG plc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;19, 2019, we announced the closing of our acquisition of BTG, a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we began to integrate BTG's Interventional Medicine business into our Peripheral Interventions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the Interventional Medicine product lines, the BTG portfolio also included a specialty pharmaceutical business (Specialty Pharmaceuticals) comprised of acute care antidotes to treat overexposure to certain medications and toxins and a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price consisted of upfront cash in the aggregate amount of &#xa3;3.312 billion (or $4.023 billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received 840 pence (or $10.20 based on the exchange rate at closing) in cash for each BTG share. The transaction price included $404 million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&#160;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.165%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of our acquisition of BTG, we recognized goodwill of $1.644 billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. The goodwill is not deductible for tax purposes. We allocated $1.406 billion to our Peripheral Interventions reporting unit and $238 million to the Specialty Pharmaceuticals reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Vertiflex, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 11, 2019, we announced the closing of our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#x2122; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $465 million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of zero to $100 million; however, the payments are uncapped over the three year earn-out period. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Millipede, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2019, we announced the closing of our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $90 million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately 20 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $325 million and up to an additional $125 million payment upon achievement of a commercial milestone. Following the closing of the acquisition, we integrated the Millipede business into our Interventional Cardiology division. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final combined purchase price allocation was comprised of the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and has been allocated to our reportable segments based on the relative expected benefit. The goodwill recorded relating to our 2019 acquisitions is not deductible for tax purposes.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;214&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $627 million. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The $102 million benefit recorded in the first nine months of 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision Medical Corporation (nVision) for milestones that would not be achieved due to management's discontinuation of the R&amp;amp;D program.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$100 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$114 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected contingent payment amounts related to some of our research and development (R&amp;amp;D), commercialization-based and revenue-based milestones are discounted back to the current period using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Strategic Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;567&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;458&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized currently in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited condensed consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $343 million, which represents amortizable intangible assets, IPR&amp;amp;D, goodwill and deferred tax liabilities. In the third quarter of 2020, we recorded a $65 million non-cash gain presented in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our unaudited condensed consolidated statements of operations to state at fair value one of our portfolio investments treated under the measurement alternative method of accounting.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTI4Nw_8e8d13a2-2af8-4f23-bbba-537d3ef79875"
      unitRef="gbp">3312000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTI5NQ_8278cb05-3e69-494c-a29a-aae883796eb0"
      unitRef="usd">4023000000.000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i8b95a6dee16943f59d2330f61315da56_I20190819"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTQ0NA_e1152520-9192-4525-a889-7bbaba2b77f3"
      unitRef="gbpPerShare">8.40</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i8b95a6dee16943f59d2330f61315da56_I20190819"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTQ1Mg_d9cd5ee7-3531-40fd-b406-9c5c35d7a6df"
      unitRef="usdPerShare">10.20</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ib9c4cfec4273436bafa5cfb391446767_D20190819-20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTYzNTU1NA_a288c082-e92d-4a92-aaf6-e2f4a18e6055"
      unitRef="usd">404000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjc0ODc3OTA4NTIzNw_f3f35e45-5103-4939-8915-476ac3cabfa1">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.165%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payment for acquisition, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmQwM2RjY2FkNjRiNTRmODM4MGNlYzI2NjhhNTU2ZGNiL3RhYmxlcmFuZ2U6ZDAzZGNjYWQ2NGI1NGY4MzgwY2VjMjY2OGE1NTZkY2JfMS0xLTEtMS0xNjQw_3961ee25-4491-4975-8729-14510d93ea44"
      unitRef="usd">3619000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjc0ODc3OTA4NTI0MQ_e7f3985c-11b6-4d63-b45d-f9415ddcc0f6">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMS0xLTEtMS0xNjUy_27004fec-b551-46bc-94da-09c08dbb736c"
      unitRef="usd">1644000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMy0xLTEtMS0xNjUy_e03a898d-9729-4554-957f-f1e0a6bd9892"
      unitRef="usd">108000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNC0xLTEtMS0xNjUy_6413e678-c612-4c25-b0af-767e774dec77"
      unitRef="usd">232000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNS0xLTEtMS0xNjUy_e5a5f2eb-3e48-4183-98f3-b61fe6da43c5"
      unitRef="usd">252000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNi0xLTEtMS0xNjUy_daae8e52-b5e0-4f23-bcd0-76230bd409e8"
      unitRef="usd">1785000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfNy0xLTEtMS0xNjUy_77c078d1-ac7b-4948-b418-4fd073cb14e2"
      unitRef="usd">537000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfOC0xLTEtMS0xNjUy_1cad64cf-b8d5-4874-9090-9b88f94e50cb"
      unitRef="usd">308000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfOS0xLTEtMS0xNjUy_657914d9-8817-4ac7-a3de-5542de030e01"
      unitRef="usd">274000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMTAtMS0xLTEtMTY1Mg_a30dd2a7-ed13-41ec-9946-a7a237bb0c10"
      unitRef="usd">358000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzM2FjOTVlMzhkZDQwMGI5NjBjYjNlYmJkMzhmNjE1L3RhYmxlcmFuZ2U6NjMzYWM5NWUzOGRkNDAwYjk2MGNiM2ViYmQzOGY2MTVfMTEtMS0xLTEtMTY1Mg_716c6622-8b39-4e5b-89bd-45808a4804ac"
      unitRef="usd">3619000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="ia1e97ccb4c3f43729acfe2c003150452_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMzI5ODUzNDg5OTEyNw_c52cc517-7c5e-4795-8774-fa6ca865da7a">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.370%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id8c1b69039194f6d941fd5b48076ee41_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi0xLTEtMS0xNjUy_05cc9fe2-5597-43cf-bebb-a31f1064076e"
      unitRef="usd">1709000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic20a36eb220b470eba748536a11f26fe_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi0zLTEtMS0xNjUy_5779301d-f64e-4385-832d-863054e2a620">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iddadff178c5c41a3977cf15d3cf00c99_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi01LTEtMS0xNjUy_fd6929c2-5140-468b-802c-8e4f6d69f03b">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="ice23b320aba74832b975dd54f9a41b8b_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi03LTEtMS0xNjUy_b312f7ef-2fe2-4c3a-96ca-0655b159f795"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="id3046b7a84674f07b8b6bc5297d63b3a_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfMi05LTEtMS0xNjUy_e47d18ab-4067-4dfb-9273-4c52f3f6357f"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i77b41059a837448d90bd8dc4312473e1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS0xLTEtMS0xNjUy_d414820f-59f6-40cd-a4ca-c1fc2e925a7d"
      unitRef="usd">75000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i77e24f9ec65b4419ab13c89e5afacd34_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS0zLTEtMS0xNjUy_4688bb42-ad61-4664-b42b-c701ff7aee36">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4948def2b3404998b1a8e76ccc208655_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS01LTEtMS0xNjUy_76844264-8593-453a-8c49-7b26a926e230">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i05dc2bca12f441518b8eae871ad3ce57_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfNS03LTEtMS0xNjUy_8dd731c2-a1b8-4a4e-8407-0f9426dc1f34"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjg4YmM1MWEwNTI2NDQ0ZGJiODIxMGQyYzQzNjUwMDI1L3RhYmxlcmFuZ2U6ODhiYzUxYTA1MjY0NDRkYmI4MjEwZDJjNDM2NTAwMjVfOC0xLTEtMS0xNjUy_0525bf38-06fb-47c6-89e7-535c04332945"
      unitRef="usd">1785000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="ibf7c7c10539a427aa016b8f246594fb1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTY0MjA2Mg_27004fec-b551-46bc-94da-09c08dbb736c"
      unitRef="usd">1644000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5ef09943eb2142468d55375ee434dff1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTY0MjI5OA_c86fbb68-5106-480b-9b9f-cc12bb7d8066"
      unitRef="usd">1406000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib6543e61e1ca452a991a93b48b5860ee_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA5OTUxMTY0MjM1Mw_07d6ad20-573d-4209-a279-249add602783"
      unitRef="usd">238000000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ideeea0ead40f44dd993b303107e7c8c0_D20190611-20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTA2OQ_4a96f9fb-7ae7-4f73-87e8-322fa0252e00"
      unitRef="usd">465000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
      contextRef="i306877ff66b94d598003e4699fa0e864_I20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTMwOA_d42f8a75-0d8d-42e0-b846-71e2c088365d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i306877ff66b94d598003e4699fa0e864_I20190611"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTMxNA_826f5fcb-d86b-4eab-be8c-3e325683d21e"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iba8ef1bb81a34679887900294644c59b_D20190129-20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjAzNA_d9110435-ecfb-4161-8c7d-6f0b805cad01"
      unitRef="usd">90000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i6e985d5f31da4655b4775f3c18736888_I20190129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjI0Mw_f8f1f572-8c11-4a89-978d-810efcccb020"
      unitRef="number">0.20</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="iba8ef1bb81a34679887900294644c59b_D20190129-20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjU2Ng_e228cd39-614b-4da7-8249-89238dc97397"
      unitRef="usd">325000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i6e985d5f31da4655b4775f3c18736888_I20190129"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMjU5Mw_a340970f-79cd-4b44-a643-99ce64aaee7d"
      unitRef="usd">125000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjA3Mw_2129e57a-cfbb-4eba-bc38-18c7c316933b">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of prior interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfMS0xLTEtMS0w_dd4ba253-9d5f-4ec4-bd30-8b92931b7242"
      unitRef="usd">763000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfMi0xLTEtMS0w_887a5bf8-7aaf-4b61-9e05-b80a78588cbd"
      unitRef="usd">127000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfMy0xLTEtMS0w_6fe09c32-0480-428c-a0d0-2e5b0d92b040"
      unitRef="usd">102000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmRiMDE4M2JmMWVjODRhMzk4Zjc1MDFkZWZlZmZlNjc0L3RhYmxlcmFuZ2U6ZGIwMTgzYmYxZWM4NGEzOThmNzUwMWRlZmVmZmU2NzRfNC0xLTEtMS0w_b4f743ae-78a0-441a-93b9-1f140e2696ea"
      unitRef="usd">992000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAwMQ_402c6e33-4c7f-4102-aa4d-db7b8e019aec">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfMS0xLTEtMS0w_22554b03-c267-4810-9118-d8e7370921c8"
      unitRef="usd">577000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfMi0xLTEtMS0w_782ecb35-5c80-4607-9582-aadba6b8b98d"
      unitRef="usd">220000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfMy0xLTEtMS0w_20f30275-1956-4572-a682-8fe162d183b0"
      unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNC0xLTEtMS0w_77661ad2-5f64-4162-8ad7-086b916c40b3"
      unitRef="usd">24000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNS0xLTEtMS0w_fb650752-9eb8-43b4-a225-8dff65d6013d"
      unitRef="usd">12000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNi0xLTEtMS0w_b0862a9e-e4cc-4143-8e42-d60b3f8d9dae"
      unitRef="usd">58000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmM1ZGQzNzQ4MzMxMzRmODI4Nzk4YWE2NjEyMGVhZWVlL3RhYmxlcmFuZ2U6YzVkZDM3NDgzMzEzNGY4Mjg3OThhYTY2MTIwZWFlZWVfNy0xLTEtMS0w_639bbd40-93ee-4b3a-b18e-9659cebeef8a"
      unitRef="usd">992000000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="i8ff1d0cbdb3e4a37849f04b90e53de4a_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAyMg_10894b5c-3137-4879-9efb-3ba024115e1f">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount Assigned&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Adjusted Discount &lt;br/&gt;Rates used in Purchase Price Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic0f8ba5a467c45fe948ec96ca784057a_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfMi0xLTEtMS0w_fba13bc3-822f-46eb-be60-08e77c66170b"
      unitRef="usd">210000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i085d4caca7b24cb58a868824db62acdc_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfMi0zLTEtMS0w_4068e51f-b094-4052-8ac4-a8a5301891aa">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i58e7195e106047a191895672017f64b9_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfMi03LTEtMS0w_ad1bc61e-e5a7-4ef7-8a28-20ff87609975"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i813c67adfd7c4a86afbb6e281c6d478c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNC0xLTEtMS0w_d6a8c0c3-0616-40d6-b7e2-b2788bf54dc0"
      unitRef="usd">10000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iec1555f039564481906b06dd35a52e71_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNC0zLTEtMS0w_d81aea45-ae70-4a0b-8293-ac086b5dfadf">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <bsx:DiscountRateFairValueInput
      contextRef="i896dbc3c04fe46f58b32c467a3593953_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNC03LTEtMS0w_76016c0f-a851-46d6-91c5-f6b1fe9db5e4"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i0fe4e49dc414447fbf120ce2ae4f4623_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNi0xLTEtMS0w_d7dbd34e-2a13-4b4b-9495-6e62a6cecf12"
      unitRef="usd">240000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <bsx:DiscountRateFairValueInput
      contextRef="ibf332292a44a478e9ebea4a33fbdd424_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNi03LTEtMS0w_6aa09b38-23f5-4eec-adb3-8399b66caa14"
      unitRef="number">0.19</bsx:DiscountRateFairValueInput>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ieb2d01db3ed445aa91fca18bd236ccdb_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOjYzYjVlNDc5NWVjMDRiNjc4MTMzZjg5YTAzMDFkMWU3L3RhYmxlcmFuZ2U6NjNiNWU0Nzk1ZWMwNGI2NzgxMzNmODlhMDMwMWQxZTdfNy0xLTEtMS0w_f94e0f7e-4ea4-4e1d-96d2-fa269586f0fc"
      unitRef="usd">461000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNTk5OA_8a3a93f0-3008-43ce-85bc-2986cd4114b0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our contingent consideration liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration net expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;214&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfMS0xLTEtMS0w_b0b53f25-f8eb-468e-b924-2b1e75169bb4"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfNC0xLTEtMS0w_92e971d8-ffb7-4430-ab1d-5d15f5e050b6"
      unitRef="usd">-102000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bsx:PaymentOfContingentConsideration
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfNS0xLTEtMS0w_b556d0c0-3f76-43e4-821c-58b43b919e6b"
      unitRef="usd">40000000</bsx:PaymentOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFmMzdmYWQ4NGIyZjQyNGU5M2U0NDhhZGRmMTI4ODRmL3RhYmxlcmFuZ2U6YWYzN2ZhZDg0YjJmNDI0ZTkzZTQ0OGFkZGYxMjg4NGZfNi0xLTEtMS0w_63e3fde3-919b-4b8f-9422-cfc2bba1fad9"
      unitRef="usd">214000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMzk2MA_457e04c7-3fcf-4b08-b93d-fe691d9e1134"
      unitRef="usd">627000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNDE1NQ_92e971d8-ffb7-4430-ab1d-5d15f5e050b6"
      unitRef="usd">-102000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAyMw_fcd8e86b-fc4f-4711-8730-be6055522101">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D, Regulatory and Commercialization-based Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$100 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue-based Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$114 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9ebccf7ca6b8470782d5496c6de481af_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS0xLTEtMS0w_244c7e12-0a49-48c2-b11d-8c270f725fd0"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="if244a5996bc34f8ca2bdf001a69336ee_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS00LTEtMS0w_5e94e803-5125-47b1-bc57-54bc54e0ec94"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i14ae891ce6774513aff2cec35b4d31ce_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS02LTEtMS0w_3e3b808f-1436-4dc4-b9d8-e47bcaedd612"
      unitRef="rate">0.02</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ic5c4aa9bf38540239bdd1ab15292743a_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMS03LTEtMS0w_8a7a2846-27d8-4a49-9267-64a8053b3fbd"
      unitRef="number">0.02</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="if244a5996bc34f8ca2bdf001a69336ee_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMi00LTEtMS0w_dfcf6a7c-885b-43d4-899e-51ab62d46e31"
      unitRef="number">0.90</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i14ae891ce6774513aff2cec35b4d31ce_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMi02LTEtMS0w_8eff97e8-e305-4ad7-aa3b-e1ebc91a45d3"
      unitRef="number">0.90</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="ic5c4aa9bf38540239bdd1ab15292743a_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfMi03LTEtMS0w_688ade03-ad73-4f88-8dc9-059a17df299e"
      unitRef="number">0.90</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4410774845a24a54a144e7dfdfd8ba6e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC0xLTEtMS0w_b377a00e-c965-4518-8022-bd095eb33c93"
      unitRef="usd">114000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:DiscountRateFairValueInput
      contextRef="i88663b924d2b458cbccc972e892704cf_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC00LTEtMS0w_d8228605-13eb-446f-86d1-de9e3bd18939"
      unitRef="rate">0.11</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i5b832479fdc344b291fe8b6401da66a0_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC02LTEtMS0w_b826590d-d607-4b46-99a1-bf02d9803a21"
      unitRef="number">0.14</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i5a217a1106c342bd90cffb6a011624ae_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNC03LTEtMS0w_5fea2dc2-3f48-4959-999f-3a66c68621e7"
      unitRef="rate">0.13</bsx:DiscountRateFairValueInput>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i88663b924d2b458cbccc972e892704cf_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNS00LTEtMS0w_6e95e5ec-dfd6-4c67-b710-c25beda97ce4"
      unitRef="number">0.53</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i5b832479fdc344b291fe8b6401da66a0_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNS02LTEtMS0w_d41b5abd-2d4a-4c5b-a7ed-7176414a63fc"
      unitRef="number">1</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <bsx:ContingentConsiderationLiabilityProbabilityOfPayment
      contextRef="i5a217a1106c342bd90cffb6a011624ae_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFiMWZjMDZlYzJhZTRmNzViMmI3ZGY5OGZiODg3ZGVmL3RhYmxlcmFuZ2U6YWIxZmMwNmVjMmFlNGY3NWIyYjdkZjk4ZmI4ODdkZWZfNS03LTEtMS0w_9b914bc9-24da-4ace-b13d-1840c2cacdff"
      unitRef="number">0.87</bsx:ContingentConsiderationLiabilityProbabilityOfPayment>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNjAyNA_1f2bb7ac-3eac-40fe-8e8a-118281960b9d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying amount of our strategic investments was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement alternative investments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held equity securities (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;567&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;458&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized currently in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMi0xLTEtMS0w_482995cb-c7bb-44db-a524-706988cf23f2"
      unitRef="usd">366000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMi0zLTEtMS0w_278889ff-0210-4317-aa72-342732df3c52"
      unitRef="usd">264000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMy0xLTEtMS0w_dca84969-d630-491c-bf5d-7466eccbd445"
      unitRef="usd">196000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfMy0zLTEtMS0w_6d6fda41-46e7-480e-8885-cee27eeff371"
      unitRef="usd">171000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNC0xLTEtMS0w_6784e71c-4aee-4115-8000-1e952907e3fe"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNC0zLTEtMS0w_3043e5f7-ca8e-41e2-abb0-9b7cf96ff6ee"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNS0xLTEtMS0w_98d7160e-7abd-4ff3-abb8-1982e3253c8c"
      unitRef="usd">4000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNS0zLTEtMS0w_6e0d0868-59ef-4d06-88cf-39d1ff8a07db"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:Investments
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNi0xLTEtMS0w_ad486df7-a3df-4319-a051-30b857f1a332"
      unitRef="usd">567000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RhYmxlOmFkYjhmOTQ2MWQwYzQ2MDRiODQ1ZTY3YTIxMzE0OTlhL3RhYmxlcmFuZ2U6YWRiOGY5NDYxZDBjNDYwNGI4NDVlNjdhMjEzMTQ5OWFfNi0zLTEtMS0w_ba699ec3-6ccd-477d-927c-e7fe009dc8bd"
      unitRef="usd">458000000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfNTg5OA_977c9df4-fd1d-4616-ad6a-ce7445281c99"
      unitRef="usd">343000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml80Ni9mcmFnOmU5MDZlNzhhYWNlNzQ0OGQ5YmJjNzFjODA1NDAxODY3L3RleHRyZWdpb246ZTkwNmU3OGFhY2U3NDQ4ZDliYmM3MWM4MDU0MDE4NjdfMTY0OTI2NzQ1NzQ5MA_e115e29c-0c09-4c79-b779-10e27265d767"
      unitRef="usd">65000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfNjA4OA_4b421231-dc7b-49a0-9c90-7c61f7a934e0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE C &#x2013; GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;383&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives. Our IPR&amp;amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. In the first quarter of 2020, following receipt of CE Mark for certain products, we reclassified certain of our IPR&amp;amp;D intangible assets to amortizable technology-related assets and began amortization to reflect their use over their remaining lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and other changes in carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,056&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,646&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;241&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Indefinite-Lived Intangible Asset Impairment Testing&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not record any goodwill impairment charges in the third quarter and first nine months of 2020 or 2019. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. In the second quarter of&#160;2020, we performed our annual goodwill impairment test for all of our reporting units and concluded that the fair value of each reporting unit exceeded its carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. We identified the following reporting units in our 2020 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In 2020, we utilized the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment in the second quarter of 2020. There were no impairment indicators in the third quarter of 2020 that necessitated an interim impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of $219 million in the third quarter of 2020, none in the third quarter of 2019, $452 million in the first nine months of 2020 and $105 million in the first nine months of 2019. The impairment charges recorded in the third quarter of 2020 were primarily associated with IPR&amp;amp;D acquired with Apama Medical Inc. following management&#x2019;s decision to cancel the program. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible asset impairment charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the first nine months of 2020 also included charges related to nVision and certain other intangible assets initially established following acquisition. In general, these charges were recorded as a result of management&#x2019;s decision to change commercial launch plans or discontinue certain R&amp;amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value. In the third quarter of 2020, we performed our annual IPR&amp;amp;D impairment test and evaluated our indefinite-lived core technology assets using the optional qualitative assessment approach and concluded a quantitative test was required for certain IPR&amp;amp;D assets, resulting in the ultimate impairment of the Apama assets discussed above. We also verified that the classification of IPR&amp;amp;D projects and our indefinite-lived core technology assets recognized within our unaudited condensed consolidated balance sheets continues to be appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. In the third quarter of 2020, we determined a recoverability test was required for certain amortizable intangible assets based on our qualitative assessment of impairment indicators, and recorded intangible asset impairment charges as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Policies and Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within Part II, Item 7. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Management's Discussion and Analysis of Financial Condition and Results of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; contained in our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfNjA1OA_6f561e4d-9659-4a86-9630-f27c6ae19067">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization/ Write-offs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;383&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6fa93356c3144962a66e1b420a7d3f9d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy0xLTEtMS0w_a22bde4f-ecf8-4448-b825-ca2acdd6e4a5"
      unitRef="usd">11834000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6fa93356c3144962a66e1b420a7d3f9d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy0zLTEtMS0w_9db17cb8-b511-437c-8088-a4c490fcc9e5"
      unitRef="usd">6102000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3790bd2f6293401b8b5a8afd9976f99e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy01LTEtMS0w_85f3f4f5-4544-4895-abea-3ac7709913cf"
      unitRef="usd">12020000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3790bd2f6293401b8b5a8afd9976f99e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMy03LTEtMS0w_e0f5030d-151d-4463-b27f-0638d69e7517"
      unitRef="usd">5706000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id56d0db5fc654680827529f68c76a516_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC0xLTEtMS0w_332238d6-1b83-4c20-bc8e-c9037cb420e3"
      unitRef="usd">514000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id56d0db5fc654680827529f68c76a516_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC0zLTEtMS0w_5fd888b2-990e-4568-85e1-63948d63d81f"
      unitRef="usd">407000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5bbb535d2f4a44f09dd05caeb7d8477a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC01LTEtMS0w_f1fe4231-4da8-4440-b06f-f748a465ccdf"
      unitRef="usd">525000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5bbb535d2f4a44f09dd05caeb7d8477a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNC03LTEtMS0w_f81ac48e-79ef-40ac-96c1-e5e37f1eeeb2"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9f9a34f6262041b292bc78770a80463c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS0xLTEtMS0w_cabbb011-4e78-4128-907a-1e3443f38270"
      unitRef="usd">1758000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f9a34f6262041b292bc78770a80463c_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS0zLTEtMS0w_b85f50f6-cfc4-41c6-aefd-34985d9d5641"
      unitRef="usd">1183000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i17832c8686724365b57112cd962e98a9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS01LTEtMS0w_ce75f30b-9365-4495-8a58-5e6d25589efb"
      unitRef="usd">1754000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i17832c8686724365b57112cd962e98a9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNS03LTEtMS0w_c89cbbb2-47b8-4c6b-a65a-1633f0d8fecd"
      unitRef="usd">1081000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi0xLTEtMS0w_401548da-8d59-444e-9301-4d6e0cbda8ae"
      unitRef="usd">14106000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi0zLTEtMS0w_260f6d60-e034-4256-a5b6-270d9777638a"
      unitRef="usd">7692000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi01LTEtMS0w_4da07433-ab23-4c61-9243-e14caa1615c3"
      unitRef="usd">14299000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfNi03LTEtMS0w_db350053-5e2f-492a-9b9b-13513cc9e5e0"
      unitRef="usd">7195000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:GoodwillGross
      contextRef="i368407ac90bd421f986c8a5c24c675ed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC0xLTEtMS0w_eca84286-dd82-490d-911c-fc58cba585df"
      unitRef="usd">20037000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i368407ac90bd421f986c8a5c24c675ed_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC0zLTEtMS0w_cac7178e-3268-4a5c-b2f2-dfaa9db32447"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="i5853d5a25ac44b929ce01432224f5764_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC01LTEtMS0w_82ce7da3-3afc-4bfa-9d92-7c46c08e17ec"
      unitRef="usd">20076000000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i5853d5a25ac44b929ce01432224f5764_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOC03LTEtMS0w_2e604728-6c0f-41a3-bb34-11fd69d3f39d"
      unitRef="usd">9900000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib57f804f076c49c08bc6003ea608e766_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOS0xLTEtMS0w_4b4485e9-41d8-426c-a61c-54b57c5d73ee"
      unitRef="usd">263000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9542da37d90b419a88f21b32b9c18e21_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfOS01LTEtMS0w_f948251b-b095-45e3-8858-566a4a031973"
      unitRef="usd">662000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie1be545420574c14979c7e504aabb492_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTAtMS0xLTEtMA_8792b2ab-9266-4819-aeab-af4bec13c857"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i26051ae85e46473d81272a66ca863cd2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTAtNS0xLTEtMA_cadadec2-695b-422f-8243-2cb74a2c4b8e"
      unitRef="usd">120000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTEtMS0xLTEtODA2Ng_d101afad-2523-4b3e-8fd2-b42ad68be6ac"
      unitRef="usd">383000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOmYyZmIyN2UxODdlNDQyMTJhNjQ2ZDBmNTYxZDA5MzQ2L3RhYmxlcmFuZ2U6ZjJmYjI3ZTE4N2U0NDIxMmE2NDZkMGY1NjFkMDkzNDZfMTEtNS0xLTEtODA2OQ_9925dad7-af81-4ae6-ad25-3328c0681d3d"
      unitRef="usd">782000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfNjA3MA_ff19eb83-dba6-418c-92ab-e37a975c2d01">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,192&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,676&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;247&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign currency fluctuations and other changes in carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,056&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,646&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;241&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i15c3d9625d044893a61231379ae0aa16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS0xLTEtMS0w_fad436a0-efee-4199-87a9-c70f7b933717"
      unitRef="usd">2061000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i88b731401f35464ab0c5a3185d967ae4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS0zLTEtMS0w_3a0eb986-ab5c-4882-a8a6-258c3d39a13c"
      unitRef="usd">2192000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6cfe5b0fd59340ada20dfb76e33e0309_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS01LTEtMS0w_9807db9c-16f9-4f9c-ba16-c8292112edc9"
      unitRef="usd">5676000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i372d2c53d9bd461a84e365951a7e89f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS03LTEtMS0w_1a0cfda3-1a48-4ac1-bb7c-ed06dc97da05"
      unitRef="usd">247000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfMS05LTEtMS0w_cfbeeb91-1b67-49b3-b406-63f2258fb523"
      unitRef="usd">10176000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC0xLTEtMS0w_72090d61-5df7-416b-a866-3167456a1b0d"
      unitRef="usd">-6000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC0zLTEtMS0w_15ab7267-1e3f-44dd-a848-6d53d5e0fb25"
      unitRef="usd">2000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC01LTEtMS0w_07102eee-3f36-47a1-ba9f-04b18ad3912a"
      unitRef="usd">-29000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC03LTEtMS0w_e0e9ea98-0195-497c-9800-43c42b452e0d"
      unitRef="usd">-7000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNC05LTEtMS0w_44349e77-c795-4411-bbfd-d6d8116f1d87"
      unitRef="usd">-39000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="if5994440a5ab43e7824bcb235c5af0d4_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy0xLTEtMS0w_41c84625-1cfa-4497-8ffb-f3fbddb1ed33"
      unitRef="usd">2056000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5043da4f04a34f68aec48682ecd51130_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy0zLTEtMS0w_a16f5ae4-0bfd-4b87-91dc-db568c603a09"
      unitRef="usd">2194000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iaddac085144a42d6aec4edf923f8c7c3_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy01LTEtMS0w_7a788c67-fa3d-4d87-ad91-2bb9e2b6ba54"
      unitRef="usd">5646000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i954b543dbcca4f58bb805011cd0e2930_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy03LTEtMS0w_fe7f13f7-5f7b-44c5-b812-27ed007f4284"
      unitRef="usd">241000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RhYmxlOjBjMmJhMDI1MmQ2MzRjZWU4MzJhM2Y1NDEwNGE3MjdjL3RhYmxlcmFuZ2U6MGMyYmEwMjUyZDYzNGNlZTgzMmEzZjU0MTA0YTcyN2NfNy05LTEtMS0w_55f8ee34-16d8-4e11-aee0-8440c6e117fa"
      unitRef="usd">10137000000</us-gaap:Goodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfMzQyNA_db804ac5-e82a-4d57-8553-6ae4ca8fe0f4"
      unitRef="usd">219000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfMzQ4MA_aa7854e8-fa75-410c-9c0a-f6481e3e2402"
      unitRef="usd">452000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml81NS9mcmFnOjc4MzgwZDgzNjI2NzRiNjk4YjEyOGNkZWUxMDQyYWU1L3RleHRyZWdpb246NzgzODBkODM2MjY3NGI2OThiMTI4Y2RlZTEwNDJhZTVfMzUwMA_7ec8d955-87fb-4aab-b8cb-ebf8aa7da1d7"
      unitRef="usd">105000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzOTA_19080c6d-5993-4c82-b62b-53ea4392b4f8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE D &#x2013; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Japanese yen, Euro, Chinese renminbi, Australian dollar and British pound sterling. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast, particularly resulting from the impact of COVID-19 on transaction volumes. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax (OCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our unaudited condensed consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our unaudited condensed consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax (AOCI)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro, Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. We elected to use the spot method to assess effectiveness for our derivatives that are designated as net investment hedges. Under the spot method, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have elected to exclude the spot-forward difference from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. Amortization of the spot-forward difference is then reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to current period earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our unaudited condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we completed an offering of &#x20ac;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. We dedesignated a portion of the net investment hedge in the second and third quarters of 2020. The notional value of our outstanding net investment hedges was $1.885 billion as of September&#160;30, 2020 and $1.950 billion as of December&#160;31, 2019, which includes our derivative and nonderivative instruments designated as net investment hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In the first nine months of 2019, we settled all outstanding contracts for $294 million, which is presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payments for settlements of hedge contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our unaudited condensed consolidated statements of cash flows. Upon settlement in 2019, we received &#xa3;3.312 billion of cash to fund our acquisition of BTG, which translated into $4.303 billion based on hedged currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized a $207 million loss in the third quarter of 2019 and a $323 million loss in the first nine months of 2019 in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;due to changes in fair value of the contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest Rate Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Management Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Designations and Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as cash flow hedges outstanding as of September&#160;30, 2020 and December&#160;31, 2019. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings at that time. In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was a $30 million loss as of September&#160;30, 2020&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and a $34 million loss as of December&#160;31, 2019. We recognized immaterial gains and losses in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the amortization of our terminated cash flow hedges in the current and prior periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no interest rate derivative instruments designated as fair value hedges outstanding as of September&#160;30, 2020 and December&#160;31, 2019. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; caption in our unaudited condensed consolidated balance sheets into earnings as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which generally offset. The balance of the deferred gains on our terminated fair value hedges within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was immaterial as of September&#160;30, 2020 and December&#160;31, 2019. We recognized immaterial gains in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; relating to the amortization of the terminated fair value hedges in the current and prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The &#x20ac;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in the second and third quarters of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining time to maturity as of September&#160;30, 2020 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next two years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited condensed consolidated statements of operations. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note M &#x2013; Changes in Other Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for the total amounts relating to derivative and nonderivative instruments presented within our unaudited condensed consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Condensed Consolidated Statements of Operations (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Condensed Consolidated Balance Sheets (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,717&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;396&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within our accompanying unaudited condensed consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $1.716 billion invested in money market funds and time deposits as of September&#160;30, 2020 and $50 million as of December&#160;31, 2019, we held $305 million in interest-bearing and non-interest-bearing bank accounts as of September&#160;30, 2020 and $165 million as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our recurring fair value measurements using Level 3 inputs related to our contingent consideration liability. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for a discussion of the changes in the fair value of our contingent consideration liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, principally the contractual right to receive future royalty payments related to Zytiga&#x2122;. This contractual right was acquired with BTG on August 19, 2019. Prior to our acquisition of BTG, BTG agreed to pay 50 percent of the Zytiga&#x2122; royalty stream, net of certain offsets, to the inventors associated with the intellectual property. In the fourth quarter of 2019, we sold the remaining 50 percent we acquired through our acquisition of BTG of the future Zytiga&#x2122; royalty stream for an upfront cash payment of $256 million to the Ontario Municipal Employees Retirement System (OMERS). In accordance with FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we are accounting for the transfer of the royalty stream to OMERS as a secured borrowing, continue to recognize the financial asset and associated liability in our unaudited condensed consolidated balance sheets and do not expect to receive any future cash benefit from Zytiga&#x2122; royalties. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have elected the fair value option to account for our licensing arrangements' financial asset and financial liability in accordance with FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, we have recorded the fair values using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$396 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$413 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of September&#160;30, 2020. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains or losses from the licensing arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;396&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Non-Recurring Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note B &#x2013; Acquisitions and Strategic Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our strategic investments, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note C &#x2013; Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of the fair values of our intangible assets including goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our outstanding debt obligations was $10.901 billion as of September&#160;30, 2020, including $1.050 billion relating to our euro-denominated December 2027 Notes, and $11.020 billion as of December&#160;31, 2019, including $1.004 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a discussion of our debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTg0MDc_219cf02b-70fc-4f85-be36-2ec2c81791ff">Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNDY2OA_212989fc-9536-46b0-b08d-e2b9a637cd1c"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNDY4Ng_90af2a81-8ecb-410e-a471-d71a43bfc787"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNDcyMw_fcca8e31-0a2a-460f-b4b2-027c8ababf14"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <bsx:NotionalValueofOutstandingNetInvestmentHedges
      contextRef="ic2b7c6355f6f4da2bc3951ba8ac457bc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNTA5NA_cd223196-6ac5-4494-aef0-b94730f9b7c6"
      unitRef="usd">1885000000</bsx:NotionalValueofOutstandingNetInvestmentHedges>
    <bsx:NotionalValueofOutstandingNetInvestmentHedges
      contextRef="i88a6cbe1bcc24e6295df27f547e399d3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNTExMA_5364c943-d3a3-4d17-8a7d-412e1acdc701"
      unitRef="usd">1950000000</bsx:NotionalValueofOutstandingNetInvestmentHedges>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="i316fcdf591d645a696cb2f1d899e6570_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0Njg3Nw_1ee7a5ce-b1ba-47ba-bdb6-51427f235ce8"
      unitRef="usd">294000000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i42fb2c3fa32c4bc597cc49dbf63d74ee_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0NzA1Ng_24e86e2c-0a97-412f-ad8d-7208e481ba0a"
      unitRef="gbp">3312000000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:DerivativeCashReceivedOnHedge
      contextRef="i42fb2c3fa32c4bc597cc49dbf63d74ee_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0NzEyMg_0f5901f4-fd46-4ed5-b085-0b45e1d01392"
      unitRef="usd">4303000000</us-gaap:DerivativeCashReceivedOnHedge>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i75faf6b7006a41fa96265cf1f9f67aa0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0ODM5MQ_4d1cdf49-494a-4863-9631-68d1e231554f"
      unitRef="usd">-207000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="if002fd16794247e590bb0cd6fee13f1c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0ODQwMw_d20c5dae-bff9-4df0-b5a5-cc4bfb1b7c63"
      unitRef="usd">-323000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNzQ2NA_b03b7dff-7af9-46c0-a0c2-21d5be15f592"
      unitRef="usd">30000000</us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet>
    <us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet
      contextRef="if782d561570d49c68f1b0b89799129fc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfNzQ4Nw_57fa2ad4-77b4-458f-9a92-e7466c20e6c9"
      unitRef="usd">34000000</us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNTI_2bb4db9d-8eb0-482c-b8c9-ac1ef03dfa67">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the contractual amounts of our hedging instruments outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Notional Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;The &#x20ac;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in the second and third quarters of 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if0eecb377e56463294ebc8b3dffe10dc_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMi00LTEtMS0w_0571bc4a-6f46-415b-a397-d5a2fa44477a"
      unitRef="usd">4118000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5ee44d3c3f9549e991f73b2fecade56b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMi02LTEtMS0w_ea330cc1-af20-4f3f-b6de-da1e2db4e399"
      unitRef="usd">3891000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie7be0d79b1114275af29836966037801_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMy00LTEtMS0w_60388291-21bb-4dbc-a4a8-7a33279193ac"
      unitRef="usd">991000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie83d791495c24438aa2a9934db0f5fbf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfMy02LTEtMS0w_a45f1171-03b5-479c-bede-b744e46c0bca"
      unitRef="usd">953000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4150ff86e91f4b1ea24f3ea91dd6cbfd_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNC00LTEtMS0w_327ce380-32d7-4a74-b80d-6df8285c17dd"
      unitRef="usd">894000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idc9f66aadb7d47b8b2707a870b298e10_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNC02LTEtMS0w_b3dc6fc0-aa37-4d37-8bcf-a7cb25efefa0"
      unitRef="usd">997000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6833b3853ecf440c91b89098a42c9d15_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNS00LTEtMS0w_4ab64d79-e7e2-47d8-b2e4-cbb8003da182"
      unitRef="usd">4283000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6bf0b89b236347bfb2a0960469c3a865_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNS02LTEtMS0w_cbc0b8d2-95e2-484a-b042-126499b940c1"
      unitRef="usd">4377000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNy00LTEtMS0w_51eef812-ef4c-492e-b1f9-044b4f86ad70"
      unitRef="usd">10286000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjEzMzY1ZjkwZTQzNjQ3YjdhNzA0ZWI3YTVkMzg1ODM1L3RhYmxlcmFuZ2U6MTMzNjVmOTBlNDM2NDdiN2E3MDRlYjdhNWQzODU4MzVfNy02LTEtMS0w_2dbe40d1-82fc-43ea-b803-6da8b0cab7d9"
      unitRef="usd">10218000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebt
      contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfODg0Mg_212989fc-9536-46b0-b08d-e2b9a637cd1c"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfODg2MA_90af2a81-8ecb-410e-a471-d71a43bfc787"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <bsx:ForwardCurrencyContractsTimetoMaturity
      contextRef="ieb220488504c46a48fd04031fccd6f33_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfOTE1NA_c9b405b4-bb5a-47ec-b1e7-bd3083e9c098"
      unitRef="units">60</bsx:ForwardCurrencyContractsTimetoMaturity>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNTU_48c92ad0-24a5-4410-862f-a43480826a2c">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect of Hedging Relationships on Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Recognized in OCI on Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Condensed Consolidated Statements of Operations (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amount Reclassified from AOCI into Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax Benefit (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Amount Reclassified and Total Amount of Line Item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pre-Tax (Gain) Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Tax (Benefit) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net investment hedges (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to earnings as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Foreign currency translation adjustment (CTA)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;OCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. No amounts were reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; to current period earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0xLTEtMS0w_61a15670-73e3-4310-87d6-84f9308fba5c"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0yLTEtMS0w_46c302b8-aae3-4cd4-8892-05eff5b20361"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0zLTEtMS0w_9da5b496-326a-4f63-b0fb-9a0204f9f689"
      unitRef="usd">-50000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS02LTEtMS0w_f9174eca-8d08-4d14-8826-c630374aa812"
      unitRef="usd">869000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS04LTEtMS0w_b75dddd8-c322-4d28-9adf-2d880069f2e0"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS05LTEtMS0w_1779c2ef-f097-4421-923b-59394b789e94"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id78fef4f44854c13b3ce34cbe1310073_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNS0xMC0xLTEtMA_94c7d291-45b8-49d9-8398-87ce28c7c473"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0xLTEtMS0w_857161aa-8099-4b95-af82-2f9709b731b4"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0yLTEtMS0w_bdcf1974-eeb6-4196-98fe-b35802305415"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0zLTEtMS0w_bf42c86a-e148-442e-80d1-00902e5feef6"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi02LTEtMS0w_af34f8ad-3765-4365-8a19-484651b3db5c"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi04LTEtMS0w_c883f57f-9d02-45fb-a4f7-282efb9a669c"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi05LTEtMS0w_a16793c6-7e62-4977-9a09-fd380595f5ea"
      unitRef="usd">1000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i4377eeea99a14aa5b92bf1a74c47d15f_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfNi0xMC0xLTEtMA_51d0e93f-fb09-447b-8dab-8ee72614ba31"
      unitRef="usd">-5000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0xLTEtMS0w_21a7e805-42f0-42c9-b89b-f3642380122e"
      unitRef="usd">-46000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0yLTEtMS0w_e4553836-935d-479d-a2c8-871a49f0c2bd"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0zLTEtMS0w_4c2a093f-08f0-442c-a499-0961241e520c"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC02LTEtMS0w_7b32b0a4-19f5-486b-9192-9ce096f8fd1e"
      unitRef="usd">-64000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC04LTEtMS0w_dd6287a4-fa49-4105-95f0-f2688d32f9b3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC05LTEtMS0w_93cceca9-9507-4f3e-b9f4-77d276bdea48"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i8fe0316282a44a288aef134dc528a100_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfOC0xMC0xLTEtMA_1a3446e5-cf28-4bda-8195-5b4f51032760"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i914745bc3935420f887e082516427691_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMS0xLTEtMA_3a390b62-5d9e-4949-b816-fd64aabbd4fc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i914745bc3935420f887e082516427691_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMi0xLTEtMA_42fcc4a0-b0d6-452e-bc8a-142e3a5a0552"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i914745bc3935420f887e082516427691_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMy0xLTEtMA_62099cff-93d9-4f17-a09e-a73585eaf679"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtNi0xLTEtMA_af34f8ad-3765-4365-8a19-484651b3db5c"
      unitRef="usd">86000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i914745bc3935420f887e082516427691_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtOC0xLTEtMA_dc185146-64ac-4e9e-a3cf-b0bf10045fd1"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i914745bc3935420f887e082516427691_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtOS0xLTEtMA_21c10603-1300-4add-8c3d-c7b9a64c1ef3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i914745bc3935420f887e082516427691_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTAtMTAtMS0xLTA_839d00d2-c649-4233-a49f-5883373da2b2"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMS0xLTEtMA_5ce37ef9-2963-4e9c-9c18-f386a6e9ff9f"
      unitRef="usd">101000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMi0xLTEtMA_67d22b76-fc01-47fb-a336-78d859647054"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMy0xLTEtMA_25a8babb-852e-4323-a993-1d0eadfd9182"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtNi0xLTEtMA_2b7e2980-d77f-4284-89a8-9248749c03e8"
      unitRef="usd">777000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtOC0xLTEtMA_6ce63063-b47d-40d0-9483-75d2ee7ea2b7"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtOS0xLTEtMA_987386b5-276c-488c-aec6-0b4e2630119e"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6967897db2ca432fa42b803e744defe7_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTMtMTAtMS0xLTA_5e6b3dd4-399d-40d5-8566-cbf8d3a65b7b"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMS0xLTEtMA_b6097fd5-0b5b-453f-8e78-dbc78e9b8bbf"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMi0xLTEtMA_d0260824-1cb8-41e4-bdef-e1464dc0fe5f"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMy0xLTEtMA_d932bc2e-0d87-453b-9324-4abaec74baea"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtNi0xLTEtMA_f311ce7d-c1c7-4f48-b947-98497d1c5093"
      unitRef="usd">95000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtOC0xLTEtMA_205a873d-b3eb-485a-a3fb-0d1ebca81f59"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtOS0xLTEtMA_2ea55e9c-2fcb-48f9-a5ed-8e05e748d9b4"
      unitRef="usd">3000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i940ca87cda69473ca7e26cf5e274767b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTQtMTAtMS0xLTA_b368b2ae-b7f1-406b-a536-205b9c37aa66"
      unitRef="usd">-9000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMS0xLTEtMA_c461f4e8-6486-46c6-8b1a-f01a347bea9b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMi0xLTEtMA_0fab17ad-74bf-42e5-8462-4016268384bd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMy0xLTEtMA_e651d270-9e81-4ec8-89f5-40cf78cc0c85"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtNi0xLTEtMA_f311ce7d-c1c7-4f48-b947-98497d1c5093"
      unitRef="usd">95000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtOC0xLTEtMA_908cd261-6fd0-4dae-8ed5-fef23fed0993"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtOS0xLTEtMA_eed0646f-4039-4c59-ac40-9bd5412f2f11"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i448bae89108a4c86a0f8e654a74073ac_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTYtMTAtMS0xLTA_7727b6a1-4d6b-4c38-9ec6-0e7772c3831f"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMS0xLTEtMA_631ab5e3-901a-438c-a0a3-85c432a21e5c"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMi0xLTEtMA_21f2f229-5c61-4569-87e1-2d74c62d5745"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMy0xLTEtMA_45bd44dd-b72d-400f-abb3-a9b8b56e6dc9"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktNi0xLTEtMA_848f402a-d704-4789-9f3b-f80a02106480"
      unitRef="usd">2465000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktOC0xLTEtMA_d965c63c-a67a-41ed-91cb-b7254e32e166"
      unitRef="usd">-70000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktOS0xLTEtMA_d3892c7d-0995-4c73-9fcd-a09de39fa78e"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic015da7b060944ef821764347c50c2bb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMTktMTAtMS0xLTA_13eee7bc-c86d-4c5a-96fd-de4ead9cb442"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMS0xLTEtMA_bf3d3628-cafb-4101-ab1f-4aa976d65673"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMi0xLTEtMA_9f0a7642-1a57-4b28-b5f6-6d1d2da4194e"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMy0xLTEtMA_42449bd3-0d50-4190-a1f5-707545f1b8e0"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtNi0xLTEtMA_28340566-52c5-44ff-9e8e-3756bcdbfe1c"
      unitRef="usd">265000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtOC0xLTEtMA_3156e3ab-91a0-4ce9-bee1-808958b4081a"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtOS0xLTEtMA_ef0814ea-4f29-446d-ad0e-e3251bad3843"
      unitRef="usd">4000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i8b16a6b62ead4826940782c007cd956c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjAtMTAtMS0xLTA_4364312c-a794-417a-a103-849b47701506"
      unitRef="usd">-14000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMS0xLTEtMA_544a45ee-6812-42f6-82c6-3f9fccfe5f05"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMi0xLTEtMA_2c09f75e-9174-47ed-9bc1-4b15c48aa9d0"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMy0xLTEtMA_2f6f5be6-93db-4390-b1e4-732c028924ef"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItNi0xLTEtMA_f9a50388-e3d8-48b7-8acc-e2735c5b6249"
      unitRef="usd">-9000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItOC0xLTEtMA_d01f9428-9629-4c9d-8878-5829f9a2f018"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItOS0xLTEtMA_36f9627c-ff79-452d-bd17-89530a4533fc"
      unitRef="usd">0</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i093f1cd62bcd42f4a8a1bd4c4db3d6cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjItMTAtMS0xLTA_010d51a4-3fc3-44e8-a10e-d44ac999d23c"
      unitRef="usd">0</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMS0xLTEtMA_4bbf6463-1c6c-40c5-baa2-5055ff233302"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMi0xLTEtMA_f53e2438-d890-42b3-8960-e7d021b20a2c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMy0xLTEtMA_65709914-6af5-4677-8051-e0a118d1c005"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtNi0xLTEtMA_28340566-52c5-44ff-9e8e-3756bcdbfe1c"
      unitRef="usd">265000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtOC0xLTEtMA_b62447c9-99bc-4f77-ab50-44833ed40e1e"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtOS0xLTEtMA_aa5e948f-3c68-4c20-a5a5-06f1052c78ef"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1bb77705e8b341ae856ecf10c645f7d0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjQtMTAtMS0xLTA_544c13bd-8c33-4020-8cb2-016b58bffd1f"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMS0xLTEtMA_a92a3ed8-c433-446e-bf9b-6a91f63bce98"
      unitRef="usd">176000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMi0xLTEtMA_ce9651f7-b266-4024-82d1-cfc7c26a0d05"
      unitRef="usd">-40000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMy0xLTEtMA_6dfd37e4-42f1-4656-acf3-21de96754381"
      unitRef="usd">136000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctNi0xLTEtMA_959cb4d8-0e1c-4cec-ab1b-a8ae8a9b4227"
      unitRef="usd">2265000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctOC0xLTEtMA_92f4b6ee-a072-4f91-a0d5-bce3754fd2ef"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctOS0xLTEtMA_805692dc-1421-4eca-8125-c2bb249a4395"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3893d347b5444056807f279202372d78_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjctMTAtMS0xLTA_898536ea-5338-4b6b-9488-e1a99fe02958"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMS0xLTEtMA_d1fbc86d-c100-450d-8f86-33e4caf2b71b"
      unitRef="usd">92000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax
      contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMi0xLTEtMA_96a49fee-7fee-41bd-9937-e2b61077c5b2"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMy0xLTEtMA_ad17444c-86b8-4d7c-9f70-960e73492caf"
      unitRef="usd">71000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:InterestExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtNi0xLTEtMA_710527c0-1f16-4971-af1e-f39d09b685bb"
      unitRef="usd">294000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtOC0xLTEtMA_fd337545-674a-4ab8-8ac4-be2b9fa23dec"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax
      contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtOS0xLTEtMA_6452223c-fe1a-4bb8-bc6a-3d6842414174"
      unitRef="usd">7000000</bsx:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i50f7e4959cc249ba95a88ab1d730b268_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMjgtMTAtMS0xLTA_d0adf6b7-f099-4979-89bb-08e87ca854d1"
      unitRef="usd">-25000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMS0xLTEtMA_bb1699e5-c5b2-47f8-8d1f-a97d000f4cb2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMi0xLTEtMA_b7613848-b313-4697-a850-a673a6258116"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMy0xLTEtMA_95cb99d8-b96b-4c73-b494-fa2288834db0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:InterestExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtNi0xLTEtMA_710527c0-1f16-4971-af1e-f39d09b685bb"
      unitRef="usd">294000000</us-gaap:InterestExpense>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtOC0xLTEtMA_920c02d3-ab4b-4782-a8ba-635cd40adb57"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtOS0xLTEtMA_fc2bcda0-b927-4b52-b9ca-33deb27b8d02"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i82f1f31e17de4a5fa0053180fbdbc86d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmRiZWJjYTllMGRhZTQ5MGU5ZDVmNTkwZDcxNWQ4YTA3L3RhYmxlcmFuZ2U6ZGJlYmNhOWUwZGFlNDkwZTlkNWY1OTBkNzE1ZDhhMDdfMzAtMTAtMS0xLTA_4a344d88-ff06-407e-9003-9b6424c52a5d"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzOTk_4da879f9-96df-4c06-a49a-2b0e219f4c50">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AOCI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to earnings within the next twelve months are presented below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Designated Hedging Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;FASB ASC Topic 815 Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate derivative contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bsx:DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i55b6e4b111f24b6c8656058dcbe12e0b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmEwZmIxMGNkYWFhYzQ4MWM4NjAzNWYxMmNhYWFlNDQwL3RhYmxlcmFuZ2U6YTBmYjEwY2RhYWFjNDgxYzg2MDM1ZjEyY2FhYWU0NDBfMS02LTEtMS0w_f60c40e4-e99f-47db-a3cb-cf6e96846287"
      unitRef="usd">79000000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet
      contextRef="i5d1ea23e5779431d819df7f113a920f6_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmEwZmIxMGNkYWFhYzQ4MWM4NjAzNWYxMmNhYWFlNDQwL3RhYmxlcmFuZ2U6YTBmYjEwY2RhYWFjNDgxYzg2MDM1ZjEyY2FhYWU0NDBfMi02LTEtMS0w_5d78479c-b2e6-46b6-b24b-1102f710ccde"
      unitRef="usd">17000000</bsx:DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i3d13e7a6daeb4e828855c9b09932fb0b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmEwZmIxMGNkYWFhYzQ4MWM4NjAzNWYxMmNhYWFlNDQwL3RhYmxlcmFuZ2U6YTBmYjEwY2RhYWFjNDgxYzg2MDM1ZjEyY2FhYWU0NDBfMy02LTEtMS0w_26d17cfd-eaf1-4f48-9a12-e5f46d2c0266"
      unitRef="usd">-5000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNjE_9835fe32-5ff2-4ed8-9cae-9f87f9ee3add">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Condensed Consolidated Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain (loss) on currency transaction exposures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net currency exchange gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi00LTEtMS0w_f822a9c0-7715-43ed-8199-5428842f56a0"
      unitRef="usd">29000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi02LTEtMS0w_c54003a5-8921-4b06-af22-74a841da1e33"
      unitRef="usd">-202000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi04LTEtMS0w_22bd245c-1001-463d-bcda-84e578d1da52"
      unitRef="usd">20000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
      contextRef="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMi0xMC0xLTEtMA_88e5458a-66e2-43ed-bc97-9df297ba2401"
      unitRef="usd">-334000000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy00LTEtMS0w_30ad15c2-5eae-4d66-99bc-40429067ac60"
      unitRef="usd">-30000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy02LTEtMS0w_0fcff472-955d-4a54-aaf1-91e8f229474a"
      unitRef="usd">-4000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy04LTEtMS0w_bb5530ac-a13b-4661-8b5c-8c6081f3fe46"
      unitRef="usd">-33000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfMy0xMC0xLTEtMA_771ea0fd-41d7-4547-b1fc-f40a1e742c9f"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <bsx:Netcurrencyexchangegainloss
      contextRef="ia00eae580c594ae5a543e0006bd42092_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC00LTEtMS0w_f5565d74-2012-47be-918f-0d2c84308c35"
      unitRef="usd">-1000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i046b4336f1e244c28f2eb9b9e38aa67a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC02LTEtMS0w_5d7b3ac2-dd54-498a-b95d-8dd9a85d7eaa"
      unitRef="usd">-207000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i84f1cb69d72f4a068050aff28c863fd9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC04LTEtMS0w_fb3854fe-8bfd-483f-b09e-66516a12d5ee"
      unitRef="usd">-13000000</bsx:Netcurrencyexchangegainloss>
    <bsx:Netcurrencyexchangegainloss
      contextRef="i93abfd5da7c04e13bbc43e962ee23d7e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmQ5YzA4YTBjOWYxYTRjNTdiOTgwZDA2NTA3ZjVjYzUxL3RhYmxlcmFuZ2U6ZDljMDhhMGM5ZjFhNGM1N2I5ODBkMDY1MDdmNWNjNTFfNC0xMC0xLTEtMA_7eaa5972-9698-4e38-9feb-e7dcfa625a25"
      unitRef="usd">-334000000</bsx:Netcurrencyexchangegainloss>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzODY_1f9fa5c9-0a88-4a19-ad68-12e1d4516588">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzNjk_9a902d30-f320-4a5e-b5c9-8c387d9a37ec">The following are the balances of our derivative and nonderivative assets and liabilities:&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location on Unaudited Condensed Consolidated Balance Sheets (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative and Nonderivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency-denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Non-Designated Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Derivative and Nonderivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i1c5fdc3e0c2841679fe97d318ea58261_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNC00LTEtMS0w_44dd3fbd-118e-4231-8474-5c81df7c83c9"
      unitRef="usd">90000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="iee25b48d00f74853992602eb2c53b356_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNC02LTEtMS0w_85d7aa31-24f7-46d0-b97c-21323b57f80e"
      unitRef="usd">72000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i7e066a79d8694e84bb7d59645a985325_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNS00LTEtMS0w_cf22c564-6b10-4634-8fd2-0b165183f10e"
      unitRef="usd">179000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ibda5c2730294403096ebcb12e679b68b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNS02LTEtMS0w_66d90f08-7aee-4f43-b74e-b39468d9abf3"
      unitRef="usd">216000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="id8dbcfebbf2c45859609734198a2ae94_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNi00LTEtMS0w_b27376f7-dcea-4995-889c-78549f8e5e3c"
      unitRef="usd">270000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="idd9c57ccd0e14aa19b6048d2641cfed5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfNi02LTEtMS0w_119805cd-15cb-404b-98fe-12dda4580bd2"
      unitRef="usd">288000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ie07d66f08df541e5a6bd2738ae221eea_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfOC00LTEtMS0w_1ec1d1dc-710d-4428-ae16-f05f7d1e0c43"
      unitRef="usd">56000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i550b85029b34440588a334f525c0ca30_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfOC02LTEtMS0w_3623cad8-9f98-457c-aefb-8370b340e5cb"
      unitRef="usd">33000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTAtNC0xLTEtMA_f71f503f-1482-4be5-862d-31f255dd1ee7"
      unitRef="usd">325000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTAtNi0xLTEtMA_74488ef0-73dc-408a-aad9-e4215c0582af"
      unitRef="usd">321000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i92fac259a6324f2aa04bf3e997577a63_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTQtNC0xLTEtMA_e37d48af-2d88-407e-9a91-4c41d80b2ce2"
      unitRef="usd">6000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i826a2b71a6644d9dbe9440eb86ce853d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTQtNi0xLTEtMA_0e67ab5d-41ef-494f-b978-9b81b154410d"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="if45df496952543af8b99e6950f252bfa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTUtNC0xLTEtMA_656ed0b7-813d-401f-8ecb-6e0f5d63687e"
      unitRef="usd">9000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ie9e0da1bd6e74a93b4391d856c9315ce_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTUtNi0xLTEtMA_8855356a-898d-45a6-aa7d-73d5196978be"
      unitRef="usd">8000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ic8125d7008104ae1b687a8452733fc60_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTYtNC0xLTEtMA_b3547faf-a689-4a98-abeb-c5e6080fd0b1"
      unitRef="usd">1042000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i908b44cb3649452a9d48f0aeb4a0b87f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTYtNi0xLTEtMA_0ea03d0e-ed86-4a0d-b414-d03f84ed201e"
      unitRef="usd">998000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="id8dbcfebbf2c45859609734198a2ae94_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTgtNC0xLTEtMA_5a82d155-fe84-42db-b15e-32e90658a6d5"
      unitRef="usd">1058000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="idd9c57ccd0e14aa19b6048d2641cfed5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMTgtNi0xLTEtMA_469c0219-d196-438a-a464-eec71c4d47d9"
      unitRef="usd">1009000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i2461e9e08ed24f98af87739812b9cab7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjAtNC0xLTEtMA_064e9dd4-0352-448a-90f0-d39b3b8c54d4"
      unitRef="usd">58000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i6077953b0caa497d9b5dd8eba2746b7c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjAtNi0xLTEtMA_ada9a20e-9b4a-4ffa-b4d6-20e446010c19"
      unitRef="usd">29000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjEtNC0xLTEtMA_19748004-b08d-402d-a433-fbd2a835e475"
      unitRef="usd">1116000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjdiN2VjZDA2YzkxYzQ3NjlhOGE4ODM3ZWE3MmQxZDFjL3RhYmxlcmFuZ2U6N2I3ZWNkMDZjOTFjNDc2OWE4YTg4MzdlYTcyZDFkMWNfMjEtNi0xLTEtMA_560a4636-9a06-4eee-bbed-8695b97f7b1e"
      unitRef="usd">1037000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgzODk_20243e74-c174-485a-bf7e-3784bd1f2ace">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value on a recurring basis consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds and time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Publicly-held securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,717&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;396&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,116&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of our licensing arrangements recognized in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.032%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.064%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Licensing Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$396 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$413 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Year of Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial asset were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;396&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of our licensing arrangements' financial liability were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for royalty rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustment expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xLTEtMS0w_878f4755-3bb5-4e19-8720-d8c437c7a4eb"
      unitRef="usd">1716000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0zLTEtMS0w_71d5830b-cc10-4221-b0aa-1e9576fa54b6"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC01LTEtMS0w_aaadbe1f-a963-4896-906b-55690f322be4"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC03LTEtMS0w_8c4c39b3-525a-424f-9a27-6f6f73575869"
      unitRef="usd">1716000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC05LTEtMS0w_2742ece2-d899-4446-bf61-73a96be7754e"
      unitRef="usd">50000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xMS0xLTEtMA_1f9a3739-70db-4157-b119-91226e3b6f05"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xMy0xLTEtMA_d167550d-09e0-4607-9b98-68e848983852"
      unitRef="usd">0</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNC0xNS0xLTEtMA_f6eee9a1-01c9-47a8-8ad3-10e668f29573"
      unitRef="usd">50000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xLTEtMS0w_840f0e25-f6ba-4751-a22e-2773300b56da"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0zLTEtMS0w_3cc7af15-660a-4867-99b2-87e2f408bf0c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS01LTEtMS0w_69a39677-f386-4852-a9d6-8e4a1cdfcae0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS03LTEtMS0w_22f9060d-0450-420d-b783-173d6ddcf1c9"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS05LTEtMS0w_23d93390-26ab-4f53-b4e7-4f38abed929a"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xMS0xLTEtMA_51e013fb-8407-4be5-ac3c-af95baa5401c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xMy0xLTEtMA_206f74a6-2ac5-454e-92ab-f1cc6ac0e54e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNS0xNS0xLTEtMA_a15c3d7f-f37c-4c39-a6c5-4e0a0f45954c"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xLTEtMS0w_728a2640-4ef9-4741-804b-7ac259bb9a5d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0zLTEtMS0w_2a95ff74-91c7-414a-87bc-10c4b4f50e61"
      unitRef="usd">325000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi01LTEtMS0w_d118b38d-3d32-430f-9842-7235b8a7c451"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi03LTEtMS0w_85e282b9-22f4-4f42-b49f-b0ac610e8b70"
      unitRef="usd">325000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi05LTEtMS0w_39c169e8-d1e0-4e73-bb84-6f9050b9dada"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xMS0xLTEtMA_69c86634-4c1c-4e14-9941-e6c044765651"
      unitRef="usd">321000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xMy0xLTEtMA_ab1a28f6-b362-4832-9744-5f95f607118d"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNi0xNS0xLTEtMA_e21df99f-ce47-4716-a353-89184d3ac1aa"
      unitRef="usd">321000000</us-gaap:DerivativeAssets>
    <bsx:Licensingarrangementsasset
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xLTEtMS0w_0609f0a3-222c-4df3-890d-2611726e5a05"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0zLTEtMS0w_7478bbee-3d85-4b16-aa15-788aa517d4a2"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy01LTEtMS0w_f8052d3b-148f-4ab7-b7b6-fc193410e259"
      unitRef="usd">396000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy03LTEtMS0w_707fc223-9f9d-45cb-803d-e5ac6b01d0c2"
      unitRef="usd">396000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy05LTEtMS0w_be161798-28c5-49a6-a889-7cbbe7b4e66a"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xMS0xLTEtMA_758e8adc-8a11-4d6e-b6ca-3196fc7671b0"
      unitRef="usd">0</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xMy0xLTEtMA_71699d3f-382a-4469-b8dc-d1b5cab10e94"
      unitRef="usd">518000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfNy0xNS0xLTEtMA_18f90606-d989-4e77-a5af-5ef17b500288"
      unitRef="usd">518000000</bsx:Licensingarrangementsasset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xLTEtMS0w_a32988a4-e5ac-42af-82b2-22da492f4a01"
      unitRef="usd">1717000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0zLTEtMS0w_78882052-72d5-4e28-9922-0df0e111c64b"
      unitRef="usd">325000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC01LTEtMS0w_f2dfc249-5b58-4f33-8d92-cbfa5a86844f"
      unitRef="usd">396000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC03LTEtMS0w_eabd199c-042b-46e3-ae8f-8eaa2912c52f"
      unitRef="usd">2438000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC05LTEtMS0w_3eb0b106-2598-418a-8942-a9c949851992"
      unitRef="usd">51000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xMS0xLTEtMA_64014363-0b0e-4285-bfa0-394d5b70c777"
      unitRef="usd">321000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xMy0xLTEtMA_45b0647c-f313-4f8c-b908-eaa430f50561"
      unitRef="usd">518000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfOC0xNS0xLTEtMA_1434ce28-8ef7-4b77-a395-1292e3a1fdc4"
      unitRef="usd">890000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMS0xLTEtMA_aee552f7-05af-438d-9ee6-17c0ef69700a"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMy0xLTEtMA_4726c3b0-e590-417a-986a-5c29c73b98ac"
      unitRef="usd">1116000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtNS0xLTEtMA_4408aacc-a1fa-4159-95c1-5246734c062f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtNy0xLTEtMA_3d207e74-5463-458e-90ed-a5ef1aa667fc"
      unitRef="usd">1116000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtOS0xLTEtMA_fcb3c032-8b22-497a-96d8-0a0d714ee330"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMTEtMS0xLTA_afa65012-fe9e-44ed-bdde-9ecc1ee4ec83"
      unitRef="usd">1037000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMTMtMS0xLTA_de9700ec-7e3b-4a6f-bcb2-1a389567cf06"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTAtMTUtMS0xLTA_546c203a-12b7-4181-bffd-7fd1049bb109"
      unitRef="usd">1037000000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMS0xLTEtMA_3918732a-3df0-4943-a0ac-6e695ac1c1e9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMy0xLTEtMA_f263f1d3-64cb-41a1-8291-e35ec58dee49"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtNS0xLTEtMA_03fc20fe-7804-4083-88a6-5a389ed5e88f"
      unitRef="usd">214000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtNy0xLTEtMA_2dbb13db-b70d-4db5-a2bc-51e382fce2f5"
      unitRef="usd">214000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtOS0xLTEtMA_2365d0fc-333d-4e05-980e-e293e49c7503"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMTEtMS0xLTA_0b9f8179-23ce-4ebf-92bd-a823f270cff1"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMTMtMS0xLTA_3b73d857-c444-4605-99aa-20fd97f80b63"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTEtMTUtMS0xLTA_4567c6be-9c1e-41cb-a3a6-03b107224739"
      unitRef="usd">354000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <bsx:Licensingarrangementsliability
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMS0xLTEtMA_8d008ac0-9442-4929-8fd0-4af291ae1280"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMy0xLTEtMA_0ecd9601-e81f-4c56-a349-fcb7c3603f13"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItNS0xLTEtMA_7afb2f80-26a3-4329-888c-0fbc9504428b"
      unitRef="usd">413000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItNy0xLTEtMA_a3a3acdb-4977-44c9-924a-2f1b975a4c24"
      unitRef="usd">413000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItOS0xLTEtMA_2c99808f-bc52-4188-b6f5-5474eee82620"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMTEtMS0xLTA_a4bb58f6-1161-4729-b3ad-ee4b3675684c"
      unitRef="usd">0</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMTMtMS0xLTA_59f17fb6-f3c2-40d0-9edd-3cc1b7b2f010"
      unitRef="usd">571000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTItMTUtMS0xLTA_44444685-beb0-4924-adbc-cf27c3235a78"
      unitRef="usd">571000000</bsx:Licensingarrangementsliability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMS0xLTEtMA_1e2053e2-cf59-4f22-80aa-06cb7eb689a4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7bdb8ff772f649cd8bf96ccee2b758f2_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMy0xLTEtMA_c97205a1-a905-4056-8b93-1959261eee43"
      unitRef="usd">1116000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtNS0xLTEtMA_a040ab17-e0a7-49c7-8cb8-c6921878c5fa"
      unitRef="usd">627000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1c292c22eea34b9f93886b4e780ea698_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtNy0xLTEtMA_cefbb472-05c9-4f32-b796-e96af1188f82"
      unitRef="usd">1743000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtOS0xLTEtMA_10ac554f-8921-49f2-abbf-a2f864786e37"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i99f579ea32bf43ada53b8f38d7eb0ab2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMTEtMS0xLTA_fd18c25b-5d26-496e-9893-dc8e791f411d"
      unitRef="usd">1037000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMTMtMS0xLTA_4636a9ed-4c52-4d55-bbf1-2ed6968e6519"
      unitRef="usd">925000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i886fe6c8da054a8d8158ea2d5e01cf9d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjE5MTAwMTJiOWY3YTRjMjM4ODExY2VlNmQ0YWIwMDIzL3RhYmxlcmFuZ2U6MTkxMDAxMmI5ZjdhNGMyMzg4MTFjZWU2ZDRhYjAwMjNfMTMtMTUtMS0xLTA_d8ab62ab-5130-4f1b-8746-fcc776da3936"
      unitRef="usd">1963000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i9bccb6fb90ef4519a7fb4bf6941d6ec7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTQxOTc_878f4755-3bb5-4e19-8720-d8c437c7a4eb"
      unitRef="usd">1716000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i10d9296653634d229d1784d4e2a5260b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTA5OTUxMTY0OTQ4OQ_2742ece2-d899-4446-bf61-73a96be7754e"
      unitRef="usd">50000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:Cash
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTQyNjM_0b5edf48-e4ee-4913-92e5-d1a818053111"
      unitRef="usd">305000000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTQ0MjA_c6c42b6c-0fd6-4027-8652-d86b121009bd"
      unitRef="usd">165000000</us-gaap:Cash>
    <bsx:Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTUyODM_b19461b3-0c1e-4762-bcda-3014a6759671"
      unitRef="usd">256000000</bsx:Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements>
    <bsx:Licensingarrangementsasset
      contextRef="i64b1627c34744a79852c22f89f4e2bd9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS0xLTEtMS0w_af2fec58-df3c-4c51-ab3b-c3c997beff8c"
      unitRef="usd">396000000</bsx:Licensingarrangementsasset>
    <bsx:DiscountRateFairValueInput
      contextRef="i0486c1f5a3dc44bbad592c4face792ce_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS00LTEtMS0w_b395e431-06f3-4f8d-b2f3-8553499f5719"
      unitRef="number">0.11</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i401066db3ff649128198d977bf21c7d9_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS02LTEtMS0w_7f88b906-dc0c-490f-9251-8a7bfd678b40"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i2d8e764d9f154c0ba1fde2f3c18ba6f4_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfMS03LTEtMS0w_141048a3-44cf-4c00-964b-168158f18d90"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsliability
      contextRef="i64b1627c34744a79852c22f89f4e2bd9_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC0xLTEtMS0w_9d1f1c01-cd7f-400a-b241-4f693a3499d6"
      unitRef="usd">413000000</bsx:Licensingarrangementsliability>
    <bsx:DiscountRateFairValueInput
      contextRef="ide565556a33042009f2db6eb39c31318_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC00LTEtMS0w_18345b37-86ed-4c54-a0b5-3aa97ebc63e8"
      unitRef="number">0.12</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="i5585c06b1a414f278e4e8698e3e9ade6_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC02LTEtMS0w_8daaead9-84bb-4c4f-8297-4d9e54195179"
      unitRef="number">0.15</bsx:DiscountRateFairValueInput>
    <bsx:DiscountRateFairValueInput
      contextRef="ie650a8a143a34390997d58eb8375e627_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOmYyZjAzMGVlNGQxODQxODg5ODMxYjg0NzkxZjM2OGQxL3RhYmxlcmFuZ2U6ZjJmMDMwZWU0ZDE4NDE4ODk4MzFiODQ3OTFmMzY4ZDFfNC03LTEtMS0w_37280b30-3771-44ec-9cba-3bad73252bbe"
      unitRef="number">0.13</bsx:DiscountRateFairValueInput>
    <bsx:Licensingarrangementsasset
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfMS0xLTEtMS0w_51dc09d6-6e2e-4d78-8bf2-986077469c80"
      unitRef="usd">518000000</bsx:Licensingarrangementsasset>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i2b1fc603c49e4452b1fe2055d66a5728_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfMy0xLTEtMS0w_3185e85f-61b6-42e5-8ce4-1b5088276a96"
      unitRef="usd">132000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i2b1fc603c49e4452b1fe2055d66a5728_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfNS0xLTEtMS0w_5a4b1809-6dca-4d83-a2a7-15ff3b4f402a"
      unitRef="usd">9000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsasset
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjc5MmU0NmVhYmFmNjQ2YTU4OTk5ZGZlOTVlZGE4YjM2L3RhYmxlcmFuZ2U6NzkyZTQ2ZWFiYWY2NDZhNTg5OTlkZmU5NWVkYThiMzZfNi0xLTEtMS0w_1cd0b171-a0c8-48e1-a3bc-1ce668db6209"
      unitRef="usd">396000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsliability
      contextRef="i1ecd3415137b492d9047dd0721eee7cd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfMS0xLTEtMS0w_811d3d70-91ec-4f7b-8dc6-2314f2999b70"
      unitRef="usd">571000000</bsx:Licensingarrangementsliability>
    <us-gaap:PaymentsForRoyalties
      contextRef="i05d67b0c2c82420f89ded5c32461a093_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfMy0xLTEtMS0w_c47b3d97-0e71-4106-9aa0-c8c5aef15315"
      unitRef="usd">165000000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption
      contextRef="i05d67b0c2c82420f89ded5c32461a093_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfNi0xLTEtMS0w_9e2e45cf-ee9b-462d-81d0-5af5e8638d6f"
      unitRef="usd">7000000</us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption>
    <bsx:Licensingarrangementsliability
      contextRef="i9b97382cd60e443c9a4d6aa4fbfc6a37_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RhYmxlOjllYjE2YzcwYzE2MjRhMDhiZDFiMzc0YmJlMGFhNjY0L3RhYmxlcmFuZ2U6OWViMTZjNzBjMTYyNGEwOGJkMWIzNzRiYmUwYWE2NjRfNy0xLTEtMS0w_0217d1a5-e992-4ad2-a57c-a0faee9f7d8a"
      unitRef="usd">413000000</bsx:Licensingarrangementsliability>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTc5MjM_37ffb8a6-b0e4-4ba9-9290-566d6bf92d0a"
      unitRef="usd">10901000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if96fb4dab0df493cb56977ec02e792ab_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTc5NDY_3e39ca0d-667e-4ae4-8b16-9a5ff93cf9a5"
      unitRef="usd">1050000000.000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTc5OTA_36bf01f7-6bea-4ace-b023-fc3f09e8161d"
      unitRef="usd">11020000000.000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i40844fee5f8f45e0b76f79276d662d4a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml82MS9mcmFnOjhkYTRkYjRiMDBkNzQzZjg5OWZmYzJlMjkwMjRmZDcxL3RleHRyZWdpb246OGRhNGRiNGIwMGQ3NDNmODk5ZmZjMmUyOTAyNGZkNzFfMTgwMTM_8affe63e-b904-4481-87ff-0f5d6bc61a08"
      unitRef="usd">1004000000.000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI2Nzc_1e110b98-3f8a-41e2-a913-cb78386372e6">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE E &#x2013; CONTRACTUAL OBLIGATIONS AND COMMITMENTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Borrowings and Credit Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had total debt outstanding of $9.336 billion as of September&#160;30, 2020 and $10.008 billion as of December&#160;31, 2019, presented net of unamortized debt issuance discounts and deferred financing costs. The debt maturity schedule for our long-term debt obligations is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, &lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;and Deferred Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 - 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which is a variable-rate instrument based on LIBOR.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain a $2.750 billion revolving credit facility (Revolving Credit Facility) with a global syndicate of commercial banks that matures on December 19, 2023 with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. The credit agreement requires that we comply with certain covenants, including a financial covenant described within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility. In April 2020, we entered into the April 2021 Term Loan, described below, and used the proceeds to repay a portion of the amounts outstanding under the Revolving Credit Facility. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. In May 2020, we completed our senior notes offering described below and used a portion of the proceeds to repay $450 million outstanding under the Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of September&#160;30, 2020 or December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Term Loans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $1.250 billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $500 million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our MCPS and common stock offerings to repay in full the remaining $750 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2020, we entered into a $1.000 billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding of the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of 0.85%. The credit agreement is subject to a financial covenant described below under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $750 million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $250 million and terminated the February 2021 Term Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2019, we entered into a $700 million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December&#160;31, 2019, we had $700 million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $300 million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2018, we entered into a $2.000 billion senior unsecured delayed-draw term loan facility consisting of a $1.000 billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $1.000 billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August&#160;19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $1.000 billion under the Two-Year Delayed Draw Term Loan and $1.000 billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $1.000 billion outstanding under the Three-Year Delayed Draw Term Loan (also referred to as the "August 2022 Term Loan" in the debt maturity schedule above). In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of September&#160;30, 2020, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Covenant&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of and through September&#160;30, 2020, we were in compliance with the financial covenant required by all existing credit facilities described above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.40 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) establish a deemed Consolidated EBITDA of $671 million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of 4.75 times through the remainder of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2020, with a step-down for each succeeding fiscal quarter end to 4.50 times, 4.25 times, 4.00 times and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 Revolving Credit Facility and February 2021 Term Loan amendments, the definition of &#x201c;Material Adverse Effect&#x201d; has been amended to remove the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of September&#160;30, 2020, we had $194 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $2.624 billion in the aggregate. As of September&#160;30, 2020, we had $946 million of the litigation exclusion remaining.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any inability to maintain compliance with this amended covenant could require us to seek to further renegotiate the terms of our Revolving Credit Facility or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable&lt;/span&gt;&lt;span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except maturity and yield)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper outstanding (at par)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum borrowing capacity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing capacity available &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0 days&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55 days&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had senior notes outstanding of $9.404 billion as of September&#160;30, 2020 and $7.661 billion as of December&#160;31, 2019. In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes comprised of $500 million of 1.900% senior notes due June 2025 and $1.200 billion of 2.650% senior notes due June 2030. We used the net proceeds from the offering to refinance $450 million of amounts outstanding under the Revolving Credit Facility, prepay $750 million of amounts outstanding under the $1.000 billion February 2021 Term Loan, prepay $500 million of amounts outstanding under the $1.250 billion April 2021 Term Loan and pay related fees, expenses and premiums.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we completed an offering of &#x20ac;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $206 million of our $450 million 4.125% senior notes due 2023, $566 million of our $1.000 billion 4.000% senior notes due 2028 and $227 million of our $750 million 3.850% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in connection with the transaction. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, we completed an offering of&#160;$4.300 billion in&#160;aggregate principal amount of senior notes comprised of $850 million of 3.450% senior notes due&#160;March 2024, $850 million of 3.750% senior notes due&#160;March 2026, $850 million of 4.000% senior notes due&#160;March 2029, $750 million of 4.550% senior notes due&#160;March 2039 and $1.000 billion of 4.700% senior notes due&#160;March 2049. We used a portion of the net proceeds from the offering to repay the $850 million plus accrued interest and premium of our 6.000% senior notes due&#160;in January 2020, the $600 million plus accrued interest and premium of our 2.850% senior notes due&#160;in May 2020 and the $1.000 billion plus accrued interest of our August 2019 Term Loan. In the third quarter of 2019, the remaining proceeds were used to finance a portion of the acquisition of BTG.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Arrangements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in our accompanying unaudited condensed consolidated balance sheets, are aggregated by contract denominated currency below (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Obligations and Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had outstanding letters of credit of $125 million as of September&#160;30, 2020 and $105 million as of December&#160;31, 2019, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of September&#160;30, 2020 and December&#160;31, 2019, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjY_a6325e4a-d642-48b0-bcd7-0cfd8835754d"
      unitRef="usd">9336000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfODI_77ab6bcf-81de-4dba-914c-4334e4c86b0d"
      unitRef="usd">10008000000.000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI3MDI_866cc801-a9b8-42a7-9a4f-41453a73c5e3">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except interest rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Coupon Rate (1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, &lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.125%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.450%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.850%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.900%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.750%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.625%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.650%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035 Notes (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.000%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.550%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.375%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.700%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022 Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Debt Issuance Discount&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;and Deferred Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 - 2049&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized Gain on Fair Value Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 - 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Various&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Note:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which is a variable-rate instrument based on LIBOR.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i01fdadf64e0a447b8a6b7edadefcae98_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMy02LTEtMS0w_05b1d198-8f3c-420f-a489-5bc61a64b956"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idf8fad34607d4972966fe7b09a5d903a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMy04LTEtMS0w_ca0eda24-0116-4b23-9d36-29d5a345c7a2"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i01fdadf64e0a447b8a6b7edadefcae98_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMy0xMC0xLTEtMA_8b49d133-ad16-423f-9bd1-7bd21755cca0"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3ce7410ffeb041b585ba5959fc091a98_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNS02LTEtMS0w_c4e5e5c3-4a78-4e66-8d14-d8e05a3b6ab8"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2127f61595964047ad8a3dafad593c19_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNS04LTEtMS0w_871914e0-52a7-4535-a2c1-410a5e7641d6"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ce7410ffeb041b585ba5959fc091a98_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNS0xMC0xLTEtMA_0ed25b91-7e36-432a-ae07-1626cbf5d7c8"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNy02LTEtMS0w_e3204423-92d7-4bc9-9567-2bd79971d956"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iec4c4d99b6f84b108d22a749ed8bcb43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNy04LTEtMS0w_e2be6776-f0ec-4c08-86ff-e3914f7c9d46"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfNy0xMC0xLTEtMA_e648368b-d43c-4427-ae44-c2b7804e7c69"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6a32bba350f7460f802d9e35490647d0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOC02LTEtMS0w_9a8aef5e-c3ca-4d6f-b256-ce8bedc1cdae"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icf53f2e2753142488c3129ebd45bd3f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOC04LTEtMS0w_bb3254d0-5272-48c1-93b6-6d28ba5f198f"
      unitRef="usd">523000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a32bba350f7460f802d9e35490647d0_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOC0xMC0xLTEtMA_eb700419-384f-4f4e-8f4d-9392e0f1504f"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOS02LTEtMS0w_88d6adcc-180f-42f7-80d1-2bf84ae34b0f"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i984aed9feb2742ae9f40f9ab8d399bee_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOS04LTEtMS0w_981d7fea-574a-46f7-b6c8-454662e81ff6"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfOS0xMC0xLTEtMA_fd9fdf50-2eaf-4722-baae-44f09d903116"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTAtNi0xLTEtMA_2297c525-c29e-4bdb-a46e-42f900b58c5f"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i074cdefffbac46a5aa907b64799c5c18_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTAtOC0xLTEtMA_17d7bd70-dc05-4199-ab7a-f36e01d5d45b"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTAtMTAtMS0xLTA_d9e76364-1899-4641-84b1-442d667c7def"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTEtNi0xLTEtMA_f38e1748-6f18-47d6-8592-7866cbd7350a"
      unitRef="usd">1054000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ide3c2b7d701e44a19150fa05ed088e19_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTEtOC0xLTEtMA_a991cee6-393d-4bc5-a442-632d32b51cc2"
      unitRef="usd">1011000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTEtMTAtMS0xLTA_fcca8e31-0a2a-460f-b4b2-027c8ababf14"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icd9e8fd2638a4eb5882534a5a95c4011_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTItNi0xLTEtMA_146fc519-02fd-48d3-8fc7-dd154e7f14ef"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i27a0bb0216b14c8eb6488725ad9369e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTItOC0xLTEtMA_0b56ea67-076a-4da7-a25f-670d4194379a"
      unitRef="usd">434000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd9e8fd2638a4eb5882534a5a95c4011_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTItMTAtMS0xLTA_09c125a4-c77a-4ee6-b1da-6b957850fed5"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i883f72b197734176a05916892d1f98aa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTMtNi0xLTEtMA_44a7f13e-47c3-4aed-a477-143e346f001a"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8dbd5b02a23541cd9066e7e6764eb0be_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTMtOC0xLTEtMA_f5efe434-e892-49a8-aa35-87ce571d417b"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i883f72b197734176a05916892d1f98aa_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTMtMTAtMS0xLTA_58acea21-a639-4374-ba71-9dfb576c7dc5"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTQtNi0xLTEtMA_49908de5-b4a7-4c08-9e1c-8fab6f59d636"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie1c7a363bc2a4be7a656ce96470fc32c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTQtOC0xLTEtMA_316203d1-fd1c-4eb1-94cb-fd4655e2ff65"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTQtMTAtMS0xLTA_1d16cb68-3ac2-4deb-906f-7fec581e6746"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i3147cace57a14c1e88a7023fa0d1a751_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTUtNi0xLTEtMA_4a41c9be-1548-4e5a-887c-ff8fa725f363"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2bcfebb0ff6544389662db268de515a9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTUtOC0xLTEtMA_97cd93fc-bd05-4af2-9c74-c6e4b77212dd"
      unitRef="usd">350000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3147cace57a14c1e88a7023fa0d1a751_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTUtMTAtMS0xLTA_132a3ab5-b645-400c-9ab0-2763a841016f"
      unitRef="number">0.07000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0024f7d8ff964efa837a696943046bff_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTYtNi0xLTEtMA_faf5e979-35e1-4d70-99af-c33772978a21"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i53fefb20cb374b77a6a68660e9ec56df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTYtOC0xLTEtMA_23b5de90-a2bc-4228-bbae-12a4e68a2cdd"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0024f7d8ff964efa837a696943046bff_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTYtMTAtMS0xLTA_7d3f8e72-99fa-4153-b0cf-1e0c7f48770b"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ic6cf239eb4aa40688db906dfe60df801_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTctNi0xLTEtMA_0c60b7e6-432c-4dba-8bd5-db877fb4f7c4"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0f7b010ef6d24932aa67070e591431ad_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTctOC0xLTEtMA_89d0dea1-77cf-48f0-8bd9-b4fa9cf481ff"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic6cf239eb4aa40688db906dfe60df801_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTctMTAtMS0xLTA_c2e9d00c-20cc-4244-9688-4fafc7d662a4"
      unitRef="number">0.07375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTgtNi0xLTEtMA_40a5e124-7930-483e-9834-e1b6c8fa8792"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib3ca8274c7c84451adfe5cc6e39d84f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTgtOC0xLTEtMA_c7423f76-ece5-4882-a486-5eceec9a5a02"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTgtMTAtMS0xLTA_d3864568-6e9c-4b05-aa0e-2c8b6069b91c"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ie14af729841249f68bb249aa9328ed14_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktNi0xLTEtNTc4NQ_0bc7c5aa-aafe-4780-b83e-bd72262c0227"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i471614cc047e493a97bc532efbc84e9e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktOC0xLTEtNTc4NQ_be3964a6-c546-44bd-8b43-1fc96b12dd06"
      unitRef="usd">1000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i97f676404a0d4a368a7a8b76358caf94_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktNi0xLTEtMA_073e7745-ec57-4c9b-8a2a-33aaf2330cee"
      unitRef="usd">-91000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i0055d17e432d43e6a5716e6ef8c734af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMTktOC0xLTEtMA_b456e17d-088a-4d54-bb67-d77ed624e7d3"
      unitRef="usd">-83000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ifef58c4a2ac34d8487fda59f2817e413_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjAtNi0xLTEtMA_ee3e7d43-21b5-4e3e-9057-e6b3f92a3bdc"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idbaf3b08ce1a47f0bab1706eec16f414_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjAtOC0xLTEtMA_517d8106-9cba-4609-8c37-9d12a8bf7032"
      unitRef="usd">7000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8512f90c15ee4bf1a751122703f3e372_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjEtNi0xLTEtMA_c5875bc0-dea7-416b-b335-e9536b441acf"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iec9765c02939444a8b21465369b4d6f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjEtOC0xLTEtMA_c863d964-5cc3-4d63-b8e9-c7ff1c1aa278"
      unitRef="usd">6000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjItNi0xLTEtMA_de20b90b-729f-4902-b638-ebd554bfe47b"
      unitRef="usd">9325000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjRkOTg3MjQyOThkNDRmOWJiNWNjZTQ5Mzk2NWE1ZTFiL3RhYmxlcmFuZ2U6NGQ5ODcyNDI5OGQ0NGY5YmI1Y2NlNDkzOTY1YTVlMWJfMjItOC0xLTEtMA_584a0fcf-30c1-4b8e-a32c-a83b222083ea"
      unitRef="usd">8592000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if4918679d9a1491c920d33be9eafbb1b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfODc5_fbe23fa3-8716-48e5-920c-252f6f4cb248"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i75ab56af73414eec9527c4729f49674b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTc5OQ_2cc871fe-dfb7-4235-a42a-fe1956554aa2"
      unitRef="usd">1360000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTY0OTI2NzQ1NzE0Mg_3d2dd5b3-cb3c-44c1-92fc-f47607c5a3a7"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6048faff94fe4e3f8ff35fae909e93f8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjE0Ng_c59ac40f-7423-42c9-ae1a-09c1a984fc87"
      unitRef="usd">450000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ShortTermBorrowings
      contextRef="i96e3727f0c4047e78994b7e46ebbd066_I20200421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjQ0MQ_b7f9bb7e-9ddc-4939-aa3d-03072ab942d4"
      unitRef="usd">1250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i188f9ed380a4434fad684f6ec8f9957c_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjgzNA_86a16439-f8eb-4f09-94b6-e4bbb13f6162"
      unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0a0778d1a32c42a698d0c0d4391be338_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMjk4Mw_79a105e2-4a07-43f9-b52b-fb9b81fedec3"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i3ac08e9e5ba84c159c3799c380213ac2_I20200227"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMzEzMQ_d9dda36c-acab-42e9-8c8e-1362a01fb419"
      unitRef="usd">1000000000.000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a1cc324ff16414fb873ed25161c08e7_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA5OTUxMTY0NTI5OQ_dbd35350-6d38-4c0b-865c-0f1ab4964e22"
      unitRef="number">0.0085</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i36af306e51d44c42bb19eb47b23ae5b4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDExOA_70e3c66d-96ca-423c-8f79-04cbc467239d"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="id56c2ccee432470da073b69f5e06f077_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDE3NQ_f6aa0c11-067b-45c7-afe5-e6e71b5adbee"
      unitRef="usd">250000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i4cad1325157949eb8729affa69cd1f9c_I20191205"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDMwOA_941c62eb-ce43-49f5-87b2-409031e5dddb"
      unitRef="usd">700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="iea83365e9d284726b2d572cf20af3e78_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDQzMw_53b466e9-40c0-4f84-8902-311bcf4119ba"
      unitRef="usd">700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i3744c29fbf454f11ad39d179e30ed2c8_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDU5MA_b78cc7de-ffc2-47f6-9bf2-780588c48c5b"
      unitRef="usd">300000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LineOfCredit
      contextRef="i6793d82e66694285af4326091ac468be_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDg1NA_9ef40779-c6d5-4687-9642-19f85963f26b"
      unitRef="usd">2000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i356171311f5740fda173fd3ecc70f05a_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNDkyMg_367d2080-d310-4870-a31a-f104ce260ab4"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i2daade2444a049a4b2e1cbdd923ce601_I20181219"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTA3NA_87f33a99-a9a9-468c-afca-2bfa72f6020e"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i83915196e3d34a92a3c8eb05366c1b25_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTI4MQ_0613ee93-cfa8-4e12-9793-58640b9d7dae"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i68796c45e93e415abbc18dda7fc8d1fe_I20190819"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTMzMA_aaa0c251-0967-4f83-841e-e7e3cf8c9709"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i7ad9677f736c4ba4aeef783f34c21d4b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNTU5OQ_487365ce-ca34-4fdf-b547-3b7dfc53154a"
      unitRef="usd">1000000000.000</us-gaap:LineOfCredit>
    <bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI3MTc_1f491378-b5f1-4f80-85ae-43626a5e2761">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Covenant Requirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum permitted leverage ratio (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75 times&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.40 times&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.&lt;/span&gt;&lt;/div&gt;</bsx:SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock>
    <bsx:MaximumLeverageRatio
      contextRef="if55fcf95b4eb4092b6c279ab4b78debc_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOmNhMTJkZmNkOTViODRiY2RhNDkxOTRiY2QzMDYwY2EzL3RhYmxlcmFuZ2U6Y2ExMmRmY2Q5NWI4NGJjZGE0OTE5NGJjZDMwNjBjYTNfMi0yLTEtMS0w_b091b7a5-b35b-47f2-a3fc-0f6924660e0f"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="idec7a450c3d54d0f8b17663bc0bb3763_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOmNhMTJkZmNkOTViODRiY2RhNDkxOTRiY2QzMDYwY2EzL3RhYmxlcmFuZ2U6Y2ExMmRmY2Q5NWI4NGJjZGE0OTE5NGJjZDMwNjBjYTNfMi00LTEtMS0w_b5cedf1a-c082-46aa-8a7d-58e970c75297"
      unitRef="number">3.40</bsx:MaximumLeverageRatio>
    <bsx:DeemedConsolidatedEBITDA
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjUyMQ_8db52f01-9367-4901-84f1-e73e65386eec"
      unitRef="usd">671000000</bsx:DeemedConsolidatedEBITDA>
    <bsx:MaximumLeverageRatio
      contextRef="ie4657030099241c583762bbda7fb257e_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjczOQ_4812f0b5-9d70-4123-9857-b489e13d3bb4"
      unitRef="number">4.75</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="ic50a96ccf5e5405ea44c3569e511b345_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjgzMg_16834dd9-f6e1-47b4-a880-e8188d0caccf"
      unitRef="number">4.50</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i0cb1b018038e41b6bcb8d9bc27e45f0f_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjgzNg_6bab6ab6-b0e2-4882-8fa1-643f46ba6a9a"
      unitRef="number">4.25</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i2a0b5203b93642e2a8fdc6e76df7568e_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjg0MA_840b6c5e-ff1f-407e-a4cf-6abae074647a"
      unitRef="number">4.00</bsx:MaximumLeverageRatio>
    <bsx:MaximumLeverageRatio
      contextRef="i54e4c18dc5a04626b7d5a7ec3770c878_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNjg1OA_09d27bc4-4c6c-4bef-85c7-5f01e20e11eb"
      unitRef="number">3.75</bsx:MaximumLeverageRatio>
    <bsx:ExclusionFromEbitdaForRestructuringCharges
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzM5NQ_e7a410f4-9321-46d1-8eff-59791f149251"
      unitRef="usd">500000000</bsx:ExclusionFromEbitdaForRestructuringCharges>
    <bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzUyOQ_1e5f2daf-f746-4b06-841a-5dac3cda2b54"
      unitRef="usd">194000000</bsx:RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <bsx:LitigationAndDebtExclusionFromEbitda
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzg2MQ_9a3ef5b7-aebf-4229-8a7f-d33a4bcde09d"
      unitRef="usd">2624000000</bsx:LitigationAndDebtExclusionFromEbitda>
    <bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfNzg5OQ_14a1661b-d201-4b98-aa83-55bfc0773c02"
      unitRef="usd">946000000</bsx:LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="iab04e6a866c54c479502399061c066c8_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI2NzY_5de7f310-8bea-4118-ba3e-70885cf0ac97">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions, except maturity and yield)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper outstanding (at par)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maximum borrowing capacity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowing capacity available &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0 days&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55 days&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i75ab56af73414eec9527c4729f49674b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfODk0MQ_2cc871fe-dfb7-4235-a42a-fe1956554aa2"
      unitRef="usd">1360000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMi0xLTEtMS0w_9c6e3e3c-54d8-421d-8644-0bd6cf9fdb58"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper
      contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMi0zLTEtMS0w_61281ee9-a910-4e6b-9f8c-e37ad1d27030"
      unitRef="usd">711000000</us-gaap:CommercialPaper>
    <bsx:MaximumCommercialPaperOutstanding
      contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMy0xLTEtMS0w_f93cc217-75ae-4d55-bf01-8f617921d039"
      unitRef="usd">2750000000</bsx:MaximumCommercialPaperOutstanding>
    <bsx:MaximumCommercialPaperOutstanding
      contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfMy0zLTEtMS0w_79dc8f8c-8a7f-44d3-b873-026d14a79130"
      unitRef="usd">2750000000</bsx:MaximumCommercialPaperOutstanding>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNC0xLTEtMS0w_bae09010-f25a-4724-b7f0-a2ff2b061c98"
      unitRef="usd">2750000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNC0zLTEtMS0w_3abd25b8-a999-431c-b638-4d26f39baf83"
      unitRef="usd">2039000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <bsx:WeightedAverageMaturityDays
      contextRef="iab04e6a866c54c479502399061c066c8_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNS0xLTEtMS0w_bd774ee7-68d3-4a02-8c82-6935144b9184">0 days</bsx:WeightedAverageMaturityDays>
    <bsx:WeightedAverageMaturityDays
      contextRef="i253c4d1492ec41528006e7fc65ed1f90_D20190101-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNS0zLTEtMS0w_159ecd17-269a-4e90-85a2-509a9bbd8ce1">55 days</bsx:WeightedAverageMaturityDays>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="i89d4dcbad7eb4283b68dbbf8d14e975f_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNi0xLTEtMS0w_6028fe78-f305-4b47-a7bf-0a2839d4f8b6"
      unitRef="number">0</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="ie4b282dc28984e44bb62c35ad8d41ccf_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjAxMjlhZTA3YzBhZTQ0YjU4Mzg1NDU3OTgzMzAzMTI2L3RhYmxlcmFuZ2U6MDEyOWFlMDdjMGFlNDRiNTgzODU0NTc5ODMzMDMxMjZfNi0zLTEtMS0w_8aff93e9-d3c8-4f05-a69c-36f0ce7e31f3"
      unitRef="number">0.0221</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebt
      contextRef="i97f676404a0d4a368a7a8b76358caf94_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTEyOQ_6a130720-0b61-490d-8aa8-fc966e66a583"
      unitRef="usd">9404000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0055d17e432d43e6a5716e6ef8c734af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTE0NQ_e76d5e65-a3ea-48fe-b070-f177d556946c"
      unitRef="usd">7661000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i43f3cd5bec824c3883ea52033763412c_I20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTE5OQ_49208b57-5f8c-411c-85f2-d2cafb5e58bb"
      unitRef="usd">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTI2MQ_4ee9ac88-d0da-4cbf-85f1-419512c40078"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id8b2c94ac6b144dea20cdca5373da9fa_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTI2Nw_fd9fdf50-2eaf-4722-baae-44f09d903116"
      unitRef="number">0.01900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTMwMQ_1af2b6ce-9e31-4f40-ba91-e9f15d53cc1f"
      unitRef="usd">1200000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i32a969aa844b45eaa688cf2e77a81451_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTMwNw_1d16cb68-3ac2-4deb-906f-7fec581e6746"
      unitRef="number">0.02650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6048faff94fe4e3f8ff35fae909e93f8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTM5NA_b0c46725-28b9-4354-8cf9-45dd82d3b446"
      unitRef="usd">450000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfDebt
      contextRef="iea047c096481465dbe4a37db91ccd61e_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTQ2NA_860beeb4-4066-4ef8-a44f-aaa285e9e933"
      unitRef="usd">750000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i3ac08e9e5ba84c159c3799c380213ac2_I20200227"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTUwMA_d9dda36c-acab-42e9-8c8e-1362a01fb419"
      unitRef="usd">1000000000.000</us-gaap:ShortTermBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i188f9ed380a4434fad684f6ec8f9957c_D20200518-20200518"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTUxNA_12d5b3ef-9c47-4735-87e0-f27105f0e98a"
      unitRef="usd">500000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="i96e3727f0c4047e78994b7e46ebbd066_I20200421"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTU1MA_b7f9bb7e-9ddc-4939-aa3d-03072ab942d4"
      unitRef="usd">1250000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebt
      contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTY0OA_212989fc-9536-46b0-b08d-e2b9a637cd1c"
      unitRef="eur">900000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i3f0f30a839ce400f83708877f49b9875_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTY2Ng_90af2a81-8ecb-410e-a471-d71a43bfc787"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ied658f8f3bf34e1eb6b39f2f2a7cde29_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfOTcwMw_fcca8e31-0a2a-460f-b4b2-027c8ababf14"
      unitRef="number">0.00625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="icf84351e6d7f46b5b417b3fe7a492801_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxMjQ_1a2aee1e-158d-40b4-90a4-571dda543324"
      unitRef="usd">206000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="if234b468e2014e5f831131ce97f1e3d4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxMzQ_7d9fff64-7051-4a29-b449-140a580b2be1"
      unitRef="usd">450000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ce7410ffeb041b585ba5959fc091a98_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxMzc_0ed25b91-7e36-432a-ae07-1626cbf5d7c8"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i8fb3528bff5c45a493e93a5e6edaa687_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxNjM_2a3dc8d9-27a1-4296-af72-8cbdd42189b7"
      unitRef="usd">566000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i6773aa82907a4a00b7b3cdf75118628d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxNzM_f4ec63de-1251-4ba9-a3fb-540bdd00f44c"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd9e8fd2638a4eb5882534a5a95c4011_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAxNzY_09c125a4-c77a-4ee6-b1da-6b957850fed5"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9e9769b9ff414bd2b8b2073ecdf42894_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAyMDU_40b211af-e6b3-493d-b502-9fcc3cb003a5"
      unitRef="usd">227000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt
      contextRef="i6ba75e1b9e124586932fb7c27ac202af_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAyMTU_3fda9f9e-868b-44e7-91b0-349a3fa8efbd"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a32bba350f7460f802d9e35490647d0_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAyMTg_eb700419-384f-4f4e-8f4d-9392e0f1504f"
      unitRef="number">0.03850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6da5402f99a740959e8d45ac53a0a17d_I20190225"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTAzOTI_5f8f3ac1-9a6f-4319-98f3-e4f8806a8802"
      unitRef="usd">4300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0NTQ_e3204423-92d7-4bc9-9567-2bd79971d956"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2fcdc57567ed49098103241ed9fc2e10_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0NjA_e648368b-d43c-4427-ae44-c2b7804e7c69"
      unitRef="number">0.03450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0ODQ_2297c525-c29e-4bdb-a46e-42f900b58c5f"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iff9eff59418d45d38da26fcd40dba083_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA0OTA_d9e76364-1899-4641-84b1-442d667c7def"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i883f72b197734176a05916892d1f98aa_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1MTQ_44a7f13e-47c3-4aed-a477-143e346f001a"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i883f72b197734176a05916892d1f98aa_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1MjA_58acea21-a639-4374-ba71-9dfb576c7dc5"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0024f7d8ff964efa837a696943046bff_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1NDQ_faf5e979-35e1-4d70-99af-c33772978a21"
      unitRef="usd">750000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0024f7d8ff964efa837a696943046bff_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1NTA_7d3f8e72-99fa-4153-b0cf-1e0c7f48770b"
      unitRef="number">0.04550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1Nzc_40a5e124-7930-483e-9834-e1b6c8fa8792"
      unitRef="usd">1000000000.000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i90cc8ab8094b4817b0b7472672466a1e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA1ODM_d3864568-6e9c-4b05-aa0e-2c8b6069b91c"
      unitRef="number">0.04700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ia241322b6fe54781a8915e284bf41aa9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA2NzY_8eeb8091-59b1-4bd5-b7db-eaf8654ab871"
      unitRef="usd">850000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i25bd1c30873b4a2495db8cd417725ada_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA3MjA_990a4b7e-8297-4672-bfe4-8e0db9061ff8"
      unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ibbbf84bbd3c14b8c9b7bd99842df6139_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA3NTE_67e31cce-504a-485c-b612-18e02715d9cf"
      unitRef="usd">600000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i51badacc45004d658f01556146c4c4d7_I20200930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA3OTU_9046011a-a4cf-442c-8e91-40d188a9880c"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i849e8308c4dc4865a29cb7ca737f1d05_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTA4Mjk_788cc678-6dba-4cd5-9e5c-b78617c9cc05"
      unitRef="usd">1000000000.000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTI2Njg_19eef041-4954-4e86-813a-d3e060e99f18">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Factoring Arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;De-recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average&lt;br/&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro denominated&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Yen denominated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Renminbi denominated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ieb811284281f4dec9c9d5f3ad78bf9ca_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi0xLTEtMS0w_6f085857-2b40-4078-8655-6837019dc565"
      unitRef="usd">150000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="if13011e07a9c4f78b791f39df452c756_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi0zLTEtMS0w_bc990c39-f7ec-4e0e-9e82-9df02fa17edc"
      unitRef="number">0.018</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i624957ecbe3e4fbbbd064e40723f0a53_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi01LTEtMS0w_507bf028-3b23-466c-81d9-0a5048cd442f"
      unitRef="usd">171000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i30818acc715047c9ad17d283e629e3a4_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMi03LTEtMS0w_b06da684-489e-4511-83b6-fa2cef33e719"
      unitRef="number">0.014</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ica793e70ab6c48b08a38c04312340dd1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy0xLTEtMS0w_f8db3d10-cc73-4a20-9438-bf4bf954b0c8"
      unitRef="usd">191000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="ife92981b4da641aabca9389a91f0a450_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy0zLTEtMS0w_97112398-a63c-468d-b04f-a0a9b886b1e9"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="ia406644c1ce04cda93abfe713b393765_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy01LTEtMS0w_2b81a750-bcb9-4faf-b805-4e144e01139d"
      unitRef="usd">226000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i413e4fb8d6234afca3447f3b21048756_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfMy03LTEtMS0w_7f441789-dc72-4934-81cf-a3abfb1459aa"
      unitRef="number">0.006</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized
      contextRef="i3df7cc192c604254acab7fbfe4adf235_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfNC0xLTEtMS0xMzI0_f4e9743b-b43c-449b-a0af-5b2375b5300c"
      unitRef="usd">1000000</us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized>
    <us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate
      contextRef="i74a0e9005e53465091e8bc2786c7dc97_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RhYmxlOjk4MGQ4ZmIzYTg1NzRhZTBhNDRiNmEzYzliODdjOWY5L3RhYmxlcmFuZ2U6OTgwZDhmYjNhODU3NGFlMGE0NGI2YTNjOWI4N2M5ZjlfNC0zLTEtMS0xMzI4_3dc58e0f-7740-4989-8f10-f9966a85d1e5"
      unitRef="number">0.035</us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTIwNjQ_319ef16e-fa32-4d48-bd9b-b05841eeb390"
      unitRef="usd">125000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml83MC9mcmFnOjMwMTBlZDE0ZGQ0NDQ4ODRiYzZhOTJlYjFkZDViZDc5L3RleHRyZWdpb246MzAxMGVkMTRkZDQ0NDg4NGJjNmE5MmViMWRkNWJkNzlfMTIwODA_91ddce07-5706-484a-b94f-3909f0f9aa10"
      unitRef="usd">105000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg2Ng_1e4afea4-bdec-4be9-95dc-c59976350ec2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE F &#x2013; SUPPLEMENTAL BALANCE SHEET INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of selected captions in our accompanying unaudited condensed consolidated balance sheets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cash, cash equivalents, restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Trade accounts receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note: Effective January 1, 2020, we adopted FASB ASC Topic 326 using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Please refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 326, we record credit loss reserves to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for credit losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; when we establish &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trade accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,579&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;894&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,064&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $84 million&#160;for the third quarter of 2020, $79 million for the third quarter of 2019, $238 million for the first nine months of 2020 and $220 million for the first nine months of 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;644&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,132&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <bsx:CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg3NQ_3f84c94c-121e-4cf0-ad40-603fca707cc9">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMi0xLTEtMS0w_870f3a58-0dde-487c-88a4-b4506ed74fdf"
      unitRef="usd">2022000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMi0zLTEtMS0w_0055a587-5d62-46bd-874a-022bbbb0845c"
      unitRef="usd">217000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMy0xLTEtMS0w_04af877b-5052-4675-87a0-5ced52d9531d"
      unitRef="usd">214000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfMy0zLTEtMS0w_9b894c75-a2cc-42b5-bcb3-4e0b196450ad"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNC0xLTEtMS0w_e9011d48-bc10-4644-88b4-5933d39b3d7b"
      unitRef="usd">46000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNC0zLTEtMS0w_246c9d99-4329-4d0b-808b-1dcbb621bad9"
      unitRef="usd">43000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNS0xLTEtMS0w_643fa283-e38b-4abe-b8a5-9e693c3f834d"
      unitRef="usd">2282000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmRkMDcxM2ZlM2QwYjQ3MjdiMjgzNWE2N2JjZDRhOWJhL3RhYmxlcmFuZ2U6ZGQwNzEzZmUzZDBiNDcyN2IyODM1YTY3YmNkNGE5YmFfNS0zLTEtMS0w_037f44a4-b3cb-49cb-baa9-b60fbbdf0ebb"
      unitRef="usd">607000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg3Ng_d3b5d7a3-2c94-4648-8524-854754a17d39">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.039%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative effect adjustment for adoption of ASU 2016-13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;103&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note: Effective January 1, 2020, we adopted FASB ASC Topic 326 using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#x2019;s contractual life. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Please refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note A &#x2013; Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMi0xLTEtMS0w_b056e292-c4bb-482a-a876-7b410519d05b"
      unitRef="usd">1701000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMi0zLTEtMS0w_d5e1c1ac-f479-4ed3-9ede-b8674ae1ae87"
      unitRef="usd">1902000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMy0xLTEtMS0w_4b52e090-631e-42fd-bf44-3c1d486366b0"
      unitRef="usd">103000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfMy0zLTEtMS0w_e7da7a52-07be-4a8f-a882-df097f7e12e2"
      unitRef="usd">74000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfNC0xLTEtMS0w_2fbae658-9852-4fc2-b5a5-a169c86b8448"
      unitRef="usd">1598000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsNotesAndLoansReceivableNetCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjAwNTQzM2UzYThmYzQ3YjY4NDUzMzhhMGI0MDJhZjA3L3RhYmxlcmFuZ2U6MDA1NDMzZTNhOGZjNDdiNjg0NTMzOGEwYjQwMmFmMDdfNC0zLTEtMS0w_b8a1ab20-5cb6-48c6-9ce6-af8b82fcaa2d"
      unitRef="usd">1828000000</us-gaap:AccountsNotesAndLoansReceivableNetCurrent>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi0xLTEtMS0w_e24c99ff-bf63-4ac8-8df4-f2635eb382db"
      unitRef="usd">94000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id7aaf89e580246e2979204c398ade960_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi0zLTEtMS0w_8025a368-a7ef-456e-8181-8785a8f9aecc"
      unitRef="usd">73000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi01LTEtMS0w_1717679c-25ba-4c71-bc2f-e68205ff6648"
      unitRef="usd">74000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMi03LTEtMS0w_d393e9d7-278f-4e83-847d-fbeeaea9ed9d"
      unitRef="usd">68000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfMy01LTEtMS0w_eacbbe17-45a2-44d0-8801-f020729dc6f0"
      unitRef="usd">10000000</us-gaap:AccountsReceivableChangeInMethodCreditLossExpenseReversal>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC0xLTEtMS0w_41c4654b-ee57-4ba4-b4b3-5215bf9ff376"
      unitRef="usd">16000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC0zLTEtMS0w_1076aa98-988a-4fa5-afbd-36d821ff1529"
      unitRef="usd">8000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC01LTEtMS0w_584c1064-5000-4b01-800c-2505ada12331"
      unitRef="usd">39000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNC03LTEtMS0w_0a70cb1c-341e-4777-b82b-cb58bfa3a7f7"
      unitRef="usd">19000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS0xLTEtMS0w_1839ea05-1bf8-4185-b68e-35524ffa2af3"
      unitRef="usd">7000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS0zLTEtMS0w_b32a8fc2-2e3b-4cde-9e5f-87d32b7b7579"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS01LTEtMS0w_949463c4-f1f6-4333-b25f-0684b75422e1"
      unitRef="usd">19000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNS03LTEtMS0w_b6f90e60-4a21-479c-9a92-5b921f6dbba3"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi0xLTEtMS0w_63fa6625-6676-4af6-8fbd-388500b4e612"
      unitRef="usd">103000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi0zLTEtMS0w_e6a3ea03-a805-476e-97be-1fb0d20fd633"
      unitRef="usd">75000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi01LTEtMS0w_18d6cd3f-a24b-4bcd-9a57-5daae96c596e"
      unitRef="usd">103000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmMwNjVhYjc3YmJmNzQ0MGZiMjYyOTQ2ZjU2ZjI2ZmRjL3RhYmxlcmFuZ2U6YzA2NWFiNzdiYmY3NDQwZmIyNjI5NDZmNTZmMjZmZGNfNi03LTEtMS0w_da7f3c0d-47cb-4a27-9ab4-89c0bc7db64c"
      unitRef="usd">75000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg3Mw_82ec1804-27e1-47f6-bcfe-09d1a8805a26">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,579&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMi0xLTEtMS0w_3885de51-bd83-4afe-b8fe-ea123d408212"
      unitRef="usd">871000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMi0zLTEtMS0w_b9180b52-53a4-4920-a6ca-fe5c511505f3"
      unitRef="usd">971000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMy0xLTEtMS0w_f590730d-d043-4d6f-92dd-87f574f0151f"
      unitRef="usd">179000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfMy0zLTEtMS0w_7c6e834b-e531-4221-b4d1-9e903607bcb1"
      unitRef="usd">192000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNC0xLTEtMS0w_166ff7d2-a669-4187-b78d-666e9c024a51"
      unitRef="usd">421000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNC0zLTEtMS0w_2e468218-780a-4e9e-a128-153467fa9e4d"
      unitRef="usd">416000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNS0xLTEtMS0w_846f9194-e6c0-4fbd-8af4-b313a565cadf"
      unitRef="usd">1472000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmEzMTg0NWZiZTAxYjRmZjFiNjg3ZWY5ZjAyZjBjYjU2L3RhYmxlcmFuZ2U6YTMxODQ1ZmJlMDFiNGZmMWI2ODdlZjlmMDJmMGNiNTZfNS0zLTEtMS0w_eb4f8f94-1c4b-4bb3-a04b-ddb9edf29102"
      unitRef="usd">1579000000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg2Mw_d1ce3bdb-c21c-4a60-bfb2-895693dcf64b">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;894&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMi0xLTEtMS0w_41a3137a-143a-43b2-8b95-650eda4afbe1"
      unitRef="usd">214000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMi0zLTEtMS0w_bfaa370b-ebd8-4414-9421-69323baf5edf"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMy0xLTEtMS0w_e4a2499f-a15e-4dde-88fd-b852d672bf8c"
      unitRef="usd">146000000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfMy0zLTEtMS0w_bae47518-f56b-41eb-8bf0-326aa718e730"
      unitRef="usd">105000000</us-gaap:DerivativeAssetsCurrent>
    <bsx:Licensingarrangements
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNC0xLTEtMS0w_69d02af3-eeef-4dc6-a78a-931693304464"
      unitRef="usd">149000000</bsx:Licensingarrangements>
    <bsx:Licensingarrangements
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNC0zLTEtMS0w_7b9f16f2-7605-4cab-80fc-8a6d9597e299"
      unitRef="usd">186000000</bsx:Licensingarrangements>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNS0xLTEtMS0w_607b83b7-71af-48d7-ae21-4f91fb7e0df7"
      unitRef="usd">385000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNS0zLTEtMS0w_10c07e17-9718-456e-ab75-68484ac10e80"
      unitRef="usd">243000000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNi0xLTEtMS0w_93a615fa-5b29-4c98-b011-e9d9dce13020"
      unitRef="usd">894000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjk4YzA1Yjg1MGNjNjQ5YzJiMDg1MmFiMTFiNzViOGQ4L3RhYmxlcmFuZ2U6OThjMDViODUwY2M2NDljMmIwODUyYWIxMWI3NWI4ZDhfNi0zLTEtMS0w_03ac42c4-512b-44e7-b25e-9189e31d7260"
      unitRef="usd">880000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTgzOA_3c586cdb-f1d5-48ca-8060-e10975ceb12e">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,064&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMi0xLTEtMS0w_d0d58d53-c1db-4a5e-963d-df7c5bb03525"
      unitRef="usd">120000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMi0zLTEtMS0w_fc9bd172-4d65-4723-af66-a252bf87e3fc"
      unitRef="usd">117000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMy0xLTEtMS0w_d5f73412-58bd-4159-a56e-1336504621fc"
      unitRef="usd">1243000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfMy0zLTEtMS0w_ac5980d3-e329-436b-93d4-9a73190c2344"
      unitRef="usd">1198000000</us-gaap:BuildingsAndImprovementsGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNC0xLTEtMS0w_33a3aee6-356c-469d-b580-a81ab4d016bc"
      unitRef="usd">3411000000</bsx:EquipmentFurnitureAndFixturesGross>
    <bsx:EquipmentFurnitureAndFixturesGross
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNC0zLTEtMS0w_ed9b8304-5367-4c9a-9707-80ca9fd8bdf1"
      unitRef="usd">3411000000</bsx:EquipmentFurnitureAndFixturesGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNS0xLTEtMS0w_6c8a1e0e-9845-4d05-b354-d3af3a734229"
      unitRef="usd">402000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNS0zLTEtMS0w_87c2f5b1-6b67-4a14-b04f-4b654204b10e"
      unitRef="usd">442000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNi0xLTEtMS0w_bbf6cb57-59dc-4fde-ade0-f32c17157a3b"
      unitRef="usd">5176000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNi0zLTEtMS0w_de704666-df19-4ef5-af50-1fb41e3fcf6e"
      unitRef="usd">5169000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNy0xLTEtMS0w_d7e46b87-7b7a-4e46-a494-99a2cd1f064e"
      unitRef="usd">3112000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfNy0zLTEtMS0w_e483a8fa-52d1-43fe-a024-d7d2b15f27d1"
      unitRef="usd">3089000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfOC0xLTEtMS0w_a51172cf-030a-4e34-b813-2b9a7c947cbb"
      unitRef="usd">2064000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjEzZmFjZTVkM2QwNzQzNjZhNjI5YTY0NmZhMWM3ZTFjL3RhYmxlcmFuZ2U6MTNmYWNlNWQzZDA3NDM2NmE2MjlhNjQ2ZmExYzdlMWNfOC0zLTEtMS0w_95b76a3f-4aa9-4a2e-a8d4-709e788af9c3"
      unitRef="usd">2079000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTYyOA_5f0d0b10-ed1f-4aaa-9289-5a897fa99093"
      unitRef="usd">84000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTY1Nw_97ae2049-196e-46d4-bf04-888bcaba995b"
      unitRef="usd">79000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTY4Ng_4ffa51d7-6cbf-48fa-991d-3220df0e2b0d"
      unitRef="usd">238000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTcwNw_f8fdb22d-65e9-4d4b-9392-b6b293401159"
      unitRef="usd">220000000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg1OA_a043013e-1c88-4232-9cc2-98fdcc1b1d40">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMi0xLTEtMS0w_0e2a8dde-90f1-4c99-aa65-f703d43ae099"
      unitRef="usd">46000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMi0zLTEtMS0w_109dcad6-e7f4-4ffc-b5ab-591b4d4b18bd"
      unitRef="usd">43000000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMy0xLTEtMS0w_8e87268f-b515-4448-bd72-95882110680a"
      unitRef="usd">311000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfMy0zLTEtMS0w_e2b679e5-d02e-4ac1-8b9f-ebab2a869db0"
      unitRef="usd">336000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssets
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNC0xLTEtMS0w_445227f9-dd80-4342-a811-a457274e0cc8"
      unitRef="usd">179000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNC0zLTEtMS0w_64f2afbc-afea-4108-b450-977fb906a486"
      unitRef="usd">216000000</us-gaap:DerivativeAssets>
    <us-gaap:Investments
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNS0xLTEtMS0w_b73d75b2-bd92-409e-96d5-4ba188d44d45"
      unitRef="usd">567000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNS0zLTEtMS0w_c5822f89-d4ee-4bf2-8a83-55330e49152a"
      unitRef="usd">458000000</us-gaap:Investments>
    <bsx:Licensingarrangementsasset
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNi0xLTEtMS0w_0c906544-f914-41e9-8ac2-df88004a1ba2"
      unitRef="usd">246000000</bsx:Licensingarrangementsasset>
    <bsx:Licensingarrangementsasset
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNi0zLTEtMS0w_d7bb1c06-0494-45c7-9d73-9fb1b5f3b116"
      unitRef="usd">332000000</bsx:Licensingarrangementsasset>
    <bsx:OtherOtherLongtermAssets
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNy0xLTEtMS0w_4e97d515-31b0-4fd8-bb2f-de2dd41b7875"
      unitRef="usd">165000000</bsx:OtherOtherLongtermAssets>
    <bsx:OtherOtherLongtermAssets
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfNy0zLTEtMS0w_8262906e-3398-4783-a6ab-e6c712cd780c"
      unitRef="usd">144000000</bsx:OtherOtherLongtermAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfOC0xLTEtMS0w_062997af-d072-4b67-9b06-4c25dd236f65"
      unitRef="usd">1516000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmE4ZjhjNGU4ODJmMDQ5ZGU4Yjc2ODQ4M2M3MThmZmQ2L3RhYmxlcmFuZ2U6YThmOGM0ZTg4MmYwNDlkZThiNzY4NDgzYzcxOGZmZDZfOC0zLTEtMS0w_4fa2387d-e90d-4107-9ca1-c7af71f80a13"
      unitRef="usd">1529000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg1OQ_bd6996f8-a41b-46d0-8649-d04fb3e3bb02">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserveCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMi0xLTEtMS0w_20116ea0-5aa9-4dce-a241-900a8a51174c"
      unitRef="usd">552000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMi0zLTEtMS0w_f7be57ba-7b15-4880-afe7-5b4f857a8e78"
      unitRef="usd">470000000</us-gaap:LitigationReserveCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMy0xLTEtMS0w_b6e89551-c8ec-4a53-a601-ea66c6978453"
      unitRef="usd">728000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfMy0zLTEtMS0w_c8e9c21b-6a25-48c8-98fd-9b73767ad0ec"
      unitRef="usd">708000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNC0xLTEtMS0w_9fb17935-1def-4229-9bbb-4562b40ae17d"
      unitRef="usd">324000000</bsx:AccruedRebatesCurrent>
    <bsx:AccruedRebatesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNC0zLTEtMS0w_9d666ec5-c2e2-4f03-8402-f53c1ba8c948"
      unitRef="usd">298000000</bsx:AccruedRebatesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNS0xLTEtMS0w_236714c4-d9a9-4b64-9eb3-171c726304be"
      unitRef="usd">47000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNS0zLTEtMS0w_38f4cc59-54e3-46a2-b1df-282c24379f44"
      unitRef="usd">56000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNi0xLTEtMS0w_6f46ea6b-b0d7-4211-93e6-04e2d420106f"
      unitRef="usd">544000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNi0zLTEtMS0w_c3b9562f-402c-41ba-a580-39e24b0839a0"
      unitRef="usd">576000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNy0xLTEtMS0w_6f1b815d-7826-4c14-b4ee-b6f28519f894"
      unitRef="usd">2195000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjllZTVjNzcyMGY5ZDQzNTFiZTMyNWRkNjQxZjdkMWNiL3RhYmxlcmFuZ2U6OWVlNWM3NzIwZjlkNDM1MWJlMzI1ZGQ2NDFmN2QxY2JfNy0zLTEtMS0w_066ea269-3789-4a20-8c47-6f11d034d363"
      unitRef="usd">2109000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTg2NQ_63b71581-6249-41b1-9d65-a4f0fd708dc5">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;644&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMi0xLTEtMS0w_62be734a-0c79-485e-a0d5-fc45e2d6a9a8"
      unitRef="usd">147000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMi0zLTEtMS0w_4de4095f-b828-4905-aaf5-e1c3375103cd"
      unitRef="usd">144000000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMy0xLTEtMS0w_b9521f03-5f1e-41c3-a71b-dbcc86aecc1a"
      unitRef="usd">151000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfMy0zLTEtMS0w_8c172a45-9753-42e0-a3a7-9be6b37b493d"
      unitRef="usd">197000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNC0xLTEtMS0w_19ac66cd-1bc6-4fb1-a071-71a927a4ee34"
      unitRef="usd">37000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNC0zLTEtMS0w_96cfd521-b749-438a-a091-2043be761936"
      unitRef="usd">265000000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNS0xLTEtMS0w_7f6527b4-ad73-4a24-8bbf-a4c8c83ecf98"
      unitRef="usd">310000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNS0zLTEtMS0w_d205c0d1-3f59-457f-b058-28becc30a98c"
      unitRef="usd">195000000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNi0xLTEtMS0w_b104e3da-b17c-497c-9685-c65cd3105afe"
      unitRef="usd">644000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOmI0YjE3MDExY2E5NDRjNTQ4N2U1NWQwZDliYjBkZGZlL3RhYmxlcmFuZ2U6YjRiMTcwMTFjYTk0NGM1NDg3ZTU1ZDBkOWJiMGRkZmVfNi0zLTEtMS0w_b9a7fc6a-e417-4b85-b264-bc0062ed74e2"
      unitRef="usd">800000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RleHRyZWdpb246ZmI3N2I5MzY5NWQyNGM3NGI1ZmQ1ZTMzYzg4OTg0ODFfMTkwMA_ccdccf54-0b5d-4f8d-94f2-627b83a89620">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licensing arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,132&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMi0xLTEtMS0w_bc56d089-2d0c-4d4c-80bd-106600dec744"
      unitRef="usd">571000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMi0zLTEtMS0w_de3d6ae3-24bc-448d-89a4-b180b08f6d6a"
      unitRef="usd">667000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMy0xLTEtMS0w_ca36ac31-a486-4382-b474-473cc5f6c699"
      unitRef="usd">48000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfMy0zLTEtMS0w_9e81c35a-0b2f-4403-ad82-53741b035e49"
      unitRef="usd">227000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNC0xLTEtMS0w_c2870e67-4aec-4dc5-a8a7-152d79ca6cfc"
      unitRef="usd">167000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNC0zLTEtMS0w_ccd4c118-48fe-4b00-aefb-1a37578b0791"
      unitRef="usd">299000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <bsx:Licensingarrangementsliability
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNS0xLTEtMS0w_9a96f889-c947-4aae-b86a-2ce5925b576d"
      unitRef="usd">262000000</bsx:Licensingarrangementsliability>
    <bsx:Licensingarrangementsliability
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNS0zLTEtMS0w_c27f9c74-186c-49d4-b501-1aa240ece497"
      unitRef="usd">374000000</bsx:Licensingarrangementsliability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNi0xLTEtMS0w_bbb93477-5aff-4c7a-a1d5-9adcc7d9e460"
      unitRef="usd">256000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNi0zLTEtMS0w_90a97d0b-abaa-421f-aa20-4d435e512486"
      unitRef="usd">276000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredRevenue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNy0xLTEtMS0w_8997332c-9aee-4089-b7cb-c25c976ebd8c"
      unitRef="usd">258000000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfNy0zLTEtMS0w_2adcdbab-7dd6-42cd-a250-b9d0a5df9338"
      unitRef="usd">257000000</us-gaap:DeferredRevenue>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOC0xLTEtMS0w_8b6ae1d4-4a13-4482-9f42-81309895e43a"
      unitRef="usd">569000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOC0zLTEtMS0w_4aff997f-218b-4284-a355-7700c9a075c3"
      unitRef="usd">535000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOS0xLTEtMS0w_e3045eea-a3e3-4867-973d-f08db6c53129"
      unitRef="usd">2132000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml84NS9mcmFnOmZiNzdiOTM2OTVkMjRjNzRiNWZkNWUzM2M4ODk4NDgxL3RhYmxlOjkyZWY0MTEzMDk1MDQ5MGFhMjVmYjVhNjNmMjdjYzg2L3RhYmxlcmFuZ2U6OTJlZjQxMTMwOTUwNDkwYWEyNWZiNWE2M2YyN2NjODZfOS0zLTEtMS0w_ef34e2e5-f11d-4b83-aaec-e0d3930280d1"
      unitRef="usd">2635000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMjAzOA_bfceb67a-7fa9-432b-8a4e-3e4fcfe64dd4">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE G &#x2013; INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate from continuing operations is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in our reported tax rates for the third quarter and first nine months of 2020, as compared to the same periods in 2019, relates primarily to a shift in geographical mix of earnings to higher-tax jurisdictions, partially offset by the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include intangible asset impairment charges, acquisition/divestiture-related net charges, restructuring and restructuring-related net charges, litigation-related net charges as well as certain discrete tax items primarily related to the resolution of an Internal Revenue Service (IRS) audit, as explained below, tax windfall benefits associated with share-based payments, and impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years. The Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91 million in the third quarter of 2020 to release the reserves related to these years. We anticipate receiving a refund of $62 million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, we had $279 million of gross unrecognized tax benefits, of which a net $185 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $455 million of gross unrecognized tax benefits, of which a net $355 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to reaching settlements with tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that within the next 12 months we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $23 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Economic stimulus legislation has been enacted in many countries in response to COVID-19. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allows us to preserve cash generated from operations to service our debt obligations and other near-term commitments.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMjAzOQ_290ff8a4-8d14-4f03-bbcc-c0e26f8d92b8">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi0xLTEtMS0w_dcde3ffd-5215-4fb7-bfd5-d6a7187f4edc"
      unitRef="number">0.317</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi0zLTEtMS0w_5fe2b42c-5d82-447a-a8a3-7d943016a4b1"
      unitRef="number">-0.387</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi01LTEtMS0w_81e4612e-b5fd-4095-a0c4-56653cdc1c11"
      unitRef="number">0.243</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RhYmxlOmJmOWNiYTliOWUxZTQyNmJiZmRhN2NlYTZmMjlkMTkxL3RhYmxlcmFuZ2U6YmY5Y2JhOWI5ZTFlNDI2YmJmZGE3Y2VhNmYyOWQxOTFfMi03LTEtMS0w_b017b7df-13a9-4c08-b2b1-2cf31fac8ba6"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTA5OTUxMTYzODgwMQ_73926589-bea3-4231-b9de-aac638663b57"
      unitRef="usd">91000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTA5OTUxMTY0MjUzOQ_5c7cfb27-7047-472e-952f-39f8c71a5347"
      unitRef="usd">62000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfODEw_4d9324fe-ad54-4dcd-a510-94cb52953b58"
      unitRef="usd">279000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfODY0_29bcd28d-d81f-4bc0-a17a-cfb210acf0b0"
      unitRef="usd">185000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfOTM3_0afa9f9e-2338-4774-8a71-65c51e5103f7"
      unitRef="usd">455000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfOTkx_4b7aaeb1-1c37-46d2-b0a3-01bed93513e4"
      unitRef="usd">355000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTI2OA_5917b429-97cd-456d-af27-12d3fbff06f0"
      unitRef="usd">23000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <bsx:TheCARESAct
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-11"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml85NC9mcmFnOmIzZTNmZDhkYTQyZDQ4MTM4MTFmZDg3NWE5YWI3ODA5L3RleHRyZWdpb246YjNlM2ZkOGRhNDJkNDgxMzgxMWZkODc1YTlhYjc4MDlfMTQ1NA_5fb1250c-17ea-45e9-a8db-d9345c35cf18"
      unitRef="usd">2200000000000</bsx:TheCARESAct>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE4MjM3_065d72cf-9a84-40a6-968c-d84fc7694347">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;NOTE H &#x2013; COMMITMENTS AND CONTINGENCIES &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our accrual for legal matters that are probable and estimable was $600 million as of September&#160;30, 2020 and $697 million as of December&#160;31, 2019 and includes certain estimated costs of settlement, damages and defense. The decrease in our legal accrual was mainly due to settlement payments related to litigation with Channel Medsystems, Inc. (Channel) and those associated with product liability cases or claims related to transvaginal surgical mesh products, partially offset by incremental reserves recorded in the third quarter of 2020 described below. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other current assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of $214 million as of September&#160;30, 2020 and $346 million as of December&#160;31, 2019. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note F &#x2013; Supplemental Balance Sheet Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded litigation-related charges of $260 million during the third quarter and first nine months of 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general. In the first nine months of 2019, our litigation-related net credits included a gain of $148 million, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation-related net charges (credits)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;in our&#160;unaudited condensed consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As such, a portion of the related gain from this settlement was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our unaudited condensed consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q for the periods ended March 31, 2020 and June 30, 2020 and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 21, 2020, approximately 54,000 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of October 21, 2020, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately 52,000 cases and claims, adjusted to reflect the Company&#x2019;s analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,000 cases and claims, approximately 47,500 have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over 3,100 of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general offices regarding our transvaginal surgical mesh products. We have responded to those requests. On December 12, 2019 the Mississippi Attorney General filed suit against BSC in State Court alleging violations of the Mississippi Consumer Protection Act which the Company plans to vigorously defend. There are fewer than 25 claims in the United Kingdom. There are also fewer than 15 cases in Canada, inclusive of one certified class action, which has settled and received Court approval. On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#x2019;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. While we believe that our accrual associated with this matter is adequate, changes to this accrual may be required in the future as additional information becomes available. While we continue to engage in discussions with plaintiffs&#x2019; counsel regarding potential resolution of pending cases and claims and intend to vigorously contest the cases and claims asserted against us that do not settle, the final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Initial trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently named a defendant in 92 filed product liability cases involving our Greenfield Vena Cava Filter, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 624 claims, none of which have been filed. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Note G &#x2013; Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; for information regarding our tax litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Matters Concluded Since December 31, 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 30, 2019, Tissue Anchor Innovations filed a complaint for patent infringement in the United States District Court Central District of California against Fountain Valley Regional Hospital and Medical Center, Los Alamitos Medical Center and us. The complaint alleged that the Solyx&#x2122; Sling System infringes US Patent 6,506,190. We reached a confidential settlement in this matter in July 2020, pursuant to which the action was dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2017, Imran Niazi filed a patent infringement action against us in the U.S. District Court for the Western District of Wisconsin alleging that a U.S. patent owned by him is infringed by our Acuity&#x2122; Lead Delivery System. On June 30, 2017, we filed a motion to dismiss for improper venue and on November 7, 2017 the Wisconsin Court granted the motion to dismiss.&#160;On November 13, 2017 Niazi refiled the same action in the U.S. District of Minnesota. We reached a confidential settlement on this matter on February 3, 2020 pursuant to which the action was dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2017, we entered into a definitive agreement with Channel pursuant to which we could have been obligated to pay $145 million in cash up-front and a maximum of $130 million in contingent payments to acquire Channel. The agreement contained a provision allowing Channel to sell the remaining equity interests of Channel to us upon achievement of a regulatory milestone and an option allowing us to acquire the remaining equity interests. We sent a notice of termination of that agreement to Channel in the second quarter of 2018. On September 12, 2018, Channel filed a complaint in Delaware Chancery Court against us for alleged breach of the agreement. Channel alleged that we breached the agreement by terminating it. We answered the complaint, denied the claims by Channel and counterclaimed to recover part of our investment in Channel, alleging fraud in the inducement. On April 2, 2019, Channel announced its receipt of FDA approval of the Cerene&#x2122; Cryotherapy Device. Trial testimony was taken in April 2019, and the post-trial briefing and hearing were completed. During the third quarter of 2019, Channel notified us that they were exercising their option to sell the remaining equity interests in Channel to us. We responded to the notification that we did not intend to purchase Channel since the previous agreement had been terminated. On December 18, 2019, the Chancery Court ruled that Boston Scientific was in breach of the agreement and granted Channel's request for specific performance to require the Company to complete the purchase. On January 10, 2020, we filed a Notice of Appeal of the Chancery Court&#x2019;s decision to the Delaware Supreme Court. On February 4, 2020, the Company settled the dispute with Channel resulting in termination of the agreement, payment by the Company of an undisclosed sum and surrender of the Company's equity interest in Channel.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE4MjM5_413d5a58-7b86-47ef-b8e8-274159fc7860">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with FASB ASC Topic 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.&lt;/span&gt;</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzM5MTM_cdd0d662-32b0-4906-af63-642ba7f1e283"
      unitRef="usd">600000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzM5Mjk_ce2b66c7-4619-4dae-a581-08883432aa4a"
      unitRef="usd">697000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ0NDY_04af877b-5052-4675-87a0-5ced52d9531d"
      unitRef="usd">214000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ0NjI_9b894c75-a2cc-42b5-bcb3-4e0b196450ad"
      unitRef="usd">346000000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LitigationSettlementExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE2NDkyNjc0NjAwNzk_1693fa01-b769-4960-85ee-f349de4f2cac"
      unitRef="usd">260000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i7517236e64694d1f8bc3fc2479c9b98c_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ2Njc_ed58f3a8-2f18-4acb-9456-6cc98d744ea5"
      unitRef="usd">-148000000</us-gaap:LitigationSettlementExpense>
    <bsx:LitigationSettlementReceivedGain
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzQ3MTE_6ad30cdd-b209-4605-b858-d6adbc878fd1"
      unitRef="usd">180000000</bsx:LitigationSettlementReceivedGain>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzk1MzU_442ab09a-2249-4100-a720-322a22f5427a"
      unitRef="claims">54000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i53217914a25e498e83f410e223fceb43_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzk5MTI_34964df8-5121-46dc-9a64-b05193cca0cb"
      unitRef="claims">52000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i53217914a25e498e83f410e223fceb43_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzEwMjgw_34964df8-5121-46dc-9a64-b05193cca0cb"
      unitRef="claims">52000</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct
      contextRef="i53217914a25e498e83f410e223fceb43_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzEwMzE1_41f89084-0def-47f9-9176-466fb3b1d24f"
      unitRef="claims">47500</bsx:TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct>
    <bsx:Productliabilitycasesorclaimsrelatedtomeshproduct
      contextRef="i1f1f44e32d174b6f98c5b0276649eb93_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzEwODg4_0a47191a-674a-40c5-a29a-f4758c993932"
      unitRef="claims">3100</bsx:Productliabilitycasesorclaimsrelatedtomeshproduct>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom
      contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzExNjg2_874da27b-cab9-4166-813d-9c49003a8b68"
      unitRef="claims">25</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom>
    <bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada
      contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzExNzQ1_2c563ed6-5611-4f51-bc4a-e50edc0799f3"
      unitRef="claims">15</bsx:ProductliabilitycasesorclaimsrelatedtomeshproductCanada>
    <bsx:CertifiedclassactionsinCanadaMesh
      contextRef="i71c575ee4ac546e0916bfef92687e6e1_I20201021"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzExNzc4_d2079012-3949-4498-93a5-16d964b1723a"
      unitRef="claims">1</bsx:CertifiedclassactionsinCanadaMesh>
    <bsx:AllegedBreachofPurchaseAgreementAmount
      contextRef="i23b934c31d804d8d9a9c89f2fed9a737_I20180912"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE2NDg5_785a3882-7f66-4080-a7c6-136ac8d44e9e"
      unitRef="usd">145000000</bsx:AllegedBreachofPurchaseAgreementAmount>
    <bsx:AllegedBreachofPurchaseAgreementAmount
      contextRef="i0dcbc3c9b20642dd97b2450bb8f713bc_I20180912"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDAvZnJhZzoyZTM5MjNkZjNkNGY0MGE2YmQ4NTQ3MjM2NTFkNjUyYy90ZXh0cmVnaW9uOjJlMzkyM2RmM2Q0ZjQwYTZiZDg1NDcyMzY1MWQ2NTJjXzE2NTI2_d63268d6-e8ee-42f3-a46a-7d093598a7ab"
      unitRef="usd">130000000</bsx:AllegedBreachofPurchaseAgreementAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzUxMTU_f6446aac-ce30-43fa-b85c-2d82a0b3d6f0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE I &#x2013; STOCKHOLDERS' EQUITY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of September&#160;30, 2020, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 1, 2020, we paid to holders of our MCPS as of August 15, 2020 a cash dividend of $1.4361 per MCPS share (or $14 million in aggregate cash dividends), representing a dividend period beginning on the May 27, 2020 issuance date through August 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On October 27, 2020, the Audit Committee of our Board of Directors, pursuant to authority delegated to such committee by our Board of Directors, declared a cash dividend of $1.375 per MCPS share (or $14 million in aggregate cash dividends) to be paid on December 1, 2020 to holders of our MCPS as of November 15, 2020, representing a dividend period beginning on September 1, 2020 through November 30, 2020. We have presented cumulative, unpaid dividends covering the period from September 1, 2020 through September 30, 2020 totaling $5 million within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within our unaudited condensed consolidated balance sheet as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue 2.000 billion shares of common stock, $0.01 par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 27, 2020, we completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note E &#x2013; Contractual Obligations and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions and investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzUy_349c6011-f469-4bcd-91a8-e1e7a614c477"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ied343c75dd384497a465543451475c7e_I20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ2OA_bdafc251-ff1e-4fe7-849c-e4f8fec8a314"
      unitRef="shares">10062500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ4MQ_3d2dd5b3-cb3c-44c1-92fc-f47607c5a3a7"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="ied343c75dd384497a465543451475c7e_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzU5Mg_8ef78e61-ea53-4c53-b76b-070f45debd91"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="if2b23f1cf3f54a46ae87e6bafb2588bd_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzY2Mw_ef4475c8-d65f-42e6-9418-acb2a2aa0df2"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="i735ff78c796c4242ade8554aac15b307_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzgwNA_3d60514c-9975-4658-82cf-34c9e95f8d44"
      unitRef="usd">1006000000.000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="ibb9143d068024fc98bd342664c920c3d_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwMjc_3d2dd5b3-cb3c-44c1-92fc-f47607c5a3a7"
      unitRef="number">0.0550</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i735ff78c796c4242ade8554aac15b307_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwNjM_abaca7d0-c1d0-41e6-be8a-a044e35651c2"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="i735ff78c796c4242ade8554aac15b307_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzIxNjU_abaca7d0-c1d0-41e6-be8a-a044e35651c2"
      unitRef="usdPerShare">100</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="i88c3b4165083494aa4c7c21c4f6d3bed_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzIzODA_16265718-9b0a-4089-9880-8daf97f182ef">2.3834</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="i927de457f17d4bfc9629007545156993_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzIzODc_c29c8001-416e-4dc4-a764-dd658b3ebca4">2.9197</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockDividendsPerShareCashPaid
      contextRef="i044387e090504fda9610329194e2938f_D20200901-20200901"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwOTk1MTE2MzMwODg_f5cbeaf6-e906-4b3b-81fc-bb6d2b53e833"
      unitRef="usdPerShare">1.4361</us-gaap:PreferredStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividends
      contextRef="i044387e090504fda9610329194e2938f_D20200901-20200901"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzEwOTk1MTE2MzMxMTA_13f19f6f-1442-4ad6-b9dc-88e7fb3ee486"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="icb5544b1d5914e58a5ff9e8a859120c7_D20201027-20201027"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzE2NDkyNjc0NDk1OTg_c5fd9a20-db1d-4cd8-8d2e-5544d50ae69b"
      unitRef="usdPerShare">1.375</us-gaap:PreferredStockDividendsPerShareDeclared>
    <us-gaap:DividendsPreferredStockCash
      contextRef="icb5544b1d5914e58a5ff9e8a859120c7_D20201027-20201027"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzE2NDkyNjc0NDk2MDI_e4660aa7-87ae-45af-bc01-7449fb63c712"
      unitRef="usd">14000000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i33acd291741444b7a9ad38bb3a5168fb_I20201027"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzM2MzY_48917e51-ada4-4f10-8edb-3ea5056cf572"
      unitRef="usd">5000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzM3MjU_68ce7413-374f-4ffc-903d-d143250be5a5"
      unitRef="shares">2000000000.000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzM3NTI_5ed2f5aa-df2c-4728-aee2-edc2060d5824"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id033163f06e84414929b16208d102740_D20200527-20200527"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ0ODU_60bf0b5b-2e04-4d23-8dbb-56619a08ecc6"
      unitRef="shares">29382500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ia10084aaaa064d9b9dd7f4c0a7135478_I20200527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ1NDE_2056922f-ab4d-416f-a50b-001033898542"
      unitRef="usdPerShare">34.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id033163f06e84414929b16208d102740_D20200527-20200527"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDYvZnJhZzpjMTk3OGJiNmQ2NDM0OWYzOTdhNzkzZDFhNzkwMTc2Mi90ZXh0cmVnaW9uOmMxOTc4YmI2ZDY0MzQ5ZjM5N2E3OTNkMWE3OTAxNzYyXzQ2MjI_6a158592-0671-4b55-bf8a-58cdf6e72421"
      unitRef="usd">975000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzIwNDk_ef51cd3f-633d-4359-8a6f-5c1d952537f8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE J &#x2013; WEIGHTED AVERAGE SHARES OUTSTANDING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,430.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,412.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,413.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,409.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the third quarter and first nine months of 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; positions in those periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net income (loss)&#160;per common share - assuming dilution&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the later of the May 27, 2020 issuance date or the beginning of the reporting period to the extent that the effect is dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the third quarter and first nine months of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; was reduced by cumulative &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Preferred stock dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, as presented in our unaudited condensed consolidated statements of operations, for purposes of calculating EPS. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issued approximately three million shares of our common stock in the third quarter of 2020, two million shares in the third quarter of 2019, eight million shares in the first nine months of 2020, and nine million shares in the first nine months of 2019, following the exercise of stock options, vesting of deferred stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first nine months of 2020 or 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzIwNTY_e5427ecb-2ae5-4695-92bb-99a4b800ff5c">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average shares outstanding - assuming dilution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,430.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,412.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,413.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,409.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItMS0xLTEtMA_7c3c44f6-cdd9-4eae-81e2-db343165bf6a"
      unitRef="shares">1430900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItMy0xLTEtMA_ec8bdd64-ad4b-4514-9066-5c8f9e40a62c"
      unitRef="shares">1393100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItNS0xLTEtMA_6bc42d5d-8663-4963-956f-e5ec45558cc4"
      unitRef="shares">1413000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzItNy0xLTEtMA_32e753d2-429e-4656-83a3-d6193136ec88"
      unitRef="shares">1390600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtMS0xLTEtMA_143bf555-8954-404f-8be1-234d6a9d88df"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtMy0xLTEtMA_700b9275-3e0c-4dc9-b2ba-33b2146da752"
      unitRef="shares">19000000.0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtNS0xLTEtMA_a8f26ac2-2890-4190-bede-57ba58f12ade"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzMtNy0xLTEtMA_6dd02ad6-ee5e-4f68-9c8f-261c9601100c"
      unitRef="shares">19100000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtMS0xLTEtMA_81496a9f-f35d-4c9b-8a53-3bec2019288c"
      unitRef="shares">1430900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtMy0xLTEtMA_c6cb21bb-22ac-42e2-b702-d868bb48d529"
      unitRef="shares">1412200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtNS0xLTEtMA_cf594b3d-1192-44a4-aef4-8959666256bd"
      unitRef="shares">1413000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTo3OThmYmM5OWE4YjE0N2VmODQ2ZDNjNmNkODU0Njg4ZC90YWJsZXJhbmdlOjc5OGZiYzk5YThiMTQ3ZWY4NDZkM2M2Y2Q4NTQ2ODhkXzQtNy0xLTEtMA_c2e6d36c-b27b-44d8-8238-b4a1a1041002"
      unitRef="shares">1409700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzIwNTA_c64e85ee-9918-473f-9a52-9df5f87af6ca">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock equivalents (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options outstanding (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCPS (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the third quarter and first nine months of 2020 due to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; positions in those periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note I &#x2013; Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic5e5a839e6644a3ebe0fc87afb8652b7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItMS0xLTEtMA_2d51adfc-b2c7-4ad2-8b7f-b43f6d1a293c"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iff49d6c4be2d449b9e042d9f93d88310_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItMy0xLTEtMA_90f03de0-8f78-43c2-9c7b-509a5609f27c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1a93e002d5af493191d6045b6aa338c8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItNS0xLTEtMA_beca971e-5e22-4824-9391-c6c86b0155e5"
      unitRef="shares">14000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if33d9aa5eec440d1be0ea74cd2b49d11_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzItNy0xLTEtMA_fa4d105e-c6f5-47a4-bfc3-e7bacc3337ac"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iefe224921843489fa50e4d09095407c2_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtMS0xLTEtMA_538c4173-d234-4912-bf04-1dcb0da9f7d8"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i833e41e801144751afbac73b9aa9265c_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtMy0xLTEtMA_f728ef7d-3be3-4908-bf1e-16d3aaa5ed19"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i35462ec189f045ddae63069211960cb6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtNS0xLTEtMA_d7c4f1af-c584-46af-a0d6-b7e6211bde87"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic884158bc4a143839655392d299dbb94_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzMtNy0xLTEtMA_4d6b5765-c6fd-4d6c-a829-731d8ebd0b16"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iefa2ca97a83b42d4bf746ff34f43d60d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtMS0xLTEtMA_5e0e1803-24d9-48df-bd01-743fb3ae7a39"
      unitRef="shares">24000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idf5f2e440b564accbedba954cc39048b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtMy0xLTEtMA_3fed3797-cc20-4dcf-b688-c4b03674efdd"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i96632a4cb64d4dc6badba032df2ac6a3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtNS0xLTEtMA_96e6c2f6-9481-4d3d-8d36-3d557aae9456"
      unitRef="shares">11000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iedfe6f2561594c8ea46a25a3b46e254b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90YWJsZTowMmMwNDI1MzQyZTY0MWZiOWU5YjZjZjU4YmMwMGNhYS90YWJsZXJhbmdlOjAyYzA0MjUzNDJlNjQxZmI5ZTliNmNmNThiYzAwY2FhXzQtNy0xLTEtMA_f5b9befe-d9fe-47b6-8cc8-656c58850215"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE1Nzk_681bc10a-ec5d-433f-af46-cbf9892deacf"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE2NTY_79b3a86b-ae1a-46e6-990c-d986768d268e"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE3MzM_6e7e4ae0-1368-4e60-9a16-b02a093b242e"
      unitRef="shares">8000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMDkvZnJhZzo1ZDU5MzY0NWU2ZjA0YzM4YmM0YTEzM2UwNjVjYjg1Yy90ZXh0cmVnaW9uOjVkNTkzNjQ1ZTZmMDRjMzhiYzRhMTMzZTA2NWNiODVjXzE3OTk_e3726bf9-357d-4457-9aaf-44bda2db1cd4"
      unitRef="shares">9000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90ZXh0cmVnaW9uOjQzNTY2NDE1NzQ5MDRlYTk4YTVjNmM0NWVjZGZkMTg3XzE5NDk_1b49f8e8-0973-4c4c-96a6-313ed855dcd9">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE K &#x2013; SEGMENT REPORTING &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, intangible asset impairment charges, acquisition/divestitures-related net charges/(credits), restructuring and restructuring-related net charges/(credits), certain EU Medical Device Regulation (MDR) implementation costs and litigation-related charges/(credits). Although we exclude these amounts from operating income of reportable segments, they are included in reported &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in our unaudited condensed consolidated statements of operations and are included in the reconciliation below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following our integration of BTG, the acquisition of which closed during the third quarter of 2019, we have included BTG&#x2019;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#x2019;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. In our Quarterly Report on Form 10-Q for the period ended September 30, 2019, we presented Interventional Medicine and Specialty Pharmaceuticals together as "BTG Acquisition" and outside of our operating and reportable segments for sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. We have revised amounts for the third quarter and first nine months of 2019 to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,323&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,807&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,831&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,218&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;693&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income of reportable segments as a percentage of net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90ZXh0cmVnaW9uOjQzNTY2NDE1NzQ5MDRlYTk4YTVjNmM0NWVjZGZkMTg3XzU1_ff2e0053-e09a-489b-8fd1-d17404d278bf"
      unitRef="reportablesegments">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90ZXh0cmVnaW9uOjQzNTY2NDE1NzQ5MDRlYTk4YTVjNmM0NWVjZGZkMTg3XzE5NjA_8146ce27-2ec9-43e7-8868-ec762c2d478e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,323&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,058&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,057&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,807&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,707&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,831&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,218&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other (Specialty Pharmaceuticals)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, including hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(498)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;693&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income of reportable segments as a percentage of net sales of reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedSurg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rhythm and Neuro&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItMS0xLTEtMA_d513ac1d-65cb-44b1-8de8-1c94b1fe7f48"
      unitRef="usd">825000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItMy0xLTEtMA_f52c67de-3fe4-4737-99ef-1b3a0698430f"
      unitRef="usd">845000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItNS0xLTEtMA_6cf04f06-ee5e-4434-abee-afbaa2c77eb0"
      unitRef="usd">2175000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id99149f63a5749519353038bc1faea89_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzItNy0xLTEtMA_149d58ba-a816-4e44-ad59-2a3027e9fe73"
      unitRef="usd">2429000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtMS0xLTEtMA_100135f2-c7a2-44cb-81a0-bccc03e57b7a"
      unitRef="usd">757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtMy0xLTEtMA_bd7e5ff1-8287-47ff-83a5-d81a5f2877d7"
      unitRef="usd">780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtNS0xLTEtMA_e9bdf861-b181-4748-92e3-c85e0327c625"
      unitRef="usd">1985000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0856ffae144147a8a676be77a9661e79_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzMtNy0xLTEtMA_5ced389a-d3ba-41cd-a896-7c51ebcbbfe5"
      unitRef="usd">2323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtMS0xLTEtMA_dadcfe72-d029-4cf5-8e9f-26d4b9865001"
      unitRef="usd">1002000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a7af187ab814d74846a21e66345162f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtMy0xLTEtMA_5a705c7c-c31b-4556-8f05-9343b8f7eaad"
      unitRef="usd">1058000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtNS0xLTEtMA_2dcba0d4-837f-42e6-b209-2544bbf89ad4"
      unitRef="usd">2862000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzQtNy0xLTEtMA_20eb41ad-c14f-42c3-8d6a-c0b2c3d85e88"
      unitRef="usd">3057000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba152e6d345944b6a404d50555024e71_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtMS0xLTEtMA_acc78775-3001-4559-b00b-26c8e03d2dbc"
      unitRef="usd">2584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57d58860b34642148a851e295ba585bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtMy0xLTEtMA_be47c2e3-2f39-4a43-b88e-88e82f2b3602"
      unitRef="usd">2684000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i048389ab0ac64d2c87536a1b5d92aa9c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtNS0xLTEtMA_24863300-47cf-4073-87f8-1dc5256000e5"
      unitRef="usd">7021000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i208885de1f9f46179e0e8abe705b572e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzUtNy0xLTEtMA_bc028ec0-bd5a-44a7-a776-9fc519088514"
      unitRef="usd">7807000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb4d909a6d644667b4efd3a44da3b9d4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtMS0xLTEtMA_91a6e4d5-eb7e-4e07-a3a6-28f059b29a7e"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4eb2858779c49a1a5ea2fe50cf134db_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtMy0xLTEtMA_e0a4c1e4-9a8d-4a16-9e53-ae94abfca67e"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtNS0xLTEtMA_2384c02b-65c1-49f1-b7f7-f520cf13300e"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i650712180e0241db9f0773a48064834d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzYtNy0xLTEtMA_fa9e4595-583b-4de7-9549-d91822edbea2"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctMS0xLTEtMA_2403f7df-dbd7-48e3-be9a-2ff552c6d607"
      unitRef="usd">2659000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctMy0xLTEtMA_62a11438-61e7-4d04-bc5b-6626363ca40d"
      unitRef="usd">2707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctNS0xLTEtMA_7f35a72c-45e5-4f4a-b937-547809260201"
      unitRef="usd">7204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzctNy0xLTEtMA_9a0fca61-9b9d-4b64-bb7c-15003bf3ab11"
      unitRef="usd">7831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTEtMS0xLTA_802e2257-0615-49ef-b107-94d1bfddd9f8"
      unitRef="usd">307000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTMtMS0xLTA_e58a53dd-4474-44b8-b074-1165106e88bf"
      unitRef="usd">319000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTUtMS0xLTA_5dcf7c46-0390-4de9-b9e0-dbeec2c0f1ca"
      unitRef="usd">738000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="id99149f63a5749519353038bc1faea89_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzExLTctMS0xLTA_f7427e95-53c4-4474-8403-9797d3ddff29"
      unitRef="usd">870000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTEtMS0xLTA_8b7cb4db-d97c-4e11-aee2-083bd6b1f05e"
      unitRef="usd">165000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTMtMS0xLTA_0fd5ac30-4613-4c37-8fcb-30ceb5e53904"
      unitRef="usd">166000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTUtMS0xLTA_0532309a-c9f0-4ba7-82aa-515a5de6d710"
      unitRef="usd">296000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i0856ffae144147a8a676be77a9661e79_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEyLTctMS0xLTA_b02b89c5-a3fe-4a97-8b01-cbd736d0ecc5"
      unitRef="usd">488000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTEtMS0xLTA_afde0179-fd92-41ae-80ec-269b2afc843d"
      unitRef="usd">208000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="i3a7af187ab814d74846a21e66345162f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTMtMS0xLTA_bc8796db-8259-4eeb-a20f-86ae93c1ffb1"
      unitRef="usd">283000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTUtMS0xLTA_e88dc4d8-6070-4247-8106-a795ada42f15"
      unitRef="usd">593000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <bsx:OperatingIncomeAllocatedToReportableSegments
      contextRef="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzEzLTctMS0xLTA_c7c6bf41-efed-487c-a3f7-362ab5f371c6"
      unitRef="usd">860000000</bsx:OperatingIncomeAllocatedToReportableSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8a76ba5fa6be4f6ca2865115cd913496_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTEtMS0xLTA_231dc0b3-f2dd-49b7-bf3d-60f11830b6bc"
      unitRef="usd">680000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0a591219122f4c2a8f9ec4a0684b5227_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTMtMS0xLTA_34a05465-c667-4621-b062-08459c0806b6"
      unitRef="usd">768000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaa3ec4a2e86a478a9dabb51fefdcad78_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTUtMS0xLTA_a8076491-1bc5-4246-88f3-62891aa44de7"
      unitRef="usd">1628000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5295e2ecdd9d4b8ea224afddd4be5043_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE0LTctMS0xLTA_5e11f459-4a8d-49d6-9670-2e83721ccf06"
      unitRef="usd">2218000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibb4d909a6d644667b4efd3a44da3b9d4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTEtMS0xLTA_02a88f3c-21c4-4b32-9315-adde5a3d61fc"
      unitRef="usd">49000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie4eb2858779c49a1a5ea2fe50cf134db_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTMtMS0xLTA_a958d285-6835-4df6-b924-3f3271aba2ed"
      unitRef="usd">13000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTUtMS0xLTA_4c194add-b19c-4038-89d7-4c21bfc1b09e"
      unitRef="usd">124000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i650712180e0241db9f0773a48064834d_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE1LTctMS0xLTA_9dae1174-7646-4b2c-a751-f701bb5713e5"
      unitRef="usd">13000000</us-gaap:OperatingIncomeLoss>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i1cb8cadf62d949b495b63577e0fda131_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTEtMS0xLTA_84de4a91-2857-4865-9ade-f2da2ff3c9f6"
      unitRef="usd">108000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i4d28c3b1694d4c69bd90388ac8bed40a_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTMtMS0xLTA_1cbc812c-7ecb-43d6-a506-7aa335e042a8"
      unitRef="usd">75000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ib92234b181bc4d4f89de8646d2dd9fa3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTUtMS0xLTA_21d307aa-5982-441b-b613-9054546ffd97"
      unitRef="usd">330000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i5664ea4ee0564071be7fd04ebb16c8e4_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE3LTctMS0xLTA_d7c9b95e-16f9-4a15-b5d2-d4eecfe3e942"
      unitRef="usd">215000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="id5f90b3ff4704d268311e2eb4815f7cd_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTEtMS0xLTA_9671c494-61de-4181-98fc-f4a70ebe9370"
      unitRef="usd">629000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i74aa340bfd624b43833d9080bc81a794_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTMtMS0xLTA_eedd754b-341c-43e3-b185-256fcf33602f"
      unitRef="usd">146000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="i7b628b4b4bcd4356b45406733cf96466_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTUtMS0xLTA_a8d64df5-df1d-4529-bf42-70cc1f8c49d7"
      unitRef="usd">957000000</bsx:OperatingIncomeUnallocatedToSegment>
    <bsx:OperatingIncomeUnallocatedToSegment
      contextRef="ieeca9d8fa162485891beef8cec914fa9_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE4LTctMS0xLTA_62461233-0db6-4f0f-a493-45cd65b5fe0d"
      unitRef="usd">210000000</bsx:OperatingIncomeUnallocatedToSegment>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTEtMS0xLTA_55da2737-f649-45b4-b71a-3a7e33fd6533"
      unitRef="usd">197000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTMtMS0xLTA_11f7771a-55aa-43fc-8d09-6e8cfcd9dd3e"
      unitRef="usd">178000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTUtMS0xLTA_5fb8bdfb-602c-4a85-8df0-21bedd7daffa"
      unitRef="usd">595000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzE5LTctMS0xLTA_0f401640-a526-474b-b8d8-15a7fbb53e55"
      unitRef="usd">498000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTEtMS0xLTA_34462ddb-b2bb-4548-ba34-746f56dc6b1c"
      unitRef="usd">-205000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTMtMS0xLTA_9b260bb7-ba8f-40b7-aaac-1ed96274746f"
      unitRef="usd">383000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTUtMS0xLTA_b1289db5-3373-454e-8f91-4e85526a4209"
      unitRef="usd">-130000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIwLTctMS0xLTA_532710d3-8970-48bd-83a1-b46c6c1474cd"
      unitRef="usd">1308000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTEtMS0xLTA_eea1ddd7-2107-4ed9-a8e0-eda2fb4efc1e"
      unitRef="usd">-22000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTMtMS0xLTA_dda37faa-9759-4fe2-a508-023446416819"
      unitRef="usd">-292000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTUtMS0xLTA_db4c0af4-5ab6-4056-bda7-997be5561120"
      unitRef="usd">-256000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIxLTctMS0xLTA_86eecda4-d2e6-4626-a0b8-3703114cf61d"
      unitRef="usd">-615000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTEtMS0xLTA_499fb652-88f2-48bb-ba67-93554d3a0ca7"
      unitRef="usd">-227000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTMtMS0xLTA_0c3915f2-27f8-4347-b0e0-6389d874ba21"
      unitRef="usd">91000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTUtMS0xLTA_a03211b8-41b1-4ad7-b43c-ce082438982b"
      unitRef="usd">-386000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzIyLTctMS0xLTA_47850e24-502b-47e4-922c-7b378bdcf030"
      unitRef="usd">693000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="ic36bb7b6e4b049649b666f05b357c2d5_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTEtMS0xLTA_4225b29d-2e88-437c-bfd1-fcc7f5299f21"
      unitRef="number">0.372</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i696952cac71b4a78b0a0b8689f49cff0_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTMtMS0xLTA_d0d5ebde-16af-4449-9c1f-52b1fbf37930"
      unitRef="number">0.378</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="ice50b087c0af47fab23de83f81c50cda_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTUtMS0xLTA_76734d04-03ae-471f-ba1f-b70cc0f71029"
      unitRef="number">0.339</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="id99149f63a5749519353038bc1faea89_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI2LTctMS0xLTA_38ae9fae-12f4-4d77-aee4-c7707d124e36"
      unitRef="number">0.358</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="iedcaa18d80f34ecd8a7e366d5ef65c51_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTEtMS0xLTA_4963e948-c933-42c0-b526-dac61f87a9d0"
      unitRef="number">0.219</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i1119dd7ed60e421c96b79b5343a56db5_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTMtMS0xLTA_84f39d3a-132e-4aff-a75a-acb7fa8dabaa"
      unitRef="number">0.213</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="ia32c5c68e1584780b49485431c11519d_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTUtMS0xLTA_ed5eb530-69ed-42ba-ba15-ce701076326e"
      unitRef="number">0.149</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i0856ffae144147a8a676be77a9661e79_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI3LTctMS0xLTA_d63e2bd2-f033-4cb9-add6-6575667d47fc"
      unitRef="number">0.210</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i4959c3cbc75e4593a190f15c17e6b48c_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTEtMS0xLTA_a47f1f87-77ce-493e-981d-c4af4ca864a1"
      unitRef="number">0.208</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="i3a7af187ab814d74846a21e66345162f_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTMtMS0xLTA_96caf9fa-fe73-4924-b014-b6f1206a67ee"
      unitRef="number">0.267</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="ia4f37ef9b3a640c59a8cdc6b1994d1b6_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTUtMS0xLTA_a1047d76-f321-4426-a4fb-b579726514a6"
      unitRef="number">0.207</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <bsx:SegmentOperatingIncomeasaPercentageofNetSales
      contextRef="ieb518f5f73914257841e56bc7b5b302c_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTUvZnJhZzo0MzU2NjQxNTc0OTA0ZWE5OGE1YzZjNDVlY2RmZDE4Ny90YWJsZTo3MmQxZWM4ZTU1NzI0MjMxYTM4MjRmNDFhMWUxMDJlMC90YWJsZXJhbmdlOjcyZDFlYzhlNTU3MjQyMzFhMzgyNGY0MWExZTEwMmUwXzI4LTctMS0xLTA_d5f2cb85-7adb-4111-bb23-b49771f6adb6"
      unitRef="number">0.281</bsx:SegmentOperatingIncomeasaPercentageofNetSales>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzI3NzU_156133ee-8359-46a6-954c-337595e3ff0f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE L &#x2013; REVENUE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our unaudited condensed consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,369&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,831&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,831&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets, which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are classified within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other long-term liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in our accompanying unaudited condensed consolidated balance sheets. Our deferred revenue balance was $405 million as of September&#160;30, 2020 and $400 million as of December&#160;31, 2019. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#x2122; Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. We recognized revenue of $28 million in the third quarter and $84 million in the first nine months of 2020 that was included in the above contract liability balance as of December&#160;31, 2019. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit and record the amount for estimated sales returns as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. We recently received FDA approval and began the U.S. launch of our next generation WATCHMAN FLX&#x2122; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#x2122; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In the third quarter of 2020, we incurred $63 million in revenue charges primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#x2122; Device in the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzI3NzI_8bc767d7-164b-4c26-86a2-23aa545648e3">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,560&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Urology and Pelvic Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm Management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Electrophysiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Cardiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peripheral Interventions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,369&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,831&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Regions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA (Europe, Middle East and Africa)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC (Asia-Pacific)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LACA (Latin America and Canada)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OUS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceuticals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,204&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,831&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets, which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd362ef82b134b30b14976f7ae67e13b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtMS0xLTEtMA_2de45f9b-fb03-4e7e-9a28-45322521f086"
      unitRef="usd">270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id836b0b6f49547e69517df5107404e82_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtMy0xLTEtMA_0f05fdc5-f919-4849-aa9b-88228a95163e"
      unitRef="usd">205000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32e3ab480d844da48762b90ffff4b1f5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtNS0xLTEtMA_475fc703-de78-426f-8c21-a762809e6d01"
      unitRef="usd">475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1f216b357084f708a38791c0e69fa94_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtNy0xLTEtMA_2c6db90d-5671-40ef-b727-c0fdbd9e0266"
      unitRef="usd">277000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18d6d998c42c481582ee64ca962cc159_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtOS0xLTEtMA_284fd85d-4b42-4567-8964-63c899b25d18"
      unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52100b5c46bd49f9a35228954f1c7417_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzMtMTEtMS0xLTA_b9dd5688-3f72-48c0-acf9-bf3c9f3e896d"
      unitRef="usd">486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6fe5ba5da50414d9f4a59566f2373e1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtMS0xLTEtMA_d8b8c739-a696-4075-9102-231d951bc32d"
      unitRef="usd">251000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c61c03b46ac4133a1766da24872ad5d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtMy0xLTEtMA_737f49d6-928c-4fca-a6d1-3decccdddb20"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f063ede9a534803a8c2cca679760529_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtNS0xLTEtMA_e3f7743f-870d-4e09-ac47-5cbf90ece933"
      unitRef="usd">350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf4c42c9955e49e7875feec90a8fca77_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtNy0xLTEtMA_d12ff206-4426-49a7-b878-df6ed3a2c37f"
      unitRef="usd">257000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5da8457277394b6d9cbdbc56a40395dc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtOS0xLTEtMA_47c71d30-4a36-4f61-8f31-a2f8c7de9a4d"
      unitRef="usd">102000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia38b75c07c0a4e8bb20367199b3a3137_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzQtMTEtMS0xLTA_7e988b82-abc9-498a-8f36-0df4e15672f4"
      unitRef="usd">359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57f25f59b9aa4aeb9d25e946e240ceec_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtMS0xLTEtMA_b3325aab-8ef8-4cd6-9e66-583e787fde09"
      unitRef="usd">275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie14bf9c81c71484eae0b513f8fc3ee21_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtMy0xLTEtMA_89370cd1-b681-4432-b74a-76e9710661a0"
      unitRef="usd">190000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dea49b278804d72b2691e583fa76c5a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtNS0xLTEtMA_258070de-14cc-449e-995e-362989017473"
      unitRef="usd">465000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie72716294dd24b2483172c0606c195a8_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtNy0xLTEtMA_b24bdbaf-bed9-4490-bd38-96953096200b"
      unitRef="usd">284000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia82abde4de7a4ad291720e38ace07b19_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtOS0xLTEtMA_323b928d-0134-49a6-a76b-8f55184e3390"
      unitRef="usd">194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c50792aabbf4ddb9b06af0078c9cdb3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzUtMTEtMS0xLTA_4b89af29-707c-4544-aec1-29ce849a7eee"
      unitRef="usd">478000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1997f45a21c8439dbfac180e2b0d74f1_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtMS0xLTEtMA_2879a4bd-3305-4d61-b238-f24a92ad352c"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fff6d00823641e094e51bf1fe888c9b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtMy0xLTEtMA_fa0ebd8e-575f-42c3-8df3-660f828be67d"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28ccbaa46c3c4964a7e1df39c1bc8aed_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtNS0xLTEtMA_bc75579a-a526-4a0e-b43f-e5b9dcad3977"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95675abed3134712b2d78ee5f0f52204_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtNy0xLTEtMA_f261ae73-4e2b-4c08-89b1-909620140407"
      unitRef="usd">38000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd0b86161ea44cba9a228eb7c635dd36_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtOS0xLTEtMA_9f9cca47-5750-432f-93fc-b64641ea0f8b"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80555f6dd4cb40a48dfd0b2587304fc3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzYtMTEtMS0xLTA_fa4aa9b1-1409-4388-959a-a5551b0c6125"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e9e41e9d4c44839842870dff12c933c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctMS0xLTEtMA_a2dc17ca-2984-40d2-b544-daa6a90eadaa"
      unitRef="usd">176000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if81b5cb71db84008b270fc47e76998e6_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctMy0xLTEtMA_2a17ce4c-a976-4e90-9658-d4d9ce68d587"
      unitRef="usd">41000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b15983e106b4e89bda000c883086e9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctNS0xLTEtMA_7d9347ce-cafc-47ce-bc3b-4caf7cb72d8f"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a5f3dece36b4d9797ed5acb0b90daf4_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctNy0xLTEtMA_d9ca4e15-1cf0-403e-80ba-18259416c410"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ab37d97d08e42a7b67c4e7178669c35_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctOS0xLTEtMA_68c1100f-2a1f-4c6b-98ca-d35493f18a54"
      unitRef="usd">39000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0acffb658960466eb1fc67e7ca045948_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzctMTEtMS0xLTA_2ba91230-3260-49bc-ad38-414121c346df"
      unitRef="usd">222000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1ce84bb33df4e31990c5963ff81d63d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtMS0xLTEtMA_b9a111bc-4f1c-4fed-b504-e046fb3cfd61"
      unitRef="usd">255000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9793b506e6474cea8ef7b144ff2a1ba9_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtMy0xLTEtMA_e1fe51a7-923b-4032-a88e-5f836541934d"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1d4510358244d6fae7ec31c72217294_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtNS0xLTEtMA_9bf3f668-e67d-4100-8573-e8c44c08d59a"
      unitRef="usd">586000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib05caee353e041109255daf8c865e2ed_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtNy0xLTEtMA_eaf5f5e5-1013-4427-b35f-5f0f56389c80"
      unitRef="usd">327000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib34d233696a544a1ae2c974370c8315e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtOS0xLTEtMA_f5a45752-5d7c-47fb-8d72-c26f708e54b5"
      unitRef="usd">373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e862fbb1c7d413192549928e2464ffa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzgtMTEtMS0xLTA_09671cbb-d765-4d93-b4c7-41fa337e1e5c"
      unitRef="usd">700000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4de65bc069d24d51825bdab4b50bd41c_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktMS0xLTEtMA_2865dd68-bffb-44a9-82db-099f485390e5"
      unitRef="usd">236000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2099af0836c24bc1b803f81eab14b8a0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktMy0xLTEtMA_c866c25e-608f-40e1-8fbc-782adb5a3edf"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb9fb1a2b2f24fa293105915ff8b08e0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktNS0xLTEtMA_d0455936-75a2-413f-8e87-7ef30dd34ea9"
      unitRef="usd">416000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id280062840b2435eb308bd4c66b47fcf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktNy0xLTEtMA_eedf5614-0390-465c-bddc-513590fba556"
      unitRef="usd">195000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10f1a708d4e547908f94f4cbfefc9425_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktOS0xLTEtMA_a5ef4a87-7f20-47cb-9eb2-42a2f3880eae"
      unitRef="usd">163000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95c352cc7257452c924fa7c4f8f29c39_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzktMTEtMS0xLTA_e63ab700-fb26-461e-a0ab-686ac934d4c0"
      unitRef="usd">358000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9ce64349f174b9898c3ae08f6a8619a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTEtMS0xLTA_32aa4e15-6c5d-4413-87e8-e0c6beaa8fb4"
      unitRef="usd">65000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i891b41394ba84479b8e900b71bab7425_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTMtMS0xLTA_6b37a241-10cd-44ce-9940-e80e881452ad"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacf8b1e5d2d9412d82011f9725561fe7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTUtMS0xLTA_e15cc870-ed88-4020-9e92-ed5bb93e2c72"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0a83ead422742818de6d2d992f45122_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTctMS0xLTA_a4c84c88-7bba-40a1-b105-1750d011637c"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida3a2a8cccb44fe89ad6947ec51b189f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTktMS0xLTA_7bf095e6-6444-4433-a877-6ffa3b89dad8"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if88abe695eff4ec79c92c9b51eb144c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzEwLTExLTEtMS0w_32b2701a-dd30-4a75-a883-f577d73dd749"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i026b1c31e2164480b52d6156bf29ceda_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTEtMS0xLTA_69e78b41-d9f3-4e24-9832-4f0777accd04"
      unitRef="usd">1560000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i083f1c7b584149eda19fe53bf7f9e950_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTMtMS0xLTA_cdf28620-2c76-49ab-a4e1-ed0b95d5dc9f"
      unitRef="usd">1098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTUtMS0xLTA_2403f7df-dbd7-48e3-be9a-2ff552c6d607"
      unitRef="usd">2659000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bca6c5210634d32ba0fb78a24986bfa_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTctMS0xLTA_e93e22c6-4f6f-44a9-a775-2087f4bd0c3f"
      unitRef="usd">1580000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i472c98506bfb45ac973bc5141d646641_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTktMS0xLTA_3306ad01-06db-49cb-8545-6fa9a55afbd4"
      unitRef="usd">1126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTo1NTA1ZDVkY2JkYTk0ODAzODRjYWMyMGZkMzMzNDMyZi90YWJsZXJhbmdlOjU1MDVkNWRjYmRhOTQ4MDM4NGNhYzIwZmQzMzM0MzJmXzExLTExLTEtMS0w_62a11438-61e7-4d04-bc5b-6626363ca40d"
      unitRef="usd">2707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00311d766dd24a468df0201eb3a98a98_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtMS0xLTEtMA_4fbc2454-2b51-45e4-9ebd-8d946ee4b1ad"
      unitRef="usd">715000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb736062dca24512bad3fa08ad4ac3b8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtMy0xLTEtMA_197e7e01-6115-43b1-8088-4f17644c1955"
      unitRef="usd">550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i300d7b781b864c99b873d04c9d8c1861_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtNS0xLTEtMA_eb31511a-b6c7-419e-9965-877365a5c7cc"
      unitRef="usd">1265000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52b26fb08edb4643836d722d1433826c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtNy0xLTEtMA_6680b28b-de70-4620-b7ad-e1f3ca1897b8"
      unitRef="usd">800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5f8b764815543ca89b15a0f65b4286a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtOS0xLTEtMA_0fcf7215-1863-4bea-8f91-104f9c61736b"
      unitRef="usd">596000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60eaf78208af46938794bfa911789a21_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzMtMTEtMS0xLTA_5b46a1a8-dbe9-4552-a911-5fb643cd361e"
      unitRef="usd">1396000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2104c8e67c9c4f7ea81b0f7fd2d47b1b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtMS0xLTEtMA_bef14f5d-84bc-445b-8489-54ae36d71796"
      unitRef="usd">650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4c6abc5823240358a6851a296ac9701_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtMy0xLTEtMA_5f1a1118-6583-4de5-827e-7c7a09cca759"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bab7eecd6e84feaaa75ed43b6cc6db4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtNS0xLTEtMA_b723a6c2-cc22-430b-bfc0-77b29b5b755e"
      unitRef="usd">910000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b57559a2bd8439daa00da2ce3307b8c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtNy0xLTEtMA_4e6d14bc-2787-4679-8624-8f6450888853"
      unitRef="usd">737000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb32d52b9c8243efbabe0b365289bfbf_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtOS0xLTEtMA_639b687f-25ef-43fb-a2b5-9f20cf95eb59"
      unitRef="usd">297000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i979e2c7f0cad4c01a72c0aa7ef8b510a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzQtMTEtMS0xLTA_8207bc49-e616-4ea2-9b5b-2178dec41011"
      unitRef="usd">1033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia41a939d6e964fdb92096b0fe824a09b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtMS0xLTEtMA_5559bec6-02d4-4e56-ac5f-c7bf5b92d4a5"
      unitRef="usd">738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied533bdc632d4ce0a14378174c2760eb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtMy0xLTEtMA_ab8f1e5d-7a0f-41f1-9128-bdcb05c02d42"
      unitRef="usd">515000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09381a44114941a4a42b342af6277fcb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtNS0xLTEtMA_9a4bf778-23f3-4a61-ab6e-f28b910eaa82"
      unitRef="usd">1253000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic24f0a567b61489ea559da0492eb8bd2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtNy0xLTEtMA_ece85057-8568-4010-b22c-60403ec63092"
      unitRef="usd">860000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i848dace5f06f4632b8e52342192aaa89_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtOS0xLTEtMA_fb181b92-2cc1-47db-a90e-55506cc9ce3c"
      unitRef="usd">607000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie907d1127d5b4f1891715b552d0f2720_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzUtMTEtMS0xLTA_5eaea30d-5bf8-4999-9751-08bf740cd98f"
      unitRef="usd">1467000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i332f62f3ea2842fab11b86ca30dc2375_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtMS0xLTEtMA_13d59c2b-0937-484a-b9a1-7f33df90bbe7"
      unitRef="usd">86000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1119d578b4ea4da9bf0365681fa56dc8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtMy0xLTEtMA_99127d7e-f448-4edd-98d8-496c938041b8"
      unitRef="usd">116000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cc7104ff33e4c48b5d13452491f1ce5_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtNS0xLTEtMA_535b8a14-1784-4c7b-a6d1-368408445afa"
      unitRef="usd">202000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i717f0d15b6c94e21a894833031631fca_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtNy0xLTEtMA_38e2b09f-86fe-4589-bd79-9f46b1f25952"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15ca578eb6044b1296051e9a07918f73_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtOS0xLTEtMA_1e32e898-c436-4756-bc57-bd3625d14dfd"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1973b158c2c7411ca93ed11aa1f7120b_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzYtMTEtMS0xLTA_f02e7285-eb84-43eb-82b5-db9d90aa43a6"
      unitRef="usd">245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i623c86db3713458ca2b7defbbf8058c7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctMS0xLTEtMA_95c6976b-1f05-4302-a33f-aa3cee2ef4c8"
      unitRef="usd">426000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89f9578856994687889ca858501676b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctMy0xLTEtMA_dab1de41-e39b-405d-acc8-3a5b8f55636c"
      unitRef="usd">103000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4f70470d3bd48dcbc4feb2bc35e086d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctNS0xLTEtMA_a4f3f94e-e346-4f62-83a3-59cf5e927787"
      unitRef="usd">529000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75f2988c1732418c928a801db05c25b5_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctNy0xLTEtMA_7166182d-c0a2-4dba-9b48-51a6c4564d8b"
      unitRef="usd">487000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i986f91df9ca9493a8d7d15802a1c0570_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctOS0xLTEtMA_68e8ee6a-330b-4960-8ec1-fe07497bea18"
      unitRef="usd">125000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f8c7b64fc864c49a306a9b4254fbaa7_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzctMTEtMS0xLTA_c159faad-6f1b-4de4-b761-011c501b5bcf"
      unitRef="usd">612000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i705232db70004ea088c0dc1093c8b9df_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtMS0xLTEtMA_3b166427-e604-419e-ac02-c2d4ac836bc2"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36bcd3ce2ebe47c5bd79a16c0d3b29d9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtMy0xLTEtMA_2a5e499a-993f-4ca4-b1d9-126631246a32"
      unitRef="usd">973000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81ba0222e4aa4c59984dae3c8006ad93_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtNS0xLTEtMA_3d38128d-0098-42f5-86fa-880c2ecb18af"
      unitRef="usd">1714000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i020fd119041d418191cf85bbfc54285c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtNy0xLTEtMA_92eb2931-a0a1-4924-a4c3-a4c4b6aeffda"
      unitRef="usd">942000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e13b532f9a64e418eb80c0976c3b6af_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtOS0xLTEtMA_307137d6-8cbc-4446-b087-5fc2ee8215b9"
      unitRef="usd">1126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49f9023219ff48cba3a2fc8ae591929a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzgtMTEtMS0xLTA_8711b5d0-df1c-464a-b1e9-e2b7f7c01dae"
      unitRef="usd">2067000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i105ce581a7544f47ad757216472bcc6d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktMS0xLTEtMA_128a8c16-c47b-4913-8c6b-ac0725732a40"
      unitRef="usd">649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59107e082d014734a4ee490225fe5ffa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktMy0xLTEtMA_0e7ceb52-9d3b-4d50-904a-cfee8db83ffe"
      unitRef="usd">499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba53a1d39d394e8280b268a72077bd5a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktNS0xLTEtMA_56f72b4c-372a-4192-ad42-5d1f21df84e8"
      unitRef="usd">1148000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i625dce25ac3c45a38e0390b9592977f2_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktNy0xLTEtMA_a3b587a6-9018-443a-8a36-94b63f6cb3f4"
      unitRef="usd">507000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3551557143ac42dc88cc80b58e98bdb0_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktOS0xLTEtMA_ed1e1328-61f3-4109-aedc-4d4523f93ac3"
      unitRef="usd">482000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd4fa8afd39046fc92a81f01071f2a60_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzktMTEtMS0xLTA_7785ed67-3027-4247-ad66-5604fdb71db6"
      unitRef="usd">989000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d6e62892f954227b719df17b5bc2c30_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTEtMS0xLTA_4ba2cdca-c8cb-412a-953c-4e346388c396"
      unitRef="usd">162000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i673c5b0fb6fe4743aa18d48721035a1d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTMtMS0xLTA_ef8fb4e2-a562-4bd1-8190-e1f676a4908f"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0973dfbf233346ae9842c7feb92c7fd1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTUtMS0xLTA_2384c02b-65c1-49f1-b7f7-f520cf13300e"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3f2be30198a405d8b8ea83a69eaf25f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTctMS0xLTA_80f9926c-d81e-4d06-bc0a-3cab376177ad"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea70c191ce524d3f869a4a09e65e620f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTktMS0xLTA_a008f848-7899-4126-86b9-1fc8552e4be4"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a3a8a2f83894a3296a3091b4bb232db_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzEwLTExLTEtMS0w_e63641d8-6368-4e35-8fa4-fc155f53cb5e"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6888bf8540af4896a7727d330b9361f8_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTEtMS0xLTA_506bcc21-ba66-4373-879f-d9e95a162f26"
      unitRef="usd">4167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b5dcb6fca7c446dacf97994b28f8ad3_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTMtMS0xLTA_3e9b0ac3-026f-4f56-9f3b-9e1a5ce31743"
      unitRef="usd">3037000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTUtMS0xLTA_7f35a72c-45e5-4f4a-b937-547809260201"
      unitRef="usd">7204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8128a4d029a94bb89cb486f5c5f0eb0a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTctMS0xLTA_a504bddf-95d3-45f5-935b-44934232452a"
      unitRef="usd">4462000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d9ab6494b964761bf03a135b4b4f64f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTktMS0xLTA_d6c338b0-7be3-4c43-88fc-403ddfad32f8"
      unitRef="usd">3369000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZToxZjc3NGQ5N2FkNjU0MjNiYjU2ZTI5YjU4ZTAyZjYxYS90YWJsZXJhbmdlOjFmNzc0ZDk3YWQ2NTQyM2JiNTZlMjliNThlMDJmNjFhXzExLTExLTEtMS0w_9a0fca61-9b9d-4b64-bb7c-15003bf3ab11"
      unitRef="usd">7831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i657eb7c32c324e8894346cfcb27b2689_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItMS0xLTEtMA_1839ede9-79d2-4bf4-85d1-49ebaa395f96"
      unitRef="usd">1496000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id843d2538e014a02a8d63e8255b29a90_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItMy0xLTEtMA_b981401a-5968-4a63-b598-2669550c4b86"
      unitRef="usd">1561000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id73057f636f442ae8f81a9ac97489ccc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItNS0xLTEtMA_90fa21f8-7909-4d7f-bc19-0182748eef19"
      unitRef="usd">4005000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i781a010211e840dc81fc687839042bbb_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzItNy0xLTEtMA_e9f0bd1a-2df4-43e4-b73c-7234b3a02048"
      unitRef="usd">4443000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54d3e241fffe450cb56f3a263380bccb_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtMS0xLTEtMA_c6a4a440-4c2e-4349-bc47-8f1037eb67ee"
      unitRef="usd">540000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f3e53dc9ca94bae9d18d4780150080e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtMy0xLTEtMA_e56ccaa5-0fae-4117-8755-bf601ace50a5"
      unitRef="usd">535000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8128e54be7e454695b08432140f99cc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtNS0xLTEtMA_804d5152-c0b7-4cb5-8f5d-59a7718129c0"
      unitRef="usd">1507000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5be373172e034996889706e0c8fad15c_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzMtNy0xLTEtMA_7f78709b-da47-4783-a663-e1fef1005d76"
      unitRef="usd">1667000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4e40dd0d92b4f80be9dc394e4027845_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtMS0xLTEtMA_bfd894c1-586a-48d9-98da-1ddf278805d4"
      unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a16b3866b9041938a6c24f85548a18b_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtMy0xLTEtMA_654fcbd6-d4c8-43ee-baa3-8dce0258bec6"
      unitRef="usd">485000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5aec6e059674fe0994035b7a01bb825_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtNS0xLTEtMA_8f5e9f4b-8653-4133-b547-6a93852a5e67"
      unitRef="usd">1292000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i630933314e5e4cf5bfcc14419acec677_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzQtNy0xLTEtMA_e6d1aef0-69b2-45b6-839b-e6f45c3be3f5"
      unitRef="usd">1403000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8511168847a45e096f858b26873d803_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtMS0xLTEtMA_eda6671f-5935-4164-b589-635c21b4bc03"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c9704b036b149d689349b41b329038e_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtMy0xLTEtMA_f0465717-5a61-493e-8357-a2cc929c6073"
      unitRef="usd">102000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id81bb93af48745e6a559b70678953bfa_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtNS0xLTEtMA_1dcbaa3c-8df7-4083-9bb8-5fba9101f398"
      unitRef="usd">217000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifba26fb5d1414c919d17e80bdc02dd30_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzUtNy0xLTEtMA_8a72b870-76b2-48fb-b0cd-d5496416b2af"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba152e6d345944b6a404d50555024e71_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtMS0xLTEtMA_0069db0c-d2be-4a85-a71b-31b3e1e8cb9b"
      unitRef="usd">2584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57d58860b34642148a851e295ba585bf_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtMy0xLTEtMA_b1161e30-58a9-42af-96fa-fa54868d35ec"
      unitRef="usd">2684000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i048389ab0ac64d2c87536a1b5d92aa9c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtNS0xLTEtMA_e12f0054-6350-4d0e-9532-ac50590d8297"
      unitRef="usd">7021000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i208885de1f9f46179e0e8abe705b572e_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzYtNy0xLTEtMA_01e60194-e145-4ea9-9f10-c3107b001e01"
      unitRef="usd">7807000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9ce64349f174b9898c3ae08f6a8619a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctMS0xLTEtMA_32aa4e15-6c5d-4413-87e8-e0c6beaa8fb4"
      unitRef="usd">65000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0a83ead422742818de6d2d992f45122_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctMy0xLTEtMzE4_a4c84c88-7bba-40a1-b105-1750d011637c"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d6e62892f954227b719df17b5bc2c30_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctNS0xLTEtMA_4ba2cdca-c8cb-412a-953c-4e346388c396"
      unitRef="usd">162000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3f2be30198a405d8b8ea83a69eaf25f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzctNy0xLTEtMzM2_80f9926c-d81e-4d06-bc0a-3cab376177ad"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i891b41394ba84479b8e900b71bab7425_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtMS0xLTEtMA_6b37a241-10cd-44ce-9940-e80e881452ad"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida3a2a8cccb44fe89ad6947ec51b189f_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtMy0xLTEtMzE4_7bf095e6-6444-4433-a877-6ffa3b89dad8"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i673c5b0fb6fe4743aa18d48721035a1d_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtNS0xLTEtMA_ef8fb4e2-a562-4bd1-8190-e1f676a4908f"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea70c191ce524d3f869a4a09e65e620f_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzgtNy0xLTEtMzM5_a008f848-7899-4126-86b9-1fc8552e4be4"
      unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacf8b1e5d2d9412d82011f9725561fe7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktMS0xLTEtMA_e15cc870-ed88-4020-9e92-ed5bb93e2c72"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if88abe695eff4ec79c92c9b51eb144c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktMy0xLTEtMA_32b2701a-dd30-4a75-a883-f577d73dd749"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i585a4990b22043b7a34314da74c8dcc7_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktNS0xLTEtMA_8df36c75-de87-46c0-ae82-d21917dbfcb0"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a3a8a2f83894a3296a3091b4bb232db_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzktNy0xLTEtMA_e63641d8-6368-4e35-8fa4-fc155f53cb5e"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTEtMS0xLTA_2403f7df-dbd7-48e3-be9a-2ff552c6d607"
      unitRef="usd">2659000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTMtMS0xLTA_c9104a88-7ca6-431d-b673-bb42e37438a2"
      unitRef="usd">2707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTUtMS0xLTA_ed67460e-2abe-4035-bb39-9dfa51e3fbae"
      unitRef="usd">7204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTctMS0xLTA_83fd2947-03b7-4abd-ad17-f59e823c3e1e"
      unitRef="usd">7831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEwLTctMS0xLTA_b51fe2ab-1eeb-4072-bcf1-b659e154cb28"
      unitRef="usd">7831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9b2155f584f430289ab76456eb294f0_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTEtMS0xLTA_eea6375a-2c99-425e-9624-5a5c8d2ba80f"
      unitRef="usd">278000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia29baba230164973991e71f75d7e2df3_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTMtMS0xLTA_30f5de8d-c3d7-44a8-837e-691e493d0938"
      unitRef="usd">310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dc339cf33204e73b732865ff098bcc1_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTUtMS0xLTA_178908b7-2c0b-4009-8ad7-ab700df00df6"
      unitRef="usd">800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie15b282dade649b69746d0ac5cab9434_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90YWJsZTozZTgwOTkxOWYyNjc0MmMzOWJhNzBjYWE1ODhhNmQ1Zi90YWJsZXJhbmdlOjNlODA5OTE5ZjI2NzQyYzM5YmE3MGNhYTU4OGE2ZDVmXzEyLTctMS0xLTA_7e1ba743-06fd-488f-9de7-1baf03004d71"
      unitRef="usd">925000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <bsx:EmergingMarketstotalnumberofcountries
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzMxMg_98ce6fd6-e78a-4bee-8a2f-0447477a0312"
      unitRef="units">20</bsx:EmergingMarketstotalnumberofcountries>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4Xzk0Nw_800f7ed8-8cd2-4f85-a395-6f326ef219b4"
      unitRef="usd">405000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4Xzk2Mw_02772638-e6a1-4c36-a43b-f81074b13895"
      unitRef="usd">400000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzEyMjY_8e0dec98-97c3-454e-ba2f-10ed5eb8b889"
      unitRef="usd">28000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzEyNTE_f0d08c46-45d4-4c1b-87f3-1a7c2870456f"
      unitRef="usd">84000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMTgvZnJhZzpkY2Y3ZWM1NGRjYWE0ZDZkYTI2YTIzYmU5MzViMDE3OC90ZXh0cmVnaW9uOmRjZjdlYzU0ZGNhYTRkNmRhMjZhMjNiZTkzNWIwMTc4XzI3NDg3NzkwODUyNjk_f7f3cb34-0b2d-4f44-91b5-8e38b9612ad6"
      unitRef="usd">63000000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90ZXh0cmVnaW9uOjg2MTFkNzA1NDViMzRmNjNhN2MyMDllZDdkMjQ3NDgyXzY0Mg_0722dd14-c59f-42ab-b9e5-9715091ef061">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE M &#x2013; CHANGES IN OTHER COMPREHENSIVE INCOME &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note D &#x2013; Hedging Activities and Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further detail on our net investment hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our cash flow hedges recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net change in derivative financial instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive income (loss), net of tax&lt;/span&gt; were reduced by immaterial income tax impacts in the third quarter and first nine months of 2020 and 2019.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90ZXh0cmVnaW9uOjg2MTFkNzA1NDViMzRmNjNhN2MyMDllZDdkMjQ3NDgyXzY0NA_98714fad-e714-4deb-ae26-47e2a0573d90">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide the reclassifications out of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss), net of tax&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;222&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Derivative Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Change in Defined Benefit Pensions and Other Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) loss amounts reclassified from accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtMS0xLTEtMA_049777f0-1bb3-4616-8116-06227de93319"
      unitRef="usd">-46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtMy0xLTEtMA_00f406ca-acaf-412e-a812-a76fb2170ae0"
      unitRef="usd">222000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtNy0xLTEtMA_bf3cdd23-88e1-4b69-b224-166b31c742a5"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id080ca0787b6468a8ad3d631ea2b1130_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzEtOS0xLTEtMA_5588a774-da52-4c0b-b0b3-747469898031"
      unitRef="usd">131000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItMS0xLTEtMA_4c84822b-0e6a-484d-89a0-ebda97f369ea"
      unitRef="usd">88000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItMy0xLTEtMA_d621b7d3-c3b6-4fd4-b48e-f3b773471188"
      unitRef="usd">-50000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItNy0xLTEtMA_7d2656fe-d5ae-4eb1-bf5c-d4c06d52ae7f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzItOS0xLTEtMA_88fb17ef-3a7c-4338-ac27-5e55cfc0bd66"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtMS0xLTEtMA_1e4b96a1-7d9a-40a2-aaa4-f81fb227f352"
      unitRef="usd">-5000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtMy0xLTEtMA_74893298-ad6f-4a6c-9bcf-0c117cd1074b"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtNy0xLTEtMA_2ef8f6eb-8960-42ba-b8f0-6b409b461c28"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzMtOS0xLTEtMA_65f3bee6-721a-48c7-89a6-d0b8c73f84ac"
      unitRef="usd">19000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtMS0xLTEtMA_536dede2-b2f6-4563-b58e-7702aea9f5db"
      unitRef="usd">84000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtMy0xLTEtMA_4a2bea45-d7f3-41ec-957a-a195228b65b8"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtNy0xLTEtMA_1b359bd5-cbf3-4f95-8125-71f05b439861"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzQtOS0xLTEtMA_de758055-084b-411b-8eb5-e719752de8dd"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtMS0xLTEtMA_e39ec550-4ab6-4892-9c2f-05205a471ca1"
      unitRef="usd">38000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtMy0xLTEtMA_d701aecd-755e-49ef-a80c-55e1c1b3125d"
      unitRef="usd">158000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtNy0xLTEtMA_d5223829-a26c-477c-8622-3f082b6b39c7"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphMzkzZDUyY2MxMGI0YTkyOTJlMmNmZTQzOGViZGZjMi90YWJsZXJhbmdlOmEzOTNkNTJjYzEwYjRhOTI5MmUyY2ZlNDM4ZWJkZmMyXzUtOS0xLTEtMA_e0c3dab9-8ffb-4201-afea-b035b187b998"
      unitRef="usd">151000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id7aaf89e580246e2979204c398ade960_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtMS0xLTEtMA_c9163386-7e9d-4e52-98c5-8cfad830696e"
      unitRef="usd">-46000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="id7aaf89e580246e2979204c398ade960_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtMy0xLTEtMA_242508c5-2821-431c-8f28-c43aefeb10c8"
      unitRef="usd">150000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id7aaf89e580246e2979204c398ade960_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtNy0xLTEtMA_eb16e90e-f32c-4a17-b7d6-fbafd2960aa9"
      unitRef="usd">26000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id7aaf89e580246e2979204c398ade960_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzEtOS0xLTEtMA_f69b10d5-47a9-4cd5-b406-63cb37abf842"
      unitRef="usd">78000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItMS0xLTEtMA_fbf08b8e-f50b-472b-ba7f-2b9e350d88ce"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItMy0xLTEtMA_4206c911-e165-4448-83be-d265e12ec562"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItNy0xLTEtMA_f4eb8bee-1d22-4512-90d1-69e7febbe411"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzItOS0xLTEtMA_e22a4090-4cad-49e4-b0de-9cbe94584a42"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtMS0xLTEtMA_c78b64fb-705f-4016-9842-61a0f0528a68"
      unitRef="usd">-9000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtMy0xLTEtMA_c6b6c83c-d9fa-4353-973e-c61b69f6b931"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtNy0xLTEtMA_54f983cb-edab-4ff6-bb59-1fa0541fea7b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzMtOS0xLTEtMA_aef8cfbd-a874-41a9-829d-442c9e0d560d"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtMS0xLTEtMA_2106a5d5-b0b3-4b0f-92b0-584b1302952b"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtMy0xLTEtMA_e07a859d-90c8-47c8-b0c3-601e30df6dbd"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtNy0xLTEtMA_9d995a06-ce16-46a5-8e6b-45c43e222fca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id3d5ae192d904df087aeb8e6081338b1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzQtOS0xLTEtMA_4a26f0ec-6ccf-4710-8d44-2f3e1b85cec2"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtMS0xLTEtMA_7643ef06-a3ca-47c3-94cb-11d17630166b"
      unitRef="usd">-48000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtMy0xLTEtMA_142e64f9-4678-4a30-981b-76b4ab093504"
      unitRef="usd">213000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtNy0xLTEtMA_418574ea-4d4b-4c49-8cb6-ab50fbd9d567"
      unitRef="usd">26000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTpkN2FkNGNiZTUwMjc0Y2IzOTc4ZDNlNzY5OTdhMDQ2OS90YWJsZXJhbmdlOmQ3YWQ0Y2JlNTAyNzRjYjM5NzhkM2U3Njk5N2EwNDY5XzUtOS0xLTEtMA_bdb44053-afc3-4fae-ab9b-db5d15dcbaf3"
      unitRef="usd">138000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtMS0xLTEtMA_46ffa41b-0308-42c0-98ea-cd6f83c957e6"
      unitRef="usd">142000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtMy0xLTEtMA_5ee14335-452d-487e-ad30-fe6ab3f9f706"
      unitRef="usd">173000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtNy0xLTEtMA_60556b55-ed12-4336-889d-b278b0a7611f"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i96d357c574ae49f6894555c699e39978_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzEtOS0xLTEtMA_484fb3b5-2f18-466d-b951-39649e112204"
      unitRef="usd">270000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItMS0xLTEtMA_d5ca2f76-34bf-40be-93eb-9ae4d3f99ad5"
      unitRef="usd">-90000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItMy0xLTEtMA_64bbcfbe-f613-4909-8d1c-9120d89d2469"
      unitRef="usd">36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItNy0xLTEtMA_f493ca5c-a843-4372-856e-04eee718555d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzItOS0xLTEtMA_dc4f2cf9-1ad8-4525-981d-8e9717798876"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtMS0xLTEtMA_b75eafdd-ee41-4b01-aaca-66bf2041d08d"
      unitRef="usd">-14000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtMy0xLTEtMA_5560b9e1-e2b9-45e4-93e0-82cd31f9c74c"
      unitRef="usd">52000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtNy0xLTEtMA_7980e13b-6441-4c30-88cc-1654d7c7afcb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzMtOS0xLTEtMA_acfdfb23-e8dc-46b2-b883-fccfd922345d"
      unitRef="usd">65000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtMS0xLTEtMA_b0282837-d7fb-400e-8cc9-54b456b47894"
      unitRef="usd">-104000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtMy0xLTEtMA_5bc52919-dd07-4a32-99be-a2b56f1b6b98"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtNy0xLTEtMA_375f3a7d-5e3d-4b8e-93f3-af2d09c1cc85"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzQtOS0xLTEtMA_330e0719-3c30-4e91-9148-e8a565c40b62"
      unitRef="usd">-119000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtMS0xLTEtMA_aca6dc01-408f-403f-811d-30070f2ad398"
      unitRef="usd">38000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtMy0xLTEtMA_53f743aa-0c79-453e-bc19-31853f578b83"
      unitRef="usd">158000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtNy0xLTEtMA_50cf60d4-c2fb-49ba-be80-21e9471eff54"
      unitRef="usd">45000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i49144bb069c54c75af6cf61abd6b94c0_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTphNmM2OWM3Zjg3ZDE0NzMyYTc5ZmQzYWI5MDc0MWEyNy90YWJsZXJhbmdlOmE2YzY5YzdmODdkMTQ3MzJhNzlmZDNhYjkwNzQxYTI3XzUtOS0xLTEtMA_f0925ef6-19a2-409f-8a01-e9e05701c900"
      unitRef="usd">151000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtMS0xLTEtMA_cc7bc786-4c00-40e5-8f54-a452c1fbb6d7"
      unitRef="usd">-53000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtMy0xLTEtMA_4f42e666-bdea-4f53-a67e-952a124bc9fa"
      unitRef="usd">111000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtNy0xLTEtMA_95dc2c1e-4c70-4ed3-bff3-cac4e9ce9a9d"
      unitRef="usd">25000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1592d8d8dd9340d3b33ae104ab8f5d9c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzEtOS0xLTEtMA_b16a18a0-9291-440c-b77b-d1da66349af7"
      unitRef="usd">33000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItMS0xLTEtMA_2952d7fd-66dd-40a0-ad08-4cb700c2d257"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItMy0xLTEtMA_ea0a11ae-651d-4400-b590-16d170e30ee5"
      unitRef="usd">136000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItNy0xLTEtMA_2d91efdf-eb7c-4dbf-9e9a-8e608689baa9"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzItOS0xLTEtMA_74ccf4ff-843f-4590-b297-11e393d62de8"
      unitRef="usd">165000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtMS0xLTEtMA_f029102b-321a-4c7a-af5a-81cc05971e12"
      unitRef="usd">-25000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtMy0xLTEtMA_ae4fb066-be76-4525-aa2a-08552c4b8f80"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtNy0xLTEtMA_ffbbb9a2-3372-4867-a982-875d554e18c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzMtOS0xLTEtMA_e450b1b4-6330-4d9d-833a-add84929b623"
      unitRef="usd">59000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtMS0xLTEtMA_efd39e73-ceab-4db9-9a69-ea6f4ee326d0"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtMy0xLTEtMA_edc75164-b1c0-4869-90ce-0103ce2f7adf"
      unitRef="usd">102000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtNy0xLTEtMA_901efa94-4ee4-4ff6-a378-88aea63ee5dd"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i124fcd123b574cb6a7dcadcc5298e89a_D20190101-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzQtOS0xLTEtMA_34a5831a-edd5-4967-9240-1977ace72121"
      unitRef="usd">105000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtMS0xLTEtMA_f90af057-c6e3-4602-970f-a04ae7edb4a2"
      unitRef="usd">-48000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtMy0xLTEtMA_982f392a-8a1b-4b6a-9d72-42550c860fc8"
      unitRef="usd">213000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtNy0xLTEtMA_7fd433b3-32af-4810-8b4e-71cb1ff9a881"
      unitRef="usd">26000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icce032be65f744de9ae2f698e732db43_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMjQvZnJhZzo4NjExZDcwNTQ1YjM0ZjYzYTdjMjA5ZWQ3ZDI0NzQ4Mi90YWJsZTozYTViNTdmYjgyMjQ0ZjljYTM2YzRkNTM4NTMzNjM2Mi90YWJsZXJhbmdlOjNhNWI1N2ZiODIyNDRmOWNhMzZjNGQ1Mzg1MzM2MzYyXzUtOS0xLTEtMA_5f7d4019-d696-4408-add0-b832234761ab"
      unitRef="usd">138000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3Njc_f8a289f1-37ee-4282-8f5f-09b76544b181">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTE N &#x2013; NEW ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Standards to be Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-10&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning after December 15, 2020, for public business entities. Early application of the amendments is permitted for any annual or interim period for which financial statements have not been issued. We are currently in the process of determining the effect that the amendments will have on our financial position and results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods.&#160;Early adoption is permitted, including adoption in an interim period.&#160;We are currently in the process of assessing in which quarter to adopt, as well as determining the effect that the adoption will have on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3NDg3NzkwNzQ4NDE_830cfc52-4aa5-4478-a08e-a687b5ddd7d2">ASC Update No. 2020-10&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2020, the FASB issued ASC Update No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Codification Improvements&lt;/span&gt;. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning after December 15, 2020, for public business entities. Early application of the amendments is permitted for any annual or interim period for which financial statements have not been issued. We are currently in the process of determining the effect that the amendments will have on our financial position and results of operations.</bsx:ASCUpdateNo202010CodificationImprovementsPolicyTextBlock>
    <bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3ODc_5ceaa7c2-8795-4e98-b691-2a5d0db4ba70">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;ASC Update No. 2020-06&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASC Update No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Subtopic 470-20) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (Subtopic 815-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock>
    <bsx:ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock
      contextRef="i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhMmU3M2EwYzJhZTQ1NWE4YTVhMzM1Y2Q2MjA5MTUyL3NlYzo4YTJlNzNhMGMyYWU0NTVhOGE1YTMzNWNkNjIwOTE1Ml8xMzAvZnJhZzoxMmI1MzRlZjMxZWQ0NWRlOTk3MTUwOWY1ODcyZGQ3Ni90ZXh0cmVnaW9uOjEyYjUzNGVmMzFlZDQ1ZGU5OTcxNTA5ZjU4NzJkZDc2XzI3NzA_1884cc7e-a4da-4449-a57a-b27a1c384e28">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC Update No. 2019-12 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASC Update No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of Update No. 2019-12 is to continue the FASB&#x2019;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods.&#160;Early adoption is permitted, including adoption in an interim period.&#160;We are currently in the process of assessing in which quarter to adopt, as well as determining the effect that the adoption will have on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</bsx:ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470604086392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Document - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingParValuePerShare', window );">Entity Listing, Par Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431,921,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470605279912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,659<span></span>
</td>
<td class="nump">$ 2,707<span></span>
</td>
<td class="nump">$ 7,204<span></span>
</td>
<td class="nump">$ 7,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">869<span></span>
</td>
<td class="nump">777<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">2,265<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,790<span></span>
</td>
<td class="nump">1,930<span></span>
</td>
<td class="nump">4,740<span></span>
</td>
<td class="nump">5,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">984<span></span>
</td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">2,760<span></span>
</td>
<td class="nump">2,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expenses</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="nump">866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration expense (benefit)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges (credits)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits)</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">1,547<span></span>
</td>
<td class="nump">4,870<span></span>
</td>
<td class="nump">4,258<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(205)<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(265)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">64<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="num">(227)<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(155)<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="num">(292)<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Preferred stock dividends</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) available to common stockholders</a></td>
<td class="num">$ (169)<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="num">$ (311)<span></span>
</td>
<td class="nump">$ 704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss)&#160;per common share &#8212; basic</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss)&#160;per common share &#8212; assuming dilution</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">1,430.9<span></span>
</td>
<td class="nump">1,393.1<span></span>
</td>
<td class="nump">1,413.0<span></span>
</td>
<td class="nump">1,390.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Assuming dilution</a></td>
<td class="nump">1,430.9<span></span>
</td>
<td class="nump">1,412.2<span></span>
</td>
<td class="nump">1,413.0<span></span>
</td>
<td class="nump">1,409.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470690919368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (155)<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="num">$ (292)<span></span>
</td>
<td class="nump">$ 704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">84<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in derivative financial instruments</a></td>
<td class="num">(64)<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in defined benefit pensions and other items</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income (loss)</a></td>
<td class="num">$ (135)<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="num">$ (411)<span></span>
</td>
<td class="nump">$ 809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470604926840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,472<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">894<span></span>
</td>
<td class="nump">880<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,160<span></span>
</td>
<td class="nump">4,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,064<span></span>
</td>
<td class="nump">2,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,137<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">6,797<span></span>
</td>
<td class="nump">7,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,172<span></span>
</td>
<td class="nump">4,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">30,845<span></span>
</td>
<td class="nump">30,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">1,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,195<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,302<span></span>
</td>
<td class="nump">4,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">9,325<span></span>
</td>
<td class="nump">8,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeferredTaxLiabilitiesNetNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of September 30, 2020 and none as of December 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,679,428,209 shares as of September 30, 2020 and 1,642,488,911 shares as of December 31, 2019</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 247,566,270 shares as of September 30, 2020 and December 31, 2019</a></td>
<td class="num">(1,717)<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">19,687<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,574)<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss), net of tax</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">15,564<span></span>
</td>
<td class="nump">13,877<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 30,845<span></span>
</td>
<td class="nump">$ 30,565<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeferredTaxLiabilitiesNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Net Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeferredTaxLiabilitiesNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470612438312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract', window );"><strong>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,679,428,209<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">247,566,270<span></span>
</td>
<td class="nump">247,566,270<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470612421544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="nump">$ 17,346<span></span>
</td>
<td class="num">$ (6,953)<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,632,148,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,001,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,374<span></span>
</td>
<td class="num">(6,528)<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,638,149,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,346<span></span>
</td>
<td class="num">(6,953)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,632,148,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,510<span></span>
</td>
<td class="num">(6,249)<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,641,342,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,374<span></span>
</td>
<td class="num">(6,528)<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,638,149,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">949,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,422<span></span>
</td>
<td class="num">(6,375)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,639,098,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,243,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,510<span></span>
</td>
<td class="num">(6,249)<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,641,342,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,146,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2019</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASU 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,388,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,589<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,646,877,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,561<span></span>
</td>
<td class="num">(2,253)<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,642,488,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(292)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Cumulative effect adjustment for adoption of ASU 2016-13</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">15,564<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">19,687<span></span>
</td>
<td class="num">(2,574)<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,428,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">17,589<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance (Shares Issued) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,646,877,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stock issuance (Par value)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock', window );">Preferred stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock', window );">Common stock issuance (Value in excess of par)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issuance (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="nump">19,590<span></span>
</td>
<td class="num">(2,405)<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,676,753,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Preferred stock dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease', window );">Stock-based compensation (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,674,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">$ 15,564<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="num">$ (1,717)<span></span>
</td>
<td class="nump">$ 19,687<span></span>
</td>
<td class="num">$ (2,574)<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance (Shares Issued) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="nump">1,679,428,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Common stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues (Preferred stock)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121321822&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121323062&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470606138184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash provided by (used for) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash provided by (used for) operating activities</a></td>
<td class="nump">$ 835<span></span>
</td>
<td class="nump">$ 1,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(217)<span></span>
</td>
<td class="num">(275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions of businesses, net of cash acquired</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4,382)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Proceeds from royalty rights</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payments for investments and acquisitions of certain technologies</a></td>
<td class="num">(130)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for settlements of hedge contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(294)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash provided by (used for) investing activities</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(4,992)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_BusinessAcquisitionContingentConsiderationCashPayment', window );">Payment of contingent consideration and royalty rights established in purchase accounting</a></td>
<td class="num">(132)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Payments on short-term borrowings</a></td>
<td class="num">(2,950)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings, net of debt issuance costs</a></td>
<td class="nump">2,245<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">Net increase (decrease) in commercial paper</a></td>
<td class="num">(714)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on borrowings from credit facilities</a></td>
<td class="num">(1,919)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Proceeds from borrowings on credit facilities</a></td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Payments on long-term borrowings and debt extinguishment costs</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(1,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet', window );">Proceeds from long-term borrowings, net of debt issuance costs</a></td>
<td class="nump">1,683<span></span>
</td>
<td class="nump">6,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid on preferred stock</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock in connection with public offering</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Paymenttonetsharesettleemployeeequityawards', window );">Cash used to net share settle employee equity awards</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash provided by (used for) financing activities</a></td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">3,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rates on cash</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease)&#160;in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">1,675<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">2,282<span></span>
</td>
<td class="nump">676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationRecognizedInPeriod', window );">Fair value of contingent consideration recorded in purchase accounting</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Noncashimpactoftransferredroyaltyrights', window );">Non-cash impact of transferred royalty rights</a></td>
<td class="num">$ (66)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_BusinessAcquisitionContingentConsiderationCashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Contingent Consideration Cash Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_BusinessAcquisitionContingentConsiderationCashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationRecognizedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration recognized in the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationRecognizedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Noncashimpactoftransferredroyaltyrights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash impact of transferred royalty rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Noncashimpactoftransferredroyaltyrights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Paymenttonetsharesettleemployeeequityawards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment to net share settle employee equity awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Paymenttonetsharesettleemployeeequityawards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes proceeds from (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602205384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statement of Cash Flows (Supplemental Disclosure) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted cash equivalents included in Other current assets</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 2,282<span></span>
</td>
<td class="nump">$ 607<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600861608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE A &#8211; BASIS OF PRESENTATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of Boston Scientific Corporation have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. When used in this report, the terms, "we," "us," "our," and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and nine months ended September&#160;30, 2020 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2020. For further information, refer to the consolidated financial statements and footnotes thereto included in Item&#160;8 of our most recent Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reported in millions within this quarterly report are computed based on the amounts in thousands.&#160;As a result, the sum of the components may not equal the total amount reported in millions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying unrounded amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our most recent accompanying unaudited condensed consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Implemented Since December 31, 2019</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2016-13</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASC Update No. 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">account. The adoption had an immaterial impact on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-18</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASC Update No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602439976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND STRATEGIC INVESTMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE B &#8211; ACQUISITIONS AND STRATEGIC INVESTMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements include the operating results for acquired entities from the respective date of acquisition. We did not complete any material acquisitions or divestitures during the first nine months of 2020. We have not presented supplemental pro forma financial information for prior acquisitions given their results are not material to our unaudited condensed consolidated financial statements. We recorded immaterial purchase price adjustments during the measurement period for the preliminary purchase price allocations of acquisitions in the first nine months of 2020. Transaction costs for these acquisitions were immaterial to our unaudited condensed consolidated financial statements and were expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Q3 2019 YTD Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BTG plc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;19, 2019, we announced the closing of our acquisition of BTG, a public company organized under the laws of England and Wales. BTG had three key portfolios, the largest of which is its interventional medicine portfolio (Interventional Medicine) that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction and superficial venous disease. Following the closing of the acquisition, we began to integrate BTG's Interventional Medicine business into our Peripheral Interventions division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Interventional Medicine product lines, the BTG portfolio also included a specialty pharmaceutical business (Specialty Pharmaceuticals) comprised of acute care antidotes to treat overexposure to certain medications and toxins and a licensing portfolio (Licensing arrangements) that generated net royalties related to BTG intellectual property and product license agreements. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price consisted of upfront cash in the aggregate amount of &#163;3.312 billion (or $4.023 billion based on the exchange rate at closing on August&#160;19, 2019) for the entire issued ordinary share capital of BTG, whereby BTG stockholders received 840 pence (or $10.20 based on the exchange rate at closing) in cash for each BTG share. The transaction price included $404 million of cash and cash equivalents acquired. We implemented our acquisition of BTG by way of a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisition of BTG as a business combination, and in accordance with FASB ASC&#160;Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#160;Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 805), we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final purchase price was comprised of the following components:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our acquisition of BTG, we recognized goodwill of $1.644 billion, which is attributable to the synergies expected to arise from the acquisition and revenue and cash flow projections associated with future technologies. The goodwill is not deductible for tax purposes. We allocated $1.406 billion to our Peripheral Interventions reporting unit and $238 million to the Specialty Pharmaceuticals reporting unit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vertiflex, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 11, 2019, we announced the closing of our acquisition of Vertiflex, Inc. (Vertiflex), a privately-held company which developed and commercialized the Superion&#8482; Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS). The transaction price consisted of an upfront cash payment of $465 million and contingent payments that are based on a percentage of Vertiflex sales growth in the first three years following the acquisition close. At the time of acquisition, we estimated the sales-based contingent payments to be in a range of zero to $100 million; however, the payments are uncapped over the three year earn-out period. Following the closing of the acquisition, we integrated the Vertiflex business into our Neuromodulation division.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Millipede, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2019, we announced the closing of our acquisition of Millipede, Inc. (Millipede), a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation. We were an investor in Millipede since the first quarter of 2018 as part of an investment and acquisition option agreement, whereby we purchased a portion of the outstanding shares of Millipede, along with newly issued shares of the company, for an upfront cash payment of $90 million. In the fourth quarter of 2018, upon the successful completion of a first-in-human clinical study, we exercised our option to acquire the remaining shares of Millipede. We held an interest of approximately 20 percent immediately prior to the acquisition date. We remeasured the fair value of our previously-held investment based on the implied enterprise value and allocation of purchase price consideration according to priority of equity interests. The transaction price for the remaining stake consisted of an upfront cash payment of $325 million and up to an additional $125 million payment upon achievement of a commercial milestone. Following the closing of the acquisition, we integrated the Millipede business into our Interventional Cardiology division. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accounted for the acquisitions of Vertiflex and Millipede as business combinations, and in accordance with FASB ASC Topic 805, we recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition dates. The final purchase prices were comprised of the following components:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final combined purchase price allocation was comprised of the following components:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated a portion of the combined purchase price to the specific intangible asset categories as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill was primarily established due to synergies expected to be gained from leveraging our existing operations, as well as revenue and cash flow projections associated with future technologies, and has been allocated to our reportable segments based on the relative expected benefit. The goodwill recorded relating to our 2019 acquisitions is not deductible for tax purposes.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">214</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the maximum amount of future contingent consideration (undiscounted)&#160;that we could be required to pay associated with our prior acquisitions was $627 million. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $102 million benefit recorded in the first nine months of 2020 related to a reduction in the contingent consideration liability for certain prior acquisitions for which we reduced the probability of achievement of associated revenue and/or regulatory milestones upon which payment is conditioned, or in the case of nVision Medical Corporation (nVision) for milestones that would not be achieved due to management's discontinuation of the R&amp;D program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$114 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected contingent payment amounts related to some of our research and development (R&amp;D), commercialization-based and revenue-based milestones are discounted back to the current period using a discounted cash flow model. Significant increases or decreases in projected revenues, probabilities of payment, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement as of September&#160;30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strategic Investments</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.787%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">567</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">458</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $343 million, which represents amortizable intangible assets, IPR&amp;D, goodwill and deferred tax liabilities. In the third quarter of 2020, we recorded a $65 million non-cash gain presented in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited condensed consolidated statements of operations to state at fair value one of our portfolio investments treated under the measurement alternative method of accounting.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600959912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE C &#8211; GOODWILL AND OTHER INTANGIBLE ASSETS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,102)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,692)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,195)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">383</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">782</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our technology-related intangible assets consist of technical processes, intellectual property and institutional understanding with respect to products and processes that we intend to leverage in future products or processes and will carry forward from one product generation to the next. We used the multi-period excess earnings method, a form of the income approach, to derive the fair value of the technology-related intangible assets and are amortizing them on a straight-line basis over their assigned estimated useful lives. Our IPR&amp;D represents intangible assets that are used in research and development activities but have not yet reached technological feasibility, regardless of whether they have alternative future use. The primary basis for determining the technological feasibility or completion of these projects is obtaining regulatory approval to market the underlying products in an applicable geographic region. In the first quarter of 2020, following receipt of CE Mark for certain products, we reclassified certain of our IPR&amp;D intangible assets to amortizable technology-related assets and began amortization to reflect their use over their remaining lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:24.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,056</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,646</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,137</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Indefinite-Lived Intangible Asset Impairment Testing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not record any goodwill impairment charges in the third quarter and first nine months of 2020 or 2019. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. In the second quarter of&#160;2020, we performed our annual goodwill impairment test for all of our reporting units and concluded that the fair value of each reporting unit exceeded its carrying value. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. We identified the following reporting units in our 2020 annual goodwill impairment test: Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. We aggregated the Cardiac Rhythm Management and Electrophysiology reporting units, components of the Rhythm Management operating segment, based on the criteria prescribed in FASB ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, we utilized the qualitative assessment approach to test all of our reporting units. We assessed recent events, including the COVID-19 pandemic, as well as changes in macroeconomic factors, industry and market conditions, overall financial performance and other entity-specific factors since the most recently performed quantitative test. After assessing the totality of events, we determined that it is more likely than not that the fair value of each of our reporting units has sufficient excess over its carrying value, and concluded that goodwill was not impaired or at risk of impairment in the second quarter of 2020. There were no impairment indicators in the third quarter of 2020 that necessitated an interim impairment test.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $219 million in the third quarter of 2020, none in the third quarter of 2019, $452 million in the first nine months of 2020 and $105 million in the first nine months of 2019. The impairment charges recorded in the third quarter of 2020 were primarily associated with IPR&amp;D acquired with Apama Medical Inc. following management&#8217;s decision to cancel the program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible asset impairment charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the first nine months of 2020 also included charges related to nVision and certain other intangible assets initially established following acquisition. In general, these charges were recorded as a result of management&#8217;s decision to change commercial launch plans or discontinue certain R&amp;D programs based on cost to complete, time to market, overall economic viability or, specific to nVision, our understanding of the clinical evidence necessary to commercialize the technology. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test our indefinite-lived intangible assets at least annually during the third quarter for impairment and reassess their classification as indefinite-lived assets. In addition, we review our indefinite-lived intangible assets for classification and impairment more frequently if impairment indicators exist. We assess qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not that our indefinite-lived intangible assets are impaired. If we conclude that it is more likely than not that the asset is impaired, we then determine the fair value of the intangible asset and perform the quantitative impairment test by comparing the fair value with the carrying value in accordance with FASB ASC Topic 350</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the carrying value exceeds the fair value of the indefinite-lived intangible asset, we write the carrying value down to the fair value. In the third quarter of 2020, we performed our annual IPR&amp;D impairment test and evaluated our indefinite-lived core technology assets using the optional qualitative assessment approach and concluded a quantitative test was required for certain IPR&amp;D assets, resulting in the ultimate impairment of the Apama assets discussed above. We also verified that the classification of IPR&amp;D projects and our indefinite-lived core technology assets recognized within our unaudited condensed consolidated balance sheets continues to be appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. If we determine it is more likely than not that the asset is impaired based on our qualitative assessment of impairment indicators, we test the intangible asset for recoverability. If the carrying value of the intangible asset or asset group exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset or asset group, we will write the carrying value down to fair value in the period impairment is identified. In the third quarter of 2020, we determined a recoverability test was required for certain amortizable intangible assets based on our qualitative assessment of impairment indicators, and recorded intangible asset impairment charges as appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within Part II, Item 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contained in our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600900360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE D &#8211; HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address market risk from changes in foreign currency exchange rates and interest rates through risk management programs which include the use of derivative and nonderivative financial instruments. We operate these programs pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes. Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Currency Hedging Instruments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk from changes in currency exchange rates consists primarily of monetary assets and liabilities; forecasted intercompany and third-party transactions; net investments in certain subsidiaries; and, during 2019 prior to our acquisition of BTG, the purchase price of BTG, which was denominated in a currency other than the U.S. dollar. We manage currency exchange rate risk at a consolidated level to reduce the cost of hedging by taking advantage of offsetting transactions. We employ derivative and nonderivative instruments, primarily forward currency contracts, to reduce the risk to our earnings and cash flows associated with changes in currency exchange rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our currency risk management program depends, in part, on forecast transactions denominated primarily in Japanese yen, Euro, Chinese renminbi, Australian dollar and British pound sterling. We may experience unanticipated currency exchange gains or losses to the extent the actual activity is different than forecast, particularly resulting from the impact of COVID-19 on transaction volumes. In addition, changes in currency exchange rates related to any unhedged transactions may impact our earnings and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our currency derivative instruments are designated as cash flow hedges under FASB ASC Topic 815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 815), and are intended to protect the U.S. dollar value of forecasted transactions. The gain or loss on a derivative instrument designated as a cash flow hedge is recorded in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax (OCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our unaudited condensed consolidated statements of comprehensive income (loss) until the underlying third-party transaction occurs. When the underlying third-party transaction occurs, we recognize the gain or loss in earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations. In the event the hedging relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the gains or losses within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax (AOCI)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also designate certain forward currency contracts as net investment hedges to hedge a portion of our net investments in certain of our entities with functional currencies denominated in the Euro, Swiss franc, Japanese yen, British pound sterling, South Korean won and Taiwan dollar. We elected to use the spot method to assess effectiveness for our derivatives that are designated as net investment hedges. Under the spot method, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have elected to exclude the spot-forward difference from the assessment of hedge effectiveness and are amortizing this amount separately, as calculated at the date of designation, on a straight-line basis over the term of the currency forward contracts. Amortization of the spot-forward difference is then reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to current period earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. We dedesignated a portion of the net investment hedge in the second and third quarters of 2020. The notional value of our outstanding net investment hedges was $1.885 billion as of September&#160;30, 2020 and $1.950 billion as of December&#160;31, 2019, which includes our derivative and nonderivative instruments designated as net investment hedges. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use forward currency contracts that are not part of designated hedging relationships under FASB ASC Topic 815 as a part of our strategy to manage our exposure to currency exchange rate risk related to monetary assets and liabilities and related forecast transactions. These non-designated currency forward contracts have an original time to maturity consistent with the hedged currency transaction exposures, generally less than one year, and are marked-to-market with changes in fair value recorded to earnings within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our non-designated forward currency contracts were entered into for the purpose of managing our exposure to currency exchange rate risk related to the British pound sterling-denominated purchase price of BTG. In the first nine months of 2019, we settled all outstanding contracts for $294 million, which is presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments for settlements of hedge contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of cash flows. Upon settlement in 2019, we received &#163;3.312 billion of cash to fund our acquisition of BTG, which translated into $4.303 billion based on hedged currency exchange rates. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized a $207 million loss in the third quarter of 2019 and a $323 million loss in the first nine months of 2019 in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to changes in fair value of the contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Hedging Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest rate risk relates primarily to U.S. dollar borrowings partially offset by U.S. dollar cash investments. We use interest rate derivative instruments to mitigate the risk to our earnings and cash flows associated with exposure to changes in interest rates. Under these agreements, we and the counterparty, at specified intervals, exchange the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. We designate these derivative instruments either as fair value or cash flow hedges in accordance with FASB ASC Topic 815.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Designations and Relationships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as cash flow hedges outstanding as of September&#160;30, 2020 and December&#160;31, 2019. Prior to 2020, we terminated interest rate derivative instruments that were designated as cash flow hedges and are continuing to recognize the amortization of the gains or losses originally recorded within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the hedged item affects earnings, provided the hedge relationship remains effective. If we determine the hedge relationship is no longer effective, or if the occurrence of the hedged forecast transaction becomes no longer probable, we reclassify the amount of gains or losses from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings at that time. In the event that we designate outstanding interest rate derivative instruments as cash flow hedges, we record the changes in the fair value of the derivatives within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> until the underlying hedged transaction occurs. The balance of the deferred amounts on our terminated cash flow hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was a $30 million loss as of September&#160;30, 2020</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a $34 million loss as of December&#160;31, 2019. We recognized immaterial gains and losses in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of our terminated cash flow hedges in the current and prior periods. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest rate derivative instruments designated as fair value hedges outstanding as of September&#160;30, 2020 and December&#160;31, 2019. Prior to 2018, we terminated interest rate derivative instruments that were designated as fair value hedges and are continuing to recognize the amortization of the gains or losses originally recorded within the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caption in our unaudited condensed consolidated balance sheets into earnings as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the same period that the discount or premium associated with the hedged items affects earnings. In the event that we designate outstanding interest rate derivative instruments as fair value hedges, we record the changes in the fair values of interest rate derivatives designated as fair value hedges and of the underlying hedged debt instruments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which generally offset. The balance of the deferred gains on our terminated fair value hedges within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was immaterial as of September&#160;30, 2020 and December&#160;31, 2019. We recognized immaterial gains in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relating to the amortization of the terminated fair value hedges in the current and prior periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8364;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in the second and third quarters of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining time to maturity as of September&#160;30, 2020 is within 60&#160;months for all forward currency contracts designated as cash flow hedges and generally less than one year for all non-designated forward currency contracts. The forward currency contracts designated as net investment hedges generally mature within the next two years. The euro-denominated debt principal designated as a net investment hedge has a contractual maturity of December 1, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the effect of our derivative and nonderivative instruments designated as cash flow and net investment hedges under FASB ASC Topic 815 in our accompanying unaudited condensed consolidated statements of operations. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note M &#8211; Changes in Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the total amounts relating to derivative and nonderivative instruments presented within our unaudited condensed consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Condensed Consolidated Statements of Operations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.533%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(207)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(334)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (FASB ASC Topic 820) and considering the estimated amount we would receive or pay to transfer these instruments at the reporting date with respect to current currency exchange rates, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Balance Sheets (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recurring Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,717</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,438</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated balance sheets, in accordance with U.S. GAAP and our accounting policies. In addition to $1.716 billion invested in money market funds and time deposits as of September&#160;30, 2020 and $50 million as of December&#160;31, 2019, we held $305 million in interest-bearing and non-interest-bearing bank accounts as of September&#160;30, 2020 and $165 million as of December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our recurring fair value measurements using Level 3 inputs related to our contingent consideration liability. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of the changes in the fair value of our contingent consideration liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our recurring fair value measurements using Level 3 inputs related to our licensing arrangements, principally the contractual right to receive future royalty payments related to Zytiga&#8482;. This contractual right was acquired with BTG on August 19, 2019. Prior to our acquisition of BTG, BTG agreed to pay 50 percent of the Zytiga&#8482; royalty stream, net of certain offsets, to the inventors associated with the intellectual property. In the fourth quarter of 2019, we sold the remaining 50 percent we acquired through our acquisition of BTG of the future Zytiga&#8482; royalty stream for an upfront cash payment of $256 million to the Ontario Municipal Employees Retirement System (OMERS). In accordance with FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we are accounting for the transfer of the royalty stream to OMERS as a secured borrowing, continue to recognize the financial asset and associated liability in our unaudited condensed consolidated balance sheets and do not expect to receive any future cash benefit from Zytiga&#8482; royalties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have elected the fair value option to account for our licensing arrangements' financial asset and financial liability in accordance with FASB ASC Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we have recorded the fair values using a discounted cash flow approach considering the probability-weighted expected future cash flows to be generated by the royalty stream. The fair value of the financial liability also considers the related contractual provisions that govern our payment obligations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$396 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$413 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant increases or decreases in projected cash flows of the royalty stream and the related contractual provisions that govern our payment obligations, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement of the licensing arrangements' financial asset and liability as of September&#160;30, 2020. However, increases or decreases in the financial asset would be offset by increases or decreases in the financial liability, other than for timing of receipt and remittance; as such our earnings are not subject to material gains or losses from the licensing arrangement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Recurring Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain assets and liabilities that are measured at fair value on a non-recurring basis in periods after initial recognition. The fair value of a measurement alternative investment is not estimated if there are no identified events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note B &#8211; Acquisitions and Strategic Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our strategic investments, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note C &#8211; Goodwill and Other Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the fair values of our intangible assets including goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our outstanding debt obligations was $10.901 billion as of September&#160;30, 2020, including $1.050 billion relating to our euro-denominated December 2027 Notes, and $11.020 billion as of December&#160;31, 2019, including $1.004 billion relating to our euro-denominated December 2027 Notes. We determined fair value by using quoted market prices for our publicly registered senior notes, classified as Level 1 within the fair value hierarchy, and face value for commercial paper, term loans and credit facility borrowings outstanding. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of our debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602164168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONTRACTUAL OBLIGATIONS AND COMMITMENTS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE E &#8211; CONTRACTUAL OBLIGATIONS AND COMMITMENTS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Borrowings and Credit Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total debt outstanding of $9.336 billion as of September&#160;30, 2020 and $10.008 billion as of December&#160;31, 2019, presented net of unamortized debt issuance discounts and deferred financing costs. The debt maturity schedule for our long-term debt obligations is presented below: </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate (1)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Deferred Financing Costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 - 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which is a variable-rate instrument based on LIBOR.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a $2.750 billion revolving credit facility (Revolving Credit Facility) with a global syndicate of commercial banks that matures on December 19, 2023 with one-year extension options, subject to certain conditions. This facility provides backing for our commercial paper program, and outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. The credit agreement requires that we comply with certain covenants, including a financial covenant described within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility. In April 2020, we entered into the April 2021 Term Loan, described below, and used the proceeds to repay a portion of the amounts outstanding under the Revolving Credit Facility. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued 5.50% Mandatory Convertible Preferred Stock, Series A (MCPS) and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. In May 2020, we completed our senior notes offering described below and used a portion of the proceeds to repay $450 million outstanding under the Revolving Credit Facility. There were no amounts outstanding under the Revolving Credit Facility as of September&#160;30, 2020 or December&#160;31, 2019. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loans </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, in a proactive step to offset the potential impact of the COVID-19 pandemic on our short-term liquidity, we entered into a $1.250 billion term loan credit agreement scheduled to mature on April 20, 2021 (April 2021 Term Loan). We used proceeds from the April 2021 Term Loan to repay a portion of the amounts outstanding under the Revolving Credit Facility and the remaining amount under the December 2020 Term Loan described below. In May 2020, as described in further detail below, we used a portion of the proceeds from the May 2020 senior notes offering to prepay $500 million of amounts outstanding under the April 2021 Term Loan, and a portion of the combined net proceeds from our MCPS and common stock offerings to repay in full the remaining $750 million outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums, after which it was terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2020, we entered into a $1.000 billion term loan credit agreement scheduled to mature on February 25, 2021 (February 2021 Term Loan). We used the proceeds from the February 2021 Term Loan to repay the remaining amounts outstanding of the Three-Year Delayed Draw Term Loan, described below. On May 28, 2020, we entered into an amendment of the credit agreement to permit payment of regularly scheduled quarterly cash dividends and other limited cash payments on our issued MCPS and other capital stock issued by us, which is or becomes mandatorily convertible into or exchangeable for shares of our common stock. The February 2021 Term Loan bears interest at an annual rate of LIBOR plus a margin of 0.85%. The credit agreement is subject to a financial covenant described below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and also contains customary events of default, which may result in the acceleration of any outstanding commitments. We used a portion of the proceeds from our May 2020 senior notes offering, described below, to prepay $750 million of amounts outstanding under the February 2021 Term Loan in the second quarter of 2020. In the third quarter of 2020, we prepaid the remaining $250 million and terminated the February 2021 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, we entered into a $700 million term loan credit agreement, which was scheduled to mature on December 3, 2020 (December 2020 Term Loan). As of December&#160;31, 2019, we had $700 million outstanding under the December 2020 Term Loan, and we used the proceeds to repay a portion of the Two-Year Delayed Draw Term Loan, described below. In January 2020, we repaid $300 million of the outstanding balance of the December 2020 Term Loan with proceeds from our commercial paper program. In April 2020, we used the proceeds from the April 2021 Term Loan to repay the remaining amounts outstanding under the December 2020 Term Loan and terminated the December 2020 Term Loan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2018, we entered into a $2.000 billion senior unsecured delayed-draw term loan facility consisting of a $1.000 billion two-year delayed draw term loan credit facility maturing in two years from the date of the closing of the acquisition of BTG (Two-Year Delayed Draw Term Loan) and a $1.000 billion three-year delayed draw term loan credit facility maturing in three years from the date of the closing of the acquisition of BTG (Three-Year Delayed Draw Term Loan).&#160;On August&#160;19, 2019, for the purpose of funding the acquisition of BTG, we borrowed $1.000 billion under the Two-Year Delayed Draw Term Loan and $1.000 billion under the Three-Year Delayed Draw Term Loan. In 2019, we repaid all amounts outstanding on the Two-Year Delayed Draw Term Loan with proceeds from the sale of the Zytiga-related royalty interests, December 2020 Term Loan and commercial paper and terminated the facility. As of December&#160;31, 2019, we had $1.000 billion outstanding under the Three-Year Delayed Draw Term Loan (also referred to as the "August 2022 Term Loan" in the debt maturity schedule above). In the first quarter of 2020, we repaid all amounts outstanding on the Three-Year Delayed Draw Term Loan with proceeds from the February 2021 Term Loan and terminated the facility. As of September&#160;30, 2020, we had no amounts outstanding under the Two and Three-Year Delayed Draw Term Loans and the facilities were terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenant</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of and through September&#160;30, 2020, we were in compliance with the financial covenant required by all existing credit facilities described above:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 21, 2020, we entered into an agreement with our banking syndicates to amend the financial covenant requirement for all of our outstanding credit arrangements as follows: (i) establish a deemed Consolidated EBITDA of $671 million for the second, third and fourth quarters of 2020, reflecting average quarterly Consolidated EBITDA, as defined in the credit agreements, for 2018 and 2019; and (ii) maintain the maximum permitted leverage ratio of 4.75 times through the remainder of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2020, with a step-down for each succeeding fiscal quarter end to 4.50 times, 4.25 times, 4.00 times and ultimately 3.75 times for the fourth quarter of 2021 and through the remaining term of the facility. In addition, pursuant to the April 21, 2020 Revolving Credit Facility and February 2021 Term Loan amendments, the definition of &#8220;Material Adverse Effect&#8221; has been amended to remove the direct and indirect effects of the COVID-19 pandemic from what constitutes a material adverse effect through the remainder of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenant requirement provides for an exclusion from the calculation of consolidated EBITDA, as defined by the agreements, through maturity, of any non-cash charges and up to $500 million in restructuring charges and restructuring-related expenses related to our current or future restructuring plans. As of September&#160;30, 2020, we had $194 million of the restructuring charge exclusion remaining. In addition, any cash litigation payments (net of any cash litigation receipts), as defined by the agreements, are excluded from the calculation of consolidated EBITDA, as defined by the agreements, provided that the sum of any excluded net cash litigation payments do not exceed $2.624 billion in the aggregate. As of September&#160;30, 2020, we had $946 million of the litigation exclusion remaining.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inability to maintain compliance with this amended covenant could require us to seek to further renegotiate the terms of our Revolving Credit Facility or seek waivers from compliance with this covenant, both of which could result in additional borrowing costs. Further, there can be no assurance that our lenders would agree to such new terms or grant such waivers on terms acceptable to us.&#160;In this case, all Revolving Credit Facility commitments would terminate, and any amounts borrowed under the facility would become immediately due and payable. Furthermore, any termination of our Revolving Credit Facility may negatively impact the credit ratings assigned to our commercial paper program which may impact our ability to refinance any then outstanding commercial paper as it becomes due and payable</span><span style="color:#4f81bd;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of September&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had senior notes outstanding of $9.404 billion as of September&#160;30, 2020 and $7.661 billion as of December&#160;31, 2019. In May 2020, we completed an offering of $1.700 billion in aggregate principal amount of senior notes comprised of $500 million of 1.900% senior notes due June 2025 and $1.200 billion of 2.650% senior notes due June 2030. We used the net proceeds from the offering to refinance $450 million of amounts outstanding under the Revolving Credit Facility, prepay $750 million of amounts outstanding under the $1.000 billion February 2021 Term Loan, prepay $500 million of amounts outstanding under the $1.250 billion April 2021 Term Loan and pay related fees, expenses and premiums.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we completed an offering of &#8364;900 million (approximately $1.000 billion) in aggregate principal amount of 0.625% senior notes due in 2027 (December 2027 Notes). The euro-denominated debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional entities. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. We used a portion of the net proceeds from our November 2019 senior notes offering to repay certain outstanding principal amounts of our senior notes including $206 million of our $450 million 4.125% senior notes due 2023, $566 million of our $1.000 billion 4.000% senior notes due 2028 and $227 million of our $750 million 3.850% senior notes due 2025 and pay accrued and unpaid interest, premiums, fees and expenses in connection with the transaction. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we completed an offering of&#160;$4.300 billion in&#160;aggregate principal amount of senior notes comprised of $850 million of 3.450% senior notes due&#160;March 2024, $850 million of 3.750% senior notes due&#160;March 2026, $850 million of 4.000% senior notes due&#160;March 2029, $750 million of 4.550% senior notes due&#160;March 2039 and $1.000 billion of 4.700% senior notes due&#160;March 2049. We used a portion of the net proceeds from the offering to repay the $850 million plus accrued interest and premium of our 6.000% senior notes due&#160;in January 2020, the $600 million plus accrued interest and premium of our 2.850% senior notes due&#160;in May 2020 and the $1.000 billion plus accrued interest of our August 2019 Term Loan. In the third quarter of 2019, the remaining proceeds were used to finance a portion of the acquisition of BTG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes were issued in public offerings, are redeemable prior to maturity and are not subject to sinking fund requirements. Our senior notes are unsecured, unsubordinated obligations and rank on parity with each other. These notes are effectively junior to liabilities of our subsidiaries (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Arrangements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable factoring programs in certain European countries and with commercial banks in China and Japan which include promissory notes discounting programs. We account for our factoring programs as sales under FASB ASC Topic 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have no retained interest in the transferred receivables, other than collection and administration, and once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. Amounts de-recognized for accounts and notes receivable, which are excluded from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our accompanying unaudited condensed consolidated balance sheets, are aggregated by contract denominated currency below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had outstanding letters of credit of $125 million as of September&#160;30, 2020 and $105 million as of December&#160;31, 2019, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of September&#160;30, 2020 and December&#160;31, 2019, none of the beneficiaries had drawn upon the letters of credit or guarantees, accordingly, we have not recognized a related liability for our outstanding letters of credit in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 and December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited financial statements contained in Item&#160;8 of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602957576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">SUPPLEMENTAL BALANCE SHEET INFORMATION</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE F &#8211; SUPPLEMENTAL BALANCE SHEET INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in our accompanying unaudited condensed consolidated balance sheets are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash, cash equivalents, restricted cash and restricted cash equivalents</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade accounts receivable, net</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted FASB ASC Topic 326 using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 326, we record credit loss reserves to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> when we establish </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if credit losses are expected over the asset's contractual life. We base our estimates of credit loss reserves on historical experience and adjust, as necessary, to reflect current conditions using reasonable and supportable forecasts not already reflected in the historical loss information. We utilize an accounts receivable aging approach to determine the reserve to record at accounts receivable commencement for certain customers, applying country or region-specific factors. In performing the assessment of outstanding accounts receivable, regardless of country or region, we may consider significant factors relevant to collectability including those specific to a customer such as bankruptcy, lengthy average payment cycles and type of account.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventories</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current assets</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Property, plant and equipment, net</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $84 million&#160;for the third quarter of 2020, $79 million for the third quarter of 2019, $238 million for the first nine months of 2020 and $220 million for the first nine months of 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term assets</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,516</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued expenses</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other current liabilities</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">644</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other long-term liabilities</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602355736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE G &#8211; INCOME TAXES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate from continuing operations is presented below:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in our reported tax rates for the third quarter and first nine months of 2020, as compared to the same periods in 2019, relates primarily to a shift in geographical mix of earnings to higher-tax jurisdictions, partially offset by the impact of certain receipts and charges that are taxed at different rates than our effective tax rate. These receipts and charges include intangible asset impairment charges, acquisition/divestiture-related net charges, restructuring and restructuring-related net charges, litigation-related net charges as well as certain discrete tax items primarily related to the resolution of an Internal Revenue Service (IRS) audit, as explained below, tax windfall benefits associated with share-based payments, and impacts of the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2020, we received notification from the IRS regarding the examination of our 2014 through 2016 tax years. The Joint Committee on Taxation completed its review on July 21, 2020, and the IRS examination was resolved. Due to the resolution of these tax years, we recorded a net tax benefit of $91 million in the third quarter of 2020 to release the reserves related to these years. We anticipate receiving a refund of $62 million from the IRS in the fourth quarter of 2020 reflecting the net balance of amounts owed to us by the IRS after consideration of tax and interest due for these years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had $279 million of gross unrecognized tax benefits, of which a net $185 million, if recognized, would affect our effective tax rate. As of December&#160;31, 2019, we had $455 million of gross unrecognized tax benefits, of which a net $355 million, if recognized, would affect our effective tax rate. The change in our gross unrecognized tax benefit is primarily related to reaching settlements with tax authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that within the next 12 months we will resolve multiple issues with foreign, federal and state taxing authorities, resulting in a reduction in our balance of unrecognized tax benefits of up to $23 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Economic stimulus legislation has been enacted in many countries in response to COVID-19. In the U.S., the CARES Act was signed into law on March 27, 2020 and provided an estimated $2.2 trillion in COVID-19 pandemic related relief, and included tax relief and government loans, subsidies and other relief for entities in affected industries. While we have not applied for government loans, we have taken advantage of the benefits offered in multiple jurisdictions, including the U.S. provision allowing taxpayers to defer payment of the employer portion of certain payroll taxes through the end of 2020.&#160;This allows us to preserve cash generated from operations to service our debt obligations and other near-term commitments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470688558280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTE H &#8211; COMMITMENTS AND CONTINGENCIES </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical device market in which we participate is largely technology driven. As a result, intellectual property rights, particularly patents and trade secrets, play a significant role in product development and differentiation. Over the years, there has been litigation initiated against us by others, including our competitors, claiming that our current or former product offerings infringe patents owned or licensed by them. Intellectual property litigation is inherently complex and unpredictable. In addition, competing parties frequently file multiple suits to leverage patent portfolios across product lines, technologies and geographies and to balance risk and exposure between the parties. In some cases, several competitors are parties in the same proceeding, or in a series of related proceedings, or litigate multiple features of a single class of devices. These dynamics frequently drive settlement not only for individual cases, but also for a series of pending and potentially related and unrelated cases. Although monetary and injunctive relief is typically sought, remedies and restitution are generally not determined until the conclusion of the trial court proceedings and can be modified on appeal. Accordingly, the outcomes of individual cases are difficult to time, predict or quantify and are often dependent upon the outcomes of other cases in other geographies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During recent years, we successfully negotiated closure of several long-standing legal matters and have received favorable rulings in several other matters; however, there continues to be outstanding intellectual property litigation. Adverse outcomes in one or more of these matters could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the normal course of business, product liability, securities and commercial claims are asserted against us. Similar claims may be asserted against us in the future related to events not known to management at the present time. We maintain an insurance policy providing limited coverage against securities claims and we are substantially self-insured with respect to product liability claims and fully self-insured with respect to intellectual property infringement claims. The absence of significant third-party insurance coverage increases our potential exposure to unanticipated claims or adverse decisions. Product liability claims, securities and commercial litigation and other legal proceedings in the future, regardless of their outcome, could have a material adverse effect on our ability to sell certain products and on our operating margins, financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, like other companies in the medical device industry, we are subject to extensive regulation by national, state and local government agencies in the U.S. and other countries in which we operate. From time to time we are the subject of qui tam actions and governmental investigations often involving regulatory, marketing and other business practices. These qui tam actions and governmental investigations could result in the commencement of civil and criminal proceedings, substantial fines, penalties and administrative remedies and have a material adverse effect on our financial position, results of operations and/or liquidity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our accrual for legal matters that are probable and estimable was $600 million as of September&#160;30, 2020 and $697 million as of December&#160;31, 2019 and includes certain estimated costs of settlement, damages and defense. The decrease in our legal accrual was mainly due to settlement payments related to litigation with Channel Medsystems, Inc. (Channel) and those associated with product liability cases or claims related to transvaginal surgical mesh products, partially offset by incremental reserves recorded in the third quarter of 2020 described below. A portion of our legal accrual is already funded through our qualified settlement fund (QSF), which is included in restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of $214 million as of September&#160;30, 2020 and $346 million as of December&#160;31, 2019. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note F &#8211; Supplemental Balance Sheet Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for additional information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded litigation-related charges of $260 million during the third quarter and first nine months of 2020, primarily related to transvaginal mesh products, inclusive of a reserve related to claims made by a coalition of state attorneys general. In the first nine months of 2019, our litigation-related net credits included a gain of $148 million, which represents a portion of the total $180 million one-time settlement payment received from Edwards Lifesciences Corporation (Edwards) in January 2019. We record certain legal and product liability charges, credits and costs of defense, which we consider to be unusual or infrequent and significant as&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-related net charges (credits)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in our&#160;unaudited condensed consolidated financial statements. All other legal and product liability charges, credits and costs are recorded within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As such, a portion of the related gain from this settlement was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our unaudited condensed consolidated statements of operations. We continue to assess certain litigation and claims to determine the amounts, if any, that management believes will be paid as a result of such claims and litigation and, therefore, additional losses </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">may be accrued and paid in the future, which could materially adversely impact our operating results, cash flows and/or our ability to comply with our financial covenant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In management's opinion, we are not currently involved in any legal proceedings other than those disclosed in our most recent Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q for the periods ended March 31, 2020 and June 30, 2020 and those specifically identified below, which, individually or in the aggregate, could have a material adverse effect on our financial condition, operations and/or cash flows. Unless included in our legal accrual or otherwise indicated below, a range of loss associated with any individual material legal proceeding cannot be reasonably estimated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 21, 2020, approximately 54,000 product liability cases or claims related to transvaginal surgical mesh products designed to treat stress urinary incontinence and pelvic organ prolapse have been asserted against us. As of October 21, 2020, we have entered into master settlement agreements in principle or are in the final stages of entering one with certain plaintiffs' counsel to resolve an aggregate of approximately 52,000 cases and claims, adjusted to reflect the Company&#8217;s analysis of expected non-participation and duplicate claims. These master settlement agreements provide that the settlement and distribution of settlement funds to participating claimants are conditional upon, among other things, achieving minimum required claimant participation thresholds. Of the approximately 52,000 cases and claims, approximately 47,500 have met the conditions of the settlement and are final. All settlement agreements were entered into solely by way of compromise and without any admission or concession by us of any liability or wrongdoing. The pending cases are in various federal and state courts in the U.S. Generally, the plaintiffs allege personal injury associated with use of our transvaginal surgical mesh products. The plaintiffs assert design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. Over 3,100 of the cases were specially assigned to one judge in state court in Massachusetts. On February 7, 2012, the Judicial Panel on Multi-District Litigation (MDL) established MDL-2326 in the U.S. District Court for the Southern District of West Virginia and transferred the federal court transvaginal surgical mesh cases to MDL-2326 for coordinated pretrial proceedings. During the fourth quarter of 2013, we received written discovery requests from certain state attorneys general offices regarding our transvaginal surgical mesh products. We have responded to those requests. On December 12, 2019 the Mississippi Attorney General filed suit against BSC in State Court alleging violations of the Mississippi Consumer Protection Act which the Company plans to vigorously defend. There are fewer than 25 claims in the United Kingdom. There are also fewer than 15 cases in Canada, inclusive of one certified class action, which has settled and received Court approval. On&#160;April&#160;16, 2019, the U.S. Food and Drug Administration (FDA) ordered that all manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse stop selling and distributing their products in the United States immediately, stemming from the FDA&#8217;s 2016 reclassification of these devices to class III (high risk) devices, and as a result, the Company ceased global sales and distribution of surgical mesh products indicated for transvaginal pelvic organ prolapse. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a product liability accrual for known and estimated future cases and claims asserted against us as well as with respect to the actions that have resulted in verdicts against us and the costs of defense thereof associated with our transvaginal surgical mesh products. While we believe that our accrual associated with this matter is adequate, changes to this accrual may be required in the future as additional information becomes available. While we continue to engage in discussions with plaintiffs&#8217; counsel regarding potential resolution of pending cases and claims and intend to vigorously contest the cases and claims asserted against us that do not settle, the final resolution of the cases and claims is uncertain and could have a material impact on our results of operations, financial condition and/or liquidity. Initial trials involving our transvaginal surgical mesh products have resulted in both favorable and unfavorable judgments for us. We do not believe that the judgment in any one trial is representative of potential outcomes of all cases or claims related to our transvaginal surgical mesh products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently named a defendant in 92 filed product liability cases involving our Greenfield Vena Cava Filter, alleging various injuries, including perforation of the vena cava, post-implant deep vein thrombosis, fracture, and other injuries. Most of the filed cases are part of a consolidated matter in Middlesex County, Massachusetts. We have received notice of an additional 624 claims, none of which have been filed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 6, 2019, Boston Scientific Corporation, Boston Scientific Scimed, Inc., and Fortis Advisors, LLC, as a Securityholder Representative for the former Securityholders of nVision Medical Corp. filed a declaratory judgment action against BioCardia, Inc. in the United States District Court for the Northern District of California to address threats and allegations by BioCardia challenging inventorship and ownership of various patents that Boston Scientific Corporation acquired through an April 13, 2018 merger with nVision as well as related threats and allegations by BioCardia of trade secret misappropriation and unjust enrichment. On December 11, 2019, BioCardia filed an amended answer and counterclaims. On </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 23, 2020, BioCardia filed a complaint against nVision, which had not been named as a defendant in the original case. On May 22, 2020, BioCardia amended its complaint against nVision to add twenty former nVision shareholders as defendants. On August 20, 2020, BioCardia again amended its complaint against Boston Scientific Corporation/Boston Scientific Scimed, Inc./Fortis Advisors, LLC and its complaint against nVision/nVision shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Note G &#8211; Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> for information regarding our tax litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Matters Concluded Since December 31, 2019</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2019, Tissue Anchor Innovations filed a complaint for patent infringement in the United States District Court Central District of California against Fountain Valley Regional Hospital and Medical Center, Los Alamitos Medical Center and us. The complaint alleged that the Solyx&#8482; Sling System infringes US Patent 6,506,190. We reached a confidential settlement in this matter in July 2020, pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, Imran Niazi filed a patent infringement action against us in the U.S. District Court for the Western District of Wisconsin alleging that a U.S. patent owned by him is infringed by our Acuity&#8482; Lead Delivery System. On June 30, 2017, we filed a motion to dismiss for improper venue and on November 7, 2017 the Wisconsin Court granted the motion to dismiss.&#160;On November 13, 2017 Niazi refiled the same action in the U.S. District of Minnesota. We reached a confidential settlement on this matter on February 3, 2020 pursuant to which the action was dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2017, we entered into a definitive agreement with Channel pursuant to which we could have been obligated to pay $145 million in cash up-front and a maximum of $130 million in contingent payments to acquire Channel. The agreement contained a provision allowing Channel to sell the remaining equity interests of Channel to us upon achievement of a regulatory milestone and an option allowing us to acquire the remaining equity interests. We sent a notice of termination of that agreement to Channel in the second quarter of 2018. On September 12, 2018, Channel filed a complaint in Delaware Chancery Court against us for alleged breach of the agreement. Channel alleged that we breached the agreement by terminating it. We answered the complaint, denied the claims by Channel and counterclaimed to recover part of our investment in Channel, alleging fraud in the inducement. On April 2, 2019, Channel announced its receipt of FDA approval of the Cerene&#8482; Cryotherapy Device. Trial testimony was taken in April 2019, and the post-trial briefing and hearing were completed. During the third quarter of 2019, Channel notified us that they were exercising their option to sell the remaining equity interests in Channel to us. We responded to the notification that we did not intend to purchase Channel since the previous agreement had been terminated. On December 18, 2019, the Chancery Court ruled that Boston Scientific was in breach of the agreement and granted Channel's request for specific performance to require the Company to complete the purchase. On January 10, 2020, we filed a Notice of Appeal of the Chancery Court&#8217;s decision to the Delaware Supreme Court. On February 4, 2020, the Company settled the dispute with Channel resulting in termination of the agreement, payment by the Company of an undisclosed sum and surrender of the Company's equity interest in Channel.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602317896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE I &#8211; STOCKHOLDERS' EQUITY</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 50 million shares of preferred stock in one or more series and to fix the powers, designations, preferences and relative participating, option or other rights thereof, including dividend rights, conversion rights, voting rights, redemption terms, liquidation preferences and the number of shares constituting any series, without any further vote or action by our stockholders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock (MCPS), Series A at a price to the public and liquidation preference of $100 per share. The net proceeds from the MCPS offering were approximately $975&#160;million after deducting underwriting discounts and commissions and offering expenses. As of September&#160;30, 2020, our MCPS had an aggregate liquidation preference of $1.006&#160;billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of MCPS will be entitled to receive, when, as and if declared by our Board of Directors, or an authorized committee thereof, out of funds legally available for payment, cumulative dividends at the annual rate of 5.50% of the liquidation preference of $100 per share, payable in cash or, subject to certain limitations, by delivery of shares of common stock or any combination of cash and shares of common stock, at our election; provided, however, that any unpaid dividends on the MCPS will continue to accumulate as described in the Certificate of Designations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain exceptions, no dividend or distribution will be declared or paid on shares of our common stock, and no common stock will be purchased, redeemed or otherwise acquired for consideration by us or any of our subsidiaries unless, in </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each case, all accumulated and unpaid dividends for all preceding dividend periods have been declared and paid, or a sufficient amount of cash or number of shares of common stock has been set apart for the payment of such dividends, on all outstanding shares of MCPS. In the event of our voluntary or involuntary liquidation, winding-up or dissolution, no distribution of our assets may be made to holders of our common stock until we have paid holders of our MCPS, each of which will be entitled to receive a liquidation preference in the amount of $100 per share plus accumulated and unpaid dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier converted, each share of MCPS will automatically convert on June 1, 2023, subject to postponement for certain market disruption events, into between 2.3834 and 2.9197 shares of common stock, subject to customary anti-dilution adjustments. The number of shares of common stock issuable upon conversion will be determined based on the average volume-weighted average price per share of common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately preceding June 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MCPS is not subject to any redemption, sinking fund or other similar provisions. However, at our option, we may purchase or exchange the MCPS from time to time in the open market, by tender or exchange offer or otherwise, without the consent of, or notice to, holders of MCPS. The holders of the MCPS will not have any voting rights, with limited exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 1, 2020, we paid to holders of our MCPS as of August 15, 2020 a cash dividend of $1.4361 per MCPS share (or $14 million in aggregate cash dividends), representing a dividend period beginning on the May 27, 2020 issuance date through August 31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 27, 2020, the Audit Committee of our Board of Directors, pursuant to authority delegated to such committee by our Board of Directors, declared a cash dividend of $1.375 per MCPS share (or $14 million in aggregate cash dividends) to be paid on December 1, 2020 to holders of our MCPS as of November 15, 2020, representing a dividend period beginning on September 1, 2020 through November 30, 2020. We have presented cumulative, unpaid dividends covering the period from September 1, 2020 through September 30, 2020 totaling $5 million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within our unaudited condensed consolidated balance sheet as of September&#160;30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue 2.000 billion shares of common stock, $0.01 par value per share. Holders of common stock are entitled to one vote per share. Holders of common stock are entitled to receive dividends, if and when declared by our Board of Directors, and to share ratably in our assets legally available for distribution to our stockholders in the event of liquidation. Holders of common stock have no preemptive, subscription, redemption, or conversion rights. The holders of common stock do not have cumulative voting rights. The holders of a majority of the shares of common stock can elect all of the directors and can control our management and affairs. Holders of common stock are junior to holders of MCPS in terms of liquidation preference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 27, 2020, we completed an offering of 29,382,500 shares of common stock at a public offering price of $34.25 per share. The net proceeds from the common stock offering were approximately $975 million after deducting underwriting discounts and commissions and offering expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used a portion of the net proceeds from the May 27, 2020 MCPS and common stock offerings to repay remaining amounts outstanding under the April 2021 Term Loan and to pay related fees, expenses and premiums as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note E &#8211; Contractual Obligations and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The remaining proceeds will be used for general corporate purposes, which may include refinancing or repayment of other outstanding indebtedness and funding potential future acquisitions and investments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600936328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Weighted Average Number Of Shares Outstanding [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE J &#8211; WEIGHTED AVERAGE SHARES OUTSTANDING </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,430.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,412.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,413.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,409.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the third quarter and first nine months of 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> positions in those periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income (loss)&#160;per common share - assuming dilution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and MCPS from the calculation if the effect would be anti-dilutive. The dilutive effect of MCPS is calculated using the if-converted method. The if-converted method assumes that these securities were converted to shares of common stock at the later of the May 27, 2020 issuance date or the beginning of the reporting period to the extent that the effect is dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the third quarter and first nine months of 2020, the effect of assuming the conversion of MCPS into shares of common stock was anti-dilutive, and therefore excluded from the calculation of earnings per share (EPS). Accordingly, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was reduced by cumulative </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Preferred stock dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, as presented in our unaudited condensed consolidated statements of operations, for purposes of calculating EPS. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued approximately three million shares of our common stock in the third quarter of 2020, two million shares in the third quarter of 2019, eight million shares in the first nine months of 2020, and nine million shares in the first nine months of 2019, following the exercise of stock options, vesting of deferred stock units or purchases under our employee stock purchase plan. We did not repurchase any shares of our common stock in the first nine months of 2020 or 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600914392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE K &#8211; SEGMENT REPORTING </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our seven core businesses are organized into three reportable segments: MedSurg, Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices. We measure and evaluate our reportable segments based on net sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. Operating income of reportable segments as a percentage of net sales of reportable segments is defined as operating income of reportable segments divided by net sales of reportable segments. We exclude from operating income of reportable segments certain corporate-related expenses and certain transactions or adjustments that our chief operating decision maker (CODM) considers to be non-operational, such as amounts related to amortization expense, intangible asset impairment charges, acquisition/divestitures-related net charges/(credits), restructuring and restructuring-related net charges/(credits), certain EU Medical Device Regulation (MDR) implementation costs and litigation-related charges/(credits). Although we exclude these amounts from operating income of reportable segments, they are included in reported </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income (loss) before income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in our unaudited condensed consolidated statements of operations and are included in the reconciliation below. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following our integration of BTG, the acquisition of which closed during the third quarter of 2019, we have included BTG&#8217;s Interventional Medicine business within our Peripheral Interventions operating segment, within the Cardiovascular reportable segment. We present BTG&#8217;s Specialty Pharmaceuticals business as a standalone operating segment alongside our reportable segments. In our Quarterly Report on Form 10-Q for the period ended September 30, 2019, we presented Interventional Medicine and Specialty Pharmaceuticals together as "BTG Acquisition" and outside of our operating and reportable segments for sales of reportable segments, operating income of reportable segments, excluding intersegment profits, and operating income of reportable segments as a percentage of net sales of reportable segments. We have revised amounts for the third quarter and first nine months of 2019 to conform to the current year presentation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages): </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,323</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,807</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,218</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(498)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(227)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(386)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">693</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470598610568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE L &#8211; REVENUE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from the sale of single-use medical devices and present revenue net of sales taxes in our unaudited condensed consolidated statements of operations. The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,560</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,126</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,462</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets, which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are classified within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other long-term liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our accompanying unaudited condensed consolidated balance sheets. Our deferred revenue balance was $405 million as of September&#160;30, 2020 and $400 million as of December&#160;31, 2019. Our contractual liabilities are primarily composed of deferred revenue related to the LATITUDE&#8482; Patient Management System. Revenue is recognized over the average service period which is based on device and patient longevity. We recognized revenue of $28 million in the third quarter and $84 million in the first nine months of 2020 that was included in the above contract liability balance as of December&#160;31, 2019. We have elected not to disclose the transaction price allocated to unsatisfied performance obligations when the original expected contract duration is one year or less. In addition, we have not identified material unfulfilled performance obligations for which revenue is not currently deferred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We generally allow our customers to return defective, damaged and, in certain cases, expired products for credit and record the amount for estimated sales returns as a reduction to revenue when we sell the initial product. In addition, we may allow customers to return previously purchased products for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. We recently received FDA approval and began the U.S. launch of our next generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device within our Interventional Cardiology business. The next generation WATCHMAN FLX&#8482; Device is indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage. In the third quarter of 2020, we incurred $63 million in revenue charges primarily related to our conversion to a consignment inventory model for our LAAC franchise with the launch of our next-generation WATCHMAN FLX&#8482; Device in the U.S. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer sales rebates and discounts to certain customers. We treat sales rebates and discounts as a reduction of revenue and classify the corresponding liability as current. If we are unable to reasonably estimate the expected rebates, we record a liability for the maximum rebate percentage offered. We have entered certain agreements with group purchasing organizations to sell our products to participating hospitals at negotiated prices. We recognize revenue from these agreements following the same revenue recognition criteria discussed above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470695963720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Income (Loss) Note [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE M &#8211; CHANGES IN OTHER COMPREHENSIVE INCOME </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note D &#8211; Hedging Activities and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further detail on our net investment hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency translation adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our cash flow hedges recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net change in derivative financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated other comprehensive income (loss), net of tax</span> were reduced by immaterial income tax impacts in the third quarter and first nine months of 2020 and 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600888056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE N &#8211; NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the FASB or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date. Prior to their effective date, we evaluate the pronouncements to determine the potential effects of adoption on our unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-10</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning after December 15, 2020, for public business entities. Early application of the amendments is permitted for any annual or interim period for which financial statements have not been issued. We are currently in the process of determining the effect that the amendments will have on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods.&#160;Early adoption is permitted, including adoption in an interim period.&#160;We are currently in the process of assessing in which quarter to adopt, as well as determining the effect that the adoption will have on our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncements issued or effective in the period had or are expected to have a material impact on our unaudited condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600791496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate events occurring after the date of our most recent accompanying unaudited condensed consolidated balance sheet for potential recognition or disclosure in our financial statements. Those items requiring recognition in the financial statements have been recorded and disclosed accordingly. Those items requiring disclosure (non-recognized subsequent events) in the financial statements have been disclosed accordingly. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note H &#8211; Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201613PolicyTextBlock', window );">ASC Update No. 2016-13 [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2016-13</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASC Update No. 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(FASB ASC Topic 326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). We adopted the standard as of January 1, 2020 using the modified retrospective method. Under this method, we applied the new credit loss measurement guidance to financial assets measured at amortized cost on the date of adoption and recognized the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings. Results for reporting periods beginning after January 1, 2020 are presented in accordance with FASB ASC Topic 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements in FASB ASC Topic 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the adoption of FASB ASC Topic 326, credit loss reserves are recorded when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. These losses were previously expensed when it became probable that a loss would be incurred. As a result of the adoption of FASB ASC Topic 326, we recorded a net reduction to opening retained earnings on January 1, 2020 related to the establishment of credit loss reserves on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recorded a corresponding increase in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a contra </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trade accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">account. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock', window );">ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-15</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2018-15 is to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). Update No. 2018-15 is effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods. Early adoption is permitted, including adoption in any interim period. We adopted Update No. 2018-15 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201818PolicyTextBlock', window );">ASC Update No. 2018-18 [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2018-18</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, the FASB issued ASC Update No. 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements (Topic 808): Clarifying the Interaction Between Topic 808 and Topic 606.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of Update No. 2018-18 is to clarify the interaction between FASB ASC Topic 808 and FASB ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (FASB ASC Topic 606) as FASB ASC Topic 808 did not provide comprehensive recognition or measurement guidance for collaborative arrangements, and the accounting for those arrangements was often based on an analogy to other accounting literature or an accounting policy election. Update No. 2018-18 is effective for annual periods beginning after December 15, 2019.&#160;We adopted Update No. 2018-18 in the first quarter of 2020. The adoption had an immaterial impact on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201613PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201613PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201818PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying The Interaction Between Topic 808 and Topic 606 [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201818PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602416456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB ASC Topic 815 requires all derivative and nonderivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. We determine the fair value of our derivative and nonderivative instruments using the framework prescribed by FASB ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurements and Disclosures</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives, Policy [Policy Text Block]</a></td>
<td class="text">Our derivative instruments do not subject our earnings to material risk, as the gains or losses on these derivatives generally offset losses or gains recognized on the hedged item.We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and by actively monitoring counterparty credit ratings and the amount of individual credit exposure. We also employ master netting arrangements that limit the risk of counterparty non-payment on a particular settlement date to the net gain that would have otherwise been received from the counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602510808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Commitments and Contingencies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Costs, Policy [Policy Text Block]</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with FASB ASC Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we accrue anticipated costs of settlement, damages, losses for product liability claims and, under certain conditions, costs of defense, based on historical experience or to the extent specific losses are probable and estimable. Otherwise, we expense these costs as incurred. If the estimate of a probable loss is a range and no amount within the range is more likely, we accrue the minimum amount of the range.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600838904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock', window );">ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ASC Update No. 2020-06</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASC Update No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Subtopic 470-20) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Subtopic 815-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The amendments in Update No. 2020-06 simplify the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock', window );">ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC Update No. 2019-12 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 740): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of Update No. 2019-12 is to continue the FASB&#8217;s Simplification Initiative to reduce complexity in accounting standards.&#160;The amendments in Update No. 2019-12 simplify the accounting for income taxes by removing certain exceptions related to the incremental approach for intraperiod tax allocation, the requirement to recognize or derecognize deferred tax liabilities related to equity method investments that are also foreign subsidiaries, and the methodology for calculating income taxes in an interim period.&#160;In addition to removing these exceptions, Update No. 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes.&#160;Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, including interim periods within those annual periods.&#160;Early adoption is permitted, including adoption in an interim period.&#160;We are currently in the process of assessing in which quarter to adopt, as well as determining the effect that the adoption will have on our financial position and results of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock', window );">ASC Update No. 2020-10 Codification Improvements</a></td>
<td class="text">ASC Update No. 2020-10<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2020, the FASB issued ASC Update No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Codification Improvements</span>. Update No. 2020-10 amends a wide variety of Topics in the Codification in order to improve the consistency of the Codification and the application thereof, while leaving Generally Accepted Accounting Principles unchanged. Update No. 2020-10 is effective for annual periods beginning after December 15, 2020, for public business entities. Early application of the amendments is permitted for any annual or interim period for which financial statements have not been issued. We are currently in the process of determining the effect that the amendments will have on our financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASC Update No. 2020-10 Codification Improvements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470612230824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Strategic Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our contingent consideration liability were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">354</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration net expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">214</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our contingent consideration liability that we expect to be required to settle include the following significant unobservable inputs:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration Liability</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D, Regulatory and Commercialization-based Milestones</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue-based Payments</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$114 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Payment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock', window );">Investment [Table Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying amount of our strategic investments was comprised of the following:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.787%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement alternative investments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held equity securities (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">567</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">458</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Measurement alternative investments are privately-held equity securities without readily determinable fair values that are measured at cost minus impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Publicly-held equity securities are measured at fair value with changes in fair value recognized currently in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> within our accompanying unaudited condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment for acquisition, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of prior interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortizable intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount Assigned</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Adjusted Discount <br/>Rates used in Purchase Price Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602957576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization/ Write-offs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,102)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,706)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizable intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,692)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,195)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 0.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,076</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">383</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">782</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:24.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MedSurg</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rhythm and Neuro</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,192</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations and other changes in carrying amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,056</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,646</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,137</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470597392136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the contractual amounts of our hedging instruments outstanding:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.430%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Notional Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,286</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,218</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The &#8364;900 million (approximately $1.000 billion) debt principal is a nonderivative instrument designated as a net investment hedge of our net investments in certain of our euro functional subsidiaries. We dedesignated a portion of the net investment hedges in the second and third quarters of 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.823%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Hedging Relationships on Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Recognized in OCI on Hedges</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Condensed Consolidated Statements of Operations (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount Reclassified from AOCI into Earnings</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax Gain (Loss)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax Benefit (Expense)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Net of Tax</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Amount Reclassified and Total Amount of Line Item</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pre-Tax (Gain) Loss</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tax (Benefit) Expense</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Gain) Loss Net of Tax</span></td></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment hedges (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;In all periods presented in the table above, the pre-tax (gain) loss amounts reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings represent the effect of the hedging relationships on earnings. All other amounts included in earnings related to hedging relationships were immaterial.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;For our outstanding forward currency contracts designated as net investment hedges, the net gain or loss reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to earnings as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> represents the straight-line amortization of the excluded component as calculated at the date of designation. This initial value of the excluded component has been excluded from the assessment of effectiveness in accordance with FASB ASC Topic 815. In the current period, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;For our outstanding euro-denominated debt principal designated as a net investment hedge, the change in fair value attributable to changes in the spot rate is recorded in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Foreign currency translation adjustment (CTA)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. No amounts were reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to current period earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock', window );">Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, pre-tax net gains or losses for our derivative instruments designated, or previously designated, as cash flow and net investment hedges under FASB ASC Topic 815 that may be reclassified from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AOCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to earnings within the next twelve months are presented below (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated Hedging Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FASB ASC Topic 815 Designation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Pre-Tax Gain (Loss) that may be Reclassified to Earnings</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate derivative contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains and losses on currency hedge contracts not designated as hedging instruments offset by net gains and losses from currency transaction exposures are presented below:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.533%"/><td style="width:0.1%"/></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on currency transaction exposures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net currency exchange gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(207)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(334)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</a></td>
<td class="text">The following are the balances of our derivative and nonderivative assets and liabilities:<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.008%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.911%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location on Unaudited Condensed Consolidated Balance Sheets (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative and Nonderivative Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency-denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Designated Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Derivative and Nonderivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value on a recurring basis consist of the following:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:34.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds and time deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Publicly-held securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,717</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,438</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,116</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of our licensing arrangements recognized in our unaudited condensed consolidated balance sheets as of September&#160;30, 2020 include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:19.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.064%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensing Arrangements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value as of September 30, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Technique</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (1)</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Asset</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$396 million</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liability</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$413 million</span></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Year of Payment</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Unobservable inputs relate to a single financial asset and liability. As such, unobservable inputs were not weighted by the relative fair value of the instruments. For projected year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial asset were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment (expense) benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of our licensing arrangements' financial liability were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustment expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470597535272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:29.398%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except interest rates)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon Rate (1)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, <br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, <br/>2019</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.125%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.450%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.850%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.900%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.750%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.625%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.650%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035 Notes (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.000%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.550%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.375%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.700%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022 Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Debt Issuance Discount</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Deferred Financing Costs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 - 2049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized Gain on Fair Value Hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 - 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Note:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The table above does not include unamortized amounts related to interest rate contracts designated as cash flow hedges. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Coupon rates are semi-annual, except for the euro-denominated December 2027 Notes, which bear an annual coupon, and the August 2022 Term Loan, which is a variable-rate instrument based on LIBOR.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB- or Baa3. The interest rates on our November&#160;2035 Notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock', window );">Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:32.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covenant Requirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as of September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum permitted leverage ratio (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75 times</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.40 times</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio of total debt to deemed consolidated EBITDA, as defined by the credit agreements, as amended.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock', window );">Transfer of Financial Assets Accounted for as Sales [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.912%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factoring Arrangements</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average<br/>Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount<br/>De-recognized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro denominated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yen denominated</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Renminbi denominated</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our commercial paper program is backed by the Revolving Credit Facility, as discussed above. Outstanding commercial paper directly reduces borrowing capacity under the Revolving Credit Facility. In the first quarter of 2020, we refinanced $1.360 billion of commercial paper using proceeds from the Revolving Credit Facility and did not have any commercial paper outstanding as of September&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except maturity and yield)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper outstanding (at par)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum borrowing capacity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing capacity available </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average maturity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 days</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 days</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of term loan and revolving credit facility agreement compliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470599665416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationAbstract', window );"><strong>Supplemental Balance Sheet Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade accounts receivable, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,598</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative effect adjustment for adoption of ASU 2016-13</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">103</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Effective January 1, 2020, we adopted FASB ASC Topic 326 using the modified retrospective method, which requires that we recognize credit loss reserves when financial assets are established if credit losses are expected over the asset&#8217;s contractual life. Prior period amounts have not been restated and are presented in accordance with FASB ASC Topic 310. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note A &#8211; Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Disclosure [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,516</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,529</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,195</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">644</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other long-term liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensing arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600961832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems', window );"><strong>Schedule of Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock', window );">Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ScheduleofIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ScheduleofIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602375448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,430.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,412.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,413.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,409.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were excluded from the calculation of weighted average shares outstanding - assuming dilution because their effect in the periods presented below would have been antidilutive:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options outstanding (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCPS (3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock equivalents pursuant to our employee stock-based compensation plans, which are anti-dilutive in the third quarter and first nine months of 2020 due to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> positions in those periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Represents common stock issuable upon the conversion of MCPS. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note I &#8211; Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470602463704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the totals reported for the reportable segments to the applicable line items within our accompanying unaudited condensed consolidated statements of operations is as follows (in millions, except percentages): </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,323</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,058</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,057</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,807</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income of reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,218</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (Specialty Pharmaceuticals)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, including hedging activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(498)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 6pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(227)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(386)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 6pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">693</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income of reportable segments as a percentage of net sales of reportable segments</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedSurg</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm and Neuro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600951656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,560</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,126</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Businesses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OUS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Endoscopy</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Urology and Pelvic Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Cardiology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peripheral Interventions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,462</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,369</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Regions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA (Europe, Middle East and Africa)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC (Asia-Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LACA (Latin America and Canada)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical Devices</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,204</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,831</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;We define Emerging Markets as the 20 countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Periodically, we assess our list of Emerging Markets, which is currently comprised of the following countries: Argentina, Brazil, Chile, China, Colombia, Czech Republic, India, Indonesia, Malaysia, Mexico, Philippines, Poland, Russia, Saudi Arabia, Slovakia, South Africa, South Korea, Thailand, Turkey and Vietnam.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470600675144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Other Comprehensive Income [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide the reclassifications out of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">222</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">173</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Derivative Financial Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Change in Defined Benefit Pensions and Other Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss amounts reclassified from accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470603267864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Details)<br> &#163; / shares in Units, $ / shares in Units, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>GBP (&#163;) </div>
<div>&#163; / shares</div>
</th>
<th class="th">
<div>Jun. 11, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 4,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 4,023<span></span>
</td>
<td class="nump">&#163; 3,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="nump">$ 404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(308)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Technology-Based Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember', window );">BTG Acquisition [Member] | Other Intangible Assets [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember', window );">Vertiflex, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_MillipedeInc.Member', window );">Millipede, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member] | In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member] | In Process Research and Development [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member] | Technology-Based Intangible Assets [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member] | Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember', window );">2019 Acquisitions (Vertiflex and Millipede) [Member] | Other Intangible Assets [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_VertiflexIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_MillipedeInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_MillipedeInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_A2019AcquisitionsVertiflexAndMillipedeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470613183144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_PaymentOfContingentConsideration', window );">Payment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember', window );">Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability Ending Balance</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | R&amp;D, Regulatory and Commercialization-based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Valuation Technique, Discounted Cash Flow [Member] | revenue-based payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment', window );">contingent consideration liability, probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ContingentConsiderationLiabilityProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration liability, probability of payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ContingentConsiderationLiabilityProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_PaymentOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_PaymentOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RDRegulatoryandCommercializationbasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bsx_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470707341896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Measurement alternative investments (1)</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Notes receivable</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470688521704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 14,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(7,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,195)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">10,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">2,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">5,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Goodwill, Translation and Purchase Accounting Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Ending Balance</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, Gross</a></td>
<td class="nump">20,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill, Impaired, Accumulated Impairment Loss</a></td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">11,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(6,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,706)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(408)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_IntangibleAssetsandGoodwillLineItems', window );"><strong>Intangible Assets and Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">1,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">$ (1,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,081)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_IntangibleAssetsandGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Intangible Assets and Goodwill [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_IntangibleAssetsandGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470591591496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities and Fair Value Measurements (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet', window );">Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 10,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(50)<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">869<span></span>
</td>
<td class="nump">777<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">2,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other Operating Income (Expense), Net</a></td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liability, Fair Value, Gross Liability</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements', window );">Proceeds from secured borrowings relating to royalty arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">10,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember', window );">November 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 1,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember', window );">Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from Royalties Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember', window );">Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Payments for Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption', window );">Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=bsx_EurodenominatedoutstandingdebtMember', window );">Euro-denominated outstanding debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_NotionalValueofOutstandingNetInvestmentHedges', window );">Notional Value of Outstanding Net Investment Hedges</a></td>
<td class="nump">1,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">2,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">1,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money Market Funds, at Carrying Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial and Nonfinancial Liabilities, Fair Value Disclosure</a></td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">$ 1,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ForwardCurrencyContractsTimetoMaturity', window );">Forward Currency Contracts, Time to Maturity | units</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivative Instruments in Hedges, Assets, at Fair Value</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivative Instruments in Hedges, Liabilities, at Fair Value</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="nump">29<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign Currency Transaction Gain (Loss), before Tax</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Netcurrencyexchangegainloss', window );">Net currency exchange gain (loss)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Payments for Hedge, Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | BTG Acquisition [Member] | Other Nonoperating Income (Expense) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">4,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | BTG Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCashReceivedOnHedge', window );">Derivative, Cash Received on Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,303<span></span>
</td>
<td class="nump">&#163; 3,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licensing arrangement liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DiscountRateFairValueInput', window );">Discount Rate, Fair Value Input</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">4,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(64)<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(50)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet', window );">Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(21)<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | foreign currency denominated in debt [Member] | Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DiscountRateFairValueInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, Fair Value Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DiscountRateFairValueInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ForwardCurrencyContractsTimetoMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forward Currency Contracts, Time to Maturity in Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ForwardCurrencyContractsTimetoMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Netcurrencyexchangegainloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net currency exchange gain (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Netcurrencyexchangegainloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_NotionalValueofOutstandingNetInvestmentHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Value of Outstanding Net Investment Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_NotionalValueofOutstandingNetInvestmentHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from secured borrowings relating to royalty arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCashReceivedOnHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period on settlement of a hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCashReceivedOnHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_LicensingarrangementliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=bsx_EurodenominatedoutstandingdebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=bsx_EurodenominatedoutstandingdebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_BTGAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bsx_ForeigncurrencydenominatedindebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470588212472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Obligations and Commitments (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 18, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 25, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 19, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,008<span></span>
</td>
<td class="nump">$ 9,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,592<span></span>
</td>
<td class="nump">9,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_DeemedConsolidatedEBITDA', window );">Deemed Consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ExclusionFromEbitdaForRestructuringCharges', window );">Exclusion from EBITDA for Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Restructuring charges remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationAndDebtExclusionFromEbitda', window );">Litigation and Debt Exclusion from EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda', window );">Legal payments remaining to be excluded from calculation of consolidated EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">711<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumCommercialPaperOutstanding', window );">Maximum Commercial Paper Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,039<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_WeightedAverageMaturityDays', window );">Weighted Average Maturity, Days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 days<span></span>
</td>
<td class="text">55 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Short-term Debt, Weighted Average Interest Rate, at Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=bsx_August2019TermLoanMember', window );">August 2019 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_CurrentRequirementMember', window );">Current Requirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_ActualCovenantMember', window );">Actual, Covenant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember', window );">Requirement, third quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fourth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember', window );">Requirement, fifth quarter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember', window );">Requirement, sixth quarter and thereafter following qualified acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CovenantAxis=bsx_Requirementextensionthroughtheremainderof2020Member', window );">Requirement, extension through the remainder of 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_MaximumLeverageRatio', window );">Maximum Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain', window );">the 2018 Facility [Member] | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember', window );">February2019AggregateOffering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember', window );">January 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember', window );">May 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember', window );">November 2019 Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember', window );">May 2022 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember', window );">October 2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember', window );">March 2024 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember', window );">May 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="nump">$ 523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember', window );">March 2026 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember', window );">December 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember', window );">March 2028 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember', window );">March 2029 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember', window );">November 2035 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember', window );">March 2039 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember', window );">January 2040 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember', window );">March 2049 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember', window );">Unamortized Gain on Fair Value Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Finance Lease Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,661<span></span>
</td>
<td class="nump">9,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_August2022TermLoanMember', window );">August 2022 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember', window );">May 2020 SN Aggregate Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember', window );">June 2025 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember', window );">June 2030 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember', window );">April 2021 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember', window );">2020 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember', window );">February 2021 Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember', window );">Three-Year Delayed Draw Term Loan [Member] | Debt Instrument, Redemption, Period Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember', window );">Two-Year Delayed Draw Term Loan [Member] | Debt Instrument, Redemption, Period Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember', window );">Aggregate Senior Unsecured Delayed Draw Term Loan [Member] | Unsecured Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember', window );">Euro Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember', window );">Yen Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember', window );">Renminbi Denominated Factoring Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized', window );">Transfer of Financial Assets Accounted for as Sales, Amount Derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate', window );">Average interest rate of de-recognized receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_DeemedConsolidatedEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed Consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_DeemedConsolidatedEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ExclusionFromEbitdaForRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion from EBITDA for Restructuring Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ExclusionFromEbitdaForRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal payments remaining to be excluded from calculation of consolidated EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationAndDebtExclusionFromEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exclusion of litigation payments and any debt Issued to fund tax deficiency payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationAndDebtExclusionFromEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumCommercialPaperOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Commercial Paper Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumCommercialPaperOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_MaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum leverage ratio permitted by revolving credit facility agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_MaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_WeightedAverageMaturityDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Maturity, Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_WeightedAverageMaturityDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=bsx_August2019TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=bsx_August2019TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_CurrentRequirementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_CurrentRequirementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_ActualCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_ActualCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CovenantAxis=bsx_Requirementextensionthroughtheremainderof2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CovenantAxis=bsx_Requirementextensionthroughtheremainderof2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=bsx_The2018FacilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_February2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2020NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2020NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2019AggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_October2023NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2024NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2026NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_December2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2029NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_November2035NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2039NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_January2040NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_March2049NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_August2022TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_August2022TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_May2020SNAggregateOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=bsx_June2030NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_April2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_A2020TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_February2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_ThreeYearDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_TwoYearDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_EuroDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_YenDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bsx_RenminbiDenominatedFactoringArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470687981736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 2,022<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted Cash Equivalents in Other long-term assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">2,282<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">2,282<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="nump">$ 829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangements', window );">Licensing arrangements</a></td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other Assets, Miscellaneous, Current</a></td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Trade accounts receivable, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent', window );">Trade accounts receivable, net</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Allowance for doubtful accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal', window );">Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charges to expenses</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Utilization of allowances</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">1,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and improvements</a></td>
<td class="nump">1,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EquipmentFurnitureAndFixturesGross', window );">Equipment, furniture and fixtures</a></td>
<td class="nump">3,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Capital in progress</a></td>
<td class="nump">402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">5,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">3,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract', window );"><strong>Supplemental Balance Sheet Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents included in Other long-term assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsasset', window );">Licensing arrangements, asset</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OtherOtherLongtermAssets', window );">Other, Other Long-term Assets</a></td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets, Noncurrent</a></td>
<td class="nump">1,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves, current</a></td>
<td class="nump">552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related liabilities</a></td>
<td class="nump">728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AccruedRebatesCurrent', window );">Accrued Rebates, Current</a></td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">2,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Accrued Royalties, Current</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes Payable, Current</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other Sundry Liabilities, Current</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Liabilities, Current</a></td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Estimated Litigation Liability, Noncurrent</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business Combination, Contingent Consideration, Liability, Noncurrent</a></td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Licensingarrangementsliability', window );">Licensing arrangements, liability</a></td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AccruedRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AccruedRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EquipmentFurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equipment, furniture and fixtures Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EquipmentFurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsasset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsasset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Licensingarrangementsliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing arrangements, liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Licensingarrangementsliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OtherOtherLongtermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OtherOtherLongtermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SupplementalBalanceSheetInformationTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet Information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SupplementalBalanceSheetInformationTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919244-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470688198152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate from continuing operations</a></td>
<td class="nump">31.70%<span></span>
</td>
<td class="num">(38.70%)<span></span>
</td>
<td class="nump">24.30%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TheCARESAct', window );">The CARES Act</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Tax Adjustments, Settlements, and Unusual Provisions</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TheCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TheCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121573983&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470613214072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 21, 2020 </div>
<div>claims</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 12, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrual for legal matters that are probable and estimable | $</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted Cash and Cash Equivalents in Other current assets | $</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation-related net charges (credits) | $</a></td>
<td class="num">$ (260)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="num">$ (260)<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_LitigationSettlementReceivedGain', window );">Litigation Settlement Received, Gain | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada', window );">Product liability cases or claims related to mesh product - Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_CertifiedclassactionsinCanadaMesh', window );">Certified class actions in Canada, Mesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom', window );">Product liability cases or claims related to mesh product - United Kingdom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bsx_AssignedtoonejudgeinMAMember', window );">Assigned to one judge in MA [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct', window );">Product liability cases or claims related to mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct', window );">Total Product liability cases and claims settled related to Mesh product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_UpfrontCashMember', window );">Upfront Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AllegedBreachofPurchaseAgreementAmount', window );">Alleged Breach of Purchase Agreement, Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bsx_MaximumContingentPaymentMember', window );">Maximum Contingent Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_AllegedBreachofPurchaseAgreementAmount', window );">Alleged Breach of Purchase Agreement, Amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_AllegedBreachofPurchaseAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Alleged Breach of Purchase Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_AllegedBreachofPurchaseAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_CertifiedclassactionsinCanadaMesh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Certified class actions in Canada, Mesh</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_CertifiedclassactionsinCanadaMesh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_LitigationSettlementReceivedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement Received, Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_LitigationSettlementReceivedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_Productliabilitycasesorclaimsrelatedtomeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims asserted related to mesh products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_Productliabilitycasesorclaimsrelatedtomeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - Canada</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability cases or claims related to mesh product - United Kingdom</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Product liability cases and claims settled related to Mesh product</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bsx_AssignedtoonejudgeinMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bsx_AssignedtoonejudgeinMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_UpfrontCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_UpfrontCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bsx_MaximumContingentPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bsx_MaximumContingentPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470688416536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Sep. 01, 2020</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds from issuance of preferred stock in connection with public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock, Liquidation Preference Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred Stock, Liquidation Preference, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareCashPaid', window );">Preferred Stock, Dividends, Per Share, Cash Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.4361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2.3834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible Preferred Stock, Terms of Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2.9197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Preferred Stock, Dividends Per Share, Declared</a></td>
<td class="nump">$ 1.375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Dividends, Preferred Stock, Cash</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends Payable</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,382,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockTermsOfConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470605291672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Weighted Average Shares Outstanding (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Number of Shares Outstanding, Basic</a></td>
<td class="nump">1,430,900<span></span>
</td>
<td class="nump">1,393,100<span></span>
</td>
<td class="nump">1,413,000<span></span>
</td>
<td class="nump">1,390,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Number of Shares Outstanding, Diluted</a></td>
<td class="nump">1,430,900<span></span>
</td>
<td class="nump">1,412,200<span></span>
</td>
<td class="nump">1,413,000<span></span>
</td>
<td class="nump">1,409,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470687684648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>reportablesegments</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | reportablesegments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 2,659<span></span>
</td>
<td class="nump">$ 2,707<span></span>
</td>
<td class="nump">$ 7,204<span></span>
</td>
<td class="nump">$ 7,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="num">(197)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(595)<span></span>
</td>
<td class="num">(498)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(205)<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(292)<span></span>
</td>
<td class="num">(256)<span></span>
</td>
<td class="num">(615)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss)&#160;before income taxes</a></td>
<td class="num">(227)<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember', window );">MedSurg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">825<span></span>
</td>
<td class="nump">845<span></span>
</td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
<td class="nump">$ 870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales', window );">Segment Operating Income as a Percentage of Net Sales</a></td>
<td class="nump">37.20%<span></span>
</td>
<td class="nump">37.80%<span></span>
</td>
<td class="nump">33.90%<span></span>
</td>
<td class="nump">35.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember', window );">Rhythm and Neuro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 757<span></span>
</td>
<td class="nump">$ 780<span></span>
</td>
<td class="nump">$ 1,985<span></span>
</td>
<td class="nump">$ 2,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales', window );">Segment Operating Income as a Percentage of Net Sales</a></td>
<td class="nump">21.90%<span></span>
</td>
<td class="nump">21.30%<span></span>
</td>
<td class="nump">14.90%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember', window );">Cardiovascular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 1,002<span></span>
</td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="nump">$ 2,862<span></span>
</td>
<td class="nump">$ 3,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeAllocatedToReportableSegments', window );">Operating Income Allocated to Reportable Segments</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
<td class="nump">$ 860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales', window );">Segment Operating Income as a Percentage of Net Sales</a></td>
<td class="nump">20.80%<span></span>
</td>
<td class="nump">26.70%<span></span>
</td>
<td class="nump">20.70%<span></span>
</td>
<td class="nump">28.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 2,584<span></span>
</td>
<td class="nump">$ 2,684<span></span>
</td>
<td class="nump">$ 7,021<span></span>
</td>
<td class="nump">$ 7,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember', window );">Total allocated to reportable segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">768<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
<td class="nump">2,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember', window );">Corporate expenses and currency exchange [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember', window );">Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract', window );"><strong>Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_OperatingIncomeUnallocatedToSegment', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="num">$ (629)<span></span>
</td>
<td class="num">$ (146)<span></span>
</td>
<td class="num">$ (957)<span></span>
</td>
<td class="num">$ (210)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeAllocatedToReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Allocated to Reportable Segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeAllocatedToReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_OperatingIncomeUnallocatedToSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Unallocated to Segment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_OperatingIncomeUnallocatedToSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_SegmentOperatingIncomeasaPercentageofNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Operating Income as a Percentage of Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_SegmentOperatingIncomeasaPercentageofNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_RhythmandNeuroMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_TotalAllocatedToReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_CorporateExpensesincludinghedgingactivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_SpecialChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470588195144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>units</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bsx_EmergingMarketstotalnumberofcountries', window );">Emerging Markets total countries | units</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,659<span></span>
</td>
<td class="nump">$ 2,707<span></span>
</td>
<td class="nump">$ 7,204<span></span>
</td>
<td class="nump">$ 7,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,560<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">4,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">3,037<span></span>
</td>
<td class="nump">3,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember', window );">Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember', window );">Global Endoscopy (Endo) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology (Uro) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology (Uro) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember', window );">Global Urology (Uro) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember', window );">Global CRM Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember', window );">Global Electrophysiology (EP) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">529<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember', window );">Global Neuromodulation (NM) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="nump">942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember', window );">Global Interventional Cardiology (IC) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">331<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">973<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember', window );">Global Peripheral Interventions (PI) Reporting Unit [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceuticals [Member] | International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,584<span></span>
</td>
<td class="nump">2,684<span></span>
</td>
<td class="nump">7,021<span></span>
</td>
<td class="nump">7,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,496<span></span>
</td>
<td class="nump">1,561<span></span>
</td>
<td class="nump">4,005<span></span>
</td>
<td class="nump">4,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="nump">1,507<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | APAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember', window );">BSX Reportable Segments [Member] | Latin America and Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bsx_EmergingMarketstotalnumberofcountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Markets total number of countries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bsx_EmergingMarketstotalnumberofcountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bsx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalCrmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalElectrophysiologyEpReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalInterventionalCardiologyIcReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bsx_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bsx_BSXReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140470603844360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract', window );"><strong>Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="num">$ (54)<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</a></td>
<td class="nump">84<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="nump">38<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(50)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="num">(64)<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>62
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M+L)2BCC 8/H9(V)DU\%E]V E<O/DK5@,J<*IDKD"Z.'+%*LZ'2.X3M7&21Q
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M_$0JOU%BG1WJS(52(LHN5YSY7.H/X/U"@"#M;W0'Q;G@];]02P,$%     @
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MXYIT$4B<$?C"!*/U<M,PS]A>J8ZM7C.<M!.K(SXV\GP&8+S(8&UCDM"85 L
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M$,@W$QL"I>9^'@+A@?T\Z14/<2L>?6+Q9BDDD"0)S5((H# Q]R>0*Y*:Z@9
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M;*\/MWV'%\FWS776$Y>2E\WCAE%5UC5 _7_%N3R^Z :Z.]?;?P!02P,$%
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M-3\;RNE*[T8A<+]$[$OL3A99F9I5/_#:RF !14Z'TI)&&4B_,NQK[0&>Q-0
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M\0L#A#; ^TO.U7:BFUCWS9+\ U!+ P04    "  %-F51"/NB&[@)   :/@
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M.?F%N<*'*T1 Q,C@^'X5(B"&0A;VSY@@;9CZ_=-T2)NM,2,T:L2QC=G!115
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M9]199!#K+<7(P(^L\IY>= 0.&&LZ5Q0KJS(5 AH"!VHNM2?P;(MQBZDZ%_E
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MV[JU_E<PKG-KS\BR-F_99A0GN?7K3>):3C*=3G^ 2%AB0Q*Z!&E9]Z]_WSD
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M.K0M*>]_0=QN.TE_<+8VU'JZ=PX4$0.0O+@8!)NS2L%:_]WR]>3L[/'J1PP
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MA!<%@ZN?2CLD)'D2<\D@+$\X3$WV@ "0>K&&2^ M&H+5($)/2XA5"$O!"\#
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M@Q/>REU?C 8],1P,!P?F&UD"C&B^4<=\SDI?JRR($EQL)OYGL<SR%&3F?P_
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M3EK;8ODUQ_62^PAR=!@^!V. .JQ)K5800]$ OUQXSS'RL$8VC"@PUE K4,F
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M%.'R3_T=&+FO:DO\$"=>?P#?+OG;,\H;UNM4KI$C$&/&&.Y%3MX_Z$^'DQ^
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MZBU##2),)UU$L/U/2W.L9'8,$= %X![9P[L_&!9B?F%RFH[]*+N_?JC^B@6
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M#:OA!1V59@-P,D6B/&4:GDJ8EWVX46FF 34Y3]C#+)$+CL@RC*<QNU&KE<R
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MGG"=%%YW[,D"]\AJQ!*Y.XVM(Z]('R02UH&A-, M%U07*B!X-NY:ES.->:;
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M%X'@0#[]"PGKN">VA4_2O?G*0QLVQ!.TGB]6U)V!S1'HI@^ZD\$H.(L^";2
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M=E3$L*UB'3^"65P++ SC1.V-G&UMWWU5 ,;?+ $W-.3OX,ZGOE/*O7P#.ZR
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M!^FPYQ-X?=/HVGW_FNH&XX&[7&"PDX87X/^9QJ3>W;""S0?1D_\#4$L#!!0
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M(!EIUI_L@D$4?F >=GM OJ"^T!QSTW*W3/A+??#=ID.8;/QMMC'^72YZ3TK
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MY/!@I'QZW::/Z%IY42Y<Q/M4?E:D4>I\ /NE<W'X8 .;_V(X^S]02P,$%
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MZJ(G3X>J*IHDAJ(U.54%E(19S^HR<Q\C4,HVF#QAN_%N_B1T6FS=F#F^ _N
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M"[5*FHOY\)<>X-C*D")<HL>L=TL=0TGP3!>B@49%8Y*(29O,J.=S*LN[;ZS
M2RNX5 [?+EH&ZQZJWQU7_B6MN$U>R/Z)P;/(%7M;W$KBX8 V4_-=+D?6+!JP
M>0^[%J;N+F%B2N%$!Z!^"J5D=COT1#[F<#?$7HI-$.!3U7EB(N-HHA'UAUM_
MPU-@MF>GHV,P\O]K>DET$%DA/6\0%1#$2+'$.BB#0<$<?KB68J\UJ,$KK#C7
MW")I]"H8L3,?1^WM!=ZUR74<"929EJW(';Y _*:(P1JHBN&1^S(0B@\PB&VU
M)L<0V6BG(XWB2?FPR\6Z-G=V&NH06O#I[[FE@<A""L#&R96I;9B!S&1HVQ1C
M-D7LQ^>H2T'OKSY$W2,0-MR/@5SGW,S9,)5\\0.-T<TF6)'QAII]E'J1AH>3
MRA30ZW[5,&C+1A]WGN]1D70XC01Y[KP4C_$!(U'M:9^)VS9UY_Q1B$( I\6U
MB\DX^RBT38<)(\HOI.88YZ3KH:L%4@IWRF*I2ES$MJF!J)EJE1M&80%L^J;&
M-C])>GZHYK<>.WTQ>H;'&%A+TZ7CFMA"2)E_1RFT,0:0,);]FEW3X<(65@$8
M6A)L>*TWW R"L4$C*.!PT]C2&57'L81(0I 3HY;/CXQ\PN!>SN H?63/QD/K
M%GJM/90HE6\Z)AO.@@#F:[!\CPEFILY\1+@XGT5MM_)^2B=;<M8T. *J/,0U
MSALAUBY_]72DMA,4>SDSH%C[@/@2Q2Y6X>@0PPZ+"B#T,Z1T*7.216?:-K'Y
M#%8-B$T1G)#"L#0^8V$ZFYBUH%4C=6U]DQN%>>LN]/',NHO79!J]CL3%2\^8
M*1@0"&PF]^*S]J>C$^ GXD1TS9;GU"A\) QADZ++7WW-K?12\?3Q$@]"[)[@
M1+,C4YMIRZ7!"RXYQV*'7T /.?]]UM1Z@+"7=$C[Y,)*55PFC$>7%Q\?4WI!
MFK%A0=G]XN.3\=/Q\RU+YZ'G+$SB!1.@$6[JAM^QSS\QF_K#4D/;ZG2-P064
MPBT7_":#2W9VC^5%75!+%FK&:.<SSG@N;>2HM.!(^7B1UZ(U%MN=BY.GG"QR
M3;9N;<?'FJ!2U+[=<'0Q5"\PBT^1_HZBE'HIU!:.APCI1L2#$/VG20>58>6E
M(^(C=THRL*5S=X&,S%TPVMPEA0#\;[6RZBR*E;R2KRO4?$TA9\^WDW.N.G@?
M8DKV5!)Y&_B[LY\G%_@\N, 9["T4NTA,Y)^.;79MY[Y%+*'>&=69-?MO*[1W
M9M:)QHZ?);J1$.>XNOFGI7"U+$?)<?\P].39<,I\CDQ8ZYW. [D364]8I]Q&
MD&Y]J@[HYHO$YSJVCB(HHGHH&5Q3((<1SD 6&G7R?!0[#=D]WGLOHR_:?J[.
MBOJ-7.S]Q=EC126?X%^STHM016U4KHCVDJJ!:2:OVP)6:U#YM'+M81^7"IU?
M\4E4.M08$K9XB&W+M4H#,$SPY9).$#@;TFF/6?+-GEC>&H7=93("M3PG#9*>
MF?87U3&?[/$ED-C]@2D^?/B@'BWL?,'W7!ZG!T:21,L+5"7"*L--^GGCI^19
MNDE]W5TJ\B"%ELK<J\+!2<LPJ??0Y[)++D?,0R^<UY,SZ5W*L?<86U.: $SH
MOSLGN<QEXI$3PRE%$&A*BA?$,+K!$;8F='4D+]O-'ZFTB3#L).>'Q[ %78Q:
MFU3X#[>^DD)VI^:VB)P@<$^X1JB3.F]!15207=(O<8)8\&?2MWW(3TC9VR?%
M&+ETH:]! >04)DM;=D*,F\OQ->> GJE45/S -R+,,\D?POUPT,VL/R-PAV(5
M%N<C# RJ=R(E"47Y<R +_P(GK.O:<Q]!XMBHJ%^VQ=D[*;3<NY3AI%&VK]9.
MK1*IC/<>!X[VE=Y[SP@MZXH3=RA.8A^(N-MXGZ):**[XR 6OX3,1*N'<Y)F]
MI-VHLRW,DH+2PZD%0RE$*(8-0T=86G-DXFSZ\@84!?A[BNEOH0=<).4&D=-+
M#CZ24;6(^6H<D_U=%?VVBG]"">*0$&'E/XS3R)S76KVW4&8[*OA K 28NENS
M=>$3)I^E5G7$%?6[L-HU,O *$>8)\-*0>+4Q*_S(#HN4,?6@%$RV*^G1#>?L
M::%#=4D=K#BO;&RH4:C*DS.%K9YG"B;@NK:F>QSFAC(X,_L=WCQ0KICI 0,K
M-UVT*P/)\_%I+B$<W]F:9=*0&A0L7CS:)6Z4^W2?7'%VE!G#6^P,.IM0S[_C
M<^.BZ[_O9_P)@\N9H2CK/149@>Z5V<"7;3]^/!])LIS(I9@-E;U8];=ML";Z
M$._?;C_,J'5_\,4;.JQD,))LA]$"!#DHH^6+$H.3Z/C20"*8UI]33-3QE',O
MH;BCF+C"QFX5$^=T) A>BTJ"&M9US?TD*NYU[.LS8"-Q1?&;):!<@I_<7.[I
MT>4OJ&MA5P*Y-4@R?\(B">KIWC''@GM-A7W'3)0.,'6FAT_9V"_ARNT<>N8D
MDC1;9/4<#AZR%W*&XBZX0NW/S!0K#OV=WE'+"+D,REN0=78JAY.,PCQOM"W&
M+Z6WBYBTCL>!?#W'M+F831L</TT-MUOS2$><\F5&1-SY0+?K&';A/#&8A=UX
MQO=)6RNAD5R?5[\$!QB/;Z^=1*>#GCO7C^A1W1IZV20?2#^&!4)+<@0=!FGB
MOOLY*79\O&=Q/NNY7X1[D71TO\\?[7-WH0_W;?=HW\YV#Z1_R@?26(ENCW_1
M-_%"3<FA=JI:?;-UO_4RW@,Y]ZEY/K'4W;U];2,#2,X)"(A?4%Z"@)VY:H%%
M/SB'4DO0?QM0?,]';MAO75I\2(@YQX-4$M\169+RWA/BR9Y_D"/2F<A<,L'/
M/JQL%]MA.3IR[PX&\3!/HY>VPQ_;/XI;QL9582SNCM4#YYCX9G,#8YR^'/^@
M)ERJ3?BV2-YJ4+]/U&?9_O/1L^/GHY-7Q_$P&+DMZ@I9O8YLI.@YLH8*PNW4
M+WVS22?[?1MZOMGIBV(^AG4ZK@0AIDXC9SD7SWY.Q((O@-$E:(RZLOJ_;+;9
M/BOMY(D^/*2]1)VD6]TEZM&X0$Z7F(J4U#)37%O>'$$(7=BE7!@16?@[@O%9
MU2/W)95_- A+%V""W/P1U?-VBW,MVNW:Y$TN?1?#2E20^,U2;M82'>I-NNMY
MY:_%%Z1-]T(VES<BFYY3'S(VR&Y-SL+D:6**>1'UWAH1*K_2$96]5\-0X:5U
M#G5!IQ^('[^-'U_T'6,J^%84#3LI-+O5"N>,P&\@41F2FN;;=ZIN+\I57:Y>
M.,=X%.SSQ+M72"'?G9P^RU<VZ#X@G0/VJR>SUJ?N/;TXR(<,?"_DZ?'6X^GF
M8G'_B^05/I!DBW>HL]PT2O-+'UI.5(0--(U?$X+3CM*E8;E,0!?/Z%<J>OFZ
M->DG%N_%"/@2OX4A9R3Y(JDN+K;2!@RE&8$D/-:ONBT)^JU=W+\^PX8OR>N"
M.\L5@:(FT,5I!TV>1$XO'QFJ$7<:LR\/MXES[':^'.71MQ.#)8[3Z+6.ZJ_(
MAV/W;@@W?)DJQMVA_=^55CK,BVP%:&IL)"?9>I[?1DN[)I+92<'&%,JD;DL4
M<P1 .YN^E8H0X_.*.X0K'?QQ/SH7/12YY$YQ"NQQ?%&W\3E&4C)=[:Y,YH*1
MP*7T.RSN//4 A%1P7;3B]=Y?G.4.:%+7.;U39U+D/&\W7+WIU096H.X=H,_5
M<L=]+^\V[/^=_LJ7KI,(O'YJ27'!*#7V%!7@++4J%T9S'W\MK^'0*WQ\!'YQ
MURVV? <L[8S@R:W?U"G!F$T\>;NA%P;"T 6-+O% 'QQT+SX88^E6%]_$]:MT
M)"EHJJUPX*$!A$B&:B7D\$&OSU4FO8]RS<7) #OBT!S;$OAB5!V8_LNR0[WC
M$VW?)&3?IIYKOH%\EX/(!?>8IZ*HWX=T4,$NEN]#2XM@R5<;&<E#9$E]W'2#
M!D:5K48M2.:-E]Y.CHOC_>3\5SGJG/&+;QF;6UO-;>GT1DFR2@X7DWY%5U_E
M\>T3M=.T;"EQ.BB@[Y#15GUGME.2-*6DXKP=$0M5CO+-0'FE-2\A78C>#==Z
M EW,IF-8;@+5 O-B""RP@\X"G(?[WLH^*MZ#YRJ5WO8/$G_DE?C\;?X'!<[D
M/?KA<?G7""[EQ175F!F&'A^^>'8@KS6G#YU?\5OU4]]U?LE_PJVQ"WH O\\\
M2I'X@1;(_\S"F_\&4$L#!!0    (  4V95'NLX%+#@H  (<:   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;,59VW+;R!']E2G&27:K8%XE2]Z5527+
MWK*3M>58=K92J3P,@2$Q%H#!SD44\_4YW8,;15&VDX<\V"(NT].7TZ>[!V<;
M8V]<KI07=V51N1>CW/OZI\G$I;DJI1N;6E5XLC*VE!Z7=CUQM54RXT5E,9E/
MI\\FI=35Z/R,[WVPYV<F^$)7ZH,5+I2EM-N7JC";%Z/9J+WQ4:]S3S<FYV>U
M7*MKY3_7'RRN)IV43)>J<MI4PJK5B]'%[*>71_0^O_!WK39N\%N0)4MC;NCB
M;?9B-"6%5*%23Q(D_MRJ2U44) AJ_-[(''5;TL+A[U;Z+VP[;%E*IRY-\9O.
M?/YB=#H2F5K)4/B/9O-&-?8<D[S4%([_%YOX[N)D)-+@O"F;Q="@U%7\*^\:
M/PP6G$X/+)@W"^:L=]R(M7PEO3P_LV8C++T-:?2#3>754$Y7%)1K;_%48YT_
MO_8FO<E-D2GK_BQ>_QZTWYY-/"33\TG:2'D9I<P/2'DNWIG*YTZ\KC*5[:Z?
M0*-.K7FKULOYHP*O53T6BVDBYM/Y]!%YB\[,!<M;?(>9XKWQ2OSS8NF\!3C^
M]<@V1]TV1[S-T:%M/EU=_O7-U:^O7G^\QC9_^_SVTS\>\N;C4MY??7HMWHH_
M_>%T/IO]+!X2*CX O,I:E0DV3?RFA+3X%WQNK/XW[GLCM'-!B>,I@%,4E ,N
MQTM.F)6HN_6.U^M*F$H)8T5I(,<IJ_&BK%C.2M\)GRM1FPW\EP#U3J\K26F%
MJRA*56FSP*I"4JJ)6EJO4UWCJEHGPM2<A]C"0)@5EA+&D6"KS"J!"FD1,KPJ
M,GVK,T6B^)5$I*:ZQ<Y,!,VM6T-2NTM8HLJX@5>VQ)U"(\H9*[FG(AE3A7()
M+>"+QBO8Q'GM \N5U;9Q0H*,A%.#YWNK8%GY6\(.3)&17)9;88*-OFQ@-A97
ME7@GMV)^$F$,00J;E'6A//PNX8H5M*+=H,1LFDR?S9/CZ700I>/Q\?2/$%+!
M#F.WXI+]X/6R4'L(^.'=Y8?K'Q-Q'4-W(20TAN4Z511#CE]8%CIE#SSL'=KS
MR0PJU#"1U1B+3^0K5(?:FE2IS(F5-26+HPU[&P -X*_&:W<:;*F*K7CR_.2X
MPYY<(3" 3A92]G  5=B-U3Y&W*4F5#Z&!TXJ@5V"%U]W>Z@[%".GX-L+]@]H
MPBL.8\L5"<>!-<LE.UFNUU:MH="C-H]1Q,0RJCH6;V((Z1&+VN"!6"JA*@"D
MB,EE5:J <D0U5U4B9%15KV!B6DB*2P.*ET9:LD&\TEB#. )2A)QJF*ULLO=*
M]?E D,.J%1SE1 $3"KA4WDI=2(H_"C(R;(L"Z9$@H0Q-UK7)XP@ %"9954$6
MPI(+.DSA!SW[5A@DM!5O"Z)(I<MA08)*OOP"B\@;*6")%@ "84;+#'! I@HH
M!>CV>89?9"W1$0.7?;&E>TL=285?H4W(HP^O2L@Z\FY;WW\F@)+E62)R\!0V
M36"BC&D;JEKJ;. ;XHD6PAQ=9#^0&#A79-KX4U%8P7:IU4L$2<=%EY2"*YTV
M#GTU8,.QN-[WB;I+5=VXI#(]N\%PX-Y#=F"K6Y1U .((0^T=YB:C[WD"LB!W
MQZFMK#K8-$?7DD6*5&44RPR\T0X&ID  ;49X(@J$;E:VI!9<&YYF9X0<;VC)
M'!.J0CE'S"V43'.*&9 "G X\F+%Z>_ZGW>C%FM)HE_0!.FWP2BZ!YJ525>\0
M$D6"8@)!F17"H)$!0I9$'QUP\'B/W^_C#FZ)XAW835*Q8JV8*&->\>( PSJ]
M$XH%Z8WD=![JD.:]?(+36+R-, $$HPCRVZTIH)^D1+#P5W\YR$"J-"SQ::@;
M<#B\%Q\Q< 9@:>1*!^T=.L(M1;N4&0,X[_GK/EP0"J\+*D7L7P[+O=?)BB1&
M%'<VN<:/1Q@0@3A (TV^]+'9)151%\#7UZ R%I\99E#(%EK9IAGP!&G6,<K:
MH6H0JT$-0HH29S8+*'1_"6AR9EPJ%CO\51OG:W1 ''9.A29Y,:K< !_PO0VQ
MO^"X,NJQ;JG\AC T'R].%T=LP'S\?/;\Y"!O#4F3^WM"@81;GV8Z!EO([ N>
MD"JNJ;]?PS)U>DS/ 48,VZ6>4Z@M0J.9\1"3M00(#%@,7XS/4CW=\!1#D6CN
MQ_ZA#]D>>>,]%C2?,GNH-' 50DL=LQK C D-+=:ZJKC=J2)I=1U?$D7,G!<T
M=F:!$380H4L0EXY=14\9PVA&1S$$M$.V^*&CB<#Z#A$QT-4-":#:VC>D#K4+
M/!,+B8MT_J8M)4VY,8V$C>*<:^F5A(#F<UFM55]88J>$&98;,/K;9 3-U VR
MN$IZ1<W0CA#N>7:HNF]$200[F[.*R1 &QT8O&69SY"-RS.#F;MTC3S$3D(_N
M-=6T7ZSH"$=?Q;BS[5NOV:"]Y=3=)R#>3O+E15@#VV)V'%>!/)BP^Z+(W=C1
MXMF,4<<K(_1^@)E/9D==0ZF'O=V.$/<C53O@A#S$W?S]ZK(#QNB10:<>TXD8
M+"/9/K<FK/-6]45C,+OA"@T=.:%O\DG8!5#MT:VW/5WCAH<Z02"(]HHPC?V@
MY[:)[6)G<@GJ&\1'VLJ^4#[HU07:\?_!J8+YKFM)7B$-AP!X/.[OP13Q[>/6
M4]\3HCVX=5'I!+<CP)B&X5C<HGAJK[O^.-GO15(B,=J'2W_<G%/W\*;[@P>L
M][(@*4_ZF8<2"!Z]2%,;.(7B^-+>)Q>%2A)8> 0 "50N_D+AIX+*=%TP%.,9
MG3PP]XP9;>2HKQT'S#'J3-M1YV"5>C(=3V<TP8M;600U' @'P]%.*: -A^T!
MG2?PF/Q?K&U;BT'CA<F*:@9-6]\T8C5G%Q'FZ&A1'K>B<7K3-3T\5.VT663'
MO<&^)?&NOQMT/X<M9$"BB0,FN0P1$JF9QFC1E)1A@3)V_\QCC\AWY&>FI_+!
M-+C#Z'L2)(K0E\@X36$XT%^DF%9YTHK-;WPW:YT=AW;)C8>WIF"7E;)" \']
M%#V6JY74UCT.@2^ATM2"F_M%C'U.YSKW_#WH-K_SO&7^/%F<WC]OV56(ST_B
MD4FW,O9#1*>+H_'\^-L.2G8[IO_/@0D8(3BN#+6Q[03A#Y_M#,MAI/%FGSU#
M7$Q8S$SXG[X#,)V74;OAG,0&Q/H(-Q8D>R8^(:KB5T.G(3%AHYPX#ZP4G;]U
MM,GC'_;0 4"@R1Q.",[%R9Q/<U]WIZ:7!$69>CKZN$(,UW% 9QFQ,'-_+6+<
M>L4[5[2=,WN->&&M*O3$=%)@X4*JCZC=F!OXB)"').H(8T]+$E>Z G$SW&ST
M3SM3QG9SZ!K,?6H)BRL:=$A%ZDQ9'5@%7L2VJ^"#;>9UIWMC,$RJ=EAXZ A[
M,O@X4"J[YD\@5/00G_B=H+O;?66YB!\7^M?C)YIWTJ(D$V^NL'0Z/CD>169I
M+[RI^5/#TG@,-OPS5YA)+;V YRL#<YH+VJ#[]G3^'U!+ P04    "  %-F51
M.#(6 1 &  #*#P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6R]5]MN
MVS@0_17""^PF@"-?>TF;!'!2M\T"28PX;1^*?: E*B)"B2I)Q?'?[QE2DNVL
M';1]V(<XHLBYG9DY(YXLM7FPF1"./>6JL*>=S+GR7:]GXTSDW$:Z% 5V4FUR
M[K T]SU;&L$3+Y2KWK#??]W+N2PZ9R?^W<R<G>C**5F(F6&VRG-N5N="Z>5I
M9]!I7MS*^\S1B][92<GOQ5RX+^7,8-5KM20R%X65NF!&I*>=R>#=^9C.^P-?
MI5C:C6=&D2RT?J#%97+:Z9-#0HG8D0:.?X_B0BA%BN#&CUIGIS5)@IO/C?:/
M/G;$LN!67&CU328N.^V\[;!$I+Q2[E8O/XLZGE>D+];*^E^V#&=?'7=87%FG
M\UH8'N2R"/_Y4XW#AL#;_AZ!82TP]'X'0][+#]SQLQ.CE\S0:6BC!Q^JEX9S
MLJ"DS)W!KH2<._OFW18)FSP*@RRP><:-L.RF<M;Q(I'%_4G/P1 =[\6UTO.@
M=+A'Z3&[TH7++)L6B4BVY7MPL/5RV'AY/GQ1X5R4$1OUNVS8'_9?T#=JHQYY
M?:,]^J;<%(C,LIDP(6+V?;*PSJ!(_GE!_[C5/_;ZQS^+ZG65+V#J)MV!+_M^
M)YX<.U<Z?OAG%]@OV[J^N9NRO]F??[P=#@;OV;?IY:?/=],/;/)U>COY-&7S
MSY/;Z9S=?+F;WTVN/UQ>?V)WF1%B*T<,"#OA?228KV'CI?T#6: 8E4)?V4.?
M%/P,CC>>6@1XC8 -<>N-N(^HGV3,!MWQJ!\=X__H>!0-:#T817V_[D>OV36X
M2:0I^ICIE,4ZS]'.Z(SX@8D?E7SD2A3.!@2&[]G@&+(;B\%/.L,MF(D>$ZDJ
M3QEKQ\:#833<<&S</X[> $?!4JU ;"1F15P9Z204+P4J2CS%JB+L4J-SYG V
MYBJN%/>Z$<GR-]U:B)A75I!*:1IDD!$R40HC=6(9&-H"%2A?$/&"&RN5L R6
M\$* #0LG@\)'\>[_*(B+?6D[&!RRP9CUP\_<[^N2 MU&XF!XR%[C!/U=7<SF
M[& $2UYP@!]2<ROJL.W^*BDK8RM$SYR&>L"7ETJO$+T_>D0,GY TIIX-F2H5
M+VR7+3,99XRH@K [:L!K@'>9- G[47'C@ E\9JDTUK&"D,L#<LBY!R2I1&.>
M:EMI"[^TE2%HKU#;-I>1#WTC-KL7H]\,#C/'9:A786))=HV,488NXRY4\CW&
M/46%-R'8IF!3C@+$,'] %  882%$,KP%/SX=O)01J'TXL(YKM#]G$F7/%TJP
MJM3!:*P+F+5U\U )1)!.R2_-KK43[+)E05]&F58)!/YB4^3?K;P?/$D\S%P!
MY_!-@U4$BO##W>=#%O!$L /*RR%YVWKF)\6NEFR=;'KZJ(&H",R_05RAR:E"
M]A;I9DX3D K^"8[J6PEN(C9#K"A!A+!7 ?F9".0,;@+QRI(*7Z9(I:W,JI;)
M!4HM\>'7=+5=7=UZR9?<),%IWWL[*4VF_E5-2(%Q%L_:)?*DV3;/FM:]6FE;
MA5M>R_0H9)]>-S[?[=X(V6GJ%]+(ZG-J7LN@=!K6?39:@C!3OO)U".V*K]CP
M3?@,"15:Q(@&1UA=XPMQ+POZMFA$C"BU<;XY?=F318_2$R6Q=;*E<<O64'VL
ME?X"MW0WE>%=6ZJ[.PBUOA^!);?;R>MZV]"$+V?],Q-.--]9U$2A>PZFL_EA
MQ"9QK W5MUIUUR1(%HU(JICFU@K?O[E7AD*9&>IT[-6^)?)1)J) 3<*IS7$'
M]B0"J@I>H=,]W6%>%8'X"JN53'QQH;\POT*W@;/@(*\KGF@"1 I"KC%I8@**
M4R(=- OEG@9W61K])$$B0JT  $W1>@QN@/H?0MPY,M8)7.KG2O8+#(Z[S%/.
M'I$7"H5R&39^19(,KK]Y0B77<P/[S\CC45A7]T*RG;^JD(2\1SK..$%=(4]F
MQ]AJC_AAY>%/)%S7CIJKV>/%ZB<@WS^3X0H%%^WZ^N]MW*]R8>[]+9+F556X
M<-5JW[87U4FXGZV/AUON%3<@",N42"':C]Z\ZC 3;HYAX73I;VL+[7#W\X\9
M+MO"T 'LIQKL7R_(0'M]/_L74$L#!!0    (  4V95%+IJ]F9P<  &$4   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;-U866_C.!+^*P5OS\(!W+8.
M'W(F"9"D,[V-18Y)TML/BWU@)-KBMB2Z22K'_/K]BI(=)W:.F<&\+)#PK"I6
M?:PJEK5WI\UWFTOIZ+XL*KO?R9U;[ X&-LUE*6Q?+V2%G9DVI7"8FOG +HP4
MF6<JBT$4!.-!*535.=CS:Q?F8$_7KE"5O#!DZ[(4YN%(%OINOQ-VE@N7:IX[
M7A@<["W$7%Y)]W5Q83 ;K*1DJI255;HB(V?[G<-P]VC(])[@7TK>V;4QL24W
M6G_GR9=LOQ.P0K*0J6,) MVM/)9%P8*@QH]69F=U)#.NCY?2?_&VPY8;8>6Q
M+KZIS.7[G:1#F9R)NG"7^NX?LK5GQ/)275C?TEU#&TT[E-;6Z;)EA@:EJII>
MW+<XK#$DP0L,4<L0>;V;@[R6GX03!WM&WY%A:DCC@3?5<T,Y5?&E7#F#704^
M=W EYX#8T:5<:.-4-=\;.(CES4':BCAJ1$0OB)C2J:Y<;NFDRF3VE'\ =58Z
M14N=CJ)7!5[)19_BH$=1$ 6OR(M7-L9>7OQ>&^G?AS?6&7C$?UX1/UR)'WKQ
MPY?$GWP^/3F[ILN3B_/+ZR]GG[=!^+J(L_/K$_HG_?UO212&/].&1#JO$4CR
M5E:4:B/IIK:08*VT)#!%3(I*_28S4I73Y'(C)2*&K14WA02G!\#NTJG,KFHS
M[]%E_N#RDD25T9FLC>[YX;$PF=*WPJ9U(4R/[G*5YBS)2,L("H31?&[D7/B0
MTC/24 P9P@B/Z_(@J" <S67%&ZP*-*^A[,SH$GO02$ ML)<R4ZDH$$>W*I6V
M3]\DUH2M814K)&]%4;,(/F>+13XB,X(N%1(82[4L=@ME;TU-5:6ZE"\2RONT
MJ+.&T$G3;M#"Z)GB?5;LG<)(X(] FV*&),=D;VG:I_._3C@IRTD+WI,Q^WO-
MR-2M0G#3S<,[U,<=-A#*YL+?>T@JL:*\BV,3M_[1R (=W. >CY#W=D"_)$,
M5U;XY Y=#(GLO\B7:_['/I/F2L[6-,ADJOR#4HKOTE#W^/S3Z0Y.Q"N3X:H)
MX7,CJ=+5QY9'5Z+HX<U"'##<I:Y9_E(QD&,)2>6W)B):17OL.:*:*[9/($X=
MJ7(AE/&.E.;"S"4[4OJCAC;,.0#"TCKEX/EV93=CW5(/NJE!L#B[T\/IR%YU
M"EHVB3%YLO(6^Q+ DZ^<#WS\??+QAPPY1^![2[JGGRYW6.M"LM+-8JJM:RZA
M@-9-%EB=MG%2GPX+E^MZGM/=HTL@_*U< ?E['*3'O \^XX&.A7'":RDQ_M(P
M=PMM[0ZN<:8;2EYTXA[N VIVBKH2B&^OL\:;5=EF9'6A,F^*A;VR\22]\AYV
M,S;]^?F<SXP$?ZH*U>!TP\5.GW[1!7JVBT_E9#(WJ\QY=/W9&[3N!;S>Y-P4
M1D!\UEPQD[E<F8Q^U *V&B:,@G#:8V1S<;NF$>3Z=V3RLP4BH$7N;=RXN6V$
M_NK]0+$!L0TH%]*H10Y+BR=L=C.]]Y9LK-;3)V/+M?E\L'Q UI6[6B 61>$>
MZ *>4XI4UHZ=T3ZJYQ,<+J/*1*&A]X8JQ.MSCMV77H@^K/%[OS;(%0]M'<"/
M!A=V% 8??R7XBC<'!RB-A,.E#*$0@1O< .ZF&FGQ;HWQ'K<=7W:3E\US>BYQ
MEF'S.D"$#A\]H-.\+K5K;'K^P#:QOIDZ6?W_E]?O6^O1J!H4Q\ J5;17]#00
M6)V9,M91Q<B732G:A@?G9P0F_W8A7QA)U-3&L#T/$M[:WJ2/262KYV$,*?Y
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M'3VR84CMIF+Z*GO7=0M;K^*IFP\CE[JUDPF]0_,3!@5^\QO4I1UQ=2[K&"-
MC&\ BHP^?EB0JB#@%A'@,"]Q4@V[2 N4JZ8$5OFDVP1/[AOV?7%]\OOYXC-]
M//M7QXQG>E73HI:$6$"3,F.V.T%:-]#NY=EB<?*J;;^Z$L6BGV[$NW-P.&#_
M%15:Z889BSN.EC$$CH%;T#_<R < -$ W#,&.8MN#>&G+U_#(+8X/(,Q@S,HL
M43;:\\3+S]\6'U\A)!8:25(!HK"@5)QLO)MUXE%TA5:MNV,(5UN%DQ6.]R (
ML$/;TL [7%V!2%$O9Q^VVZK.AY(8O])YR]*"51!T(U7L!<Z@>_S>P179@;;(
M[]7 O3)G0^%$>?)MRBHI[69=2GTS)8?'NBWJ0Z9S22U>PQ&E%=(FW: K"_X3
M(WZ!SNN_&+<]_'UGUO<VY&K/,4OH'/H7KAB<-L((/:-U-"'K:S18];-+'Y#5
M7G[SO+:EVH9TLO"OK[@/1KQV%4_U'2K"M)+V%FA'M\3L+=A3WO+3=I?WPA9=
M/6HUDS"V5*OVY*\"0?%74E,T13N=0<09S1DF'N*BT==6SBBN=*U7U!H'PV*'
M<73]3=5QIJ#/(?7-S[9006FA: Y>3S 8K  [DQK.%ZS96%^9FL\]\'&IUQ94
M7@L!\_'J?IMR_]-7H-L]I?8^G0FE%GJO&=NQ;^J,E%N)'QIN3C[N0PX?^]IY
MM/<1F<\6\JG<AW-"^)[<C_9?XQ?A(_1N>OB4CR,)6@@ON?GN8'@X'1^ 1N3S
M>'BH;26?I)>V!OKD%F<D%&V>@/<KB_-5^\ ;]/^C>/]?4$L#!!0    (  4V
M95$A/\U4H 0  !@/   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;.57
M;5/C-A#^*SMIIY/,,,0O<0@<,).$4.B4EX&4?NC<!\5>QRJVE)-DX/Y]5[)Q
M3(_D[@I?;OHEMF3MH]UGGU6TAX]2W>L,T<!3D0M]U,F,61WT^SK.L&!Z5ZY0
MT)=4JH(9&JIE7Z\4LL09%7D_\+QAOV!<=(X/W=RU.CZ4I<FYP&L%NBP*ICY/
M,)>/1QV_\SQQPY>9L1/]X\,56^(MFC]6UXI&_08EX04*S:4 A>E19^P?3 9V
MO5MPQ_%1M][!1K*0\MX.SI.CCF<=PAQC8Q$8/1YPBGEN@<B-3S5FI]G2&K;?
MG]%/7>P4RX)IG,K\3YZ8[*@SZD""*2MS<R,?S[".)[)XL<RU^X7':NT>[1B7
MVLBB-J9QP47U9$\U#RV#D;?!(*@- N=WM9'S\H09=GRHY",HNYK0[(L+U5F3
M<US8I-P:15\YV9GC:<;$$C5P 5<F0P5365!V,TO[ \*YB&6!AWU#6UF#?ES#
M3BK88 /L/EQ(83(-,Y%@\M*^3RXV?@;/?DZ"K8"WN-J%T-N!P N\+7AA$W?H
M\,(->)N#A>[O4NL>7%)%R!3F[&D'KE%QF4!%%OPU7FBC2$\?MS@R:!P9.$<&
MFQ*PS05I:+<Y/AF8Y#*^__A:(K;#7U[-9W !O_PT"GS_ TS/QI>_SF[A_!*N
MYF>S&YA>75S?S,YFE[?G=S.:IO$,YAE"*G,J6"Z68-@B)X6LE'S@"0(11]48
MYTQKGO*8V>+20/5NV:IHC5_$Q.N8<AO3#HB*5\.>X "ZI+N"Y[G%Z '5&561
M@&FI%(KX,\P5$SIW6\ X^9O*@<X#HUUNZF00P EEYX'9ZH93+IB(.<N)2<I1
M^?KRE$A*8(*"W@PEUQTQ&IA(Z@#.#18:YM(0T(3E!(G M'7[MU)@HT/X&;J#
M88\>01"X060'?NA_G0A8(!VIKU$Y&D$W\GI5SH(/$-*XTD4/K"FP0I8VK+4I
M19,J6= 9%Y=%2831A-SB ;G9]0?K+;K^?J\.=YM9Y?AH -UARYAX>,D1U2KQ
MMR"8%E$4!3$3C5HT1?X/G7]_?YU_/W)B"-Q@;_26].]9^V=N1\-WS_V^S?VP
ME7OK]+?FOAOT8!@TML.OI;[F:.1JQ _7'/E6U3]:\D\PKH/SF^#\@:U\?R]<
M"SO8\]XB@.X^%7\X7"<HHF)[;Q78ZN]&04L&P^@[9.![UMZ/VD>(/4/^/P?!
MO[7@XHE"%X_O.Z&[X,+P+5H(/:H4.@/\'OC#Z-U58%WLANT_@N@[_@@&X'M!
MY9L7O>4@N,&4%AI977A.FMO*&29+>P,9VZL[-QRKU)PRKN".Y27"!3)=*JRR
M2QQ"6BKG=X*&<0I"T,U$N3L'%P]8R08RPD7'FU1T/;5:>%9<_*PXTU(<:RG.
M.F A8Z8S2.F*]!J:U5G<Z"Q9RS)M9,E;LMQU-ZXEM5 5OJ67$*4UK22ZJ"5J
MOZ[JEH@[;6Z4CEWZWR"_U-/X&_7TQ17OM0MRO]6M%*B6KB?3A$ABKAJ79K9I
M^\95M[->7O6,%TPM;80YIF3J[>Y%'5!5'U8-C%RYWF<A#752[C6CUA6574#?
M4TF*JP=V@Z89/OX'4$L#!!0    (  4V95& N]?@_ 8  .H2   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;+U876\;MQ+]*P-=X*(%9'W%B=/4,2 [
M;NJ'R$;DW#P4?:!V1Q*177)#<BVKO_Z>(5?KE2L[Z6UQ <-:?LS,F9DS0^Z>
M;JS[XM?,@>[+POBWO74(U9OAT&=K+I4?V(H-5I;6E2I@Z%9#7SE6>10JB^%D
M-'HU+)4VO;/3.'?CSDYM'0IM^,:1K\M2N>TY%W;SMC?N[28^ZM4ZR,3P[+12
M*YYS^%3=.(R&K99<EVR\MH8<+]_VIN,WY\>R/V[XC^:-[SR3>+*P]HL,KO*W
MO9$ XH*S(!H4?N[X@HM"% '&UT9GKS4I@MWGG?9?HN_P9:$\7]CBL\[#^FWO
M=8]R7JJZ"!_MYE=N_'DI^C);^/B?-FGOR7&/LMH'6S;"0%!JDW[5?1.'CL#K
MT1,"DT9@$G$G0Q'E.Q74V:FS&W*R&]KD(;H:I0%.&TG*/#BL:LB%LQGB-LTR
M6YN@S8ING#5XSAAQ#_YT&&!"-@ZS1MUY4C=Y0MU/],&:L/9T:7+.]^6'@-;B
MF^SPG4^>53CG:D O1GV:C":C9_2]:/U]$?6]>$)?Q]=Y4"97+O?TJ<I58,*0
M+M;*K)BTV8^*-IFN"J;?I@L?'*CT^S-8CELLQQ'+\1-8WK'/G*XB.^V2GDT%
MS6R@+8ITFMLJ<$Z_W?)]H//"9E]^/Y2GYTW/KF\O:4;__M?KR7C\,\TN/]/T
MXN+ZT^SV:O:>;CY>S_!\<?GA<G8[IQMVVN8Z4T6Q[9,!3/4 L]J'J1R"YWT-
MA(LMA373+]/Y.5E'%@-T@R;HY#E$^04TLQ_01\Z@H-CNI'V;G;"MDFW*+1F$
MP?'76L..DE!(\ 1*08J6=:@QS\LEQV(G2>M T@?[P0H<[1XM]VD#B3M5U$(!
M ?S((\CE'-BA^)IU&["@5=%H\I*\%HO\U0Z05)UK251F40K&IR=O"RU6<UIJ
MHT J:(&G(=D:=#@)LPNFJQ*LDS5(3.<7.Z;.[" 6Q-%X1%>&KK-@%PBN3/4?
M@MY$\K!<GRX0^24B&V'#D+-WC<N#0W84UH!+28-BNE-.<]B*Z[<6^?%2,F)Y
M3ROFK,LY!E\G"W&31$)[A#&+&OXD)Y4HDZJJBMV<T(?M$OE::U1BP>I.^/.>
M#;O(#M0.Q](X5+D>&<EB;><'O=.^PPN<=8!@:B2GBMSWR,5*&R,JU1)DH'>@
M:RDQ'[_L-W$7J:I> # M:@^V>.@$C!#Y?:D<,'8=:AR/<4UQ!XA*B!8B02*(
M[0X(1AHT<+IL,,4-B$6V/L@E6BMX(N6R8#8-%P;TF6.)9K5S3;F9'>DS 0Q0
M.[:+L[*4XH)'%1X#WNBB2(8:VC\@J:S7;2X=>YR243NN$R[ZCY@<8N;HE3!Z
M6J]P]OT%0H]>]9&31:"C]+/180U.F3MV?H?B.G:@ZUBGGGZ8UXL@U*7CD]'1
M9/1CW/,.L;U3P@(?Q[]ROI) '(FRV/DCTR\EK]O8/D]^]G2]P12:$@KB0>WK
M\<NCX]&/;[I\E)PE5$$OP.(K@^.D;EJG'#]=(^HY.P.Z?40><RB6'F57Z.6V
M*3MI)_<BKKRWR),0+89*B+D5A)\&\P&]GTYO(M8,0'&SZ^15=Q!'2525($;<
M?) ^@!P76BUT$8D?O>((>8"[ :CG*\YBI<?3Y!&AEA9W'DK53JL:O1)]."'I
M1$T_BEK>)HU\!H(1WTLKD+PWHGM!Y?V@6@1UA_! !/_4&9;: SP.8^6^W1?&
M?1C-"IP%V+)?P"E^L?ZLYSVU;;O8G2K=SM!'>PFH;,+.0DMS15_[:ZA&_R.J
M?Z)[[%SZIWO'^*>C\41Z1^NLS'U']XB"?4BB/)ANU3U8^T,\U.@DUN^\J:&=
M2X_J>4\PE655NTJB!\P',.IXN@LKM:FY!=@2LK'7'LT&P4CLAICCO,[V2EE(
M_8"HO3=]LT$D,'L-0NU[II-G(7J&ZYSCTL9#=]<6VCKS6"MB-TG7+!%U\2!"
M.M%;G%5R3J5#S*GF!(-B0ANPR=&4JN9R)Z+)W<RNC/Z#Y0!$G;=#O'DQ6)B4
M=!M.!TBJ:BH97,YA&4T]-)<ZH:-0617>"BZ\O1F\F2Z\SK5<;7R_O80D<5O8
MU3:U$U5D-6RDVNE$*'67_7(:""-5GB<^1X>:&$*U[W0J&#R0G0@O*X!HN6NF
M3<)DF*[42CIJ*I!OY'#P!!O_[LWG.WO)ON)O]+@'G0\;#L;W.WH2#CL\)7S-
ME>EKK5Q(%].H'^D&6D9+PN__JX?-;)/"Y]^IFL9ENZ\N.R=3(:U57)8X\+VP
M(?$_(E-4*HF8G-UEA6/P[[VB''KO'7:^/Y3L5O$KBZ?H3_H4T<ZV'W*FZ?O%
MP_;T%>B#<J";Q_5^"='1X.1ECUSZLI(&N%O%KQD+&X(MX^.:%3J#;,#ZTN+U
MK!F(@?;SUME_ 5!+ P04    "  %-F51&L,*&J4'  "W%0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6S-6%UO&S<6_2N$%FAM0)9D.;;5U#8@JTGK
MHLT:L=,^%'V@9BB)&PXY(3E2U%_?<R]'XY$M>9WT81<PK/G@_>2YY][AQ<KY
MCV&A5!2?"V/#96<18_FZWP_90A4R]%RI+-[,G"]DQ*V?]T/IE<Q9J##]X6!P
MUB^DMIVK"WYVZZ\N7!6-MNK6BU 5A?3K:V7<ZK)SW-D\>*_GBT@/^E<7I9RK
M.Q4_E+<>=_U&2ZX+98-V5G@UN^R,CU]?G]-Z7O";5JO0NA84R=2YCW1SDU]V
M!N20,BJ+I$'B9ZDFRAA2!#<^U3H[C4D2;%]OM+_EV!'+5 8U<>9WG<?%96?4
M$;F:R<K$]V[UDZKC.25]F3.!_XM56GMVUA%9%:(K:F%X4&B;?N7G.@\M@=%@
MC\"P%ABRW\D0>_F#C/+JPKN5\+0:VNB"0V5I.*<M;<I=]'BK(1>OKF700;B9
MN/4J*!LEYVKWTX-;9W2F53B\Z$?8)@W]K+9SG>P,]]CY3OSJ;%P$\<;F*M^6
M[\/GQO'AQO'KX;,*[U39$R>#KA@.AH-G])TTB3AA?2=[](VSS%4V:CL7FS#%
M'^-IB![ ^?,9 Z\: Z_8P*M]#E?3H#Y5R*9XL\3_T$V&UN*/^O=>?8[BVKCL
MXY^[$OR%ZL7O2JBE-)6,=,&/7)95WE.,<A:5%W&A1$[OL=6N\J)P(:+4,M(B
MD9"BE'9-RRLKJUQ'E8O,80-M2%<!CI-\CLHPTF9*)"8!68C21:C1TI!"-[>:
M,807N0Z9<:'R2FC+9F?:0IB6!D!-%>1K3]PO7, 2W >H^%1I=KRM#.(4P2YQ
ML9!+):9*69;P )V0-M\8I[N,'D.E6>^SU?+TP#I[5-O^"]+A(=TIMX<O]&:/
M ^_5C/;#B7=(F_A)?/.OT?#X^'LQ<46A8U)"_D\<8U19!B@]88&;1N N C\+
M9W+EP[?B#4*):]Z/PG'"$X\C>[UG,'W:8/KT6="-[R;B0\D(>N=Z*,7CLZ/C
MDY<"^JMTWUCQ<V45WW<YX6_'=]="AU AI[N%NN)MLRDW%B5=I80>B8E7@+7X
MQ86 =!ZP*M)Q[TJ=B9/AF7BI[&&/"D[FKJ1R(+^P_3:7'AO-5/JSM!7:GCA.
ME"6J0!"CA87+]4Q#RJOH72@5=RI1J+AP>4]\0,%1J8*1TZ.N6,%261I=6[)H
M?EGR!M"B99) 2XZ*>84*I<H$MAZ@*>%S;!;"1=0[ !(9VQFQ@+-;[,"!<1NU
MN6C5 :W)JJ(RDGU6LQF\)P%--2J-6;.GZTVL[:1(:,O_@Q['CL(_6D#C!BW>
M$ I4(2V8+F!,24_O I5+0-L-#&RO2O(<,J7RVN4!A3;7UC[0W./42U1"F3H;
MM&I;ER+;6^FX$$]QT$,KU,1J;(*2535U;5W<, V7?&(:,I)<VVW#J+E$C?PX
M'M_6E%-S!=8^MG^,/O<>M*R7<FH -H"BK#>HV1@DZJG;W2U<4,A^2;S!OM6T
MN%K ]2?0H"44SM1H<#HBF+55U3K49P(KWKIEW4U8FKGH_/M +8+[9P6]1L\4
M$2U\V*A8J;012^VJ *20.FXM[)*FK&:RH"5N2H'# @$U!;-RE4'?(4ZCIJ90
M*6-X14$"&I2.EZ1GU4J$1"%1^\NK-#$"D1LT/H$@U<=C6'EE>/=K)#?98WB[
MV>ZM@)Y[+W/%^&!,^6:CFV*KW<,%Y+#SU#4H;HSA06T:S]A@PF9\455L;U:7
MI6DSGK.6GO$F/21N(0G/0F-H1RT10C3&@HP98KMYER[H%D>D"J7) D7#+2<\
MUW/.FIYS]H5]871T?-H%.<,]*\W1!Z3DSLWBBA#ZPE;T-2:I%8VK.?B+G[RD
M&36>2CO77,F;MOVC<_E*&\.Y^S<T^>;5[L .,/#%A./3P=&KP:%X+2;\O:!\
M4W^MH98P<5.4ADDFS?,3\'R ^E0^S%%B8EQ%4T915BPV]AZ^IE9R3]5W0S5V
M!^QJ &U2U[=(F"DK7](<A3W?D2[T+U2&-'J>\+I%>@Q96>J(]W\QNK=]S=A7
MO>4K9C;V4;9\9(;0Y&.H?=QP4&+=?VH8$>08^(PK:91U4Z(%O*UWJ$+PH=DA
MVLH=/H;:29N9BBIQGSQP2VQXV-N3S-1KJ>M2#-):8ME]+? 'E'DQQ04!$$J^
MZ]8.)":ARBX:8<H4DPIMYK;BGG@C/37U#3W $;S"C KF:^M\6$!\L'YD8VM8
MVA7>9I;VJ*Y/8%F* ; BGOT?\=-YPT_G7TX6HY<2T5?I!A&]0P?F_?T"*L*Z
MB3-&3IU/T]NX#=*#U"5'@]$AF,5(KV?-%,>4)%.7O%9Q1<-/LYS3F^[.!F?_
MG1E&-3-DR08;T"T#T]K H_:]L?3H,4S2K(1OL@KX\:YH2"KANB')I^,^1 ]I
M+MUA*-<YCWF81)8Z)U(I,+<LZ'!JJ1Y_X.X<OYEGMK+=IH0NA\(#RS9EUS78
MWI@5?T_@XYJ/HW+!@,:?-&Z^YJ&%VT=+D=&4S4C?L<P4[7=E@N7FF&P'V8S^
M.=D\7^ZC_ZMR[[<.TP"3.1\9TBB+A*5SM>9I<RHY3H=Q#\O3D>:OTB,Q :/^
M#**#WCF^>'TZ)DPW:.!\-#=U$9CDRX7">.9I =[/'#[NZQLRT)S57OT-4$L#
M!!0    (  4V95'+*N7P>00  *X*   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;)56P6[;.!#]E8%/6R!K.TZRVRT< W;2H'L(-FBZ[:'H@9;&$AN*
M5$DJCO?K]PTEJTJ0N.W%EBC.S)LW;X:<;YV_"R5SI(?*V' ^*F.LWTPF(2NY
M4F'L:K;XLG&^4A&OOIB$VK/*DU%E)K/I](])I;0=+>9I[<8OYJZ)1EN^\12:
MJE)^MV+CMN>CX]%^X;TNRB@+D\6\5@7?<ORWOO%XF_1><EVQ#=I9\KPY'RV/
MWZS.9'_:\%'S-@R>23)9.W<G+W_GYZ.I &+#610/"G_W?,'&B"/ ^-;Y'/4A
MQ7#XO/=^E7)'+FL5^,*93SJ/Y?GH]8ARWJC&Q/=N^XZ[?!+ S)F0?FG;[9V.
M*&M"=%5G# 25MNV_>NAX^!F#66<P2[C;0 GEI8IJ,?=N2UYVPYL\I%23-<!I
M*T6YC1Y?->SBXDII3Q^5:9BN687&,QB/@=YQ7FA;T%)8TU%S(&5S>FG[;S?.
MZ R[7LTG$;#$^23K(*Q:"+,7(/Q%U\[&,M!;FW/^V'Z"=/J<9ON<5K.##F^Y
M'M/)](AFT]GT@+^3GJ.3Y._DQQQ=ZI 9)WD'^KQ<A^@AJR\'8ISV,4Y3C--?
MJL,1)5YW]+G[_\ /D5;&97=?GB/Z!S&6MRM:WE[0!U?KC%X?GZ&MOC5:DE'&
M0,Q>WROIDE1KZ^Q@15LDV[35CH[6#-O,%5;_QSFI2+%D9+"1-.XE#;@,Q!K+
M'D^!8>8\&:W6VK1Z0D_B*WK**)LQ)0V/Z1,#1V0/K7/Z_MTEN0VYQO\\SB:(
MA),3KRJ6^4 872'S>@W4ZQT]I60&U;RD<8DUJ/^!HI_U13\[6)#+'G;XU4H?
M=OS/8Y:&G.0.A$4,X?57#,;$)RMO052J*^8<[)0AK\/=D=10Z"LPW=OZ.91R
M7[K @R"!"K;LH:,=ZK1!P?O-OK,?"*:K?8DI@S<=N1JC\)6R. @H<]"#16NE
MN8VB9ZZQ@%4K'W>4><YU3/BD@D97D!/*K+*,ZZC6AH?[16@IK:^ L=$64I/L
MA!$=&PD0,'%CB17D$(4C*KS*N8^CQ#OJTP<2X*J2$ E;NXT?ZB0+":9MCIF9
M-XCS!(E(")C;HPA$5<[JZ+QX?3;'-G8R>QQU&.(Q@-1!R@1'7-7&(88*\$N6
M8TN3]\H6G:1CB<Y-B27_B=.G?*.]?J_5+C$CQRBE9++&*)SM<&J2+\HA'$E>
M_"!6*GGK?^L:DU.I($0GXV"K(9PULQSJ&8.('.WIJF0YC#RFI8FE:XHR*39S
MR >3 ;2Q0+8(F!_1EO>2AFR"AB!?3J4[K;OY%33$N-&9 GKH7 %.D*^P:L5=
M>Q?;RT,8TU7C!?R1\/'<)!KVF((.]@V&6#BCC;05B@41)@[ 7-9X#4S#>HAS
M+^E@RT[RB4(B8-SKD)2:^!3O.>-6EG<E$21/%),(5?:)D@C=9;/=^+G1-1G<
M(2KV1;HIA9:_]CK1K_:7L65[!_F^O;W)72M?2+\;WL!T.OX3P\JWMZ/V);HZ
MW4C6+N)^DQY+7"C9RP9\WS@0W[U(@/Z*NO@?4$L#!!0    (  4V95&!'^!M
M  ,  ',&   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;)U538_;1@S]
M*X1.#6!8CM?;I(%MP'8:=($&6<1I<PAR&(\HB]CY4&>H:O??ES.RM0Z0]:$7
MS1??>R1G2"U['QYB@\CP:(V+JZ)A;M^59=0-6A6GOD4G)[4/5K$LP[&,;4!5
M99 UY7PV^[6TBERQ7N:]^[!>^HX-.;P/$#MK57C:HO']JGA=G#<^T['AM%&N
MEZTZXA[YK_8^R*H<62JRZ")Y!P'K5;%Y_6Z[2/;9X&_"/E[,(45R\/XA+>ZJ
M53%+#J%!S8E!R? O[M"81"1N_'/B+$;)!+R<G]D_Y-@EEH.*N//F*U7<K(JW
M!518J\[P9]__@:=X;A.?]B;F+_2#[1M1U%UD;T]@65MRPZ@>3WFX +R=O0"8
MGP#S[/<@E+U\KUBME\'W$)*UL*5)#C6CQ3ERZ5+V'.24!,?KG;>66++,$92K
M8.<=DSNBTX01KI_^<N\-I=FK9<GB2V(L]4EW.^C.7]#]#3X*5Q/A=U=A]2.^
ME!C&0.;G0+;SJX1[;*=P,YO ?#:?7>&[&1-SD_EN_E=BWE/4QL<N('S;'"('
M>5W?KZ@N1M5%5EV\H/HG'I41K<AQ CF]3_#M-'[!1X:M\?KA^\_R?9WX+A6
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M155]>P#+7HME+V+9NP_+]'QM^J,91 ]WLH,^O1$S3SOI;RG]@LZ-OA$VMD3
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M\7@6QN$"[W!APP9\+XSQZTDPT+[L3_\!4$L#!!0    (  4V95'DDH\&&@@
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ML+;VI-1QT@C_$^Z(41:[I+M-'YI89.H- 'LEKD:MVSO6S62S+B^.Z)7ZG D
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M\G3^HT#^8-7"O8B?*&M5XK[.<>L3FA9@?JIP]2P>2$'YT\S%_P%02P,$%
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M+TR*K+CS,S@S&P5X#CPY*<Z=1")1X'@\%1&X^R)E':_;#&(Z&P*822MJE0!
M*PN -^SYTP"^@\D$A)6"Y O[J!K%,?,&L'/L+H!+I $U^N]_38/Q\.?98)#+
MGW7X9J/5HX2()>(M._;Z UA=V-6N96&C91+*#:"1X.\L4>"3A=V56F854CEM
M;&+;&4E]S< U"X5.(3'D.T2F%5MF2>A8--G"R$AR#5&GSSX+0%=%R#9*D\'
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M$<:C/S-'0^?R=MZM:!;+93#5/G1UA0N2,^VWZ;J>2K&U="_CHGL9?W?WDJ[
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M<]NV$OTK.[J>3CPC6R3X*=?VC&PGTW32UA.[-P^=/L D).&&)%@ M)S^^GL
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M\ :L^Z]J_1^K6O\EZT99JVI_N19X;]7N =Q?*HSSPQ^G8/MM\_2_4$L#!!0
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M*2ED5P[3A.(B\>)!9OUT[#>7I660.9#?P .+5D$62?RZV'[L</""YBHD]95
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M[7<(5S)7-4*XY*L*S6 :6=K3>49Y&W_1Q$^>B7\&[Y2TI8&?9('%8_^(L':
MDP? B^1HP!O<GD(:GT 2)_&1>&E'0.KCI<_$.Y;UK\J8 ?Q&K:'6L.3W)W"-
M6J@"&M;@P\7*6$V%]?$(D&$'9.B!#%^DQ >O!"SQWL*B4OGMQZ<T.;J3Z_-S
ML^4YS@+:P*"^PV"^+!'6JJ(F%7(#UNL-6ZWN1(% >*@#\XH;(]8BYZZA#%"/
M.V(:M/DCM*)EL'(,GH!L*+3\'LXAI QK454NQ@"HMZAS)%SNM$:9?X:EYM)4
M?@NX*/ZF%J SP!HO0\L[!7A#0MQQU]'P5D@N<\$KXHCDV#V]?$TD%+! 22-+
M.OICQ0"719O E<7:P%)9"K3@%85$X,;!_F4GL2LY^!["X6A CR1)O)$Y@Z7L
MRT3 "ND8?8K*R03"+![ #]]-$I;\""G9C>(#<*[ :[5S:1U<*9NU5C6=:_FN
MWA%A-*&.(""8(1L>M@C9V:!-]YA; WPRA'#4<R8>'G-$;4G\K2A,CRC*@IC)
M)CV:,O9-Z\_.#OJSS!=#XHWQY"7RCYW_ [>3T:MK?^:T'_6T=Z#_J_9A,H!1
MTOF.OB1]R]'$]PA+#QPQ5]7?FOAO,&^38UUR;.@ZGXW30V$GX_@E!1">4?.G
MHX- &37;:U>!Z_XP2WIE,,J^H@Q8[/Q9UC]"W!GR_SD(_ET+/I\L]?DPY@O=
M)Y>F+ZF%-*9.H3. #8"-LE>O @<Q3/M_!-E7_!$,@<5)@RW.7G(0/'5CBGKW
MV!KUQM_6#>&AE)LK;3?;?1!<-/?@P_+F:^(=UQM!9%:X)M?X=)P%H)L;>F-8
MM?6WXI6R=,?VPY(^:E"[!?1^K91],-P&W6?2_!]02P,$%     @ !39E4:\+
M3B^'"0  ,$(  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULS5Q;<]NV
M$OXK&)WTC#WC6 1X =G:GK&MQ/&9I/782?K0.0\T!5F<\J*2E"^=_O@#4+26
M,@F HLWHO"02"2QVL8OO6V A'SVDV9_YG+$"/<91DA^/YD6Q^'D\SH,YB_W\
M,%VPA+^9I5GL%_QK=C?.%QGSIV6G.!H3PW#&L1\FHY.C\ME5=G*4+HLH3-A5
MAO)E'/O9TQF+TH?C$1X]/[@.[^:%># ^.5KX=^R&%=\65QG_-EY+F88Q2_(P
M35#&9L>C4_SSI4=%A[+%]Y ]Y+7/2)ARFZ9_BB^7T^.1(31B$0L*(<+G_]VS
M<Q9%0A+7XZ]*Z&@]INA8__PL_6-I/#?FUL_9>1K]'DZ+^?'(':$IF_G+J+A.
M'SZQRB!;R O2*"__10]56V.$@F5>I''5F6L0A\GJ?_^QFHA:!X(E'4C5@;SH
M8,HZF%4'L^L(5M7!ZMK!KCK873LX50>G:P=:=:!=.[A5!_=E!TO2P:LZ>&4X
MK/Q7.G_B%_[)498^H$RTYM+$AS*"RM[<YV$B@OVFR/C;D/<K3DZ#OY9A'HK
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MKGOF199ELRTG6FQ=OWH2VG0_-]R8Z%':#>;Y2IA;54VL@_J39_P74$L#!!0
M   (  4V95&I5U_X3@8  !DD   9    >&PO=V]R:W-H965T<R]S:&5E=#0P
M+GAM;+U:6W.;.!3^*QI/']J9ID828#OC>":.0S<SS:XG:7<?.ON@@&*S!>05
M<MSTUZ^X!!D0,FV\?K$-_LY5A^](0M,=X]_2-:4"?(^C)+T8K(78G ^'J;^F
M,4D_L U-Y#^/C,=$R$N^&J8;3DF0"\71$%F6.XQ)F QFT_S>DL^F;"NB,*%+
M#M)M'!/^/*<1VUT,X.#EQEVX6HOLQG VW9 5O:?BRV;)Y=6PTA*$,4W2D"6
MT\>+P24\]QR<">2(/T.Z2_=^@RR4!\:^91<WP<7 RCRB$?5%IH+(KR=Z1:,H
MTR3]^+=4.JAL9H+[OU^T>WGP,I@'DM(K%OT5!F)],1@/0$ ?R382=VSW&RT#
M<C)]/HO2_!/L"NQ(6O2WJ6!Q*2ROXS IOLGW,A%[ E*/7@"5 J@I8'<(X%(
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MT\.ZB!8KHL5]B;98Z-*@ODNQM_S]U!6HAEXG$ZNY=.T'\P["ZH$JNL:'=BO
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M3S\!JI88J_-W05$(%<:F "RY'X^LOBJVVI957*S.5H0DWE;J3!3IVZ9>.Y=
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MB;U)L6MN3+F(3L-AI!VE.X H "*A(=\B1X\.V D=/@>YZ!P.5$@G8:P=[+B
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M<FMS:&5E=',O<VAE970T-"YX;6RE5]MNXS80_15"V 42(+5NO@:V =^"!F@
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M.()EEQ$.[B"- =Y?"Z'W"^.@_"LP_ ]02P,$%     @ !39E42CDF0(?!0
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M9_;.3J6W>NF+D9ODRF<AC9%A\K@&[H.R$_#WI93F]<4ZR.]6Q_\ 4$L#!!0
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MYZ%,?\$NMW4[P$^DXE$.U@PB%F?_R4.^$!4 ]!H * >@M@"< _!S &X >#G
M:SM"/P?TVP(&.6#0%C#, <.V@%$.&*71S<*1QG).%)E.!-\!8:RU-W.1)D2*
MUB%DL<G=I1+Z+=,X-5TJ[M]N>!A0(7\%G^\2IA[!^SE5A(7R _@-7"_GX/V[
M#^ =<(#<$$$E8#&XCIF27?U07U^R,-1I*">.TH2,6\?/!S_-!D<-@__AJQY
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MSBJX_;#2N^D%/Z&'^6JM5EC@FJ I^O0 >BMJG8?#MH][KTH@A_T7MV_ _X5
M["TR=*TFMIFE$,=FBQT2:4.J>/*/KF(Y\(VY PL4ZQJJLW<SVMRSI^9V>38^
MPW=S[!A?Z'NYN?H=X*M+_0/A&UH(E$&J0@4W Z4<7MV3JXYD.W,1?&1272M-
M<PLD :X-U/N4,?G2T0&:?RLF_P)02P,$%     @ !39E43524;A@!P  BB<
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MH88:&5&>KQEK0OG0Z[!VHPN 5FNO-T/ZRT_0=WZ]I[(-I:M@"_)$S3T -'E
M3VT#*H2Z PR:<-!R0!OEAQUU'B)E/[+:?T/C2<DEJ]W0BHELI0$JSH3?2)K?
M3Q]0,2JT4^J!"02VR35 ^I(V@5Q/#W,;A.! KV FE(O"CC@K0H=V1G]1$H&*
M[*&=[=4DFH5XF:8LJD>2(]^IGFC2W?Y<P3;K8IV^AR80#/40&?@;!WJ$VJ!@
MX'0$2)$\'%@]L5HS+8^0 A!P2WDD?Y4[V"IT'^0^>D+2CKID'P</3I'SLZG[
MWRT8& 5'NP3Q:6@4'.\2]-HC;GM7=2O0WJ[<S9_%/ ,DCZ7S2L[VJG>J08#A
M2]<[I/@:V?GZP/6N&6UK"7CZ8C*! JT]&1E , ST>F= (8PZ> TI7D?P]=0[
MI.@6V>GV(/6N&6/+L;Y.24:0KX>H#4*AWG@80&[0T68BU2,@_#+U;L<X"'94
MG^%N06RN=SL$H=M5[W:/Z%CK'5)-$+(W04/"XX0]D"(J4\+WJ79(M1+HQ0\'
MD&H8T(L>#Z VET/'T?<Q1I2G;U -*!3X2%]-IF9EH\!N^T6U#^@5'1(@Q;O(
MSKN'J7=!V[%.H,?( &IMJPT@+\1ZA-J@P._H[Y#J$9#]%.%P]<X^#G(ZVK3A
M+D'_=-!1[W:.:!8<[Q(,3J&UWF'5!&%[$W0U^=N43?L4/JQZ"FSO*7Y X<.J
M<\#VSN' A0\;F-\+M./,H0GEZZB1 35PD';*,3:A J>C\.&-\WD[:7YD@J2
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
M  @ !39E48S',4LY!   ?2$   \   !X;"]W;W)K8F]O:RYX;6S%FM]OVS80
M@/\50B_+7F;KA],VJ NXSMH:V)H@#M+'@9;.-A&*]$C*:?O7[R3%*;4)A[[<
M_&2+HJ5/1XG?'>6W3]8];JQ]%%]K;?P\V8=PN)I,?+F'6OK?[ $,[ME:5\N
MFVXW\0<'LO)[@%#K23:=7DYJJ4SR[NWI6+=N$F_8 &50UF!CV_"@X,G_V-]N
MBJ/R:J.T"M_F2?==0R)J952MOD,U3Z:)\'O[],DZ]=V:(/6Z=%;K>9+V.Q[
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MZC.>PF-[*75YZT3[T;^(*&;M2N&VT7J);3?F#RNKT[\'3O]\>/</4$L#!!0
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M058^R"'(RP?5$%27#YI T*1\T",$/98/>H*@I_)!4PB:E@^2,<HX)DBZP9I
M:T&NA<!K0;"%0&Q!LH7 ;$&TA4!M0;:%P&U!N(5 ;D&ZA<!N0;R%0&]%O95
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MB_J8S]H?O]-/4$L! A0#%     @ !39E40=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  %-F51+^V.
MR.\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  %-F51F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  4V95$\,1MT208  ",<
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  %-F51C8Y^;*@&  !_'0  &               @(&-#@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ !39E42/N#9MT
M P  H L  !@              ("!:Q4  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    (  4V95%2R_!72 8  !$9   8              "
M@149  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  %-F51
MSKQ8$;X"  "_"   &               @(&3'P  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ !39E40C[HANX"0  &CX  !@
M     ("!AR(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M  4V95'?,T<=  <   T=   8              " @74L  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    "  %-F51BV.;S+\"  !J"   &
M            @(&K,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ !39E49@H?3;,"0  MQD  !@              ("!H#8  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (  4V95$&=T#,P1$  /TR
M   9              " @:)   !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ !39E4>#7\,4%#0  &"0  !D              ("!FE(
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  %-F51*\J3
M?=H<  #D:P  &0              @('67P  >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    (  4V95%:MAJGNQ0  )U$   9
M  " @>=\  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M!39E437"@D5M"   '!4  !D              ("!V9$  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    "  %-F51>*0DSBH'  !N$   &0
M            @(%]F@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    (  4V95$#]I&@Q!<  ')!   9              " @=ZA  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ !39E4>ZS@4L."@
MAQH  !D              ("!V;D  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    "  %-F51.#(6 1 &  #*#P  &0              @($>
MQ   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (  4V95%+
MIJ]F9P<  &$4   9              " @67*  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ !39E4;=SV'S<"@  KQ@  !D
M     ("! ](  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  4V95&!'^!M  ,  ',&   9              "
M@:SU  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ !39E
M4:\]"2>&!0  Y0\  !D              ("!X_@  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    "  %-F51Y)*/!AH(  "F&0  &0
M        @(&@_@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   (  4V95%*\3+;0 0  !H*   9              " @?$& 0!X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ !39E48;0JK)+#   Q2H
M !D              ("!: L! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    "  %-F51.=C/\68'  !Z$P  &0              @('J%P$
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (  4V95'6[DW:
M!0<  .<4   9              " @8<? 0!X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ !39E42G7.JM3 @  004  !D
M ("!PR8! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  %
M-F51Y" T CL$  !Y"@  &0              @(%-*0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  4V95&I%L:7T@0  "T+   9
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M970S."YX;6Q02P$"% ,4    "  %-F519IHL>3P#  #^"   &0
M    @(&?3 $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M  4V95&I5U_X3@8  !DD   9              " @1)0 0!X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ !39E4<UAD)O,%   \Z(  !D
M             ("!EU8! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    "  %-F51H9"][V(0  "$<@  &0              @(&::P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (  4V95$H1@#)D H
M #TZ   9              " @3-\ 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ !39E44(Y$6BT P  %@P  !D              ("!
M^H8! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  %-F51
M*.29 A\%  !G%0  &0              @('EB@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    (  4V95$5;\[R1@4  /,7   9
M      " @3N0 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ !39E485=[]/D P  N1   !D              ("!N)4! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    "  %-F51-5)1N& '  "*)P
M&0              @('3F0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    (  4V95'=MYHR)0H  &Y$   9              " @6JA 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ !39E40DW(]^U
M!0  AAP  !D              ("!QJL! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    "  %-F51/&00CXL"  !>#P  #0
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:+GAM;%!+!08     .@ Z ,T/  "DO0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>496</ContextCount>
  <ElementCount>444</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>124</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statement of Cash Flows (Supplemental Disclosure)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statement of Cash Flows (Supplemental Disclosure)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105102 - Disclosure - Acquisitions and Strategic Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</Role>
      <ShortName>Acquisitions and Strategic Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - Hedging Activities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</Role>
      <ShortName>Hedging Activities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - Contractual Obligations and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</Role>
      <ShortName>Contractual Obligations and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</Role>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2130109 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2132110 - Disclosure - Weighted Average Shares Outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</Role>
      <ShortName>Weighted Average Shares Outstanding</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2135111 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2138112 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2141113 - Disclosure - Changes in Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</Role>
      <ShortName>Changes in Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2145114 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2215203 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies</Role>
      <ShortName>Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2228204 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</Role>
      <ShortName>Commitments and Contingencies Commitments and Contingencies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2246206 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Acquisitions and Strategic Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</Role>
      <ShortName>Acquisitions and Strategic Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</Role>
      <ShortName>Goodwill and Other Intangible Assets Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Contractual Obligations and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</Role>
      <ShortName>Contractual Obligations and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Supplemental Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</Role>
      <ShortName>Supplemental Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Weighted Average Shares Outstanding (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</Role>
      <ShortName>Weighted Average Shares Outstanding (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReporting</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2339309 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/Revenue</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2343310 - Disclosure - Changes in Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</Role>
      <ShortName>Changes in Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/AcquisitionsDetails</Role>
      <ShortName>Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContingentConsiderationDetails</Role>
      <ShortName>Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Strategic Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StrategicInvestmentsDetails</Role>
      <ShortName>Strategic Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Goodwill and Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Hedging Activities and Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails</Role>
      <ShortName>Hedging Activities and Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420408 - Disclosure - Contractual Obligations and Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails</Role>
      <ShortName>Contractual Obligations and Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2423409 - Disclosure - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2426410 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/IncomeTaxesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2429411 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2431412 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/StockholdersEquity</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434413 - Disclosure - Weighted Average Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails</Role>
      <ShortName>Weighted Average Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2437414 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/SegmentReportingTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2440415 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/RevenueTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="bsx-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2444416 - Disclosure - Changes in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Changes in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bsx-20200930.htm">bsx-20200930.htm</File>
    <File>bsx-20200930.xsd</File>
    <File>bsx-20200930_cal.xml</File>
    <File>bsx-20200930_def.xml</File>
    <File>bsx-20200930_lab.xml</File>
    <File>bsx-20200930_pre.xml</File>
    <File>exhibit311-ceo302q32020.htm</File>
    <File>exhibit312-cfo302q32020.htm</File>
    <File>exhibit321-ceo906q32020.htm</File>
    <File>exhibit322-cfo906q32020.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20200930.htm": {
   "axisCustom": 1,
   "axisStandard": 28,
   "contextCount": 496,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 669,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 5
   },
   "keyCustom": 52,
   "keyStandard": 392,
   "memberCustom": 70,
   "memberStandard": 48,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Document",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105102 - Disclosure - Acquisitions and Strategic Investments",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments",
     "shortName": "Acquisitions and Strategic Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Hedging Activities and Fair Value Measurements",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
     "shortName": "Hedging Activities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - Contractual Obligations and Commitments",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitments",
     "shortName": "Contractual Obligations and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Supplemental Balance Sheet Information",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation",
     "shortName": "Supplemental Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - Income Taxes",
     "role": "http://www.bostonscientific.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130109 - Disclosure - Stockholders' Equity",
     "role": "http://www.bostonscientific.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132110 - Disclosure - Weighted Average Shares Outstanding",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding",
     "shortName": "Weighted Average Shares Outstanding",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135111 - Disclosure - Segment Reporting",
     "role": "http://www.bostonscientific.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138112 - Disclosure - Revenue",
     "role": "http://www.bostonscientific.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141113 - Disclosure - Changes in Other Comprehensive Income",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome",
     "shortName": "Changes in Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145114 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation Basis of Presentation (Policies)",
     "role": "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies",
     "shortName": "Basis of Presentation Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2215203 - Disclosure - Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "role": "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies",
     "shortName": "Fair Value Measurements Hedging Activities and Fair Value Measurements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2228204 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Policies)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies",
     "shortName": "Commitments and Contingencies Commitments and Contingencies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalCostsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2246206 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - Acquisitions and Strategic Investments (Tables)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
     "shortName": "Acquisitions and Strategic Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Goodwill and Other Intangible Assets Goodwill (Tables)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables",
     "shortName": "Goodwill and Other Intangible Assets Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Hedging Activities and Fair Value Measurements (Tables)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables",
     "shortName": "Hedging Activities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Contractual Obligations and Commitments (Tables)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables",
     "shortName": "Contractual Obligations and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Supplemental Balance Sheet Information (Tables)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables",
     "shortName": "Supplemental Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Weighted Average Shares Outstanding (Tables)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables",
     "shortName": "Weighted Average Shares Outstanding (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339309 - Disclosure - Revenue (Tables)",
     "role": "http://www.bostonscientific.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343310 - Disclosure - Changes in Other Comprehensive Income (Tables)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables",
     "shortName": "Changes in Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Acquisitions (Details)",
     "role": "http://www.bostonscientific.com/role/AcquisitionsDetails",
     "shortName": "Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i8b95a6dee16943f59d2330f61315da56_I20190819",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbpPerShare",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i96d357c574ae49f6894555c699e39978_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Contingent Consideration (Details)",
     "role": "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
     "shortName": "Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bsx:PaymentOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Strategic Investments (Details)",
     "role": "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
     "shortName": "Strategic Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Goodwill and Other Intangible Assets (Details)",
     "role": "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i96d357c574ae49f6894555c699e39978_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForHedgeInvestingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - Hedging Activities and Fair Value Measurements (Details)",
     "role": "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
     "shortName": "Hedging Activities and Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnCashFlowHedgeIneffectivenessNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420408 - Disclosure - Contractual Obligations and Commitments (Details)",
     "role": "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
     "shortName": "Contractual Obligations and Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bsx:DeemedConsolidatedEBITDA",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423409 - Disclosure - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails",
     "shortName": "Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i96d357c574ae49f6894555c699e39978_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426410 - Disclosure - Income Taxes (Details)",
     "role": "http://www.bostonscientific.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bsx:ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429411 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i96d357c574ae49f6894555c699e39978_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431412 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.bostonscientific.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "ied343c75dd384497a465543451475c7e_I20200527",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434413 - Disclosure - Weighted Average Shares Outstanding (Details)",
     "role": "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails",
     "shortName": "Weighted Average Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437414 - Disclosure - Segment Reporting (Details)",
     "role": "http://www.bostonscientific.com/role/SegmentReportingDetails",
     "shortName": "Segment Reporting (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportablesegments",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "bsx:EmergingMarketstotalnumberofcountries",
      "reportCount": 1,
      "unitRef": "units",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440415 - Disclosure - Revenue (Details)",
     "role": "http://www.bostonscientific.com/role/RevenueDetails",
     "shortName": "Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i96d357c574ae49f6894555c699e39978_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444416 - Disclosure - Changes in Other Comprehensive Income (Details)",
     "role": "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
     "shortName": "Changes in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ComprehensiveIncomeNoteTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i726300376e8d4180bbe6cd70d93649cc_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "if8ba508544a742afb3886d6afa51d329_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "ibc127a01b37a47e08d86d8c2afe2db89_D20190101-20190331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i49144bb069c54c75af6cf61abd6b94c0_I20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statement of Cash Flows (Supplemental Disclosure)",
     "role": "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
     "shortName": "Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statement of Cash Flows (Supplemental Disclosure)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.bostonscientific.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bsx-20200930.htm",
      "contextRef": "i0b5dd3ef7bf047e7a05c66700a3483ec_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 124,
   "tag": {
    "bsx_A2019AcquisitionsVertiflexAndMillipedeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2019 Acquisitions (Vertiflex and Millipede) [Member]",
        "label": "2019 Acquisitions (Vertiflex and Millipede) [Member]",
        "terseLabel": "2019 Acquisitions (Vertiflex and Millipede) [Member]"
       }
      }
     },
     "localname": "A2019AcquisitionsVertiflexAndMillipedeMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A2020TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2020 Term Loan [Member]",
        "label": "2020 Term Loan [Member]",
        "terseLabel": "2020 Term Loan [Member]"
       }
      }
     },
     "localname": "A2020TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ASCUpdateNo.201613PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments [Policy Text Block]",
        "label": "ASC Update No. 2016-13 [Policy Text Block]",
        "terseLabel": "ASC Update No. 2016-13 [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201613PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]",
        "label": "ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]",
        "terseLabel": "ASC Update No. 2018-15, Internal-Use Software [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201815InternalUseSoftwarePolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo.201818PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC Update No. 2018-18, Collaborative Arrangements (Topic 808): Clarifying The Interaction Between Topic 808 and Topic 606 [Policy Text Block]",
        "label": "ASC Update No. 2018-18 [Policy Text Block]",
        "terseLabel": "ASC Update No. 2018-18 [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201818PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]",
        "label": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2019-12, Income Taxes (Topic 740) [Policy Text Block]"
       }
      }
     },
     "localname": "ASCUpdateNo.201912IncomeTaxesTopic740PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity\u2019s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity\u2019s Own Equity",
        "label": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity\u2019s Own Equity (Subtopic 815-40) [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity\u2019s Own Equity (Subtopic 815-40)"
       }
      }
     },
     "localname": "ASCUpdateNo202006DebtDebtWithConversionAndOtherOptionsSubtopic47020AndDerivativesAndHedgingContractsInEntitysOwnEquitySubtopic81540PolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ASCUpdateNo202010CodificationImprovementsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC Update No. 2020-10 Codification Improvements",
        "label": "ASC Update No. 2020-10 Codification Improvements [Policy Text Block]",
        "terseLabel": "ASC Update No. 2020-10 Codification Improvements"
       }
      }
     },
     "localname": "ASCUpdateNo202010CodificationImprovementsPolicyTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_AccruedRebatesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Rebates, Current",
        "label": "Accrued Rebates, Current",
        "terseLabel": "Accrued Rebates, Current"
       }
      }
     },
     "localname": "AccruedRebatesCurrent",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ActualCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Actual Covenant.",
        "label": "Actual, Covenant [Member]",
        "terseLabel": "Actual, Covenant [Member]"
       }
      }
     },
     "localname": "ActualCovenantMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AggregateSeniorUnsecuredDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]",
        "label": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]",
        "terseLabel": "Aggregate Senior Unsecured Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "AggregateSeniorUnsecuredDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AllegedBreachofPurchaseAgreementAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Alleged Breach of Purchase Agreement, Amount",
        "label": "Alleged Breach of Purchase Agreement, Amount",
        "terseLabel": "Alleged Breach of Purchase Agreement, Amount"
       }
      }
     },
     "localname": "AllegedBreachofPurchaseAgreementAmount",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_April2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "April 2021 Term Loan [Member]",
        "label": "April 2021 Term Loan [Member]",
        "terseLabel": "April 2021 Term Loan [Member]"
       }
      }
     },
     "localname": "April2021TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_AssignedtoonejudgeinMAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assigned to one judge in MA [Member]",
        "label": "Assigned to one judge in MA [Member]",
        "terseLabel": "Assigned to one judge in MA [Member]"
       }
      }
     },
     "localname": "AssignedtoonejudgeinMAMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_August2019TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "August 2019 Term Loan [Member]",
        "label": "August 2019 Term Loan [Member]",
        "terseLabel": "August 2019 Term Loan [Member]"
       }
      }
     },
     "localname": "August2019TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_August2022TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "August 2022 Term Loan [Member]",
        "label": "August 2022 Term Loan [Member]",
        "terseLabel": "August 2022 Term Loan [Member]"
       }
      }
     },
     "localname": "August2022TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BSXReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "BSX Reportable Segments [Member]",
        "label": "BSX Reportable Segments [Member]",
        "terseLabel": "BSX Reportable Segments [Member]"
       }
      }
     },
     "localname": "BSXReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BTGAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "BTG Acquisition [Member]",
        "label": "BTG Acquisition [Member]",
        "terseLabel": "BTG Acquisition [Member]"
       }
      }
     },
     "localname": "BTGAcquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_BusinessAcquisitionContingentConsiderationCashPayment": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition Contingent Consideration Cash Payment",
        "label": "Business Acquisition Contingent Consideration Cash Payment",
        "negatedTerseLabel": "Payment of contingent consideration and royalty rights established in purchase accounting"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationCashPayment",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiovascular [Member]",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular [Member]"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]",
        "verboseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsLineItems",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_CertifiedclassactionsinCanadaMesh": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Certified class actions in Canada, Mesh",
        "label": "Certified class actions in Canada, Mesh",
        "terseLabel": "Certified class actions in Canada, Mesh"
       }
      }
     },
     "localname": "CertifiedclassactionsinCanadaMesh",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_CondensedConsolidatedBalanceSheetParentheticalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "label": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]",
        "terseLabel": "Condensed Consolidated Balance Sheet (Parenthetical) [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedBalanceSheetParentheticalAbstract",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "xbrltype": "stringItemType"
    },
    "bsx_CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "label": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]",
        "terseLabel": "Condensed Consolidated Cash Flow Supplemental DIsclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedConsolidatedCashFlowSupplementalDIsclosureAbstract",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "xbrltype": "stringItemType"
    },
    "bsx_ContingentConsiderationLiabilityProbabilityOfPayment": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "contingent consideration liability, probability of payment",
        "label": "contingent consideration liability, probability of payment",
        "terseLabel": "contingent consideration liability, probability of payment"
       }
      }
     },
     "localname": "ContingentConsiderationLiabilityProbabilityOfPayment",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_ContingentConsiderationRecognizedInPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent consideration recognized in the period",
        "label": "Contingent consideration recognized in the period",
        "terseLabel": "Fair value of contingent consideration recorded in purchase accounting"
       }
      }
     },
     "localname": "ContingentConsiderationRecognizedInPeriod",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_CorporateExpensesincludinghedgingactivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate Expenses including hedging activities [Member]",
        "label": "Corporate Expenses including hedging activities [Member]",
        "verboseLabel": "Corporate expenses and currency exchange [Member]"
       }
      }
     },
     "localname": "CorporateExpensesincludinghedgingactivitiesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CovenantAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Axis]",
        "terseLabel": "Covenant [Axis]"
       }
      }
     },
     "localname": "CovenantAxis",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_CovenantDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Covenant.",
        "label": "Covenant [Domain]",
        "terseLabel": "Covenant [Domain]"
       }
      }
     },
     "localname": "CovenantDomain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_CurrentRequirementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Current Requirement.",
        "label": "Current Requirement [Member]",
        "terseLabel": "Current Requirement [Member]"
       }
      }
     },
     "localname": "CurrentRequirementMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_December2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "December 2027 Notes [Member]",
        "label": "December 2027 Notes [Member]",
        "terseLabel": "December 2027 Notes [Member]"
       }
      }
     },
     "localname": "December2027NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_DeemedConsolidatedEBITDA": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deemed Consolidated EBITDA",
        "label": "Deemed Consolidated EBITDA",
        "terseLabel": "Deemed Consolidated EBITDA"
       }
      }
     },
     "localname": "DeemedConsolidatedEBITDA",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DeferredTaxLiabilitiesNetNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Net Noncurrent",
        "label": "Deferred Tax Liabilities, Net Noncurrent",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetNoncurrent",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "label": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) that may be Reclassified from AOCI to Earnings within Twelve Months [Table Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossthatmaybeReclassifiedfromAOCItoEarningswithinTwelveMonthsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "label": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Derivative Used in Net Investment Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "DerivativeUsedinNetInvestmentHedgeGainLosstobeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_DiscountRateFairValueInput": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discount Rate, Fair Value Input",
        "label": "Discount Rate, Fair Value Input",
        "terseLabel": "Discount Rate, Fair Value Input"
       }
      }
     },
     "localname": "DiscountRateFairValueInput",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EmergingMarketstotalnumberofcountries": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Emerging Markets total number of countries",
        "label": "Emerging Markets total number of countries",
        "terseLabel": "Emerging Markets total countries"
       }
      }
     },
     "localname": "EmergingMarketstotalnumberofcountries",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_EntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Entity [Abstract]",
        "label": "Entity [Abstract]",
        "terseLabel": "Entity [Abstract]"
       }
      }
     },
     "localname": "EntityAbstract",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "xbrltype": "stringItemType"
    },
    "bsx_EquipmentFurnitureAndFixturesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment, furniture and fixtures Gross.",
        "label": "Equipment, furniture and fixtures Gross",
        "terseLabel": "Equipment, furniture and fixtures"
       }
      }
     },
     "localname": "EquipmentFurnitureAndFixturesGross",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_EuroDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Euro Denominated Factoring Arrangements [Member]",
        "label": "Euro Denominated Factoring Arrangements [Member]",
        "terseLabel": "Euro Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "EuroDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_EurodenominatedoutstandingdebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Euro-denominated outstanding debt [Member]",
        "label": "Euro-denominated outstanding debt [Member]",
        "terseLabel": "Euro-denominated outstanding debt [Member]"
       }
      }
     },
     "localname": "EurodenominatedoutstandingdebtMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ExclusionFromEbitdaForRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exclusion from EBITDA for Restructuring Charges",
        "label": "Exclusion from EBITDA for Restructuring Charges",
        "terseLabel": "Exclusion from EBITDA for Restructuring Charges"
       }
      }
     },
     "localname": "ExclusionFromEbitdaForRestructuringCharges",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_February2019AggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "February2019AggregateOffering [Member]",
        "label": "February2019AggregateOffering [Member]",
        "terseLabel": "February2019AggregateOffering [Member]"
       }
      }
     },
     "localname": "February2019AggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_February2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "February 2021 Term Loan [Member]",
        "label": "February 2021 Term Loan [Member]",
        "terseLabel": "February 2021 Term Loan [Member]"
       }
      }
     },
     "localname": "February2021TermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForeigncurrencydenominatedindebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "foreign currency denominated in debt [Member]",
        "label": "foreign currency denominated in debt [Member]",
        "terseLabel": "foreign currency denominated in debt [Member]"
       }
      }
     },
     "localname": "ForeigncurrencydenominatedindebtMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ForwardCurrencyContractsTimetoMaturity": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward Currency Contracts, Time to Maturity in Months",
        "label": "Forward Currency Contracts, Time to Maturity",
        "terseLabel": "Forward Currency Contracts, Time to Maturity"
       }
      }
     },
     "localname": "ForwardCurrencyContractsTimetoMaturity",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_GlobalCrmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global CRM Reporting Unit [Member]",
        "label": "Global CRM Reporting Unit [Member]",
        "terseLabel": "Global CRM Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalCrmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalElectrophysiologyEpReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "label": "Global Electrophysiology (EP) Reporting Unit [Member]",
        "terseLabel": "Global Electrophysiology (EP) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalElectrophysiologyEpReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalEndoscopyEndoReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "label": "Global Endoscopy (Endo) Reporting Unit [Member]",
        "terseLabel": "Global Endoscopy (Endo) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalEndoscopyEndoReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalInterventionalCardiologyIcReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "label": "Global Interventional Cardiology (IC) Reporting Unit [Member]",
        "terseLabel": "Global Interventional Cardiology (IC) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalInterventionalCardiologyIcReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalNeuromodulationNmReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "label": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "terseLabel": "Global Neuromodulation (NM) Reporting Unit [Member]",
        "verboseLabel": "Global Neuromodulation (NM) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalNeuromodulationNmReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalPeripheralInterventionsPiReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "label": "Global Peripheral Interventions (PI) Reporting Unit [Member]",
        "terseLabel": "Global Peripheral Interventions (PI) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalPeripheralInterventionsPiReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_GlobalUrologyandPelvicHealthReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "label": "Global Urology and Pelvic Health Reporting Unit [Member]",
        "terseLabel": "Global Urology (Uro) Reporting Unit [Member]"
       }
      }
     },
     "localname": "GlobalUrologyandPelvicHealthReportingUnitMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_IntangibleAssetsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible Assets [Axis]",
        "label": "Intangible Assets [Axis]",
        "terseLabel": "Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IntangibleAssetsAxis",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_IntangibleAssetsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Intangible Assets [Axis]",
        "label": "Intangible Assets [Domain]",
        "terseLabel": "Intangible Assets [Domain]"
       }
      }
     },
     "localname": "IntangibleAssetsDomain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_IntangibleAssetsandGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Schedule of Intangible Assets and Goodwill [Table]",
        "label": "Intangible Assets and Goodwill [Line Items]",
        "terseLabel": "Intangible Assets and Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsandGoodwillLineItems",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_January2020NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "January 2020 Notes [Member]",
        "label": "January 2020 Notes [Member]",
        "terseLabel": "January 2020 Notes [Member]"
       }
      }
     },
     "localname": "January2020NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_January2040NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "January 2040 Notes [Member]",
        "label": "January 2040 Notes [Member]",
        "terseLabel": "January 2040 Notes [Member]"
       }
      }
     },
     "localname": "January2040NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes [Member]"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_June2030NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "June 2030 Notes",
        "label": "June 2030 Notes [Member]",
        "terseLabel": "June 2030 Notes [Member]"
       }
      }
     },
     "localname": "June2030NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LatinAmericaandCanadaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Latin America and Canada [Member]",
        "label": "Latin America and Canada [Member]",
        "terseLabel": "Latin America and Canada [Member]"
       }
      }
     },
     "localname": "LatinAmericaandCanadaMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "label": "Legal payments remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Legal payments remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LicensingarrangementassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Licensing arrangement assets [Member]",
        "label": "Licensing arrangement assets [Member]",
        "terseLabel": "Licensing arrangement assets [Member]"
       }
      }
     },
     "localname": "LicensingarrangementassetsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_LicensingarrangementliabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Licensing arrangement liabilities [Member]",
        "label": "Licensing arrangement liabilities [Member]",
        "terseLabel": "Licensing arrangement liabilities [Member]"
       }
      }
     },
     "localname": "LicensingarrangementliabilitiesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Licensingarrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Licensing arrangements",
        "label": "Licensing arrangements",
        "terseLabel": "Licensing arrangements"
       }
      }
     },
     "localname": "Licensingarrangements",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsasset": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Licensing arrangements, asset",
        "label": "Licensing arrangements, asset",
        "terseLabel": "Licensing arrangements, asset"
       }
      }
     },
     "localname": "Licensingarrangementsasset",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Licensingarrangementsliability": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Licensing arrangements, liability",
        "label": "Licensing arrangements, liability",
        "terseLabel": "Licensing arrangements, liability"
       }
      }
     },
     "localname": "Licensingarrangementsliability",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationAndDebtExclusionFromEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exclusion of litigation payments and any debt Issued to fund tax deficiency payments",
        "label": "Litigation and Debt Exclusion from EBITDA",
        "terseLabel": "Litigation and Debt Exclusion from EBITDA"
       }
      }
     },
     "localname": "LitigationAndDebtExclusionFromEbitda",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_LitigationSettlementReceivedGain": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation Settlement Received, Gain",
        "label": "Litigation Settlement Received, Gain",
        "terseLabel": "Litigation Settlement Received, Gain"
       }
      }
     },
     "localname": "LitigationSettlementReceivedGain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_March2024NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "March 2024 Notes [Member]",
        "label": "March 2024 Notes [Member]",
        "terseLabel": "March 2024 Notes [Member]"
       }
      }
     },
     "localname": "March2024NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2026NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "March 2026 Notes [Member]",
        "label": "March 2026 Notes [Member]",
        "terseLabel": "March 2026 Notes [Member]"
       }
      }
     },
     "localname": "March2026NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2028NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "March 2028 Notes [Member]",
        "label": "March 2028 Notes [Member]",
        "verboseLabel": "March 2028 Notes [Member]"
       }
      }
     },
     "localname": "March2028NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2029NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "March 2029 Notes [Member]",
        "label": "March 2029 Notes [Member]",
        "terseLabel": "March 2029 Notes [Member]"
       }
      }
     },
     "localname": "March2029NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2039NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "March 2039 Notes [Member]",
        "label": "March 2039 Notes [Member]",
        "terseLabel": "March 2039 Notes [Member]"
       }
      }
     },
     "localname": "March2039NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_March2049NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "March 2049 Notes [Member]",
        "label": "March 2049 Notes [Member]",
        "terseLabel": "March 2049 Notes [Member]"
       }
      }
     },
     "localname": "March2049NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MaximumCommercialPaperOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Commercial Paper Outstanding",
        "label": "Maximum Commercial Paper Outstanding",
        "terseLabel": "Maximum Commercial Paper Outstanding"
       }
      }
     },
     "localname": "MaximumCommercialPaperOutstanding",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_MaximumContingentPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Contingent Payment [Member]",
        "label": "Maximum Contingent Payment [Member]",
        "terseLabel": "Maximum Contingent Payment [Member]"
       }
      }
     },
     "localname": "MaximumContingentPaymentMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum leverage ratio permitted by revolving credit facility agreement.",
        "label": "Maximum Leverage Ratio",
        "terseLabel": "Maximum Leverage Ratio"
       }
      }
     },
     "localname": "MaximumLeverageRatio",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bsx_May2020NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "May 2020 Notes [Member]",
        "label": "May 2020 Notes [Member]",
        "terseLabel": "May 2020 Notes [Member]"
       }
      }
     },
     "localname": "May2020NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2020SNAggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "May 2020 SN Aggregate Offering",
        "label": "May 2020 SN Aggregate Offering [Member]",
        "terseLabel": "May 2020 SN Aggregate Offering [Member]"
       }
      }
     },
     "localname": "May2020SNAggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2022NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "May 2022 Notes [Member]",
        "label": "May 2022 Notes [Member]",
        "terseLabel": "May 2022 Notes [Member]"
       }
      }
     },
     "localname": "May2022NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_May2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "May 2025 Notes [Member]",
        "label": "May 2025 Notes [Member]",
        "terseLabel": "May 2025 Notes [Member]"
       }
      }
     },
     "localname": "May2025NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MedsurgMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "MedSurg [Member]",
        "label": "MedSurg [Member]",
        "terseLabel": "MedSurg [Member]"
       }
      }
     },
     "localname": "MedsurgMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_MillipedeInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Millipede, Inc. [Member]",
        "label": "Millipede, Inc. [Member]",
        "terseLabel": "Millipede, Inc. [Member]"
       }
      }
     },
     "localname": "MillipedeInc.Member",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Netcurrencyexchangegainloss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net currency exchange gain (loss)",
        "label": "Net currency exchange gain (loss)",
        "terseLabel": "Net currency exchange gain (loss)"
       }
      }
     },
     "localname": "Netcurrencyexchangegainloss",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Noncashimpactoftransferredroyaltyrights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-cash impact of transferred royalty rights",
        "label": "Non-cash impact of transferred royalty rights",
        "terseLabel": "Non-cash impact of transferred royalty rights"
       }
      }
     },
     "localname": "Noncashimpactoftransferredroyaltyrights",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_NotionalValueofOutstandingNetInvestmentHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notional Value of Outstanding Net Investment Hedges",
        "label": "Notional Value of Outstanding Net Investment Hedges",
        "terseLabel": "Notional Value of Outstanding Net Investment Hedges"
       }
      }
     },
     "localname": "NotionalValueofOutstandingNetInvestmentHedges",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_November2019AggregateOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "November 2019 Aggregate Offering [Member]",
        "label": "November 2019 Aggregate Offering [Member]",
        "terseLabel": "November 2019 Aggregate Offering [Member]",
        "verboseLabel": "November 2019 Aggregate Offering [Member]"
       }
      }
     },
     "localname": "November2019AggregateOfferingMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_November2035NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "November 2035 Notes [Member]",
        "label": "November 2035 Notes [Member]",
        "terseLabel": "November 2035 Notes [Member]"
       }
      }
     },
     "localname": "November2035NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_October2023NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "October 2023 Notes [Member]",
        "label": "October 2023 Notes [Member]",
        "terseLabel": "October 2023 Notes [Member]"
       }
      }
     },
     "localname": "October2023NotesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OperatingIncomeAllocatedToReportableSegments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Income Allocated to Reportable Segments",
        "label": "Operating Income Allocated to Reportable Segments",
        "terseLabel": "Operating Income Allocated to Reportable Segments"
       }
      }
     },
     "localname": "OperatingIncomeAllocatedToReportableSegments",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingIncomeUnallocatedToSegment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Income Unallocated to Segment",
        "label": "Operating Income Unallocated to Segment",
        "negatedTerseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated"
       }
      }
     },
     "localname": "OperatingIncomeUnallocatedToSegment",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OperatingleaseLiabilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating lease, Liability [Axis]",
        "label": "Operating lease, Liability [Axis]",
        "terseLabel": "Operating lease, Liability [Axis]"
       }
      }
     },
     "localname": "OperatingleaseLiabilityAxis",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OperatingleaseLiabilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Operating lease, Liability [Axis]",
        "label": "Operating lease, Liability [Domain]",
        "terseLabel": "Operating lease, Liability [Domain]"
       }
      }
     },
     "localname": "OperatingleaseLiabilityDomain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OperatingleaserightofuseassetAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating lease, right-of-use asset [Axis]",
        "label": "Operating lease, right-of-use asset [Axis]",
        "terseLabel": "Operating lease, right-of-use asset [Axis]"
       }
      }
     },
     "localname": "OperatingleaserightofuseassetAxis",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OperatingleaserightofuseassetDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Operating lease, right-of-use asset [Axis]",
        "label": "Operating lease, right-of-use asset [Domain]",
        "terseLabel": "Operating lease, right-of-use asset [Domain]"
       }
      }
     },
     "localname": "OperatingleaserightofuseassetDomain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossafterReclassificationTax",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Current Assets [Abstract]",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_OtherOtherLongtermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other, Other Long-term Assets",
        "label": "Other, Other Long-term Assets",
        "terseLabel": "Other, Other Long-term Assets"
       }
      }
     },
     "localname": "OtherOtherLongtermAssets",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_PaymentOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payment of contingent consideration",
        "label": "Payment of contingent consideration",
        "negatedLabel": "Payment of contingent consideration"
       }
      }
     },
     "localname": "PaymentOfContingentConsideration",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Paymenttonetsharesettleemployeeequityawards": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payment to net share settle employee equity awards",
        "label": "Payment to net share settle employee equity awards",
        "negatedTerseLabel": "Cash used to net share settle employee equity awards"
       }
      }
     },
     "localname": "Paymenttonetsharesettleemployeeequityawards",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from secured borrowings relating to royalty arrangements",
        "label": "Proceeds from secured borrowings relating to royalty arrangements",
        "terseLabel": "Proceeds from secured borrowings relating to royalty arrangements"
       }
      }
     },
     "localname": "Proceedsfromsecuredborrowingsrelatingtoroyaltyarrangements",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_Productliabilitycasesorclaimsrelatedtomeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product liability cases or claims asserted related to mesh products",
        "label": "Product liability cases or claims related to mesh product",
        "terseLabel": "Product liability cases or claims related to mesh product"
       }
      }
     },
     "localname": "Productliabilitycasesorclaimsrelatedtomeshproduct",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductCanada": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - Canada",
        "label": "Product liability cases or claims related to mesh product - Canada",
        "terseLabel": "Product liability cases or claims related to mesh product - Canada"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductCanada",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product liability cases or claims related to mesh product - United Kingdom",
        "label": "Product liability cases or claims related to mesh product - United Kingdom",
        "terseLabel": "Product liability cases or claims related to mesh product - United Kingdom"
       }
      }
     },
     "localname": "ProductliabilitycasesorclaimsrelatedtomeshproductUnitedKingdom",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_RDRegulatoryandCommercializationbasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "label": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]",
        "terseLabel": "R&amp;D, Regulatory and Commercialization-based Milestone [Member]"
       }
      }
     },
     "localname": "RDRegulatoryandCommercializationbasedMilestoneMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RenminbiDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Renminbi Denominated Factoring Arrangements",
        "label": "Renminbi Denominated Factoring Arrangements [Member]",
        "terseLabel": "Renminbi Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "RenminbiDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_Requirementextensionthroughtheremainderof2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Requirement, extension through the remainder of 2020 [Member]",
        "label": "Requirement, extension through the remainder of 2020 [Member]",
        "terseLabel": "Requirement, extension through the remainder of 2020 [Member]"
       }
      }
     },
     "localname": "Requirementextensionthroughtheremainderof2020Member",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfifthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Requirement, fifth quarter following qualified acquisition [Member]",
        "label": "Requirement, fifth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fifth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfifthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementfourthquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Requirement, fourth quarter following qualified acquisition [Member]",
        "label": "Requirement, fourth quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, fourth quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementfourthquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]",
        "label": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]",
        "terseLabel": "Requirement, sixth quarter and thereafter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementsixthquarterandthereafterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RequirementthirdquarterfollowingqualifiedacquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Requirement, third quarter following qualified acquisition [Member]",
        "label": "Requirement, third quarter following qualified acquisition [Member]",
        "terseLabel": "Requirement, third quarter following qualified acquisition [Member]"
       }
      }
     },
     "localname": "RequirementthirdquarterfollowingqualifiedacquisitionMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA.",
        "label": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA",
        "terseLabel": "Restructuring charges remaining to be excluded from calculation of consolidated EBITDA"
       }
      }
     },
     "localname": "RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "revenue-based payments [Member]",
        "label": "revenue-based payments [Member]",
        "terseLabel": "revenue-based payments [Member]"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_RhythmandNeuroMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rhythm and Neuro [Member]",
        "label": "Rhythm and Neuro [Member]",
        "terseLabel": "Rhythm and Neuro [Member]"
       }
      }
     },
     "localname": "RhythmandNeuroMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "label": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate from Continuing Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofEffectiveIncomeTaxRatefromContinuingOperationsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Line Items]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Line Items]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationLineItems",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIncomeTaxRateReconciliationTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Income Tax Rate Reconciliation [Table]",
        "label": "Schedule of Income Tax Rate Reconciliation [Table]",
        "terseLabel": "Schedule of Income Tax Rate Reconciliation [Table]"
       }
      }
     },
     "localname": "ScheduleofIncomeTaxRateReconciliationTable",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_ScheduleofIntangibleAssetsandGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Intangible Assets and Goodwill [Table]",
        "label": "Schedule of Intangible Assets and Goodwill [Table]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleofIntangibleAssetsandGoodwillTable",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_SegmentOperatingIncomeasaPercentageofNetSales": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Segment Operating Income as a Percentage of Net Sales",
        "label": "Segment Operating Income as a Percentage of Net Sales",
        "terseLabel": "Segment Operating Income as a Percentage of Net Sales"
       }
      }
     },
     "localname": "SegmentOperatingIncomeasaPercentageofNetSales",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits",
        "label": "Special Charges [Member]",
        "terseLabel": "Intangible asset impairment charges, acquisition/divestiture-related net (charges) credits, restructuring- and restructuring-related net (charges) credits, EU MDR implementation costs and litigation-related net (charges) credits"
       }
      }
     },
     "localname": "SpecialChargesMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SpecialtyPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Specialty Pharmaceuticals [Member]",
        "label": "Specialty Pharmaceuticals [Member]",
        "terseLabel": "Specialty Pharmaceuticals [Member]"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StatementAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "statement [Axis]",
        "label": "statement [Axis]",
        "terseLabel": "statement [Axis]"
       }
      }
     },
     "localname": "StatementAxis",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_StatementDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for statement [Axis]",
        "label": "statement [Domain]",
        "terseLabel": "statement [Domain]"
       }
      }
     },
     "localname": "StatementDomain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Common stock)",
        "label": "Stock Issued During Period, Value, New Issues (Common stock)",
        "terseLabel": "Common stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesCommonStock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_StockIssuedDuringPeriodValueNewIssuesPreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "label": "Stock Issued During Period, Value, New Issues (Preferred stock)",
        "terseLabel": "Preferred stock issuance (Value in excess of par)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesPreferredStock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summary of term loan and revolving credit facility agreement compliance with debt covenants.",
        "label": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]",
        "terseLabel": "Summary Of Term Loan And Revolving Credit Facility Agreement Compliance With Debt Covenants [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfTermLoanAndRevolvingCreditFacilityAgreementComplianceWithDebtCovenantsTableTextBlock",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bsx_SupplementalBalanceSheetInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information [Abstract]",
        "terseLabel": "Supplemental Balance Sheet Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationAbstract",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "xbrltype": "stringItemType"
    },
    "bsx_SupplementalBalanceSheetInformationTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supplemental Balance Sheet Information.",
        "label": "Supplemental Balance Sheet Information (Textuals) [Abstract]",
        "verboseLabel": "Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetInformationTextualsAbstract",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bsx_The2018FacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "the 2018 Facility",
        "label": "the 2018 Facility [Domain]",
        "terseLabel": "the 2018 Facility [Member]"
       }
      }
     },
     "localname": "The2018FacilityDomain",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TheCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The CARES Act",
        "label": "The CARES Act",
        "terseLabel": "The CARES Act"
       }
      }
     },
     "localname": "TheCARESAct",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bsx_ThreeYearDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Three-Year Delayed Draw Term Loan [Member]",
        "label": "Three-Year Delayed Draw Term Loan [Member]",
        "terseLabel": "Three-Year Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "ThreeYearDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalAllocatedToReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total allocated to reportable segments [Member]",
        "label": "Total allocated to reportable segments [Member]",
        "terseLabel": "Total allocated to reportable segments [Member]"
       }
      }
     },
     "localname": "TotalAllocatedToReportableSegmentsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Product liability cases and claims settled related to Mesh product",
        "label": "Total Product liability cases and claims settled related to Mesh product",
        "terseLabel": "Total Product liability cases and claims settled related to Mesh product"
       }
      }
     },
     "localname": "TotalProductliabilitycasesandclaimssettledrelatedtoMeshproduct",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bsx_TwoYearDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-Year Delayed Draw Term Loan [Member]",
        "label": "Two-Year Delayed Draw Term Loan [Member]",
        "terseLabel": "Two-Year Delayed Draw Term Loan [Member]"
       }
      }
     },
     "localname": "TwoYearDelayedDrawTermLoanMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_UpfrontCashMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upfront Cash [Member]",
        "label": "Upfront Cash [Member]",
        "terseLabel": "Upfront Cash [Member]"
       }
      }
     },
     "localname": "UpfrontCashMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_VertiflexIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vertiflex, Inc.",
        "label": "Vertiflex, Inc. [Member]",
        "terseLabel": "Vertiflex, Inc. [Member]"
       }
      }
     },
     "localname": "VertiflexIncMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_WeightedAverageMaturityDays": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Maturity, Days",
        "label": "Weighted Average Maturity, Days",
        "terseLabel": "Weighted Average Maturity, Days"
       }
      }
     },
     "localname": "WeightedAverageMaturityDays",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "durationStringItemType"
    },
    "bsx_YenDenominatedFactoringArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Yen denominated factoring arrangements.",
        "label": "Yen Denominated Factoring Arrangements [Member]",
        "terseLabel": "Yen Denominated Factoring Arrangements [Member]"
       }
      }
     },
     "localname": "YenDenominatedFactoringArrangementsMember",
     "nsuri": "http://www.bostonscientific.com/20200930",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "verboseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share",
        "terseLabel": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC [Member]"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r354",
      "r357",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r540",
      "r588",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r354",
      "r357",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r540",
      "r588",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r211",
      "r330",
      "r334",
      "r541",
      "r587",
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r211",
      "r330",
      "r334",
      "r541",
      "r587",
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r342",
      "r354",
      "r357",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r540",
      "r588",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r342",
      "r354",
      "r357",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r540",
      "r588",
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r212",
      "r213",
      "r330",
      "r335",
      "r590",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r212",
      "r213",
      "r330",
      "r335",
      "r590",
      "r607",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r287",
      "r355",
      "r506"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Scenario [Axis]",
        "verboseLabel": "Statement, Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r513",
      "r515",
      "r518"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r5",
      "r31",
      "r65",
      "r217",
      "r218",
      "r569"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Trade accounts receivable, net",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounts and Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "verboseLabel": "Trade accounts receivable, net"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable from change in methodology.",
        "label": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)",
        "terseLabel": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)",
        "verboseLabel": "Cumulative effect adjustment for adoption of ASU 2016-13"
       }
      }
     },
     "localname": "AccountsReceivableChangeInMethodCreditLossExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r27",
      "r552",
      "r572"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Accrued Royalties, Current"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r49",
      "r274"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r79",
      "r84",
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTerseLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r74",
      "r81",
      "r83",
      "r84",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r81",
      "r83",
      "r84",
      "r575",
      "r599",
      "r603"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r80",
      "r84",
      "r87",
      "r143",
      "r144",
      "r145",
      "r423",
      "r594",
      "r595"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r364",
      "r365",
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r383",
      "r384",
      "r385",
      "r386",
      "r543",
      "r544",
      "r545",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r36",
      "r219",
      "r235"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsNotesAndLoansReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Less: allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r124",
      "r259",
      "r267"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization expense",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r133",
      "r195",
      "r201",
      "r207",
      "r228",
      "r419",
      "r424",
      "r480",
      "r549",
      "r570"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r68",
      "r133",
      "r228",
      "r419",
      "r424",
      "r480"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r220",
      "r221",
      "r242",
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r438",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r12",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r353",
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r353",
      "r356",
      "r397",
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r405",
      "r406",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1": {
     "auth_ref": [
      "r395",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination",
        "terseLabel": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r123",
      "r414"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "verboseLabel": "Contingent consideration expense (benefit)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": {
     "auth_ref": [
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r404",
      "r407",
      "r411"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Business Combination, Contingent Consideration, Liability Ending Balance",
        "periodStartLabel": "Business Combination, Contingent Consideration, Liability Beginning Balance",
        "terseLabel": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r404",
      "r408"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r404",
      "r408"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "ACQUISITIONS AND STRATEGIC INVESTMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r399",
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r399",
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsMember": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A borrowing recorded for a lease meeting the criteria for capitalization. A lease is defined as an agreement conveying the right to use property, plant, or equipment (land or depreciable assets) usually for a stated period of time.",
        "label": "Capital Lease Obligations [Member]",
        "terseLabel": "Finance Lease Obligation"
       }
      }
     },
     "localname": "CapitalLeaseObligationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r46",
      "r604",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash Acquired from Acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r46",
      "r126"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r118",
      "r126",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r118",
      "r487"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease)\u00a0in cash, cash equivalents, restricted cash and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]",
        "terseLabel": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r131",
      "r133",
      "r164",
      "r165",
      "r166",
      "r168",
      "r170",
      "r179",
      "r180",
      "r181",
      "r228",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r22",
      "r550",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r61",
      "r286",
      "r558",
      "r579"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,679,428,209 shares as of September 30, 2020 and 1,642,488,911 shares as of December 31, 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r92",
      "r97",
      "r418",
      "r428",
      "r561",
      "r583"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r96",
      "r105",
      "r560",
      "r582"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Income (Loss) Note [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Capital in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r318",
      "r319",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Contract with Customer, Liability [Abstract]",
        "terseLabel": "Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "terseLabel": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockTermsOfConversion": {
     "auth_ref": [
      "r28",
      "r29",
      "r308",
      "r311",
      "r312",
      "r313"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.",
        "label": "Convertible Preferred Stock, Terms of Conversion",
        "terseLabel": "Convertible Preferred Stock, Terms of Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockTermsOfConversion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r100",
      "r541"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r557",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "verboseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "CONTRACTUAL OBLIGATIONS AND COMMITMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r551",
      "r554",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r59",
      "r135",
      "r308",
      "r311",
      "r312",
      "r313",
      "r498",
      "r499",
      "r501",
      "r567"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r301",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r124",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r70",
      "r71",
      "r479"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCashReceivedOnHedge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash received during the period on settlement of a hedge.",
        "label": "Derivative, Cash Received on Hedge",
        "terseLabel": "Derivative, Cash Received on Hedge"
       }
      }
     },
     "localname": "DerivativeCashReceivedOnHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r69",
      "r72",
      "r441",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r69",
      "r72",
      "r441",
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liability, Fair Value, Gross Liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r439",
      "r442",
      "r451",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r436",
      "r439",
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r436",
      "r439",
      "r451",
      "r458",
      "r459",
      "r463",
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Assets, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "terseLabel": "Derivative Instruments in Hedges, Liabilities, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r70",
      "r71",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r431",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r430",
      "r432",
      "r433",
      "r436",
      "r437",
      "r445",
      "r451",
      "r460",
      "r462",
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r137",
      "r430",
      "r432",
      "r436",
      "r437",
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.",
        "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]",
        "terseLabel": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]"
       }
      }
     },
     "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r330",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r25",
      "r27",
      "r553",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends Payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r314",
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "terseLabel": "Dividends, Preferred Stock, Cash",
        "verboseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r314",
      "r565"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "negatedTerseLabel": "Preferred stock dividends"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r98",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r161",
      "r164",
      "r168",
      "r169",
      "r170",
      "r175",
      "r176",
      "r562",
      "r584"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r98",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r164",
      "r168",
      "r169",
      "r170",
      "r175",
      "r176",
      "r562",
      "r584"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss)\u00a0per common share \u2014 assuming dilution"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r171",
      "r173",
      "r174",
      "r177"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Weighted Average Number Of Shares Outstanding [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstanding"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r487"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rates on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate from continuing operations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r159",
      "r178",
      "r232",
      "r307",
      "r314",
      "r364",
      "r365",
      "r366",
      "r385",
      "r386",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r47",
      "r196",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Measurement alternative investments (1)"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r468",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r467",
      "r468",
      "r471",
      "r472",
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "HEDGING ACTIVITIES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r343",
      "r344",
      "r349",
      "r352",
      "r468",
      "r510"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r343",
      "r344",
      "r349",
      "r352",
      "r468",
      "r511"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r468",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r473",
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurement, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/FairValueMeasurementsHedgingActivitiesandFairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r474",
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r222",
      "r223",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r260",
      "r263",
      "r266",
      "r269",
      "r542",
      "r546"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "verboseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r266",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r260",
      "r265"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r481",
      "r483",
      "r485",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r343",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnCashFlowHedgeIneffectivenessNet": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness.",
        "label": "Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net",
        "terseLabel": "Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net"
       }
      }
     },
     "localname": "GainLossOnCashFlowHedgeIneffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": {
     "auth_ref": [
      "r439",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments",
        "terseLabel": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r250",
      "r251",
      "r548"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill Ending Balance",
        "periodStartLabel": "Goodwill Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, Gross"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impaired, Accumulated Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r253",
      "r254",
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Translation and Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r99",
      "r133",
      "r195",
      "r200",
      "r203",
      "r206",
      "r209",
      "r228",
      "r480"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r436",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r124",
      "r270"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charges",
        "verboseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]",
        "verboseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r95",
      "r195",
      "r200",
      "r203",
      "r206",
      "r209",
      "r547",
      "r559",
      "r564",
      "r585"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss)\u00a0before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r377",
      "r381",
      "r382",
      "r387",
      "r389",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.",
        "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority",
        "terseLabel": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority"
       }
      }
     },
     "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r158",
      "r159",
      "r193",
      "r375",
      "r388",
      "r390",
      "r586"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in fair value adjustment on other assets (liabilities) carried at fair value under the fair value option on the statement of cash flows of Federal Home Loan Banks (FHLBanks).",
        "label": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option",
        "terseLabel": "Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r262",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "verboseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r262",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r258",
      "r264"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r94",
      "r189",
      "r497",
      "r500",
      "r563"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "verboseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense [Member]"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r343",
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Unamortized Gain on Fair Value Hedges"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r38",
      "r247"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r4",
      "r66"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r40",
      "r247"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r39",
      "r247"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Table Text Block]",
        "terseLabel": "Investment [Table Text Block]"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r580"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r11",
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r130",
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Costs, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesCommitmentsandContingenciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r35",
      "r133",
      "r228",
      "r480",
      "r555",
      "r577"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r57",
      "r133",
      "r228",
      "r420",
      "r424",
      "r425",
      "r480"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r26",
      "r554",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term Line of Credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r53",
      "r135"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r61",
      "r286",
      "r293"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves, current"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r61",
      "r286"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Estimated Litigation Liability, Noncurrent"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "negatedLabel": "Litigation-related net charges (credits)",
        "terseLabel": "Litigation-related net charges (credits)"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r26",
      "r302",
      "r554",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term Debt and Capital Lease Obligations",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r59",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r296",
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "verboseLabel": "Accrual for legal matters that are probable and estimable"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money Market Funds, at Carrying Value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash provided by (used for) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash provided by (used for) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r118",
      "r121",
      "r125"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash provided by (used for) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r161",
      "r162",
      "r167",
      "r170",
      "r195",
      "r200",
      "r203",
      "r206",
      "r209"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r154",
      "r175",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r383",
      "r384",
      "r385",
      "r386",
      "r543",
      "r544",
      "r545",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r195",
      "r200",
      "r203",
      "r206",
      "r209"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SegmentReportingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "verboseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "totalLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other Assets, Miscellaneous, Current"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Other Assets, Noncurrent",
        "verboseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r75",
      "r81",
      "r482",
      "r484",
      "r488"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r84",
      "r93",
      "r489",
      "r491",
      "r495"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r77",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "verboseLabel": "Net change in derivative financial instruments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r77",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r77",
      "r81",
      "r440",
      "r446",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r81",
      "r85"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r81",
      "r85",
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r447",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax": {
     "auth_ref": [
      "r78",
      "r81",
      "r447",
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r89",
      "r92",
      "r93",
      "r96",
      "r307",
      "r489",
      "r494",
      "r495",
      "r560",
      "r582"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Total other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss) Net of Tax, Period Change [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodChangeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "terseLabel": "Net change in defined benefit pensions and other items",
        "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r81",
      "r85",
      "r86",
      "r350"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r56"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "totalLabel": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Other long-term liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other Operating Income (Expense), Net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r56",
      "r298"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other Sundry Liabilities, Current"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForHedgeInvestingActivities": {
     "auth_ref": [
      "r111",
      "r122"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Payments for Hedge, Investing Activities",
        "negatedTerseLabel": "Payments for settlements of hedge contracts",
        "terseLabel": "Payments for Hedge, Investing Activities"
       }
      }
     },
     "localname": "PaymentsForHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r108",
      "r111",
      "r138"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Proceeds from royalty rights"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Payments for Royalties"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash dividends paid on preferred stock",
        "terseLabel": "Payments of Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r109",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for acquisitions of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Payments for investments and acquisitions of certain technologies"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareCashPaid": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Preferred Stock, Dividends, Per Share, Cash Paid"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "terseLabel": "Preferred Stock, Dividends Per Share, Declared"
       }
      }
     },
     "localname": "PreferredStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "auth_ref": [
      "r29",
      "r131",
      "r308",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "terseLabel": "Preferred Stock, Liquidation Preference Per Share"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred Stock, Liquidation Preference, Value",
        "terseLabel": "Preferred Stock, Liquidation Preference, Value"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value - authorized 50,000,000 shares - issued 10,062,500 shares as of September 30, 2020 and none as of December 31, 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r44",
      "r45"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r6",
      "r8",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestiture"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock in connection with public offering",
        "verboseLabel": "Proceeds from Issuance of Common Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Net proceeds from issuance of preferred stock in connection with public offering",
        "verboseLabel": "Net proceeds from issuance of preferred stock in connection with public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes proceeds from (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).",
        "label": "Proceeds from Issuance of Long-term Debt and Capital Securities, Net",
        "terseLabel": "Proceeds from long-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r114",
      "r116",
      "r127"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "Net increase (decrease) in commercial paper"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from other long-term debt.",
        "label": "Proceeds from (Repayments of) Other Long-term Debt",
        "terseLabel": "Proceeds from borrowings on credit facilities"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "negatedTerseLabel": "Proceeds from Royalties Received"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings, net of debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r88",
      "r91",
      "r117",
      "r133",
      "r147",
      "r158",
      "r159",
      "r195",
      "r200",
      "r203",
      "r206",
      "r209",
      "r228",
      "r418",
      "r421",
      "r422",
      "r427",
      "r428",
      "r480",
      "r564"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r48",
      "r273"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r275",
      "r578"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r19",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, plant and equipment, net [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.",
        "label": "Receivable with Imputed Interest, Effective Yield (Interest Rate)",
        "verboseLabel": "Average interest rate of de-recognized receivables"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestEffectiveYieldInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r84",
      "r87",
      "r93",
      "r489",
      "r493",
      "r495"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r200",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "verboseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r199",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of Commercial Paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r116",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "terseLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedTerseLabel": "Payments on borrowings from credit facilities"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-term Debt",
        "negatedTerseLabel": "Payments on long-term borrowings and debt extinguishment costs"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedTerseLabel": "Payments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r18",
      "r126",
      "r128"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted Cash and Cash Equivalents in Other current assets",
        "verboseLabel": "Restricted cash and restricted cash equivalents included in Other current assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r10",
      "r21",
      "r128",
      "r608"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash equivalents included in Other long-term assets",
        "verboseLabel": "Restricted Cash Equivalents in Other long-term assets"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r124",
      "r278",
      "r280",
      "r281"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Restructuring charges (credits)"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r33",
      "r314",
      "r367",
      "r576",
      "r598",
      "r603"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r159",
      "r232",
      "r364",
      "r365",
      "r366",
      "r385",
      "r386",
      "r594",
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r186",
      "r187",
      "r199",
      "r204",
      "r205",
      "r211",
      "r212",
      "r215",
      "r329",
      "r330",
      "r541"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r333",
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "verboseLabel": "Trade accounts receivable, net [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r84",
      "r494",
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Other Comprehensive Income [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r397",
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "verboseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r397",
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r59",
      "r135",
      "r308",
      "r311",
      "r312",
      "r313",
      "r498",
      "r499",
      "r501",
      "r567"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Schedule of Long-term Debt Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r439",
      "r451",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r256",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r41",
      "r42",
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Disclosure [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r450",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r62",
      "r131",
      "r179",
      "r180",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of Weighted Average Number of Shares [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r215",
      "r587"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r182",
      "r184",
      "r185",
      "r195",
      "r198",
      "r203",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r214",
      "r215",
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending Balance (Shares Issued)",
        "periodStartLabel": "Beginning Balance (Shares Issued)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r23",
      "r551",
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term Debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Short-term Debt, Weighted Average Interest Rate, at Point in Time"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r215",
      "r256",
      "r277",
      "r279",
      "r282",
      "r587"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Statement, Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails",
      "http://www.bostonscientific.com/role/RevenueDetails",
      "http://www.bostonscientific.com/role/SegmentReportingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r131",
      "r133",
      "r164",
      "r165",
      "r166",
      "r168",
      "r170",
      "r179",
      "r180",
      "r181",
      "r228",
      "r307",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsandStrategicInvestmentsTables",
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails",
      "http://www.bostonscientific.com/role/CoverDocument",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r64",
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r159",
      "r178",
      "r232",
      "r307",
      "r314",
      "r364",
      "r365",
      "r366",
      "r385",
      "r386",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r495",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r178",
      "r541"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsCondensedConsolidatedStatementofCashFlowsSupplementalDisclosure",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Payment Arrangement"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r358",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r29",
      "r30",
      "r307",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Stock issuance (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the number of shares issued.",
        "label": "Stock Issued During Period, Shares, Period Increase (Decrease)",
        "terseLabel": "Stock-based compensation (Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r29",
      "r30",
      "r307",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r133",
      "r143",
      "r144",
      "r145",
      "r148",
      "r157",
      "r228",
      "r232",
      "r314",
      "r364",
      "r365",
      "r366",
      "r385",
      "r386",
      "r416",
      "r417",
      "r426",
      "r480",
      "r489",
      "r490",
      "r495",
      "r595",
      "r596"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r314",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r307",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stock issuance (Par value)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r496",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r496",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r496",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r496",
      "r505"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationMaterialSubsequentEventDetails",
      "http://www.bostonscientific.com/role/CommitmentsandContingenciesDetails",
      "http://www.bostonscientific.com/role/StockholdersEquityDetails",
      "http://www.bostonscientific.com/role/StrategicInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Events, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "verboseLabel": "SUPPLEMENTAL BALANCE SHEET INFORMATION"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "terseLabel": "Tax Adjustments, Settlements, and Unusual Provisions"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes Payable, Current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/AcquisitionsDetails",
      "http://www.bostonscientific.com/role/GoodwillandOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.",
        "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized",
        "verboseLabel": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.",
        "label": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]",
        "terseLabel": "Transfer of Financial Assets Accounted for as Sales [Table Text Block]"
       }
      }
     },
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r222",
      "r223",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": {
     "auth_ref": [
      "r76",
      "r454"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.",
        "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "terseLabel": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ChangesinOtherComprehensiveIncomeDetails",
      "http://www.bostonscientific.com/role/HedgingActivitiesandFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r63",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofStockholdersEquityCondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r63",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r63",
      "r315",
      "r316"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost - 247,566,270 shares as of September 30, 2020 and December 31, 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r150",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r383",
      "r384",
      "r385",
      "r386",
      "r543",
      "r544",
      "r545",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/BasisofPresentationASUsImplementedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r372",
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt [Member]"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContractualObligationsandCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r139",
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charges to expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedLabel": "Utilization of allowances"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/SupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow [Member]"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/ContingentConsiderationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r163",
      "r170"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Assuming dilution"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted-average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r161",
      "r170"
     ],
     "calculation": {
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.bostonscientific.com/role/WeightedAverageSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3098-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121321822&loc=d3e3913-113898"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121323062&loc=d3e15009-113911"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28511-109314"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28446-109314"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r618": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r619": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r621": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r622": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r623": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0000885725-20-000044-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-20-000044-xbrl.zip
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MC1SY7O^V&6 T$GS53T:0-;@1-O?ZJ%T[LGIM!^_-ZVO@IAAA:T13C>WX5H!
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M^T7Y *#GJWP5U<6+\_UB\\.+;SU\]4(O-^8.= .3Y+1U26[&N%9M3 A..59
MPVQ*C4W$^F;+B*SQ7I('),G;M\GMO(Y<M,I *V")N5DVG#&AA@O8WI7D;800
MMSIN;]'Y3[( (H5]4N6/$+U#$"Z9?6U-K*F3"8IOF89]3/\>O%:^>ZO+<]_<
M[:9NXD,CL?J69O/O%ZO5UV>7O_M4CL]O<'4T>_'V35[M-A]7SJ#W3X7J-:;
M "BJ[RUY#4FE4%6AYJGD#/82/"@)WF2R.+&8FI"MM>!2H.8P^X@Q&I^R&4%?
MX+T$;TJ"1YR\E>Q5B"U@WT,)/A/UOL4>*IL6&K>](=Z+\0BL,=A@6LM1E$@
M6R$'S0NAK346;B/8%SQ8"7JC2ST2OM2C<KI<RKR<Z8,O3F;GMS738)4_6UG>
M9+_P@BU&HLJI0N+,+IE$.1E6AJ'QW?!-\EZ61RW+F]PJE+UGGX.7T@!,0<L9
M#68"5[#:,'R[/ IZ<<N9PMLI^L:MY_K8^>C5S#5V9# :B%@\Y3B"U5![T=B<
MU7B]Z*Z_6+VW[*Z;Z_,C5U^_\:([8><,*/@&"D2"W*H!XVTK?<K$CV#YZRC$
M[%-<^E L4DVY20-U5#E L>JXBGCH2YN\-2;YRPTC:00;1B8O,S>^B1M-,=Y?
MK-8_M&=T_-%UD5LC?;>>%7UW&\\-)[(WN(T'^@R6:)2.9($H,#INEI(:ZJ3<
ML.WU;:KZ]IU*P5(#F@W/X8\CT-J]XJF;4P8473[O/NAR)FG60RW!95)7-R+%
MV\O\/LTQ,NU#"PE"W\C@>\FOEG,2DUVP$5R*:/?:-Q7M>_?'>PNY33O]/<_\
M>*8)8\J8*KM"X%TC<)R-EP10I4D:T=+?/<_<QW5_0M]VLT 9P13*J52*",D7
M2N)B:4%<@A03[_5MJOJVC^MVJG@ F<_[S9I,4'(D)9<2 U "DSR5$2G>7N;W
MS'+X"E>,#942FV@00%IV-D7PD'HI/\<\HA)3>T^W9Y9_,I+;?N&OS#92Y.B$
M*F2G]-*D[(HQ2C8QQ++7MZGJVYY9[KB68M]96J/C4J'W(<MDN4*!RKZOL!V1
MXNUE?C]C,#+ML\PI)1,DLX?S/A-12K.F1 @M5;/7OJEHWSZN&X3"^8R^]E6I
MH9>9#3&;U%Q"_8U>83_E$958V//,?5SW)_,HVR\$$4Q+ ABPEY!#)@R4,[&M
MR1MV<:]OD]6W?5RW4\7+KMGFK=A4!2@T,B9XFTWCRB7'.B+%V\O\GED.7^%"
MX"C0BT8T!QQ5QT(T(=>^R\")X?UVE#V7^Q0)OYUJ/;7OJ/<24D+PMF:+M:5F
MK2>-B=H(.@2/1V@_:T)T*]+KJ_62*%82!LE.I2L49(/H7>,QF-RA"<Z>56RA
M;8LQ0A)R;T0&^H(">%'IBES!&70C6B4^H"J? RJYN9NUT 8B@_>Q67$ Q>7F
MA)%1>NFGF&A$2\3V8C6<A5 9FBT<L:8^.6QB;V1$K;FL 8YO%4<T0[47J^',
MPZ G;K4OL2L&Q'KFHEX0HQ-QOJ8Q-1[8B]5PDC"VA%:+TBGU?] +J3?!5+W-
M0B&[N*_=.:*,Z]=T3/,BSXY$?D>IGBSE!<WJI1*M[LWKN9K=/U_=LKZW6LEZ
M+-VPU.P%AER-:0ER\(@N&B5PO><[^Q#W-9/V@KLYP=U@';@D)D9*6'-$D S,
MJ0;LO:A0Q=CMZ\!-2G"O:$P9H8GE2J&XY(U# .,-1N'"UHG2!(YY7YE^+ZD#
ML:DU5RY-F)LK$+*:T][Q'BQF<B0X@B[HGT51N8HEI-)[.O<B5U:-B%$&YR)8
M!:^.H,SE8%':9#<'DVJ,S>3: E@)%+FJ$\@DSED1&KXN#<+J;X73CB7/<3M3
M\<%P#DI.V)\O3<Z9O(<67"BFD!]!<?"]H Y74#=H4=$U*BX@1>^@.2(#W+P@
MII"2?KBWJ#MWOIOFT9>Z\?V,>'8\6\]&TV0^NTB.DZ48 2I6EA[[">=8) =?
M]T9U+ZM#L:L-0FV $=7E@Z>6N?=PQV":"X[;GJE.3U;?Y"?&9UH%Q=2^5SQ*
M D+/X-'6'&)!;T.1O6G=B^N K&O)UH6:5(ZL 1++,2?*$%SROI5HAF]=]Y*R
M'<.&)C- 81\!53X(*^1F^A)CT@@]C:!QXEY2MF-3'$3;W6"6JI$P9N5L*7E4
M2\-8B-/P;<H@7.!M$?OQ96DVV83+I(3!LRE$@*DBAUJS,+D$D5,9OA7;R^:@
M9'.3&40NA6-C-*)!KT5*C8%;1+ :3901V,UO:+;\.QV?RM=GKU_^IUZ1EN7H
M['MY*<?O2.G52=_-7YRN5^=GV$V)R+6;>731/*T_S3=+^>=I+_+T.W=R[=35
M4^D^>#Q;:!)7SJVEY)J2M%(S-XREB#A.(3<W*@&Z9<RV*M-N) *$C,EG5VHT
M N +$M2HCK*QQH+DQV6!IB1 ?B0"9(M#5YP3(0^,#7W.D4%2-D(1\UZ !HB9
MJ>@PQM#[TE;GL-J4H8(X"BZ:$2P W-..W?)6;"&A:KSC!IXJ:7R5F\\U"1MB
M-RH!FI+7N%7:L4$!LE*J!QNL3PSH*AI(M9K45Z))*B.8CIZH -TJ[=B@ "G)
M:!)+KF0"4*[9ABSD:A!C2\.]  T0LPALHTO%0P*@A#ETXM@R-F4>7'%45'&8
M&K9!DF@@QV);(%\+ #/5H$0?&A5)^D*&B]9JN;[[M.= +\#H;Q_-YK.3TY.-
M6=K9G.9E1L=O$K)O2HM_/RO]_/DA+9?]+OI1&M/^(##6Q%C9MYY4LBY;S!53
MXN9L2:/0TUO!Y]\2/'IU \$;"O*N9DD1*C8;H!@FVZJXYHO-3+&-8+_-<)#_
MA\P.C_K,\DOU#X<?JVPP% FH$F(((9+W!CK4S56.PAZ+M]Z.(9WS9R7@>'-S
M5?^VYQD*_"'D4$QD2V"AN90%)$?,X@6IR@C*( X-_E'9?XG!]+XWX,F#1X.8
MJL95G'T*HM1]#_]GX00<V[X2T!=  0C]K3@30HV1%+ \HE)7@V'JNZ\T912_
MQ*:XDIVZ=HV[J]10?%^\18KAE%&]N9:/$MJ&L3%48M,W3OC"(6J\)L6X'JO3
M".J__B&B#T^7BVL=NA:GZV[:JD)\@U9=0S&J8#) $PDM-PAB.,6FX*2H5M55
MH!%D+(>)T08SE$;C7:HM@A@"2)PI<A+]2%HA&<-D]O>+^>%:EB</=-"?G[V0
M-P ]HC.]>?=XL1[- O2JJD+50S2I J8^9=U$71A2J&C\"%1F]W!L4#M\D036
MM"9LP+*&BDP! [9BT-*XM>.'LE[HEWK[LS%IB+,NM6@["A$,)*J9?*76D_6^
M6!RSAFP3DDWNA6BEEI!"5,<!&D)G:Y1B6ZFJ)T[L"/97_9'16I8CO7T8DXY(
MZ4U\$3FV#&Q-KLY1TM"V9BX,?LPZLCU -CD/W-<-,?G>$D]]>\O&510?5%LB
M]%ZOH]:0[M;#F/2CM.";$Y>"M^ @Y^*M0^$*@:MO(UC,M7LX-EKSCEU!H!+9
M E0A9]2A4/!)'3N.H?K![\/Q7Z=S&9MZ8 ;JSEO8)>A5!QN8AL2Y>O4I,H+M
M_0/ 8Y/501I*:P'!9K50U>=*+BKG E.93!Y!U:6/N_,X)@4Q"4I52!I3@4B!
M"$UB]>2()92+*>.Q*LCV -FD!Q%?'*>:C!4 TK%7ID4F2-6QDW$'A0^DG']+
M,4ECPJ0HP\VMNN@S@7#(V04/JBP8"A@[@GX,'U>2/":KY1(99N-LIUDEBQJL
MG'7(J**/*&G,2K(]0#:ZHMNWY-ABZA6>4U2#A39F=-7VBA*CYKU7@."8-"17
MKD$UA)R&YE8-F(E1DL04U8 9'C7QW1X@F\R_.\*(1!F (0A1U%A=(_>4*%L(
MH_8A%Y&(-V-2$+$ED8^>BR/@WG\UQ"*HS->TXMT(*HL, (]-ZH>%5*A(2*0N
MW4K.E(SS2GVKI31N_7B\>'G)>_VHLB?NHG^#:2T& )^Q+W9@%W.58)7]CEE'
MMHK))E<Y& <MU=R:VBIIE+V:+O4LX'OKU-;&K">7CMV/BFD%WZ2Q,X5] NZU
MP]6UQV@$I8181U!H;PB ;#):C\JK//9*AP1&:59E9;^U232U93-J3_)?-#^E
MY9DS,"JR95IB8XVT6!V@4F&*R20C&B2"MS2"#;_#@&2352!,*9DX&]1X)%O%
MAQ,D%Y.#&,D.>(?HC<T6C,J/L"^478*2BL:(0;6B22@EBL>:X6+[WEAU9'N
M;++GD@5JR6$&JT:KQ<RL_Q*I_<I2[0CV4_X^(/=.#T]7Z[Z&\;D>_WY!\Y%H
M"20;-3XL!I*H)R%,7()WRL!4:Y1RC5E+M@O*)GU):CVQ:$"#=2 ?-72GS"GZ
MD NU,73Z^S H5T>?R7RV6([)F9B^X<NJBGA7P4O?^66C1&FY)*]F;:QJLF5$
M-KGR09IJ Y"CXD$=>DZM4L#F<H?)CG;EP]71[_19E[):/Z6U//N-7HQ$42I3
M\VQR$4N0FF%BFTP4*38VL*-E7;N 99/SB<&ZIB&*#2+ [3P#;)U+QC<O/HV@
M-.X?PW*?7LS6=/R]T$I^X./9X7E-[+%X%RF88BC&H4< 4%_O+/2"E,A08QOM
MHJ$=HK/1#EQH<TQ8D:R^+.A,]9Z5'%-CMB/83_K];"X_M/M+J;/U-U3ZWM^S
M-S3Y^9'H>.6K P\6)S2;_RXJ-_[1#_W<U;&G\G)Q_'(V/WS[I)&H:PK$(6HL
MZ]6AJ6?#X%(!C6Q[G[8$_.[><3]@O?UL)>,3]JG[:W;E$_:I,_=L;34Q]RFH
M@IFK!Q<C= M3?+T4([@2HSA< _-LK6/0OW/_F%:K']JS]:+\>BT0#\$\NO_D
MV3,='%G=NWTPX>9@QLT4'>A-WALU#<Z;@/B66_.AD:!!07T[(C#W-F%W8H2Q
MLW&-FTK?P"HI(P)K/!N%62W%5<DI<(/U*)T!?J@DPKT7R]FQWKS=5H(4#MQ&
MBC/GW%"JS[T(@H=&-69H48I^C"&52\4.-A]<O=A#\U'-"@<VWU"SKI_Z*05_
MR*24JR7O"KC>C*&:8FIO3\KB_96!5BIW</5BC^,-<'3IQCB^.?43</143-;8
M*S!E*#9@\7UOC>JGLWKL*I/AQ@??-\++BYGO[1E)=PV43UG81K;TVEFMV=AK
M)7).7JH+-MJ.U@A*Y0T)E V%J5Y#5&^B!%L!U.8QV[Z()['SI.H#(Z*DNT5G
M][2PAEA<[V0&JF3)5/5EGB.V("8V]6N74*815*L;%I1IZ]7IH%"U7DUC2 BJ
MCSDYU+A1"4GI>WM>KY,W86P(WNOCM+V9=A,V8".%LO<Q"%:7^VHM=E6'JS1G
MU'9J^#7\S/M T-C,GH6DCLIAXP8!FK54?>_&A>*-LHGR7JG5 2=6=P3+[K.:
M,:&OV4F,$<'E0$U]5NPUT0K$?+E1+EMG<730'1XNY;#/^YXOEOAQONHM9Z0^
MD&,ZTW^6]-L-@;WQK?SQM-JU.[CEHI*YJ[C%3:AXB#99;VT+"4RK9)-OU4LI
MR303:/CB\<>8O"T\3Z7*R8L^V?GD?(B>_[;8E&C\GI3J3_PDM/SS0CD4"7&5
MJ(KK\^ &D("=V,*UHO-%XL5V@PE+R-%2/E89_=-EI/_(N*4D>[3!]G1Y]4#H
MR/>R!2;X&(ME%RZ(F\D3E9+)VA$\,'DS$A)SPEA N;T7L(&8B\VU4FHE:Z0E
M$Y>02=N1S4E)HHHQI9:\R@H3D$A+V3>O@8BM,(+NOWLIV<(2L!!::1@8A,&@
MXUA<0F+@E*MP&6Y^NP-P?_%2YG0=DONGR^6Y./SS=';1/W,D.>TJ)1&$OCPF
M0#4MLTVQ%YTPS#[% :_Z_C 0]\KZE(ZO/A\)" (Q).-UF-&!+2'KR#OF[EJ5
M>:4!;W7\, C7U$"?\>+<]=%R<7IXM#X2/4"S>97EHO7'&@E&)1A2^E-:D  F
M" $4C;U1@K7L(8P8H_71;%G_>4I+]7IM<7R\^&TV/]3WQ_T'*Q4]<37K/FXD
M4)G"EC4V,CXK4>7(A7-%5@\C$)H9< 6*CT+5%J?+]=&$L')D.#CC&7T$)XYR
MJR5*BK6E$/.835^;M4E!%4"@1WPED('H(J<:*$GQ*9F2TX ;='P4JM7LU6NH
M:%[/G12UB>!&;$ BY1A+@ ()@W$>T?2E)/K9F/KM/3M:+-?/?W];S.+D1):]
MA]03T@$:U&S0AF:[,U:HA:DF#9Q<]AQS96ZY6A!,8<"^;2@8WA*#9Y==+2YC
M5C,)S-$I/:2:JQ+Z,H+MS,.!99/=<H(OH*J!3@K8X+(QRBU:B4'ZVA#339_%
M2].G+_9J<R/3U].%-S1]_=1-+?3QS9<:6'J'T>)S]D*=.O8T!5AWE3,:\'KQ
MCW42,<\>OYX3_Z$U'9KYX6T;P.NKP3]IW8^!5 Q&R'VG;64!\JDRJO6KT<H$
M5O7O9D'=]A?VEY;!!RNQI@:1 X--[)LD4CO:R].=&TUK+HWFD)W:+MN_O6,P
MK;FQP7S+^WU*WU[G@4&#:+TJ],ZPWEIOB_+$9L57N)KXW^/W$4*2-U<VHK%7
M&L*MA0)!%<H+>@H2-;"DF-,D=.NV&P3L7K-B2IXH.S1J%,D85@-9>L;*VAQ=
MKF/6K"VV=]B<7J$:M8B,K9?$X>HXLS/)BX*B43+"1/3J-MO-#4"KF%(0RRC6
M0<@1O6N<BDM4]+DO:X*-5JNVU"IP<SH5*P4PKB%2 H,!I;=$HQ(\&;+ILB:N
M<6ZP&RM^'XXW7-[B5D.N'@^[ [>)K1;DP'KG.#8)D+*EC#:(R\!J!(EP1'G=
M&Q0O=K=5O'CW.5T7N-KB34Z>05%%#9]SJ1IVG7>,&G5OHMO'[W9J'?><.C!7
M7Y1/Y(+*\"IB!E=;M'X:NG69=)JL7@7+JCU% RUCH,:0F[$A1 OQO&?W"#91
M[PJ[V^GX!<H@U,KIT!?(,9##HO2.DD_-5A-&I%._DXR_7B/9XB WI6U(M82S
MM4HU7+8-JA0L6$/S5%/FAF4$+NOWLKP/3Y>+!S)?G,SF.C;U&RKK12>%]Y9+
MFA]>K!88B<(UZXVU8A)A@:;()+3-HX;$P944XH@4;EAH[5[_8F>)20J+%VA\
M7LL*!$QROAD*?OCSS<-"]'9V7YMLL_*/9$.?'$.J&C6[["4Z%$_PSNSS'JW;
MGXO>5*I*60MZ2898N61FD\GG8L KAF!J'4$+I]]#]">93\7]"3K,EJ%2[ D1
M+H0^(ZD3-'W+PP3<WT[ VKWWZUW3(D"Q10R4JK 2-TG6LT>?8ABO]]NQ]FW0
M^8$]9R:Y1M?[>13R *EY=M9 OB2?(W=^.]>^W?@^7ULJQ:(KT8 +0(4X-55
MH-J<'_!.F(\!^E3F"B;/)N( $Y 1-"9(\!"#02NY[X+)L:1:,$W  >X.L=U[
MP6JR*6123APA9LI4?8W>"CFV&OI?ZN$6JA#^:0&/&]J\FHA:1@F]X'L4APF=
M$@*/.A2"T5S.4 YM!+K9WM (I& UY(^B H!0;5/]]JTX2%B0,9=W%SAOH<#7
MK?JP3RBJ=3J?70Q:.:;9R>KU,)P(K4Z7<FY.+@Y=7>#JR-7[?H4/HV!+2+T1
M$)6@<JB&-JH[;.AB3A+E,AJT9KA%QI^=\DK^>:I?>OA2__I /[.W3[AE#VC-
M9FJ-!^]L0@OD@@!FR;Z!->*<*HDP^.$#\_UL?=G=I[>$.%V]VV5NO3Z6^N:D
M396>F*@\V&8;@'A7;0*.32UD8..21I,HC .6A]5R?4T6[M/J^I33:C4[G$M=
M+Q9S^>6T'LIL_NAC34$^=U%P?<NQ<@5;LX&:*Q*6C,TUT9?)IXO%9FK*W=!$
MX6K<OSY=S>:R6MU[LR/UC4S\^*(M]7%54(YN>;F9Z9'E!@ QM2AY4=KB3 17
M*R9V$ QS;CVS4T8.R"-Z-3LY/;FOCZRQB5[X"9V=W+*Z;! =J1Y\2:%6GP$P
MD0:4 3P$"RF4UR5*!MSD8=<ME=[==K61/@'-L7(96YIO 103DLXXF7K=F)RY
MCJ@)QZ[QV7TGCN1#:RF7\S)[#IP&L5F5C*C8P-Z,8+W2KC&\G75+N7@&&X/)
M'E#A@)**LP5:K)ZECBB-ME%\;L19G_84W,4O]+>/9O/N!:>8CD.7JD!(S:8*
MW I&A\:DH"XR1-388B\F-Q>3"[(T13$Q %Y]M$$3#+1*&*WQ#BV"./2Y78H)
MOA83,[A8="C6_ETP\<^ :3:R#(35/P/;&K#OL,VD#APE4PZ]X4BYG&&QYI)^
M]1>?!9@W_]6=)Q?>$:*>7K@A[7OKU$^93_54JEJ !!94F!(A:9#%["G8F!N_
M3DKM96=@LO->8FH3(5WMDS31-Q-%(^U>NP;91F=R[2( 9AHAW?6Z-3VWK0>F
M&-*1U7'5D('(1*C(6'M1C6(H6=\W[8TZ;;(5#&\E;5*"!,H>I2\C(R\LII6<
MJ'&.P?&8VK_=TRO4V?'I>O92GO7N-;.U&MF'K\KQ:97ZS7)QHO"\.%V?SQO\
MT![2<CZ;'ZZ>R/+9$2WEZ[,/7^ =2]JQ[=?17S^_T)/C:3:3:PVP]L+UXBJ
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M>HXH+@#O.<0.K<-6N,/KK4]+>;%8KHF/Y?*>/[P-ZOW3KBY\XRU1Q4?FQ%&
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M6C'0KC'>43-!AT&<E%J5)G-6<N6 6JWZ1DD6^&EYX5UCO!M_; MG5=@6745
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MJ+<Q[!#<@_H>.[#-V=@W>9H,+9WW14]HBU$#H>1@#.S],_<F.RJOF&NLB+F
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M8XC9-J4@M>S7=(VM=<B.LNFEI/^?O3=O:BO)TH>_BH*>F9\KPDGEOM@]1&#
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M//Y;Z4V_'X:KO; 3!U\[/@YW8!(*%=V BEIK4\XYK*,UQ$GD0?]"7','9FG
MB#.E [R@7 ,5:7EGU]SE>+]7C>NZ6ZU/'JDS<#H5I-X/4B<.)"&=-%)3)"4!
M? 9ND0/+&#D7G//$)"X(* WJSNZC@M3Z(O4A'2,%Q+,"\<3_(;6/L'0YTLPE
M$+<.\)LT1](P:ZSUWBF2O<!<B@+CQPOCA[3L"XQG!>.) 8\M5322A P&LYU3
MBT$64XED2CH$R:S+;DSZG-8*QK<-1UHD&_W-H#\<9@L]=4:W,LUGXFY=:')Z
MR$"<:KK>5;-5V.@F;+0S9<,;203'B2*L$D-<.8&,31ZQY+A0-BEF]-(*>:X,
M7A1WXHPV50KB:Q=T4A!_:\1/? $\FL"2I(B::!''SB"M8P(S(C)F(];"^XQX
MF*B"^(+X^?H1"N)OC?B)XR DP;16 45 .^(Q<&2S'X'0)!G8C)S(M+3"GRM>
M$%\0/V>70T'\K1$_\3%0"20=0;R+0#CBUDADA77(&1#\/%FGN5I:$<]%3L^T
M&(B_(K^O^$U^WWL]0%F>L4#/> K>JZVCF+-2]3XWXO>CV!O&X8M;G8J]KL@L
MSZC/,V840541LQSG?JOS4M^)7?CP\_/&Y]B#1=^MRJ7:<-CI=8:CP;@^^CD(
M2HS5@\58G4W+F_&DK/;"ZD]3LC&>D:+5W4"KVYJ.MZ*,"BL310)'@WC %&D3
M/2*.1.R-Q(F(I16C[QS^7K9_ZXO:A_2W%D#?!Z GKECCHG)$)B25Q(A+[9&A
M7"!GJ59&LD!S "5YC@DMD'Z\D'Y(AVJ!]'U >N)K99$J(@'#QN3C&9C2<9 6
M\T0H;AV-V%5'=>6=?:T%TO6%]$-Z3 ND[P/2$V>J-3"75#"DM>*(4V,16$<8
M*6UP\ SF.=$,:<WK=-!A1BZO17$);,=AM ._7[D"0OP:N_VCP]@;W<T/<,F8
M/#ZNFKD?X'PN@(K6)S-QQD.3TZ#^/\>=00R;O:JD\G"8@TT+2]V$I:8#N72@
M"N8L("M4/H)%%;(\8:2)4MQI'[TD2RN,W#FH]#<\L0"[N(\;RC,_C%6@_&!0
MGK@%0J !2RL1EDPC#EA&+D2P(0*/6H$!@9D$*.-9[=T6*-<0RC-P"A0HSPG*
M4Z%7ADCFC$,QI!R(82-R&$MD2,)))VM29$LK6LPJ;U>!<@VA/ -G0('RG* \
M<0.H(+A5S"%*>0"I+"7HUH*#ONV4%""I<8PYVT&=I/(3BPO8[I_8[NCDW.8O
M6_\/9_*/1[[X&F^1W:F]F@EF;,FO?O*<FH!]0$YI@KA.H/QS9Q$UA"5ADHE*
M+*V4#<''#,_9F_$%GG>"Y\D/>!ILL2)2(Y$D: %..E  A$:, UZ#"R0&#/"L
MT]'M L_:F^8%GG>!9VLB/9EW&HQL"LC,7O"H%+(L$10 M%PF0ZE12RNL2,]'
M#,_9F]L%GG>"YT1Z$LYQT$(B(5W.-H 9LM))I(BPP3HA9'424=<(GD]L'WWU
ML ^-.:W*F]_)CGX2GKV9V]'3P[^5-GLCV_O<<=V84R>/AH5Z;D0]&]-V-7:>
M<T(5<D8JL*M%0C;!O!!NF/?:FZ" >H@IGOA'C->9&]8%K[/%ZT15D,Y0&[U!
MEC..N&?PRA*"'(G1"V=3H-D/INZL*Q2\UA>O,[>T"UYGBM<IR]MQZE4TH-!3
M9C->'3*)4H2-<5[ 'T["THHP)?[L$>-UYJ9WP>ML\3J1KYZ"P:TI1R3@JIH2
M0=;8O..D68"I VV9@2ENZB1?2['INA2;7NPX@0F/-&PFDD;G\,AV!M5Y ;]O
M!Y]+VH ']'EL_AC\BPS_(Y@IYZ#^UNEV"^7?B/*;TRZ0X#3FN8QHU!14M" 4
MTD(P)&WDWNH4<>)+*Y34Z1A3V1VIGPMD^F3B:1ST@QWN%U _**@G>EQR-,HD
M08]+*N6P1(,<X!F92"B-!F99FB4 L*:$OBS ?KS GKFOI$#X/B$\Y3JQ5FG!
MHX8EI 3B!'MD/+8(4*U)9)%R3,$4$R5JX1'#=^:NDP+?>X7O1 *KZ'4P0B"M
MDLMG?!QRVCL47=( [6!)4$LK!-<I)O")137DLL30[,J^[_>&G5"ERIQ$.#2>
MN=B+J3/ZH\0Z/)C=_^IX".W)QY(.7:=7S<=DGM:FIVEU, #ZBIG+AFO[^>5F
M;_409@"H[8I;WG:LZW0[HQ-2J.U&U/;^Y\,(ENO(/-)"4<2IP\B)Q)"D! =A
MP*;P?&FE3B>>RI9._?P%!?8+ ?N)1F.YI E;C'20"6"?"++:<V2"#<2 .N-=
M6%JIT\Y0@?UU8/_L8=T)0^@PO"H$L!@$,.61(%8:K8U$E!N:LQB"<4."1XY0
MY[&6P/>527/1(W%!@2[H7T3TS\ ;4="_6.B?<FA8'4,,% G0_!"/'O1_$A7R
M$40!I4)Z*I=6+NX2S@7[3RQT83L.1X-C/SH>Y$H?9\$*C6=^$$-G-+R=^^))
M^%?O(\OA9";6QA-16.=&K//AI^@$;3%.W"$G+$/<2I?M#8&\=IQ[J5W4<6F%
MU<B)6O9 ZNYK*!B=!4:G@@T,MPR3@%P(!'&..=(T&F0L* DX"%4P^M@Q>A]Y
M"0M&[XK1*=M=JF1H2J"X$P<8%0PDJL(*62R5\8HRH0G8[G=VVA>0UA>D]Y%Q
ML(#TSB"="%).H^*$4!2CS&<N )^..86$E=XZQ3A.+CO8:@32)Q8R\+8SZGRN
MG$IH$+MV%$.C%T<SLK@7UXDX3XM[,B4[<33JQJFDIX6+;L1%N].&-Y&&)0NS
MX)0TB!N)D18QHL2X"9$GZJU?6J%W+UA4//[U!>O,3>\"UAF"=2K_(+429LG"
M@HDYP1EV2/L0$'.@/S </15@@=-RROH18W7F)GC!ZNRP^E-<?TR$QP!:O?&(
M2^^1%5@BK"VUPO$HF2B"=1'!6H^M] +;&<)V(F)9,-R2Y!&H/2!BN9#($@PB
M5@N)DXI,R\HVOQC_ML@;X+4VQB_GPYOX^UQ_$.( C?I'+_) #_O=3FB<-WP!
M&>AA[?!KUR+=.JHB<7J?SWBH. EO1D1^VC WC(;DN &M04?$?<#(!<N0T,$9
M%[S2L2H/;NZ>5.FF*%D@3_\31OZ,S_H7Y-\O\J<B\)S'7A&/'%=@.>CHD;&,
M(:8L<Y2R@%/>PWLN^)W3E1;D/T;DS\!%4)#_8,B?\AE@4,@X]1@9'ET^<0=F
M"+4<>2*"HQ%SS,+2"G^NU:SV!@OR'Q7R9^!N*,A_..1/9'Z4VDF=%)($)\19
MH$A[K!!8:3XD*3'1%?*IF%5YA'M'_HQ"!FKMFOB!@4:GY_N'L?&LVQ_>+2S@
ML;'73;RE,W!67.$M_3%1F]4\O859*G1U([KZ_)-SPF%K;8R($2R KA1!3@J#
M**$:,Z(DEWESXY*L)S?VDM9&0YGAIL=CP_@\0PT*LF> [(DB0AE.0@J)F#8$
M<4\,TB*!1:(54TD3IXU96F'ZSF'^!=X+ ^]Z9 XH0+\[T*>+)5(7"6$",9G3
M?& AD+5!H4AL#($J[;1>6B'LHJ>AB/!'B/&Z.QD*Z&\/^NFM!6U9"@D1FZK<
M/B#8C9-(@-F5=#"41YJW%M@E\0TUE>]G;H;SAIPO:E$A>];>Q_*,Q_6,)^&C
M&NW'P0__U%G.RS]>7.FCFH4 +<^HSS.>6(Z43=!4!G$XNE/]VL4])_K [M9?
MLDZ?C7V)0[V%IG;P4\5:K9*D,#=(&F= 4X-7!GN%=+0I<N(<MVQI15\\R'U]
MZZR<X:XQ-F?N)RW8O",VIWRDT5"8%8=$% YQ'@";RD3D"3-.$V&$#TLKE\1E
M%FP^"FS.OMA*P>:=L#E=B58$B5,*"%-%$,<F(>VC0EQJ$QA+!%N:CUT5<#Y2
M<,Z^E$H!Y]W .1&<.7^XQMP@ZG/8@(X!N>JMXB$$227F.=F X?4 YQ-+>E(Y
MBI[G1"<EK<F#F<S5H+?ZO?[/&QV%;&Y#-IO3%K1EQ%/G.4I)Y!K742.C01VP
MU!+%160TYO(E%[FFG+^N-UP?V(R^*ARA '>FP)UH"9H;J[P)*'D20(67#-ED
M+*(B8I^(LL[F(]CFXNFG4G^@MJ"=IWE=H#I3J$Y9V]Q;T( <8),2AK@C'%DE
M)/+,Q(25QQ+;RXH%%!%;;[36(\5)P>UL<3N5RAN 2:(7R#B>$)<61"Q7"5'I
M.3- LC!=2RN,UJ3$SU/(<K(Y?8!HS(\NIOX@GH=NC.SW."Q94.IVLF@2F/AZ
MT#\<ER8ZAI$\BUSL]X:OJFD<7]?.D[CQ?32P,!F=GAV<;([BX1!(+C=WT.]V
M*YH;>QP+P]V(X9K3UK^0GM%$,'(X%S$SCL$K"G\T4UC)X P!S832NQ@1Y0SU
MPG#%?'?>"T/4AB&FW PB6*E$0F!*QG$LM$U$(V&!,;34Q!$-M@M9E//6A246
M+0B@:!2UYXOIA*[>$;!U TK4<<1%\LCD"LE"AL2T#%:I7/YH%B%YA2OJSQ7S
M#4DH#%$;AICRJA '6B*VR'$!&H5)%FG#,6(B81^CM]B!1B'-K$JD+4H*ET4)
M@-C\X6@Y/SS0>.9B+Z;.Z*E5>JF3;P7XZ\SE^VH\&86C;L11[Z?](I$'F@0W
M"&P<C3@1!%D:159E: #YQ*S$2RNJ)H[?LENS. $1!:PS NM$H9#812JE091A
MB7CP#ADF%'+.!B7A"YTXF!PSR+)4P%I'L-ZWCZ& ]:Y@G?(/:(>-D%HA+G1
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M4_KVGQ+G>.ILL8FIJ824MR<G9J^:E[]@5IJQ?Y".[#\%I69"*3]]@$HD@KN
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M%XS+$HHVIX-ZI"5FB,0@!3,N\'R:C%QG2A2*6E!QE5!QEN10D4((V$7I&/=
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M:*"<VK5-73"MOFVL5'CO+K&:PWC6CZ<N=HMBS6.Y*H\R42=T2,+SR)1)QG'
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MI-=/\2J85I<V5BK(=Y="WK[M^N.A/![%#Y+'N[YK^_(44[@01EMLG0F26P$
M0!)1.:T_*^W'JJ[JI_2TR./-'9AW)^7Q"'&22P!B+;3(QWQ39#"F64G?1,>(
MU-JM@BS3K :YX-20IP66NL'N_2L 9K[]Y<33ZP3X86!:Y/'JC<-C\127-'.&
M$Z12"H@'[Y#6FJ.DG94>^+$AIN#PXE+T"MF[F^QI['!*6MI@ \^)+]AC10RL
M89^D5>1>9*_(XST5TDS*XW'#/74),>P3XMAII"D #P +<18#] Q$08 6KFNE
MUBF_?A1'P9O"^PKO>P[>]S!<+96?=<'="0%DYJ26.B# 68DXBP$!VD:DO*(L
M64VI$TLNCU? MH!M[<!VIEPG*;6+(B6;!%=.@T\F4[#61:6YD7>@;1$?61)$
MGI#'(Y1;*S5&D1@*3)@'Y*BN?EA@P22YH!XOCU= L8!B[4!Q!DQ4PKK$"% 5
MS[AWP:7(>9!8QFB#INY^D<<"A?6#PND3[)2D '1(1J$1X*)!FD2)B',2QQ!M
M#'(@CZ=-8:@%C L8+X:A1I6"T#@1+"R/@H&1,DVC)-0X0PM#70E8'I<C:N99
M,$8A+8E'G!B+K'8<.2Q("(89'OA 'N]ZD+90U(**2XR*LX BP"!53F'M-+?)
M.AVM$)X*CYWT@[/C2I"TQH W+EE* &PP3P*)8'4^3CD@G9)%B6*?O,8PO_F0
M>'D]4;20T!=83S4?>;SK>H7S%OB:8VYNZ67I9>GE',ZP7 EYO%E\1XV9<4KQ
M)#SG1'O#G5!>*T65ILR.*KGYJ(A&,GS/2NXBE/= \K,W+3[CE"= 7)$-B2,>
ML$>.&XXPDYHY8J2BX.T1/M_3>A8LDK=8"%JIHI:B7%/:*&V4-HIRS>!@+RP%
MH5Y2H0EGRL'_Q12MLRXP8=4C^$Y1KID[$]J?"@-AF;#A6B*/(T.P% 3221FD
M/!8BJUT8JM8VV1SR,DJ@Y5YV]Z8+IM/MQCR@'?^UT>KUSFW;QP=5QZZ>8L&-
M-1$,JY"DD0Q A[.@+)!YYBPL:QJ,8^PG^#,WH1:X]^JML7-6RB;N TEO)PME
M<1;3PI&B2()&.3D0&8DU8IY%K6 .F3=92VL=2[HN\'6!T-41,GA9IGW#D?6/
ML^N'%V7^1'&I$(U[6O4X*5_B2*B5 >6<MES^[I#!%J-@%6&2DD28OKWL<G5,
MNK11SS9>.M0&3[ACP7J#&2<6NT"-IE&0)(.%V[\'U Y U?7^N8TD59)/EQSI
MDNA65Q=LG15;)W)*/3.!6>Z1DMPB'CU&CA&/$E<I@6..F2)KFT:) JRU;>,%
MQ,>W.Z>GG?9]_=JZ1/?JTL9*1AEG\_.IMY81@2FEA'N>M"&<\B"EP]8I@8N?
M7^^GUOLI>02 0AN30388@[C6 >D@#0I&!JV,X)':M4UJUIF>BY\_QS!D,>WY
MDL]'VG7Q\Q=MU6,_/UJN3!1 10U)B"?!D".!P9]2YY/GM=%V;GY^C4VZ+FV\
M=&AY?K]VP'*+4_L0()D2,G96$A\]DB8"DI@0D5%:HA2=Y%3+X')%SAR<VH(B
M3];&"]RO#:UOK1#;H5=.&BEME#9*:+[.Z>0[([":#L9O5\Y3X2XS<)</4_GE
M2BC-8\+(1JL0%^  :8X9HDE@Y;D71HJUS>O,I9QMNMH1\+F>2K8,!+"XLRL;
M!"^GDLWAL>$G(^)&4P./^(AT\@1QK^"I89-$3LJ8F"(V>+*VR0U;UY07K_?%
MM/&R0.\)8WCE3++GP[7)4)ZPB6>!$"1X!&"C7"'M>4 F2!.,<(8$"G1XE;?X
MEKV-E8KDW74FV;_/V['!\"..)+M>(SNM.E)KL)['$16!&Y6,3,2YP'V*%@O*
MN(]<NZ HQ4.5H,<0TW)$Q4.1^?-DK06+'FLN**(Y6,$MXT VM4;P:-48*RZ(
M"7?66BR/%M!,5KG@4,H30DO=0/?^HFNSW?MRPND-W/=!6%J.(ZLW D\<5N%,
MP$0X)!VX^SSJA%QT"G%)>#(".X+Y*AQ'MDSP6UC>?5B>A=OWR5,CB>?),RNI
MLB)RAKV EWEA>0O%F(FXHF;4!.X\LH)0Q)T0\)M+*&!&B<]19!NJ@\B47%>"
MK0NYS&?C+!/2%*)7B-ZCX+1(Z]8%;L>4SN<JO.@SF[,<<9H2TE1@)#CV1'OX
M#[M\PD/!V(*Q!6.?]5 '[:4*Q'@3K>"<,:VL!KB5GD1&3'"W@VPYU&%)@'CB
MV#$N0W1>4B2PE8@#'"-M%0976UALG&-2^\<?.U:PL&!A76YZ!B@D1G-M."=!
M<NX4,1*[Z ,/B5 AO;I?8+$@8/T0<'+G'3-XP'& 0.D"1MS ;X8'@[!1S,'T
M>YAX@$"S+DS9W"D87##X>?EHXCS7N@,*,PLH'+1WG,@D(J5*:,L*'UT!-!Z7
M!3A,DQ'6(ZL\$-*@)0(B:@&-H['&*0ZSGP\9XW@.I0$%# L8+ORF9]GIIE1Z
MAK%+WG(1C1/@I0E'N9-)*B=+ +3F.#<6E7;4.AZRSRU20EPZC)R)'F% /QVH
M<%'EL\48*91SSGK7RU<2-9^#Q8;W??NY)+7)KBU=+%TL7;QW8<L]NEC'!)O'
M%WU;JRWXA$HP[;DWVIB@L3=6!Q5)TG18]*)&12^FG"'VU"3GZX0SMT?VWWXB
M40B"(T9"\PC^'$W(..X0YX)A)9QP*4?7Q&.\N=GL8(G*768%GY6J0'G^ \26
M3?6CM%':>"EMK*3"S0Q<QS,C2- \:"]X9,QQ@K65U.@0@X[R'ERG'!OVM.3G
M:&LBPK-'#MY^4AQSR3E%A$>@/#0R9*..*&*80B^,T22L;=(ZG<_S L(I\Y6C
M6X;*Y-)&:>,YVUA)-8YZ1":*'-V\GM:[4Z&*YMM/-!*AO0W(F: 0]\0@(Z5%
M)$HI>!#>YO.WR'59H86<\UD7NW\!,8>Y2M(MF^-5G+>Y2-)Q1JV*E"=-*& )
MLX1Z[K!T!B>66/C)$Z%(TM7IT;$W+AW]\O;')\PQ"\Y(E, G1SS7C6HK)(I.
M44%5XEJ(G+,D%5^7G-7(VZLC6*Q2&R\+^*[S8!D=Y58$QZWFR5CKA0B&6A]U
M<N/3:>\?M2JR=$^/;>/D^#W<_/XI*6MBH 'Q8#WBCG-D-=$H,$>"HMQ91?,A
M$P76:MO&2@7U[E*F.XQG_7CJ8O=Q\G33VZ^#V[JV _MR94UB"(Y%88F1E!O@
M/ $P76H)CXL@(QX)+CV&PA99DX?B]_Y8O.[+%O\D+&6&1(((\PIQ!3ANJ77(
M8V<2)QIS)59$OFZ.5KO@H,S"@*ENJ'[_@H!YCLQR0O5U]OTPG"[">/5&]Y&*
MRI?=BT\A,>XI8<A'EQ 7."$MDD=4*\48 +T.9!6D\58'V@O_G(-X,E7"6LHM
M#9%+YXR*A&$JF1;2:^\*_UPH0HUCH[OT4V#1&A,<+!LE$2?! T(%BY@0B@)"
M:6O)0%C/K'.JURDV!:=J@%.%@A8*.I>*U8= =:E8K0N47Y+-O>^?*'/2)4V1
M ^\!R*:R2"LJD15 0Z.,7#.^Y*)]!;\+?J\^?L^2R4:E#XDXKK#+0EA>,T*M
M-!Y\2V8UC;<#>)%?61*0OY0#_+*'/RFO@;([@K!T&G&-#3).8I0##2$X'##!
MCQ<$+#A;<';U<7:6\AX'O#C0H+/6JM+>*,(XQ0F\8\<L)O<+U19TK1^Z3F13
M7!QL?0I<<@:.#^+2</C!&#+<"F1(TIJ2".C+*K5!J0N1+@!?(S0K /\H(DUP
MTB%RKQS\#"XYK"E/8.6&6*ZB*D1Z!:#^LI[DQ_[G3PYH--:,(YW/"^3> =1C
M9Y WE"7#I'#6Y+1@H>904E*0MB#M"B/M#$#+A;0>.%8,5G(CHJ82"'7D4@K)
MU%U4NH!H+4#TLH3^1_/S)XN9\Y19)*LC_ZAA2+,@49"P=DWRF&F5]8.662>Q
M!A!>90C_5JUD^#>TOFW^J_HQN /7_>UR..?PYF@D)KKXY;S7;Z6+>8,+P3^;
M+UH5^,78:'?ZT&"_T^@?1X 7"X;>K^K]VB&V!Y5_[6K0;7XYM=JV[5OV!+H*
M+YS&=K^WT=@ZA6GM]QJG]B*W!X0-?H3SF)NM9ARF:>/6X1AVB=,-):#;9YU>
M*R_D5]UX8ONM;_'W[ZW0/QX!XL0'ARL&CS]B'73UO'_[1ZZNC@4-O)P>C,F?
MN;,58&I+HV(6>VHC%\)J*RQCP@=)L2&"?LJ[3L,/'7='=W!F/T?DNM%^138!
M%+^R)]_M16_MMZEA.&VUT95AOSIBMPY,2D\V, /CA8=3IUN5L+R"I1.[^2KH
MDZU-7QK'W?S$_:^?3Q% ]%'&EIRCOYT?UF E__K-;MXT_7>-^9,NQC\.#H\.
MFHW#[;W=YM'>Z[WMQO;!NS<'[[:.]N#EK>9.X_#]'X=[.WM;[_9V#^N/:ML'
MS9W=YN'N#MQ'\_#@K[V=K2/XX_ (_MF'6SQL'+QN;&\=_G?C]5\'?Q\V?GG?
MW'J_LP?7_#K;S56/C3$85<\IN,D3>]:+KT:__!Y:O;,3>_&JU:ZZ6GWHZD,)
MGFYC ]S  R,<%JX,VQ^^O5&]=>71.GA/Z0VA]*UOXPURZWMW-:LWI!$/:O7N
M]P2[_3L?TU=UKU9_4AKTTS1&<^W2&QPL'S,;?AY_XIIQW.Q0-.&5QCY<=MQK
M[ *BA>G:H2GN=L\QJH=G637XJM6'+_/W435IM1OP/2> [/=33;R-AM[ 1&N^
M!.XL#YOQCN]3LK=*(T?,+!8R@GYPS^+=@_1<5SY4M>2ADUBW$%/6"VJ<=3M9
M3"@TW$7CE_/LXZ1.]]=&YRQFJM?^W,B>]#?P*.(U:;2YC=.*!>1FOOU5B;IA
M)T)@,2F7<-[.L%AX*:%9R[AFT0\K_<F]*_V;L9\7Z9OA&OWCXCTLT+WVP6AQ
M;EVNS=J$V)K;PQ#;EP__[.\<'S?_WL?[1[OTPY=W7YH[7\6'HW#R\?0M;_ZY
M1P_^_O=I\\O'UCC$]@[^WL<?CG;%AR\Y7 :O_]CB'_]\RSZ>-K\>_/FNM?\%
MKCCZ]^G5$%OSSP]T_\>[X_VC$[C&X^:?K[_ ]W_]N!-.X9Z@C;V+?;K_S_[I
MQW19/G2(OW^*+NG(E$;"8(RXY@%I:1.2D4:/)0G4NK5-S:Z+<R]/<.T!P+V4
MIST58%U-8"64)Q\(94XH[IVT*G@;O!?4Z*B-S<!*S!!8X9?'I @5S'TJS/UQ
MB;E>)1.9YXA2JA% '$4:.X\BB88RG$](R!L:ZX1?WQ4NJ'N+7/&5$#KA%:;6
M12*Q+FVLE%3CS<"ZU_X6>U=\EU?ST&FLU;W/8J*+$B!:S@&;DU)2A65RL*%4
MXP%X<][UQ[87*^VDLVYV_/L7ZXVS$]ON-VP[-.+_GK?.\N;F8V24ZER._GBI
MY[D[OF_L1;6=?-39\C#\W?AF.#%O\K1LM</N:%(*"9N!A#5;$XXOXYYS 20L
MX6@03Y;G4D:-B'3)1RVU47QMD\ZCQJ5&"7;%:.?H5!6C?1ZC'7M.+"@5LJEB
MHSP8;20(9B8B392)ECEG0CY-1<WA*+F%G*1RAP#F$E");@>Z'WJ-U.V<-GIV
MD.LQ?T[Q$E1SYT\IAI/S&N;F$*;F(!5XF@L\74QQ"NUL$%D>(0G$A0E(!QR0
M2-@K2[C"VE09;RLKD_O2[7;^K*+8[5/9[9A6$&XI<<XA+20'6J$P6+ 6"/P!
MFAS+YS;(M<WKI&+ISVA;%F8QI-9Y&Z-A,[L>)#E700MWWH,/]'JQM]YHQWY^
MR>?4!CM@X:'$+187M_CC<FZJ\R3SSM+PG5#0:@:T.MB>8!F>)$R<B$BJB!%G
MCB/KA4$I*1.(]I;JM+9Y_8R1$K=8!:-]SLW@8L]/9\\300WL;#*8(TQ)/CN(
M"J0M]D@I:4+$6KCHUC;Y.M.T'C;]DL,:W<Z%/>E?-*IANOVXV)?N!\V!6MQR
M^N4(DUYWNI.^4766]>76;\E2>1@L'4[0C"0D-8(J1(61B#NED*&4(D\5<UI'
MYI5:VY0EFK&Z5CQGKG';,0+%I)_4I,=,0Q"B5' *L<#!I#6X#X; CX!CU)1[
MP66X_:R $NU80+2C5:W_P=]YZ^1J],-#OVVKW>A'?]R&_GV^H5*C.$_/%_'8
M&\]7P:E9$F2/ML:G5FU]8C8)S9)"F'E *LH2,HQ@Y)U6!AXTE,A\$#>[?EA5
MB7*L@J$^?79&,=1'&.K%I:%&%S@6G".<<D8&3!%RQ"4D@_+8*V&QJ0RU)FE4
M+SET$5H5E>Z?=V.)6RPB[V)G/ $':1Q*+? S$_SL3O($F8A@D>5@*26(&^.0
M<XRB*(U361F,IIBUP6KDS)0@1>V"%,5DG]QDQXPAGP1O50I(1J6!VGN%C+46
M.6ZH9@)+1L!DS75F7^(/"X@_]&*_?S(0M\OAAN,8/L?*_O*LO+!(P_/RB!DC
MI_^=9Z9$2Q\+57N3["((%T,TX-QPG=/-+4 58Q9I@:DE(DABV=SBI24<\0+#
M$<5PYVBX8X[!)5:"$XEH &;!N2/ ,;  $\Z6#-;*-5W;I&8.JNLUBDK4@U3,
MKC;5NJ%B^S$1BE4Z%OF9=S=N2;JX116DH-9C46M_:M,C\6 %=HAP#E@50DY(
M)PHE>/ 08:5768N)RL>@UDPFLD0ACI=J\W-@)K,?+E/@X.G@8$QBJ,9:*ZZ1
MD9$ASCQ#SAJ,HI0I.!]\#"3GA1KSF+S09P&$HM%3-'HF$>[UX.R$HM%3-'J*
M1L]] [)5NA=<##>0_\J'D<#3=W D0Y4;-IV;WH!GL74GK=XQ^%FM=N-LJ/0#
M)N?S&270S,L*WRXD4<SU_GDUVC?:&N?N;5_.X_;D-%:L:C#;A3G-Q)P^3#I2
MQC"6HM4H!140UYH@QWQ$F#FG+7!EX_.N,*M)/4T)U]8U7%NL]]FL=^SW^"AI
M N1%!@>-N$H&V:@(B@1F3T1+B.39>HO(SR(WA\$">\>=;A_U8_>T >YCM_,=
M;N>%E<0],Z>X=X3F73P;3M1!.LS3= 2SM!-= :;9@,E/T@H?=0HF<A0XLXC#
MK.7X+$4R6<>D3MX9G$_S->(Q:>DEU:R^)OR<Q??%A.=FPA/<PE.EHV7(49:W
M@VE$UD1P#T(,&GM&E:=9>AU67#U,^(5%.J8E!&_B%Y<B/P%,H='J]<YMV^>4
MM%Y)1ZL%]9A2+"NX]6#<^CQ)/; VAC@?46*&(NZ"12:HB(@ Y)+&&J=BIAZ4
M/SK5O00V:FO&SU6/7RQX7A8\9A[)>^Y$C,AKY7)4 S@(5QZ)R((70B7NYU=[
M7\(;#S3&)G"+5MMW8]XH^05,I_HMIZC!S9^>QFYUX/N9/8O=$NA8@/C/!#)-
M^D?;EW/S)D]-P:F9<.KK)-.PDM"@O428,IHEU@TRPF!$/?,Z1<^YTFN;BLPA
M":V$.%:28A23?1:3'5,+HY1@6EJ$=3"(9[_ 4@TF&Y,63F"O6,@;)J6BK@:;
M)N-(QB#( 0PCM/J-9'WKY.&9[TOK_2S#!LI?G?;G[ +]E?>! ;FJ&2N -0M@
M?9E2][$B.>NB1\RP? "FH<@2*Y%3!/['$J$X[_"NFWS&?!WV>$L@HW8LXSZ!
MC&+$<S?BB?1T[@1UA(%G(#SB4C-D39 P89X9R4QP^13;$M"HTX[*!/D  YT/
M]7@)7M&B]D\F :R20QVA6(G&S@Q>T[I!ED5#<V89XP%<)J A-GEPGBR/1%(K
M:! #!E+TC5?7K!>PGU(L>JX6/:8C+ I'E+ (^QP$B1I\"AD((D _%+<,SW-_
MI41"YA ).8&5?S6[HZICJ3([X![@A?-6[_AT4.WRXO([EB$T4B#L<1 V)3>4
MN$N"$(Q,%BSAP3J@)S$A@9UTP7A)DGM\<EH)B]37C!>57UK,^-%F/"%P&!07
MC#FD2 Z,:(F1PY&@*("%:)J"TCZ;,5<UJ3][R1&1FTC(W%-,7X(OM:@0R=YP
M>L81WHQ?6^VP;<]:?7MR&/UYMXIN-6.!M=E@;4J=*(9 7948XA-#/+F$+(\6
M416DH<P(RJK4>:GKM-%<0B:U#ID4,Z^'F4]4R/ D!(PZ2L8:Q+%WR/'$D>=&
M4R[ ^&-:VY3KE-?)S.<:1:DW?ZF4%$,K*V^U@<6<V5;(T92S;DRQVXUYO#O^
M:PF5//L94 =I9S0K!8!F J"WESP#^O2CN?4I.94,BPP1&B* $#-(1\G@1^#Y
MX<-%R)&0FLBWEC!(K3G&S\33B]T^PFXOINPV$!R"![MENO(1-$8NJH"T%C;9
M("UW9N5S0NI-'W*%R]E4".0RP-%)5UG$H.ZEW8X#F_W>ZA\WSL[=2<O#Q7#A
M0S7$7H*G]*1'28W=H>U.NQH?=Q+?C";O,,]=P;('<I"<'B*LD#YP%(@+B!,B
MD6:,(I,8C=X%[G((UZARKM3JVN\"DD.*53\=0ZE*VP1AG&$4&0&O@FN!#/R*
M:%0X4D,,QW+E4T26F9WD$MRL._:4U.0E.%C/1DWR=!78FAVVWD^2$8(U<Y8D
M9+"RB&NCD35"HY28LA'+2+2>"QDI(9':6NR"R4BQXP?;\:2N*0U)$X9"#HEP
MXAC2R7#D)) /YC68,5[YX$CMTT.J[97J;*I^I\H#Z1W;;AR>@]F(IV<GG8L(
MO_SO>:M_T;#?;3>\L*20A>FH#P.V_0Y,2S4K@TD9S<E@2@8S4G!J)IR:4D]7
M7$O*(T6"QX2X#1AIARGR2<3@%>9$V[5-\9C2W!+VJ*_)SE4\O9CL$YKLA ((
M=4D:+?.Y]PQQ+"TRG#HD"38V!4U=5@"9Q\%QM8MGU)Y0O+DQG-&[%L\X.^_F
MM_J9=US2C,%;<-U9;/?&)[U<GN5R=@(=*W&.1<0Y*G_H31[_@EPS(=>4ICJQ
MU ;P;)!4EB"N.$<V,(]42#QQI[7G.=,#JQHY1"6X4;O@1C'3IS#3";$/DS!-
MFJ.4 I@I-3SOA4JDDN+)6ALM!Y^ /%YCK'YQBWIPB]E/U4XWG+'X)*=JXZ4\
M9+>FI2VW'*U[>6!F.5KW@7 V):?NO*(B>8E2=!Q81TA(*RY0$(I%S(71"N=:
M%D*NE^B-;&@!S]2';4'?VW"7* 3S<L'H.0MP"A@]'1B-N17A,@J6*(HF)\TZ
M;L$%(A'IZ(B4F! K 8S8NC37G: "1N6H\7+4^%W+=#>EZ*MJ;H ]>*/=B/_X
M8]O^'!M=VX\#(3P N;*']_QR_H.Y.4B[PQEY!Q-R4!VCFO_;_=_SUC=XJ+3[
MO7>QU^^V?#^&_,96.TR_,'%E>1#-\B#Z,2W+RX$62\N1S5R8&Y5%\11!6)#
M HY:4;*VJ>NQB5#V_>JW[U?,O+YF/I$&3;AE1DDDA <S9]X@+:A',DD)7-,K
M9_,QIO4P\[K1N7OQUT5SO=D[.<\<+US[+=E;3GD:>#2M 1]<KWY6>5Y#S%EO
M="_A:/!FWHJ]^MK$!UX6I:QI0/51CYDW,!*=L#=<*CO#A0)_GYSGV9E\H T>
M<N6Y---S:4K^,+A F&$4.2XXXE0XY+)X&I68B62$,<Q6 D.E[&[9L*$>/+1
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MGT 7\F>KL0)V$*L;:H,]-$[!2(Y[.1J?E]*H6G$P\0RO-_*#IP$KMIKK44_
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MI6!<O<QYI!P_7=SI(!H6^$6GZWJ^?;^<H-6;7,L.NM--[Y#>[&/\=!@.!WT
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MN1#-8\6ZIQ_\+1*V7IOM^^L.+%70WT.BQ>\_.K5V,GLO_IG):&+.#D,U8S7
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MF=%-W09$[9UZ>(?-E 4 &NBZ]&V"@#^W/FUE[W9VWJ<T"<-'#%)^ANP<6K(
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M4A(BB-/8X.V2W_-CO0M$CA>:K]XPG\7\[(F3TY[WQ6'\WFF_>--QWA4?_?G
MGQG?*PA\66"(U-3>+9U2LLQ,^D9%SV]LR7"I>V[<DN&!>2;+4&<%GK;\@/R
M1WW TODT3<Y NU\^39Y2LSU3:I90<[GB0BKA#+::$APTQ49"X@6ES@<ODIJ+
MU%#-C;\\UKCWG.=S#U7WL)[GPZPGP@<%L.(D>:HL4!9)$(CDFGL5@@JI%O_!
MNFZ>AO5<<6:9HML5 ,UZA[YGN+D'W$Q":EPXC(W@(-BXA52DSK2$<""DDTQQ
M*B!+0V9(,\9A9:#9*J!Y"@I-]M[=$V,F.4V8:6FT,4"F),:XNP1HI0A(_3ZU
M"TXAB7?VA&R61K.IBI"&N>YN,#N[_4'1#<5YK^LN[*"?K'&7;<]G =6..*8]
M4M@I2%V 4FAOI.=0(D*D04M#=3I,Q^%=M^OZT7[\Z'L_6M;W/\83E5%W2=2M
M)4M%K<YC)2%P0@1 L:1 *BV!PE0*JFP4KC*BKA!/#W8S\&P/\&RI,9JSM%8%
M6;4L+6X])Y 38*AP@$('@:*2 ,$<]EYX'3$M&J,X&Z,9:)ZV,9J]7"L EHE3
M74E!)#<,8,$MH%):H+WE !KJ4[X_0LJO8%1K!I?G"BY/1(O)WJ[[>KMJN6K,
M<T.<HX H56HQ#$C&.; F2$<T9T:8G3UTW>[:B!;S#'J.W#"7 S^SN1S+9-%2
M:+44UFFNJ"!6BR@F;6 >"RJX,"M5@/(TCD> J#_K.0:&0R5"Q"5HF &4D0"D
M%Q(X8X7TRDACPMR^O+GK7R,TB!6PYR/W^\\,>P^&G?AR'<0<2DP!LD8"BCP%
M)NJ*:8P]I\["X%E*"FI@(^TGR:M-E:1Y(L<FV'02Z':*8&.Q!]!)D>2J ?$O
M%%!MM+>"QI]Z9X\U=8Y.'LRQWKX:3QKH5AX5SGTS'H9+M5!P( A9+^)Y1#:U
M^J82F"B-@))4"8<LB[NQLZ<>[/]L,"X]2?9LOLV0!W"LG]%K 50,6=QCXH A
M/AKVDFF@23!1'T'>Q.U'@:EH)SPD@)KMA&;;"7G$QN89LM:2PFO&4@T/#C8Q
M9%! ,^^ ])!Y0:53AN[L7<^N;X;@?9),V0RAF4=J/+ZA7HO1&<*EP=H#(P("
M%'(3^9+PN(O,*$N$UIQ'C;@9<C(/TLB#-/(]\B"-/$AC'9HWI=)H+Q6"4E,K
MN89!>LZH%A0*HNT",CX/TFBV[/]4#WY;RE&@7@).)0>46PZD01H$F 9M">.U
M,KE+7.;YYO!\9OA[,/S$^PV#-DAH!P0UJ1#*,R IQU'K1QQS220U+C-\9OCF
M,'R.Q=^7ZR>Q^+B[R&$!@?(R6OC>2B#+*?30!B&MA5:R;>?Z/$ACC0'_-WF0
M1DX(>$K@N+F$@*>(BYG]UZYQY1+MAB!'+<- 06D=Y@CPX""@3GL@O6,@^(!)
M\ ZJA!S;U(@[,_7VFU'98[(")I^X2'WD8TYYB,8248!:IH"V-)I2QC&*<, !
MH6VWG3*K;YO\SEZ1^WI%:HD/0F!AN$91=',369M(H,I."%[$C^(_"0K;);_S
M((V]H_B7V^=H8)CG:.0Y&OD!^0%YCD:>H_'$F_$LH>5:B)C3PD .%:4^1(M&
M<$JHL Q:;,QP7!Q:W[BXG.:S,DWW>SW-AQ.D#?,$*(@TH"2U_(*: ,DL)5AC
MY-.L:-JP[J<99K8'9I8I)%@!SN0Q&HU#FUJS911PP%@!9GFTK1E70 H?-],)
M:CEV3% 6S>KK=G7N7)J!YCGH,]EW=T^,F60T468<I<X!(W#J*P@#T,:D61I&
M&L8]=U;M[!'>+(UF4_4@#7/<Y3$:&:JGH1H:YASQ09@ J?!"PZ@[< &CD4(E
M\78!J*['4CL79ZX[&'Z>)VRL#9!K6522RD AUL )2 $54@$5B %!0@TQ@IQ*
MN+.'7U+>L,[2J\#DC$K;@TI;:JGF!*Y5@58M@<LI'N4,L4!SH5,K20<4LB8I
ME8QZ@CU*E>_B>H^Z;*EFH'E2EFIV@:T 6"8.=T>DPE8X )5B@%I!HC9D'=!0
M.4]4T$+ZG3W4,/,TH\OVH,L346.R+^R^OK!:'ALBWGMA++"2NY2BJH'BP0'G
MJ==.64,IWMECUPVO/&0C#]EH"$9)@[CFAN-X8JG$7%$H)+80"NL4XXMX@%;:
MDC.G(JP*K+[M3XW;",01CB6P.IAH<L7]U 8%0+56@CO.N" [>[EY?^;0/&AC
M(ZPZ<>FJ '74$S% F@E 361:PP('W"&'G:9(T6C$X(?$\3.O9E[-(S<>QK"U
MH#BF5!E' '0,1MFJ(- H,""@8)0%9*1/,9B'V $-[FJ?IVT\);1[W.!Q;JZQ
M2DBJA86Q)!2F@9\,6P8H#2'U(/* ",:-=29X9",D/3PHW&!@>I+\V7QM)(_;
M6#^GUV*I!#'NB39 (1V5#^L5,-XC(*%43!H*)=([>T@V3_EXDOSYN.R9QVTT
MA2%KC2M"9#GJ-: !JRAZN0/:00\\P0P9[8BD<SUMS1"\3Y(IFR$T\[B-QS?2
M:]$Z2C@E"%N@A:+12A<Z6NF0 !EM=RH$1 SRYLRO?0;S-N+1C__LC!L@ .<[
MW;-61P^\BQQE!GG<1KY''K=Q9WB;Y/#VS3XJ10*RCF-C'<6!:JF1<=129XCC
M=DTI.#F\_0C2_7T]O,THU91Y#[A$&,2=YB J;1R0H(*U:30]9%'I;HAP?_(L
M^K@<FJ/:C>70FD?:0A4$\T AD0J54LZ_L0A0@YBE4FOE8%2_\QC*+$ES:'O#
M7#L);4=!&ICQ'"CB#*!$06"0IT"0R,]8*DQ]V-DC#<Q%R:'MZ_Q><MK+HN-O
M-JTSSCT\JGT;SAV?^U[$L\[7"N.&H>YH,&246A*EZJ,DE&:02 D\<1)0:020
MVEK@L2#,,L,Q58V9I)O#W(TS(![:#SZ'O-?/[O7R88B"HE@"Q5.$S2H'I!02
M,(E5A (<()*K;@V?[8FMXMH<$M\\PTZ\<X2'R*K"@A!$9%B&'3 .12&M&(&:
M,D*"S0S[K!DV!\DW9^[7@N1Q_QQ#FH+(D030-*):(^B!HU1;I93#I)&<^@S"
MY>.\]&@_^LA9(\?8 ^<&;$-L-]\CQ\O7T$]_&=G^K.<P(6.$$)!Y:0A%VDO&
MO0T(6DY9$ X^@HF=^]:O5PWXLQY-I\8$3CD!R'*;IE4S8+3&@$'&0L"$$(CS
M[+7,\\WA^<SP]V#XF@.=$8\ID<!)!0'%AD3;G$/@XT9C9##4>.5J?V;XS/"Y
MF?OC<_TDN,^9@$HA"K@.#% N!)"0(>"A1D@Z9&%*FMMNKG^,,>PK?,96I!&L
MLD+^64-NKJ!O&#ANL(+^*0)CYO^UJURYO7E#H*.6GY#RC:BP"BAE+* AZE7:
MI,Y $=2)=Q1ZY%=7 9SMJ(9E$*Z J]?5]C<S]CT8>^(7U9IY164 Q'()J,40
M:*89@#QN;]03A/1S!]<OG6>8>3H+ZMS >SW^CUJV Z/4(F(<D)800./.Q=\,
M!A!QPZ0)P:%4W;!%@GI^5'>!&/%" ]D;YIV8GR=Q%/]2',:OG?:+-QWG7?'1
MGP_\F?&]@L"7!89(36W=TKDCR\RP;U28_,8^#)>ZY\9]&!Z84+(,=5;@4LL/
MR ]XU <LG3C3Y%2S^R7.Y($UVS.P9@DMETA%'*'"1+TH^3XE% $+%35:(K 3
M,FFY2 VUW/C+HPUNS@D]RVNZMI[0HQ76Q#L)+$V*+N4>F* ,X%JAP(FQ7LEH
MN(H\&"OCS"-XR%8 -*ORD.5THI7!S21V%N&$,Q0$,)CS9%=3(+%#P 8K+.8:
MNK(;3Y[OF8'F>2HTV7EW3XRI)2^YX(CP-#7[0H!RQH&V@0",7$0?P2B1*/43
M:IA*LZG:CX:Y[FZP.[O]0=$-Q7FOZR[LH)_,<9>-SV>!U0C38!W"Q#!!K>%:
M.*N=M0PKZ:72"V!U/?VT<W'FNH/AY[,PGL[9<7C7[;I^M"T_^MZ/EO7]C_&P
M941>$I%K&5.*I9&GT<B$'MDTB<"F$8,&:*F]U,I0C,7.'GZY@IRIYF%R1J7M
M0:4M-55SKM:J0*N6JZ5PH(9[#S04&-"@4/S-,6"L)U&)# ZGE XJLJF:@>9I
MFZK9![8"8)FXW&7<1(6=!8CB:)]ZJX%$F &+C<%4:4H4B_;I=1]8]KAG='E.
M:DQVAMW7&5;+9)-*,L*]!HP0":)&8X"BJ2$FTDH%#[%B<F=OCC-L(VK,,^@]
M<L.L#OS,9G4L 5$,!N%I<B+8*!^-5DQ+J0UR@D"#^6HUH#RAXQ$@ZFL]!<&A
M8*SD\4C'DP$H@P[((#D@Q%.K S8"F9T]A1O45.S)<^<R&L0*V/.1^_]GAKT'
MP];<N5S3J#IX(-(/BHP#2A$!/#8<02$L,WAG#S>P]?^3Y-6F2M(\H6,3;#J)
M@VN'1+3I+)#<1,W?"0M4$! H#KT@5.$H7'?VQ'4V;89<S6,ZUMM?XTD#W0IB
MQKE_QBIQJ18-%JDB5E@(4$ <4"40T %Y$(AR4!DNF8GZ/E9-'82=1W-LK=&0
MQW&LG]-K(=3@2 J5,L %U8#JJ(9(;2DPT5)006,2-W1GCUPOH\V&PE,Q%/*X
MC<TSY,35QBG#&!,+@D>1(4UD2&.Y!L1Q23%%-%H,T21HJ.!]DDS9#*&9AVL\
MOJ5>"](YJ%W@1H  E4HJL0)2&0-@-%:$U9)1AZ)*?#T[<B.",H_4R",U\CWR
M2(VUC=38/BF^A!"7.*! D$?">:I9T! R@B0,QI5AT"7+&?+(C,8)]U_[]?"V
M,8@KY1E(83% 18A&L$,!:"5</).!6K/RD1E9\W[./)L9]AX,._%/&\$1D32:
MQ@010+D2(&K@$&@NB.:8281X9MC,L+GJ>_-<>U6K,;1&*1>Y5G$#J!4$&*IH
M/(@82RD)=08VG6MSR#N'O'/(^ZF 4PYY9_Y<K4J2RX0;PMI39<+00NP(T(9&
MO4-('*T%HP$GS#H*M8MPO+I.T=E.6'%(;05<F4<R-(@Q)WZW8+&Q3L-H$& !
MJ&$X_F8U(,1Y@X61+HVJS4GJ65#F0M2UV>>U&#?5A%(G)0@!IM:/P@,%(0%1
M_:681C-%,Q=UX 8)RC)J]\^!-FT?_^M:/_;^*_X8/7KX!) "<:\('_%?J^.B
M#?T*(%FJP8_+:K@4?^BWBF;7?[[O%+K=+L[C?;NN7T2&Z">#WQ6M3A&9I"C?
MM="F^\._+/\0OP$&^F?QXFMDC=^*=F2.0I]%>@_Z16_,)?$&H=<]*T:;M)Z7
M+F_XJC6(6V47(,/^\>OWZUW0K8\O!MW"ZUXG'I%$JB&I2Z+&\^EMV<XN_2N%
M2^.7XG>J_)O^:>N\7T2('%V]6^S'/>LF$!O3OM6I*FK2QM6>$N\0_Q:?//^F
ME]&>+UIG9_%;O99N[XZ9:GO.-K[Q;+_M]HKN1?K_H#_0G;3^Y,.]88!%%!A)
M;ROII?M%9UY1=L4"Z:-T^HMX__+\YW._\+F/E-617JEE8Q+Z\<0WBE0W^18W
M0;8Q1/3+4]>/QS1]#-)7$]M'.?5+CZA8HLBPJ"Z>Z6%572)WE&7VHH(!7:&-
M2QE,\9K1@8^WV"U.3EL)1%J#" /%#]V^\+?<]C3>UWC?F7Q6GOKT[<@'OM\O
M>29>7P%;U*\Z\8\)FK2UW9[3'>N+R];@M'B[__&/8O_CZ^*D>]ZRA41LMWA?
MB9Z*10=#V?0R8E7A6J[H= >)X;I?.Y&6A>Y<E;S8'S&C+Y&RO'ZTW&EPO+[(
MDK>O+W6,MEL(BF0I4/07O2Z(:^Z>M2K\B_90I'LODJUU'H_#-#+JN=A80:,]
MU9U(RTB]H%N]X3G2@T&O92XJ52*"0?6E_F@S^N?=859=JX32-&5EM%.- H<B
MTB[^NS,1'H-)DFRAQUFRQ8O7)_N_;1(Z)IS:-(#=K"C:+8ZZ8XVIU'VRZ+Y+
M=$_#\$VH.+31CB[.XM=L]>^D6K4Z%R5[3.%FS>A*/-,*5T.8W/LOT_OGWHUX
M^]C7#6E!\:Y@D5[GW7XKO<NK2H?^X7^_;+G!Z<B?4;MP.+</3B[1IM]M7PQN
MOF36$%VUX$!PH1U'8F9?:S]/>Q/!]]4#T_/Z.RB+<E[I]J6^ZN_\<^J5HC0!
M,R2<??L;7S*$M;UD):1=$C3ET7QU$>5U+WTKKDDW9BW%:2\YO_[1DAI[032T
M6'O*F):::9)B"1Q#A1C^(G;V3DK9&L'^=?*;=5(RNMZ;MY,S;%DYK20S&E&J
ME'*,(JJU@UQ0#!V2."@G*W=<O,:[_93_8J"!EEOHG3/4:"*A#DXP:*E$E'D]
M=NX-X6#:FP<-<X[X($R 5'BA(;.<"P@UH9)X.W= ZJ1V;-)$XGTGZL0797>(
MD9]N<*H'9_K*U!)JO$NPGH!TT'TS!*^D>K8Z)Y>^_<-7XQ]+ I[$-?[1[MKO
MV^G,:_O__G#U^6]W;C#EQ^\^G!Z]^] Z>O?^\O#=G^3HX.CL^. [^WSV^5M<
M^]7QR?[5T;O/\9YOP^')UU_')]^_4*>E4$$!Q5T U$(.-%4:8 ,]1BI0R^)6
M^+[5YPFQ>A?^1@R;QMG'1K']?N*%\2S/2O.M!GKB^'/DPQH9\G7C(0SUXUJ%
M1VMRSFJJ\,MT4;S3CU;WHM^^FOJD-+M&V>]1R9[O32A*9I]C A7I&!?Q'$<C
MZ[$TE EEFZ*B++C74^Z%BK&'7IJ?T=PM6;PX*WF\T#U?\W :GW;G1?QZ7%4[
MN<1^>W6C*G"F>U^C.!L*]F3J#?^2ID'R\SDI4_'H5Q;/6"<HIT=&LK3U>=^_
M&OWRNVOUS]OZZE6K4[Y<>=&L&SH^92@[E=IE'"7Q.:P>&=Y^*%EW2\DZXQ.O
M/L-RER)VX\=P%]WS,T;HO:Z\;;%([$J*MV2QF.U2(;=EL6B7<[+0;>\H4FI$
M+=(UE)A?OG<P<6'\]] 3/E$?%JC<6R++LB')E L29H[T.9CX!9\S9?[5M4/W
M:J?XJZ,O7"N=GJA@N^09+G\K1P"7A^KC(/ZG4A&BYG$<C>4JRO*<";A?.EH2
M/?X=%:Z3J' E-;UXD13UWZ9TG+JVGN3Y2$^_>_;ZJL8V-PO#YF=,K&?X^J--
MQF[:H5VH:C53=G64761BVRKHNS*:;GAJP8)T77QLP=+OOZ$$L@5??)D^*<QP
M3PU"*&!JN)6<<<BDL\8C[*'Y\G[B:KHM<6P8 7H]1."YN6(GW3^FW$\'%[U(
MT*.X%H0K9],3R1I[<_GY[/W/PW='WS_]_?;TTZ\_Z>'?A_3HVWY\SJ>?AV='
MI_'O[:.#/R]GL\8^G?QQ]NE;?"?\(7WGV]'!UY^??GW%AP>'Z/.W-U>?<+Q?
M6OO!'^'P(\1E N='>/DE<&@I]!1XI0*@PAF@B37 !NX5EY1C*7;VA%I1SM@R
MZ/LXTPV:U#AE,VK+TQMXNB =YXV)R!1<AH(+5PZN@GJW)6TO.B%INV6N0UYC
MXID0BA+D)%(NB( 0T0K#P.^2N=/!GK^BR=WJW-P<<- U=TC=>&T6O,L(WE9-
M\#(G)!7* H,]!Y0;'G^C!B $<1 (6NM\%3UNS(BRK6ZQM"RBK;8KV=,K+=].
MZW^[B+<2\?I$BX<7).%2<_H<(EYH[K0WU$LL)6-6&:@4P<'<9M/>4)\XVK\/
M$4ON:=EF&;NDC+VJR5C,'1(V..!U0( &*H'2" // N4.6X@YW]EK4LO/Z5*H
MV1S ^V;@K2=W:'3*/]H([1=M?QS**L")AMD_Z@XF8<+]_C!.6,LRF@1YCL/;
M5D=W;$NW_^U[96.@CO7['3?Y\S#S;Q1%>O8)1D??WGQ1DK#@"08L! RH=_&$
M6^V!"E($Y3V)!W,K$HR.QIE#*;MG4G<P]G%4-063XJ)4M3"=1C\JR*IG%W5#
MZ,<[FZM::E+M 67VSW3R^5!,1(G;[5]$\)Z7XW+/K!95"MYUY+!$6;<+*W-R
MV206(G<94FM(M2!R#:D6<%?B;5FLW,6,;\E:Q:Y$Z\BW6<]:&5Y'UM6:UDJ6
M2@V:R93'O,*,5>4YW/;57O=RUA)HJKG4\/P2M:4$/#GM>5]4AD?QII.JQL8I
MOP6!+Y\S;8Y2D>B"I)G/RX@MP,L-\9$MGK)<6=GUG-_U9&@MXO79QM2.^:<M
MV5J+>'L6>>/G1CFD5GL"GQ1Q\K%:T;%Z]LF3(XN]>-$NTT]O,=8W[?7?RG,X
MG^JEB^UE\F;D1+^<Z/<(20<:0J\]D] R1>,OFE'BX^JX<11#A8<.8C'E(+XM
MXV\4^SCNS.3^S:U#O=.%_$2B(W^R3[_VX_/^^';\]Z>?\?IO1R>N=7SR]?+S
MP3X^.MDGG[_]Y]NG7W_]O-8P[J#][3 UA'MWR#Y_>WMZ].X0'>'W[#@^^_#@
M$SH\<&=QK?%^;U,& IRD_DF,M;(0"($8B+OJ@$1* 4:QE!0'QC5,'9.W)?4O
M8V#&P#5%AB'EAA+" _*84HMEP-XHHSR16G,Q:OPNEF]AF]%PHV@XB15;%H\)
MT0Q(A1&@)I7J!XR!H%I2Y#3RA)0&U,.CQ1D),Q(VZ<67:1Q, [*&*R=PH!IR
M"1G4(6!I)2?!J;GI ED;;"S^T4FN##8.4V9!/!,1_SAQ(/7V!I)Z)J2+",AP
MPK^L#68,?((8N(PVJ(@VP3&GA874(V*,C=:3XMA[3)SP]Q]HD-%PHVCX\W R
M=$1*SRB3&G#N<64=&ZL$4"Y@)8S&%**=/4*NSQ-JGC[X'(KB;G-'STWLRI5>
MC^AW?MXU7LL(EQ7X6V\0+C,BY63"%-.C,Y_.%(Y'$AQ7-:<J@=HA9C%@<1<!
M=9P#I8P%%%*L(!?:<AC%QG4U>G&IL<**KLR^V^,IS.R[-O:=> %AL"%0@8%B
MS $:P1?H5#NBD(\[B1455._L/43GR]S;8.Y=@7LK<^]C<^_$AV4,8U$ 6Z"C
M40XHYPA(PRR04>A*%$CPE">;+;/O]K#OX_IE%IE(GUEY;:Q<=\ (@;R&(4IA
MY 2@C I@4+ @4*B1%Q1;%58V;3YW25@N&=X/)MX5_W,XI*;F?METQM\Z[[&@
M.V]8 TCB,7+=BU3S-]J7K8T9S#\,]XT9K() 39%=\RFS6;]/:O<3&77$IR,V
M35R:>#3+IB5DT]'K>N(<8YPY09,6@0$5QD?[4 8 ';:2$B@M82L9>[PZ1MF.
M*&J&S R9&_6U9<A<*61.=3LS1%L,G&,44"4U,(HY()U36L9/O=8IN^1ZN[,,
MFADT,VBN#C17[^+,H+E2T)RX,X,ADM'@@33)#2))  8J#SAGB&N$'?.I1>1#
MW)D9,S-F9LQ\_(2_C)DKQ<PIOW%4)9E*(5RN)*#1&  J> .\<#9HCIG&;+6)
M>QN$S06:!CZ)P<'YNGQ=OBY?EZ_+U^7KUG_=S)3Y\V'OW5<]WRZK4*[-G9^T
M_"EU(3BY1)NH]EP,;KYD5N-Y_$23L@,MDO/&NU<_3\>]W,[U5P],S^OO0(>!
M[[W2[4M]U=_YYW0;V%8'S)!P]NUO?,D0UO:2E7(9#9-NU>SP53DO.WTKKDDW
M9BW%:2^97?]H28V](!I:K#UE3$O--"',.HZA0@Q_$3M[91OHU,+Q=;+8.JG9
MD-Z;MY,S:G!E5QEHH.46>N<,-9I(J(,3#%HJ$65>5X9@O,:[_9061+E%-%"K
MJ3'40:L]4S X*K$DWC-WX\E>>W?E\H[S.O9=,W_+T_Y6MWK%?W3[PA>'7J>"
MF+.*>#. <'^466_3\;3^<OFUU?\[FE?VJOKYG!N#'Q]\^H*""II9!:"6T0K6
M2 'MN 0(>^0H0YQ)>:TQ^";R^^:,2^[Y_[UHE:VWV^WZ");4N+N3NKF._U)O
M]3WHIL&WO0@H7SOQ^:[0@S2V/A[SD,[ZCW18^JE/N&^E6J;X6]^GYJ^]HMW2
MIM6.TJIJ.9YFW1O=3OWGB_ZI]X/=XN\T"B:B_5EJ IH^G]PR04_WHK?X.B_Z
MJ4EY>9->/-*7W=[WLK^X[;5,:C!^5<R2!,.7Q8CW'AL];MBT^>A1OOE!JV_;
M,R5V,RZ)39RSXL5ULOY6+CA"4[^5-FNX+3XBV%G55+Z:MWSIB\ON1=NEP^73
M=L8S<ZZOTHDK*PM#/$WQPO[T/E?'+UYSWNT-TKU3W^'B,AZ^^+?^N;>#=(/*
M S@OFRX-(.J_C+>L#22*_T[WM#WO6H-X<@:G\3W[90?C\N]IN;YWKGN#JY3*
M6EQTHJ;2+KFA3,X;*6753J5CV[WL7+_=S*7)(SFY=+=X'R_QO4&Z87KAQ"AQ
M89%*:?CTQ:"5KBK":&Y#<=9UOEWRYUEU5A[ />7#73>1L]\MGWE1DOW\(B%
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M](3#D_W!T61:01 H,$@"0%1B0(UG0'+L $$!,^:BWN]%U!0PNZ8JK+DCX#U
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MKR!G4G/'2DV8;4VON@P)V]&:,D-"DR!AHEY3KBS$2 &'5%2O22H:HYP"[ZU
MECHJG"HA :XJ+)+;5^;VE;E:)_=;S.1L7!K_5M?Y/*FTH@;$GE:5QI]3$Q94
MKC'E**4G2.\P#='*#E((HB3"1EEMQ'I[6(Y4ZZNL6-]3L?XVU=,&<NJ5<Q1
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M G'!(S(4)"ZHOUY:CV.9,EBS[<JS[;S"R#6#SH%!)V+'E@C/@DHH,>51+BM
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MZ5K/+UCRS7X8:&_M9K-4\8HN;&(C-;P%$.VWV@XVXD=),96CX,65"'AL.X?
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M];'QY?BOTR^?W]#=;Q_/QX,T(8$%A9&!4T(\*8=T\!+!8?!$C3%.Y7B0NMR
M\ EI='4\:.EDS17QH.'DVYSS58>#;CLS5@2I'/;4:\HI3MJ$&(1GE$MBP4B>
M/1PT.(:W[<XH&E1#["P0.QD%\EPY%HQ"..;B)((E,M9BY+47-B8B&!'3!]2O
M712H#C'=+<0TB# 5SP81IJNMG;4/,<T=+.L0TU)![SE_I8DT<N$3BM$XQ"4-
M2). D;!)1"V9#C)MO%1UB*D.,:VDSZ$.,3U\B*EV2MP)MB<U9DR)"L0*%(VA
MB-M D17*(XN3!21/*F@[O9/;$W)*+'.8Z=J"PHDX2[DS2Q*(NFX$]6Z[A3Z.
MI@U/S(+<F9@R/)\*KV6,T'V.Q5&["0H%D('-Q8:E*GJN&A"4T:K@,9?,#2H,
M0P%_3X;S<IDB<!L:#VYVMMNHRB]A9>T ]\RCR^$-N*-M#B<SY^.8-MW>GJME
MM$VXM%65VC9:/^+ MAD4P<*?C>.R7+-1UCSF,&%9W0?8"E]K)-"CB_BC&A?=
M*?PX*.D;'=\_[I9U@H.'/+9G50GFN;)+L*B 4<", F4N5PNVIP4TJQ+=X>HV
M"Y FN5"Q72P8>FX?^RJ/?+?=B\6KXO_]2U-"?B^V_#_]1K<\B.K</_5RP>IA
MPQ?O1P_3?23T+!=<NOQL64_;[^8"W&'TN#M:Z7C;N\_+AUC"+7\]VO)W[78X
M;32;Y4KWRG+6]RT@PL-&1O?*&ERZ#3]/[Z/!ZXWQP@?84<U$SQ!P.'C..57(
M+B-^7D:NO"GM?B^#2KD)(;ISA>'%*1@WLS06YH;DL5Q8&B^X5V"@2I\DL2Y(
M9[C'5ZNC<(R BW"+G[T7K?YQ:/<&GU]T5&S#&M^/&A:,? PC-=4\336U&?_S
M\>SKYW#B*)=[[SX>[;[[V-A]]_YTY]T'MKN]>[RW_5U\/?[Z#=9^MK>_!6KH
M5[CGV[2S[\7.MYT#IE)RVDKDP!) W%F###48"2EA\Y.A 8.V2?"FP9>C8(6K
M$@RN+Z9_/L$OLU!%,C(Y'JS#(7'#O!/2*!4]IGEJFW4U52R$*G:WOQRPR(RW
M." I500;!$A#.Y)=]R(E.(H$+X J-K' 5Q-%U3H$#AWT@[(Q0;_3!A6UU3YN
MM$I=9I1.D1OB%%F"#$3;+%1B9&!@'@F55VF2U(8+(;PT!I[!*'UU?+VFDGM0
M"?Q]P  @,$D*21<M4(F/@"*4H>19PB9J(DG(X_LV2[?6]=@QI(4!= SR:^X*
M'1QKSE.,(NG$1<1.R028H0#3) W<UD2Q *(X/-W9WSG0%NP'R8 4# :!PC5!
M&F0,PDF 0/$YSJ!+Z,!\OM"Q68"E%R*84? E^,J$SN+.BGZ9@OE/OYVO!B/^
M>^P5)YU&-HJR*EBVN.F#"N.;9_#KAXTNW >^V8VM!GS<JK#)-T$!K(PMH-H_
MP.!J%J0X;?2.+J=_'C5BQW;\T5D%:7G6Z."3_'N^?7P<.V7ZYXD]R7UF\KJ+
M9ML.3!0/O][(!JBO4D-=N]-IGY9]7294K^6VP-Z,S('7$TV&]B84Q?RDKV$K
M&DML@EW4;A^B_=1@99QN*@&K/VE7UNN+83>N<?;M_Y[OCS/PI.'Q)=9UV\U^
M[^I++OK+'LG,H.3"OD[\FU=;@JFVH/LQBST%82^$U598QH0/.?>>"'J0\[4&
M%QV-^GV>V$. HTZTWU'IH7EAFZ?VK+OQ[_.>O48+7=CWBUMVY<ZD]"B>O?^S
M2[.6XJB3)>^_;G%$8%*6F>C 7QD7*L:W+Z<=?R4?=D'$ E1?"&4[$0*+28$.
MPE54%H/2)Q7&EG'-HI\:RKXLPG-'XF8[N^'VX=:OFFW__7$%-]MY/13<.R!0
M7S6_;K_!7]]]P+O;'_C>]L?&EU]?C_;@?E^^O?W^=?OO!@AN<5%P[_S:^KGS
M[N_O.R#XOV[G:P_Y[KO_?ML]?B-VCO]N['S^^'WW\W]!<#=!<+^GN[_\ 8F$
M8&<T8DF#-D<B1=80AKQ3FFG)%(VR4K, ZG+8/D\$4H10[\%*%(8[DPPGQ 5&
M>:0A,<\WB@CJT$E&F4X_/GHKKTMQLTI6P<Y/RJJ]W?V/6Z_W_]KZH]A[]<?[
M=UO[[_=V/Q5;N]OPV<[.^_V=-[O[G^;F\'EXD3U]&UZ--8Q2+%<*R-9$<&]U
M?5PY1F #J%&P60.!/^'? J!:0F_65BN\MB?Y>/_(F3<3:M6RV" /#F6[W[X<
M6,FHB-RB(#E%7#N,G \*89^"UDPHP<$H-9N,7:[3NYT_:UE=%#5!7"*(O>WW
M!TI9!X9GRLE/N>F3LP@8U"/.&(_<:^EP*#V<&%_N^W1++\6@HRW8A:U8]B7M
MP_&T.SV H%#A2:/;[9=Y/\.>J17*AFR^94-S4 X(:./;W=Q0-[O=RRN! /J=
M; )V_5$,_68<&:S-=NL0E7;C)0]\HSNQ)A>;[=,7Q7D87JQJ]6FPUKUTWD_2
M76,MB^T -6HIO=>P<]8XC7AN^6 L3Z!O<<&L8EY$=IW6=%/EYX+J/(W95%C=
MI<R3 M0:?:<RS^L_$XPMHGA44U,O=@&+99N<W*XLMU[L3(M5FYJK6>J=+SB9
M"+]V>#%=P7KHYT7\Z4&YRZ']"&)RT,#\VC+I:S;D7,GTO?9Q^H2%1\TJ?3]4
M7+:OF]*YQANT,]3/;MJ@VVZ*>:(;L955Y'ELP"I0Q>MV_P3,ACSHK'A&SB/+
M=!RF4W%XACT[K_'-:3[=HV[B^>J(TI=TVY%*M]F$]=K,<\TK!GMYN8/%G#J#
M+-\,N/J;BZPB?8(-7Z:KB3OV+#OY:)53<)\AH[.@S+RW]5'AY[J-S9-<ZRV=
M,ZTN8DOGMHW+5E4X?2O7H)/1_8O'20HV),DCMIRKG#7L5(2W8O(V&GU3T>#0
M-_Q'NW6X'SO'V3.\+&6"=_4'#\H$/W[?VS]D.]\^G.WM'WW?W?YXO/?YOPWX
MC6^P3K'SZSN%M9*O^V\;E[I1OOL@]K;]V>[V>[&7?^_=%_'E^#T\SVYS=_O[
MK[W]+[#>OYL[G_^;&VN,)V=CX4@@1B.=F$>YF!]9K@T298Z=Y,X(N?%2X,N9
METO:/Z@&KAJX%@-<(>ED ^,2J\"-HD;*%)7#QHI@,+LF&[@&KGD!%Q]W!+(8
MA ;E"!,B$7>4(1.81-0$81D77EFZCL"UIDKLE7S<ZF=OQ5QT$'%]\O[[010@
M.^L^]7)^^9^QD[?*'H[S^1&M&?TVC/YSY_6@F<'6@7;<!,(8LB&S.F4)&1<(
M4BY0HH3P@ 4;+]DF4Y?;?_WO-)?I8[M'ZF\^LKMIJ1O^3 >X/=]K#RI5V#V\
M2A>>_$[2X^;=6T(!L=4_['=[V7?$ZHV[*^$M=.=6LPGI# 8&\U%Q@E.*#G/B
MA!;."B-,\M@06WM&%JYW['Z:\(QX'D44GB%NE48\2HET(!P%'3%8&$Y:IS=>
M4GZY_O!N38P>TH:H6?*VP]0(54F2S(628ZYLT)8%FVP0AGEB:IM_\2PYMOFU
M@KT&FPV)G/#*!1/(4E_V [8B*LE)D*O.DBNG7\QFN=]-1M:6^\.QZZ3ECF.@
MPADPU2,#RYU1BVS$"A%)I7=)!.5!AO)-0FO+?2V_N0[MQG=R_X9L/O'ER 9Y
M6N+A;72=ONV<31V45&_=[0AOH?NV]NWP:?+!"R6DBH$;;#3!C'(2 V@E-))K
M*G5K(V$^6L=D1D-D%'.>PX$T@)'@O$$&C@91%Y0QBH0RHT%/:3GV>!WK:Y:<
M,TM&SST/QCB9-'<$ZT#!9.0F!NV\XZRVVQ?/DF.[/5(7I5(2)9P'I'FLD98I
MH<C G$_*F\!7GB573KN8S6Z_FXQ\O_NVMMP?C&$G+?<HN692.Q1XS@OD5('E
MSCGRU"F->51>YBG5FWP*T\YDN:]$<':00BWJP.P#9_2O^:[1Q>[:VH=_I&74
M.<L$3HI+G#2FP40F0())KD)MV2U:*NV]GK#LC-4V)A&19]XB'F1"C@J)?-0N
M!D]\L''CI:"71]JL3OAG[5G2)\$2C50)1CCE6GM&J(DN<.$"?%);=HMGR;%E
MYQRC@N=I@%3E-FF>(,.<1#)0[:Q(Q.BTZBRY<KK%;);=W61D'9%].'8]9]<Y
MA3$G!C&=VX4E'I%./ #7&AIQ(@+SE.VZ:<Z8>]IU3S!T]]]^*][7L%M;!]'
M1+E5GXUZURZ17!VS6V@QGW;4&VZ]=(3S$"W%/G@KF&+!FF1KRV[1<FDRUU;K
M(&WP'A&-02K1I)#&@2#JDN8V,NYPFF<QWS(&"-:>)4T^ZF!2=%1Q:J-)'"=C
MG0[,&!?C[?H;_XJ==K#=HYI1Y\>H8WO/:!)4BA;E+M2(2V!4)[U&7' I:=0D
M)9FG^&I*Z.\KS*PKIW;,9O/=37K6-M_#L>RDS9< 5$,2&-%H0;HJ2I&S-B+.
M$S:Y=0$A,L_2,E/DZSK&\@99<[*.YCU&NN;:;MV8\.J@WB+US)0,R&=A.-&!
MB\!TL%0F'S@.SF+-:M-OT>T=]K=ZNXV1>*+4*"^H0)X:$$HN.&2YC-D,!(GD
MA/8BS24[;(EC"&O/E%AQ'X M$SP_EU98:[!RDBMCO/#DFN$V-5/.C2GWQCHC
M44&YH# *'@O$B3'(.F518C)B$D0.MZXZ4ZZ<AC&;D7<W.5FG;#XHRY;_^Y39
M=NL@F*@DDQP1#>S*)2<H)[_G[,T@I?(* #;']E0=VYML9#Z>_5Q'JF;9P-WV
MC^$&UI5Y]Z"].M"WT$J@((5..C&7&(\D.NF82311JT#AI&8.8S1KG?/. NS-
MI"&8F(Y$<8UD(AIQ%232PE"D\K0[4$:9P';C)7F.Q;T;?"QQ:&'M.39$EJM,
MP/@@D7,+5I_ R6(1 ]9 (-?TW*DY]B$X=L)*M,80($F)F&$AU]H*9$';1)+1
MP*@3Q'M:<BPA*\RQ*Z>>S&8GWDW"UL' !V3922LQ>6]U9 1A2W,('R?DN*,(
M-%&OK;,N$;[Q$F_*^_;D6:UHH*ZC@?>+!NIZZ^Y&>'4T<*'U1,%$G0*53%L>
MG=":"L:ML$9X#GI+'0U<N'QZ/VD$$BZ3%\2 /$J@4NK D$Y>H1"(X%&!<,I.
M3,Y6N<?CVC,E518[ARG)^65>@TK)M594V&"8-%'5T< '8,H).P\[(:.5"F$E
M<^6M5<A2D9!4.'!B.%/&KCI3KIR&,9N5=S<Y65MY#\BPDU8>-IX 7G+DE0*.
MS3X:1X)%TAFAM, I!I$[K^+YYWP^P5C@2-DV=2"P;M'Y*(171P$7J5!JS9*B
MCABE&">@Q&!AB-2&!I*,MG6YW^+ET\ZDE<>Y!5..1<15.6$C!F2Y4HAP%AE8
M@!@3N^H= 6NF#"X(L/(L98(34#"QE%%%J20HF-A=4_!7,^7<F'+"RDLBI@A&
M'(H C(@;JY&U3""M?!2*@*6GYI/SN<1,N7(:QFQ6WMWD9)WS^: L.VGG"6U]
MM)0@*YE!G"F.G%4$F9"<4-*KX!=EYSW!:-Z@N0;#=3#O@?NYK.VNC4BN#N,M
M4I=DU!IIK-6<.RZBM5)KGVA4RFK"Q35AO#II;/$RZ\,YV\\8K$,4R/$\Q2UW
M@S>1>*23=3()$R3+Y>C/Z?W;O2QQ.&'M.1:.7%DFF?/4<A>5E4+Z:"17.'E&
M?=WNY=&8=<(F9$2"\ H$I0 L"G8YJ);<._B32R$B34F*N35\66)V73F]9,:Q
MBW<2KW7T[P&9=M(J)(%([Z1&S'J*>(@.&2P34BEZH4F4*@]<H9MRZ2H!0^/'
MHU>SL4&[S^(9_:T8[4:YLMKG-.->XL7VL5SEK6-U"]#%FHR$*V^S:]L2[DG4
MVBI,6;(X$*NN,QEK57-.4NNO<W:AY<0;%Q$17(.J*2S26GF4$EB&BHH$QL+&
M2[;2X8>U9TKJ?(K.X6Q7<,ZTD9(&1V5V&!!AKRG^JYER;DPY8?\9Y8-AR2,7
M<A\8FR@R7G'D9>1.*;#Z0EAUIEPY)6-&V^].<K*."3XHRYZS_L!:9]8)Y"0'
MGL78(V,=1E1)!A8\P42FC9>JC@F>2\%C]\G]7%LW4MWO<PZ$5X<&%]I:$%.>
M5- I&<ECLIHI*XTTG&$N74JUG;=P^?3E7)L7FT0TRB F(D$\-QDTQB;D&0.%
MTBAM*0'QM-*M!=>>*05+,3F*O6,J&Q)66JFEQ-%$+V1(M9WW $PY8>=1YD2(
M!B,+%CCBE&KDG(V(4,NC!);TV<Y;;:9<.0UC-COO;G*RMO,>E&4G[3P56-)1
M41"?R2).!$,.^X1(Q%XEKI7"+N=^BJ6+\CU*(IYM#0P5?I_TS[5U&DWTK,1U
ME=^=2:^.Z2VTFXOTB3(3';>68ZEU< :#.ADE#DGC.J:W>!GE)VT]["5V*DK$
M&06U,CB+M L"!0?2*3G0-SS?>,GJP7ZKS)0X*8<)CDD&R@VCUDJ%%8["$,Z(
M#;6M]P!,.6'K:1-PB)8@I4!;Y#KAS)0& 3M:XT%Q)"FM.E.NG(XQ8S>7.\G)
MVM9[4):=M/4\C<"UV".*??;/<(X,'!L"EDU>!2FIY3FFQU3=M7,<6N%U3*^.
MZ3T.X=4QO46JE 904%NGL>$.]!70+YWBBDI%N926Q+K<[S%%U^&YM$YL1224
M(P6G =HFB\CHW&2"Y,G1R6IEJA[Q=;G?*G.L8]YJJKA77G,NP.Q+47@O(S-!
M\\3KJ0Z/R[$3]J%7G+*D)(H^"N!839'E6B(!?T=OK+!X#3AVY723V2S$NTG8
MVD)\4*8]-_V/:<F%U$A& Q:BPP)9BR.B7CN)I7&&^!P-5'7'3V"&K?YAO]O+
M_4QHD65&\4?;MNJHUIVVL&[Z>6?:JZ.!BVTQP6U2U&@.]H=)4CL'_V^M853'
M0/CMK,2ZQ<3<)=?WD8&XN^_Y[H<#[, N$-:"R$JY*:C&R&5+T05%J:0>6$7-
MK<W$$H<EUIYEN2*2<.\Q5Y$;9HUR7C :DP.S,9IK>H+69N)#\.W03!SPK0/S
M77(KD1=<(LY=0-IQADCR1KI<'(CEG$S%)>;:N][CH4,QC]9<XR_@P#:LZ5<,
M16:[XGVWV[<M'XOM1M?#$_;.M]EXM(7:5EY@BIT.K/1MHP5KA(TN7K>[O>X]
M.H$LP.>P+/=X&BIWUO,*5 =F[K9[SV:)S*B4&WAC;G'@EDEME=5.22:TM\E<
MHW-WX3GAU?7^HPDD&4+'GYUXW.@?;[5"^=4!LI0LNQMK"7]7S3QG[RD6E>("
M12]RIT;CD,Y#0QD#-9TRAD&V;;PTEV?[_K8*#N":ES$6(A!0Q!D-G$5I!6CG
M4<:DO6)@6E^MC->\O!2\/!'4<5S(2%1 6.L\PDUPY)Q4*"@5@Z0\JL V7FJV
MFKQ\UWNL@RM\4CE_9QNM D#AK6UTBK]MLQ^+_\1PN#RU,LMRCR>F]E)6>YH7
MZ;9*,8%^RT$Y\HP'S;5*P0J3J,[BD["Z[F31TN[;UJ3F&B-HKJ"S($J<0#SF
MI",,.FR4CB5#+7/!;[R4*^R36GN6#,XFYK#VD5BN$G;6$85EC)[(Q,DU"4<U
M2\Z-)2<44 '*IR98(N,=** 2&Z0]4\@$0JUV26%&-UZJ%6;)I^(F?I2<\]+7
M&HL_HNW&8L_!BFP^_F5)/U^6>SP-O?-OVVFT^XLMNUA-]\PLXQ,%H<E@3T2,
MW*6R%R.A%' TL<@4K77.A0NX-Y,ZIQ=:"><Q"C'/M2'2(<>80-$()AWGQ/HT
M!YUSB;TL:\^2T1LEA<?4,,,Y![6&$B[A^(WC029=ZYP/P)*3F>Q:LF D1\+G
M,<-!,N1T-,BKE(@GUE*E5YLE:\=G9F0UE;$SEZ%>3OX-P&>UAW/Q][CI.M?N
MA-A!%56\8,!#H=UWS5@,B6'PA5[[Y$7FL&Z[V0BC#V^4+4M'@?\SJUD[QPU:
M%J$[?6=F21DTA'/GL#1><*^$3=(G2:P+TAGN\9QK0;=:X;4]:?1LL[15QZ9J
MMY;4,TGJ]Y/*<X@4.X,=4M0DQ VFR$FF471!"+!N(L^SQ\US1B_W-Q@RT6,H
MAW?S3LV/C1_9MU4#>@WH<P=T(P,3R@O%;2S+-@P70GAI3&3&J&NLJ!K0'Q?0
M)]W]FEN<?$(,>X(XF%W(YAYP5C-'*<6:1;OQ4C\7AM: OCR /I]@Q;][%AY^
M(IM[>*_!)2@#]PNBSZ/YMWZWUTAG\P8H<Q,^T6KP7B^^6 CA7?S]2W17_GZQ
M?Q2+<ML*Z]H_(A 0W+O5[A6-EF_V0P3$'.?IP*M^J]<M.K&9:ZB+7AN^5E56
M%QUXIP34S$Y=0,B<C%=^RW8+;[M'16JV3XNC,J]GL[B4>3_UK)@<GE6C%6*K
M]P+ETUOT44W?JF?DMXI++__[NMT_ >&2MZ!;V$XLNO&X@6RKU;?-YT7\Z2.P
M%TB)H@>['?N=-H*':1\WJOV9:'%+5=4YZGEQ>M3P1X6+ME/ DU:W@NW-O_.\
MR/4"^593RXF'US9@*<4/VVGDTT7E\31&29"% YD3<L[5'^]?[7W<?(+'0:\Y
MCLY)NZ+'3@R-DC9S/47C^*23!UW&3,/']@SHN-MO9E*'G0*1W2FC@/!7WEL;
M,C# 'IVG<-BQ=K]33)O;"MQ0GN_/7M[@WI'ME5\%JL]77UA*=\!OKUZ]0@50
MQBMKV6;)C>=^KWOQ!ZLGG/C5TT:S"712G,#YVQ;\<C,_5S[I(8OF136&E2\5
M':3RS6DK@W5U,^>.+NUF:FXU8(FM\O=@Y;$![W>*K7+A6RS_>P0G$SL7R&@@
M8'>!XCH-?XZLKL3?E__G.O]^>24Y+AZWQP*[O..+K*$U_"T(\F/\T6[^*.MV
MJ@U]:WVCV>B=78UU3V$7KGWFSQ'X" C6EBST/[.DKG%#M%0F&$O@I3<4!\9<
M--$FYXB;A_L$EKN7JL,8GL6._=DX[A^_:G<Z[5,X*U#!X9/>V4CG-D]3YV[&
M_WP\^_HYG#C*Y<ZOK9\[[_[^OK/_$;Z3KSWDN^_^^VWW^(W8.?Z[L?/YX_?=
MS__]OONKF4#/%@?)Q3Q9CR&MB$1<1X'@/#RB@B:9N(>;ZCRX>]H@CL(! .7#
M[HSH?P H:4C_SZYDC=\ OGI'0#J'S;8# =<]:P70-3/.)J"78P .WX#WG6U]
M[U:0"F??[U2X.!*<Q#POLTVKN[6!2L^RX"R1N)O7UCXI+:OG1;?OOD7?R]CF
M0:_-= MD"4O*'V?\!7@;K3M+BP8H,D761?/JLPC/8#RQLA,+P)N_>=BQQY5D
M;O=[ +ZM4&[%Q6^&1@=^O\3HT/?YWD-2!"6IHD5@&U#:2X2^<N,J43'8:'O8
MB:54@YO^TV_DW2FWZC0K9,<G\&/EOHP?^$=L69"!SP=*7KZ_+5)5=UBJ&=47
MLA+G.PT'LB#? "Y=L(DT(^*^':WX]6#%CV3"5:JTBR!0-XOWE?Z0&AV0K?_T
M;0?$>2;GC&?/\YET8K75L*VS(*82U@EIDV*<\-P12U#E>79<<B,5=P?;)6(2
M3%#Y@MW#4?$QGMBS4D\" !V1\)^9@M<6*7?VO=C[<$"]!Y1,$87D%.*4"60Y
MM2A%8H04@EN;VY1M,GD-5IY'MPH9^MW,AX D8.8&0*%.^_@F# !2VSKI-)IC
MVBJ3LBJEM5+\1I^320MAS-@ET5:XU<\60;YFM :X1R=3 J##2;8!JY67VO'
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MV=9A+/TT60GI'ME2!THC=:3=JGZM!(62PX;<5:H ,5-X_NXY6ZZ=X(DRFU[
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M&FRB@3_'A]%\<A@M[X$.L[PD.4FF/\F2><6&0%TT-@X=]EPJ*A#5+F>R"(Y
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MK @6"4>C[<\]R<5!@I&1*:H2[&M5TTUM#'<J<AF="X!:8TC@].ZAR ()5Z2
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M;%ON1(&";0^*;3/E!LE:IK!#T06-."<<&4X)DH91YFP2,9]$,;ZHK(%2;K
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M9]ODS[7L><Z-@LFJ$BQR)E*W5<5,X)[9L\XCCZWN:65MY#M<YBPU*[A:J^V
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MZWBHK^+!0:X8;K3\6>G^)I]UJXG$7(8_G?O]C=/*H:7&;$\TH%?#:5=J%$3
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M#.[]@6[O/F.P?IRE\2Y)[Z)-BD13*2(<=T33Y(ES*C G>=0<4<(?"Z[HV=Y
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M948>/2.ZO/A(CBGG4$08AL%H/$/?N7W/CHXOH83/3X7 4O#AS@CP=>%*O\_
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M&QX?]^#5H^7,2Z]TI%(+V'XGC-!2<.HI!4L[]'&'N\5RG;A#-"XDK2AQ% <
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M#K4BB3-*A$!0/)$<<;(V-5.2"JNRY=$+CUYX_+@LLY-4)YEJ;JA@LM:"1JG
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M#&=CG,&04+(DUKUSQ3*#F-4M;8P+CBP *2HZ!0^M4"<:94L'\0A!O!"SJ);
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M=L:G%K7H(%Y>$&<RI E32A&@%@R470!?DE518>B1QW&"^.T'$/M89;#%"0<
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M@ ;/&K5SPCK9VEIZE:-;60TX)HOY+B3//]MED-#F_N'DYPUB8S25@V%LE_/
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MSUJA)!]2T"E$JTI4 $EUO\$8H7^XD(L4M6\M3-MY8 'DK2!$(ZKU/GN3LX?
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M_<EO9?'NQZ/F)_D:,-SDR?O/HF(^9[]^>*([#)/'AVMO7OZ.1?)$!A3!)R/
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M>>OIH_QV[?DO9HV?;_W]YM:K1^L;+]^\?<??]>?+YT_,)UVHP-5*H**01J(
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MM4>&HV,L U9!=W@;EK+K<'/<9^X8>]PM=P)OE%UH7*G(L=F:>ARYJ!Y6]3!
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MR+$,ISLP[)$[[IJ6Y5@]W=*?W\[0-KH,M$].$F(A-0JR50 UB;Y62[M5G]P
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MG$4/8V2CA2>'?HKU4 M@5LB/L&@8\\IC<^B<);K+*+D%4#L!E*O!)WT/ PW
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M9.NN-Z%T9AZX>8$"UES,1 :8+PU^24QS=M^291*T@7)K=U_R./@'5((+V)6
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M_&>61\<5H/2X]@&!A]BX,A4*&"Y*\ETAQTVGR?>Y^X=WI3-1$I(2+O#A2X$
M*&& Z4*R(RT-H<2(EAY?G\^\?'25S?R6V+D0NTZ]N19_!8L4YW.AO'1>+)2G
MQ(LK36!K!*03&(&,@\^0O4N>=2(FH".+&<S(:U,-ECQ>$S<59R,00 0P*IZA
MF:PL#:D1T2CDN'-,-1HP2!;%K_,QX9KF%6VS.=:(X#K!;R%ZD@==);B._0U9
M5- \3-!_TE'.#SY@CEADD&3SA2(+G2.@*NRA314*^4G'<H%G5B2U#VQ>"CJS
M%+&8$ 4:$:.Z 8V!;>>$9V4(@9.@$J55809E7/&T9X;,%#GJI]I#V&0MD!/L
M!QHDW=H4YQTDW/SN(7/="-\W8E'DR8?B:U#IA+&N3*-5JJJARD,1=,3W,74(
M*(U/)B+_!'DXH<M%DA"M/I-%&# VG\8G77^^&'1DRYEH?#+BR1VRH8'(Y D5
M'G&(?Q6'Y8$\6JF<V-S0#=&2?\/3KC@;,LF2N7C9CF!F*..VBGAS0@\1:,E2
M:D*_E >*L< <OA/.4U]&-/D5Q*7QG(-MP4<'!?:@30#B;VT\VJ%=1:<JR,@
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M@:A&#D))M!W-&F!<;'RVJ<$:-> :8UMV_!V+XW0FR;V14(@ZG@E"%^(M\P*
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MFNMS#\F.IE#1$UW*J%\Q=F-LQY/21337@1F*Q:[F*Z3N;CVGM)^2+:*YKNJ
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MFLB0RD<)),XN+P"?Q/=QPF<M6JJ[EN:'P:0-6C[+3CXP*A(X)(,F').),&H
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M:X7"PC5):)8C/O&"@+JNC)?W#6D?+2<+ HC7<!7<=4SJ^!L>N-F#&/(^HP+
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M5EFY&!>5Z=GKC[-,6O;RJEL]KFR(\D?JN5A[3.6W;([?Q!N>H#/.P4IP];P
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MR+M.A];>9IR#JFUZ\MOTS!CN'I:J?:+VR8GMDZ'R9FJ7UD07U2Y=Z\VZIME
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MTL+2-Q^SQ]Y=>%EW,/MA)B2""]N?3<BU,XSK^E8:.)O2A0_60HOFY W0&*>
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M5]SO0(_1HT- 2UE_FH\"U[*?8'&#K*^#\C(\3G3=>5E<<B5+<'>;>Q6'+,F
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MN,HQR:AL^0[%%;!#D:39;2?M%)NA>%=3A."VBSB'.2 B5O6C=-,=YK/"V=&
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ME(!YJ9B/EB26/9$^H3ZSD,1JDV+B&)S(=I6_E808TPKUI$QN:OVC\/=]^<$
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M-&(86FJ=:=201%92B":U$BU"N7TJ V\V_OQ_?G8.R!"#B[^-1(NBD1+X6,8
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MV/_^\<VOW[V8I/,S',^_>SY%F&/^[O-P_N&[?V2<_?.[,IV<??>/R?2?PT_
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MD^Z[99;T7]-H,L/\M^_GTW.\^N%D/,<O\Y]&6%7F;]_/\/U5LO+NM)_/V'N
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MD8"IP D8F?RB1"EHN1 ZMK&B-R$Z>27IAXL6AXG7@%W7Y)H+A-,TK-D 'VL
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MXS71U.YD\Z\OQW.<XFS^\O*V^3).6PR424H4'IE%H6N 0&11%\V"U-%H$U3
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M=I9V@_NK9Y_(JEQHYF3Z%D9XA>X%QOG5=X/D#&'3E37#:[P8[9((@:&B';*
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MXY8%;G^E\\N:@E"G'[Z-XT6&.LP.Z[+3XK*VP7CS&69G.!^YF!*/4)A$1]Z
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M'?(< K#GC=^3"(]S]]=$GP,XLK\RCL*:)%("&PU#:Z&V^Q7,!TR,UX:?*6?
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M=XG,#P%W6@1II(0-3-D[-EN[ M<D\4TW""9PF<#F"@9H3_.:>1,U"]E8KDU
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M9&X9&4Z*,\BU&RE(H9&^T1SZ-FS?A.I82:>'8,6V?NY[:Z='!M45ENM.J /
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M^MD/WQ_5K%03F2<XUK9>%R$VFCV.(%4JASI32)),Y4QG?DGJ7,2.C<%76E^
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M6MIT\9M@V@1K)");WE+8*#2%;7G+%":,8ZDQ)1%S2O-^6M38V&&C+=A1MT-
MZ0F03\=UA(.N;Q]C.-3<@S'"H3=0V,49*'K%5;@!TQ)!<:*!P6(EW QI1D4X
MOM'QYN;#?+$L_K/Z2F[T;GGT"5;&K4HEA206'"*=2\@HTO\_>^^ZW#BNI0N^
M"B(F8DY5A+&'%X $SOQRWFK[3%9F3MJU>SKJAP)7)[MER5N2LS+[Z0>@*(FV
M) H 09J[9TZ?R%VV26"M#^3'A85U@2AC--&"\LRO<7#W=%,CUK:T.]^&9QIF
M-[P9XFG!$8-220.JUAED*:<PES+1QIYE.,D],V'[ SQJZNO@$+L9MO&>RX&_
M6L_P6FIP$!5L98V8M>J$2=0TU>X9Q\U+==+^*!'5[:XPKOZP7*GJ?O'^A_AF
MAE5OEXMZL]T8&4(JC;@N#+C8V+\2EY 3S*%6J+ MWA,DG.Q?I]FFQM2-L& G
M+=B)&U@(O!MJ-TZ)!N# E-(#.V].<<(D)J5T3S@JHSCI_I)0W&X*[;>N'EDE
MZ_*=,YD2@BA2D&2BL&7O4D@3F4(F",^-W9>QU.N0JSWXU-BBD:U'!=YGT+G1
M02@@ [_].RSN.D$(:(!^K&W<GN>M\4=N<WZLV7%G\Q/7^+<R?+_85)N?3=F*
MK^K1VA:+>YN2];2><586,C&[,DHS:O8.K#!;LZR 25FF,D]1AK23+_S21%-[
M>;>R[HJT@+VT8"NN>[_#3G2[W^F8F W\?H?"Y=44T06+'@T2.X<?K5FBBY+M
MQHE.UX=]N3^:O?G\[7*].6K0G1LK7^4Y@Y1D"J)"EY#Q$D%ALVD2BFE9YCZ?
M\;,S38T6:D%!+6F\3NCG<7;[YD=!;V""Z N<MVEP$928=L+YR48U&B[J_-*"
MN'Q#&'-\WGQ3JZTWHM4S A&2E"3)8):C!")<))#+C$"9()KQ4G&%,K]FHB?G
M\7GJQVDJ6HL)YLO%/30D]0!8MP_- ](<I;1(A3)&F;*="@P',\2-M28+G)14
M:5X6L\URP^8C 7J8:V@XMU(ZM>GP -2-<7O#-##;>B/D3:^=",2DUM,3C4JK
MG;J^I-3NB_WC$1K7S'8@\5.JQ?*A6M@SDVHA%=\Y"[DH<LWS$M)2,8BRU'
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M"2ZE%AQFM7N#%0Q2HBG,,$?F_SA7*/$*53X]S]1XN!$3'.0,+)AP#E<WDHB
MUL ,$0*4?SAL-PQ1 U3/3#5NR&BWOD=!G!<N#_4'VPB8._;C_0_VT+2(W+5X
M_/E5Z:>%O);_\;1UVWPP.FS%L#_]6[7Y9FZL%O?73YMORY6Y8:82C J,2F/$
M80)1HC+(B?F'2)FD!"?&LO,BDKCB38U_FA11(R5HZ7>U[__Z$_RRU?%7<- 2
MV"<)'/0$?QE%P593L%?5UV,;]2EP=?J^UMH.[C<>?UD#_-!#H!_7E1U5PI&]
MX4.@>^Q0'V26L"_)]7=6S6UXY(?EZI;9HA*[>I/6IW?X:<8E2Q@J<D@+6[<K
MS6U>'**P8!D1J912":_8(M>)I\;^VZS1E1*J^F[%]Z-L9[C=R'@($,?PX+>+
MR>YU@'JY@FO6 :DW7?KB$Y,(G><>E>)\$7E)7M[W!VYY=\'=VRJXMA##<F&/
M(*]_5&NS\15<TI+!0I0Y1(52D J*8<)42?,\3R7S*CC3.=O4"&@O[!5H2C,?
MY 5_6HE]M\&=6#MNAF,A.##[>"/FOQ]V02+JKKASPG'WQBZZ'^V0G6Z*7]7J
M+5M_^S!?_O6L,NJU-J_PR\HNUPMI2R-EAEE03A'DS%I ),\AQV9)4$F$H E/
M>8[\//0QQ9N>3]_F)HAOMG<$J!9 'K+.]"[UU/Q^G_,3K\25]\(22B5F16K6
ME%.(*!6028FAD@D3A2:"2O,YL?$9TU[6@XC#+:I#S2RK(K ZGBQOS:RN1P6U
MZO.+J(7.O)\"MP_=:ZWMP-_%UUK6J"720O$?JV::MWR3*:(6BJQ/5;7@.?RC
MBIIMRL\TXW?59JYF9L,@J% I) J9#SIG$C)&"DB0TE@@K7"!7".+7@X^M?U#
M+90].$ZS7_BONZVXH^OY)'K=S-D7DX&9SQ<.K[BC<WKWB#TZ&G*T^*-SRK1C
MD,Y>$Y[W4/?-_% MJO4W)>O3];K0XE>U5JOO:CTCB40B4QH2;<!"MDHB4RF#
MF>;<&.F<*RY]\R$NS#FU5[K5*78G]#8L9%^F=">Y?TK )?A=3XVB@CKX45!O
M/(,R#!P1BIUY<&G:T3,2''$XE:G@>FL8'[UY6E<+96R5Y0-O3FZ,<;*\7U3_
MI>2--+,;(\5Z1Z_7:[597XM_/M5=RQ=R=\!3J;7YF]GRRJ85\/;*K_OSA/6,
M)DE)L$*PU!DQVU'.(=6DA*)(>"(XSKE?!<(QA)X:(^YT!BVEZ]9*C=J@K3?8
MJ@-VFF\3# ZZ@T;Y0Q_N[0WU@#L$_)AUE ?)C9JG]G@,S.T3>C*\OQ%C+E7,
MC\PH<H_ZE1IS)5Y^YD:=.SS3[U""Z9-Y'9OFZ10C7FHEH,H*!)&F*:2(%[ P
M)CNA:4$SX57QX-Q$4_L>U:?>!T&-'6DN#NQ+?Q9<-[Z/ =D8,0+^: 6E^G5!
M$3O)[^1<HZ?W=6E\*K&O\WH_?EBO-K/?C7'^\/30Q%HG)2X5)0R695TG30O(
M<"JAI(JEMFB1X(7;H=K1V-,[$6O$\PQ7/P9-Y)Q+A024N;8E#:SS@],<YB3A
MB-,R4;D3B_:"; S:C 58-S/V@F%@*G1&P)G\SFK;P7;FGA;3F9]>LMSQH*/0
MVEE==CQV_@+_YBRW3X^/VS!,-G_#YK:.\NTW99NLUF65ZY.)7<4AGB J"Z*A
M>2VYV<.3##)",UBJW+ :8T61E:X-6SSFG=K[VQ8=-+*#6GC0DMZ[Z)/O:G2_
M_@-B/# Y3 1>]U8Q \$\4OL8-[C_%J>33 !4'=UE?$8;K>-,@(KM+C0AMP>Z
M?5NC[ZH-[S:TF12(,PR31 J($GMH3(PYJW&9&9I'99%XI<.?GVIJW/[\!=C)
M&KBG[4#8T8L9!;>A?8^!D/D["B^B$=6]=WZV<9UR%[4^<J5=OB,P?OW;<K79
ME1#]-U7=?[.=.LPND]VKFX5Y/=5Z\Y5MU"Q+<UP@AB#/J3WL(1P2+$O(&-(Y
M3C/)%/4*97><>&IL4LM]J&1[!7:R@T9XL),>6/&O -N +\MJL;&QI7?5@V<>
MCO/ZN+'/$*@/;3L.!KA_R+PG>E&CYUWG'C>0WA.1HYAZW_O[=NQ[-N&V XM0
MF>$NR6'*<PP1*7/(I=D'ZR1)22H3+0NON)RNR2;'9HVL-E3DQ8L6UCFG$VE'
MCHJ$W]"\U .Z'KW<SF,R3(NU$_.]4N>S\YJ?;TC6<4]?)NEL"'.SV&<+G6YL
M=FBUB+3$$J,$*IYJB,HLA237".8*)SC1A>;:L^QO=!FG=T#AWAHJ1B?.6$OM
MRW^OL'R#'YA&7;<>/!H9VV'(-Y:0K\38D3$^3_.Q)YI8T.4L$RDO4YW %"D.
M4<[,YMM8JS#-<D%U7BJ-TTE$6D[-OATEB&XB$96O'48YH<_,ZR[[=,(E!W&B
M#B;L?X_ R+,NW,$G'*#S\4<C\HWY=JYG#-&$)T4)J98%1+A4D&9*04G+K"P5
MXIIYE55RFW9JWQ,G^]5*#VKQ8[8=/BR%&\_'!W@*>P,7;./V_#V":K1^O8>9
MI]-K]P@-KSZYQW?[<998/BTVJY^S/VYGA2Z(5+;X16+/H[20D-M"[UIF&F/%
MN99.35@.0TZ-:_Y85/:4H]Z\.-J8+7RZ22),ZX$)X(]/-W?OWX';N^N[][?]
MW^YC'3NRF9N+MV]N\\/+E[8UX"@OY+$"NY?MQ%\&"1.T.^,G-C\T*-1*F__/
M,<2%IA#Q%$&&&(6*$%$4@DE5.$9!!THP/5>D6[!5U("VHV7I?ME'@'KHLQ:W
M^,%?=BK\.E0HX1'R44,*^ZS _T=#"\]!UB_$\&C4*84:GE/9,^3P[#"#'(R=
M<<(NUY659=^1]'!6PDLLLH*6D*=Y84O7I9 EI8:4\R0KA5:LS*,>B_E*.,$O
M4>M$^O1FRH;$[+6TE^WU!#M%KT"K;^_ 1VC>#T64 [0A%WK$F(/15SCV85OH
M.HQXU.8MXI0.VD+Q]3QF"YXF8,>RFZ@N^)NP@F>**%O>/8<(80FYU!DL4(:R
M$I6%((5SZE)[Y*DY M;[]]FG:O(Q8 Z[A% 8!N:]6 AX6.NA2(QDASLCXF=P
MG]*ZRY1^=OUX1O(I,9^9OR<OB%^:N2[9=,=^?#'$N)1OZQK"^ZUABA5+"%>P
MS$@)#3U12"DOH.)$<JQSGDNG6HU]!9D:G5TLX;JK76;TN0);C<!6)>]M?>]%
M=+,XQUB:@2EVX%6)6C_7!=*Q:N5VRC*9NK@NB/G4P'4:+XQO]Q;CNVHMYLOU
MDWG*6]&R#.6%S6!,,Y)!E @*&<IL"7244"E$DB.G?'6GV:;&G']__^ZWFT^_
M@>NW=S?_N+F[>7\+KC^] Q^N;[Z"?UQ__.,]^/W]]>T?7]___O[3W?D3E #8
MW6@P&I@#<UUK_]N2U.R%A]@%.X$2DZVZ)QR5DIQT?\D[;C>%D8OA+5N^^\MJ
M^;V22K[Y^<=:R9O%YT>U,@;[XOY:F-WM-M)F9P%@4<BD3!'DJ4P@R@H*B4HX
MI,28<8CRLDB\8B_]19@:#=4%]A\;^0'_"7YY,BH O5S]"I8[-0#;Z^%'1 %+
MY,9.PP(_,&59XZO&_4L;=ZL!J!:_@KT2X*#%(&99.(@Q*2Y BE%Y+QREEV38
M8Z30AF:&9;\MY^:.];;1D6TD>*#B@TU ""<I%R44B=G5(I%C2%F"H%"$JB1-
MI:9>$8'.,T^-#V_O/K_]O_[^^>.[]U]O_P=X_W__<7/W[[Z=S5Q!=SP!&0+*
MH<\V6C+_CUW'."MVRT8;R$3SABMN6S37R4=ND>:)R7&[--\!0ELO'-+$;_]B
MCTTEO5(9LTUD*61%H<U&,<\A11K!K% L89G4*??:*)Z>9FI4](?YXW*UJ7,<
MZKC9Y:)]VE>WK/'NK7 27S<BZH_:P*SSK'8$L")&K&#HAD+<+@DG9QJY,4*7
MML>]$#JO#N.$WY??:_?_S<(^]]L*6_/Y\B\;![.^7LA=EX6OR_G\PW+U%UO)
M&6*B2!3)(*$DAP@+L^,K<@HU26F&15X0EOH%G 1(,;V@DKW$=G\'Y/*);_33
MW.SNZAA43RX)61<WHAD8ZZ%MG_=OP>Z8_0JD&4SH%=BI9$,Z]DJ!@U9UGMI.
M+_"GU0PTJD7DKA[ QB2V$#%&9;T>.+VDQ#Y#A?&E341;B&I>U9/9+C3?U>))
M?3!:WJK[.LSC;OEVN5@OYY4T1"VW]5QD@E*1\11R+ UE,J8@3YF&99:DN3*$
MRJA3#D8_,:9F@SW78MN$J=8#V*<&[#0!FR5HZQ)6;R=PY=Q(=?CU&)A7AUH*
M;Q;MAV1,(@V49%0N[8?62SKM.5H8HUY+6<>_L?D75LF;Q5OV6&W8_.WRX6&Y
MJ+?&,U&HA',;L*:P]9]A#FF:<2B)D @E6A6YU\'"Y2FGQI0'B<&C$1D:0T=L
MA?8C00>PW0@O+H0#DUL+/2NM-1,;>:_ 5F)0BQR/Q=SAB<E8#K..RD[N*+QD
M(H\[PUCGBX%=K59*UH-]K/[Y9!G-S+C]@S+ZU8Z@F4AQ*A-50J*3Q/8BQ9"0
MO( IXQ*GI"Q9EOAPC^O$4V.@O=S;5^4*M$0'!]FOMOXS/U9R7@PW;AH"XH$9
M*A*ZWCSE"U5,MG*>>U3.\D7D)7-YW^\?W/^Q$C;*;''/5BL;3E8;9LQ6.)DI
MHA'1FD!A:V AKLR.4V<(9C+E2HHRRY+<-=+__#13XZ:]I* MZA6HA76/@._
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MTQ*^SK0SXH.#_."Y H9%C J>7Q&_Q7&,)A@*\N%C W;(WFX,P[.57.^::5W
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M>-.<9<*8*H40&)8T*^RRU*Z,J" *"DE-):2R:Z:@(O9Q:HR-6]I6U+V%MG:
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M"J&46^V-2P/,C2DJ&8$5$E12!A09/HMC_Z<? YV1O_FQ@''/=QT*T$3IKOY
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MMOC*,*>J2NZ]6T*?$S,X:^L3FK7QR6;YS79K*U!7SNIG^]-'_?%Q;RM@[*J
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M^JS.<<]9/QUBXI/59_4[/4M]_K+ >CR7S_'<"..-/]ZQO9(W]YOM?O6?]18
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M&X/?:"#4U@9WP%Z)V_7F;O/-F\]ZY\*-P0;C.]%YUQ;8_:9-.P =22,>=G7
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M5:LR^-/H#%JE%X=3$3_M[G>K.*@TAX\/X*B[+3;>:&\NK?2W^TDM C9$V,$
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M6J;IKVGQ\<?ZP1^?+P@6E^HFTC>/6G_]A/_RE]7TXZ<97O[LPQ++O_PEKKY
M53'SDM7W_\_;O__C-3F?EKBB'VW8_Y5^</&8^M+C2<,O:YQG/&?_\HVS1;KU
MH5D5_F)Y^9NS$'&V^>F$N)C\3*];?WT65^ME2.N)EC9EE0R$$B,H%3,XR4QE
MMD3#4\JZ/"**^T\]E\?^]&6<GC]IBJMW(<YPXG5.A6$&[90&%70"QXE:%QB*
M@D$;5+?)JR)>D8PW6%IA^NO[Q><?Z<&$*>[K%U"_ ,8OD/0_[[WT-O4W]?EL
MF7Y8+#,NR99<OC4LTSW=WL;QQ2=^_!26]"!('Z:S?/G;U:@,HIOU8@@1GBN(
M"/[+#\1WP>42\Z_G^GF0O0UO:[*QN/GDH;H_6\'[$#Y-WI*HL2+_^2RL5J_*
MV_4B_?W9E^EJHC3S0KD$Q'X@*YD9Q. SF!QY25+SH-Q]+%Q"H815W!!]\:(?
M*X9_Q-EZ=?F3#:IO .-1BL8!RI$:7K00=P>XN4G_B\7',)U/E%$I,E4@T$("
ME3B'*(B#;&U,"K-/,;4 S'U2QD'*P#I>#"KP'B"S^/AQ,=\P\!M^C+B<9"FU
M25E DK2<E(T"?#0():J,P2JKHVB"F+N4C N88U5[%RE'R7E$H-0]^2W.IXOE
M[PN*!LZ0U&<O6'!!('-.@C>*D4#0@_.V@'"<\^(]#\SMX#@]\/B=]"\ZU_]0
MXAL9 <^T9K\]?_WV+2YIRWUVP4 1)E@*WX 7[<ET1D?[+6V_@5E)D@J"#.@.
M^M_Z\)VT+Y^ ]H\7W8BZOW*TOKZ<E\7RXV5(AR]I-UU-N(PV6Z,@)?I#B4 R
MT2Q#3%K(S+CS.@P5FFRE8!P;,8S[.:!L1T;(9:#^CCX[L8PIYXR $@RM$Z$-
MT1TYF%"XY%J&>-<H'(2)F^\<.0@90'^+ 839"0C^[[.PI"?.OK[!3XOE>F)8
M9#Y;#L%$VN6D5!!=*>3L>+*;F<)[S0?$PYW7CVP@VD#C&!%W@I+7M!LN\L_S
M_(+BLDGRHEB='/@B=8W!1!5(92!F9VTUH7E C-QZ^3B.1F.$'"[>3O#Q;AGF
MJVD5R@7&A9<4%[D F$M-!%*D%(H@EKA/!M'3"HA#;BMWWK\32M030\E10N["
M*_UE.L/?SS8>-??*&EL0K*BG2"*31RVU@Z!BE*JHX!,.YHM>OW<G8.@G HRC
MA-H%(-[@^VD].IBO?P\?<8(.A3,Q@]*$:N4P$>F6S!\Y4"5[EP(?PAG=]NZ=
M@&&>%#".$&X7X'@Y3XLE&;J-4#89X>>+L_EZ^?7Y(I.OG4W"Q!@(BM]J2!X@
M".+)<\5#DA3@RR&#V6^0LA-T[)."SG"B/QA)GW$9%X-AZ5WX\C)?G%MOF+JP
MF"2=Z&AA@)2A1FQ90\A&@TQ)Z9(X2EL&0]$#1.R$'_>D\#.$N+NP0<]R)GVL
M+OZJXN$3*31]E!MP6=5D(#$1"R(4:R1BR"X[/QAFMA"P$U[\D\++L6+N"2O/
MZ<M7RW>+/^>3B*@-UBQ0M9:*906TSQKPJ(3BAN6LV-!(N7[];GDV]A2!<J",
M>X+)9E=]M7R]7'R>SA-.3$P)E4*2!HF$XCH/Y*U9X)ZV6V&#"V&PNJ$':-@-
M,$\E,SN8M'M"S>O%:AUF_^_TT\818URB*I)DP8($I;2'8%F 7(3%H+A-:8AD
M[<,4[(:8IY*P'4C2(^.EVL9G2PSGKKI*Q2?% 9,TH+BJ)UW1@]&,A2PU3V:(
M-,O-=^Z&B:>2HCU8FB.CH-8SSUY_6,PO<T/:QL@,3R <5MI] 6>= 5LKMHGN
M',H0MN+N>W=#PU-)Q1XEU9$1\1;3V9($PD5\-UW/",W!.L6U@FQ3 &6U) =;
M:M )<TI2F2CT (BX^][=$/%4<K!'275D1+Q;AGJOY.W7CW$QFPC#HTRY@&?6
M@G+)0D3-:E%$E&3=> IR #C<>NEN6'@J:=?#Y=F):?CY2_H0YN]QDR]6T:/V
MQ#MC29/+0SM>\&3?>!#,J!"LMT-L&-O>O1LLGDI*]6CI=A& /#];5MF='SU6
ME)-"SE83(36:S ,(40^K.7/@6$3@1AE'TM$Y;[GB<& (LIV&W=#RM!*H TB[
M"]2\G-/30EI//^.+L X7;$T,RR%J3?MC%@Z4%(8"J\0@,"DP<N>T&B[MOIV&
MW5#SM-*H TB["]34(^WE\[#&]XOEUTEP%'<Y"KM=KE<^/*M74E%1Z.4"Q>0I
MQC*$G[KEU;N5HSVM#.KALNT"&F\_AMGLI[,526.UFGCRH01##EI%$D7!6G#)
M-* 3066/IO@A?-8MK]X-&D\K5WJX;+N QL\?<?F>]LJ_+1=_KC\\7WS\%.9?
M)UE%(J@:/TYQN4HY@L\%P12=I5'%.S.<]=A*PFY0>5I)TN-EW05DWG[ V>R2
M>D,1>HPHP$0>06D1P)>L0,8LHF"E>#T<4FZ^>3> /)6,Z9&2[0(7OTY7U>M^
M'9;_'F9G^!J7;S^0+"=2N"*Y(4OH:W>,>JO(^9 W@7WR27F'PT4[#Q"Q&UJ>
M2D9U.'EW 9P;%T<W'*Q>G:UKLY&:%YK((LBK8@8*.>+D;$D'(;L B9-\6$P<
M[1!%T8]3LAN$GDH*=F#)]X$C$N,RS%[.,W[YO_#KQ#(TLK;:(2YJX50HX$4@
MS:L<BG.9ISA<=<"=E^^&EJ>2I#U>OF.?[YY'];],5RG,_A\,RZM[(R(%HP."
M<XS"_(@,O+4"I!%<:.%9L4-L3@^]?S>8/)6D[2!2[N1VSC43O]!/5A,EN$4K
M%?ADL?8R4! <85]+<L:"5L6%(>]OW7G];CAY*NG:(63<%4S.[Z*=,V&#Y4EK
M!]QQ"4I61XP'"YI\,"DX9BN'O,5UCX#=H/)4<K3#R'EDL#PC#O*&BUEX/\'H
M!#/> 4&:"#?U)@#25QF=4T['[*X/;X\ R*V7[G8#]*DD90^7YV! ^.<?[TF2
M^/K[\?T*R;F:KS#3%ZO%;)IK>\JKQDZK17GU"<\OF*S^F(>S/%W?O=:Z8UO#
M UXS</?#8QD]LDGB91N4>FOG(UZ]^:HK'THK;9(!"M<6%*H,GOQ<,.BRQEB$
M#UO,^/$]HAZ@9[!^>^?-/'B416HG(&9+*R^F6(VG!\&--=+H)/,6&S1@D[T1
M6S .J?D'^^SM+^81]ZC5<GU-^=N$\T#;[*9S',_1!F,T6)5KWUI!#"3DP#UM
ML%YJEO*64MA[.*$7W, (?7<7'P]2T$E+O0/4N1A2MJ/>"-RP<$'Y'_/5)TQD
MRS%?-(TROMC"48 W+M:+C1Z""0(,LS5%Y(31NYB2W2#R$!7CP&0@W2Z&%G,'
M31>OQ'+M[04?,3$;JF+)KC**\YPUC,PL(T;06^/;[CE7I(S;=F\ HS*0E#O
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M7L^E[EZR9'")0B]4Z+037C<JR!^8C^YZ%A\3R(ZIX\$@?LJ3\)\";3<)WWY
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MKF8A6*T&*746'@HD-6IRLUNLA-.R.>ZQY,"+I&.$=+!='&<L9)3>U8$%GJ5
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M1L08(NQ@IWD=3FI[PR_'B%>[\[DI+=Y;S@)AV!90BARX&(4"F65B47"22YN
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ME0K:UYVP"I GH8P+*0V:(35:^-['&>,8RA\8PN^EB:Z0==O:KJXYBMG$R&6
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M;!-'%#QJ/2R*O/_LB8=Y-3(">TNO@S.$<P[\K6/26H91Q^GD5/L]BAR 0.O
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M.%0.D+@K(=N J4E!Q"Z")AY4-:)9&D/BG2+G8@VX.JJ=:0-2.%G[=.IZ)<9
M&F,Q&F[("7@N['1AB491^0 <[2'_B<M##TIE^7"5Y,R8X=$7#0SK)6QD]5"8
M%4@*4_3&&:'U@!!B'&JF'0LS@JF:2#%='))63C8S1VXQ]&K])BR7/V?S;_\=
M3L[P*-B2M8D*ZK134&PSWSTR$#%8)TSRF;49YSF$NND"P2E <[>MQ^CZZP*6
MMZ7V.(-12YN-Y)"M]]7)]1!8R9"=XJ((';$T.9)X(IW3Y;=U -66.NW 0=PI
MO>O3Y2-E"_,F"W)-I*L-=<E3B;7!>Q%*B!*]ONX6W ZF6VF;+L6M.V@>KKLN
M;.BC<GWU@%R/8M J.YG!)$-.M><!HI.>OE6&85*!M8'J051/ER#7 8B?3]\3
M!U'W4P-O%%$Q)YC3H%5=I+2!D*,C*E.>ZZ)9MMP-"(QVO^%E9*CO<^LPHF2[
MVXT?=S9LDB(J@<#H;U!:!?"NCNW1RH684BG:OQ0'LDFL,Q8T#G0*GZ*G#F#X
M%I?$26U5<"ZS"P$>,9E#%HF!(Z->L_HDN"03I(+",2^RYJ8%W';0,YU5:P2K
M,>0^=</>6<+YBH!/^ _S;QO+OZK#$'.QGJ(@4_M;:*O 2<TAU.D<.1@69!JP
MP6U]^'0AP,@H&$=\'9B/&VG!O\Y6"4]HV\?%V16<%9<\ZMK$U6M-[B(%RTY[
M7L=1%Z>4MR$WV;4>H6LZ-[R1.1E3#WW!ZI(#BF&-4LH"FGIN7L@Z>I(,A;BH
MG? %K6R2E7&?E.EJ3=J#9Q]I[X^719TB/@9>;I6JDH^VJ5:]KE#]#=>74KN4
M%WH*0;CB4#@3H'(NQ*")0"Z:*UHESEV3K.HG4_HR*CL/R2)KJ[PN3KHN6;SF
MZJ_+Q>IJM2$J%UV*0,:9@7(D0H>I7@QFDR2WVL8FN^3#9$U[1]\8%3LP.(*"
M.M@^7YV<+/ZHZ_67Q?+MXBRNR]G)?0XOF>/<)&L=0DZ>UJ[$ M''!-$*QHVR
MEL<F'9*>1.6TZ4;/#,9FZGLZ-OTY-N?XK<[P>-[-^DC;9)0.#ESA')15-1@V
M&HH)0MC 3+0XZ28];6;)-"9R7+5UX#S^NOBQ\7+>S^L)WKGV+E?@ZOQ* I<_
M</5Y<7)"*_*/L,Q',2!3*3 *H%+-Z(H,8JF>CY;%YNR<]TUV[#UH?1D]&0YQ
M(%LKL L7\F'6+L1[)'+!$ED <YY+30(-WB+Y+37&E^2XN"86<Q!UTSJ4S5&R
M:*VPO7'X'9>S1?ZR#LMUHW#FS7$]PGP__Q77QXM\WIWV SG0[_[\CO,5?JYC
M>U?AY$@IS)SY#$P6<J2%,."#0M!,)LV\*/%N3[Y6D<Y BJ?U.Y\;L\^CV XB
MI(?%>3ZD,W]=O%FL-KU6SID]DJ&0DTU<"=J@R+%)!H)P#J3,CO/LA"U-4D[V
MHG9:W[0O:SN&0KM'[5O,9ZE^NCJ*2A@?. .2F:D%!^2!U\8LB$[:$C"RNQ6\
MSP'4:P*G\4G[Q.:>:NLBE!_FX]@0HU%.@D1+JRQD#5%R#T*X6!RCH+,T2<X?
MSREM-D.E+RCNH[ #G=)W\W&0>-44\C>\/NY()"5?,M8RFP@*D63&I820F(K:
M$2FY2=+]-F)>1H>Z0\+P@U7019Q]Q<4OL_EL=8SYKXM%7A%+'\OE,CF*7M1Q
M0@)0Q1JTN0U3&;SQSLDL4K!-3LP'T#9MC'TX!'9A:B1M=.#$7;'TM\7R[^_G
MGY8+,L)W6*+]GFG-!*1H2FTGQ<$K@X",#+!PPMG4Y!AG &W3!L3M #:2-GH"
MV.?PQZ_DZBUGX>0.1Y(;7Y05()SGH(I2$'12$%%Z1KQQIMOB:R=ITT:M[> U
MCBYZ0A=Q<13(02R&/ 7K#3F*AD03B&3@R;$07!UZVZ2#_TTBIHTEVR'FJ?+M
MX"9M9X_BF\*Q6+(O(8"V,=7^[!Y<%IEB&!3.2"N$;=)5=0AQ+Z.C[R%.^N@J
MZL)I_Q#F^:B4Z(J/AN10#*@4/43K!#AGDO,A26F;=#FI+Y_6[1Y?J7?G#CY5
MOAUL5*_/2&:S^;=ZP/'^]/ORXJ1EM4GL.LK1T6KA"#IP8J9(#\%&"2DYZS-7
M6;HF9U(/4C6M;]T<1>-I9.+*ERO)_'*VG,_69TO<3,;YLWYUP8WP-NG((P29
M/:AZJ!N=X.0"D.46J!5+0\I@'G_3M YS,\PT$','-NG-8C,0=G/<OPDVOQ$G
M%ZQPFX(.B" 2J\.3L@(?I ..V?N<"CF-;5K8[*9I6M>ZN3T:2QL= &NGK,ZY
M*<S'F$A*N9A,'F.NDT&$)*$EZRUG6;(F'2D?)FO:JY?F\!I1)QT@[%5*9Z=G
M)_7J\"T2$6EVT:^:PI:-RN;YU>EBN9[]W^;?=S)_A"H'8U""X9:3R584O7">
M  M%,AFE-#(V2@$:A8%I8L1G0^TD>NX WP\)EM9J5*EH!<7*5"_F+<3:95^:
MRB3/4ICGM9]#S[V:3;>?SGH^51\3GHL-/-BI,QS.PLEU,2=3W/ H G E'"T=
M0PZM(^=#!^.,=X4;?&S$P9ZO?AD#A?;M'M-:%UV<A=VTVD=":.YJ75#AC(+J
M3"LP)A8 7<C.:&6M:Y((=I.(KN<@'*;O>TT]]A1]%\"Y409^W57NNL#<%\R<
M(T3%-P7F B*2+4?E+$:NC0U-ML 'J7H9XZ<..:\?3RD=^%A#NABFX))EO*Z_
MV@ G*/(9:!6"28ZY$KCB;:9OC-6!LMDA_XA(V*.YY%/4T@'2/I+O2)J9?_N
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M!B+SNB;[646A+XDJ-]S[[M+301I)(QB-H8 .</0U_(FK3^'GS1[^PA#?W@A
MBBG('2@.O. <G,D4@!A6E&H2,&ZAI8-$DD;X.53P'6!G(YXO9_.\_+G%_:LW
M7#HA@Q@5@N)10K",W$LO U/D")HV]S</4M5!QDDC/(VGC%Z0M>W\UK L&%?@
MZM&MXA;!!<^!XI-H="E)M&EUMX.>#E)66J+I0 5T&--MN8EWZ(-+7$.VK#:\
M2@Q"'7:9C.4J(H^JS6C9QTD;YH)/5:K2)+([4#]=W#1?.(;OYVEQBIM=_D:6
MABA>D40"V%P3U[VC**,X 1Q+BK'PY%F3>\&'B.HKU#L4 MO=],.UT<&N>._Z
M_ 8K+(IZ9R5 &VO)=21^:/$5\)ZAKI.^<VB2>?4 37W%?B/C:BQ== "K/6ZD
M;C%;2O$Y0>&>F#4D3O(LB=GDE)7*,BN;]#D[B.J^PLJ1H?E\^NQQY/O))4]'
M.B?OI4@@(@4^"FN&M:B=39/@T8KD9!R2*_'P6_H**$="TLC"[<#&W2[[VH;[
M'(.)6EG0&16H9!1XB0Z$1&&9,L6%-A.]'Z.LKR!S9%LUKEXZ -J=VX4CE$IF
M%RTDE6IO$(J.G',,8C:9G$\1/6\R8NP.'1V44K0#T2$R[P R.](R;JP!XX(M
M3))U%4C"T0F)%R_J.9XR)J?,V\SW?)2R#DHL&MJF4?72"]"V<R),SCX8 S8*
MLK(Z"G ZD.OGBE),8- -#^OWA];HS32>$UJ':V*T$];__,L]*7^@?]A\M/FD
M_M9G+/]6__[]\_M;SX^+U9JBBC2C7YV56?J/M#@]?\V-4Y?;)*]FI]]/'FL:
M=?.W_W)-RETB+QYR3_U[D(5_KG&>,?_[H576%\]_.UNED\6JMHJ]1 WYS#H:
M[RBR2O507D>(+ 9 ADEGK[GB3<+E!V@ZO*C\WJ-K'Z/7]#-_/W(E.2$RT5./
MB"F<S! C,2THGDPL%=EL.-%NHJ:>2C0..NX7G8^DAA%/T=O;E:_U_OQ ZW+Q
MC%8V9AN)SV%IBF$Y,P^^L%*O_\@+SLX 8R*5K-!(WZ1%5@-+L[F22L>8STYP
M4:Y>\#FL"3R)]D[:1L_[IU51'PGN3 P,P4I-JTBR"-X*#1*C25);*^[F_VYO
M6#CXC1T;E"> X%9OPC;2[L )_N^PG%6Z*SNO_IRMCE+65M:K2RF,)8<+-;A0
MD)!=#$^>8L;89$>^2\B$C0D;*?O>M,\#)-\9<MXN3L-L?L2CEM(( UA;9RN!
MHG9^35#;92N)B0+!)F'3?5*F-4&'J?8!G.PAYXDO)08M)O(I\/T:3U='Z$L1
M-5/4.(M !ID<,U4X.69:&Q>=5H:-M5==O76:F]EG,#6-%= -M-Z5@JFV(;O%
M8A7U^4W?V6S^[>)HG=S3C3RO8X$25%(L&HB:Z5H$;2$$$\ IRSQFY^^E]SX"
MN4.HF7J 9TO7Z=FT-!HNV\=K;W$=9B<'!FR7#VD5L6TE\AE"-D8A.CHKR-!E
M RK6;CZ8+%B'T=FJ<]GDG+_AX=#V-; =_UOL])5H)"<;[3V17@*9:5T33Q77
M((I5,L:2HVI2?3<2_?U&B$_!W+V&&Q,HMX- 8#C;1R(QQXJUH V7Y,08#8'E
M")H[+W0=2&*:!)?#29P6F9,@:&\4/TF='0#U]_F2Q/5M/OL_S,36:YQCF:U7
M1^1':!<I, O:U&J0K,GGU0:L1E^_2RXU&7JT@YYI?< >(#B&HOK%V]?CL/[;
MXNRDCMDD25T)_$*>1PJ%=876$GKT%(+1[A/J5T;GY%BJLW2:Y"[O1^ZTN:,=
MHW5,-7< YK>8EC4I[?U\![_O5Y_I\\6<XK:?GQ:KU:R>6@09BZXSTDOM=[&9
ML^)SRA HE-1:"6]MD]XC>U';;_!]B%?:7G$3GP-]/<8WKSZ_^_**!$5T2N&(
MV%2$ "6TH'6LB $ME"]9%9_NU/MO/<RY\<AI[=O8H#A$7AT8(1+$J_R_9Q?-
MY+_@>GU>EE>'5O\^/UN=A9-/R\6/V6KCGMJ<JUL0P!<5"<.,@8M*@N/:EI#1
MEKL9[Z,5[@^G<MJ,^59&IYVB.D#AE=#>_1E.+TI*KG*U/V,YF^=KYG\AF5_S
M_[?9^IA^D3R35V?KX\6RU@YX)] $RT%(6HA*B  NF 2YH,(L"XNM)D^,R<:T
M>?FM<#RAJGL_Q7ZS.#V=G:_O,,]7)57TD_L<9S_TM%'/M0>3/=(!]XWWO;KS
MOFVW+)$[2ZX79-J&01G!P4DAP:+D/HOD2VQ2'_$D*@^UGX->=GWUX[U.(I@"
M/)%[HM (B)%6LD3ZCY9-YJE)2_*GD3GMP6$[E-VUB V5UW^FY0/&XX&//BU.
M9N.;Q2$O?"[+^63F)S&NQC&1@F:0-5IR!$HF-S,+8,)$Q;$P79K</CRK<?V
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M(6HNEI1-=0:[<F!=;5X<R3@&9!*8\RYFDX)G3<+([>1,[/4>K.9'<+.'S#M
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M=YRO\*@(^?_+^[+FMHXDW??[7W*F]N7E1LB4ID<QML2PK)@[3XBLC<0,"6@
M4&WUK[]9 '>"T %P"N?0'1UM619U*I>OLC*K<I'2F0))%$/.0+3@!69"B9>:
MYV1]FX[2.V@:V<UC3U:N)QWL#R>_@=,LT_*W/WO<V*27C/Q.-GCZ/:>_58<U
M,>^M(?*]()=#%:R=SP*2W\$1?99DL;OTS_W9.B.[,#@.);T+=N"[R//%/-W$
MU?W IXC+O)POXA5.KY>+?%61N)I?Y^7EM\U/3F0*GL03(3+4=7"! W0&@4F'
M.0I$^]SOVHJ:O1<>F<-^/(S:BOZMX>H,9YAPDFRTQK$ Q49'6X>.;H<4"W'A
MN2V1,Q&Z-*T\</EAQR>- 6,'J&%@I)WE1:UUR(F86BXQKIOB3&<;1GXCSB;.
M<,\J,][P#$IX!+2TBW2V6AN+20KL@*F?+C3LE*0&Z.E7M&_-(GV=3>D__0?)
M,\VO)\7*D))+4+*C,SUS#BY23%&4-S(&Z;R(+0S3$RJ&'98T!OMTN%*&;N93
M1S%M91=G:</O<I,<<\_V;X^._J"R-44S\-Z8VS*]*!4PQ. ]3RIVRIL^CHI.
M\/-O"'XG5,K0.0=75_DBIU\6&>/EO)S?+.)ES<6X6.1U_/+N>GXS6TT4>9$I
MZMI^,)(]]^C 8W+ =6V7Q53VSSL3;\\^Z+1:MTM2]H;PU$#*8Z^._;*:Q_^Y
MG%^1LI;U(F[UXRGEG:IAMWRDU^K7GQ'94[7KRV4^S5>/2JVC8!3Y,[!*N=HR
M(H +(H! RUC,6(IMDL^^FZRC7XRW?GU;RXR4C=>U#64TM2B<:W(6 P8(4CM)
ML2W/O$N:9$_\CZ[528_H>?&\W$1';\\T'5ZO__JW&ANJEM7Y/T%<+*@<M[J"
MK78EEAG024]'8>*!"YV3:=*?J*V].JNQ[.>R7N1A!RSON;:"CE\E"SAFZ>QW
MDG: 8O4&EQG/HDM!M^E4M9NN4=NF?9#RHN]2C_H8P1/>W5B86XY^^;'F;Y/>
M0<N1M<X<=*[Y/+ZVIXK!01**1\L$SZ%)&?4.F@9N]-"G[I^?>3TI8@R8(HVL
MXX?'\MKD+.;BI8B.0LY8NY#Y0#%*,756=9 A2*\1VYCH5R@:V$SUI?,7_E,?
M"A@!DIYLN$W:(LI$4:B-M553 47>)9#)+A!T*$JKY#PVZ=+ZDI2AC[A>=+SK
M=-M?X$/?&FG-?CL[__(E+Z9DEF_34F/QF0(1#A0G*% ""W@M/#CEM++!A.BZ
MO !O_?B(SJ,#M#7O4W1C,!?SZ^M:_4GBN$M)-C+7_B7@B[:@I/. ED+1()+2
M,B5,NLGHLA>4#)O>UA-0^I'S"(!R?K?N8QZ$CTQ;9H"3!.C$#1)", X$)IF*
M"B6G)N[N-F*&357K&2Y'2WL$B'FM"B=1(,F#%.!Y;6^#/@'&&,$')90I$ANY
M(\=4NS4S,\W\V1Z$/TX,W>XN;81RHA#YFGA0S.OZ1B?)F@I)(2593WDJ%(W"
MM^U#WYU+WO81_OA0=&M..98HF$1PIF:.:YUK[Z3:]$)G:W+,431)MWY3)6][
M:;I3R=L^8A^XV</O.+O8;*/(DS%8#;!'VD;917!:)'+M$[?)ID32Z("53MT=
M[E<=UJ/I^V0Z7*!C0,%]O6;)@2PJ:,,BJ""([*(3\"QCS:&TQG1Y.NB.@Z'[
M.1RHL><Z/T!\ VO]M^FL=M^[)=S7B$R&",FD2CA!WPMEP7H;BPA9*=:;WI^L
M/+#F#]';O \A#JW]3>_%N\ K>.2<9Q#:4R0G)$7IP0EP0JF %-,9V64:6S?M
M/UYYF-BD-^T?+,01^(R/ _I?[]/&BG$N:1& %5/JY%."< BU/9J+: O/(C9)
M<-E*S;!E5ZTBU^,%/P+T/+V_^7*)]<US,TOM'SE-N$NRJ&P@%BY *:_(&^8,
M@G ^$ZN1XK+V]V;/R1K/S?R!>M]YB7:4$D8*J8_+Y0UQHK3E-C )/'%7QP0*
M")9,-2_<%^NSXFWN0EXG:3QW]^V@=(#P1P&C><PY+>O$Q\H!SB*9\+/Y['LM
M!2+C_935B4J%;#F=V*5F)BKM9>TD:\ P;QPOH@Y":X.MO>@<S^U_7X!KIZ91
M].1X2O_[Z?=IRK-4Q\N?YT6LRKO(D^"ULT6J^IB:0'&4@(:3Y^F-][H48=J,
M/>M"W+#>5VL3UX-"1F'L'O/TZ_1_;Z9IK:+-'V3:5!,GO7 J>R!_(!!+!@&Y
MU)!\+)(%3XY!DQ$Z'6@;MB"^-<2.5\?;0-BF3XT(*@9F"T@7*8AV5@$J(8 Q
MFTT*/,DV>7Q="1RV,'X0K.VOF!$ [E47X(^\N%[>N0AU./TDU'9<G#P!P>JL
M7%='-%H9(<HL?:3@AV+R-ID\74D<MIZ^?] U4LX(8+?=.UB2:[ .AFJ3KG.<
MIHE@6MCH$@CR1D')9"FH%@8$F6\619 !FUR0=:1OV/+Z4SEMQZEE#&C;3#HB
M6=VS-$F.>9M)^284LM.UX2 Y!@I89)X+8;42;0+1E[0,6R7? $5'BGL,B-F]
M$=[G>$6_I D/M98R9="^OD+X;-<)ER!25BXR+54X843Y@KZ!"^9/;J .TLL(
MX/; R!/^JKV=9$XQC*OSWG32H +/$"AJ!E=BU*QXD=K,^=U!4S=8O:&K_;[D
M/RHHX8_Z>'9VLZ@R?3=+G^:SN/G-1'%II# >A!:U#XGSX&M6<:E!"@8NF6KR
M8-2%N&[@>D.7_;UK9 0H>U1_\.(A3'LF(II4:4>RO4Z!TT&!3]HPI7W6LDF?
M[1TT=</4&[K/[TO^XX+2.2X^+]9E=6E]F7)WK$^T8C)H(T#'2*)B,0,FGL 6
MS8.A+<-MD\8"'6CK!JTW=''?MSY& +$U,YOWU?<WB^GL@AB9SM-FYWS*?U__
MT7(BO!4Z1061UPH;5L<_12LA!DS!9FTEMLG@[D1>-Z"]H>O[!EH9 ]8>/>:?
M+Z;Q8=.@YU8;;NA@1P[*8,T-H3A8))]E<$GYU,3I>I6B;HAZ0Y?T_<A^!"!Z
M[;G^WC)/N&$I%*M ,U'G%%CR%Q$C2#0^6(/.N$;/C#^AK!NHWM E?+^ZZ#%9
MHE$3K/_,TXM+.O'?T8IXD3=[ZO/-:KG"62(K_9233KVP?OK)7EMB[<= 3YVQ
M/N!B1M^^OXFZ[TC#-,MU1C9(41]F2O& 01F06F<50R@4YK78J*\1=*QI>O[=
MATYP0@F1I;/ O&:T#4H&MWZ'BN0:1I3>BR;5VZ]2-&P":B^(>&Z,^I'^V/OP
M_6P'K[/"#VG*U_'#)S5'VYAI;92L$9X P6K\AJ"B%>!"8/5X=,DR9Y)J<D73
MRB@]% \\D_:GFUHL0O[ 6NIK43]L&9V*L;X$T)I5*1A-YS838!1/A19)PK6I
M^3Z$VI$:LWV0]'K#M59:&X$K_\#D.[(,:7IULYI^SU]RI)!W-<W+#W_&JQO:
MZM6])*?RV\U&J9_+ZZ;>%Z>=Y!S0Q#HW-&<(04?P.B?.O,F6M^GAUCLKP^;U
M-P;U(/I^ZT?[X0UWNW[YI(=[RV:\K\+7,9%49!I*YA2/8I'@F$Q@0U9&(,K,
MFUPTM3_=C]U2ZVI"\KVCL])2?&Y3'4%C@:)W!E%8KK662?,V78I[96.D_L ^
MV&MG.O?6\P@<A2-Y_N7']@^LFRW88A,OEH+#; 0HD^I<<,N!9&*]K+.[;!./
MH2%/8^D;>WJHSL>)F]%NH4]X?==^2!3)I2D9?&2*^,D(07D/043Z&E/</)]6
MTW(?/! V+)A'@Z!.R#Y0G2. YR:GC$299\M-[<@5SF[;64AK@W>2@7!"@THA
M@0\>(2H9(DHA&K5)W4'3&$%YJ/*W/3WWH(D1@.H#A4;S'SFO6?K\K3)SRT@.
M%#BF8&K8*$E ==A8* @F<\'H>)'^>=?EGL* UR@:-MIO"JA^M##.YMVRYOI8
M!]ID5VL]9.VQ(T$G1.:T* &?/6#UW+R[65I>$T3T(\@1&)8CO8*'QW>>ZNM3
M+%!-)RA;.UIDKB&ZC"EQE@OOTN[JU,''KWOU13I!1]^W'FD<AH@1[(2=KQ./
M+OM^P>4T3G3!HC1&T#X@2;@(P(P%M(J,3H*<G&E26+87E6/T[5H#:7XJK8X5
MLN^KR'-ZP>&[]-\WRU4MV9LX[X/1-3,J&&*3%0:>8P(DT+G$<^!6G@R\/Z=W
MC![E&&#<LZ;'"NA:8+J=T0F*Y)0S%H1-!A0%;^"3(P<\Z2@Q*1=,D_S(/>D<
MHP,\!@#WI-G#@5OG?(_!C;X= )VUCU9[XE=P7_.7"P0K.!0>3)WOHAPV<2IZ
MH7[8UE:C /GI43 "F[VSP&-S=8S+G![?PTULB4($%\ Y27O:H0;'E07M>&:<
M1Y2R2;KL ;0.VTYK%+!NK>&Q9[-\R1?5F?H]?YLO5H?EQK_X1+_CH7<2V-=4
MZ&>+/"0#..E0&@XZK$OG31W$J@HHGKTB]].H1O/K7R'H:(/V[+O;YJ$S86(I
M0H,U-L Z%0(SEY"U*5J3;RW;E-9WH&W@)_,^4/+" /6LD?&7YSSG^.!<^%<^
MU-3\-,QU?Q5>PC"!QA?PUI/Z+1UM6%R$3 $P"HR!89MTKT9&Z/<<Y[,XO9K>
MGNR?OU'<5!<X7\S+=/7K?+DN5;M=?OG'_(QT,[^J[0IS>M@5"J.Q6 H4F6FO
M143P(C(Z^T7D29$SD)O<RO=#_DA-V3Y8>V[*!M#KV[-VAZ<'O_:EIO:N9?KO
MJR#D/FDZ/QEP4\C!%M9#,(S@Z+00N2B%^DUY77<W0IL/UQ/D;@], B,>L3[+
M:E%9K;$$;4!PS$EF PL8FI0<OD[22 W3/IAX;IAZDO\(+B2>F]C?\_<\N\D[
MS.KZS51PSKC, 5@0')3G"BAJ#>"C]SGE.NF]R[2^HX_*;N0._%S= H$GT-L(
MT+ENM%.9^>5F.9WEY?*.MW4B)3K!>#("K'/$3)0,,-5)WRBXRIK%Y-L4?>VB
M:EAK=PI8O+CPZDM'8P#<AO;;9*=4=!V[$ !58+1!$X+S"L%J@<EK]"GSAF[#
M&!*A>]3N]GN* T0]Z'25FLSV6T[+F\7%71);+I%B' Z^D"U7(0GP6AF@T(*G
M0O2]Z!RY-1OPR4='X3,=HIIY'U(:..GS]\L?J\MKG*5/^68QOZ7?\LPM,0L^
MESJ$2M0A5%D#*_0?K65)BI_%6Z]]>Q3NR9'*/EIF ^O\#!=I.O^.RWASA8M;
M^ET*@A@6D##5]%1G(63/03BIBRO"%QT[Z'S;MP>>/-V+SH^6V< Z_^7+_WL9
MP-U-T@WD!-4K]^1J&)=\ G2L7B%)[9%[3EQV4/V.)0:>+=H+ OJ2X,! ^*.F
MMKR[6O\0N<3S5WE"C#$:[B G2SPQX< Y<G]")"$%[T0*O ,JNJXW['-Z/Q!I
M(MN!\?+E6XY3O%K].+_$Q37&?+.:1KRZXR06GH.+$C(YQX3\1$(K'J%4W*.)
M(>LNKL+N58:=)M4/-GJ4X]#NPWQ!L":$?_BSIG5DBI5JULET=G&9TP7]@G$U
M_;[.1[EE+KBB8@D6N)((2FD-R(E#*]$8@R*;YU?2VWV+?1<>=B!43XY'4VD/
M'E[>;HLSVA07]QP(GU,QT8(TEF1EA0=7^TEP%TQ4B?9)P.Y&Y<FWAQW9U*LI
M.5QFX[E\NK\HOKV\N[_3FUW4]+1?[]/4!)V6FB4+1AM-LHH.4"@-UAHZ2%E-
M5V]Y/=65SF'#VR%N1!OJ<00P?21!DMOZ*>,_IZO+LYOE:GZ=%YM\R_K.L23+
MO*P"_7,B'.>&(P>VOBBL<8"/M!W)_&9=?!$A-!E:=P"MH[AZ:X.=%V](;14Y
MBBG81^60W#_59;3>*N9!RRKFF!4$SAQ(9:6,0AG-FO3%[(7Z4=POG@C1IU;V
MP'''/8,?9Y'V[,XX>Q)0!BL=4H1-W*C,:^,9BJQ2IEUM"('*F XNY#YKCNLU
M] 1PF)] -^/"W-<9/G!VR\_$%2D=M\1.R71,A))J37V&Y$-R+%BK-=L?:MN6
M&I=W.2C"CM;$_L#R&V#-\L4FY;*W3AO7];#XQZU4/Y)&9Q=UYG-U16BW,"<"
M$Z(.='8UL"-9.8X"O(F%22&+<DUJLG>3->R;SG!0;*"T8Y'8"PB?;:\JP4E4
M'(-$\D[6S4)\+0]W2M0F.$P95\?V-AF(M86681^0AH?;L>H902C]:3Z;/^7B
M]D9SDE16I?*06"T))/K!U]F%S%NNF:= RS9)L'R5HF'?HH9'6S^J&@'F'G;+
M7> _G=T04[<B);G]DLM\D3<_1S%_+:$E^9&*IS-<_%A':75,:[TRF%^M [@9
MD9>7JTG*4AI>-$B1R<0G5]_PK(*DM">_-BO[_'VT']0VY&G8=[;A<3\6N S8
MMV+]OK"1\+,S!Y=XGA>Q(N(BS\NGO/J"5WDY,9R<FD0F(1M)T9PBI\=S.I6T
MK\TS2?[,=,D>V6O181_VA@V$VFEG[.7VM[=I3\GM5/UU]S=[K?;:2DY/U5T_
MN:Y^&%42?1#U/':RM@0I%&S4MD[U_48[P7U!V:@VI1-]C9]?'LU(2<R**#VD
M.AM6*1O!.S*VV6)TBNQN+$.\N8RD8+4%FO9\8#E,56_$(AU<A/_T[[>P3@U+
M[KNBRGAM!8^"3K:"M?&M E]D!JDI?%#*<RZ:7".<R$:]GR[QXF)1[V(>/[H_
ML!\<0RX)X*$6 QBGP2NBUM9Q4B5H6=ID+OR$KK=AD?;!SG.+U*=B1A#+OL+.
ML_%XWMILA8R0,8C:'L^ "[&^7F,A.?K0J.M[)^J&Q5RO>.B&M2.4\T:.OL,[
M,CS[0(O#KV7_A:X6+%KAC2P9M*GS)!CI'+W54$P.2:A ?]AD0X[D]$O*28HQ
M,\6VPM12. ]HT$/AGO'D.,6G3=KO_"5.OWVPL^_IMX]B1G[Z3;(L!A4/( LK
M9+F9)\M-L!""RU)*%JS-?+-=1(W[K-M+^WN<=7NI8@2PVEWRS5WRAM5!AKZV
MJJ@N:% B <KB94 KA6,M<#7BI@O]*7^OU@K[:&(,L'J2YQ]]*%(K#HY'$DO-
M" BTSX#[8FC[L:Q2FZ:V;Z6UPE[:W=E:81]1C[@BUP0>4^8,"IEF4+Q$",$F
M$"Z;J*(KV7>IO3RV(O=$31?V4EK'BMQ])#@@$):+U>1\,4\W<?5Y\24OOD]C
M7F\)YD1,:".@9;K.GJ*C.G$+VDH=<B")E"[]&>G[C^P%_>ZYK7B-@&%3#7L_
M97J1\SAPLGPW2[<<+&\WD%76>&D*L%Q'BYF(X*25X+U3606=@NF2L;\/6%Y2
M,8Q%Z4>Q+U%RI)0'/EO^=C4/>/5AEN;+./_VH_[+?4W"U]ET==>S1-&.0:.
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M<9G?Y\VO]QPK'X,C]L"+%&_ODKP6P+*SZ(H27H@6>^1XTH>=83O(%CBQOD>
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MM7>O;_^@_B/@,O_?__/_ 5!+ P04    "  %-F51$E+:I"L)  #"40  &P
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MWGW1:[&<O2KYR(,198)\\,A'.I()FU9)P!0*1<R(FA<'G:,]Z FY4\28JB%
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MZ; 6D#D=S$Y18 ,EXI>(7R+^*EB$)>+O/^)?.$A=AV8\CY+O-MB2%>3?(D[
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M;.T5@/,1LT/ESZO0 6@V,W=7*8J&[PBRES[=VPWM>Q;/_@]02P,$%     @
M!39E45R9,6HO"0  AU$  !L   !E>&AI8FET,S$R+6-F;S,P,G$S,C R,"YH
M=&WM7%ESVS@2?M]?@9%K<E3IOFS+CJL2VZGQU$R2\7@VNT];$-F4L"8)#@!*
MUO[Z[08HZZ)M*?$A5>BJ,"+10#>:P-<' ![_=/;Y].K?7\[9T$0A^_+7A]\N
M3EFI4JM];9W6:F=79^R7J]]_8^UJO<&N%(^U,$+&/*S5SC^56&EH3-*KU<;C
M<77<JDHUJ%U=UJBI=BV44D/5-W[IY)B>X!6X?_*/XY\J%78FO32"V#!/ 3?@
MLU2+>,"^^J"O6:6249W*9*+$8&A8L]ZLLZ]278L1=^5&F!!.INT<U]S]<<TR
M.>Y+?W)R[(L1$_Z[DH!Z][#3Z3=:!^"U@PX<M!J\W>@$^]X![[0.V_]IH) U
M)'=UM)F$\*X4B;@R!.+?:S>K^YW$'(V%;X:]1KW^<\F2GAP',C;(3V%]]],U
ML]*8@1M3X:$8Q#W;I9*K.BWV9"A5;Z]N_XZHI!+P2(23WNLK$8%FGV#,+F7$
MX]=EC:^AHD&)P!%J\3] F5 \>SMV(N]C.Z&(8=J%1K/^\Y&5P@=/*D[OL9?&
M/BBB*IV<_^N7BP\75ZS5J#87^Y+?B_^FVHA@\N3]:.?THW3R:J_1K1]MDYQY
M^BZ=G)Y?7EU\O#A]?W7Q^=.?VR3OKN@U7\Z+,COCL8"0_5IE'Q3$,8_+S -%
M,C$SY.;57N?@&SJ2,Y?SJWD(.Z#6JA5Q-4 LZ4MC9-3K8@>S)T8FO4.\S6O6
M\'X(TQ;Z4N%$K:!V0YYHZ$U_'/E")R&?]$1L=60K'8U(#1X/LR:12P9<AXUJ
MM]LE[#(HKO&GS6>P5K6P5C/^:EFSVND>W%E:KS;N++NOU5:U6>\^>JN']>IA
M<[UF:U8/3A>H4YWP^%VI59I62+COHUWJ-9,;UEA\3]FHR='UT\T(VV)/&&3E
MW3]'K(%JW [(3 VW/>R6E@96-C2QCTS+4/AL+[!_1UFY<LVN%&^9@NY5QP4;
M\A$P!2,!8W0YS%!H]D?*%<ZW<,(N(9'*,!FSCU)%#@<;]<H?3 ;L@]0&"_[T
M!,Y.$0@/71.59$84@>;P:$'5V:B:=O 6N!*R^ODC+=-S",%]:JZ3DDN/\4+O
M8/3 Z\Z*";;6%/*!";:6-/>SVY*AM^'<;#[>W'S"5[DENKU7DQ^XQLF,LS.:
ML.M8CD/P!U!VLUNY.>U+9!=+C#:P-2YBQN,)2V.C4C*P&'_84 3G.6<1WBG!
M0Q9P#Q\I)B-AF)&.;H4@!@^TYFI")!&_!N0[UZ;&9SX*@RQ#&\<@#R+PA,*X
M!<EBK,ZL$\[&0^$-F4[I,JL_!@59(]2!2.@0 QR*E<;"#+&#.@'/"DCM)BB:
MI+&$;P>5TI_,J^$9<&IS?-C6D5^ V!I3KU6 V%.#&+! 8&CC$>+,8*&,"(;D
M6*SFRD4<H.=B?1+\[86ICVTB],QA0!EA2Y"WDR!R$.@1&(;A#-4R0-%+K!$X
M?9OY*1-%&B(!0IE$O+'LM)7'XWK(@E".]13G% R$-HHC(TX/G=PH97D.KO14
MF!5I"\0J$.MQ$:N]/F+]X(ATM3!]7^L,;;(,"SD@,L! "!_1E+Y@7($%#P0#
M08D+G.0,-.4CA!X2.9%%Z'R1 T;WOM!>*'6*]<@M4_@B+$VBI <^/M;L#8*&
M#XA"#AG.;[PACP? WJ/'<YF&H+,HK<4KC<X;>&OK-SJ^NW.W@M(IL8,P8L+(
M-YI#-H<T)-!FW((%;@%RHQXO@QY24-"YF(O:0B#;2BZ[!(?/H]D<X*#F\E'C
MA=*V&R(R?SN=%R^!<FY*SU^7EG%><@CO@IDX XT"(&+:P/5A3"]33.WQ5*]?
MA8+;/B T9YQ<N"Q3!,\4/<B1T-8O12J(;3N4_9]YM/->L8*06ZS/XN495)<S
MCYD*!7JW*(M]*79Q4J=]+7S!E: ."!?56S\]II9239&VM8_:AN76BY4:&&4+
MC:V4<'IA:<C)^<9N62%F$3O6</'_?-H"?_6!"-$_QOK@;[T_O)5<"C/R YB1
M_I:9D1U81ZW?M=Y;&+V-C-[:$<:*[5L_-EG;!*+9' F?+!O7,K9+R%RC5:1,
M,YD[KORIZ4%C*'A?A,),*%^3QY8,L;52U@ Y&[I .I>IM@'?3=:A)%4)&D!M
M\TN>AR_>"F!SU@.(0?$0[2"60$(&EDC2V#A;AX98)#;<*JQ=8>T*:Y<#0-X.
M6+O"BCR@QO,1#U,;7Q#$0A" 9\0(P5'GY,]?ZW4B)7>;GTRWY@(K8I2C7<J^
M+U-S-^]U8CE^2PVT'A$\O C)^M.5#FL!P>E@NHN"&!2(7R!^@?C+8.$7B+_[
MB'_F('45FFD_2K;:8$N6D'^#.(%27]+S4D70.Y=G6F@ODMK@$]IJBJUH5 W[
MV^V#8V]6B .T&^BU+]%E8GJ(YG;C#.VIB=-;6=XZ289<WR;BR-^W=@9\&PC9
MWF=!RH2%XAK";!?-$GWY.Q126)6[N11KU=N]5MTIUJJ?:*W:[@/VIV!<GOFD
MY"+/@^/,/260VR#1L[*^@$+QU!=&*GV;5;$/L+$H$L8 Y#K]?<F5]:Q]@3+9
MZF\0/-''UN3#X_^TNC%%>?@[%2BRQ?4T]NS6G+?%XG/A51=>]4XL/A=>]3>H
M\7T8,LJ+T[D,VG1#>WCHH ;^T]FNHVPI> S\FE(<+B]MDQPVHV[W>4_W,FZ$
M]-FJK=O\E./,<A\K:KCU97.L0I:!1V)%YS+1'-D,B]9EIM,HX@I58;N1Q0JY
M^ST+/W=7</[[O.[M\/U_.#NQ"ZO+6QWP[80=B2<L4.B4EQ'5P480:!?LJ9O,
M@)1=5D/$(QF.@%(;,1]DAX=4%G1 E(1R E@Z'DH7:? %\X3FY#NS/-55D*_9
M@[^/=\YY]<3RLQU1/JSNU_>_Z8ARMUI?\]CO,S5[7UFSVF@_OK#M>K73;CZZ
ML(UJIWLWTPT.5#^->;'0M#RDW-A]J4PO(L9JW+WM)OE%5?8)X2[J(^)URO9S
M+^MK[GE2@R^JG"6#_PWGD#(17\34;]U8>[77WC_2]KKZ&9&\$.I)CWW]"".T
MF+3;=7@PZ_R.:;28JR\R5PN5;?5<WD$#?'X#7DH[SM@_A0?LBP(M?,A.3)X.
M!03LXVW@^]DMWFT0]2Y]M2^1[K.%/7?^9P0KW_&;O3W[VNJS*KR/6D[-W54V
M^"38PM5]HM!^+/'D_U!+ P04    "  %-F51^ W6@2@&   X*P  &P   &5X
M:&EB:70S,C$M8V5O.3 V<3,R,#(P+FAT;>U:6W/:.!1^WU^ADFF:SH OW,*M
MS!#B3)A)0QJ<;?NT(RP9M#665Q(A[*_?(]DT@80V39.69&$8#_:1SDWG\EFH
M]>JPW_4_GWEHK"81.KLX..EU4:Y@VQ]+7=L^] _1L?_^!)4MQT6^P+%DBO$8
M1[;MG>90;JQ4TK#MV6QFS4H6%R/;/[<UJ[(=<2ZI113)M5OZ"5PI)NT_6J\*
M!73(@^F$Q@H%@F)%"9I*%H_01T+E%U0H9*.Z/)D+-AHK5'2*#OK(Q1=VB5.Z
M8BJB[06?EIW>MVPCI#7D9-YN$7:)&'F78[CJU.J58(B'U6(95_>'-'"&)*A0
MIT+"4D#_<D%)&X:G<Z2:1_1=;L+BPIAJ^8URT=JO)*HY8T2-&Z[CO,Z9H>U6
MR&,%\@3,3W^F;&XQ4_1*%7#$1G'#F)1+IR[( 8^X:.PXYM/4E$*()RR:-][X
M;$(E.J4S=,XG.'Z3E[ ,!4D%"].!DOU+02=0S]S.4I7W@4_$8KHPP2TZKYM&
M"T(#+K!>Q\8T)E3H4;FV]^FX=]#S4:EHN<NVW&W%WU.I6#A_<CO*=]B1:^_N
MN%6GN=7S<>(BU^YZYW[OJ-?M^+W^*>H?H>YQSSM"WB>O>^'W_O3@$5"]<R@1
MYX.+SJF/_#YR:^C"&EA=:_/M&WA=8YE;JCBH,T"=P_Z9[QTNF;,84W>JV@/^
ML?<,[.J<'W1.O4&A_^G$^XPZ75^K7G2<XH_K?D<9V\24ZL4HX'%, UW!T(RI
M,5)CBCY,L5!0S.;HG"9<* 3$(RXF:0:Z3N$#XB$ZX%(!81 PZ!HL9 $T&9%D
MY1#M:4:[.[5BT6EV^23!\=S<N<VW*.3"R$E :TX0A<I)T( FBDZ&5*122DX^
M;558HI!%,."K>@,:3 4T3_ #C@GRKH(QCD<4Q$\F3$HM';YZ)(&&B,944%#W
MID*I60M]\F:LJ=\2U@1$=<>,AL 8!"EV25$_!/.HT%;KH9D]AO-PCH"B[:<R
MCY*ID%,,"ZGX=4IKA;5/,O=!VN2U59CP1/?KFW.61NKDR20.L!CBF,I"_RJB
M<]0)E*;HV-3*8X6&6 (K,'O,)/H2\QEX;$1W=RJU!U3,;T?O!(L1M/,A5XI/
M&E4(M.R)XDFC#K<W^ 80&E0 6X6'$5UP&'(!OBY E$<XD;2Q^-$D3"81GC=8
M;&+53&I>:O<&.,I8@I0,.]3+5JU6TO!!@;J*+-AGR,(RR,)6Y#:M:KEE=RW5
ML=;3OL6U9#G5]=2'<JWM6^5Z_5YL;>.'U!?@4PE!^BY7RJVX/:(AY'\"Q89'
MC*"=T'R:"28$@&.CF%PA=WD5L^A878DT GY]Z7+N0 .9:WZ!U1!_3V>RX=A@
M"D0%]W#"GOLV]</-ZT_[)*.*5-!S#Q1=/K,V%DXCZ&D!5.](-X^O#470?Z9,
M4/WV(W5=7:G7>SCS,K0MM[)'%G?A:C?ZVHFR^NS62V4HP?6F[E-+RW*_3,U*
M[-H5^O;ZZ7*\?O4<O7:Y^T3)4VKQ3-.N^%-I]W,.79>6C^SOWYZS+ :8.$G!
M)(!4A9E&9BP%=HN$QDRCU$10J7,WK\DXBA!, \$X@LR6"22S3"%>R&(<!_HY
M,"1F^\4@2!@UC=+4YX!)C4SY78AKW<YHVR"6%_BBX&M8F>'<(%T3.=:>CCE@
M3P#:%*HG 7A=*C<-6C>_#-#70!D@;L(ES<-PD4UD-^<!\AWJ%0\R[\(CP-6"
MA@"PXT!38(1F!+SUYI;!ZJO5][KHEA"_1;VK-H.$$18DHM*LMA8PHC$$0'1#
M%VUK!#.G>*0507(:C#,]UK^L+V/D^F_$R/M6J5I["$8N6^5*Y='1;-FUJO7B
MH[.M.%:E4GIZD/R2BNSCHL7_I4NVG?P!'MTF8.:;@_GR_LQJN%4?YWWM);EL
M=Z>\WY3FBMXSZ.@T0D<6>H_'/*;S;9C]\CJ?:?_,7/*=T'F"39,7'E#;9-N"
MJG4N.8/7:T;T"07]KKWFKY5M_FWS;YM_S\ EVP3;^*WR3?/=)KE,L]LH?YWR
M2W/J 572\P[;S8>GS^,?WZ;?D+-N]_G/8.689<+3<Z8-02.L$=>M@Y?7867B
MR;F>@H>P_%.U?LI=N]AK-%RZIF=*S>G6]G]02P,$%     @ !39E46\*NB<B
M!@  N"H  !L   !E>&AI8FET,S(R+6-F;SDP-G$S,C R,"YH=&WM6NM3(CD0
M_WY_12_6NFZ5S(/A#4L5(I9<>> *>[O[Z2K,9"#G,)E+@LC]]=?)#+[Q+%?W
MU(.R*&8ZZ7=W?HEIOML?=$;?C[LP5;,(CK_L'?4ZD,O;]E>O8]O[HWTX'/UV
M!$7+<6$D2"R98CPFD6UW^SG(395*ZK:]6"RLA6=Q,;%')[9F5;0CSB6U A7D
M6DW]!K\I"5J_--_E\[#/_?F,Q@I\08FB <PEBR?P-:#R%/+Y;%2')TO!)E,%
M!:?@P%<N3MD92>F*J8BV5GR:=OK<M(V0YI@'RU8S8&? @D\Y5BS5:J%7=@N4
M>,70J]1<4BJYU7+)J?A!N5SYPT4E;1R>SI%J&=%/N1F+\U.JY=>+!:M22E1C
MP0(UK;N.\SYGAK::(8\5RA,X/_V9LKG%3-%SE2<1F\1U8U(NG;HB^SSBHK[E
MF$]#4_(AF;%H6?\P8C,JH4\7<,)G)/ZP*S$,>4D%"].!DOU-42=4SSPN4I4K
MR"=B,5V9X!:<]PVC14!]+HB.8WT>!U3H4;E6]]MA;Z\W J]@%:[;<K<5?\ZE
M8N'RV>THWF%'KK6]Y9:=QD;/I\F+7*O3/1GU#GJ=]J@WZ,/@ #J'O>X!'/3Z
M[7ZGUS["5TCMGF"+.!E^:?=',!J 6X4OUM#J6"_?OF&W8RQSO9(#[2&T]P?'
MH^[^-7-68VI.67M@=-A]!7:U3_;:_>XP/_AVU/T.[<Y(JUYPG$?4\!UM["66
M5"\&G\<Q]74'@P534U!3"I_G1"AL9DLXH0D7"I!XP,4LK4#7R7\&'L(>EPH)
M0Y_AJL%"YN,B(Y*L'<*.9K2]52T4G$:'SQ(2+\V3V_@((1=&3H):\P H=LX
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M\?$R)"86SN44,D;7S=7Z*7<=!Z\Y9;[VG=[I-+=+6_\ 4$L! A0#%     @
M!39E44!<**K9;0, O*LI !               ( !     &)S>"TR,#(P,#DS
M,"YH=&U02P$"% ,4    "  %-F51[U[4YL\5   F[P  $
M@ $';@, 8G-X+3(P,C P.3,P+GAS9%!+ 0(4 Q0    (  4V95$1S^:<920
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M2P$"% ,4    "  %-F517)DQ:B\)  "'40  &P              @ $%108
M97AH:6)I=#,Q,BUC9F\S,#)Q,S(P,C N:'1M4$L! A0#%     @ !39E4?@-
MUH$H!@  ."L  !L              ( !;4X& &5X:&EB:70S,C$M8V5O.3 V
M<3,R,#(P+FAT;5!+ 0(4 Q0    (  4V95%O"KHG(@8  +@J   ;
M      "  <Y4!@!E>&AI8FET,S(R+6-F;SDP-G$S,C R,"YH=&U02P4&
/  H "@"H @  *5L&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
